Drug	Variant/Haplotypes	Gene_Symbol	Allele	Phenotype_outcome	Effect_direction	Effect_type	Previous_Condition_Term	Metabolizer_status	ATC	Variant_Normalized
nicotine	rs1801272	CYP2A6	AA	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs1801272:AA
nicotine	rs1801272	CYP2A6	AT	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs1801272:AT
sacituzumab govitecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C1458155		No_ATC	*1/*28
sacituzumab govitecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C1458155		No_ATC	*28/*28
tacrolimus	rs2740574	CYP3A4	T	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs2740574:T
aripiprazole	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0033975	ultrarapid metabolizer	N05AX12	__UNKNOWN__
sulfamethoxazole / trimethoprim	rs1799930	NAT2	A	Toxicity	increased	Adverse_Event	Disease:C0032285		J01EE01	rs1799930:A
atorvastatin, fluvastatin, hmg coa reductase inhibitors, pitavastatin, pravastatin, rosuvastatin, simvastatin	HLA-DRB1*01:01, HLA-DRB1*04:06	HLA-DRB1	*04:06	Toxicity	increased	Adverse_Event	Healthy		C10AA|C10AA01|C10AA03|C10AA04|C10AA05|C10AA07|C10AA08	*04:06
ethanol	rs615470	CHRNA5	T	Toxicity, Other	decreased	Adverse_Event	Healthy		V03AB16	rs615470:T
liraglutide	rs2254336	GLP1R	AT	Toxicity	increased	Adverse_Event	Other:C0011849		A10BJ02	rs2254336:AT
liraglutide	rs2254336	GLP1R	TT	Toxicity	increased	Adverse_Event	Other:C0011849		A10BJ02	rs2254336:TT
peginterferon alfa-2a, ribavirin, simeprevir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB11	rs8099917:TT
drugs for treatment of tuberculosis	rs1041983	NAT2	T	Toxicity	increased	Adverse_Event	Other:C0041296		J04A	rs1041983:T
drugs for treatment of tuberculosis	rs1799931	NAT2	A	Toxicity	increased	Adverse_Event	Other:C0041296		J04A	rs1799931:A
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
gefitinib	rs2231142	ABCG2	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs2231142:GG
liraglutide	rs3765467	GLP1R	AA	Toxicity	increased	Adverse_Event	Other:C0011849		A10BJ02	rs3765467:AA
liraglutide	rs3765467	GLP1R	AG	Toxicity	increased	Adverse_Event	Other:C0011849		A10BJ02	rs3765467:AG
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
tamoxifen	CYP2D6*4	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4
atorvastatin, pravastatin, simvastatin	rs2276307	HTR3B	G	Toxicity	increased	Adverse_Event	Disease:C0020443		C10AA01|C10AA03|C10AA05	rs2276307:G
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	Adverse_Event	Disease:C0009324		L04AD02	*3/*3
nortriptyline	rs2500535	UST	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AA10	rs2500535:A
tacrolimus	rs1851426	CYP3A4	G	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs1851426:G
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004238		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004238		B01AA03	*3
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*17
osimertinib	rs1800796	IL6	CG	Efficacy	decreased	Adverse_Event	Other:C0007131		L01EB04	rs1800796:CG
osimertinib	rs1800796	IL6	GG	Efficacy	decreased	Adverse_Event	Other:C0007131		L01EB04	rs1800796:GG
flucloxacillin	HLA-DQB1*03:03	HLA-DQB1	*03:03	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*03:03
risperidone	rs6311	HTR2A	CT	Toxicity	increased	Adverse_Event	Other:C0036341		N05AX08	rs6311:CT
risperidone	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Other:C0036341		N05AX08	rs6311:TT
tamoxifen	CYP2D6*6	CYP2D6	*6/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*6/*6
tamoxifen	CYP2D6*5	CYP2D6	*5/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5/*5
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3
risperidone	rs6313	HTR2A	AA	Toxicity	increased	Adverse_Event	Other:C0036341		N05AX08	rs6313:AA
risperidone	rs6313	HTR2A	AG	Toxicity	increased	Adverse_Event	Other:C0036341		N05AX08	rs6313:AG
oxazepam	rs1902023	UGT2B15	AA	Metabolism/PK	decreased	LADME	Healthy		N05BA04	rs1902023:AA
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AG
oxazepam	rs1902023	UGT2B15	AA	Metabolism/PK	decreased	LADME	Healthy		N05BA04	rs1902023:AA
sulfamethoxazole / trimethoprim	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*08:01
efavirenz, isoniazid	poor metabolizer	CYP2B6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease	poor metabolizer	J04AC01|J05AG03	__UNKNOWN__
phenytoin	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3
phenytoin	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3
tacrolimus	rs4823613	PPARA	GG	Toxicity	decreased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs4823613:GG
mercaptopurine, methotrexate	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	*1/*3A
nitrous oxide	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0549433		N01AX13	rs1801133:AA
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*2/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*3/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*3/*3
risperidone	rs167771	DRD3	G	Toxicity	increased	Adverse_Event	Disease:C0005586|Disease:C0036341		N05AX08	rs167771:G
antipsychotics	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*1/*10
antipsychotics	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*10/*10
flucloxacillin	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*02:01
flucloxacillin	HLA-A*01:01	HLA-A	*01:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*01:01
amoxicillin	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*58:01
cisplatin, paclitaxel	rs5751901	GGT1	CC	Toxicity	decreased	Adverse_Event	Other:C1458155		L01CD01|L01XA01	rs5751901:CC
antithyroid preparations	HLA-B*27:05	HLA-B	*27:05	Toxicity	increased	Adverse_Event	Healthy		H03B	*27:05
flucloxacillin	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*07:01
busulfan	CYP2B6*1, CYP2B6*5, CYP2B6*9	CYP2B6	*1/*1	Efficacy	increased	Efficacy_Response	Disease:hemopoietic_stem_cell_transplant		L01AB01	*1/*1
busulfan	CYP2B6*1, CYP2B6*5, CYP2B6*9	CYP2B6	*1/*5	Efficacy	increased	Efficacy_Response	Disease:hemopoietic_stem_cell_transplant		L01AB01	*1/*5
busulfan	CYP2B6*1, CYP2B6*5, CYP2B6*9	CYP2B6	*1/*9	Efficacy	increased	Efficacy_Response	Disease:hemopoietic_stem_cell_transplant		L01AB01	*1/*9
tamoxifen	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C1458155	intermediate metabolizer and poor metabolizer	L02BA01	__UNKNOWN__
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	*3
capecitabine, fluorouracil	rs17822471	ABCC11	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs17822471:AA
capecitabine, fluorouracil	rs17822471	ABCC11	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs17822471:AG
sulfamethoxazole / trimethoprim	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*15:02
antipsychotics	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*1/*4
antipsychotics	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*5	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*1/*5
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	Indeterminado	LADME	Healthy		N06AB08	*1/*10
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*5	Metabolism/PK	Indeterminado	LADME	Healthy		N06AB08	*1/*5
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	Indeterminado	LADME	Healthy		N06AB08	*10/*10
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	Indeterminado	LADME	Healthy		N06AB08	*5/*10
dipeptidyl peptidase 4 (dpp-4) inhibitors	HLA-DQA1*05	HLA-DQA1	*05	Toxicity	increased	Adverse_Event	Other:C0011849		No_ATC	*05
peginterferon alfa-2a, peginterferon alfa-2b	rs9657182	IDO1	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		L03AB10|L03AB11	rs9657182:CC
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs3129763	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Other:C0011849		No_ATC	rs3129763:AA
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs3129763	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Other:C0011849		No_ATC	rs3129763:AG
dipeptidyl peptidase 4 (dpp-4) inhibitors	HLA-DQB1*03:01	HLA-DQB1	*03:01	Toxicity	increased	Adverse_Event	Other:C0011849		No_ATC	*03:01
nitrous oxide	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Other:C0549433		N01AX13	rs1801131:GG
ciprofloxacin, levofloxacin, moxifloxacin	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Healthy		J01MA12|S01AE07|S03AA07	*57:01
omeprazole	rs11188072	CYP2C19	TT	Dosage, Metabolism/PK	decreased	LADME	Other:C0024198		A02BC01	rs11188072:TT
methadone	rs3735451	CYP3A4	C	Toxicity	increased	Adverse_Event	Disease:C0028043		N07BC02	rs3735451:C
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2
carboplatin, paclitaxel	rs2032582	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01CD01|L01XA02	rs2032582:AA
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*1
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*1/*6
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6
sulfamethoxazole / trimethoprim	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*13:01
antipsychotics	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Toxicity	Indeterminado	Adverse_Event	Disease:C0036341		N05A	*10
antidepressants	CYP2D6*2, CYP2D6*2xN	CYP2D6	*2/*2xN	Efficacy	increased	Adverse_Event	Disease:C0011581	ultrarapid metabolizer	N06A	*2/*2xN
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*10
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
asparaginase	rs59569490	ATL2	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01XX02	rs59569490:T
azathioprine, mercaptopurine	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*02:01
aspirin, cilostazol, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	Efficacy_Response	Other:C0155626|diabetes_e.g.)		B01AC04|B01AC23	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2
escitalopram	rs4986893	CYP2C19	A	Dosage, Metabolism/PK	increased	LADME	Disease:C0004936		N06AB10	rs4986893:A
platinum compounds	rs1862513	RETN	GG	Toxicity	increased	Adverse_Event	Other:C0024121		L01XA	rs1862513:GG
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*1/*6
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*6/*6
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*4
nilotinib	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA03	*6/*6
nilotinib	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA03	*6/*28
primaquine	rs1137070	MAOA	CC	Efficacy	increased	Adverse_Event	Other:C0024530		P01BA03	rs1137070:CC
primaquine	rs1137070	MAOA	CT	Efficacy	increased	Adverse_Event	Other:C0024530		P01BA03	rs1137070:CT
omeprazole	rs12248560	CYP2C19	TT	Dosage, Metabolism/PK	decreased	LADME	Other:C0024198		A02BC01	rs12248560:TT
primaquine	normal metabolizer	CYP2D6	__UNKNOWN__	Efficacy	decreased	Adverse_Event	Other:C0024530	normal metabolizer	P01BA03	__UNKNOWN__
azathioprine, mercaptopurine	rs746071566	NUDT15	GGAGTC	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs746071566:GGAGTC
primaquine	CYP2D6*4	CYP2D6	*4	Efficacy	increased	Adverse_Event	Other:C0024530		P01BA03	*4
escitalopram	rs11188072	CYP2C19	TT	Dosage, Metabolism/PK	decreased	LADME	Disease:C0004936		N06AB10	rs11188072:TT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tenofovir	rs2125739	ABCC10	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF07	rs2125739:C
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:heart_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:heart_transplantation		L04AD02	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*5	CYP2C19	*5	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*5
efavirenz, isoniazid	poor metabolizer	CYP2B6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease|Other:C0032961	poor metabolizer	J04AC01|J05AG03	__UNKNOWN__
rosuvastatin	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Other:C0027051|Other:C0242339|Other:C0011849|Other:C0007222		C10AA07	rs2231142:GT
rosuvastatin	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0027051|Other:C0242339|Other:C0011849|Other:C0007222		C10AA07	rs2231142:TT
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Other:C0235031		L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Other:C0235031		L04AX01	*1/*3C
atorvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Other:C0007222|Other:C0011849|Other:C0027051|Other:C0242339		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Other:C0007222|Other:C0011849|Other:C0027051|Other:C0242339		C10AA05	rs4149056:CT
tacrolimus	rs2687116	CYP3A4	A	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs2687116:A
carboplatin, paclitaxel	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0007131		L01CD01|L01XA02	rs1128503:AG
carboplatin, paclitaxel	rs1128503	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01CD01|L01XA02	rs1128503:GG
carboplatin, paclitaxel	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0007131		L01CD01|L01XA02	rs1128503:AG
carboplatin, paclitaxel	rs1128503	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01CD01|L01XA02	rs1128503:GG
escitalopram	rs4244285	CYP2C19	A	Dosage, Metabolism/PK	increased	LADME	Disease:C0004936		N06AB10	rs4244285:A
none	rs11322783	IFNL4	TT/TT	Other	increased	Other	Disease:C0019372		A03DA02	rs11322783:TT/TT
mercaptopurine	rs72552763	SLC22A1	del	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs72552763:del
carboplatin, cisplatin	rs6856089	__INTRONIC__	AA	Toxicity	decreased	Adverse_Event	Other:C0007131		L01XA01|L01XA02	rs6856089:AA
carboplatin, cisplatin	rs6856089	__INTRONIC__	AG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01XA01|L01XA02	rs6856089:AG
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0023449		L01BB02	*1/*2
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Metabolism/PK	decreased	LADME	Disease:C0023449		L01BB02	*1/*3A
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Metabolism/PK	decreased	LADME	Disease:C0023449		L01BB02	*1/*3C
none	rs36232792	SOD1	GCCCAGTAAAGCATGGGGCCTGGGGCCAGGGACCCCCTTGTTCAGGTGTG/del	Other	decreased	Adverse_Event	Healthy		A03DA02	rs36232792:GCCCAGTAAAGCATGGGGCCTGGGGCCAGGGACCCCCTTGTTCAGGTGTG/del
none	rs36232792	SOD1	del/del	Other	decreased	Adverse_Event	Healthy		A03DA02	rs36232792:del/del
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3A
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*3A/*3A
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3C
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3C/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*3C/*3C
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*5	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*5/*5
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*5/*6
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*5/*7
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*14	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*14
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7/*7
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy, Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*2/*2
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy, Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*2/*3
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy, Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*3/*3
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3A
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*3A/*3A
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3C
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3C/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*3C/*3C
none	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Other	increased	Adverse_Event	Other:C0178298		A03DA02	*1/*3
none	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Other	increased	Adverse_Event	Other:C0178298		A03DA02	*3/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*1/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*1/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*17
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*3/*3
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*1/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*1/*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*17
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*3/*3
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3A	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3B	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AX01	*1/*3B
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3C	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AX01	*1/*3C
antineoplastic agents, tamoxifen	CYP2D6*10	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Side_Effect:C1458155		L01|L02BA01	*10/*10
cyclosporine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*3A
cyclosporine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3B	Toxicity	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*3B
cyclosporine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*3C
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT
cisplatin, pemetrexed	rs1801131	MTHFR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BA04|L01XA01	rs1801131:GG
cisplatin, pemetrexed	rs1801131	MTHFR	GT	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BA04|L01XA01	rs1801131:GT
escitalopram	rs12248560	CYP2C19	TT	Dosage, Metabolism/PK	decreased	LADME	Disease:C0004936		N06AB10	rs12248560:TT
phenytoin	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*13:01
sufentanil	rs1801253	ADRB1	GG	Efficacy	decreased	Adverse_Event	Other:C0549433		N01AH03	rs1801253:GG
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*5	Efficacy	decreased	Efficacy_Response	Side_Effect:C1458155		L01|L02BA01	*10/*5
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Side_Effect:C1458155		L01|L02BA01	*10/*10
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*41	Efficacy	decreased	Efficacy_Response	Side_Effect:C1458155		L01|L02BA01	*10/*41
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
tenofovir	rs9349256	ABCC10	G	Toxicity	increased	Adverse_Event	Healthy		J05AF07	rs9349256:G
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3
imatinib	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Other:C0023480		L01EA01	rs1045642:A
imatinib	rs3814055	NR1I2	TT	Toxicity	increased	Adverse_Event	Other:C0023480		L01EA01	rs3814055:TT
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3
selective serotonin reuptake inhibitors	rs6295	HTR1A	C	Efficacy	increased	Adverse_Event	Other:C0003469|Other:C0011581		N06AB	rs6295:C
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*1/*4
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*7	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*1/*7
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*1/*9
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*4/*4
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*7/*7	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*7/*7
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*9/*9
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11322783:TT/TT
methotrexate	rs1801394	MTRR	G	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801394:G
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC03	*4
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*7	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC03	*7
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*9	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC03	*9
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*10	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC03	*10
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3
clopidogrel, rosuvastatin	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Other	increased	Other	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04|C10AA07	*2
clopidogrel, rosuvastatin	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Other	increased	Other	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04|C10AA07	*3
methadone	rs4646437	CYP3A4	A	Toxicity	increased	Adverse_Event	Disease:C0028043		N07BC02	rs4646437:A
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*1/*4
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*7	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*1/*7
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*9	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*1/*9
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*4/*4
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*7/*7	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*7/*7
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*9/*9	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*9/*9
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*17/*17
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*3	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*3
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*4	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*4
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*5	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*5
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*6	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*6
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*7	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*7
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*14	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*14
azathioprine	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
lamotrigine	HLA-C*07:18	HLA-C	*07:18	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*07:18
lamotrigine	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*58:01
rivaroxaban	rs4148738	ABCB1	CC	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01	rs4148738:CC
lamotrigine	HLA-DQB1*06:09	HLA-DQB1	*06:09	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*06:09
rivaroxaban	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Other:C0004238		B01AF01	rs1045642:AA
tamoxifen	CYP2D6*10	CYP2D6	*10	Toxicity	increased	Adverse_Event	Other:C1458155		L02BA01	*10
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	*3/*3
methotrexate	rs2236225	MTHFD1	A	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs2236225:A
methadone	rs2242480	CYP3A4	T	Toxicity	increased	Adverse_Event	Disease:C0028043		N07BC02	rs2242480:T
carboplatin, cisplatin	rs2297136	CD274	AG	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs2297136:AG
carboplatin, cisplatin	rs2297136	CD274	GG	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs2297136:GG
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*17/*17
carboplatin, cisplatin	rs822336	CD274	CC	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs822336:CC
carboplatin, cisplatin	rs822336	CD274	CG	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs822336:CG
carboplatin, cisplatin	rs2282055	CD274	GT	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs2282055:GT
carboplatin, cisplatin	rs2282055	CD274	TT	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs2282055:TT
hydromorphone, morphine	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		N02AA01|N02AA03	rs1799971:AA
antipsychotics	CYP2D6*1, CYP2D6*2	CYP2D6	*2	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*2
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02
doxorubicin	rs1883112	NCF4	AA	Toxicity	decreased	Adverse_Event	Other:C1458155		L01DB01	rs1883112:AA
doxorubicin	rs1883112	NCF4	AG	Toxicity	decreased	Adverse_Event	Other:C1458155		L01DB01	rs1883112:AG
azathioprine	NUDT15*1, NUDT15*2, NUDT15*3	NUDT15	*1/*2	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer	L04AX01	*1/*2
azathioprine	NUDT15*1, NUDT15*2, NUDT15*3	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer	L04AX01	*1/*3
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*2
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*3C
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*8	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*8
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*9	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*9
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*12	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*12
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*24	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*24
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*2/*3A	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*2/*3A
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*3A/*3A	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*3A/*3A
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*3C/*3C	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*3C/*3C
doxorubicin	rs3787728	CBR1	CT	Efficacy	decreased	Adverse_Event	Other:C2239176		L01DB01	rs3787728:CT
doxorubicin	rs3787728	CBR1	TT	Efficacy	decreased	Adverse_Event	Other:C2239176		L01DB01	rs3787728:TT
infliximab	HLA-DRB1*04:04	HLA-DRB1	*04:04	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*04:04
doxorubicin	rs1005695	CBR1	CG	Efficacy	decreased	Adverse_Event	Other:C2239176		L01DB01	rs1005695:CG
doxorubicin	rs1005695	CBR1	GG	Efficacy	decreased	Adverse_Event	Other:C2239176		L01DB01	rs1005695:GG
atorvastatin	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*1/*5	Toxicity	increased	Adverse_Event	Healthy		C10AA05	*1/*5
atorvastatin	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*5/*5	Toxicity	increased	Adverse_Event	Healthy		C10AA05	*5/*5
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Other	increased	Other	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	*2
dabigatran	rs2244613	CES1	GG	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AE07	rs2244613:GG
dabigatran	rs2244613	CES1	GT	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AE07	rs2244613:GT
olanzapine, quetiapine, risperidone	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Toxicity	increased	Adverse_Event	Healthy		N05AH03|N05AH04|N05AX08	
rivaroxaban	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AF01	rs1045642:AA
rivaroxaban	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AF01	rs1045642:AG
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02
capecitabine, platinum	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C2931822		L01BC06|L01XA	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
capecitabine, platinum	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C2931822		L01BC06|L01XA	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
ondansetron	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Other	Disease:C0085762		A04AA01	
chop, rituximab	rs8133052	CBR3	AA	Toxicity	increased	Adverse_Event	Other:C0024299		L01FA01	rs8133052:AA
chop, rituximab	rs8133052	CBR3	AG	Toxicity	increased	Adverse_Event	Other:C0024299		L01FA01	rs8133052:AG
lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*15:02
chop, rituximab	rs8187710	ABCC2	AA	Toxicity	increased	Adverse_Event	Other:C0024299		L01FA01	rs8187710:AA
chop, rituximab	rs8187710	ABCC2	AG	Toxicity	increased	Adverse_Event	Other:C0024299		L01FA01	rs8187710:AG
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	decreased	Efficacy_Response	Other:C0026640		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
cyclophosphamide	CYP2B6*1, CYP2B6*5, CYP2B6*6	CYP2B6	*5/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01	*5/*6
methotrexate	rs1051266	SLC19A1	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0023449		L04AX03	rs1051266:T
selective serotonin reuptake inhibitors	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Toxicity	increased	Adverse_Event	Healthy		N06AB	
warfarin	CYP2C9*1, CYP2C9*11	CYP2C9	*1/*11	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*1/*11
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3C
gemcitabine, platinum compounds	rs1042927	RRM1	C	Efficacy	decreased	Efficacy_Response	Disease:C0025500		L01BC05|L01XA	rs1042927:C
methotrexate	rs1051266	SLC19A1	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CC
selective serotonin reuptake inhibitors	rs6311	HTR2A	CC	Toxicity	decreased	Adverse_Event	Other:C0011581		N06AB	rs6311:CC
selective serotonin reuptake inhibitors	rs6311	HTR2A	TT	Toxicity	decreased	Adverse_Event	Other:C0011581		N06AB	rs6311:TT
amoxicillin, clavulanate	HLA-B*15:18	HLA-B	*15:18	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*15:18
irinotecan	UGT1A1*1, UGT1A1*28, UGT1A1*37	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28
irinotecan	UGT1A1*1, UGT1A1*28, UGT1A1*37	UGT1A1	*28/*37	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*37
capecitabine, paclitaxel	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD01	rs11280056:TTAAAGTTA/TTAAAGTTA
azathioprine, mercaptopurine	rs11664064	PTPN2	C	Toxicity	increased	Adverse_Event	Other:C0021390|Other:C0409974|Other:C0004364		L01BB02|L04AX01	rs11664064:C
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*3/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*3/*4
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*4/*4
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*4/*5
bevacizumab, fluorouracil, irinotecan, leucovorin	rs1979277	SHMT1	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs1979277:A
methotrexate	rs2236225	MTHFD1	AA	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0029463|Other:C0024299|Other:C1261473		L04AX03	rs2236225:AA
tamoxifen	rs3892097	CYP2D6	CT	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs3892097:CT
tamoxifen	rs3892097	CYP2D6	TT	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs3892097:TT
methotrexate	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1045642:GG
methotrexate	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0029463|Other:C0024299|Other:C1261473		L04AX03	rs1695:AA
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0029463|Other:C0024299|Other:C1261473		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0029463|Other:C0024299|Other:C1261473		L04AX03	rs1801133:AG
mercaptopurine, methotrexate	rs1142345	TPMT	C	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1142345:C
methotrexate	rs11045879	SLCO1B1	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs11045879:T
amoxicillin, clavulanate	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*15:01
amoxicillin, clavulanate	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*02:01
amoxicillin, clavulanate	rs1363907	ERAP1, ERAP2	G	Toxicity	increased	Adverse_Event	Healthy		J01CA04	rs1363907:G
cyclophosphamide	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	
amoxicillin, clavulanate	rs2476601	PTPN22	A	Toxicity	increased	Adverse_Event	Healthy		J01CA04	rs2476601:A
cyclophosphamide	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	
capecitabine	rs3786362	TYMS	G	Toxicity	decreased	Adverse_Event	Other:C0023055		L01BC06	rs3786362:G
capecitabine	rs699517	TYMS	C	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs699517:C
capecitabine	rs11280056	ENOSF1, TYMS	TTAAAGTTA	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs11280056:TTAAAGTTA
capecitabine	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
capecitabine	rs2790	ENOSF1, TYMS	G	Toxicity	decreased	Adverse_Event	Other:C0023055		L01BC06	rs2790:G
none	rs2302254	NME1, NME1-NME2	TT	Efficacy	decreased	Adverse_Event	Other:C0023055		A03DA02	rs2302254:TT
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*1a/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*1a/*3
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*2/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*2/*3
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*3/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*3/*3
rivaroxaban	rs76292544	SUSD3	TT	Toxicity	increased	Adverse_Event	Other:C1861172		B01AF01	rs76292544:TT
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*1/*6
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*6/*6
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*1/*6
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*6/*6
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*1a/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*1a/*3
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*2/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*2/*3
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*3/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*3/*3
methotrexate	rs4149081	SLCO1B1	G	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs4149081:G
sulfamethoxazole / trimethoprim	HLA-A*02:07	HLA-A	*02:07	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*02:07
aspirin	rs11587213	FCER1G	AA	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs11587213:AA
lapatinib	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Disease:C1458155		L01EH01	*02:01
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*7
lapatinib	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Other:C1458155		L01EH01	*02:01
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:C
lapatinib	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Other:C1458155		L01EH01	*07:01
none	rs569108	MS4A2	AG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs569108:AG
none	rs569108	MS4A2	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs569108:GG
lapatinib	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C1458155		L01EH01	*07:01
paclitaxel	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01CD01	rs2032582:AA
ethambutol, isoniazid / pyrazinamide / rifampin	rs536560	FECH	CC	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs536560:CC
none	rs11587213	FCER1G	AG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs11587213:AG
none	rs11587213	FCER1G	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs11587213:GG
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*1/*3
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*2/*2
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*2/*3
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3/*3
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Adverse_Event	Healthy		B01AA07	*3
cisplatin, radiotherapy	rs1051740	EPHX1	CT	Toxicity	increased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01	rs1051740:CT
cisplatin, radiotherapy	rs1051740	EPHX1	TT	Toxicity	increased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01	rs1051740:TT
cisplatin, radiotherapy	rs13181	ERCC2	GG	Efficacy	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms|Other:C0024121|Other:Neoplasm_of_esophagus		L01XA01	rs13181:GG
cisplatin, radiotherapy	rs13181	ERCC2	GT	Efficacy	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms|Other:C0024121|Other:Neoplasm_of_esophagus		L01XA01	rs13181:GT
cisplatin, radiotherapy	rs1799793	ERCC2	CT	Efficacy	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms|Other:C0024121|Other:Neoplasm_of_esophagus		L01XA01	rs1799793:CT
cisplatin, radiotherapy	rs1799793	ERCC2	TT	Efficacy	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms|Other:C0024121|Other:Neoplasm_of_esophagus		L01XA01	rs1799793:TT
gemcitabine, platinum compounds	rs2072671	CDA	C	Toxicity	increased	Adverse_Event	Disease:C0025500		L01BC05|L01XA	rs2072671:C
none	CYP2A6*4	CYP2A6	*4/*4	Other	increased	Adverse_Event	Other:C0039338		A03DA02	*4/*4
anthracyclines and related substances	rs4646450	CYP3A5	AA	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0029463		L01DB	rs4646450:AA
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*6	NUDT15	*1/*2	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	*1/*2
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*6	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	*1/*3
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*6	NUDT15	*1/*6	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	*1/*6
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*6	NUDT15	*2/*2	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	*2/*2
anthracyclines and related substances	rs7853758	SLC28A3	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L01DB	rs7853758:AA
azathioprine	TPMT*1, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AX01	*1/*3C
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Adverse_Event	Disease:C0079487		A02BC01	*1/*1
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Adverse_Event	Disease:C0079487		A02BC01	*1/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Adverse_Event	Disease:C0079487		A02BC01	*1/*3
ethambutol, isoniazid / pyrazinamide / rifampin	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	__UNKNOWN__
phenprocoumon	rs9923231	VKORC1	TT	Dosage, Other	increased	Adverse_Event	Healthy		B01AA04	rs9923231:TT
methotrexate	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs11280056:TTAAAGTTA/TTAAAGTTA
carboplatin, gemcitabine	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01BC05|L01XA02	rs11280056:TTAAAGTTA/TTAAAGTTA
methotrexate	rs4149056	SLCO1B1	C	Other, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149056:C
asparaginase	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Other:C0023449		L01XX02	*07:01
enalapril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Adverse_Event	Disease:C0017658|IGA		C09AA02	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
succinylcholine, volatile anesthetics	rs193922752	RYR1	G	Toxicity	increased	Adverse_Event	Healthy		N01	rs193922752:G
egfr inhibitors	rs2227983	EGFR	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EB	rs2227983:GG
gemcitabine, platinum compounds	rs12806698	RRM1	A	Toxicity	decreased	Adverse_Event	Disease:C0025500		L01BC05|L01XA	rs12806698:A
gemcitabine, platinum compounds	rs11030918	RRM1	C	Toxicity	decreased	Adverse_Event	Disease:C0025500		L01BC05|L01XA	rs11030918:C
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
verapamil	rs1801252	ADRB1	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		C08DA01	rs1801252:AA
verapamil	rs1801252	ADRB1	AG	Efficacy	increased	Adverse_Event	Disease:C1956346		C08DA01	rs1801252:AG
heroin	rs12364283	DRD2	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs12364283:G
repaglinide	CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Healthy		A10BX02	*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*3/*3
azathioprine	TPMT*1, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AX01	*1/*3C
sulfamethoxazole / trimethoprim	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J01EE01	__UNKNOWN__
azathioprine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*3/*3
tacrolimus	rs2257401	CYP3A7	C	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs2257401:C
simvastatin	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA01	*3/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*3/*3
phenytoin	rs4986893	CYP2C19	A	Toxicity	increased	Adverse_Event	Healthy		N03AB02	rs4986893:A
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*5	CYP2D6	*3/*5	Dosage, Efficacy	increased	Adverse_Event	Healthy		N02AX02	*3/*5
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3/*3
tramadol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Dosage, Efficacy	increased	Adverse_Event	Healthy		N02AX02	*4/*4
tacrolimus	rs4646437	CYP3A4	G	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs4646437:G
isoniazid, rifampin	NAT2*4	NAT2	*4	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0041296		J04AC01	*4
asparaginase	rs4880	SOD2	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	rs4880:GG
none	rs762551	CYP1A2	AC	Other	increased	Adverse_Event	Other:C0426596		A03DA02	rs762551:AC
none	rs762551	CYP1A2	CC	Other	increased	Adverse_Event	Other:C0426596		A03DA02	rs762551:CC
antithyroid preparations	HLA-B*39:01	HLA-B	*39:01	Toxicity	increased	Adverse_Event	Other:C0242656		H03B	*39:01
trastuzumab	rs1136201	ERBB2	AG	Toxicity	increased	Adverse_Event	Disease:C1458155		No_ATC	rs1136201:AG
trastuzumab	rs1136201	ERBB2	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		No_ATC	rs1136201:GG
simvastatin	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA01	*3/*3
phenytoin	rs1799853	CYP2C9	T	Toxicity	increased	Adverse_Event	Healthy		N03AB02	rs1799853:T
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
beta blocking agents	rs61767072	ADRA2C	GGGGCGGGGCCG/GGGGCGGGGCCG	Efficacy	increased	Adverse_Event	Other:C0027051		S01ED	rs61767072:GGGGCGGGGCCG/GGGGCGGGGCCG
paclitaxel	rs7001034	FZD3	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD01	rs7001034:A
capecitabine, fluorouracil	rs11280056	TYMS	TTA/TTA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs11280056:TTA/TTA
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	Indeterminado	Adverse_Event	Healthy		M04AA01	*58:01
sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB06	
clozapine	HLA-DRB1*04:02	HLA-DRB1	*04:02	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	*04:02
direct acting antivirals	rs12979860	IFNL3, IFNL4	TT	Toxicity	increased	Adverse_Event	Other:C0019372		J05A	rs12979860:TT
gliclazide, glimepiride, glipizide, gliquidone, glyburide	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Other	increased	Adverse_Event	Disease:C0011849		A10BB07|A10BB08|A10BB09|A10BB12	*2
gliclazide, glimepiride, glipizide, gliquidone, glyburide	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Other	increased	Adverse_Event	Disease:C0011849		A10BB07|A10BB08|A10BB09|A10BB12	*3
tramadol	CYP2D6*1, CYP2D6*5	CYP2D6	*5/*5	Dosage, Efficacy	increased	Adverse_Event	Healthy		N02AX02	*5/*5
aspirin, beta blocking agents, clopidogrel, hmg coa reductase inhibitors	rs1799983	NOS3	T	Other	increased	Adverse_Event	Disease:C1956346		B01AC04|C10AA|S01ED	rs1799983:T
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CE02|L01XA01	rs4148323:AA
anthracyclines and related substances, tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01DB|L02BA01	*4/*4
aspirin, clopidogrel	rs1057910	CYP2C9	AC	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	rs1057910:AC
aspirin, clopidogrel	rs1057910	CYP2C9	CC	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	rs1057910:CC
tacrolimus	rs6956344	CYP3A4	C	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs6956344:C
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CE02|L01XA01	rs4148323:AA
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*1/*28
carbamazepine	HLA-B*15:21	HLA-B	*15:21	Toxicity	increased	Adverse_Event	Other:C0014544|Other:C0040435|Other:C0522067		N03AF01	*15:21
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28
paclitaxel	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Other:C0220650		L01CD01	rs1045642:AG
clopidogrel	CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*2
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3
clopidogrel	CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2
paclitaxel	rs776746	CYP3A5	C	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CD01	rs776746:C
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BA01	*4/*4
infliximab	HLA-DQB1*02:01	HLA-DQB1	*02:01	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*02:01
infliximab	HLA-DPB1*10:01	HLA-DPB1	*10:01	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*10:01
infliximab	HLA-DRB1*03:01	HLA-DRB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*03:01
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*4
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*5
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*10
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*10x2	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*10x2
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*10x2	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*10x2
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*14	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*14
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*21	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*21
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*36	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*36
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*41
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1xN/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1xN/*10
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*5/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5/*5
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*5/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5/*10
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*5/*21	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5/*21
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*5/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5/*41
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*10
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*21	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*21
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*36	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*36
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*41
none	HLA-DPB1*03:01	HLA-DPB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		A03DA02	*03:01
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*4
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*5
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*10
tramadol	CYP2D6*1, CYP2D6*6	CYP2D6	*6/*6	Dosage, Efficacy	increased	Adverse_Event	Healthy		N02AX02	*6/*6
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Dosage, Efficacy	increased	Adverse_Event	Healthy		N02AX02	*4/*5
clopidogrel	CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2/*2
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0235889|Gouty		M04AA01	*58:01
cyclophosphamide, cytarabine, daunorubicin, doxorubicin, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine	rs12283870	CPT1A, IGHMBP2	T	Toxicity	increased	Adverse_Event	Other:C0023449		L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03	rs12283870:T
folfirinox	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Other:C0030297		No_ATC	*28
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*5
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*14	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*14
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*21	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*21
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*36	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*36
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*41
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:lung_transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	rs2242480	CYP3A4	C	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs2242480:C
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10/*10
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*2
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3A
methazolamide	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*01:02
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Other	increased	Other	Disease:Kidney_Transplantation		L04AD02	*1/*1
flecainide	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*4	Metabolism/PK	increased	LADME	Healthy		C01BC04	*4
flecainide	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*5	Metabolism/PK	increased	LADME	Healthy		C01BC04	*5
flecainide	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*10	Metabolism/PK	increased	LADME	Healthy		C01BC04	*10
flecainide	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*21	Metabolism/PK	increased	LADME	Healthy		C01BC04	*21
flecainide	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*36	Metabolism/PK	increased	LADME	Healthy		C01BC04	*36
tranilast	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0151744		No_ATC	*28/*28
nortriptyline	CYP2D6*1, CYP2D6*3	CYP2D6	*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*3
flecainide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*5/*36	Metabolism/PK	decreased	LADME	Healthy		C01BC04	*5/*36
flecainide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		C01BC04	*10/*10
flecainide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*10/*36	Metabolism/PK	decreased	LADME	Healthy		C01BC04	*10/*36
flecainide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*21/*36	Metabolism/PK	decreased	LADME	Healthy		C01BC04	*21/*36
antithyroid preparations	HLA-DRB1*08:03	HLA-DRB1	*08:03	Toxicity	increased	Adverse_Event	Other:C0242656		H03B	*08:03
antithyroid preparations	HLA-DQA1*01:03	HLA-DQA1	*01:03	Toxicity	increased	Adverse_Event	Other:C0242656		H03B	*01:03
antithyroid preparations	HLA-DQB1*06:01	HLA-DQB1	*06:01	Toxicity	increased	Adverse_Event	Other:C0242656		H03B	*06:01
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*1/*3
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*20, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*4/*4
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*20, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*4/*41
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*20, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*1/*5
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*20, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*2/*5
capecitabine	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs67376798:AT
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA
cytarabine, idarubicin	rs2032582	ABCB1	CC	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs2032582:CC
clopidogrel	rs2069514	CYP1A2	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs2069514:A
opioids	rs548646	OPRM1	T	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs548646:T
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:heart_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:heart_transplantation		L04AD02	*1/*3
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*10
tacrolimus	rs2242480	CYP3A4	C/T	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	rs2242480:C/T
tacrolimus	rs2242480	CYP3A4	T/T	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	rs2242480:T/T
rhodamine 123	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:GG
aspirin, clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	rs4244285:AA
aspirin, clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	rs4244285:AG
mercaptopurine, thioguanine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	Indeterminado	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*3A
aspirin, clopidogrel, ticagrelor	rs2768759	PEAR1	AC	Toxicity	increased	Adverse_Event	Other:C0018839		B01AC04|B01AC24	rs2768759:AC
lamotrigine	HLA-A*68:01	HLA-A	*68:01	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*68:01
celecoxib	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		M01AH01	*1/*3
azathioprine, mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	*2	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*2
azathioprine, mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	*3	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*3
azathioprine, mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	*4	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*4
azathioprine, mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	*5	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*5
azathioprine, mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	*6	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*6
carbamazepine	HLA-A*01:01	HLA-A	*01:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*01:01
tetanus antitoxin	HLA-A*02:06	HLA-A	*02:06	Toxicity	increased	Adverse_Event	Healthy		J06AA02	*02:06
carbamazepine	HLA-A*11:01	HLA-A	*11:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*11:01
acetaminophen	HLA-A*24:02	HLA-A	*24:02	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	*24:02
carbamazepine	HLA-A*24:02	HLA-A	*24:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*24:02
infliximab	HLA-B*08:01	HLA-B	*08:01	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*08:01
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
vancomycin	HLA-A*32:01	HLA-A	*32:01	Toxicity	increased	Adverse_Event	Healthy		J01XA01	*32:01
phenytoin	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*38:02
nevirapine	HLA-B*14:02	HLA-B	*14:02	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*14:02
phenytoin	HLA-B*15:01	HLA-B	*15:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:01
antiepileptics	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Other:C0014544		N03A	*15:02
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
antiepileptics	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03A	*15:02
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11
phenytoin	HLA-B*15:13	HLA-B	*15:13	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:13
azathioprine, mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX01	*3A
azathioprine, mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3C	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX01	*3C
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*2
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*4	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*4
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*6
clindamycin	HLA-B*15:27	HLA-B	*15:27	Toxicity	increased	Adverse_Event	Healthy		J01FF01	*15:27
nevirapine	HLA-B*35:01	HLA-B	*35:01	Toxicity	increased	Adverse_Event	Healthy		J05AG01	*35:01
clozapine	HLA-B*38:01	HLA-B	*38:01	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02	*38:01
lamotrigine	HLA-B*38:01	HLA-B	*38:01	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*38:01
sulfamethoxazole / trimethoprim	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*38:02
infliximab	HLA-B*39:01	HLA-B	*39:01	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*39:01
carbamazepine	HLA-B*40:01	HLA-B	*40:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*40:01
oxcarbazepine	HLA-B*40:02	HLA-B	*40:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*40:02
mirtazapine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0235876		N06AX11	*3/*4
mirtazapine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Disease:C0235876		N06AX11	*4/*6
phenytoin	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*51:01
carbamazepine	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*51:01
nilotinib	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023473|BCR-ABL1_positive		L01EA03	*28/*28
clindamycin	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		J01FF01	*51:01
phenytoin	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*51:01
phenytoin	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*51:01
isoniazid	HLA-B*52:01	HLA-B	*52:01	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*52:01
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01
methazolamide	HLA-B*59:01	HLA-B	*59:01	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*59:01
methazolamide	HLA-B*59:01	HLA-B	*59:01	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*59:01
mirtazapine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4	Metabolism/PK	increased	LADME	Disease:C0004936		N06AX11	*4
mirtazapine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*5	Metabolism/PK	increased	LADME	Disease:C0004936		N06AX11	*5
opioids	rs609148	OPRM1	A	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs609148:A
atazanavir	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	*1/*28
methazolamide	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*01:02
cyclosporine	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*1
cyclosporine	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*18	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*18
sulfamethoxazole / trimethoprim	HLA-C*07:27	HLA-C	*07:27	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*07:27
nevirapine	HLA-C*08:02	HLA-C	*08:02	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*08:02
infliximab	HLA-C*12:03	HLA-C	*12:03	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*12:03
none	HLA-DPB1*03:01	HLA-DPB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		A03DA02	*03:01
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
phenytoin	HLA-C*15:02	HLA-C	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02
tacrolimus	rs890293	CYP2J2	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs890293:AA
tacrolimus	rs890293	CYP2J2	AC	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs890293:AC
carbamazepine	HLA-DQB1*03:03	HLA-DQB1	*03:03	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*03:03
abacavir	HLA-DQB1*03:03	HLA-DQB1	*03:03	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*03:03
nevirapine	HLA-DQB1*05:01	HLA-DQB1	*05:01	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*05:01
flupirtine	HLA-DQB1*05:02	HLA-DQB1	*05:02	Toxicity	increased	Adverse_Event	Healthy		N02BG07	*05:02
amoxicillin, clavulanate	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	increased	Adverse_Event	Disease:C0699744		J01CA04	*06:02
nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*01:01
nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Healthy		J05AG01	*01:01
nevirapine	HLA-DRB1*01:02	HLA-DRB1	*01:02	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*01:02
hydralazine	HLA-DRB1*04:01	HLA-DRB1	*04:01	Toxicity	increased	Adverse_Event	Other:C0020538		C02DB02	*04:01
oxcarbazepine	HLA-DRB1*04:03	HLA-DRB1	*04:03	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*04:03
abacavir	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*07:01
asparaginase	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	*07:01
lapatinib	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Healthy		L01EH01	*07:01
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4969170	__INTRONIC__	AA	Toxicity	decreased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs4969170:AA
pravastatin	rs2738466	LDLR	G	Efficacy	increased	Adverse_Event	Healthy		C10AA03	rs2738466:G
lamotrigine	HLA-DRB1*13:01	HLA-DRB1	*13:01	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*13:01
flupirtine	HLA-DRB1*16:01	HLA-DRB1	*16:01	Toxicity	increased	Adverse_Event	Healthy		N02BG07	*16:01
thalidomide	rs4630	GSTT1	AA	Toxicity	increased	Adverse_Event	Disease:Multiple_Myeloma		L04AX02	rs4630:AA
minocycline	HLA-B*35:02	HLA-B	*35:02	Toxicity	increased	Adverse_Event	Healthy		J01AA08	*35:02
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AB02	*1/*2
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AB02	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*3
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0740394		M04AA01	*58:01
rosiglitazone	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Toxicity	decreased	Adverse_Event	Disease:C0011849		A10BG02	*3
tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*3
calcineurin inhibitors, cyclosporine, tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD|L04AD01|L04AD02	*3
aspirin, cilostazol, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	Efficacy_Response	Other:C0155626|diabetes_e.g.)		B01AC04|B01AC23	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3
paclitaxel, platinum compounds	rs1799931	NAT2	AA	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01CD01|L01XA	rs1799931:AA
caffeine	low activity	CYP1A2	__UNKNOWN__	Other	increased	Other	Disease:C0032961	low activity	N06BC01	__UNKNOWN__
hmg coa reductase inhibitors	rs5443	GNB3	CT	Efficacy	decreased	Adverse_Event	Disease:C0020443		C10AA	rs5443:CT
hmg coa reductase inhibitors	rs5443	GNB3	TT	Efficacy	decreased	Adverse_Event	Disease:C0020443		C10AA	rs5443:TT
none	rs3846662	HMGCR	AA	Other	decreased	Other	Healthy		A03DA02	rs3846662:AA
atazanavir, ritonavir	UGT1A1*28	UGT1A1	*28	Metabolism/PK	Indeterminado	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	*28
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5	NUDT15	*2/*2	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	poor metabolizer	No_ATC	*2/*2
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5	NUDT15	*2/*3	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	poor metabolizer	No_ATC	*2/*3
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5	NUDT15	*3/*3	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	poor metabolizer	No_ATC	*3/*3
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5	NUDT15	*5/*5	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	poor metabolizer	No_ATC	*5/*5
methotrexate	SLCO1B1*15	SLCO1B1	*15	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX03	*15
caffeine	rs35320474	ADORA2A	T/del	Efficacy	increased	Adverse_Event	Other:Apnea_of_prematurity|Other:C0022876		N06BC01	rs35320474:T/del
caffeine	rs35320474	ADORA2A	TT	Efficacy	increased	Adverse_Event	Other:Apnea_of_prematurity|Other:C0022876		N06BC01	rs35320474:TT
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*3
none	rs70991108	DHFR	del/del	Other	increased	Other	Healthy		A03DA02	rs70991108:del/del
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02|L01XA01	rs4148323:AA
fluoxetine	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Efficacy	decreased	Adverse_Event	Other:C0003469|Other:C0235876|Other:C0011581		N06AB03	*1/*17
fluoxetine	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Efficacy	decreased	Adverse_Event	Other:C0003469|Other:C0235876|Other:C0011581		N06AB03	*17/*17
fluoxetine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	decreased	Adverse_Event	Other:C0003469|Other:C0235876|Other:C0011581		N06AB03	*1/*1
fluoxetine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	decreased	Adverse_Event	Other:C0003469|Other:C0235876|Other:C0011581		N06AB03	*1/*3
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*20	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*20
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*26	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*26
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*24	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*24
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*9	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*27	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*27
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*17	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*17
cocaine, ethanol, opioids	rs3823010	OPRM1	A	Toxicity	increased	Adverse_Event	Healthy		N01BC01|N02A|V03AB16	rs3823010:A
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11
capecitabine, fluorouracil, folfox, xelox	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055|Other:C0027651		L01BC02|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
capecitabine, fluorouracil, folfox, xelox	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055|Other:C0027651		L01BC02|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
cocaine, ethanol, opioids	rs495491	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		N01BC01|N02A|V03AB16	rs495491:G
interferon beta-1a, interferon beta-1b	rs9272105	HLA-DQA1	G	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs9272105:G
capecitabine, fluorouracil, folfox, xelox	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055|Other:C0027651		L01BC02|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
repaglinide	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*37/*37	Metabolism/PK	decreased	LADME	Healthy		A10BX02	*37/*37
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*04:01
egfr inhibitors	rs2227983	EGFR	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		L01EB	rs2227983:A
atazanavir, ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	*28/*28
atazanavir, ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	*1/*28
nevirapine	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*08:01
interferon beta-1a, interferon beta-1b	rs4961252	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs4961252:G
methotrexate	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
methotrexate	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
pegaspargase	HLA-DRB1*16:02	HLA-DRB1	*16:02	Toxicity	increased	Adverse_Event	Other:C0023449		L01XX24	*16:02
asparaginase, cytarabine, daunorubicin, etoposide, mercaptopurine, methotrexate, prednisone, vincristine	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Adverse_Event	Disease:C0023449		H02AB07|L01BB02|L01BC01|L01CA02|L01CB01|L01DB02|L01XX02|L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
methotrexate	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
gemcitabine	rs9937	RRM1	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01BC05	rs9937:G
none	rs1799752	ACE	del/del	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs1799752:del/del
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	PD	decreased	Adverse_Event	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	PD	decreased	Adverse_Event	Healthy		B01AA03	*3/*3
ethanol	rs1381376	OPRM1	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1381376:T
nevirapine	HLA-B*35:01	HLA-B	*35:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*35:01
pegaspargase	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Healthy		L01XX24	*02:01
pegaspargase	HLA-DQB1*02:02	HLA-DQB1	*02:02	Toxicity	increased	Adverse_Event	Healthy		L01XX24	*02:02
pegaspargase	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Healthy		L01XX24	*07:01
methotrexate	rs70991108	DHFR, MSH3	TGGCGCGTCCCGCCCAGGT/TGGCGCGTCCCGCCCAGGT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs70991108:TGGCGCGTCCCGCCCAGGT/TGGCGCGTCCCGCCCAGGT
methotrexate	rs11280056	ENOSF1, TYMS	TTA/TTA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs11280056:TTA/TTA
methotrexate	rs11280056	ENOSF1, TYMS	TTA/TTAAAGTTA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs11280056:TTA/TTAAAGTTA
none	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Other	decreased	Adverse_Event	Healthy		A03DA02	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
cyclosporine, tacrolimus	rs1128503	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD01|L04AD02	rs1128503:GG
none	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Other	decreased	Adverse_Event	Other:COVID-19		A03DA02	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
amitriptyline, clomipramine	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AA04|N06AA09	*2/*2
amitriptyline, clomipramine	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*1	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AA04|N06AA09	*2/*1
amitriptyline, clomipramine	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AA04|N06AA09	*2/*17
none	rs1799752	ACE	del	Other	increased	Adverse_Event	Healthy		A03DA02	rs1799752:del
aspirin, beta blocking agents, clopidogrel, hmg coa reductase inhibitors	rs1050450	__INTRONIC__	A	Other	increased	Adverse_Event	Disease:C1956346		B01AC04|C10AA|S01ED	rs1050450:A
none	rs1799752	ACE	del/del	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs1799752:del/del
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AB06	*2/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*1	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AB06	*2/*1
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AB06	*2/*17
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*2	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*2
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*3
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*5	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*5
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*6	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*6
clopidogrel	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__
leflunomide	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Toxicity	decreased	Adverse_Event	Other:C0003873		No_ATC	*1/*17
leflunomide	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Toxicity	decreased	Adverse_Event	Other:C0003873		No_ATC	*17/*17
anakinra, canakinumab, rilonacept, tocilizumab	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Other:C0003873|Other:Adult-onset_Still_disease		L04AC03|L04AC04|L04AC07|L04AC08	*15:01
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	GG	Efficacy	increased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs11322783:GG
nortriptyline	CYP2D6*1, CYP2D6*3	CYP2D6	*3	Metabolism/PK	increased	LADME	Healthy		N06AA10	*3
flucloxacillin	HLA-B*57:03	HLA-B	*57:03	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*57:03
cisplatin	TPMT*1, TPMT*3B, TPMT*3C	TPMT	*3B	Toxicity	increased	Adverse_Event	Other:C0027651		L01XA01	*3B
cisplatin	TPMT*1, TPMT*3B, TPMT*3C	TPMT	*3C	Toxicity	increased	Adverse_Event	Other:C0027651		L01XA01	*3C
prednisone, tacrolimus	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Other:heart_transplantation		H02AB07|L04AD02	rs1045642:GG
carbamazepine	HLA-A*11:01	HLA-A	*11:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*11:01
flucloxacillin	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*57:01
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
atazanavir	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE08	*1/*3
atazanavir	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE08	*1/*1
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*3A
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3B	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*3B
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*3C
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*2
antiinflammatory agents, non-steroids	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*3
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
egfr inhibitors	rs712829	EGFR	T	Toxicity	Indeterminado	Efficacy_Response	Healthy		L01EB	rs712829:T
antineoplastic agents	rs11280056	TYMS	TTA	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs11280056:TTA
carbamazepine	HLA-A*74:01	HLA-A	*74:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*74:01
carbamazepine	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*08:01
carbamazepine	HLA-A*24:07	HLA-A	*24:07	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*24:07
carbamazepine	HLA-A*24:02	HLA-A	*24:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*24:02
azathioprine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0035435		L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*1	Efficacy	increased	Efficacy_Response	Disease:C0035435		L04AX01	*1/*1
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
clopidogrel	CYP2C19*1, CYP2C19*4	CYP2C19	*4	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*4
atazanavir	UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	*28
atorvastatin, pravastatin	rs429358	APOE	CC	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03|C10AA05	rs429358:CC
atorvastatin, pravastatin	rs429358	APOE	CT	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03|C10AA05	rs429358:CT
clozapine	GSTM1 non-null, GSTM1 null	GSTM1	null/null	Toxicity	decreased	Adverse_Event	Healthy		N05AH02	
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*3
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*3/*3
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*17
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*3/*17
opioids	rs1799971	OPRM1	AA	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs1799971:AA
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
tamoxifen	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*5
tamoxifen	CYP2D6*4, CYP2D6*7	CYP2D6	*4/*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*7
tramadol	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Healthy	poor metabolizer	N02AX02	__UNKNOWN__
methotrexate	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs4149056:CC
methotrexate	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs4149056:CT
tamoxifen	CYP2D6*4, CYP2D6*6	CYP2D6	*4/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*6
carbamazepine	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*07:01
carbamazepine	HLA-DRB1*12:02	HLA-DRB1	*12:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*12:02
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*4
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*5
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10/*41
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*41
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*4
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*5
carbamazepine	HLA-DRB1*04:05	HLA-DRB1	*04:05	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*04:05
omeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Other	Disease:C0041582		A02BC01	*1/*2
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
carbamazepine	HLA-B*46:01	HLA-B	*46:01	Toxicity	increased	Adverse_Event	Other:C0014544		N03AF01	*46:01
nortriptyline	CYP2D6*1, CYP2D6*5	CYP2D6	*5	Metabolism/PK	increased	LADME	Healthy		N06AA10	*5
carbamazepine	HLA-DRB1*09:01	HLA-DRB1	*09:01	Toxicity	increased	Adverse_Event	Other:C0014544		N03AF01	*09:01
carbamazepine	HLA-DQA1*03:02	HLA-DQA1	*03:02	Toxicity	increased	Adverse_Event	Other:C0014544		N03AF01	*03:02
ticagrelor	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Efficacy	increased	Efficacy_Response	Healthy		B01AC24	*1/*22
efavirenz	HLA-DRB1*08:03	HLA-DRB1	*08:03	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AG03	*08:03
efavirenz	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AG03	*01:02
nevirapine	HLA-DRB1*04:05	HLA-DRB1	*04:05	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AG01	*04:05
tamoxifen	CYP2D6*4, CYP2D6*11	CYP2D6	*4/*11	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*11
cyclosporine	rs1128503	ABCB1	AA	Dosage, Metabolism/PK	increased	LADME	Disease:C0026896		L04AD01	rs1128503:AA
none	rs383510	TMPRSS2	CC	Other	increased	Adverse_Event	Healthy		A03DA02	rs383510:CC
lapatinib	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C1458155		L01EH01	*07:01
tamoxifen	CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*3/*4
fluvastatin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		C10AA04	*2
fluvastatin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		C10AA04	*3
nortriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Metabolism/PK	increased	LADME	Healthy		N06AA10	*4
tamoxifen	CYP2D6*3, CYP2D6*5	CYP2D6	*3/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*3/*5
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28, UGT1A1*36	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*28/*28
cyclosporine	rs2032582	ABCB1	AA	Dosage, Metabolism/PK	increased	LADME	Disease:C0026896		L04AD01	rs2032582:AA
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB06	*1/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB06	*1/*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB06	*2/*17
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB06	*2/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB06	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*3/*3
methadone	rs2246709	CYP3A4	G	Toxicity	increased	Adverse_Event	Disease:C0028043		N07BC02	rs2246709:G
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB08	*10/*10
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB08	*5/*10
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	*2/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*2/*4	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	*2/*4
pravastatin	rs20455	KIF6	AG	Efficacy	decreased	Adverse_Event	Healthy		C10AA03	rs20455:AG
pravastatin	rs20455	KIF6	GG	Efficacy	decreased	Adverse_Event	Healthy		C10AA03	rs20455:GG
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*4
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*5
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10/*41
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*41
methazolamide	HLA-B*55:02	HLA-B	*55:02	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*55:02
methazolamide	HLA-B*59:01	HLA-B	*59:01	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*59:01
acetaminophen, codeine, levomepromazine	CYP2D6*1	CYP2D6	*1/*1	Efficacy, Metabolism/PK	Indeterminado	LADME	Disease:C0004604		N02BE01|N05AA02|R05DA04	*1/*1
lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*15:02
methadone	rs2242480	CYP3A4	T	Other	increased	Adverse_Event	Disease:C0028043		N07BC02	rs2242480:T
docetaxel, thalidomide	rs12960	RPL13, SNORD68, SPG7	G	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs12960:G
docetaxel, thalidomide	rs1871450	CHST3	A	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs1871450:A
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*3/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*2/*3
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*2
peginterferon alfa-2b, ribavirin	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	
methadone	rs4646440	CYP3A4	A	Other	increased	Adverse_Event	Disease:C0028043		N07BC02	rs4646440:A
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0007222	normal metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0007222	normal metabolizer	B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0007222	normal metabolizer	B01AC04	*2/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Adverse_Event	Other:C0007222	normal metabolizer	B01AC04	*1/*17
carbamazepine	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*03:02
ethanol, opioids	rs511435	OPRM1	T	Toxicity	increased	Adverse_Event	Healthy		N02A|V03AB16	rs511435:T
docetaxel, thalidomide	rs1799931	NAT2	G	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs1799931:G
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*1/*17
docetaxel, thalidomide	rs4646487	CYP4B1	T	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs4646487:T
sulfamethoxazole / trimethoprim	HLA-B*07:02	HLA-B	*07:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*07:02
sulfamethoxazole / trimethoprim	HLA-C*07:02	HLA-C	*07:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*07:02
sulfamethoxazole / trimethoprim	GSTM1 null	GSTM1	null/null	Toxicity	increased	Adverse_Event	Disease:C0001175		J01EE01	
carbamazepine	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*58:01
carbamazepine	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*07:01
olanzapine	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*28
olanzapine	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*28/*28
folfirinox	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0030297	intermediate metabolizer and poor metabolizer	No_ATC	*1/*6
folfirinox	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0030297	intermediate metabolizer and poor metabolizer	No_ATC	*1/*28
folfirinox	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:C0030297	intermediate metabolizer and poor metabolizer	No_ATC	*6/*28
folfirinox	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0030297	intermediate metabolizer and poor metabolizer	No_ATC	*6/*6
folfirinox	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0030297	intermediate metabolizer and poor metabolizer	No_ATC	*28/*28
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
methotrexate	rs3045983	DHFR	GGGAGCTGG/del	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs3045983:GGGAGCTGG/del
methotrexate	rs3045983	DHFR	del/del	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs3045983:del/del
opioids	rs589046	OPRM1	CC	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs589046:CC
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*03:02
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*2
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*3
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	decreased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	decreased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3C
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*2
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*3
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*1/*2
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*2/*2
alprazolam	low activity	CYP3A4	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:C0085762|Other:C0003469	low activity	N05BA12	__UNKNOWN__
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*1/*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*1/*3
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*2/*2
paclitaxel	CYP3A4*1, CYP3A4*8, CYP3A4*20	CYP3A4	*1/*8	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0919267		L01CD01	*1/*8
paclitaxel	CYP3A4*1, CYP3A4*8, CYP3A4*20	CYP3A4	*1/*20	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0919267		L01CD01	*1/*20
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*5
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*41
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*41
carbamazepine	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*33:03
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02
docetaxel	rs144854329	VEGFA	del/del	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02	rs144854329:del/del
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*3/*3
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*3/*2	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*3/*2
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*3
citalopram	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531T/L allele-rs25531T	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AB04	
azathioprine, mercaptopurine	NUDT15*1, NUDT15*3, NUDT15*6	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*1/*3
azathioprine, mercaptopurine	NUDT15*1, NUDT15*3, NUDT15*6	NUDT15	*3/*3	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*3/*3
azathioprine, mercaptopurine	NUDT15*1, NUDT15*3, NUDT15*6	NUDT15	*1/*6	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*1/*6
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Disease:C0011581		N06A	
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Other:C0001418		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*2/*3
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*3/*3
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*2/*2
haloperidol	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Other:C0033936		N05AD01	*1/*4
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC
none	HLA-DPB1*04:01	HLA-DPB1	*04:01	Toxicity	decreased	Adverse_Event	Healthy		A03DA02	*04:01
carboplatin, cisplatin	DPYD Reference	DPYD	Reference	Efficacy	increased	Efficacy_Response	Other:C0007131		L01XA01|L01XA02	Reference
methamphetamine	rs947267	DAOA	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs947267:T
carbamazepine, oxcarbazepine, phenobarbital	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AA02|N03AF01|N03AF02	*15:02
tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*36	CYP2D6	*10/*10	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	N02AX02	*10/*10
tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*36	CYP2D6	*5/*10	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	N02AX02	*5/*10
tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*36	CYP2D6	*36	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	N02AX02	*36
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*2
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*3
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	Indeterminado	Other	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
methamphetamine	rs2075572	OPRM1	C	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs2075572:C
acetaminophen	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		N02BE01	*13:01
acetaminophen	HLA-A*02:06	HLA-A	*02:06	Toxicity	increased	Adverse_Event	Healthy		N02BE01	*02:06
acetaminophen	HLA-B*44:03	HLA-B	*44:03	Toxicity	increased	Adverse_Event	Healthy		N02BE01	*44:03
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*2
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*3
acetaminophen	HLA-C*14:03	HLA-C	*14:03	Toxicity	increased	Adverse_Event	Healthy		N02BE01	*14:03
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*3
carbamazepine, lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01|N03AX09	*15:02
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*5
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*41
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*41
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*4
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*5
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*2
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*3A
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*3C
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*9	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*9
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*21	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*21
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*33	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*33
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*34	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*34
methadone	rs2246709	CYP3A4	A	Other	decreased	Adverse_Event	Disease:C0028043		N07BC02	rs2246709:A
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:A
atorvastatin, pravastatin	rs7412	APOE	CT	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03|C10AA05	rs7412:CT
atorvastatin, pravastatin	rs7412	APOE	TT	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03|C10AA05	rs7412:TT
atorvastatin, pravastatin, simvastatin	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*5	Toxicity	increased	Adverse_Event	Disease:C0020443		C10AA01|C10AA03|C10AA05	*5
phenytoin	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3
antivirals for treatment of hiv infections, combinations	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AP|S02DA30	*28
phenytoin	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3
atenolol, hydrochlorothiazide, trandolapril, verapamil	rs2230345	GRK5	AT	Other	decreased	Adverse_Event	Other:C1956346		C03AA03|C07AB03|C08DA01|C09AA10	rs2230345:AT
atenolol, hydrochlorothiazide, trandolapril, verapamil	rs2230345	GRK5	TT	Other	decreased	Adverse_Event	Other:C1956346		C03AA03|C07AB03|C08DA01|C09AA10	rs2230345:TT
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Disease:Leprosy		J04BA02	*13:01
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A
methamphetamine	rs6265	BDNF	CC	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs6265:CC
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
tacrolimus	rs1045642	ABCB1	GG	Efficacy, Metabolism/PK	increased	Adverse_Event	Healthy		L04AD02	rs1045642:GG
drugs for treatment of tuberculosis	NAT2*4	NAT2	*4	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A	*4
anticholinergic agents	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N04A	__UNKNOWN__
antiepileptics	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03A	*15:02
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:human_liver_microsomes		L04AD02	*1/*3
azathioprine	NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*2	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*2
azathioprine	NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*3	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*3
azathioprine	NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*5	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*5
azathioprine	NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*6	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*6
none	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Other	increased	Adverse_Event	Healthy		A03DA02	
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Healthy		J05AG01	*04:01
none	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Other	increased	Adverse_Event	Healthy		A03DA02	
methamphetamine	rs2391191	DAOA	A	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs2391191:A
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*1/*6	Toxicity	decreased	Adverse_Event	Other:C0206624	intermediate metabolizer and poor metabolizer	L01AA01	*1/*6
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*6/*6	Toxicity	decreased	Adverse_Event	Other:C0206624	intermediate metabolizer and poor metabolizer	L01AA01	*6/*6
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*4/*6	Toxicity	decreased	Adverse_Event	Other:C0206624	intermediate metabolizer and poor metabolizer	L01AA01	*4/*6
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*5/*6	Toxicity	decreased	Adverse_Event	Other:C0206624	intermediate metabolizer and poor metabolizer	L01AA01	*5/*6
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*1/*1	Toxicity	increased	Adverse_Event	Other:C0206624	normal metabolizer and rapid metabolizer	L01AA01	*1/*1
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*1/*5	Toxicity	increased	Adverse_Event	Other:C0206624	normal metabolizer and rapid metabolizer	L01AA01	*1/*5
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*1/*4	Toxicity	increased	Adverse_Event	Other:C0206624	normal metabolizer and rapid metabolizer	L01AA01	*1/*4
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*1/*22	Toxicity	increased	Adverse_Event	Other:C0206624	normal metabolizer and rapid metabolizer	L01AA01	*1/*22
irinotecan	rs2859101	HLA-DQB3	C	Toxicity	decreased	Adverse_Event	Healthy		L01CE02	rs2859101:C
cyclosporine, methotrexate	rs3737967	MTHFR	GG	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs3737967:GG
nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Healthy		J05AG01	*01:01
antidepressants	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0011581		N06A	*1/*1
cyclophosphamide, epirubicin, fluorouracil	rs55633228	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs55633228:T
clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AA
carboplatin, dexamethasone, etoposide, irinotecan	UGT1A1*6	UGT1A1	*6	Efficacy	increased	Efficacy_Response	Disease:C0024299|Large_B-Cell|Diffuse		L01CB01|L01CE02|L01XA02|S02BA06	*6
sulfasalazine	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		A07EC01	*13:01
acenocoumarol, warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	*1/*3
acenocoumarol, warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	*3/*3
azathioprine, mercaptopurine	rs746071566	NUDT15	GGAGTC	Toxicity	increased	Adverse_Event	Other:C0004364|Other:C0021390		L01BB02|L04AX01	rs746071566:GGAGTC
cyclosporine, methotrexate	rs2274976	MTHFR	CC	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs2274976:CC
tamoxifen	CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Healthy		L02BA01	*4/*4
cyclophosphamide, epirubicin, fluorouracil	rs117101815	PERP	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs117101815:T
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*3A
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3B	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*3B
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*3C
cisplatin	rs11615	ERCC1	GG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs11615:GG
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28, UGT1A1*36	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*28/*28
pravastatin	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*15/*15
capecitabine, fluorouracil	low activity	DPYD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0027651	low activity	L01BC02|L01BC06	__UNKNOWN__
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	*3
cisplatin, radiotherapy	GSTM1 non-null, GSTM1 null	GSTM1	null/null	Efficacy	decreased	Adverse_Event	Disease:C0007869		L01XA01	
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2/*17
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA07	*3/*3
antidepressants, antiepileptics, beta blocking agents, calcium channel blockers	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Other	decreased	Other	Other:C0150055		C08|N03A|N06A|S01ED	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
antidepressants, antiepileptics, beta blocking agents, calcium channel blockers	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Other	decreased	Other	Disease:C0338480		C08|N03A|N06A|S01ED	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1
irinotecan	rs1042482	DPYD	T	Toxicity	increased	Adverse_Event	Healthy		L01CE02	rs1042482:T
pazopanib	UGT1A1*6, UGT1A1*28, UGT1A1*37	UGT1A1	*28	Toxicity	increased	Adverse_Event	Disease:C0007134	reduced metabolizers	L01EX03	*28
pazopanib	UGT1A1*6, UGT1A1*28, UGT1A1*37	UGT1A1	*37	Toxicity	increased	Adverse_Event	Disease:C0007134	reduced metabolizers	L01EX03	*37
pazopanib	UGT1A1*6, UGT1A1*28, UGT1A1*37	UGT1A1	*6	Toxicity	increased	Adverse_Event	Disease:C0007134	reduced metabolizers	L01EX03	*6
methadone	rs4646440	CYP3A4	A	Toxicity	increased	Adverse_Event	Disease:C0028043		N07BC02	rs4646440:A
warfarin	rs9923231	VKORC1	CC	Other	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CC
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA04	*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA04	*3
cyclophosphamide, epirubicin, fluorouracil	rs3805945	PPP2R5D	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs3805945:C
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Adverse_Event	Disease:C0007820		B01AC04	*2
atazanavir / ritonavir, lamivudine, zidovudine	UGT1A1*1, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	*1/*36	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease|Other:C0032961		J05AE03|J05AE08|J05AF01|J05AF05	*1/*36
atazanavir / ritonavir, lamivudine, zidovudine	UGT1A1*1, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	*28/*36	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease|Other:C0032961		J05AE03|J05AE08|J05AF01|J05AF05	*28/*36
atazanavir / ritonavir, lamivudine, zidovudine	UGT1A1*1, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	*36/*37	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease|Other:C0032961		J05AE03|J05AE08|J05AF01|J05AF05	*36/*37
atazanavir / ritonavir, lamivudine, zidovudine	UGT1A1*1, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	*1/*1	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease|Other:C0032961		J05AE03|J05AE08|J05AF01|J05AF05	*1/*1
cyclophosphamide, epirubicin, fluorouracil	rs77769901	CCNK	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs77769901:G
carbamazepine	rs3812718	SCN1A	TT	Efficacy	increased	Adverse_Event	Other:C0014544		N03AF01	rs3812718:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, simeprevir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10|L03AB11	rs11322783:TT/TT
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28
rosiglitazone	rs894160	PLIN1	CT	Toxicity	decreased	Adverse_Event	Other:C0011849		A10BG02	rs894160:CT
rosiglitazone	rs894160	PLIN1	TT	Toxicity	decreased	Adverse_Event	Other:C0011849		A10BG02	rs894160:TT
platinum	rs836554	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs836554:T
cyclosporine, methotrexate	rs17264736	ABCC1	GG	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs17264736:GG
cyclosporine, methotrexate	rs17264736	ABCC1	GT	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs17264736:GT
methadone	CYP2B6*6	CYP2B6	*6	Toxicity	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	*6
oxcarbazepine	HLA-B*15:01	HLA-B	*15:01	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AF02	*15:01
cyclophosphamide, epirubicin, fluorouracil	rs118129530	PIK3R2	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs118129530:A
citalopram	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N06AB04	*1/*4
cyclophosphamide, epirubicin, fluorouracil	rs148013902	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs148013902:T
drugs used in nicotine dependence	rs4680	COMT	AA	Efficacy	increased	Adverse_Event	Healthy		N07BA	rs4680:AA
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	decreased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	decreased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*3/*3
nicotine	rs1800497	ANKK1	AA	Efficacy	increased	Adverse_Event	Other:female_gender		N07BA01	rs1800497:AA
nicotine	rs1800497	ANKK1	AG	Efficacy	increased	Adverse_Event	Other:female_gender		N07BA01	rs1800497:AG
valganciclovir	rs11568658	ABCC4	AC	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		J05AB14	rs11568658:AC
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*3
cyclophosphamide, epirubicin, fluorouracil	rs145623321	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs145623321:T
cyclosporine, methotrexate	rs1017860	NFATC1	CC	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs1017860:CC
cyclophosphamide, epirubicin, fluorouracil	rs117458836	CYP2C8	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs117458836:A
prasugrel	rs822442	PEAR1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs822442:AA
tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Efficacy	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*3
carbamazepine	HLA-B*07:02, HLA-B*15:21	HLA-B	*15:21	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:21
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT
nicotine	rs4680	COMT	G	Toxicity, Other	decreased	Adverse_Event	Other:smokers		N07BA01	rs4680:G
fluorouracil	deficiency	DPYD	__UNKNOWN__	Toxicity	Indeterminado	Adverse_Event	Disease:C0023055	deficiency	L01BC02	__UNKNOWN__
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*3	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*3
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*5
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*41
amoxicillin, clavulanate	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*15:01
risperidone	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Healthy		N05AX08	*4/*4
risperidone	CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C0036341	poor metabolizer	N05AX08	*4/*4
risperidone	CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C0036341	poor metabolizer	N05AX08	*4/*5
risperidone	CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Efficacy	decreased	Efficacy_Response	Disease:C0036341	poor metabolizer	N05AX08	*4/*6
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	*3
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*1/*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*2/*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*1/*3
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*3/*3
phenytoin	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*02:01
lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Side_Effect:C0014544		N03AX09	*15:02
bosentan	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		C02KX01	*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*3
clozapine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*2
bosentan	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		C02KX01	*2
capecitabine, fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs3918290:CT
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
atorvastatin	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA05	rs1800629:GG
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
lamotrigine	HLA-B*44:03	HLA-B	*44:03	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AX09	*44:03
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	G/TT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs11322783:G/TT
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	GG	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs11322783:GG
peginterferon alfa-2b, ribavirin, telaprevir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs11322783:TT/TT
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
lamotrigine	HLA-A*02:07	HLA-A	*02:07	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AX09	*02:07
flucloxacillin	HLA-C*06:02	HLA-C	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*06:02
nicotine	low activity	CYP2A6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Other:C0039338	low activity	N07BA01	__UNKNOWN__
fluvoxamine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08	
nicotine	low activity	CYP2A6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Healthy	low activity	N07BA01	__UNKNOWN__
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3
methazolamide	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*01:02
methazolamide	HLA-B*59:01	HLA-B	*59:01	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*59:01
warfarin	CYP2C9*1, CYP2C9*6	CYP2C9	*6	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*6
methotrexate	rs11045879	SLCO1B1	T	Other, Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs11045879:T
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*17/*17
warfarin	CYP2C9*1, CYP2C9*11	CYP2C9	*11	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*11
warfarin	CYP2C9*1, CYP2C9*5	CYP2C9	*5	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*5
codeine, tramadol	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Adverse_Event	Disease:C0030193	poor metabolizer	N02AX02|R05DA04	__UNKNOWN__
bosentan	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		C02KX01	*2
tacrolimus	CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
clopidogrel	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*7
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*3/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3
ace inhibitors, plain	rs71103505	BDKRB2	(GGTGGGGAC)2/(GGTGGGGAC)2	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs71103505:(GGTGGGGAC)2/(GGTGGGGAC)2
ace inhibitors, plain	rs71103505	BDKRB2	(GGTGGGGAC)2/GGTGGGGACGGTGGGGACGGTGGGGAC	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs71103505:(GGTGGGGAC)2/GGTGGGGACGGTGGGGACGGTGGGGAC
codeine, tramadol	poor and ultrarapid metabolizers	CYP2D6	__UNKNOWN__	Efficacy, Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0030193	poor metabolizer and ultrarapid metabolizer	N02AX02|R05DA04	__UNKNOWN__
none	rs727957	KCNE1	T	Other	increased	Other	Healthy		A03DA02	rs727957:T
amoxicillin, clavulanate	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	decreased	Adverse_Event	Healthy		J01CA04	*07:01
oxcarbazepine	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Healthy		N03AF02	*38:02
hydrochlorothiazide	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs1799752:del/del
methotrexate	rs11280056	TYMS	del/del	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AX03	rs11280056:del/del
perindopril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Toxicity	increased	Adverse_Event	Disease:C0011849		C09AA04	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
methotrexate	rs11280056	TYMS	del/del	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs11280056:del/del
none	rs34717272	RGS2	TC/del	Other	increased	Adverse_Event	Healthy		A03DA02	rs34717272:TC/del
none	rs34717272	RGS2	del/del	Other	increased	Adverse_Event	Healthy		A03DA02	rs34717272:del/del
carbamazepine	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*02:01
methotrexate	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
carbamazepine	HLA-DRB1*14:05	HLA-DRB1	*14:05	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*14:05
cyclophosphamide, epirubicin, fluorouracil	rs74743371	CBR3	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs74743371:T
carbamazepine	HLA-B*58:01	HLA-B	*58:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*58:01
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3
methotrexate	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
lamotrigine	HLA-A*30:01	HLA-A	*30:01	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*30:01
carbamazepine	HLA-DRB1*03:01	HLA-DRB1	*03:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*03:01
oxcarbazepine	HLA-B*13:02	HLA-B	*13:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*13:02
oxcarbazepine	HLA-B*15:27	HLA-B	*15:27	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*15:27
oxcarbazepine	HLA-B*15:19	HLA-B	*15:19	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*15:19
oxcarbazepine	HLA-B*48:04	HLA-B	*48:04	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*48:04
raloxifene	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Efficacy	increased	Efficacy_Response	Disease:C0029456		G03XC01	*28/*28
aspirin	HLA-DQB1*03:02	HLA-DQB1	*03:02	Efficacy, Toxicity	decreased	Adverse_Event	Side_Effect:Aspirin-induced_asthma		No_ATC	*03:02
oxcarbazepine	HLA-B*27:09	HLA-B	*27:09	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*27:09
nevirapine	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*58:01
tamoxifen	rs1045642	ABCB1	AG	Other	increased	Adverse_Event	Disease:C1458155		L02BA01	rs1045642:AG
nevirapine	HLA-B*58:02	HLA-B	*58:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*58:02
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
prasugrel	rs3737224	PEAR1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs3737224:TT
nevirapine	HLA-C*02:10	HLA-C	*02:10	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*02:10
cyclosporine, methotrexate	rs4781712	ABCC1	AA	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs4781712:AA
cyclosporine, methotrexate	rs4781712	ABCC1	AG	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs4781712:AG
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
capecitabine, fluorouracil	rs895819	MIR27A	CT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs895819:CT
olanzapine	rs4728709	ABCB1	GG	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs4728709:GG
bupropion	rs3211371	CYP2B6	TT	Efficacy	increased	Adverse_Event	Other:female_gender		N06AX12	rs3211371:TT
cyclophosphamide, epirubicin, fluorouracil	rs118088833	TP53AIP1	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs118088833:T
aspirin, sulfasalazine	CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3	Dosage, Toxicity	increased	Adverse_Event	Side_Effect:C0006444		A07EC01	*3
aspirin, sulfasalazine	CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4	Dosage, Toxicity	increased	Adverse_Event	Side_Effect:C0006444		A07EC01	*4
prasugrel	rs41273215	PEAR1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs41273215:TT
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	
tamoxifen	rs1045642	ABCB1	AG	Other	increased	Adverse_Event	Disease:C1458155		L02BA01	rs1045642:AG
cyclophosphamide, epirubicin, fluorouracil	rs112242273	GNL3	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs112242273:T
tramadol	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Dosage	Indeterminado	Other	Healthy		N02AX02	*10/*10
prasugrel	rs822441	PEAR1	CC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs822441:CC
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Toxicity	increased	Adverse_Event	Disease:Lung_transplantation		J02AC03	*1/*17
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Disease:Lung_transplantation		J02AC03	*17/*17
clopidogrel	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3
cytarabine, idarubicin	rs2032582	ABCB1	CC	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs2032582:CC
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR long form (L allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A	
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A	
caffeine	high activity	CYP1A2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0032961	high activity	N06BC01	__UNKNOWN__
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Other	Healthy		B01AA03	*1/*3
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR long form (L allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A	
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A	
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR long form (L allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A	
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A	
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
cyclophosphamide, epirubicin, fluorouracil	rs181501757	TOP2A	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs181501757:A
lamotrigine	HLA-B*13:02	HLA-B	*13:02	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*13:02
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	
lamotrigine	HLA-A*33:03	HLA-A	*33:03	Toxicity	decreased	Adverse_Event	Healthy		N03AX09	*33:03
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06A	
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*1/*60	Toxicity	increased	Adverse_Event	Disease:C0027651		No_ATC	*1/*60
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*60/*60	Toxicity	increased	Adverse_Event	Disease:C0027651		No_ATC	*60/*60
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	
cyclophosphamide, epirubicin, fluorouracil	rs9402944	PERP	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs9402944:T
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A	
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs2660	OAS1	AG	Toxicity	decreased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs2660:AG
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR long form (L allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A	
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A	
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
olanzapine	rs3842	ABCB1	CC	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs3842:CC
irinotecan	rs10929302	UGT1A1	A	Toxicity	increased	Adverse_Event	Healthy		L01CE02	rs10929302:A
cyclophosphamide, epirubicin, fluorouracil	rs112783657	CBR3	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs112783657:T
bupropion	rs2717162	GALR1	CC	Efficacy	decreased	Adverse_Event	Healthy		N06AX12	rs2717162:CC
bupropion	rs2717162	GALR1	CT	Efficacy	decreased	Adverse_Event	Healthy		N06AX12	rs2717162:CT
carbamazepine	HLA-B*46:01	HLA-B	*46:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*46:01
heroin	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:AG
cyclosporine, methotrexate	rs8090560	NFATC1	GG	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs8090560:GG
vincristine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	*1/*3
allopurinol	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*33:03
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*03:02
azathioprine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX01	*1/*3A
risperidone	rs7799039	LEP	A	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs7799039:A
bupropion	rs2717162	GALR1	CC	Efficacy	increased	Adverse_Event	Disease:C0039338		N06AX12	rs2717162:CC
bupropion	rs2717162	GALR1	CT	Efficacy	increased	Adverse_Event	Disease:C0039338		N06AX12	rs2717162:CT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs231775	CTLA4	AG	Toxicity	decreased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs231775:AG
cyclophosphamide, epirubicin, fluorouracil	rs149212925	NOS1	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs149212925:G
cyclosporine, methotrexate	rs34965641	DHFR	GG	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs34965641:GG
etravirine	rs4244285	CYP2C19	AA	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG04	rs4244285:AA
etravirine	rs4244285	CYP2C19	AG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG04	rs4244285:AG
cisplatin	rs3212986	ERCC1	A	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01XA01	rs3212986:A
rosuvastatin	rs2231142	ABCG2	T	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA07	rs2231142:T
fluorouracil	rs1801131	MTHFR	TT	Toxicity	increased	Adverse_Event	Disease:C0022665		L01BC02	rs1801131:TT
fluoxetine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB05	
cyclophosphamide, epirubicin, fluorouracil	rs58695150	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs58695150:T
pemetrexed	rs11545078	GGH	A	Toxicity	decreased	Adverse_Event	Disease:C0007131|Disease:C0025500		L01BA04	rs11545078:A
metformin	rs72552763	SLC22A1	GAT/del	Other, Metabolism/PK	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs72552763:GAT/del
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0522067		N03AF01	*15:02
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
phenazepam	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Other:C0085762|Other:C0003469		No_ATC	*2
capecitabine	rs602950	CDA	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs602950:AG
capecitabine	rs602950	CDA	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs602950:GG
methotrexate	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Other:C0023449		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
fluorouracil, irinotecan, leucovorin	low activity	DPYD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0023055	low activity	L01BC02|L01CE02	__UNKNOWN__
phenytoin	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*08:01
fluorouracil	deficiency	DPYD	__UNKNOWN__	Toxicity	Indeterminado	Adverse_Event	Disease:C0027651	deficiency	L01BC02	__UNKNOWN__
cyclophosphamide, epirubicin, fluorouracil	rs150688309	PIK3R2	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs150688309:G
capecitabine	rs602950	CDA	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs602950:AG
capecitabine	rs602950	CDA	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs602950:GG
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
tamoxifen	CYP2D6*2	CYP2D6	*2	Efficacy	decreased	Adverse_Event	Healthy		L02BA01	*2
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
tamoxifen	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BA01	*22
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
carbamazepine	HLA-A*74:01	HLA-A	*74:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*74:01
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Adverse_Event	Disease:C0085096		B01AC04	*2
carbamazepine	HLA-A*02:01	HLA-A	*02:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*02:01
codeine	low activity	SLC22A1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	low activity	R05DA04	
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Disease:C0178298		J04BA02	*13:01
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*1/*3C
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*3A/*3A
oxcarbazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*15:02
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Other	Disease:C0027051		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Other	Disease:C0027051		B01AC04	*3
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*2
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3C
venlafaxine	CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AX16	*4/*4
cyclophosphamide, epirubicin, fluorouracil	rs299293	HMMR	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs299293:T
exemestane	rs934635	__INTRONIC__	AA	Toxicity	Indeterminado	Adverse_Event	Disease:C1458155		L02BG06	rs934635:AA
cyclophosphamide, epirubicin, fluorouracil	rs9389568	PERP	C	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs9389568:C
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Other	Disease:C0010068		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Other	Disease:C0010068		B01AC04	*3
cyclophosphamide, epirubicin, fluorouracil	rs144991623	FOXO1	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs144991623:T
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*1/*6
prasugrel	rs12407843	PEAR1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs12407843:AA
digoxin	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C01AA05	rs1045642:AA
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT
prasugrel	rs77235035	PEAR1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs77235035:AA
venlafaxine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0028768		N06AX16	*4/*4
venlafaxine	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0028768		N06AX16	*1/*4
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*2
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*17/*17
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*17
digoxin	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C01AA05	rs2032582:AA
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*3
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*6	Toxicity	Indeterminado	Adverse_Event	Disease:C0027651		L01CE02	*6
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*28	Toxicity	Indeterminado	Adverse_Event	Disease:C0027651		L01CE02	*28
digoxin	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C01AA05	rs1128503:AA
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	B01AC04	*3/*3
capecitabine	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs1801131:GG
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*1/*6
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6
cyclophosphamide, epirubicin, fluorouracil	rs8110364	PIK3R2	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs8110364:A
olanzapine	rs10248420	ABCB1	G	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs10248420:G
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*28/*28
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*28
fluorouracil	rs56293913	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C2931822		L01BC02	rs56293913:AG
fluorouracil	rs56293913	DPYD	GG	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C2931822		L01BC02	rs56293913:GG
fluticasone propionate	rs2569190	CD14, TMCO6	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs2569190:AA
cyclophosphamide, epirubicin, fluorouracil	rs117341846	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs117341846:T
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	Indeterminado	Efficacy_Response	Healthy	intermediate metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	Indeterminado	Efficacy_Response	Healthy	intermediate metabolizer	B01AC04	*1/*3
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB10	
cyclophosphamide, epirubicin, fluorouracil	rs115457081	IRS1	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs115457081:A
carbamazepine	HLA-B*40:01	HLA-B	*40:01	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AF01	*40:01
lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AX09	*15:02
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Efficacy	Indeterminado	Efficacy_Response	Healthy	poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Efficacy	Indeterminado	Efficacy_Response	Healthy	poor metabolizer	B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Efficacy	Indeterminado	Efficacy_Response	Healthy	poor metabolizer	B01AC04	*3/*3
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*15:02
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*1/*17
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*17/*17
cyclophosphamide, epirubicin, fluorouracil	rs142244113	INSR	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs142244113:T
citalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB04	
aspirin, clopidogrel	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	*1/*3
aspirin, clopidogrel	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	*3/*3
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*3
methotrexate	rs2372536	ATIC	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs2372536:GG
doxepin	CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*4/*4
cyclophosphamide, epirubicin, fluorouracil	rs79430272	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs79430272:T
olanzapine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	*1/*3
olanzapine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	*1/*4
cyclophosphamide, epirubicin, fluorouracil	rs4968187	TP53	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs4968187:T
citalopram, fluoxetine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB03|N06AB04|N06AB05	
cisplatin	rs3212986	ERCC1	AA	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs3212986:AA
palbociclib	rs2231137	ABCG2	CT	Toxicity	increased	Adverse_Event	Other:C1458155		L01EF01	rs2231137:CT
cyclophosphamide, epirubicin, fluorouracil	rs117951771	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs117951771:T
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*2/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*2/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*3/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*4/*4	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*4/*4
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*2/*4	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*2/*4
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*3/*4	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*3/*4
exemestane	rs934635	__INTRONIC__	AA	Toxicity	Indeterminado	Adverse_Event	Disease:C1458155		L02BG06	rs934635:AA
primaquine	deficiency	G6PD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0024530|Vivax	deficiency	P01BA03	
cyclophosphamide, epirubicin, fluorouracil	rs148235907	PIK3R2	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs148235907:A
methamphetamine	rs3916965	DAOA	C	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs3916965:C
none	rs34993780	UGT1A1	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs34993780:G
cyclophosphamide	poor metabolizer	CYP2C9	*2	Toxicity	increased	Adverse_Event	Disease:C0042384|Disease:C0043092	poor metabolizer	L01AA01	*2
cyclophosphamide	poor metabolizer	CYP2C9	*3	Toxicity	increased	Adverse_Event	Disease:C0042384|Disease:C0043092	poor metabolizer	L01AA01	*3
capecitabine	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0017185		L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
desipramine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA01	*10/*10
desipramine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA01	*5/*10
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	*1/*1
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	*1/*1
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3
atazanavir, ritonavir	UGT1A1*28	UGT1A1	*28	Other	increased	Adverse_Event	Healthy		J05AE03|J05AE08	*28
atazanavir	UGT1A1*28	UGT1A1	*28	Other	increased	Adverse_Event	Healthy		J05AE08	*28
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
palbociclib	rs182420	SULT2A1	CC	Toxicity	increased	Adverse_Event	Other:C1458155		L01EF01	rs182420:CC
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*1/*4
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*4/*4
imipramine	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	*1/*17
imipramine	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	*17/*17
cyclophosphamide, epirubicin, fluorouracil	rs299313	HMMR	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs299313:A
primaquine	deficiency	G6PD	__UNKNOWN__	Other	increased	Other	Healthy	deficiency	P01BA03	
sulfanilamide	deficiency	G6PD	__UNKNOWN__	Other	increased	Other	Healthy	deficiency	J01EB06	
chloramphenicol	deficiency	G6PD	__UNKNOWN__	Other	increased	Other	Healthy	deficiency	S03AA08	
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*3
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0042065|Other:C0030297		L01CE02	*28/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0042065|Other:C0030297		L01CE02	*6/*6
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0042065|Other:C0030297		L01CE02	*1/*6
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0042065|Other:C0030297		L01CE02	*1/*28
codeine, morphine, tramadol	rs73823859	UGT2B7	A	Efficacy	increased	Efficacy_Response	Other:C0002895		N02AA01|N02AX02|R05DA04	rs73823859:A
cisplatin, docetaxel	rs671	ALDH2	AA	Toxicity	increased	Adverse_Event	Other:C0027651		L01CD02|L01XA01	rs671:AA
cisplatin, docetaxel	rs671	ALDH2	AG	Toxicity	increased	Adverse_Event	Other:C0027651		L01CD02|L01XA01	rs671:AG
cyclophosphamide, epirubicin, fluorouracil	rs299314	HMMR	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs299314:C
warfarin	CYP2C9*1, CYP2C9*8	CYP2C9	*8	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*8
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:C0027651		L01CE02	*28
anthracyclines and related substances	rs1056892	CBR3	G	Toxicity	increased	Adverse_Event	Healthy		L01DB	rs1056892:G
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28
cisplatin	rs13181	ERCC2	G	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01XA01	rs13181:G
allopurinol	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Disease:C0013182		M04AA01	*33:03
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Disease:C0013182		M04AA01	*03:02
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0018839		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0018839		B01AC04	*2/*2
allopurinol	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Disease:C0013182		M04AA01	*08:01
anthracyclines and related substances	rs10836235	CAT	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01DB	rs10836235:CC
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3
exemestane	deficiency	UGT2B17	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C1458155	deficiency	L02BG06	
paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Disease:C0040435		N06AB05	
paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531C	Toxicity	increased	Adverse_Event	Disease:C0040435		N06AB05	
paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531T	Toxicity	increased	Adverse_Event	Disease:C0040435		N06AB05	
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*3
valproic acid	rs2269577	XBP1	G	Efficacy	increased	Adverse_Event	Disease:C0005586		N03AG01	rs2269577:G
ace inhibitors, plain	rs1799752	ACE	del	Toxicity	increased	Adverse_Event	Disease:C1956346		A03B|C09A	rs1799752:del
paclitaxel	rs1056836	CYP1B1	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD01	rs1056836:GG
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10/*10
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*10
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*5/*10
docetaxel	rs1056836	CYP1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0033578		L01CD02	rs1056836:CC
warfarin	CYP2C9*1, CYP2C9*8	CYP2C9	*8	Dosage, Metabolism/PK	decreased	LADME	Healthy		B01AA03	*8
cyclophosphamide, doxorubicin, fluorouracil	rs9561778	ABCC4	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs9561778:T
cyclophosphamide	rs9561778	ABCC4	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C1458155		L01AA01	rs9561778:T
cyclophosphamide	rs9561778	ABCC4	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C1458155		L01AA01	rs9561778:T
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01
hydrochlorothiazide	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Other	increased	Other	Disease:C0020538		C03AA03	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
hormonal contraceptives for systemic use	rs6025	F5	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs6025:T
enalapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs1799752:del/del
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*4
clozapine	HLA-B*38:01	HLA-B	*38:01	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*38:01
paroxetine	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB05	*1/*1xN
flucloxacillin	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*57:01
flucloxacillin	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*57:01
drugs for treatment of tuberculosis	NAT2*4	NAT2	*4	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A	*4
capecitabine	rs143414470	ANK3	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs143414470:T
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Disease:C0007131	poor metabolizer	L01EB01	*10/*10
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*5/*10	Toxicity	increased	Adverse_Event	Disease:C0007131	poor metabolizer	L01EB01	*5/*10
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*2	Other	increased	Adverse_Event	Disease:C0004096	poor metabolizer	A02BC03	*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*3	Other	increased	Adverse_Event	Disease:C0004096	poor metabolizer	A02BC03	*3
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*8	Other	increased	Adverse_Event	Disease:C0004096	poor metabolizer	A02BC03	*8
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*9	Other	increased	Adverse_Event	Disease:C0004096	poor metabolizer	A02BC03	*9
nevirapine	rs130072	CCHCR1	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs130072:T
nevirapine	HLA-B*35:05	HLA-B	*35:05	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*35:05
ritonavir	rs5128	APOC3	G	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03	rs5128:G
efavirenz	rs3745274	CYP2B6	T	Toxicity, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
metformin	rs6265	BDNF	C	Efficacy	increased	Adverse_Event	Healthy		A10BA02	rs6265:C
efavirenz	CYP2B6*1, CYP2B6*18	CYP2B6	*1/*18	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*18
lumiracoxib	HLA-DRB1*01:01, HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		M01AH06	*15:01
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		N07BC02	*6/*6
mercaptopurine, methotrexate	TPMT*1, TPMT*12	TPMT	*12	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	*12
mycophenolate mofetil(mycophenolic acid)	rs2278293	IMPDH1	CT	Toxicity	decreased	Adverse_Event	Disease:C0277631		L04AA06	rs2278293:CT
mycophenolate mofetil(mycophenolic acid)	rs2278293	IMPDH1	TT	Toxicity	decreased	Adverse_Event	Disease:C0277631		L04AA06	rs2278293:TT
mitoxantrone	rs2032582	ABCB1	AA	Other	increased	Other	Healthy		L01DB07	rs2032582:AA
lumiracoxib	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	increased	Adverse_Event	Healthy		M01AH06	*06:02
acenocoumarol	CYP2C9*3	CYP2C9	*3	Metabolism/PK	increased	Adverse_Event	Healthy		B01AA07	*3
aspirin, clopidogrel	rs662	PON1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0002962		B01AC04	rs662:CT
aspirin, clopidogrel	rs662	PON1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0002962		B01AC04	rs662:TT
acenocoumarol	CYP2C9*2	CYP2C9	*2	Metabolism/PK	increased	Adverse_Event	Healthy		B01AA07	*2
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	increased	Adverse_Event	Healthy		N07BC02	*6/*6
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		N07BC02	*6/*6
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Healthy		N06AA06	*4/*4
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*5	Toxicity	increased	Adverse_Event	Healthy		N06AA06	*3/*5
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*3	Toxicity	increased	Adverse_Event	Healthy		N06AA06	*3/*3
clopidogrel	rs1045642	ABCB1	A	Other	increased	Adverse_Event	Disease:C0010068		B01AC04	rs1045642:A
nevirapine	rs9461684	HLA-C	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs9461684:T
aspirin	rs1143627	IL1B	A	Toxicity	Indeterminado	Adverse_Event	Disease:C0007222		No_ATC	rs1143627:A
paclitaxel	rs35599367	CYP3A4	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CD01	rs35599367:AA
paclitaxel	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CD01	rs35599367:AG
cyclophosphamide, doxorubicin	rs714368	SLC22A16	CC	Toxicity	decreased	Adverse_Event	Other:C1458155		L01AA01|L01DB01	rs714368:CC
cyclophosphamide, doxorubicin	rs714368	SLC22A16	CT	Toxicity	decreased	Adverse_Event	Other:C1458155		L01AA01|L01DB01	rs714368:CT
phenytoin	rs2234922	EPHX1	G	Toxicity	increased	Adverse_Event	Other:C0240802		N03AB02	rs2234922:G
phenytoin	rs1051740	EPHX1	T	Toxicity	increased	Adverse_Event	Other:C0240802		N03AB02	rs1051740:T
nevirapine	rs2073724	TCF19	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs2073724:T
risperidone	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	*10
carboplatin, paclitaxel	rs1649942	NRG3	G	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01CD01|L01XA02	rs1649942:G
phenprocoumon	rs1051740	EPHX1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs1051740:CC
none	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Disease:C0020443		A03DA02	rs4149056:C
efavirenz	CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*1/*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*2/*2
cyclophosphamide, doxorubicin, fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
caffeine	rs5751876	ADORA2A	TT	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs5751876:TT
paclitaxel, platinum compounds	rs1208	NAT2	AG	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01CD01|L01XA	rs1208:AG
paclitaxel, platinum compounds	rs1208	NAT2	GG	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01CD01|L01XA	rs1208:GG
drugs for treatment of tuberculosis	HLA-DQB1*05:01, HLA-DQB1*05:02, HLA-DQB1*05:03	HLA-DQB1	*05:01	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*05:01
drugs for treatment of tuberculosis	HLA-DQB1*05:01, HLA-DQB1*05:02, HLA-DQB1*05:03	HLA-DQB1	*05:02	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*05:02
drugs for treatment of tuberculosis	HLA-DQB1*05:01, HLA-DQB1*05:02, HLA-DQB1*05:03	HLA-DQB1	*05:03	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*05:03
venlafaxine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5/*4	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0011581		N06AX16	*5/*4
venlafaxine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0011581		N06AX16	*6/*6
venlafaxine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6/*4	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0011581		N06AX16	*6/*4
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*5	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB08	*1/*5
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB08	*10/*10
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB08	*5/*10
nemonapride	rs1800497	ANKK1	A	Toxicity	increased	Adverse_Event	Other:C0036341		No_ATC	rs1800497:A
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*3	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*3/*3
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*4
methotrexate	rs1051266	SLC19A1	TT	Other, Metabolism/PK	increased	LADME	Disease:C0003873		L04AX03	rs1051266:TT
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
fluvoxamine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB08	__UNKNOWN__
methotrexate	rs3758149	GGH	AA	Metabolism/PK	decreased	LADME	Disease:C0003873		L04AX03	rs3758149:AA
risperidone	rs1799978	DRD2	C	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs1799978:C
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3
risperidone	rs1800497	ANKK1	AA	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs1800497:AA
risperidone	rs1800497	ANKK1	AG	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs1800497:AG
mycophenolate mofetil(mycophenolic acid)	rs11706052	IMPDH2	G	Other	increased	Other	Disease:Kidney_Transplantation		L04AA06	rs11706052:G
mercaptopurine	rs2281547	XDH	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs2281547:CC
mercaptopurine	rs2281547	XDH	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs2281547:CT
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*2/*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*1/*2
mycophenolate mofetil(mycophenolic acid)	rs4149117	SLCO1B3	G	Metabolism/PK	decreased	LADME	Other:C1262018		L04AA06	rs4149117:G
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0002962		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	*3
indinavir	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE02	*6/*28
anastrozole	rs1045642	ABCB1	AA	Other	decreased	Adverse_Event	Disease:C1458155		L02BG03	rs1045642:AA
methotrexate	rs1801131	MTHFR	GG	Efficacy	decreased	Other	Disease:C0023449		L04AX03	rs1801131:GG
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	increased	Adverse_Event	Healthy		B01AA03	*2
none	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1799971:AG
none	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1799971:GG
mercaptopurine	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs1127354:AC
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Disease:C0009324		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0009324		L04AD02	*1/*3
flecainide	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		C01BC04	*3/*3
ethanol	rs671	ALDH2	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs671:GG
didanosine	rs1429376	XDH	AA	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs1429376:AA
daunorubicin	rs6603859	SZRD1	T	Other, Metabolism/PK	decreased	LADME	Healthy		L01DB02	rs6603859:T
didanosine	rs11598702	NT5C2	CC	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs11598702:CC
didanosine	rs11598702	NT5C2	CT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs11598702:CT
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Other	Disease:C1956346		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Other	Disease:C1956346		B01AC04	*2/*2
didanosine	rs1594160	XDH	AA	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs1594160:AA
clopidogrel	CYP2C19*1, CYP2C19*6	CYP2C19	*6	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*6
daunorubicin	rs7929521	__INTRONIC__	GG	Other, Metabolism/PK	increased	LADME	Healthy		L01DB02	rs7929521:GG
irinotecan	UGT1A1*1, UGT1A1*28, UGT1A1*37	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*28/*28
azacitidine	rs11280056	TYMS	del/del	Efficacy	decreased	Efficacy_Response	Disease:C0026986		L01BC07	rs11280056:del/del
daunorubicin	rs3750518	MAN1B1	T	Other, Metabolism/PK	increased	LADME	Healthy		L01DB02	rs3750518:T
oxycodone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	*3/*4
oxycodone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	*4/*4
oxycodone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	*4/*5
oxycodone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	*4/*6
oxycodone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*7	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	*4/*7
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Other	Disease:C0027051		B01AC04	*2
didanosine	rs11191561	NT5C2	CG	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs11191561:CG
didanosine	rs11191561	NT5C2	GG	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs11191561:GG
drugs for treatment of tuberculosis	HLA-DQA1*01:02	HLA-DQA1	*01:02	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A	*01:02
iguratimod	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0003873		No_ATC	rs4244285:A
cyclosporine	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD01	*1/*22
phenytoin	HLA-C*14:02	HLA-C	*14:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*14:02
phenytoin	HLA-B*56:02	HLA-B	*56:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*56:02
nicotine	rs1801272	CYP2A6	AT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1801272:AT
nicotine	rs1801272	CYP2A6	TT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1801272:TT
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
olanzapine	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*3
olanzapine	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*2/*3
olanzapine	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6	CYP2C9	*3/*6	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*3/*6
desipramine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA01	*10/*10
desipramine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA01	*5/*10
gefitinib	rs11568315	EGFR	(CA)16/(CA)16	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)16
olanzapine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*3A
olanzapine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*3C
none	NAT1*4, NAT1*11B	NAT1	*11B/*4	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*11B/*4
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*32, TPMT*33, TPMT*34	TPMT	*1/*3C	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L01BB02|L01BB03	*1/*3C
olanzapine	rs1799735	GSTM3	CCT/CCT	Metabolism/PK	decreased	LADME	Healthy		N05AH03	rs1799735:CCT/CCT
olanzapine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Healthy		N05AH03	*1/*1
olanzapine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Healthy		N05AH03	*1/*3
mercaptopurine	rs2281547	XDH	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs2281547:CC
mercaptopurine	rs2281547	XDH	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs2281547:CT
anastrozole	rs727479	CYP19A1	AA	Efficacy	increased	Other	Disease:C1458155		L02BG03	rs727479:AA
oxycodone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		N02AA05	*4/*4
oxycodone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Disease:C0027651		N02AA05	*4/*6
fluvastatin	rs11045819	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA04	rs11045819:CC
oxycodone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		N02AA05	*4/*4
oxycodone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		N02AA05	*3/*4
efavirenz	CYP2B6*18	CYP2B6	*18/*18	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*18/*18
cyclophosphamide, doxorubicin	rs1143684	NQO2	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs1143684:C
pioglitazone	CYP2C8*1, CYP2C8*2	CYP2C8	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A10BG03	*1/*2
pioglitazone	CYP2C8*1, CYP2C8*2	CYP2C8	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A10BG03	*2/*2
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3
diclofenac	rs7668258	UGT2B7	T	Toxicity	increased	Adverse_Event	Healthy		S01BC03	rs7668258:T
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	increased	Adverse_Event	Disease:C0019158		J05AP01|J05AP02|L03AB10	rs8099917:TT
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*1/*17
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*17/*17
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	decreased	Adverse_Event	Disease:C1956346		B01AC04	*1/*17
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	decreased	Adverse_Event	Disease:C1956346		B01AC04	*17/*17
ibuprofen	CYP2C8*1, CYP2C8*2	CYP2C8	*1/*2	Metabolism/PK	increased	LADME	Healthy		M02AA13	*1/*2
cisplatin, cyclophosphamide	rs36120609	GSTM3	TCCTC/TCCTC	Toxicity	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs36120609:TCCTC/TCCTC
aspirin, clopidogrel	rs4244285	CYP2C19	A	Toxicity	Indeterminado	Adverse_Event	Other:drug-eluting_stents		B01AC04	rs4244285:A
none	rs1801123	IRS1	C	Other	Indeterminado	Other	Disease:C1458155		A03DA02	rs1801123:C
estradiol	rs1864729	__INTRONIC__	A	Other	increased	Other	Disease:C1458155		G03CA03	rs1864729:A
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28
gefitinib	rs11568315	EGFR	(CA)16/(CA)16	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)16
gefitinib	rs11568315	EGFR	(CA)16/(CA)17	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)17
acenocoumarol, warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Disease:C0004238|Disease:C1861172		B01AA03|B01AA07	*3
gefitinib	rs11568315	EGFR	(CA)16/(CA)16	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)16
gefitinib	rs11568315	EGFR	(CA)16/(CA)17	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)17
carbimazole, methimazole, propylthiouracil	HLA-DRB1*08:03	HLA-DRB1	*08:03	Toxicity	increased	Adverse_Event	Disease:C0242656		H03BA02|H03BB01	*08:03
anthracyclines and related substances	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB	
ethambutol, isoniazid, pyrazinamide, rifampin	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	__UNKNOWN__
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB04	*2
diclofenac	rs717620	ABCC2	T	Toxicity	increased	Adverse_Event	Healthy		S01BC03	rs717620:T
antiarrhythmics, class i and iii	rs10033464	__INTRONIC__	GG	Efficacy	increased	Adverse_Event	Disease:C0004238		C01B	rs10033464:GG
carbimazole, methimazole	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Disease:C0242656		H03BB01	*38:02
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2/*3
gefitinib	rs11568315	EGFR	(CA)16/(CA)16	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)16
gefitinib	rs11568315	EGFR	(CA)16/(CA)17	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)17
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	*3
gefitinib	rs11568315	EGFR	(CA)16/(CA)16	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)16
gefitinib	rs11568315	EGFR	(CA)16/(CA)17	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)17
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*3
rifampicin	SLCO1B1*15	SLCO1B1	*15	Toxicity	increased	Adverse_Event	Healthy		J04AB02	*15
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	*2
fluvoxamine, paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08	
fluvoxamine, paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele)/L allele-rs25531C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08	
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Other	decreased	Other	Healthy	poor metabolizer	N05AX08	*4/*5
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Other	decreased	Other	Healthy	poor metabolizer	N05AX08	*4/*6
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Other	decreased	Other	Healthy	poor metabolizer	N05AX08	*3/*4
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Other	decreased	Other	Healthy	poor metabolizer	N05AX08	*4/*4
none	rs2854744	IGFBP3	T	Other	Indeterminado	Other	Disease:C1458155		A03DA02	rs2854744:T
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*28
carbamazepine	HLA-A*24:02	HLA-A	*24:02	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*24:02
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11
nevirapine	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	
cisplatin, cyclophosphamide	rs36120609	GSTM3	TCCTC/TCCTC	Toxicity	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs36120609:TCCTC/TCCTC
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
carbamazepine	HLA-B*40:01	HLA-B	*40:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*40:01
cisplatin, cyclophosphamide	rs36120609	GSTM3	TCCTC/TCCTC	Toxicity	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs36120609:TCCTC/TCCTC
paroxetine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB05	*4/*5
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*3
none	rs36120609	GSTM3	TC/TC	Other	increased	Adverse_Event	Other:C0029463		A03DA02	rs36120609:TC/TC
none	rs36120609	GSTM3	TC/TCCTC	Other	increased	Adverse_Event	Other:C0029463		A03DA02	rs36120609:TC/TCCTC
fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*5/*4
fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*1/*3
fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*1/*4
fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*1/*5
fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*6	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*1/*6
peginterferon alfa-2b, ribavirin, telaprevir	rs1127354	ITPA	CC	Other	Indeterminado	Adverse_Event	Disease:C0019158		J05AP01|J05AP02|L03AB10	rs1127354:CC
carboplatin, cyclophosphamide, thiotepa	rs6151031	ALDH1A1	CTGGTGAGGAGAGAACC/del	Toxicity	increased	Adverse_Event	Disease:C0027651		L01AA01|L01AC01|L01XA02	rs6151031:CTGGTGAGGAGAGAACC/del
antithyroid preparations	HLA-B*27:05	HLA-B	*27:05	Toxicity	increased	Adverse_Event	Healthy		H03B	*27:05
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	*1/*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	*2/*2
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	*1/*28
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	*6/*28
paroxetine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N06AB05	*1/*4
paroxetine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Healthy		N06AB05	*1/*5
diclofenac	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Metabolism/PK	increased	LADME	Healthy		S01BC03	*1/*3
diclofenac	CYP2C8*1, CYP2C8*3	CYP2C8	*3/*3	Metabolism/PK	increased	LADME	Healthy		S01BC03	*3/*3
paroxetine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB05	*3/*4
heparin	HLA-DRB3*01:01	HLA-DRB3	*01:01	Toxicity	increased	Adverse_Event	Healthy		S01XA14	*01:01
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*2
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*6	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*6
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28
peginterferon alfa-2b, ribavirin, simeprevir	rs11322783	IFNL4	TT/TT	Toxicity	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10	rs11322783:TT/TT
citalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB04	
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
ibuprofen	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*1/*3
tenoxicam	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Healthy		M01AC02	*1/*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2
tenoxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		M01AC02	*1/*3
efavirenz, lamivudine, stavudine, zidovudine	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF01|J05AF04|J05AF05|J05AG03	*6
tamoxifen	low activity	CYP2D6	__UNKNOWN__	Efficacy	increased	Adverse_Event	Disease:C1458155	low activity	L02BA01	__UNKNOWN__
piroxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		M02AA07	*1/*3
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*9, CYP2A6*10	CYP2A6	*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*9, CYP2A6*10	CYP2A6	*10	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*10
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*9, CYP2A6*10	CYP2A6	*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9
aspirin, clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*17
lumiracoxib	HLA-DQA1*01:01, HLA-DQA1*01:02	HLA-DQA1	*01:02	Toxicity	increased	Adverse_Event	Healthy		M01AH06	*01:02
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2
paroxetine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0028768		N06AB05	*4/*4
ibuprofen	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Other	decreased	Other	Healthy		M02AA13	*1/*2
irinotecan	rs2070959	UGT1A6	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs2070959:A
ibuprofen	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Metabolism/PK	increased	LADME	Healthy		M02AA13	*1/*3
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Other:C0023055		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
imatinib	rs2072454	EGFR	CC	Toxicity	increased	Adverse_Event	Other:C0238198		L01EA01	rs2072454:CC
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*3	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*1/*3
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*1/*4
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*5	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*1/*5
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*6	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*1/*6
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*41	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*4/*41
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*6/*10	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*6/*10
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*10/*10
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*41/*41	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*41/*41
piroxicam	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Efficacy	increased	Efficacy_Response	Healthy		M02AA07	*1/*2
piroxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		M02AA07	*1/*3
piroxicam	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Healthy		M02AA07	*1/*2
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*114	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Disease:C0007131		L01EB01	*10/*10
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	G	Efficacy	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:G
citalopram, escitalopram	rs1065852	CYP2D6	A	Other	Indeterminado	Other	Disease:C0011581		N06AB04|N06AB10	rs1065852:A
hydrochlorothiazide	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs1799752:del/del
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0027051|Disease:C0027051		B01AC04	*1/*1
carbamazepine, lamotrigine, phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	Indeterminado	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*15:02
mirtazapine	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	increased	LADME	Healthy		N06AX11	*1/*1xN
tacrolimus	CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0026896		L04AD02	*3/*3
none	CYP2D6*2xN	CYP2D6	*2xN	Other	increased	Adverse_Event	Other:gene_duplication/multiduplication		A03DA02	*2xN
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy	increased	Adverse_Event	Disease:C0027651		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy	increased	Adverse_Event	Disease:C0027651		B01AA03	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*3
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Adverse_Event	Healthy		B01AA03	*3
mirtazapine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AX11	*4/*4
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
none	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Other	decreased	Adverse_Event	Healthy		A03DA02	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*3
irinotecan	rs11692021	UGT1A9	C	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs11692021:C
metoprolol	rs1042714	ADRB2	CG	Toxicity	increased	Adverse_Event	Disease:C0020538		C07AB02	rs1042714:CG
lamotrigine	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AX09	*33:03
tamoxifen	rs2016347	IGF1R	GG	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	rs2016347:GG
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*1/*28
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*28/*28
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027651		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0027651		B01AA03	*1/*3
none	CYP2D6*1xN	CYP2D6	*1xN	Other	increased	Adverse_Event	Other:gene_duplication/multiduplication		A03DA02	*1xN
allopurinol	HLA-B*48:01	HLA-B	*48:01	Toxicity	increased	Adverse_Event	Disease:C0745761		M04AA01	*48:01
paclitaxel	rs10509681	CYP2C8	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs10509681:C
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*1/*28
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*28/*28
pazopanib	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0919267|Disease:C1261473|Disease:C1561230		L01EX03	*57:01
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*1/*28
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*28/*28
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
quetiapine	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*1/*2	Metabolism/PK	increased	Adverse_Event	Healthy		N05AH04	*1/*2
quetiapine	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*2/*2	Metabolism/PK	increased	Adverse_Event	Healthy		N05AH04	*2/*2
quetiapine	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*2/*4	Metabolism/PK	increased	Adverse_Event	Healthy		N05AH04	*2/*4
caffeine	rs35060421	ADORA2A	TTTTTTT/TTTTTTT	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs35060421:TTTTTTT/TTTTTTT
allopurinol	HLA-DRB1*14:01	HLA-DRB1	*14:01	Toxicity	increased	Adverse_Event	Disease:C0745761		M04AA01	*14:01
allopurinol	HLA-DRB1*09:01	HLA-DRB1	*09:01	Toxicity	increased	Adverse_Event	Disease:C0745761		M04AA01	*09:01
ethambutol, isoniazid, pyrazinamide, rifampin	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	__UNKNOWN__
zonisamide	HLA-A*02:07	HLA-A	*02:07	Toxicity	Indeterminado	Adverse_Event	Healthy		N03AX15	*02:07
phenobarbital	HLA-B*51:01	HLA-B	*51:01	Toxicity	Indeterminado	Adverse_Event	Healthy		N03AA02	*51:01
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*1/*28
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*17/*17
tramadol	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative		N02AX02	*10/*10
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
lamivudine, nevirapine, stavudine	HLA-B*35:05	HLA-B	*35:05	Toxicity	Indeterminado	Adverse_Event	Disease:HIV_infectious_disease		J05AF04|J05AF05|J05AG01	*35:05
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28
methotrexate	rs3740065	ABCC2	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3740065:AG
methotrexate	rs3740065	ABCC2	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3740065:GG
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0740394		M04AA01	*58:01
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
metoprolol	rs1042714	ADRB2	CC	Toxicity	decreased	Adverse_Event	Disease:C0020538		C07AB02	rs1042714:CC
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
methotrexate	rs9516519	ABCC4	GG	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs9516519:GG
methotrexate	rs9516519	ABCC4	GT	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs9516519:GT
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0022661		M04AA01	*58:01
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
azathioprine, mercaptopurine, thioguanine	rs746071566	NUDT15	del	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L01BB03|L04AX01	rs746071566:del
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AG
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	*2/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	*2/*3
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	*2/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	*2/*3
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB05	
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB05	
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Dosage, Metabolism/PK	decreased	LADME	Disease:C0004936		N06AB10	*17/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*3/*3
mirtazapine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AX11	
escitalopram	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Dosage, Metabolism/PK	increased	LADME	Disease:C0004936		N06AB10	*3
lisinopril	rs35068180	MMP3	del/del	Efficacy	decreased	Adverse_Event	Disease:C0020538		C09AA03	rs35068180:del/del
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*3
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AB05	
acenocoumarol, warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Disease:C0004238|Disease:C1861172		B01AA03|B01AA07	*2
escitalopram	CYP2D6*1, CYP2D6*4, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	*4/*41
peginterferon alfa-2a, peginterferon alfa-2b	rs11322783	IFNL4	TT/TT	Efficacy	increased	Adverse_Event	Disease:C0019372		L03AB10|L03AB11	rs11322783:TT/TT
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Toxicity	increased	Efficacy_Response	Healthy		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Efficacy_Response	Healthy		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Toxicity	increased	Efficacy_Response	Healthy		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Toxicity	increased	Efficacy_Response	Healthy		B01AC04	*2/*2
fentanyl	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0027651|Disease:C0030193		N02AB03	*3/*3
direct acting antivirals, sofosbuvir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05A|J05AP08	rs11322783:TT/TT
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Dosage, Metabolism/PK	increased	LADME	Disease:C0004936		N06AB10	*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Other	Disease:C0027051		B01AC04	*2
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28
citalopram	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB04	__UNKNOWN__
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Disease:C0022661		M04AA01	*03:02
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*6
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	increased	Adverse_Event	Healthy		J05AG03	*6/*6
allopurinol	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Disease:C0022661		M04AA01	*33:03
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Disease:C0022661		M04AA01	*03:02
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0024121		No_ATC	*28/*28
efavirenz	CYP2B6*1, CYP2B6*9	CYP2B6	*9	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*9
capecitabine, fluorouracil	rs56038477	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs56038477:CT
clopidogrel	CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*2/*2
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	UGT1A6*2a	UGT1A6	*2a	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03|L01CE02|L01XA03	*2a
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*28/*28
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*28
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	UGT1A1*28	UGT1A1	*28	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*28
folfox	rs11280056	TYMS	TTA/TTA	Toxicity	increased	Adverse_Event	Other:C0027651		No_ATC	rs11280056:TTA/TTA
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	UGT1A1*60	UGT1A1	*60	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*60
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*10
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
drugs for treatment of tuberculosis	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*04:01
isoniazid, rifampin	NAT2*4	NAT2	*4	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0041296		J04AC01	*4
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3
methotrexate	rs11280056	TYMS	TTA/TTA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs11280056:TTA/TTA
efavirenz	CYP2B6*1, CYP2B6*9	CYP2B6	*9/*9	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*9/*9
efavirenz	CYP2B6*1, CYP2B6*9	CYP2B6	*1/*9	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*1/*9
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*2	Efficacy	increased	Adverse_Event	Disease:C0007787|Disease:C0018839		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*3	Efficacy	increased	Adverse_Event	Disease:C0007787|Disease:C0018839		B01AC04	*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*8	Efficacy	increased	Adverse_Event	Disease:C0007787|Disease:C0018839		B01AC04	*8
folfox	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Other:C0027651		No_ATC	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
mercaptopurine, methotrexate	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	*1/*2
mercaptopurine, methotrexate	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	*1/*3A
mercaptopurine, methotrexate	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B	TPMT	*3A/*3B	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	*3A/*3B
egfr inhibitors	HLA-A*02:01	HLA-A	*02:01	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01EB	*02:01
cyclophosphamide, fludarabine	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Toxicity	decreased	Adverse_Event	Disease:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01|L01BB05	*1/*6
cyclophosphamide, fludarabine	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	decreased	Adverse_Event	Disease:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01|L01BB05	*6/*6
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
antineoplastic agents, tamoxifen	UGT2B15*1, UGT2B15*2	UGT2B15	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*2/*2
antineoplastic agents, tamoxifen	UGT2B15*1, UGT2B15*2	UGT2B15	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*1/*2
egfr inhibitors	HLA-A*03:01	HLA-A	*03:01	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01EB	*03:01
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*1/*28
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28
docetaxel	rs3834935	SLCO1B3	A	Other, Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs3834935:A
carbamazepine, phenytoin, valproic acid	rs2279020	GABRA1	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AB02|N03AF01|N03AG01	rs2279020:GG
paclitaxel	CYP2C8*2, CYP2C8*3, CYP2C8*4	CYP2C8	*2	Toxicity	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L01CD01	*2
paclitaxel	CYP2C8*2, CYP2C8*3, CYP2C8*4	CYP2C8	*3	Toxicity	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L01CD01	*3
paclitaxel	CYP2C8*2, CYP2C8*3, CYP2C8*4	CYP2C8	*4	Toxicity	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L01CD01	*4
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3
ethambutol, isoniazid, pyrazinamide, rifampin	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*6
amoxicillin, clavulanate	HLA-A*30:02	HLA-A	*30:02	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*30:02
citalopram, escitalopram	rs1074145	__INTRONIC__	A	Other	Indeterminado	Other	Disease:C0011581		N06AB04|N06AB10	rs1074145:A
nevirapine	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*06:02
nevirapine	HLA-DQB1*06:03	HLA-DQB1	*06:03	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*06:03
antineoplastic agents, tamoxifen	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*2/*2
nevirapine	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*06:02
nevirapine	HLA-DRB1*15:03	HLA-DRB1	*15:03	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*15:03
nevirapine	HLA-DQB1*06:09	HLA-DQB1	*06:09	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*06:09
nevirapine	HLA-DQB1*02:01	HLA-DQB1	*02:01	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*02:01
imatinib	rs11636419	CYP1A2	AA	Toxicity	increased	Adverse_Event	Other:C0238198		L01EA01	rs11636419:AA
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Other	Healthy		B01AC04	*2
nevirapine	HLA-DQB1*02:01	HLA-DQB1	*02:01	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*02:01
nevirapine	HLA-DQB1*03:02	HLA-DQB1	*03:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*03:02
nevirapine	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*06:02
nevirapine	HLA-DQB1*03:02	HLA-DQB1	*03:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*03:02
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*04:01
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*04:01
ethanol	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Healthy		V03AB16	
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*17
nevirapine	HLA-DQB1*05:01	HLA-DQB1	*05:01	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*05:01
carbamazepine, phenytoin, valproic acid	rs2279020	GABRA1	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AB02|N03AF01|N03AG01	rs2279020:G
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*3/*17	Other	Indeterminado	Other	Healthy		C07AB02	*3/*17
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*3/*4	Other	Indeterminado	Other	Healthy		C07AB02	*3/*4
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*10	Other	Indeterminado	Other	Healthy		C07AB02	*4/*10
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*17	Other	Indeterminado	Other	Healthy		C07AB02	*4/*17
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*4	Other	Indeterminado	Other	Healthy		C07AB02	*4/*4
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*41	Other	Indeterminado	Other	Healthy		C07AB02	*4/*41
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*5	Other	Indeterminado	Other	Healthy		C07AB02	*4/*5
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*6	Other	Indeterminado	Other	Healthy		C07AB02	*4/*6
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*5/*10	Other	Indeterminado	Other	Healthy		C07AB02	*5/*10
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*5/*17	Other	Indeterminado	Other	Healthy		C07AB02	*5/*17
bucillamine	HLA-DRB1*08:02	HLA-DRB1	*08:02	Toxicity	increased	Adverse_Event	Disease:C0003873		No_ATC	*08:02
mercaptopurine	deficiency	TPMT	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	deficiency	L01BB02	__UNKNOWN__
azathioprine, cyclosporine, prednisone	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		H02AB07|L04AD01|L04AX01	*1/*2
azathioprine, cyclosporine, prednisone	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		H02AB07|L04AD01|L04AX01	*1/*3A
azathioprine, cyclosporine, prednisone	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		H02AB07|L04AD01|L04AX01	*1/*3C
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28
bucillamine	HLA-DQB1*04:02	HLA-DQB1	*04:02	Toxicity	increased	Adverse_Event	Disease:C0003873		No_ATC	*04:02
cyclophosphamide	rs3211371	CYP2B6	CT	Efficacy	increased	Efficacy_Response	Disease:C0024299		L01AA01	rs3211371:CT
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*2/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*5	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*5
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*6	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*6
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*11	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*11
sulfamethoxazole / trimethoprim	HLA-C*06:02	HLA-C	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*06:02
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J04BA02	*13:01
dapsone	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		J04BA02	*15:02
lapatinib	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Disease:C1458155		L01EH01	*02:01
dapsone	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		J04BA02	*15:02
lapatinib	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C1458155		L01EH01	*07:01
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J04BA02	*13:01
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2
mercaptopurine	deficiency	ABCC4	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	deficiency	L01BB02	
clopidogrel	rs4244285	CYP2C19	A	Efficacy	Indeterminado	Other	Healthy		B01AC04	rs4244285:A
amoxicillin, clavulanate	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*06:02
clozapine	HLA-DQB1*05:02	HLA-DQB1	*05:02	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*05:02
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Adverse_Event	Other:patients_undergoing_PCI		B01AC04	*2
aspirin	HLA-DQB1*06:09	HLA-DQB1	*06:09	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*06:09
aspirin, clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Other:patients_undergoing_PCI		B01AC04	*3
aspirin	HLA-DRB1*13:02	HLA-DRB1	*13:02	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*13:02
sulfamethoxazole / trimethoprim	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*15:02
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*1/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*28/*28
clozapine	HLA-DQB1*05:02	HLA-DQB1	*05:02	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*05:02
clozapine	HLA-DPB1*04:01	HLA-DPB1	*04:01	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*04:01
clozapine	HLA-DRB5*02:02	HLA-DRB5	*02:02	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*02:02
sulfamethoxazole / trimethoprim	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*08:01
aspirin, clopidogrel, prasugrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	decreased	Adverse_Event	Disease:C0039338		B01AC04|B01AC22	*17/*17
aspirin, clopidogrel, prasugrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	decreased	Adverse_Event	Disease:C0039338		B01AC04|B01AC22	*1/*17
oxcarbazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF02	*15:02
amoxicillin, clavulanate	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*15:01
paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531T/L allele-rs25531T	Other	Indeterminado	Other	Disease:C0011581		N06AB05	
amoxicillin, clavulanate	HLA-DRB5*01:01	HLA-DRB5	*01:01	Toxicity	increased	Adverse_Event	Disease:C0699744		J01CA04	*01:01
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Healthy		L01EX02	*1/*28
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Healthy		L01EX02	*28/*28
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Healthy		L01EX02	*1/*28
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Healthy		L01EX02	*28/*28
amoxicillin, clavulanate	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Disease:C0699744		J01CA04	*15:01
sunitinib	rs1128503	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1128503:AA
sunitinib	rs1128503	ABCB1	AG	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1128503:AG
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3
ticlopidine	HLA-DRB1*13:02	HLA-DRB1	*13:02	Toxicity	increased	Adverse_Event	Healthy		B01AC05	*13:02
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Other:patients_that_had_undergone_coronary_angiography_or_had_an_uneventful_PCI		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Other:patients_that_had_undergone_coronary_angiography_or_had_an_uneventful_PCI		B01AC04	*3
amitriptyline	CYP2D6*1, CYP2D6*41	CYP2D6	*41	Other, Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*41
ticlopidine	HLA-C*14:03	HLA-C	*14:03	Toxicity	increased	Adverse_Event	Healthy		B01AC05	*14:03
cyclophosphamide	rs3211371	CYP2B6	CT	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L01AA01	rs3211371:CT
atorvastatin	rs1805094	LEPR	GG	Other	increased	Other	Disease:C0027051		C10AA05	rs1805094:GG
ticlopidine	HLA-DQB1*06:04	HLA-DQB1	*06:04	Toxicity	increased	Adverse_Event	Healthy		B01AC05	*06:04
ticlopidine	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Healthy		B01AC05	*33:03
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*28/*28
busulfan, cytarabine, etoposide	rs4148405	ABCC3	G	Efficacy, Toxicity	decreased	Other	Disease:C0023418|Myeloid|Acute		L01AB01|L01BC01|L01CB01	rs4148405:G
ticlopidine	HLA-B*44:03	HLA-B	*44:03	Toxicity	increased	Adverse_Event	Healthy		B01AC05	*44:03
cocaine, ethanol, nicotine	rs1799972	OPRM1	TT	Toxicity	increased	Adverse_Event	Healthy		N01BC01|N07BA01|V03AB16	rs1799972:TT
nevirapine	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*08:01
antipsychotics	rs4680	COMT	A	Other	increased	Other	Disease:C0036341		N05A	rs4680:A
isoniazid	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	__UNKNOWN__
aspirin	HLA-DRB1*09:01	HLA-DRB1	*09:01	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	*09:01
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*3
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*6/*6
aspirin	HLA-DPB1*05:01	HLA-DPB1	*05:01	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	*05:01
clopidogrel	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__
drugs for treatment of tuberculosis	CYP2E1*1A, CYP2E1*5B	CYP2E1	*1A/*5B	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*1A/*5B
aspirin	HLA-DQB1*03:03	HLA-DQB1	*03:03	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	*03:03
drugs for treatment of tuberculosis	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	__UNKNOWN__
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
aspirin	HLA-DRB1*13:02	HLA-DRB1	*13:02	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*13:02
mercaptopurine, thioguanine	TPMT*1, TPMT*3C	TPMT	*1/*3C	Toxicity	Indeterminado	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*3C
aspirin	HLA-DQB1*06:09	HLA-DQB1	*06:09	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*06:09
fluticasone propionate	rs2569190	CD14, TMCO6	AA	Other	decreased	Efficacy_Response	Disease:C0004096		R03BA05	rs2569190:AA
fluticasone propionate	rs2569190	CD14, TMCO6	AG	Other	decreased	Efficacy_Response	Disease:C0004096		R03BA05	rs2569190:AG
bleomycin, dacarbazine, doxorubicin, vinblastine	GSTM1 non-null, GSTM1 null	GSTM1	non-null/non-null	Toxicity	decreased	Adverse_Event	Disease:C0019829		L01AX04|L01CA01|L01DB01|L01DC01	
efavirenz, nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01|J05AG03	*01:01
nevirapine	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*15:01
ethanol	rs1229984	ADH1B	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1229984:T
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*04:01
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*28/*28
isoniazid, rifampin	GSTT1 null	GSTT1	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0041296		J04AC01	
capecitabine, fluorouracil, tegafur	rs56038477	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs56038477:T
isoniazid, rifampin	GSTM1 null	GSTM1	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0041296		J04AC01	
allopurinol	HLA-DQB1*05:02	HLA-DQB1	*05:02	Toxicity	increased	Adverse_Event	Disease:C0013182		M04AA01	*05:02
ethambutol, isoniazid, pyrazinamide, rifampin	GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3A
nevirapine	HLA-B*35:01	HLA-B	*35:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*35:01
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3A
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
methadone	rs3735451	CYP3A4	C	Other	increased	Adverse_Event	Disease:C0028043		N07BC02	rs3735451:C
irinotecan	UGT1A1*1, UGT1A1*27	UGT1A1	*1/*27	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	*1/*27
clozapine	CYP2C19*17	CYP2C19	*17/*17	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02	*17/*17
nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*01:01
clozapine	HLA-B*59:01	HLA-B	*59:01	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*59:01
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	*1/*6
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*04:01
phenytoin	HLA-B*07:02, HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*13:01
fluoxetine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	Indeterminado	LADME	Disease:C0004936		N06AB03	*4/*4
none	rs920829	TRPA1	CT	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs920829:CT
none	rs920829	TRPA1	TT	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs920829:TT
ethanol	rs671	ALDH2	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs671:A
none	deficiency	NAT2	__UNKNOWN__	Other	Indeterminado	Adverse_Event	Healthy	deficiency	A03DA02	__UNKNOWN__
fluoxetine	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB03	*1/*2
fluoxetine	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB03	*1/*3
nortriptyline	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA10	*1/*4
nortriptyline	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA10	*1/*5
ritodrine	rs10774053	CACNA1C	AA	Other	decreased	Adverse_Event	Disease:C0022876		G02CA01	rs10774053:AA
ritodrine	rs10774053	CACNA1C	AG	Other	decreased	Adverse_Event	Disease:C0022876		G02CA01	rs10774053:AG
spironolactone	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	Indeterminado	Efficacy_Response	Other:C0745744		C03DA01	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
spironolactone	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del	Efficacy	Indeterminado	Efficacy_Response	Other:C0745744		C03DA01	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT
warfarin	rs429358	APOE	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs429358:TT
warfarin	rs7412	APOE	CC	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs7412:CC
amoxicillin, clavulanate, flucloxacillin	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	*06:02
atorvastatin, quinapril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA06|C10AA05	rs1799752:del/del
timolol	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy, Metabolism/PK	increased	LADME	Healthy	poor metabolizer	S01ED01	__UNKNOWN__
lansoprazole	normal metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	Other	Healthy	normal metabolizer	A02BC03	__UNKNOWN__
amoxicillin, clavulanate, flucloxacillin	HLA-C*06:02	HLA-C	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	*06:02
rabeprazole	normal metabolizer	CYP2C19	__UNKNOWN__	Efficacy	decreased	Other	Healthy	normal metabolizer	A02BC04	__UNKNOWN__
none	rs1615111	AREG	A	Other	decreased	Other	Disease:C0001418		A03DA02	rs1615111:A
cisplatin, epirubicin, fluorouracil	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus|Disease:C0026640		L01BC02|L01DB03|L01XA01	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*3
atorvastatin, quinapril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA06|C10AA05	rs1799752:del/del
atorvastatin, quinapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C09AA06|C10AA05	rs1799752:del/del
amoxicillin, clavulanate, flucloxacillin	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	*57:01
clopidogrel	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2/*2
vincristine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	*1/*3
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2
ethanol	rs2031920	CYP2E1	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs2031920:T
cisplatin, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CE02|L01XA01	*1/*28
cisplatin, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CE02|L01XA01	*28/*28
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Other	increased	Adverse_Event	Disease:C0004238|Disease:C0004239|Disease:C0042487		B01AA07	*3
tolterodine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		G04BD07	*10/*10
tolterodine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Healthy		G04BD07	*5/*10
amoxicillin, clavulanate, flucloxacillin	HLA-DQB1*03:03	HLA-DQB1	*03:03	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	*03:03
phenytoin	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*3
anastrozole	rs1008805	CYP19A1	GG	Other	decreased	Adverse_Event	Disease:C1458155		L02BG03	rs1008805:GG
ace inhibitors, plain	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
olanzapine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*1
cyclophosphamide, epirubicin, fluorouracil	rs41412545	INSR	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs41412545:A
cyclosporine, methotrexate	rs2177735	ATIC	AA	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs2177735:AA
levetiracetam	HLA-A*11:01	HLA-A	*11:01	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AX14	*11:01
allopurinol	HLA-DRB1*03:01	HLA-DRB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*03:01
cyclophosphamide, epirubicin, fluorouracil	rs56022120	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs56022120:T
valproic acid	rs6759892	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	G	Dosage, Metabolism/PK	increased	LADME	Healthy		N03AG01	rs6759892:G
valproic acid	rs2070959	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	G	Dosage, Metabolism/PK	increased	LADME	Healthy		N03AG01	rs2070959:G
cyclophosphamide, epirubicin, fluorouracil	rs138602176	PIK3R2	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs138602176:A
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*03:02
phenytoin	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*02:01
nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*01:01
clopidogrel	rs5853517	MED12L, P2RY12	T/del	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs5853517:T/del
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2/*2
phenytoin	HLA-A*24:02	HLA-A	*24:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*24:02
exemestane	rs16964189	__INTRONIC__	TT	Toxicity	Indeterminado	Adverse_Event	Disease:C1458155		L02BG06	rs16964189:TT
cyclophosphamide, epirubicin, fluorouracil	rs78428806	PERP	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs78428806:A
aspirin, clopidogrel, prasugrel	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	increased	Adverse_Event	Disease:C0039338		B01AC04|B01AC22	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*3
fluorouracil	deficiency	DPYD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	deficiency	L01BC02	__UNKNOWN__
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
antipsychotics	rs11123469	INSIG2	CC	Efficacy	increased	Adverse_Event	Disease:C0036341		N05A	rs11123469:CC
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2
fenofibrate, sertraline, terbinafine, ticlopidine	HLA-A*33:01	HLA-A	*33:01	Toxicity	increased	Adverse_Event	Healthy		B01AC05|C10AB05|D01BA02|N06AB06	*33:01
carbamazepine, phenytoin, valproic acid	rs2032582	ABCB1	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AB02|N03AF01|N03AG01	rs2032582:T
fluorouracil, leucovorin, oxaliplatin	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2
fluorouracil, leucovorin, oxaliplatin	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/3	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/3
warfarin	CYP4F2*1, CYP4F2*3	CYP4F2	*3	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004238		B01AA03	*3
aspirin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0007222		No_ATC	*1/*3
capecitabine, fluorouracil, tegafur	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs67376798:A
metoprolol	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		C07AB02	*1/*4
metoprolol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		C07AB02	*4/*4
fluorouracil	deficiency	DPYD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0027651	deficiency	L01BC02	__UNKNOWN__
atazanavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	*28
none	rs2285666	ACE2	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs2285666:C
"""ace inhibitors, plain"", ""beta blocking agents"", ""calcium channel blockers"", ""digoxin"", ""diuretics"""	rs1799752	ACE	del	Efficacy	increased	Efficacy_Response	Disease:C0085605		C03|C08|C09A|S01ED	rs1799752:del
ivacaftor, tezacaftor	rs113993960	CFTR	del/del	Other	decreased	Adverse_Event	Disease:C0156318		R07AX02|R07AX31	rs113993960:del/del
mercaptopurine	TPMT*1, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3C
desipramine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N06AA01	*1/*1
pamaquine	deficiency	G6PD	__UNKNOWN__	Toxicity	Indeterminado	Adverse_Event	Other:G6PD_deficient_mice	deficiency	No_ATC	
metoprolol	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Efficacy, Other	increased	Other	Healthy		C07AB02	*1/*4
metoprolol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy, Other	increased	Other	Healthy		C07AB02	*4/*4
primaquine	deficiency	G6PD	__UNKNOWN__	Toxicity	Indeterminado	Adverse_Event	Other:G6PD_deficient_mice	deficiency	P01BA03	
itraconazole, ketoconazole	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Other, Metabolism/PK	decreased	Adverse_Event	Other:Human_Liver_Microsomes		J02AB02|J02AC02	*1/*1
itraconazole, ketoconazole	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Other, Metabolism/PK	decreased	Adverse_Event	Other:Human_Liver_Microsomes		J02AB02|J02AC02	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	*3
hmg coa reductase inhibitors	rs3764261	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs3764261:A
capecitabine	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Adverse_Event	Disease:C0010068		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Disease:C0010068		B01AC04	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Adverse_Event	Healthy		B01AA04	*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Adverse_Event	Healthy		B01AA04	*3
osimertinib	rs28399433	CYP2A6	CC	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01EB04	rs28399433:CC
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	*3
amitriptyline, fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*1xN	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09|N06AB03	*1/*1xN
amitriptyline, fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	*2/*2xN	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09|N06AB03	*2/*2xN
pazopanib, pemetrexed	rs833061	VEGFA	CC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BA04|L01EX03	rs833061:CC
pazopanib, pemetrexed	rs833061	VEGFA	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BA04|L01EX03	rs833061:CT
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3
penicillin g, penicillin v	HLA-B*55:01	HLA-B	*55:01	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*55:01
ethanol	rs2948694	GHSR	AG	Other	Indeterminado	Other	Healthy		V03AB16	rs2948694:AG
opioids	rs495491	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs495491:AG
opioids	rs495491	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs495491:GG
opioids	rs10457090	OPRM1	AA	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs10457090:AA
opioids	rs10457090	OPRM1	AG	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs10457090:AG
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	*1/*3
allopurinol	HLA-B*58:01	HLA-B	*58:01/*58:01	Toxicity	increased	Adverse_Event	Disease:C0235889|Gouty		M04AA01	*58:01/*58:01
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*15:02
carbamazepine, phenytoin, valproic acid	rs17183814	SCN2A	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AB02|N03AF01|N03AG01	rs17183814:A
warfarin	CYP2C9*2	CYP2C9	*2	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*2
atorvastatin, pravastatin, simvastatin	rs1935349	HTR7	T	Toxicity	increased	Adverse_Event	Disease:C0020443		C10AA01|C10AA03|C10AA05	rs1935349:T
methotrexate	rs45445694	TYMS	CCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC	Toxicity	increased	Adverse_Event	Disease:C0235763		L04AX03	rs45445694:CCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC
nevirapine	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*6/*18	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*6/*18
docetaxel, tegafur	CYP2A6*1, CYP2A6*4	CYP2A6	*4/*4	Efficacy	decreased	Adverse_Event	Disease:C0026640		L01BC03|L01CD02	*4/*4
cisplatin	rs1799793	ERCC2	T	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01XA01	rs1799793:T
carbamazepine	HLA-B*40:01	HLA-B	*40:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*40:01
cocaine	rs3836790	SLC6A3	CACATACCATGCAACATACACACTCAGACA/CACATACCATGCAACATACACACTCAGACA	Toxicity	increased	Adverse_Event	Disease:C0278080		N01BC01	rs3836790:CACATACCATGCAACATACACACTCAGACA/CACATACCATGCAACATACACACTCAGACA
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	*2
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*15:02
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2
phenytoin	HLA-DRB1*16:02	HLA-DRB1	*16:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*16:02
paroxetine	CYP2D6*1, CYP2D6*4, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N06AB05	*1/*4
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Side_Effect:C0235030		N03AB02	*1/*3
ibuprofen	CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		M02AA13	*3
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*1/*1
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	*1/*1
acetaminophen	CYP2E1*1, CYP2E1*5B	CYP2E1	*1/*5B	Metabolism/PK	increased	LADME	Disease:C0341439		N02BE01	*1/*5B
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	LADME	Disease:C0023449		L01BB02	*1/*3A
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Other	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Other	Healthy		B01AA03	*3/*3
warfarin	CYP2C9*2	CYP2C9	*2	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*2
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*2
warfarin	CYP2C9*1, CYP2C9*3, CYP2C9*4	CYP2C9	*1/*3	Dosage	decreased	Other	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*3, CYP2C9*4	CYP2C9	*1/*4	Dosage	decreased	Other	Healthy		B01AA03	*1/*4
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01
mercaptopurine	rs73032311	CYP2A7	C	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs73032311:C
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2/*2
bupropion	CYP2B6*18	CYP2B6	*18	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*18
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*1/*1
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*1/*1
antiepileptics, carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03A|N03AF01	*15:02
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*2/*3
phenytoin	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*13:01
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*3
none	NAT1*10, NAT1*11A	NAT1	*10/*11A	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*10/*11A
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Other	Healthy		B01AA03	*2
none	NAT1*4, NAT1*10	NAT1	*10/*4	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*10/*4
isoniazid, pyrazinamide, rifampin	GSTT1 null	GSTT1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	
drugs for treatment of tuberculosis	slow acetylator	NAT2	*5	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*5
paclitaxel	CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Disease:C0919267		L01CD01	*3
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6
clopidogrel	CYP2C19*2	CYP2C19	*2	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	*2
irinotecan, raltitrexed	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BA03|L01CE02	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2
clopidogrel	CYP2C19*3	CYP2C19	*3	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	*3
temsirolimus	rs6785049	NR1I2	AG	Toxicity	decreased	Adverse_Event	Disease:C0877645		L01EG01	rs6785049:AG
temsirolimus	rs6785049	NR1I2	GG	Toxicity	decreased	Adverse_Event	Disease:C0877645		L01EG01	rs6785049:GG
tacrolimus	rs2242480	CYP3A4	C/C	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:C/C
none	NAT1*3, NAT1*11B	NAT1	*11B/*3	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*11B/*3
none	NAT1*10	NAT1	*10/*10	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*10/*10
oxcarbazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*15:02
calcineurin inhibitors, cyclosporine, tacrolimus	CYP2C8*3	CYP2C8	*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD|L04AD01|L04AD02	*3
daunorubicin	rs10932125	NRP2	C	Dosage, Metabolism/PK	increased	LADME	Healthy		L01DB02	rs10932125:C
cisplatin, cyclophosphamide	rs1799735	GSTM3	CCT/CCT	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1799735:CCT/CCT
cisplatin, cyclophosphamide	rs1799735	GSTM3	CCT/CCT	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1799735:CCT/CCT
cisplatin, cyclophosphamide	rs1799735	GSTM3	CCT/CCT	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1799735:CCT/CCT
metoprolol	rs5030655	CYP2D6	del/del	Other	increased	LADME	Healthy		C07AB02	rs5030655:del/del
antidepressants	rs57098334	SLC6A4	(CCCACCCGA)12/(CCCACCCGA)12	Toxicity	increased	Adverse_Event	Disease:C0235876		N06A	rs57098334:(CCCACCCGA)12/(CCCACCCGA)12
valproic acid	rs1105879	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	C	Metabolism/PK	increased	LADME	Healthy		N03AG01	rs1105879:C
nevirapine	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*6/*6
isoniazid, pyridoxal phosphate	CYP2E1*1A	CYP2E1	*1A/*1A	Toxicity	increased	Adverse_Event	Disease:C0041296		A11HA06|J04AC01	*1A/*1A
atenolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C07AB03	rs1801253:CC
amitriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N06AA09	*4/*4
amitriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N06AA09	*4/*4
repaglinide	SLCO1B1*1, SLCO1B1*37	SLCO1B1	*37/*37	Metabolism/PK	decreased	LADME	Healthy		A10BX02	*37/*37
phenytoin	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*08:01
benzene	rs1800566	NQO1	AA	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1800566:AA
atazanavir, efavirenz	rs4570625	TPH2	TT	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE08|J05AG03	rs4570625:TT
methotrexate	rs70991108	DHFR	TGGCGCGTCCCGCCCAGGT/TGGCGCGTCCCGCCCAGGT	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs70991108:TGGCGCGTCCCGCCCAGGT/TGGCGCGTCCCGCCCAGGT
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*03:02
efavirenz	CYP2B6*1	CYP2B6	*1	Efficacy, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*1
antithyroid preparations	HLA-B*08:01	HLA-B	*08:01	Toxicity	increased	Adverse_Event	Healthy		H03B	*08:01
tegafur	CYP2A6*1	CYP2A6	*1	Other, Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*1
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*1/*2
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*1/*3
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6
cyclosporine	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*1	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	*1/*1
antiepileptics	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Adverse_Event	Disease:C0014544		N03A	*1/*3
atorvastatin	UGT1A3*1, UGT1A3*2	UGT1A3	*2/*2	Efficacy, Metabolism/PK	increased	LADME	Healthy		C10AA05	*2/*2
atorvastatin	UGT1A3*1, UGT1A3*2	UGT1A3	*2	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Healthy		C10AA05	*2
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
doxepin	CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*3/*3
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01|J05AG03	*1/*2
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC01|J05AG03	*1/*3
tacrolimus	CYP2C19*2	CYP2C19	*2/*2	Other	increased	Other	Disease:Kidney_Transplantation		L04AD02	*2/*2
mercaptopurine	rs4680	COMT	A	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs4680:A
rosiglitazone	CYP2C8*3	CYP2C8	*3	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BG02	*3
nortriptyline	CYP2D6*1, CYP2D6*2xN	CYP2D6	*1/*2xN	Metabolism/PK	increased	LADME	Healthy		N06AA10	*1/*2xN
pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*15
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*3
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2
none	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Other	Indeterminado	Adverse_Event	Healthy		A03DA02	*17
caffeine	rs5751876	ADORA2A	TT	Other	increased	Adverse_Event	Healthy		N06BC01	rs5751876:TT
methotrexate	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)3	Efficacy	increased	Adverse_Event	Disease:C0003873		L04AX03	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)3
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Other:patients_that_had_undergone_coronary_angiography_or_had_an_uneventful_PCI		B01AC04	*3
efavirenz	CYP2B6*6	CYP2B6	*6/*6	Toxicity, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Other:patients_that_had_undergone_coronary_angiography_or_had_an_uneventful_PCI		B01AC04	*2
atorvastatin	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Healthy		C10AA05	*3/*3
nevirapine	rs2125739	ABCC10	CC	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs2125739:CC
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
metformin	rs36056065	SLC22A1	GTAAGTTG	Toxicity, Metabolism/PK	Indeterminado	Adverse_Event	Disease:C0011849		A10BA02	rs36056065:GTAAGTTG
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
drugs for treatment of tuberculosis	CYP2E1*1A	CYP2E1	*1A/*1A	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*1A/*1A
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
clopidogrel	CYP2C19*17	CYP2C19	*17	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	*17
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*2
none	NAT1*10, NAT1*11B	NAT1	*10/*11B	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*10/*11B
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01|J05AG03	*1/*2
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC01|J05AG03	*1/*3
drugs for treatment of tuberculosis	HLA-DQB1*02:01	HLA-DQB1	*02:01	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*02:01
none	NAT1*4, NAT1*11A	NAT1	*11A/*4	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*11A/*4
warfarin	CYP2C9*3	CYP2C9	*3	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*3
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	LADME	Disease:C0023449		L01BB02	*1/*3A
pravastatin	SLCO1B1*1, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*1/*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*1/*15
pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*1/*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*1/*15
warfarin	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Dosage	decreased	Other	Healthy		B01AA03	*1/*13
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage, Toxicity	increased	Adverse_Event	Healthy		B01AA04	*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage, Toxicity	increased	Adverse_Event	Healthy		B01AA04	*3
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*3
metoprolol	CYP2D6*4	CYP2D6	*4	Dosage, Toxicity	increased	Adverse_Event	Healthy		C07AB02	*4
pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*15/*15
drugs for treatment of tuberculosis	GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A	
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3
aspirin, clopidogrel	CYP2C19*2	CYP2C19	*2	Efficacy	increased	Adverse_Event	Other:patients_undergoing_PCI		B01AC04	*2
aspirin, clopidogrel	CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Other:patients_undergoing_PCI		B01AC04	*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Other	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Other	Healthy		B01AA03	*1/*3
doxepin	CYP2D6*3, CYP2D6*5	CYP2D6	*3/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*3/*5
haloperidol	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AD01	rs4680:AG
atorvastatin	CYP2D6*4	CYP2D6	*4	Toxicity	increased	Adverse_Event	Healthy		C10AA05	*4
doxepin	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*4/*5
warfarin	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*1/*13
warfarin	CYP2C9*3	CYP2C9	*3	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*3
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Other	Healthy		B01AA03	*2
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Other	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*14	CYP2C9	*1/*14	Dosage	decreased	Other	Healthy		B01AA03	*1/*14
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Other	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*1/*3
clopidogrel	CYP2B6*5	CYP2B6	*5	Efficacy	Indeterminado	Efficacy_Response	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	*5
venlafaxine	CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		N06AX16	*10/*10
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Other	Healthy		B01AA03	*2
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3
venlafaxine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Healthy		N06AX16	*1/*10
warfarin	CYP2C9*1, CYP2C9*14	CYP2C9	*1/*14	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*1/*14
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*1/*3
phenprocoumon	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*3
phenprocoumon	CYP2C9*3	CYP2C9	*3	Efficacy	increased	Adverse_Event	Healthy		B01AA04	*3
phenprocoumon	CYP2C9*2	CYP2C9	*2	Efficacy	increased	Adverse_Event	Healthy		B01AA04	*2
escitalopram	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*4/*10	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10	*4/*10
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Other	Healthy		A02BC03	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Other	Healthy		A02BC03	*1/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Other	Healthy		A02BC03	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2
tramadol	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*10/*10
tramadol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Healthy		N02AX02	*4/*4
omeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Other	Disease:C0041582		A02BC01	*1/*2
paroxetine	CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N06AB05	*4/*4
paroxetine	CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Healthy		N06AB05	*3/*4
tramadol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Dosage, Efficacy	decreased	Efficacy_Response	Healthy		N02AX02	*4/*4
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*3/*3
tamoxifen	CYP2D6*6, CYP2D6*7	CYP2D6	*6/*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*6/*7
escitalopram	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10	*5/*10
tamoxifen	CYP2D6*3, CYP2D6*6	CYP2D6	*3/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*3/*6
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Dosage, Efficacy	decreased	Efficacy_Response	Healthy		N02AX02	*3/*4
clomipramine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06AA04	*2
nortriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*4
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	Indeterminado	LADME	Healthy		N02AA05	*4/*4
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Metabolism/PK	Indeterminado	LADME	Healthy		N02AA05	*3/*4
paroxetine	CYP2D6*1, CYP2D6*41	CYP2D6	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N06AB05	*1/*1
paroxetine	CYP2D6*1, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	decreased	LADME	Healthy		N06AB05	*1/*41
nortriptyline	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*5/*10
desipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N06AA01	*1/*1
tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*2/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*2/*10
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*5	CYP2D6	*3/*5	Dosage, Efficacy	decreased	Efficacy_Response	Healthy		N02AX02	*3/*5
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*5	CYP2D6	*5	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*5
paroxetine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB05	*1/*10
paroxetine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB05	*1/*5
cotinine	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17, CYP2A6*20	CYP2A6	*1/*1	Metabolism/PK	Indeterminado	LADME	Healthy		No_ATC	*1/*1
mirtazapine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AX11	*4/*4
paroxetine	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0028768		N06AB05	*1/*4
clomipramine	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06AA04	*3
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		N06AB04	*2/*2
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		N06AB04	*2/*3
paroxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB05	*10/*10
paroxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB05	*1/*10
mirtazapine	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	increased	LADME	Healthy		N06AX11	*1/*1xN
codeine	CYP2D6*1, CYP2D6*36	CYP2D6	*36	Metabolism/PK	decreased	LADME	Healthy		R05DA04	*36
codeine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*1	Metabolism/PK	increased	LADME	Healthy		R05DA04	*1/*1
codeine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		R05DA04	*1/*4
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*2
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3
none	rs34946978	UGT1A1	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs34946978:T
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
flurbiprofen	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		S01BC04	*1/*3
diclofenac	CYP2C8*1, CYP2C8*4	CYP2C8	*1/*4	Metabolism/PK	increased	LADME	Healthy		S01BC03	*1/*4
diclofenac	CYP2C8*1, CYP2C8*4	CYP2C8	*4/*4	Metabolism/PK	increased	LADME	Healthy		S01BC03	*4/*4
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*3/*3
pyrimidine analogues	rs895819	MIR27A	CC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC	rs895819:CC
pyrimidine analogues	rs895819	MIR27A	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC	rs895819:CT
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*3/*3
citalopram	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06AB04	__UNKNOWN__
timolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*3	Metabolism/PK	increased	LADME	Healthy		S01ED01	*3/*3
timolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Healthy		S01ED01	*3/*4
timolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		S01ED01	*4/*4
timolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*5/*4	Metabolism/PK	increased	LADME	Healthy		S01ED01	*5/*4
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02
clopidogrel	rs662	PON1	C	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs662:C
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
tenoxicam	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	increased	LADME	Healthy		M01AC02	*3
ibuprofen	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Toxicity	decreased	Adverse_Event	Healthy		M02AA13	*1/*3
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
clopidogrel	rs2046934	P2RY12	A	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs2046934:A
antiepileptics	HLA-B*58:01	HLA-B	*58:01	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03A	*58:01
aspirin	HLA-DPB1*03:01	HLA-DPB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*03:01
sulfonamides, urea derivatives	rs7903146	TCF7L2	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs7903146:CC
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3
lumacaftor	rs113993960	CFTR	del/del	Toxicity	increased	Efficacy_Response	Disease:C0156318		R07AX30	rs113993960:del/del
caffeine	rs762551	CYP1A2	AA	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs762551:AA
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Disease:Leprosy		J04BA02	*13:01
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Efficacy_Response	Disease:C0004238		B01AA07	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Efficacy_Response	Disease:C0004238		B01AA07	*2/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Efficacy_Response	Disease:C0004238		B01AA07	*3/*3
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*3
codeine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA04	*1/*10
codeine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA04	*10/*10
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*2
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3C
bosentan	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		C02KX01	*2
codeine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*1	Other	increased	Other	Healthy		R05DA04	*1/*1
codeine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Other	increased	Other	Healthy		R05DA04	*1/*4
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*2
tetrabenazine	intermediate metabolizer	CYP2D6	__UNKNOWN__	Efficacy	Indeterminado	Efficacy_Response	Healthy	intermediate metabolizer	N07XX06	__UNKNOWN__
warfarin	CYP4F2*1, CYP4F2*3	CYP4F2	*3	Toxicity	decreased	Adverse_Event	Healthy		B01AA03	*3
citalopram	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele)/L allele-rs25531C	Toxicity	increased	Adverse_Event	Disease:C0497327		N06AB04	
citalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB04	*1/*17
clopidogrel	rs1330344	PTGS1	T	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1330344:T
clomipramine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Toxicity	increased	Adverse_Event	Healthy		N06AA04	
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04	*1/*2
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*2
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	
phenobarbital	CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		N03AA02	*2
olanzapine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*3A
olanzapine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*3C
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*1/*2
carbamazepine	HLA-B*07:02, HLA-B*08:01	HLA-B	*07:02	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*07:02
trichloroethylene	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*13:01
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3
azathioprine, cyclosporine, prednisone	TPMT*3A, TPMT*3C	TPMT	*3A/*3C	Toxicity	Indeterminado	Adverse_Event	Disease:Kidney_Transplantation		H02AB07|L04AD01|L04AX01	*3A/*3C
allopurinol	HLA-A*02:01	HLA-A	*02:01	Toxicity	decreased	Adverse_Event	Healthy		M04AA01	*02:01
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*3
allopurinol	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Disease:C0745761		M04AA01	*08:01
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	UGT1A7*3	UGT1A7	*3	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03|L01CE02|L01XA03	*3
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	*1/*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	*2/*2
osimertinib	rs1057910	CYP2C9	CC	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB04	rs1057910:CC
citalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB04	
mycophenolate mofetil(mycophenolic acid)	rs11572076	CYP2C8	CC	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs11572076:CC
allopurinol	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*33:03
clozapine	HLA-DRB3*02:02	HLA-DRB3	*02:02	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*02:02
mercaptopurine	rs1142345	TPMT	C	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs1142345:C
mycophenolate mofetil(mycophenolic acid)	rs7438135	UGT2B7	G	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs7438135:G
clozapine	HLA-C*07:01	HLA-C	*07:01	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*07:01
clozapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH02	*01:01
azathioprine, mercaptopurine	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*07:01
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Other	Disease:C0027051		B01AC04	*2
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3
sulfasalazine	HLA-B*39:01	HLA-B	*39:01	Toxicity	increased	Adverse_Event	Healthy		A07EC01	*39:01
methazolamide	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*01:02
carbimazole, methimazole, propylthiouracil	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Disease:C0242656		H03BA02|H03BB01	*38:02
platinum compounds, pyrimidine analogues	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Other:C0026640		L01BC|L01XA	rs1801265:AG
platinum compounds, pyrimidine analogues	rs1801265	DPYD	GG	Toxicity	increased	Adverse_Event	Other:C0026640		L01BC|L01XA	rs1801265:GG
cilostazol, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04|B01AC23	*2
cilostazol, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04|B01AC23	*3
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*15:02
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0005586|Disease:C0014544		N03AF01	*15:02
capecitabine, fluorouracil	deficiency	DPYD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0027651	deficiency	L01BC02|L01BC06	__UNKNOWN__
dolasetron	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Efficacy	increased	Adverse_Event	Disease:C0520904		A04AA04	*1/*1xN
cyclosporine, methotrexate	rs6123048	NFATC2	AA	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs6123048:AA
cyclophosphamide, epirubicin, paclitaxel	CYP2C8*1, CYP2C8*4	CYP2C8	*4	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	*4
tamoxifen	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*2
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	Indeterminado	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01
ifosfamide	rs3764435	ALDH1A1	AA	Efficacy	decreased	Efficacy_Response	Other:C1561230|Other:C1261473		L01AA06	rs3764435:AA
aspirin, clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*17
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J04BA02	*13:01
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT
clozapine	GSTT1 non-null, GSTT1 null	GSTT1	null/null	Toxicity	increased	Adverse_Event	Healthy		N05AH02	
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3
peginterferon alfa-2b, ribavirin, telaprevir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs11322783:TT/TT
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11322783:TT/TT
azathioprine, mercaptopurine	rs746071566	NUDT15	del	Toxicity	increased	Adverse_Event	Other:C0004364|Other:C0021390		L01BB02|L04AX01	rs746071566:del
hmg coa reductase inhibitors	rs402007	ADAMTS1	CC	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA	rs402007:CC
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
nicotine	CYP2B6*1, CYP2B6*4	CYP2B6	*1/*4	Toxicity	increased	Adverse_Event	Healthy		N07BA01	*1/*4
nicotine	CYP2B6*1, CYP2B6*4	CYP2B6	*4/*4	Toxicity	increased	Adverse_Event	Healthy		N07BA01	*4/*4
nicotine	CYP2A6*1, CYP2A6*12	CYP2A6	*1/*1	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	*1/*1
antithyroid preparations	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Healthy		H03B	*38:02
antithyroid preparations	HLA-DRB1*08:03	HLA-DRB1	*08:03	Toxicity	increased	Adverse_Event	Healthy		H03B	*08:03
amoxicillin, clavulanate, flucloxacillin	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	*15:01
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*3
gefitinib	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0007131	poor metabolizer	L01EB01	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3
carboplatin, paclitaxel	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD01|L01XA02	*1/*3
lamotrigine	rs3812718	SCN1A	C	Efficacy	increased	Efficacy_Response	Healthy		N03AX09	rs3812718:C
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:human_kidney_microsomes		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*3
pemetrexed	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Efficacy	decreased	Efficacy_Response	Disease:C0025500		L01BA04	rs11280056:TTAAAGTTA/TTAAAGTTA
methotrexate	rs11280056	TYMS	del	Toxicity	increased	Adverse_Event	Disease:C0235763		L04AX03	rs11280056:del
none	rs4149056	SLCO1B1	C	Other	decreased	Other	Healthy		A03DA02	rs4149056:C
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Other:C0014544		N03AF01	*15:02
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
levofloxacin	HLA-B*13:01, HLA-B*13:02	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J01MA12	*13:01
levofloxacin	HLA-B*13:01, HLA-B*13:02	HLA-B	*13:02	Toxicity	increased	Adverse_Event	Healthy		J01MA12	*13:02
phenytoin	HLA-A*03:01	HLA-A	*03:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*03:01
aspirin, clopidogrel	intermediate metabolizer	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__
beta-lactam antibacterials, penicillins	HLA-DRB1*10:01	HLA-DRB1	*10:01	Toxicity	increased	Adverse_Event	Healthy		J01C|J01D	*10:01
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*2	Toxicity	increased	Adverse_Event	Other:C1956346	intermediate metabolizer and poor metabolizer	B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*3	Toxicity	increased	Adverse_Event	Other:C1956346	intermediate metabolizer and poor metabolizer	B01AC04	*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*8	Toxicity	increased	Adverse_Event	Other:C1956346	intermediate metabolizer and poor metabolizer	B01AC04	*8
clopidogrel, proton pump inhibitors	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*1	Toxicity	increased	Adverse_Event	Other:C1956346	normal metabolizer and ultrarapid metabolizer and rapid metabolizer	A02BC|B01AC04	*1/*1
clopidogrel, proton pump inhibitors	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Toxicity	increased	Adverse_Event	Other:C1956346	normal metabolizer and ultrarapid metabolizer and rapid metabolizer	A02BC|B01AC04	*1/*17
clopidogrel, proton pump inhibitors	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Other:C1956346	normal metabolizer and ultrarapid metabolizer and rapid metabolizer	A02BC|B01AC04	*17/*17
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Other:C1458155		L02BA01	*10/*10
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Efficacy	decreased	Efficacy_Response	Other:C1458155		L02BA01	*1/*10
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*1	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*1/*1
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*1/*17
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*17/*17
aspirin, clopidogrel	poor metabolizer	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:high_on-treatment_platelet_reactivity	poor metabolizer	B01AC04	__UNKNOWN__
cyclosporine, methotrexate	rs4818789	SLC19A1	TT	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs4818789:TT
atenolol, metoprolol	rs1042714	ADRB2	GG	Toxicity	increased	Adverse_Event	Disease:C0020538		C07AB02|C07AB03	rs1042714:GG
zoledronic acid	rs1152003	__INTRONIC__	CC	Toxicity	increased	Adverse_Event	Disease:Multiple_Myeloma		M05BA08	rs1152003:CC
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02
antidepressants, antipsychotics	intermediate metabolizer	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C1868980	intermediate metabolizer and poor metabolizer	N05A|N06A	__UNKNOWN__
atorvastatin	rs17671591	HMGCR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0010068		C10AA05	rs17671591:T
antidepressants, antipsychotics	intermediate metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C1868980	intermediate metabolizer and poor metabolizer	N05A|N06A	__UNKNOWN__
tacrolimus, voriconazole	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	Adverse_Event	Other:Kidney_Transplantation		J02AC03|L04AD02	*3/*3
carboplatin, paclitaxel	rs1052536	LIG3	T	Toxicity	increased	Adverse_Event	Other:C0919267		L01CD01|L01XA02	rs1052536:T
clopidogrel	rs2069514	CYP1A2	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs2069514:A
cyclosporine, methotrexate	rs4819128	SLC19A1	TT	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs4819128:TT
ethambutol, isoniazid / pyrazinamide / rifampin	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	__UNKNOWN__
atorvastatin	rs10474433	HMGCR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0010068		C10AA05	rs10474433:T
vancomycin	HLA-A*32:01	HLA-A	*32:01	Toxicity	increased	Adverse_Event	Healthy		J01XA01	*32:01
mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:T
atorvastatin	rs11591147	PCSK9	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0010068		C10AA05	rs11591147:T
"""beta-lactam antibacterials, penicillins"", ""other beta-lactam antibacterials"""	HLA-A*02:07	HLA-A	*02:07	Toxicity	decreased	Adverse_Event	Healthy		J01D	*02:07
"""beta-lactam antibacterials, penicillins"", ""other beta-lactam antibacterials"""	HLA-A*01:01	HLA-A	*01:01	Toxicity	increased	Adverse_Event	Healthy		J01D	*01:01
"""beta-lactam antibacterials, penicillins"", ""other beta-lactam antibacterials"""	HLA-C*06:02	HLA-C	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01D	*06:02
"""beta-lactam antibacterials, penicillins"", ""other beta-lactam antibacterials"""	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01D	*15:01
"""beta-lactam antibacterials, penicillins"", ""other beta-lactam antibacterials"""	HLA-DQB1*03:02	HLA-DQB1	*03:02	Toxicity	increased	Adverse_Event	Healthy		J01D	*03:02
clopidogrel	poor metabolizer	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__
valproic acid	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	*1/*3
valproic acid	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	*3/*3
atorvastatin	rs429358	APOE	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0010068		C10AA05	rs429358:T
enalapril	rs495828	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Disease:C0020538		C09AA02	rs495828:TT
ribavirin, sofosbuvir	rs1127354	ITPA	AC	Efficacy	increased	Adverse_Event	Other:C0019372		J05AP01|J05AP08	rs1127354:AC
enalapril	rs495828	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Disease:C0020538		C09AA02	rs495828:TT
atorvastatin	rs7412	APOE	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0010068		C10AA05	rs7412:T
none	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Efficacy, Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		A03DA02	
simvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs2231142:TT
cisplatin, docetaxel, fluorouracil	rs11280056	TYMS	TTA/TTA	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs11280056:TTA/TTA
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11
none	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	A03DA02	*2
none	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	A03DA02	*3
efavirenz	poor metabolizer	CYP2B6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0233407|Other:HIV_infectious_disease	poor metabolizer	J05AG03	__UNKNOWN__
capecitabine, fluorouracil	rs143004875	DPYS	(T)7/(T)8	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs143004875:(T)7/(T)8
fluvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA04	rs2231142:TT
capecitabine, fluorouracil	DPYD c.1129-5923C>G, c.1236G>A (HapB3)	DPYD	c.1129-5923C>G, c.1236G>A (HapB3)	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	c.1129-5923C>G, c.1236G>A (HapB3)
osimertinib	CYP2A6*4	CYP2A6	*4	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB04	*4
osimertinib	rs2622604	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB04	rs2622604:TT
l-asparagine, prednisone, vincristine	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	*3/*3
l-asparagine, prednisone, vincristine	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*6	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	*3/*6
l-asparagine, prednisone, vincristine	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*7	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	*3/*7
l-asparagine, prednisone, vincristine	rs3832526	ASNS	(GCGGGGCGCAGGGC)3/(GCGGGGCGCAGGGC)3	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	rs3832526:(GCGGGGCGCAGGGC)3/(GCGGGGCGCAGGGC)3
pravastatin	rs17655652	NPC1L1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs17655652:CC
pravastatin	rs17655652	NPC1L1	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA03	rs17655652:CC
ethambutol, isoniazid / pyrazinamide / rifampin	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	__UNKNOWN__
clopidogrel	CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Other:C0007222		B01AC04	*2
clopidogrel	CYP2C19*2	CYP2C19	*2	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*2
clopidogrel	CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2
clopidogrel	CYP2C19*17	CYP2C19	*17	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*17
tramadol	poor metabolizer	CYP2B6	__UNKNOWN__	Efficacy	decreased	Adverse_Event	Other:C0030193|Postoperative	poor metabolizer	N02AX02	__UNKNOWN__
tramadol	poor metabolizer	CYP3A4	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer and poor metabolizer	N02AX02	__UNKNOWN__
citalopram, escitalopram	poor metabolizer	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0011581	poor metabolizer	N06AB04|N06AB10	__UNKNOWN__
irinotecan	rs9266271	HLA-B	C	Toxicity	decreased	Adverse_Event	Healthy		L01CE02	rs9266271:C
antiinflammatory agents, non-steroids	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*02:01
antiinflammatory agents, non-steroids	HLA-A*34:01	HLA-A	*34:01	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*34:01
antiinflammatory agents, non-steroids	HLA-DRB1*16:02	HLA-DRB1	*16:02	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*16:02
atorvastatin	rs3846662	HMGCR	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs3846662:GG
clopidogrel	rs1128503	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Other:C0018839		B01AC04	rs1128503:GG
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*3/*3
drugs for treatment of tuberculosis	NAT2*4, NAT2*6	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*6
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*1/*3
azathioprine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0009324|Disease:C0010346|Disease:C0241910		L04AX01	rs116855232:CT
azathioprine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0009324|Disease:C0010346|Disease:C0241910		L04AX01	rs116855232:TT
beta blocking agents, metoprolol	rs1801252	ADRB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AB02|S01ED	rs1801252:AG
beta blocking agents, metoprolol	rs1801252	ADRB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AB02|S01ED	rs1801252:GG
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC03	*2/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC03	*2/*3
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC03	*3/*3
folfiri, folfox, xelox	rs11280056	TYMS	del/del	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs11280056:del/del
irinotecan	rs1051713	ALOX5	T	Toxicity	increased	Adverse_Event	Healthy		L01CE02	rs1051713:T
etoposide	rs6539870	__INTRONIC__	GG	Other	increased	Other	Healthy		L01CB01	rs6539870:GG
"""interferon alfa-2b, recombinant"", ""ribavirin"""	rs1127354	ITPA	CC	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB05	rs1127354:CC
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*3
"""interferon alfa-2b, recombinant"", ""ribavirin"""	rs1127354	ITPA	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB05	rs1127354:CC
asparaginase	rs6025	F5	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01XX02	rs6025:CT
dabigatran	rs2244613	CES1	GG	Metabolism/PK	decreased	LADME	Disease:C0004238		B01AE07	rs2244613:GG
dabigatran	rs2244613	CES1	GT	Metabolism/PK	decreased	LADME	Disease:C0004238		B01AE07	rs2244613:GT
desipramine	rs2228478	MC1R	G	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AA01	rs2228478:G
acenocoumarol	rs9934438	VKORC1	AA	Dosage, Efficacy, Toxicity	decreased	Efficacy_Response	Healthy		B01AA07	rs9934438:AA
desipramine	rs2228479	MC1R	A	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AA01	rs2228479:A
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*16/*7
carbamazepine	rs1800629	LTA, TNF	A	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs1800629:A
asparaginase	rs11556218	IL16	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L01XX02	rs11556218:GG
asparaginase	rs11556218	IL16	GT	Toxicity	increased	Adverse_Event	Other:C0023449		L01XX02	rs11556218:GT
mercaptopurine	rs2413739	PACSIN2	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs2413739:TT
gemcitabine	rs9394992	SLC29A1	CT	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs9394992:CT
gemcitabine	rs9394992	SLC29A1	TT	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs9394992:TT
docetaxel, thalidomide	rs2292954	SPG7	A	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs2292954:A
antineoplastic agents	rs648743	CTH	CC	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs648743:CC
docetaxel, thalidomide	rs2238472	ABCC6	C	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs2238472:C
docetaxel, thalidomide	rs2227291	ATP7A	G	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs2227291:G
mercaptopurine	rs10948059	GNMT	CT	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02	rs10948059:CT
mercaptopurine	rs10948059	GNMT	TT	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02	rs10948059:TT
acenocoumarol	rs2108622	CYP4F2	CC	Other, Metabolism/PK	decreased	Other	Disease:C0004238		B01AA07	rs2108622:CC
acenocoumarol	rs2108622	CYP4F2	CT	Other, Metabolism/PK	decreased	Other	Disease:C0004238		B01AA07	rs2108622:CT
dabigatran	rs2244613	CES1	GG	Toxicity	decreased	Adverse_Event	Disease:C0004238		B01AE07	rs2244613:GG
dabigatran	rs2244613	CES1	GT	Toxicity	decreased	Adverse_Event	Disease:C0004238		B01AE07	rs2244613:GT
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A
acenocoumarol	rs2108622	CYP4F2	CC	Dosage, Efficacy, Toxicity	decreased	Efficacy_Response	Disease:C0004238		B01AA07	rs2108622:CC
clopidogrel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1045642:AA
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*4
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*10
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*5
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*41
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*3	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*3
irinotecan	rs4149015	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs4149015:AA
irinotecan	rs4149015	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs4149015:AG
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*16	NAT2	*16/*16	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*16/*16
salbutamol, salmeterol	rs1042713	ADRB2	AA	Efficacy	increased	Adverse_Event	Disease:C0004096		R03AC12|R03CC02	rs1042713:AA
irinotecan	rs3832043	UGT1A9	del/del	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs3832043:del/del
antipsychotics, aripiprazole, clozapine, olanzapine, quetiapine, risperidone	rs1414334	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A|N05AH02|N05AH03|N05AH04|N05AX08|N05AX12	rs1414334:C
cisplatin	rs4788863	SLC16A5	T	Toxicity	decreased	Adverse_Event	Disease:C0039591		L01XA01	rs4788863:T
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*5	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*5
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*5G	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*5G
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*6	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*6
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*17	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*17
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*16	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*16
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*7	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*7
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*34	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*34
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*14	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*14
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*5J	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*5J
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*30	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*30
irinotecan	rs3740066	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs3740066:CC
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7/*7
enalapril, imidapril, lisinopril	rs1799722	BDKRB2	CT	Toxicity	increased	Adverse_Event	Disease:C0085580		C09AA02|C09AA03|C09AA16	rs1799722:CT
enalapril, imidapril, lisinopril	rs1799722	BDKRB2	TT	Toxicity	increased	Adverse_Event	Disease:C0085580		C09AA02|C09AA03|C09AA16	rs1799722:TT
irinotecan	rs2231137	ABCG2	CT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs2231137:CT
irinotecan	rs2231137	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs2231137:TT
clozapine, risperidone	rs1414334	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AX08	rs1414334:C
hmg coa reductase inhibitors	rs11868035	SREBF1	AA	Other	increased	Other	Disease:C0036341		C10AA	rs11868035:AA
hmg coa reductase inhibitors	rs11868035	SREBF1	AG	Other	increased	Other	Disease:C0036341		C10AA	rs11868035:AG
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*3/*4	Dosage	increased	LADME	Healthy	poor metabolizer	N02AA05	*3/*4
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*4	Dosage	increased	LADME	Healthy	poor metabolizer	N02AA05	*4/*4
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*5	Dosage	increased	LADME	Healthy	poor metabolizer	N02AA05	*4/*5
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*6	Dosage	increased	LADME	Healthy	poor metabolizer	N02AA05	*4/*6
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*7	Dosage	increased	LADME	Healthy	poor metabolizer	N02AA05	*4/*7
cisplatin	rs1695	GSTP1	G	Toxicity	increased	Adverse_Event	Disease:C0039591		L01XA01	rs1695:G
ace inhibitors, plain	rs1799722	BDKRB2	T	Toxicity	increased	Adverse_Event	Disease:C0020538		A03B|C09A	rs1799722:T
atorvastatin	rs2231142	ABCG2	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		C10AA05	rs2231142:TT
lansoprazole	intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	Other	Healthy	intermediate metabolizer	A02BC03	__UNKNOWN__
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*5/*7
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*6
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*7
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*5, NAT2*6, NAT2*7	NAT2	*7/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*7/*7
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*7
irbesartan	rs5186	AGTR1	AC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA04	rs5186:AC
irbesartan	rs5186	AGTR1	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA04	rs5186:CC
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*6
opioids	rs12305038	PDE3A	A	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs12305038:A
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*5/*7
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*6/*6
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*6/*7
dexmedetomidine	rs1800544	ADRA2A	G	Efficacy	increased	Efficacy_Response	Healthy		N05CM18	rs1800544:G
paclitaxel	rs1113129	CYP2C8	G	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CD01	rs1113129:G
opioids	rs11882256	MUC16	T	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs11882256:T
isoniazid, rifampin	NAT2*6	NAT2	*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01	*6
rosuvastatin	rs2231142	ABCG2	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		C10AA07	rs2231142:TT
isoniazid, pyrazinamide, rifampin	NAT2*6	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*6/*6
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*16
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*5	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*5
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*6
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*6
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*7
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*7
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*14
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*14
irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs4148323:AA
rosuvastatin	rs2231142	ABCG2	GG	Dosage, Metabolism/PK	decreased	LADME	Other:C0024198		C10AA07	rs2231142:GG
drugs for treatment of tuberculosis	NAT2*6	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*6
isoniazid, rifampin	NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01	*6/*7
sorafenib	rs1800629	TNF	GG	Toxicity	increased	Adverse_Event	Disease:C2239176		L01EX02	rs1800629:GG
opioids	rs12305038	PDE3A	A	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs12305038:A
irinotecan	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs4149056:CC
irinotecan	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs4149056:CT
alfentanil	rs1799971	OPRM1	AG	Efficacy	increased	Adverse_Event	Other:Extracorporeal_shock_wave_lithotripsy_(ESWL)		N01AH02	rs1799971:AG
alfentanil	rs1799971	OPRM1	GG	Efficacy	increased	Adverse_Event	Other:Extracorporeal_shock_wave_lithotripsy_(ESWL)		N01AH02	rs1799971:GG
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*16/*16
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*16/*6
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*16/*7
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*6/*6
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*6/*7
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*7/*7
"""interferon alfa-2b, recombinant"", ""ribavirin"""	rs1127354	ITPA	CC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB05	rs1127354:CC
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6
alfentanil	rs1799971	OPRM1	AG	Metabolism/PK	increased	LADME	Disease:C0030193		N01AH02	rs1799971:AG
alfentanil	rs1799971	OPRM1	GG	Metabolism/PK	increased	LADME	Disease:C0030193		N01AH02	rs1799971:GG
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7
salmeterol	rs1042713	ADRB2	AA	Efficacy	increased	Adverse_Event	Disease:C0004096		R03AC12	rs1042713:AA
peginterferon alfa-2b, ribavirin	rs6051702	DNAAF9, ITPA	C	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs6051702:C
clopidogrel	rs1463411	MIR6076	GG	Toxicity	increased	Adverse_Event	Other:C0027051		B01AC04	rs1463411:GG
clopidogrel	rs1463411	MIR6076	GT	Toxicity	increased	Adverse_Event	Other:C0027051		B01AC04	rs1463411:GT
lansoprazole	intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	Other	Healthy	intermediate metabolizer	A02BC03	__UNKNOWN__
tamoxifen	rs10509373	LRMDA	C	Efficacy	decreased	Other	Disease:C1458155		L02BA01	rs10509373:C
opioids	rs36024412	CRYBG2	T	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs36024412:T
ethambutol, isoniazid / pyrazinamide / rifampin	rs1799930	NAT2	G	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1799930:G
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*7
opioids	rs168107	CLCC1	T	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs168107:T
capecitabine	rs1048977	CDA	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1048977:CT
capecitabine	rs1048977	CDA	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1048977:TT
boceprevir, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|J05AP03|L03AB10	rs12979860:CC
platinum compounds	rs10759637	SLC31A1	AC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs10759637:AC
opioids	rs41269255	POM121L2	T	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs41269255:T
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection	slow acetylator	J04A|J05AP|S02DA30	*16/*16
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection	slow acetylator	J04A|J05AP|S02DA30	*16/*6
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection	slow acetylator	J04A|J05AP|S02DA30	*16/*7
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection	slow acetylator	J04A|J05AP|S02DA30	*6/*6
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection	slow acetylator	J04A|J05AP|S02DA30	*6/*7
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	No_ATC	*16
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	No_ATC	*6
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	No_ATC	*7
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	No_ATC	*14
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*14
methotrexate	rs3740065	ABCC2	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs3740065:AG
methotrexate	rs3740065	ABCC2	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs3740065:GG
irinotecan	rs61754806	NR3C1	A	Toxicity	decreased	Adverse_Event	Healthy		L01CE02	rs61754806:A
irinotecan	rs7294	VKORC1	T	Toxicity	increased	Adverse_Event	Healthy		L01CE02	rs7294:T
platinum compounds	rs2233914	SLC31A1	AA	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA	rs2233914:AA
opioids	rs9393888	ZNF165	C	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs9393888:C
cisplatin, cyclophosphamide	rs1142345	TPMT	CT	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01AA01|L01XA01	rs1142345:CT
hmg coa reductase inhibitors	SLCO1B1*5	SLCO1B1	*5	Toxicity	decreased	Adverse_Event	Other:cardio-metabolic_conditions		C10AA	*5
gemcitabine	rs9937	RRM1	AA	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs9937:AA
olanzapine, risperidone	rs1799978	DRD2	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH03|N05AX08	rs1799978:C
platinum compounds	rs2233914	SLC31A1	AA	Efficacy	increased	Adverse_Event	Disease:C0007131		L01XA	rs2233914:AA
clopidogrel	rs12248560	CYP2C19	CT	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs12248560:CT
clopidogrel	rs12248560	CYP2C19	TT	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs12248560:TT
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*6
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*7
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*5/*5	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*5/*5
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*5/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*5/*6
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*6/*6J	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6J
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*6J/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6J/*7
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7/*7
methotrexate	rs9516519	ABCC4	GG	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs9516519:GG
methotrexate	rs9516519	ABCC4	GT	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs9516519:GT
escitalopram	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0235876|Other:C0003469	poor metabolizer	N06AB10	__UNKNOWN__
risperidone	normal metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	N05AX08	__UNKNOWN__
paliperidone	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX13	__UNKNOWN__
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	*6/*6
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	*6/*7
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	*7/*7
tramadol	CYP2D6*10	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Other:C0030193		N02AX02	*10/*10
clopidogrel	rs12248560	CYP2C19	CT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs12248560:CT
clopidogrel	rs12248560	CYP2C19	TT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs12248560:TT
isoniazid	NAT2*6, NAT2*7	NAT2	*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*6
isoniazid	NAT2*6, NAT2*7	NAT2	*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*7
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01	*16/*16
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01	*16/*6
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01	*16/*7
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01	*6/*6
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01	*6/*7
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7
antiinflammatory agents, non-steroids	HLA-DRB1*04:03	HLA-DRB1	*04:03	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*04:03
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AG
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*16	NAT2	*16/*4	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*16/*4
platinum compounds	rs10759637	SLC31A1	AC	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA	rs10759637:AC
capecitabine	rs2072671	CDA	AC	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2072671:AC
capecitabine	rs2072671	CDA	CC	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2072671:CC
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*7
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7
isoniazid	NAT2*16	NAT2	*16	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01	*16
drugs for treatment of tuberculosis	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*16
drugs for treatment of tuberculosis	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*6
drugs for treatment of tuberculosis	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*7
olanzapine, risperidone	rs1799732	DRD2	del	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03|N05AX08	rs1799732:del
drugs for treatment of tuberculosis	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*5/*6
drugs for treatment of tuberculosis	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*5/*7
drugs for treatment of tuberculosis	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*6/*6
drugs for treatment of tuberculosis	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*6/*7
drugs for treatment of tuberculosis	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*7/*7
opioids	rs3745274	CYP2A7P1, CYP2B6	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs3745274:GG
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*16
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*6
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*7
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7/*7
antiinflammatory agents, non-steroids	HLA-B*35:03	HLA-B	*35:03	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*35:03
platinum compounds	rs4979223	SLC31A1	AC	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA	rs4979223:AC
none	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Other:C0007131		A03DA02	rs1051730:A
ribavirin, sofosbuvir	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Other:C0019372		J05AP01|J05AP08	rs1127354:CC
proton pump inhibitors	rapid and ultrarapid metabolizer genotypes	CYP2C19	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Healthy	ultrarapid metabolizer and rapid metabolizer	A02BC	__UNKNOWN__
antineoplastic agents	rs2853539	TYMS	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs2853539:AG
antineoplastic agents	rs2853539	TYMS	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs2853539:GG
cyclophosphamide, dactinomycin, vincristine	rs2279343	CYP2B6	AG	Efficacy	increased	Efficacy_Response	Disease:Rhabdomyosarcoma		L01AA01|L01CA02|L01DA01	rs2279343:AG
cyclophosphamide, dactinomycin, vincristine	rs2279343	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Disease:Rhabdomyosarcoma		L01AA01|L01CA02|L01DA01	rs2279343:GG
antipsychotics	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0036337|Other:C0036341	poor metabolizer	N05A	__UNKNOWN__
omeprazole	normal metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	Other	Healthy	normal metabolizer	A02BC01	__UNKNOWN__
tamoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1458155	intermediate metabolizer and poor metabolizer	L02BA01	__UNKNOWN__
antineoplastic agents	rs1937840	AKR1C3	G	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs1937840:G
antihypertensives	rs266729	ADIPOQ	CG	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs266729:CG
antihypertensives	rs266729	ADIPOQ	GG	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs266729:GG
mycophenolic acid, tacrolimus	rs2278293	IMPDH1	T	Efficacy	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06|L04AD02	rs2278293:T
gemcitabine	rs2072671	CDA	AA	Toxicity	decreased	Adverse_Event	Disease:C0030297		L01BC05	rs2072671:AA
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*3/*3	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*3/*3
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*3/*4	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*3/*4
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*3/*5	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*3/*5
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*3/*6	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*3/*6
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*4/*4
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*4/*4xN	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*4/*4xN
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*4/*5	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*4/*5
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*4/*6	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*4/*6
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*5/*5	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*5/*5
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*4xN/*5	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*4xN/*5
codeine	poor metabolizers	CYP2D6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Other:C0030193|Postoperative	poor metabolizer	R05DA04	__UNKNOWN__
nicotine	CYP2D6*2xN, CYP2D6*4, CYP2D6*5	CYP2D6	*2xN	Toxicity	increased	Adverse_Event	Healthy		N07BA01	*2xN
gemcitabine	rs4694362	DCK	TT	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs4694362:TT
cyclophosphamide, epirubicin, fluorouracil	rs141084494	RBX1	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs141084494:A
ethambutol, isoniazid / pyrazinamide / rifampin	rs1801280	NAT2	T	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1801280:T
platinum compounds	rs4978536	SLC31A1	AG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs4978536:AG
platinum compounds	rs4978536	SLC31A1	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs4978536:GG
opioids	rs11030096	BDNF-AS	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs11030096:CC
opioids	rs11030096	BDNF-AS	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs11030096:CT
irinotecan, platinum compounds	rs1799930	NAT2	AA	Efficacy	increased	Efficacy_Response	Other:C0024121		L01CE02|L01XA	rs1799930:AA
platinum compounds	rs10817464	SLC31A1	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs10817464:CC
platinum compounds	rs10817464	SLC31A1	CT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs10817464:CT
voriconazole	poor metabolizer genotype	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	J02AC03	__UNKNOWN__
platinum compounds	rs4979223	SLC31A1	AC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs4979223:AC
cocaine	rs2251214	SYT1	G	Toxicity	increased	Adverse_Event	Healthy		N01BC01	rs2251214:G
azathioprine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0241910		L04AX01	rs116855232:CT
azathioprine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Other:C0241910		L04AX01	rs116855232:TT
valganciclovir	rs2229109	ABCB1	CT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		J05AB14	rs2229109:CT
fluoxetine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*4/*4
tetrabenazine	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	Indeterminado	Other	Healthy	ultrarapid metabolizer	N07XX06	__UNKNOWN__
mycophenolate mofetil(mycophenolic acid)	rs3832043	UGT1A9	T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs3832043:T
olanzapine	poor metabolizers	CYP2C9	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	N05AH03	__UNKNOWN__
"""folic acid"", ""vitamin b-complex, plain"""	rs1801394	MTRR	AA	Efficacy	decreased	Adverse_Event	Disease:C0338480		B03BB01	rs1801394:AA
"""folic acid"", ""vitamin b-complex, plain"""	rs1801394	MTRR	AG	Efficacy	decreased	Adverse_Event	Disease:C0338480		B03BB01	rs1801394:AG
nicotine	rs3758987	HTR3B	TT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs3758987:TT
capecitabine	rs11280056	TYMS	TTAAAGTTA	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs11280056:TTAAAGTTA
capecitabine	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C2931822		L01BC06	rs67376798:AT
antidepressants	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06A	*3/*4
antidepressants	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06A	*4/*4
antidepressants	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06A	*4/*5
antidepressants	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06A	*4/*6
enalapril	rs1044147	PCGF3	A	Toxicity	increased	Adverse_Event	Other:C0020538		C09AA02	rs1044147:A
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*3/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*4
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*3/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*5
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*3/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*6
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*4/*11	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*11
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*4
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*5
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*4/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*6
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*4/*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*7
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*5/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*5/*5
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*6/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*6/*6
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*6/*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*6/*7
paroxetine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB05	*3/*4
paroxetine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB05	*4/*4
paroxetine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB05	*4/*5
tramadol	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0549433		N02AX02	rs4680:AA
tramadol	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0549433		N02AX02	rs4680:AG
anticholinergic agents	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N04A	__UNKNOWN__
venlafaxine	normal metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0028768	normal metabolizer	N06AX16	__UNKNOWN__
antineoplastic agents	rs2231164	ABCG2	CC	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01	rs2231164:CC
antineoplastic agents	rs2231164	ABCG2	CT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01	rs2231164:CT
citalopram, clomipramine, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, paroxetine, sertraline, venlafaxine	normal metabolizers	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Disease:C0028768	normal metabolizer	N06AA04|N06AB03|N06AB04|N06AB05|N06AB06|N06AB08|N06AB10|N06AX11|N06AX16|N06AX21	__UNKNOWN__
mycophenolate mofetil(mycophenolic acid)	rs3832043	UGT1A9	T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs3832043:T
mycophenolate mofetil(mycophenolic acid)	rs2273697	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs2273697:AG
capecitabine	rs2297595	DPYD	CT	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC06	rs2297595:CT
opioids	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Other:C0030193		N02A	rs1799971:GG
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*3/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Toxicity	increased	Adverse_Event	Healthy	ultrarapid metabolizer	B01AC04	*1/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Healthy	ultrarapid metabolizer	B01AC04	*17/*17
atenolol	rs2245360	PAH	AA	Toxicity	increased	Adverse_Event	Other:C0020538		C07AB03	rs2245360:AA
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*4	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*3/*4
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*5	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*3/*5
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*4/*4
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*4/*5
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7	CYP2D6	*3/*4	Efficacy	increased	Adverse_Event	Healthy	poor metabolizer	L02BA01	*3/*4
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7	CYP2D6	*3/*5	Efficacy	increased	Adverse_Event	Healthy	poor metabolizer	L02BA01	*3/*5
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Healthy	poor metabolizer	L02BA01	*4/*4
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Healthy	poor metabolizer	L02BA01	*4/*5
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7	CYP2D6	*4/*7	Efficacy	increased	Adverse_Event	Healthy	poor metabolizer	L02BA01	*4/*7
aspirin, clopidogrel	rs662	PON1	CT	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs662:CT
aspirin, clopidogrel	rs662	PON1	TT	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs662:TT
opioids	rs1125394	DRD2	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1125394:CC
opioids	rs1125394	DRD2	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1125394:CT
opioids	rs1799971	OPRM1	G	Toxicity	decreased	Adverse_Event	Other:C0030193		N02A	rs1799971:G
sorafenib	rs3025040	VEGFA	CC	Toxicity	increased	Adverse_Event	Disease:C2239176		L01EX02	rs3025040:CC
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L01|L02BA01	*5/*10
opioids	rs1079596	DRD2	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1079596:CT
opioids	rs1079596	DRD2	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1079596:TT
tramadol	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0549433		N02AX02	rs4680:AA
tramadol	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0549433		N02AX02	rs4680:AG
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L01|L02BA01	*5/*10
efavirenz	poor metabolizer and intermediate metabolizer genotypes	CYP2B6	__UNKNOWN__	Other	increased	Adverse_Event	Disease:HIV_infectious_disease	intermediate metabolizer and poor metabolizer	J05AG03	__UNKNOWN__
anthracyclines and related substances	rs3740066	ABCC2	TT	Toxicity	increased	Adverse_Event	Other:C1561230|Other:C1261473		L01DB	rs3740066:TT
azathioprine, mercaptopurine, purine analogues	intermediate metabolizers	TPMT	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0021390	intermediate metabolizer	L01BB|L01BB02|L04AX01	__UNKNOWN__
fluorouracil	rs2847153	TYMS	AG	Efficacy	decreased	Adverse_Event	Disease:C0030297		L01BC02	rs2847153:AG
fluorouracil	rs2847153	TYMS	GG	Efficacy	decreased	Adverse_Event	Disease:C0030297		L01BC02	rs2847153:GG
morphine	rs4148412	ABCC3	T	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs4148412:T
sorafenib	rs7574296	UGT1A9	AA	Toxicity	increased	Adverse_Event	Disease:C2239176		L01EX02	rs7574296:AA
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*1	Toxicity	decreased	Adverse_Event	Other:C0024121		L01CE02	*1/*1
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	decreased	Adverse_Event	Other:C0024121		L01CE02	*1/*28
sorafenib	rs2071559	KDR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2071559:AA
tacrolimus	intermediate metabolizer and normal metabolizer	CYP3A5	__UNKNOWN__	Dosage	increased	Adverse_Event	Other:Kidney_Transplantation	normal metabolizer and intermediate metabolizer	L04AD02	__UNKNOWN__
tramadol	rs4680	COMT	GG	Efficacy	increased	Adverse_Event	Other:C0549433		N02AX02	rs4680:GG
"""folic acid"", ""vitamin b-complex, plain"""	rs1801133	MTHFR	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0338480		B03BB01	rs1801133:AG
"""folic acid"", ""vitamin b-complex, plain"""	rs1801133	MTHFR	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0338480		B03BB01	rs1801133:GG
amitriptyline, clomipramine, doxepin, imipramine, trimipramine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0004936	poor metabolizer	N06AA02|N06AA04|N06AA06|N06AA09|N06AA12	__UNKNOWN__
sorafenib	rs2257212	SLC15A2	CC	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2257212:CC
fluorouracil	rs9344	CCND1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01BC02	rs9344:AA
azathioprine	intermediate metabolizer genotype	TPMT	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0021390	intermediate metabolizer	L04AX01	__UNKNOWN__
capecitabine	rs2279199	UMPS	CC	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2279199:CC
capecitabine	rs2279199	UMPS	CT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2279199:CT
metformin	rs578427	__INTRONIC__	TT	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs578427:TT
capecitabine	rs2853741	TYMS	CT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2853741:CT
capecitabine	rs2853741	TYMS	TT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2853741:TT
clopidogrel	rapid and ultrarapid metabolizer genotypes	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0007222	ultrarapid metabolizer and rapid metabolizer	B01AC04	__UNKNOWN__
capecitabine	rs4149178	SLC22A7	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs4149178:AG
capecitabine	rs4149178	SLC22A7	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs4149178:GG
cisplatin	rs1051640	ABCC3	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1051640:G
galantamine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*3/*4
galantamine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*4/*4
galantamine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*4/*5
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*4
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*5
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*6
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*4
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*5
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*6
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*6/*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*6/*7
clopidogrel	normal metabolizers	CYP2C19	__UNKNOWN__	Other	decreased	Adverse_Event	Disease:C1956346	normal metabolizer	B01AC04	__UNKNOWN__
methotrexate	rs1051266	SLC19A1	T	Toxicity	increased	Adverse_Event	Disease:C0235763		L04AX03	rs1051266:T
clopidogrel	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__
abt-751	rs6755571	UGT1A4	AC	Metabolism/PK	decreased	LADME	Disease:C0027651		No_ATC	rs6755571:AC
capecitabine	rs4678145	UMPS	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs4678145:CC
capecitabine	rs4678145	UMPS	CG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs4678145:CG
abt-751	rs6431558	UGT1A8	CC	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	rs6431558:CC
abt-751	rs6431558	UGT1A8	CT	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	rs6431558:CT
imipramine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AA02	__UNKNOWN__
antineoplastic agents	rs1760217	DPYD	AA	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01	rs1760217:AA
antineoplastic agents	rs1760217	DPYD	AG	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01	rs1760217:AG
azathioprine	rs1142345	TPMT	CC	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	L04AX01	rs1142345:CC
azathioprine	rs1142345	TPMT	CT	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	L04AX01	rs1142345:CT
antineoplastic agents	rs17091162	SERPINA3	AC	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01	rs17091162:AC
antineoplastic agents	rs17091162	SERPINA3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01	rs17091162:CC
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0007222	intermediate metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	decreased	LADME	Disease:C0007222	intermediate metabolizer	B01AC04	*2/*17
valproic acid	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0014544	intermediate metabolizer and poor metabolizer	N03AG01	__UNKNOWN__
aspirin, clopidogrel	rs10306114	PTGS1	AG	Toxicity	increased	Adverse_Event	Other:C1536220		B01AC04	rs10306114:AG
aspirin, clopidogrel	rs10306114	PTGS1	GG	Toxicity	increased	Adverse_Event	Other:C1536220		B01AC04	rs10306114:GG
metformin	rs12943590	SLC47A2	AA	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs12943590:AA
tamoxifen	rs1804645	NCOA1	CT	Other	increased	Adverse_Event	Healthy		L02BA01	rs1804645:CT
clopidogrel	intermediate metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention_(most_of_the_patients)	intermediate metabolizer	B01AC04	__UNKNOWN__
citalopram, escitalopram	rs352428	__INTRONIC__	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AB04|N06AB10	rs352428:A
clopidogrel	intermediate metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention_(most_of_the_patients)	intermediate metabolizer	B01AC04	__UNKNOWN__
citalopram	rs352428	__INTRONIC__	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AB04	rs352428:A
clopidogrel	poor metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention_(most_of_the_patients)	poor metabolizer	B01AC04	__UNKNOWN__
midazolam	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Healthy		N05CD08	rs1057868:CT
clopidogrel	poor metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention_(most_of_the_patients)	poor metabolizer	B01AC04	__UNKNOWN__
lenvatinib	rs2231142	ABCG2	GG	Toxicity	increased	Adverse_Event	Other:C0030521		L01EX08	rs2231142:GG
nicotine	rs578776	CHRNA3	G	Metabolism/PK	increased	LADME	Other:tobacco_users		N07BA01	rs578776:G
galantamine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*3/*4
galantamine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*4/*4
galantamine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*4/*5
trazodone	normal metabolizer genotype	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	normal metabolizer	N06AX05	__UNKNOWN__
capecitabine	rs17376848	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C2931822		L01BC06	rs17376848:AG
risperidone	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Disease:C0004352	ultrarapid metabolizer	N05AX08	__UNKNOWN__
aspirin, clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:C1536220		B01AC04	rs4244285:AA
lenvatinib	rs2242480	CYP3A4	C	Toxicity	increased	Adverse_Event	Other:C0030521		L01EX08	rs2242480:C
lenvatinib	rs776746	CYP3A5	C	Toxicity	increased	Adverse_Event	Other:C0030521		L01EX08	rs776746:C
capecitabine	rs699517	ENOSF1, TYMS	TT	Toxicity	increased	Adverse_Event	Healthy		L01BC06	rs699517:TT
heroin	rs6473797	OPRK1	C	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs6473797:C
heroin	rs1534891	CSNK1E	T	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs1534891:T
capecitabine	rs12119882	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs12119882:AG
ethanol	rs16969968	CHRNA5	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs16969968:G
heroin	rs694066	GAL	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs694066:A
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Other	Healthy	poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Other	Healthy	poor metabolizer	B01AC04	*3/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Other	Healthy	poor metabolizer	B01AC04	*2/*3
heroin	rs2236861	OPRD1	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2236861:A
capecitabine	rs2270860	SLC22A7	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2270860:TT
heroin	rs3766951	OPRD1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3766951:C
methadone	rs1500	CRHBP	G	Other	decreased	Other	Disease:C0028043		N07BC02	rs1500:G
methamphetamine	rs324420	FAAH	A	Other	increased	Adverse_Event	Healthy		No_ATC	rs324420:A
ethanol	rs1051730	CHRNA3	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1051730:G
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*4	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*3/*4
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*5	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*3/*5
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*6	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*3/*6
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*4/*4
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*4/*5
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*6	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*4/*6
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*6/*7	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*6/*7
heroin	rs2236857	OPRD1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2236857:C
naloxone	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:AG
naloxone	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:GG
tamoxifen	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C1458155	ultrarapid metabolizer	L02BA01	__UNKNOWN__
capecitabine	rs699517	ENOSF1, TYMS	CT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs699517:CT
capecitabine	rs699517	ENOSF1, TYMS	TT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs699517:TT
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*1	Toxicity	increased	Adverse_Event	Other:C1458155	normal metabolizer	L02BA01	*1/*1
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Toxicity	increased	Adverse_Event	Other:C1458155	normal metabolizer	L02BA01	*1/*10
heroin	rs3758987	HTR3B	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3758987:C
metoprolol	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	C07AB02	__UNKNOWN__
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC04	*1/*3
osimertinib	rs2231142	ABCG2	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB04	rs2231142:GG
tamoxifen	normal metabolizers	CYP2D6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C1458155	normal metabolizer	L02BA01	__UNKNOWN__
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
escitalopram	rs6318	HTR2C	C	Efficacy	decreased	Adverse_Event	Disease:C0522067		N06AB10	rs6318:C
oxycodone	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	__UNKNOWN__
oxycodone	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Healthy	poor metabolizer	N02AA05	__UNKNOWN__
mercaptopurine	rs10948059	GNMT	CT	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02	rs10948059:CT
mercaptopurine	rs10948059	GNMT	TT	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02	rs10948059:TT
nicotine	rs16969968	CHRNA5	A	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs16969968:A
oxycodone	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	decreased	LADME	Healthy	poor metabolizer	N02AA05	__UNKNOWN__
nicotine	rs1051730	CHRNA3	A	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1051730:A
paroxetine	normal metabolizers	CYP2D6	__UNKNOWN__	Other	increased	Other	Disease:C0003469	normal metabolizer	N06AB05	__UNKNOWN__
irinotecan, platinum compounds	rs1799931	NAT2	AA	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01CE02|L01XA	rs1799931:AA
paroxetine	poor metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0004936	poor metabolizer	N06AB05	__UNKNOWN__
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Other	Healthy	intermediate metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Other	Healthy	intermediate metabolizer	B01AC04	*1/*3
heroin	rs3778151	OPRM1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3778151:C
escitalopram	intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0011581	intermediate metabolizer	N06AB10	__UNKNOWN__
paroxetine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB05	__UNKNOWN__
capecitabine	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1801265:AG
capecitabine	rs1801265	DPYD	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1801265:GG
paroxetine	poor metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0011581	poor metabolizer	N06AB05	__UNKNOWN__
fluoxetine	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1	Metabolism/PK	increased	LADME	Disease:C0011581	normal metabolizer	N06AB03	*1/*1
capecitabine	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C2931822		L01BC06	rs1801265:AG
capecitabine	rs1801265	DPYD	GG	Toxicity	increased	Adverse_Event	Disease:C2931822		L01BC06	rs1801265:GG
alkylating agents, cisplatin	rs2207396	ESR1	A	Toxicity	increased	Adverse_Event	Other:C0699790		L01A|L01XA01	rs2207396:A
heroin	rs510769	OPRM1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs510769:T
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	B01AC04	*3/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	B01AC04	*2/*3
antidepressants	poor metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0011581	poor metabolizer	N06A	__UNKNOWN__
citalopram	poor metabolizers	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Disease:C0011581	poor metabolizer	N06AB04	__UNKNOWN__
tamoxifen	normal metabolizers	CYP2D6	*1/*1	Efficacy	increased	Efficacy_Response	Disease:C1458155	normal metabolizer	L02BA01	*1/*1
tamoxifen	normal metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	normal metabolizer	L02BA01	__UNKNOWN__
antipsychotics	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0036341	intermediate metabolizer and poor metabolizer	N05A	__UNKNOWN__
osimertinib	rs4796793	STAT3	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB04	rs4796793:GG
escitalopram	rs1065852	CYP2D6	AA	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB10	rs1065852:AA
3,4-methylenedioxymethamphetamine	poor metabolizer genotype	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	V04CX05	__UNKNOWN__
drugs for treatment of tuberculosis	rs4149014	SLCO1B1	GG	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs4149014:GG
drugs for treatment of tuberculosis	rs4149014	SLCO1B1	GT	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs4149014:GT
docetaxel, epirubicin	poor metabolizer genotype	__INTRONIC__	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L01CD02|L01DB03	
none	rs6968865	__INTRONIC__	T	Dosage	increased	Other	Healthy		A03DA02	rs6968865:T
sulfamethoxazole	rs761142	GCLC	AA	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J01EC01	rs761142:AA
azathioprine, mercaptopurine	intermediate metabolizer genotype	TPMT	__UNKNOWN__	Efficacy, Toxicity, Metabolism/PK	increased	LADME	Disease:C0021390	intermediate metabolizer	L01BB02|L04AX01	__UNKNOWN__
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C1956346	poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C1956346	poor metabolizer	B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C1956346	poor metabolizer	B01AC04	*3/*3
none	rs2472297	CYP1A1	T	Dosage	increased	Other	Healthy		A03DA02	rs2472297:T
sulfamethoxazole	rs761142	GCLC	A	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J01EC01	rs761142:A
apixaban, dabigatran, edoxaban, rivaroxaban	rs2244613	CES1	GT	Toxicity	increased	Adverse_Event	Other:C0040038		B01AE07|B01AF01|B01AF02|B01AF03	rs2244613:GT
apixaban, dabigatran, edoxaban, rivaroxaban	rs2244613	CES1	TT	Toxicity	increased	Adverse_Event	Other:C0040038		B01AE07|B01AF01|B01AF02|B01AF03	rs2244613:TT
tramadol	normal metabolizer and ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0024031|Disease:C0022408	normal metabolizer and ultrarapid metabolizer	N02AX02	__UNKNOWN__
anthracyclines and related substances	rs2273697	ABCC2	AG	Efficacy	increased	Efficacy_Response	Other:C1561230|Other:C1261473		L01DB	rs2273697:AG
anthracyclines and related substances	rs2273697	ABCC2	GG	Efficacy	increased	Efficacy_Response	Other:C1561230|Other:C1261473		L01DB	rs2273697:GG
sorafenib	rs1870377	KDR	TT	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs1870377:TT
tacrolimus	rs35599367	CYP3A4	AG	Other	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:AG
anthracyclines and related substances	rs3740066	ABCC2	TT	Efficacy	decreased	Efficacy_Response	Other:C1561230|Other:C1261473		L01DB	rs3740066:TT
clopidogrel	rs662	PON1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0151744		B01AC04	rs662:CC
antipsychotics	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0036337|Other:C0036341	ultrarapid metabolizer	N05A	__UNKNOWN__
isoniazid	rs117491755	ASTN2	C	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	rs117491755:C
alectinib	rs4253728	PPARA	AA	Toxicity	increased	Adverse_Event	Other:C0007131		L01ED03	rs4253728:AA
alectinib	rs4253728	PPARA	AG	Toxicity	increased	Adverse_Event	Other:C0007131		L01ED03	rs4253728:AG
valproic acid	rs2298771	SCN1A	TT	Efficacy	decreased	Adverse_Event	Other:C0014544		N03AG01	rs2298771:TT
sulfamethoxazole / trimethoprim	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*13:01
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*6
atomoxetine	CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Adverse_Event	Other:C1263846	intermediate metabolizer	N06BA09	*10/*10
cisplatin	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01	
cisplatin	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01	
aripiprazole, olanzapine, risperidone	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Other:C0036341	intermediate metabolizer and poor metabolizer	N05AH03|N05AX08|N05AX12	*1/*4
aripiprazole, olanzapine, risperidone	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Other:C0036341	intermediate metabolizer and poor metabolizer	N05AH03|N05AX08|N05AX12	*4/*4
codeine	rs2032582	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0030193		R05DA04	rs2032582:AA
ethanol	rs10055255	CRHBP	TT	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs10055255:TT
sunitinib	rs2276707	NR1I2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2276707:TT
antipsychotics	rs1799732	DRD2	del	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05A	rs1799732:del
lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*15:02
oxaliplatin	HLA-DRB1*12:01	HLA-DRB1	*12:01	Toxicity	increased	Adverse_Event	Healthy		L01XA03	*12:01
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4	Efficacy	decreased	Adverse_Event	Other:C0026640		L01BC03	*4
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*7	Efficacy	decreased	Adverse_Event	Other:C0026640		L01BC03	*7
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*9	Efficacy	decreased	Adverse_Event	Other:C0026640		L01BC03	*9
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*10	Efficacy	decreased	Adverse_Event	Other:C0026640		L01BC03	*10
cefaclor	HLA-DRB1*14:54	HLA-DRB1	*14:54	Toxicity	increased	Adverse_Event	Healthy		J01DC04	*14:54
ethanol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:AG
ethanol	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:GG
sulfasalazine	HLA-A*11:01	HLA-A	*11:01	Toxicity	increased	Adverse_Event	Healthy		A07EC01	*11:01
sulfasalazine	HLA-B*39:01	HLA-B	*39:01	Toxicity	increased	Adverse_Event	Healthy		A07EC01	*39:01
sulfasalazine	HLA-B*56:03	HLA-B	*56:03	Toxicity	increased	Adverse_Event	Healthy		A07EC01	*56:03
metoprolol	CYP2D6*1, CYP2D6*2	CYP2D6	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		C07AB02	*1/*2
methamphetamine	rs778293	DAOA	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs778293:C
cefaclor	HLA-DRB1*04:03	HLA-DRB1	*04:03	Toxicity	increased	Adverse_Event	Healthy		J01DC04	*04:03
cefaclor	HLA-DRB1*04:03	HLA-DRB1	*04:03	Toxicity	increased	Adverse_Event	Healthy		J01DC04	*04:03
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01
atorvastatin, simvastatin	SLCO1B1*15	SLCO1B1	*15	Efficacy, Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*15
atorvastatin, simvastatin	SLCO1B1*20	SLCO1B1	*20	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*20
atorvastatin, simvastatin	SLCO1B1*37	SLCO1B1	*37	Efficacy	decreased	Adverse_Event	Healthy		C10AA01|C10AA05	*37
atorvastatin, simvastatin	SLCO1B1*5	SLCO1B1	*5	Efficacy	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*5
atorvastatin, simvastatin	SLCO1B1*15	SLCO1B1	*15	Efficacy	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*15
atorvastatin, simvastatin	SLCO1B1*5	SLCO1B1	*5	Efficacy, Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*5
sorafenib	rs2071559	KDR	GG	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2071559:GG
atorvastatin, simvastatin	SLCO1B1*15	SLCO1B1	*15	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*15
atorvastatin, simvastatin	SLCO1B1*14	SLCO1B1	*14	Efficacy	decreased	Adverse_Event	Healthy		C10AA01|C10AA05	*14
tacrolimus	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs1045642:AG
risperidone	rs1042713	ADRB2	G	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	rs1042713:G
beclomethasone, budesonide, fluticasone, fluticasone propionate, mometasone	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:C0004096		R03BA01|R03BA02|R03BA05|R03BA07	*1/*1
beclomethasone, budesonide, fluticasone, fluticasone propionate, mometasone	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Other:C0004096		R03BA01|R03BA02|R03BA05|R03BA07	*1/*3
nicotine	CYP2A6*1, CYP2A6*1x2	CYP2A6	*1/*1x2	Toxicity	increased	Adverse_Event	Healthy		N07BA01	*1/*1x2
cytarabine	rs2228224	GLI1	AA	Efficacy	decreased	Efficacy_Response	Other:C0023418|Myeloid|Acute		L01BC01	rs2228224:AA
cytarabine	rs2229300	ARHGAP9, GLI1	GT	Efficacy	decreased	Efficacy_Response	Other:C0023418|Myeloid|Acute		L01BC01	rs2229300:GT
cytarabine	rs2229300	ARHGAP9, GLI1	TT	Efficacy	decreased	Efficacy_Response	Other:C0023418|Myeloid|Acute		L01BC01	rs2229300:TT
codeine	rs1128503	ABCB1	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0030193		R05DA04	rs1128503:A
capecitabine, fluorouracil, leucovorin, oxaliplatin	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06|L01XA03	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2
sorafenib	rs1870377	KDR	TT	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs1870377:TT
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0013182		M04AA01	*58:01
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0740394		M04AA01	*58:01
codeine	rs2032582	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0030193		R05DA04	rs2032582:AA
codeine	rs1045642	ABCB1	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0030193		R05DA04	rs1045642:A
clopidogrel, respiratory system	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:Elderly_Adult|Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04|V09E	*1/*2
clopidogrel, respiratory system	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:Elderly_Adult|Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04|V09E	*1/*3
clopidogrel, respiratory system	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:Elderly_Adult|Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04|V09E	*2/*2
clopidogrel, respiratory system	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:Elderly_Adult|Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04|V09E	*2/*3
clopidogrel, respiratory system	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:Elderly_Adult|Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04|V09E	*3/*3
none	rs602633	CELSR2, PSRC1	T	Metabolism/PK	Indeterminado	LADME	Disease:C0679403		A03DA02	rs602633:T
cocaine, ethanol, opioids	rs524731	OPRM1	A	Toxicity	increased	Adverse_Event	Healthy		N01BC01|N02A|V03AB16	rs524731:A
atazanavir, indinavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE02|J05AE08	*28/*28
atazanavir, ritonavir	UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	*28/*28
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*1/*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*1/*3
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*2/*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*3/*3
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*2/*3
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*1/*28
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*28/*28
methotrexate	rs4149081	SLCO1B1	G	Other, Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs4149081:G
beta blocking agents	rs2230345	GRK5	AA	Efficacy	decreased	Adverse_Event	Other:C0085605		S01ED	rs2230345:AA
valproic acid	rs10167228	SCN1A	AA	Efficacy	decreased	Adverse_Event	Other:C0014544		N03AG01	rs10167228:AA
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*3
tacrolimus	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs1045642:AG
clopidogrel	CYP2C19*1, CYP2C19*5	CYP2C19	*5	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*5
mirtazapine	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N06AX11	*4/*4
mirtazapine	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Healthy		N06AX11	*4/*6
troglitazone	rs10811661	__INTRONIC__	C	Efficacy	increased	Efficacy_Response	Other:high_risk_for_type_2_diabetes		A10BG01	rs10811661:C
platinum compounds	rs1799793	ERCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1799793:CC
platinum compounds	rs1799793	ERCC2	CT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1799793:CT
nevirapine	rs3745274	CYP2B6	T	Metabolism/PK	increased	Other	Disease:HIV_infectious_disease		J05AG01	rs3745274:T
citalopram	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB04	*3
methamphetamine	rs713729	PICK1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs713729:T
imatinib	rs2231142	ABCG2	T	Toxicity	increased	Adverse_Event	Other:C0238198		L01EA01	rs2231142:T
caffeine	rs1110976	DRD2	GG	Other	decreased	Adverse_Event	Other:C0024198		N06BC01	rs1110976:GG
opioids	rs4530637	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs4530637:AG
opioids	rs4530637	__INTRONIC__	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs4530637:GG
nevirapine	rs1045642	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs1045642:A
cocaine, ethanol, opioids	rs3778156	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		N01BC01|N02A|V03AB16	rs3778156:G
none	rs1111875	__INTRONIC__	C	Metabolism/PK	decreased	LADME	Other:high_risk_of_type_2_diabetes		A03DA02	rs1111875:C
cisplatin	rs9332377	COMT	T	Toxicity	increased	Adverse_Event	Healthy		L01XA01	rs9332377:T
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*4	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB03	*4
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*6	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB03	*6
opioids	rs1384401	TACR3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1384401:AG
opioids	rs1384401	TACR3	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1384401:GG
cisplatin	rs4646316	COMT	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs4646316:C
folfiri	rs2273697	ABCC2	GG	Toxicity	decreased	Adverse_Event	Other:C0030297		No_ATC	rs2273697:GG
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*2
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*3
platinum compounds	rs316003	SLC22A2	CT	Efficacy	increased	Efficacy_Response	Other:C0024121|Other:C0039338		L01XA	rs316003:CT
platinum compounds	rs316003	SLC22A2	TT	Efficacy	increased	Efficacy_Response	Other:C0024121|Other:C0039338		L01XA	rs316003:TT
methotrexate	rs717620	ABCC2	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs717620:T
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4
methamphetamine	rs713729	PICK1	T	Other	increased	Adverse_Event	Disease:C0036502		No_ATC	rs713729:T
opioids	rs1065852	CYP2D6	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1065852:AA
folfiri	rs1885301	ABCC2	AA	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	rs1885301:AA
citalopram, escitalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB04|N06AB10	*1/*2
opioids	rs6280	DRD3	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs6280:CC
opioids	rs6280	DRD3	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs6280:CT
hydrochlorothiazide	rs17137967	__INTRONIC__	CC	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs17137967:CC
hydrochlorothiazide	rs17137967	__INTRONIC__	CT	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs17137967:CT
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*4	Other	decreased	Adverse_Event	Healthy		A03DA02	*4/*4
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*7	Other	decreased	Adverse_Event	Healthy		A03DA02	*4/*7
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*9	Other	decreased	Adverse_Event	Healthy		A03DA02	*4/*9
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*7/*7	Other	decreased	Adverse_Event	Healthy		A03DA02	*7/*7
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*7/*9	Other	decreased	Adverse_Event	Healthy		A03DA02	*7/*9
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*9/*9	Other	decreased	Adverse_Event	Healthy		A03DA02	*9/*9
opioids	rs324029	DRD3	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs324029:AA
opioids	rs324029	DRD3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs324029:AG
tamoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Disease:C1458155	intermediate metabolizer and poor metabolizer	L02BA01	__UNKNOWN__
opioids	rs718656	EXOC4	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs718656:TT
ethambutol, isoniazid, pyrazinamide, rifampin	rs4646244	NAT2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs4646244:A
amisulpride, clozapine, haloperidol, olanzapine, quetiapine, risperidone, ziprasidone, zuclopenthixol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0005586|Other:C0031212|Other:C0033975|Other:C0028768	poor metabolizer	N05AD01|N05AE04|N05AF05|N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	*4/*4
nicotine	rs2072660	CHRNB2	T	Other	increased	Adverse_Event	Other:smokers		N07BA01	rs2072660:T
direct acting antivirals	rs11322783	IFNL4	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05A	rs11322783:GG
platinum compounds	rs3213239	APLF	CCGG/CCGG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs3213239:CCGG/CCGG
platinum compounds	rs3213239	APLF	CCGG/del	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs3213239:CCGG/del
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:GG
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*1/*28
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*28/*28
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
platinum compounds	rs50872	ERCC2	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs50872:GG
platinum compounds	rs1448784	ABCG2	GG	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01XA	rs1448784:GG
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799930	NAT2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799930:A
nicotine	rs2072661	CHRNB2	A	Other	increased	Adverse_Event	Other:smokers		N07BA01	rs2072661:A
codeine, hydrocodone, oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*3	Toxicity	decreased	Adverse_Event	Healthy		N02AA05|R05DA03|R05DA04	*3/*3
codeine, hydrocodone, oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Toxicity	decreased	Adverse_Event	Healthy		N02AA05|R05DA03|R05DA04	*4/*4
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*1	Toxicity	decreased	Adverse_Event	Other:C0024121		L01CE02	*1/*1
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	decreased	Adverse_Event	Other:C0024121		L01CE02	*1/*28
boceprevir, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP03|L03AB10	rs12979860:CC
platinum compounds	rs11615	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs11615:AA
platinum compounds	rs11615	ERCC1	AG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs11615:AG
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11
hydroxychloroquine	rs10882526	CYP2C8	GG	Toxicity	increased	Adverse_Event	Other:C0003873|Other:C0024141		P01BA02	rs10882526:GG
opium alkaloids and derivatives	rs660652	CHRNA5	GG	Toxicity	increased	Adverse_Event	Disease:C0030193		R05DA	rs660652:GG
methamphetamine	rs1421292	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1421292:T
ace inhibitors, plain	rs495828	ABO	GT	Toxicity	Indeterminado	Adverse_Event	Healthy		A03B|C09A	rs495828:GT
ace inhibitors, plain	rs495828	ABO	TT	Toxicity	Indeterminado	Adverse_Event	Healthy		A03B|C09A	rs495828:TT
amitriptyline, clomipramine, doxepin, imipramine, maprotiline, nortriptyline, opipramol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Disease:C0235876		N06AA02|N06AA04|N06AA09|N06AA10|N06AA12|N06AA21	*4/*4
gliclazide	rs5219	KCNJ11	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BB09	rs5219:CT
gliclazide	rs5219	KCNJ11	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BB09	rs5219:TT
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1	Efficacy	decreased	Other	Disease:C1956346		B01AC04	*1
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17	Efficacy	decreased	Other	Disease:C1956346		B01AC04	*17
platinum compounds	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1128503:AA
drugs for treatment of tuberculosis	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	__UNKNOWN__
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*3/*3
opioids	rs7597593	ZNF804A	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs7597593:CC
nortriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*4/*4
opium alkaloids and derivatives	rs1051730	CHRNA3	AA	Toxicity	increased	Adverse_Event	Disease:C0030193		R05DA	rs1051730:AA
hydroxychloroquine	rs776746	CYP3A5	TT	Toxicity	increased	Adverse_Event	Other:C0003873|Other:C0024141		P01BA02	rs776746:TT
platinum compounds	rs7170924	IL16	GT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs7170924:GT
platinum compounds	rs7170924	IL16	TT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs7170924:TT
indomethacin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	increased	Adverse_Event	Other:C0013274		S01BC01	*2
none	rs1051730	CHRNA3	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs1051730:AA
none	rs1051730	CHRNA3	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs1051730:AG
nevirapine	HLA-B*15:10	HLA-B	*15:10	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*15:10
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*2	Efficacy	increased	Adverse_Event	Other:C0007787|Other:C0018839		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*3	Efficacy	increased	Adverse_Event	Other:C0007787|Other:C0018839		B01AC04	*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*8	Efficacy	increased	Adverse_Event	Other:C0007787|Other:C0018839		B01AC04	*8
aspirin	rs1131882	TBXA2R	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0011849		No_ATC	rs1131882:A
opioids	rs2023239	CNR1	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2023239:TT
none	rs1800566	NQO1	AA	Other	Indeterminado	Other	Disease:C0007131		A03DA02	rs1800566:AA
busulfan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	increased	LADME	Disease:hemopoietic_stem_cell_transplant		L01AB01	*2
busulfan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	increased	LADME	Disease:hemopoietic_stem_cell_transplant		L01AB01	*3
platinum compounds	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1128503:AA
metformin	rs3889348	SLC29A4	G	Toxicity	increased	Adverse_Event	Other:C0011849		A10BA02	rs3889348:G
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*1/*28
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*28/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28
none	rs1800566	NQO1	A	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1800566:A
hydrochlorothiazide	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
drugs for treatment of tuberculosis	GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	
drugs for treatment of tuberculosis	GSTT1 null	GSTT1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	
opioids	rs6928499	CNR1	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs6928499:CC
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L01|L02BA01	*5/*10
nevirapine	rs58425034	CYP2B6	CC	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs58425034:CC
nevirapine	rs58425034	CYP2B6	CG	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs58425034:CG
fluorouracil	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Efficacy	decreased	Adverse_Event	Disease:C0022665		L01BC02	rs11280056:TTAAAGTTA/TTAAAGTTA
clopidogrel	CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Disease:C0002962		B01AC04	*2/*2
docetaxel, thalidomide	rs4148945	CHST3	C	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs4148945:C
"""folic acid"", ""vitamin b-complex, plain"""	rs1801133	MTHFR	AG	Efficacy	decreased	Adverse_Event	Disease:C0338480		B03BB01	rs1801133:AG
"""folic acid"", ""vitamin b-complex, plain"""	rs1801133	MTHFR	GG	Efficacy	decreased	Adverse_Event	Disease:C0338480		B03BB01	rs1801133:GG
carbamazepine	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*51:01
docetaxel, thalidomide	rs2301159	SLC10A2	A	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs2301159:A
axitinib, sorafenib	rs11549465	HIF1A	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EK01|L01EX02	rs11549465:CT
fluorouracil, irinotecan, leucovorin	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Efficacy	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs11280056:TTAAAGTTA/TTAAAGTTA
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*6/*6
methotrexate	rs1051266	SLC19A1	CC	Efficacy	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CC
methotrexate	rs1051266	SLC19A1	CT	Efficacy	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CT
sorafenib	rs2071559	KDR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2071559:AA
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2
nicotine	rs77905	DBH	AA	Efficacy	increased	Adverse_Event	Disease:C0039338		N07BA01	rs77905:AA
nicotine	rs77905	DBH	AG	Efficacy	increased	Adverse_Event	Disease:C0039338		N07BA01	rs77905:AG
methotrexate	rs2298383	ADORA2A	GG	Toxicity	increased	Adverse_Event	Disease:C0745761		L04AX03	rs2298383:GG
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L01|L02BA01	*5/*10
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Other	increased	Other	Disease:C0027051		B01AC04	*1/*2
risperidone	rs3892097	CYP2D6	CT	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AX08	rs3892097:CT
risperidone	rs3892097	CYP2D6	TT	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AX08	rs3892097:TT
none	rs3211371	CYP2B6	TT	Other	increased	Adverse_Event	Other:rs1800497_GG_genotypes		A03DA02	rs3211371:TT
none	rs3211371	CYP2B6	CT	Other	increased	Adverse_Event	Other:rs1800497_GG_genotypes		A03DA02	rs3211371:CT
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*3	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*3
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*41
fluoxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB03	
irinotecan	rs4124874	UGT1A1	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs4124874:G
none	rs2762939	CYP24A1	C	Other	decreased	Adverse_Event	Healthy		A03DA02	rs2762939:C
opium alkaloids and derivatives	rs16969968	CHRNA5	A	Toxicity	increased	Adverse_Event	Disease:C0030193		R05DA	rs16969968:A
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Other:orthopedic_patients		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Other:orthopedic_patients		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Other:orthopedic_patients		B01AA03	*2/*3
morphine	rs739923	ABCC3	G	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs739923:G
citalopram	rs11628713	PAPLN	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	rs11628713:T
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2
sulfonamides, urea derivatives	rs5219	KCNJ11	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs5219:CT
sulfonamides, urea derivatives	rs5219	KCNJ11	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs5219:TT
fluoxetine	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	decreased	LADME	Disease:C0004936		N06AB03	*1/*1xN
imatinib	rs1867351	SLC22A1	TT	Toxicity	increased	Adverse_Event	Other:C0238198		L01EA01	rs1867351:TT
fluorouracil, leucovorin	rs13181	ERCC2	GG	Efficacy	increased	Adverse_Event	Disease:C0023055		L01BC02	rs13181:GG
fluorouracil, leucovorin	rs13181	ERCC2	GT	Efficacy	increased	Adverse_Event	Disease:C0023055		L01BC02	rs13181:GT
verapamil	rs11739136	KCNIP1, KCNMB1	CT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C08DA01	rs11739136:CT
verapamil	rs11739136	KCNIP1, KCNMB1	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C08DA01	rs11739136:TT
opioids	rs9288993	DRD3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs9288993:AG
opioids	rs9288993	DRD3	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs9288993:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT
osimertinib	rs1057910	CYP2C9	AC	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01EB04	rs1057910:AC
opioids	rs2654754	DRD3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2654754:AG
opioids	rs2654754	DRD3	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2654754:GG
opioids	rs10405238	ZNF568	G	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs10405238:G
antiepileptics	HLA-B*53:01	HLA-B	*53:01	Toxicity	increased	Adverse_Event	Healthy		N03A	*53:01
sulfamethoxazole, sulfamethoxazole / trimethoprim	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		J01EA01|J01EC01	*15:02
penicillin g	HLA-DPB1*05:01	HLA-DPB1	*05:01	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*05:01
sulfamethoxazole, sulfamethoxazole / trimethoprim	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J01EA01|J01EC01	*13:01
sulfamethoxazole, sulfamethoxazole / trimethoprim	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Healthy		J01EA01|J01EC01	*38:02
apixaban, dabigatran, edoxaban, rivaroxaban	rs3842	ABCB1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AE07|B01AF01|B01AF02|B01AF03	rs3842:CC
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0007820|Other:C0007282	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0007820|Other:C0007282	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0007820|Other:C0007282	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0007820|Other:C0007282	intermediate metabolizer and poor metabolizer	B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0007820|Other:C0007282	intermediate metabolizer and poor metabolizer	B01AC04	*3/*3
metformin	rs784892	AMHR2	G	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs784892:G
mycophenolate mofetil(mycophenolic acid)	rs4149117	SLCO1B3	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs4149117:GG
clopidogrel	intermediate metabolizer	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:percutaneous_coronary_intervention	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*1/*9	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*1/*9
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*2/*13	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*13
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*9/*17	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*9/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2
aspirin, clopidogrel	rs662	PON1	CT	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs662:CT
aspirin, clopidogrel	rs662	PON1	TT	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs662:TT
opioids	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1799971:AA
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*17	CYP2C19	*2	Other	increased	Adverse_Event	Healthy		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*17	CYP2C19	*4	Other	increased	Adverse_Event	Healthy		B01AC04	*4
clopidogrel	CYP2C19*1, CYP2C19*8	CYP2C19	*8	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*8
clopidogrel	CYP2C19*1, CYP2C19*5	CYP2C19	*5	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*5
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	increased	Adverse_Event	Other:C0018839		B01AA07	*2
atezolizumab, durvalumab, ipilimumab, nivolumab, pembrolizumab	HLA-A*26:01	HLA-A	*26:01	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0030793|Other:C0859290|Other:C1458155|Other:Head_and_Neck_Neoplasms		No_ATC	*26:01
carboplatin, gemcitabine	rs9937	RRM1	GG	Toxicity	Indeterminado	Adverse_Event	Disease:C0007131		L01BC05|L01XA02	rs9937:GG
ethanol	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:AA
metformin	rs628031	SLC22A1	A	Toxicity, Metabolism/PK	Indeterminado	Adverse_Event	Disease:C0011849		A10BA02	rs628031:A
opioids	rs4906902	GABRB3	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs4906902:AA
amitriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Other, Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*4
amitriptyline	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Other, Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*10
beclomethasone dipropionate, fluticasone propionate	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:C0004096		R03BA05	*1/*1
beclomethasone dipropionate, fluticasone propionate	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Other:C0004096		R03BA05	*1/*3
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*1/*3
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*2/*3
mycophenolate mofetil(mycophenolic acid)	rs7311358	SLCO1B3	AA	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs7311358:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, sofosbuvir	rs12979860	IFNL3, IFNL4	TT	Efficacy	decreased	Adverse_Event	Other:C0019372		J05AP01|J05AP08|L03AB10|L03AB11	rs12979860:TT
isoniazid, rifampin	HLA-DPB1*05:01	HLA-DPB1	*05:01	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*05:01
isoniazid, rifampin	HLA-A*11:01	HLA-A	*11:01	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*11:01
ethanol	rs1799732	DRD2	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799732:GG
salbutamol	rs892940	THRB	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs892940:A
opioids	rs735668	TACR1	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs735668:AA
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*3	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*3
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*6
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*7
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*9	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*9
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*41
aspirin, clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1045642:AA
aspirin, clopidogrel	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1045642:AG
aspirin, clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1045642:AA
aspirin, clopidogrel	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1045642:AG
apixaban, dabigatran, edoxaban, rivaroxaban	rs13306198	APOB	AA	Toxicity	increased	Adverse_Event	Healthy		B01AE07|B01AF01|B01AF02|B01AF03	rs13306198:AA
apixaban, dabigatran, edoxaban, rivaroxaban	rs13306198	APOB	AG	Toxicity	increased	Adverse_Event	Healthy		B01AE07|B01AF01|B01AF02|B01AF03	rs13306198:AG
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*3	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*1/*3
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*1/*4
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*1/*5
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*41/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*41/*41
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*4
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*5
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*3/*4
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*3	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*3/*3
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*3/*5
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*10
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*41
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*5/*41
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*5/*5
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*10/*10
opioids	rs510769	OPRM1	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs510769:CC
ethanol	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:G
first-generation cephalosporins, fourth-generation cephalosporins, other cephalosporins, third-generation cephalosporins	HLA-B*55:02	HLA-B	*55:02	Toxicity	increased	Adverse_Event	Healthy		J01DB|J01DD|J01DE|J01DI	*55:02
amoxicillin	HLA-B*15:01	HLA-B	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*15:01
"""metformin"", ""sulfonamides, urea derivatives"""	rs72552763	SLC22A1	GAT/del	Efficacy	increased	Adverse_Event	Other:C0011849		A10BA02|S01AB	rs72552763:GAT/del
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4	NAT2	*4	Toxicity	decreased	Adverse_Event	Disease:C0041296	rapid acetylator	J04AC01|J04AK01|J04AK02	*4
isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*16/*16
isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*16/*6
isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*16/*7
isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*6/*6
isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*7/*7
first-generation cephalosporins, fourth-generation cephalosporins, other cephalosporins, third-generation cephalosporins	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Healthy		J01DB|J01DD|J01DE|J01DI	*01:02
first-generation cephalosporins, fourth-generation cephalosporins, other cephalosporins, third-generation cephalosporins	HLA-DQB1*06:09	HLA-DQB1	*06:09	Toxicity	increased	Adverse_Event	Healthy		J01DB|J01DD|J01DE|J01DI	*06:09
infliximab	HLA-DQA1*05	HLA-DQA1	*05	Efficacy	increased	Adverse_Event	Other:C0010346		L04AB02	*05
nicotine	rs72552266	CYP2A13	CT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs72552266:CT
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*1
cyclophosphamide	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Other:Rhabdomyosarcoma	intermediate metabolizer and poor metabolizer	L01AA01	*1/*3
cyclophosphamide	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*6	Toxicity	increased	Adverse_Event	Other:Rhabdomyosarcoma	intermediate metabolizer and poor metabolizer	L01AA01	*1/*6
cyclophosphamide	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Other:Rhabdomyosarcoma	intermediate metabolizer and poor metabolizer	L01AA01	*3/*3
cyclophosphamide	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*3/*6	Toxicity	increased	Adverse_Event	Other:Rhabdomyosarcoma	intermediate metabolizer and poor metabolizer	L01AA01	*3/*6
none	UGT1A1*28	UGT1A1	*28	Other	increased	Adverse_Event	Healthy		A03DA02	*28
doxorubicin	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	
dipeptidyl peptidase 4 (dpp-4) inhibitors	HLA-DQB1*03:01	HLA-DQB1	*03:01	Toxicity	increased	Adverse_Event	Other:C0011849		No_ATC	*03:01
irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs4148323:AA
irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs4148323:AG
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*1
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*6
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*6
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*6
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*28
folfiri	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C2939419|Other:C0023055		No_ATC	*1/*6
folfiri	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C2939419|Other:C0023055		No_ATC	*6/*6
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*28/*28
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*1/*3
sacituzumab govitecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C1458155		No_ATC	*28/*28
folfiri	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		No_ATC	*28/*28
folfiri	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		No_ATC	*6/*6
folfiri	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		No_ATC	*6/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		L01CE02	*28/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		L01CE02	*1/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		L01CE02	*28/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		L01CE02	*1/*28
sunitinib	rs1870377	KDR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs1870377:TT
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Healthy		L01CE02	*28
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*6	Toxicity	increased	Adverse_Event	Healthy		L01CE02	*6
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Healthy		L01CE02	*28
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Healthy		L01CE02	*6/*6
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*6
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*6
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*28
mirabegron	intermediate metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	G04BD12	__UNKNOWN__
mirabegron	deficiency	SLCO1B1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	deficiency	G04BD12	__UNKNOWN__
tramadol	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Efficacy	decreased	Adverse_Event	Other:C0030193|Postoperative	ultrarapid metabolizer	N02AX02	__UNKNOWN__
methotrexate	rs3768142	MTR	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs3768142:GG
carbamazepine	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*13:01
carbamazepine	HLA-B*15:01	HLA-B	*15:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:01
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity, Metabolism/PK	increased	LADME	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3A
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3C	Toxicity, Metabolism/PK	increased	LADME	Disease:C0021390		L01BB|L01BB02|L04AX01	*3A/*3C
cisplatin	GSTT1 non-null, GSTT1 null	GSTT1	non-null	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	
sulfamethoxazole / trimethoprim	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*4	Toxicity	decreased	Adverse_Event	Disease:C0032285		J01EE01	*4
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Dosage	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3A
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Dosage	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3C
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Dosage	increased	Adverse_Event	Disease:C0023449		L01BB02	*3A/*3A
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8	CYP2C19	*2	Efficacy	decreased	Adverse_Event	Healthy		B01AC04	*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8	CYP2C19	*3	Efficacy	decreased	Adverse_Event	Healthy		B01AC04	*3
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8	CYP2C19	*8	Efficacy	decreased	Adverse_Event	Healthy		B01AC04	*8
tacrolimus	rs4646437	CYP3A4	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4646437:AG
tacrolimus	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4646437:GG
dihydropyridine derivatives	rs877087	RYR3	TT	Efficacy	increased	Adverse_Event	Other:C0010068		C08CA	rs877087:TT
none	rs1126742	CYP4A11	AG	Metabolism/PK	decreased	LADME	Healthy		A03DA02	rs1126742:AG
none	rs1126742	CYP4A11	GG	Metabolism/PK	decreased	LADME	Healthy		A03DA02	rs1126742:GG
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*1x2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*1x2
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*2x2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*2x2
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1x2/*41	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1x2/*41
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*2/*2x2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*2/*2x2
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*2xN/*4	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*2xN/*4
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*1	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*1
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*10	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*10
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*2
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*41	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*41
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*41x2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*41x2
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*9	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*9
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*2/*2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*2/*2
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*2/*41	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*2/*41
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*2/*9	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*2/*9
ticagrelor	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC24	*1/*2
ticagrelor	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC24	*1/*3
ticagrelor	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC24	*2/*17
ticagrelor	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC24	*3/*17
pemetrexed	rs914232	SLC19A1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs914232:TT
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C0024121		L01CE02	*6
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C0024121		L01CE02	*28
fluorouracil, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02|L01CE02	*1/*28
fluorouracil, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02|L01CE02	*28/*28
fluorouracil, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02|L01CE02	*6/*6
fluorouracil, irinotecan	DPYD c.1627A>G (*5)	DPYD	c.1627A>G (*5)	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02|L01CE02	c.1627A>G (*5)
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*2
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*3
pemetrexed	rs1051298	SLC19A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs1051298:AA
pemetrexed	rs1051298	SLC19A1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs1051298:AG
risperidone	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*1/*1	Toxicity	increased	Adverse_Event	Healthy		N05AX08	*1/*1
risperidone	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Healthy		N05AX08	*1/*2
cetuximab	rs1801274	FCGR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs1801274:GG
amoxicillin, ampicillin, bacampicillin	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CA06|S01AA19	*02:01
methamphetamine	rs6280	DRD3	CC	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		No_ATC	rs6280:CC
methamphetamine	rs6280	DRD3	CT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		No_ATC	rs6280:CT
nicotine	low activity	CYP2A6	__UNKNOWN__	Other	decreased	Adverse_Event	Disease:C0039338	low activity	N07BA01	__UNKNOWN__
vincristine	rs2268979	ACTN1	T	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs2268979:T
capecitabine, fluorouracil	rs2070474	UPB1	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs2070474:GG
pemetrexed	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs1801133:AA
pemetrexed	rs1801133	MTHFR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs1801133:AG
capecitabine, fluorouracil, folfiri, folfirinox, folfox	DPYD c.2194G>A (*6)	DPYD	c.2194G>A (*6)	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0026640		L01BC02|L01BC06	c.2194G>A (*6)
vincristine	rs12235805	PAPPA	A	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs12235805:A
capecitabine, fluorouracil	rs2070474	UPB1	GG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs2070474:GG
capecitabine, fluorouracil	rs1801265	DPYD	AA	Toxicity	increased	Adverse_Event	Disease:C0017185		L01BC02|L01BC06	rs1801265:AA
capecitabine, fluorouracil	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0017185		L01BC02|L01BC06	rs1801265:AG
pemetrexed	rs3788189	SLC19A1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs3788189:GG
pemetrexed	rs3788189	SLC19A1	GT	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs3788189:GT
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0236036	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0236036	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0236036	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2
nicotine	rs1800497	ANKK1, DRD2	AA	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs1800497:AA
nicotine	rs1800497	ANKK1, DRD2	AG	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs1800497:AG
capecitabine, fluorouracil, folfox	DPYD c.1129-5923C>G, c.1236G>A (HapB3), DPYD c.1679T>G (*13), DPYD c.2846A>T	DPYD	c.2846A>T	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0027651	deficiency	L01BC02|L01BC06	c.2846A>T
capecitabine, fluorouracil, folfox	DPYD c.1129-5923C>G, c.1236G>A (HapB3), DPYD c.1679T>G (*13), DPYD c.2846A>T	DPYD	c.1129-5923C>G, c.1236G>A (HapB3)	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0027651	deficiency	L01BC02|L01BC06	c.1129-5923C>G, c.1236G>A (HapB3)
capecitabine, fluorouracil, folfox	DPYD c.1129-5923C>G, c.1236G>A (HapB3), DPYD c.1679T>G (*13), DPYD c.2846A>T	DPYD	c.1679T>G (*13)	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0027651	deficiency	L01BC02|L01BC06	c.1679T>G (*13)
amitriptyline, antidepressants, clomipramine, desipramine, fluoxetine, imipramine, nortriptyline, paroxetine, venlafaxine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Toxicity	increased	Adverse_Event	Disease:C0235876		N06A|N06AA01|N06AA02|N06AA04|N06AA09|N06AA10|N06AB03|N06AB05|N06AX16	*3
amitriptyline, antidepressants, clomipramine, desipramine, fluoxetine, imipramine, nortriptyline, paroxetine, venlafaxine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Toxicity	increased	Adverse_Event	Disease:C0235876		N06A|N06AA01|N06AA02|N06AA04|N06AA09|N06AA10|N06AB03|N06AB05|N06AX16	*4
amitriptyline, antidepressants, clomipramine, desipramine, fluoxetine, imipramine, nortriptyline, paroxetine, venlafaxine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Toxicity	increased	Adverse_Event	Disease:C0235876		N06A|N06AA01|N06AA02|N06AA04|N06AA09|N06AA10|N06AB03|N06AB05|N06AX16	*5
amitriptyline, antidepressants, clomipramine, desipramine, fluoxetine, imipramine, nortriptyline, paroxetine, venlafaxine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Toxicity	increased	Adverse_Event	Disease:C0235876		N06A|N06AA01|N06AA02|N06AA04|N06AA09|N06AA10|N06AB03|N06AB05|N06AX16	*6
sirolimus	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		No_ATC	rs1045642:AA
sirolimus	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		No_ATC	rs1045642:AG
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*6
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*28
folfiri	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*1	Toxicity	decreased	Adverse_Event	Other:C0023055|Other:C2939419		No_ATC	*1/*1
atomoxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	__UNKNOWN__
vincristine	rs12253008	NRG3	T	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs12253008:T
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Efficacy	decreased	Efficacy_Response	Other:C0023055|Other:C2939419		L01CE02	*28/*28
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Efficacy	decreased	Efficacy_Response	Other:C0023055|Other:C2939419		L01CE02	*6/*6
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Efficacy	decreased	Efficacy_Response	Other:C0023055|Other:C2939419		L01CE02	*6/*28
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3B	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*1/*3B
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*1/*3C
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3A/*3B	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*3A/*3B
mercaptopurine, methotrexate	intermediate metabolizer	TPMT	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0023449	intermediate metabolizer	L01BB02|L04AX03	__UNKNOWN__
vincristine	rs10997459	LRRTM3	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs10997459:G
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Other:C0021390	intermediate metabolizer	L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Other:C0021390	intermediate metabolizer	L04AX01	*1/*3C
vincristine	rs8006511	ARHGAP5	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs8006511:G
mercaptopurine, methotrexate	normal metabolizer	TPMT	__UNKNOWN__	Efficacy	increased	Adverse_Event	Disease:C0023449	normal metabolizer	L01BB02|L04AX03	__UNKNOWN__
nicotine	rs28399433	CYP2A6	CC	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs28399433:CC
vincristine	rs79802223	METTL8	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs79802223:G
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*2/*3
none	rs4148325	UGT1A1	CT	Metabolism/PK	decreased	Adverse_Event	Healthy		A03DA02	rs4148325:CT
none	rs11888492	UGT1A1	G	Metabolism/PK	decreased	Adverse_Event	Healthy		A03DA02	rs11888492:G
naloxone	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:AG
naloxone	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:GG
cisplatin	rs13022792	CERS6	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01XA01	rs13022792:T
cisplatin	rs10759932	TLR4	C	Toxicity	decreased	Adverse_Event	Other:C0027651		L01XA01	rs10759932:C
vincristine	rs10961381	NFIB	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs10961381:G
antiarrhythmics, class i and iii	rs10033464	__INTRONIC__	GT	Efficacy	increased	Efficacy_Response	Disease:C0004238		C01B	rs10033464:GT
antiarrhythmics, class i and iii	rs10033464	__INTRONIC__	TT	Efficacy	increased	Efficacy_Response	Disease:C0004238		C01B	rs10033464:TT
vincristine	rs1815857	MCM3AP	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01CA02	rs1815857:T
vincristine	rs12474420	SPDYA	T	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs12474420:T
vincristine	rs12658429	PDE4D	C	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs12658429:C
vincristine	rs12656510	FBN2	T	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs12656510:T
vincristine	rs17129858	VTI1A	T	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs17129858:T
vincristine	rs200858088	ZFAND3	C	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs200858088:C
antiinflammatory agents, non-steroids	HLA-DRB1*11:01	HLA-DRB1	*11:01	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*11:01
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2
mycophenolate mofetil, prednisone, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Other	increased	Adverse_Event	Other:Kidney_Transplantation		D08AE03|H02AB07|L04AD02	*1/*1
mycophenolate mofetil, prednisone, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Other	increased	Adverse_Event	Other:Kidney_Transplantation		D08AE03|H02AB07|L04AD02	*1/*3
sirolimus	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		No_ATC	rs1045642:AA
sirolimus	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		No_ATC	rs1045642:AG
acetaminophen / codeine	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Other:C0030193|Postoperative	poor metabolizer	N02AJ06	__UNKNOWN__
rasburicase	deficiency	G6PD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0740394	deficiency	V03AF07	
nevirapine	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AG01	*1/*6
nevirapine	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AG01	*6/*6
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AG03	*1/*6
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AG03	*6/*6
sirolimus	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		No_ATC	rs1128503:AA
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Other:C0010068|Other:C0549433	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Other:C0010068|Other:C0549433	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Other:C0010068|Other:C0549433	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Other:C0010068|Other:C0549433	intermediate metabolizer and poor metabolizer	B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Other:C0010068|Other:C0549433	intermediate metabolizer and poor metabolizer	B01AC04	*3/*3
risperidone	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	N05AX08	__UNKNOWN__
isoniazid	NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*5/*7
isoniazid	NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*5/*6
isoniazid	NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*6/*6
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*3
adalimumab, amiodarone, bevacizumab, bicalutamide, carboplatin, cyclophosphamide, docetaxel, erlotinib, everolimus, fluorouracil, gefitinib, gemcitabine, irinotecan, leucovorin, methotrexate, oxaliplatin, paclitaxel, pembrolizumab, sitagliptin, tegafur / gimeracil / oteracil, trastuzumab	HLA-DRB1*04:05	HLA-DRB1	*04:05	Toxicity	increased	Adverse_Event	Healthy		A10BH01|C01BD01|L01AA01|L01BC02|L01BC03|L01BC05|L01CD01|L01CD02|L01CE02|L01EB01|L01EB02|L01EG02|L01FG01|L01XA02|L01XA03|L02BB03|L04AB04|L04AX03	*04:05
tamsulosin	intermediate metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	G04CA02	__UNKNOWN__
anastrozole, exemestane, letrozole	rs79048288	CCDC148	CT	Toxicity	decreased	Adverse_Event	Other:C1458155		L02BG03|L02BG04|L02BG06	rs79048288:CT
anastrozole, exemestane, letrozole	rs79048288	CCDC148	TT	Toxicity	decreased	Adverse_Event	Other:C1458155		L02BG03|L02BG04|L02BG06	rs79048288:TT
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0740394		M04AA01	*58:01
pemetrexed	rs1650697	DHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0007131|Disease:C0025500		L01BA04	rs1650697:AA
pemetrexed	rs1650697	DHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0007131|Disease:C0025500		L01BA04	rs1650697:AG
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*3	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*6	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*3/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*7	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*3/*7
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6/*6	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*6/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6/*7	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*6/*7
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*7/*7	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*7/*7
tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*1	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*1/*1
fluorouracil, folfiri, folfox	DPYD c.85T>C (*9A)	DPYD	c.85T>C (*9A)/c.85T>C (*9A)	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02	c.85T>C (*9A)/c.85T>C (*9A)
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*2/*2
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*2/*3
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*3/*3
fluorouracil, folfiri, folfox	DPYD c.1627A>G (*5)	DPYD	c.1627A>G (*5)/c.1627A>G (*5)	Toxicity	decreased	Adverse_Event	Other:C0023055		L01BC02	c.1627A>G (*5)/c.1627A>G (*5)
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01
aspirin	rs12042763	PTGS2	GG	Efficacy	decreased	Adverse_Event	Healthy		No_ATC	rs12042763:GG
methotrexate	SLCO1B1*1, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*37/*37	Toxicity	decreased	Adverse_Event	Other:Precursor_T-Cell_Lymphoblastic_Leukemia-Lymphoma|Other:C0029463|Other:C0024299		L04AX03	*37/*37
methotrexate	SLCO1B1*1, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*37/*15	Toxicity	decreased	Adverse_Event	Other:Precursor_T-Cell_Lymphoblastic_Leukemia-Lymphoma|Other:C0029463|Other:C0024299		L04AX03	*37/*15
none	rs56267346	CYP2A6	G	Other	decreased	Adverse_Event	Other:C0039338		A03DA02	rs56267346:G
none	rs6479643	DBH	C	Other	decreased	Adverse_Event	Other:C0039338		A03DA02	rs6479643:C
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*16	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*16
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*7
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*16
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*5	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*5
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*6
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*7
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*14
flurbiprofen, irinotecan	UGT1A1*1, UGT1A1*36	UGT1A1	*1/*36	Efficacy	decreased	Efficacy_Response	Other:C0023055		L01CE02|S01BC04	*1/*36
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*5	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*5/*5
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*5/*6
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*5/*7
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*6/*6
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*6/*7
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*14	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*6/*14
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*7/*7
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD02	*3/*3
irinotecan	rs4148323	UGT1A1	A	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs4148323:A
none	rs1052576	CASP9	T	Efficacy	increased	Adverse_Event	Other:C0023449		A03DA02	rs1052576:T
capecitabine, fluorouracil	rs1801265	DPYD	AA	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs1801265:AA
capecitabine, fluorouracil	rs1801265	DPYD	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs1801265:AG
irinotecan	rs4148323	UGT1A1	A	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs4148323:A
cyclosporine, methotrexate	rs1051266	SLC19A1	CC	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs1051266:CC
cyclosporine, methotrexate	rs17514110	ATIC	CC	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs17514110:CC
cyclosporine, methotrexate	rs3787186	NFATC2	TT	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs3787186:TT
cyclosporine, methotrexate	rs3740065	ABCC2	AA	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs3740065:AA
cetuximab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs396991:CC
cyclosporine, methotrexate	rs8058040	ABCC1	AA	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs8058040:AA
carbamazepine, lamotrigine, phenytoin	HLA-A*24:02	HLA-A	*24:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*24:02
carbamazepine, lamotrigine, phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*15:02
atazanavir, efavirenz	rs7305115	TPH2	GG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE08|J05AG03	rs7305115:GG
carbamazepine, lamotrigine, phenytoin	HLA-A*01:02	HLA-A	*01:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*01:02
carbamazepine, lamotrigine, phenytoin	HLA-B*52:01	HLA-B	*52:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*52:01
carbamazepine, lamotrigine, phenytoin	HLA-DRB1*03:01	HLA-DRB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*03:01
atazanavir, efavirenz	rs1386493	TPH2	GG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE08|J05AG03	rs1386493:GG
carbamazepine, lamotrigine, phenytoin	HLA-DRB1*13:01	HLA-DRB1	*13:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*13:01
capecitabine	rs2612091	ENOSF1	TT	Efficacy	increased	Efficacy_Response	Other:C0023055		L01BC06	rs2612091:TT
carbamazepine, lamotrigine, phenytoin	HLA-A*02:01	HLA-A	*02:01	Toxicity	decreased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*02:01
carbamazepine, lamotrigine, phenytoin	HLA-B*40:02	HLA-B	*40:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*40:02
carbamazepine, lamotrigine, phenytoin	HLA-A*31:03	HLA-A	*31:03	Toxicity	decreased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*31:03
carboplatin, paclitaxel	rs544093	OPRM1	GG	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01CD01|L01XA02	rs544093:GG
carboplatin, paclitaxel	rs544093	OPRM1	GT	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01CD01|L01XA02	rs544093:GT
mycophenolate mofetil(mycophenolic acid)	rs2228075	IMPDH1	T	Efficacy, Toxicity	increased	Adverse_Event	Disease:Organ_Transplantation		L04AA06	rs2228075:T
capecitabine, fluorouracil	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs1801160:CT
capecitabine, fluorouracil	rs1801160	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs1801160:TT
isoniazid	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator and intermediate acetylator	J04AC01	__UNKNOWN__
erlotinib, gefitinib	rs3744797	USP36	CC	Efficacy	increased	Adverse_Event	Other:C0007131		L01EB01|L01EB02	rs3744797:CC
osimertinib	HLA-B*51:02	HLA-B	*51:02	Toxicity	increased	Adverse_Event	Other:C0024121		L01EB04	*51:02
dexmedetomidine	rs10764319	CACNB2	CT	Toxicity	decreased	Adverse_Event	Other:C0549433		N05CM18	rs10764319:CT
dexmedetomidine	rs2236957	CACNA2D2	AA	Toxicity	decreased	Adverse_Event	Other:C0549433		N05CM18	rs2236957:AA
drugs for treatment of tuberculosis	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04A	__UNKNOWN__
dexmedetomidine	rs1841042	UGT2B10	AA	Toxicity	decreased	Adverse_Event	Other:C0549433		N05CM18	rs1841042:AA
dexmedetomidine	rs3813662	ADRA2B	AA	Toxicity	increased	Adverse_Event	Other:C0549433		N05CM18	rs3813662:AA
dexmedetomidine	rs3813662	ADRA2B	CC	Toxicity	increased	Adverse_Event	Other:C0549433		N05CM18	rs3813662:CC
methylphenidate	rs2307227	CES1	T	Toxicity	increased	Adverse_Event	Other:C1263846		N06BA04	rs2307227:T
purine analogues	NUDT15*1, NUDT15*3	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB	*1/*3
clopidogrel	rs7807369	THSD7A	G	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs7807369:G
clopidogrel	rs1149515	__INTRONIC__	C	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1149515:C
ondansetron	normal metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Adverse_Event	Healthy	normal metabolizer	A04AA01	__UNKNOWN__
none	rs17524572	ERAP2	TT	Toxicity	increased	Adverse_Event	Other:C0041296		A03DA02	rs17524572:TT
mycophenolate mofetil(mycophenolic acid)	rs1042597	UGT1A8	CC	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs1042597:CC
pembrolizumab	HLA-DRB1*13:01	HLA-DRB1	*13:01	Efficacy	decreased	Adverse_Event	"""Other:C0001418|""Other:C0007131|""Other:C0007097|Squamous_Cell""|""Other:Neuroendocrine_Carcinoma"""		No_ATC	*13:01
pembrolizumab	HLA-DPB1*02:02	HLA-DPB1	*02:02	Toxicity	increased	Adverse_Event	"""Other:C0001418|""Other:C0007131|""Other:C0007097|Squamous_Cell""|""Other:Neuroendocrine_Carcinoma"""		No_ATC	*02:02
capecitabine, fluorouracil	rs1801158	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs1801158:CT
morphine	rs72552763	SLC22A1	del/del	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs72552763:del/del
drugs for treatment of tuberculosis	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy		J04A	
none	rs4661636	CASP9	C	Efficacy	increased	Adverse_Event	Other:C0023449		A03DA02	rs4661636:C
none	rs6736233	CASP8	G	Efficacy	increased	Adverse_Event	Other:C0023449		A03DA02	rs6736233:G
clozapine	rs6657868	LEPR	AG	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs6657868:AG
clozapine	rs6657868	LEPR	GG	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs6657868:GG
clozapine	rs762551	CYP1A2	AA	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs762551:AA
cisplatin, paclitaxel	rs2017869	GGT1	CC	Toxicity	decreased	Adverse_Event	Other:C1458155		L01CD01|L01XA01	rs2017869:CC
cisplatin	rs12201199	TPMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs12201199:T
none	rs4148323	UGT1A1	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs4148323:A
clozapine	rs1137101	LEPR, LEPROT	AA	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs1137101:AA
dolutegravir	rs2472677	NR1I2	CT	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AJ03	rs2472677:CT
dolutegravir	rs2472677	NR1I2	TT	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AJ03	rs2472677:TT
cisplatin	rs1800460	TPMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1800460:T
clozapine	rs1805096	LEPR	GG	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs1805096:GG
clozapine	rs9436746	LEPR	AC	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs9436746:AC
clozapine	rs9436746	LEPR	CC	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs9436746:CC
risperidone	rs1800497	DRD2	AA	Toxicity	increased	Adverse_Event	Other:C0033975		N05AX08	rs1800497:AA
risperidone	rs1800497	DRD2	AG	Toxicity	increased	Adverse_Event	Other:C0033975		N05AX08	rs1800497:AG
none	rs35350960	UGT1A1	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs35350960:A
cisplatin	rs1142345	TPMT	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1142345:C
warfarin	rs4379440	ASPH	T	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs4379440:T
carboplatin, paclitaxel	rs7311358	SLCO1B3	AA	Toxicity	decreased	Adverse_Event	Other:C0919267		L01CD01|L01XA02	rs7311358:AA
aspirin, clopidogrel, ticagrelor	rs12041331	PEAR1	AA	Toxicity	increased	Adverse_Event	Other:C0018839		B01AC04|B01AC24	rs12041331:AA
aspirin, clopidogrel, ticagrelor	rs12041331	PEAR1	AG	Toxicity	increased	Adverse_Event	Other:C0018839		B01AC04|B01AC24	rs12041331:AG
capecitabine, fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs67376798:AT
methotrexate	rs1801131	MTHFR	G	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801131:G
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs1127354:AC
hmg coa reductase inhibitors	rs3764261	CETP	A	Efficacy, Metabolism/PK	increased	Other	Healthy		C10AA	rs3764261:A
methotrexate	rs1127354	ITPA	A	Toxicity	Indeterminado	Adverse_Event	Disease:C0003873		L04AX03	rs1127354:A
gefitinib	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs1128503:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs231775	CTLA4	A	Efficacy	increased	Efficacy_Response	Healthy		J05AP01|L03AB10|L03AB11	rs231775:A
caffeine	rs4410790	__INTRONIC__	T	Other	Indeterminado	Other	Healthy		N06BC01	rs4410790:T
liraglutide	rs6923761	GLP1R	AA	Efficacy	increased	Adverse_Event	"""Other:C0011849""|""Other:C0028754"		A10BJ02	rs6923761:AA
liraglutide	rs6923761	GLP1R	AG	Efficacy	increased	Adverse_Event	"""Other:C0011849""|""Other:C0028754"		A10BJ02	rs6923761:AG
methamphetamine	rs2234693	ESR1	CC	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2234693:CC
none	rs11887534	ABCG8	CG	Other	increased	Adverse_Event	Healthy		A03DA02	rs11887534:CG
platinum	rs17655	ERCC5	GG	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01XA	rs17655:GG
platinum	rs17655	ERCC5	GG	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01XA	rs17655:GG
risperidone	rs3813929	HTR2C	T	Toxicity	decreased	Adverse_Event	Disease:C1510586		N05AX08	rs3813929:T
paclitaxel	rs10771973	FGD4	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs10771973:A
caffeine	rs2470893	CYP1A1	T	Other	Indeterminado	Other	Healthy		N06BC01	rs2470893:T
citalopram	rs25531	SLC6A4	C	Toxicity	increased	Adverse_Event	Disease:C0497327		N06AB04	rs25531:C
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4969170	SOCS3	AG	Toxicity	decreased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs4969170:AG
midazolam	rs1057868	POR	TT	Other, Metabolism/PK	increased	LADME	Healthy		N05CD08	rs1057868:TT
enalapril	rs13009649	PNPT1	G	Toxicity	decreased	Adverse_Event	Other:C0020538		C09AA02	rs13009649:G
methotrexate	rs1127354	ITPA	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0003873		L04AX03	rs1127354:A
nicotine	rs11606194	HTR3B	CT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs11606194:CT
nicotine	rs11606194	HTR3B	TT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs11606194:TT
aspirin	rs499368	SLC6A12	A	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs499368:A
gefitinib	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs1045642:AA
warfarin	rs2189784	CYP4F2	GG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2189784:GG
aspirin	rs557881	SLC6A12	G	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs557881:G
platinum compounds	rs10878232	WIF1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs10878232:GG
platinum compounds	rs10878232	WIF1	GT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs10878232:GT
antiepileptics	rs1045642	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs1045642:G
anthracyclines and related substances	rs1056892	CBR3	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L01DB	rs1056892:AG
platinum compounds	rs12819505	WNT5B	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs12819505:AG
platinum compounds	rs12819505	WNT5B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs12819505:GG
platinum compounds	rs4541111	AXIN2	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs4541111:AA
platinum compounds	rs4541111	AXIN2	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs4541111:AC
mercaptopurine, methotrexate	rs2413739	PACSIN2	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs2413739:T
mercaptopurine	rs11045879	SLCO1B1	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs11045879:T
mercaptopurine, methotrexate	rs1127354	ITPA	CC	Efficacy	increased	Efficacy_Response	Disease:C0023449		L01BB02|L04AX03	rs1127354:CC
platinum compounds	rs4413407	CXXC4	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs4413407:AA
platinum compounds	rs4413407	CXXC4	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs4413407:AG
enalapril	rs13015243	PNPT1	C	Toxicity	decreased	Adverse_Event	Other:C0020538		C09AA02	rs13015243:C
azathioprine, mercaptopurine, thioguanine	rs11969064	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L01BB03|L04AX01	rs11969064:T
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	T	Efficacy	increased	Efficacy_Response	Healthy		J05AP01|L03AB10|L03AB11	rs8099917:T
platinum compounds	rs13181	ERCC2	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs13181:GG
platinum compounds	rs1799793	ERCC2	CT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1799793:CT
platinum compounds	rs1799793	ERCC2	TT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1799793:TT
doxorubicin	rs1883112	NCF4	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L01DB01	rs1883112:AA
doxorubicin	rs1883112	NCF4	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L01DB01	rs1883112:AG
amphetamine	rs12364283	DRD2	AA	Efficacy	decreased	Other	Healthy		No_ATC	rs12364283:AA
antiepileptics	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs1045642:AA
antiepileptics	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs1045642:GG
paroxetine	rs6313	HTR2A	GG	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB05	rs6313:GG
clopidogrel	rs34394661	CD80	AA	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs34394661:AA
mycophenolate mofetil(mycophenolic acid)	rs6714486	UGT1A9	A	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation		L04AA06	rs6714486:A
carbamazepine	rs1633021	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs1633021:TT
platinum compounds	rs11868547	AXIN2	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs11868547:CC
platinum compounds	rs11868547	AXIN2	CG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs11868547:CG
mycophenolate mofetil(mycophenolic acid)	rs17868320	UGT1A9	T	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation		L04AA06	rs17868320:T
morphine	rs1045642	ABCB1	GG	Toxicity	decreased	Adverse_Event	Disease:C0030193|Postoperative		N02AA01	rs1045642:GG
cyclosporine, mycophenolate mofetil	rs1042597	UGT1A8	CC	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs1042597:CC
tacrolimus	rs1800871	IL10	AA	Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs1800871:AA
methotrexate	rs4948496	ARID5B	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4948496:CC
methotrexate	rs4948496	ARID5B	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4948496:CT
none	rs3760657	CYP2B6	AA	Other	decreased	Adverse_Event	Other:C0039338		A03DA02	rs3760657:AA
follitropin beta, thyrotropin alfa, urofollitropin	rs6166	FSHR	T	Efficacy, Metabolism/PK	Indeterminado	Efficacy_Response	Healthy		G03GA04|G03GA06|V04CJ01	rs6166:T
aspirin, clopidogrel	rs4244285	CYP2C19	AA	Efficacy, Other	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AA
aspirin, clopidogrel	rs4244285	CYP2C19	AG	Efficacy, Other	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AG
none	rs11726322	UGT2B10	CC	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs11726322:CC
hormonal contraceptives for systemic use	rs6025	F5	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs6025:T
aspirin, clopidogrel	rs12248560	CYP2C19	CT	Efficacy, Other	decreased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs12248560:CT
aspirin, clopidogrel	rs12248560	CYP2C19	TT	Efficacy, Other	decreased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs12248560:TT
hormonal contraceptives for systemic use	rs1799963	F2	A	Toxicity	increased	Adverse_Event	Healthy		G03A	rs1799963:A
clopidogrel	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs1045642:AG
capecitabine, fluorouracil	rs11479	TYMP	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs11479:AA
capecitabine, fluorouracil	rs11479	TYMP	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs11479:AG
warfarin	rs2108622	CYP4F2	CT	Metabolism/PK	increased	LADME	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Metabolism/PK	increased	LADME	Healthy		B01AA03	rs2108622:TT
capecitabine, fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs67376798:AT
capecitabine, fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs3918290:CT
capecitabine, fluorouracil	rs75017182	DPYD	CG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs75017182:CG
alendronate	rs1544410	VDR	CC	Efficacy	increased	Efficacy_Response	Disease:C0029456		No_ATC	rs1544410:CC
fenofibrate	rs135543	PPARA	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AB05	rs135543:TT
fenofibrate	rs9626730	PPARA	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AB05	rs9626730:CC
fenofibrate	rs9626730	PPARA	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AB05	rs9626730:CT
warfarin	rs2108622	CYP4F2	CT	Dosage	decreased	Other	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	decreased	Other	Healthy		B01AA03	rs2108622:TT
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AG
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AG
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AG
fenofibrate	rs135550	PPARA	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AB05	rs135550:TT
alendronate	rs1544410	VDR	CC	Efficacy	decreased	Efficacy_Response	Disease:C0029456		No_ATC	rs1544410:CC
exemestane	rs7176005	CYP19A1	TT	Toxicity	Indeterminado	Adverse_Event	Disease:C1458155		L02BG06	rs7176005:TT
tacrolimus	rs4253728	PPARA	GG	Toxicity	decreased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs4253728:GG
vincristine	rs1013940	SLC5A7	AG	Toxicity	increased	Adverse_Event	Healthy		L01CA02	rs1013940:AG
vincristine	rs1013940	SLC5A7	GG	Toxicity	increased	Adverse_Event	Healthy		L01CA02	rs1013940:GG
ethanol	rs1229984	ADH1B	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1229984:T
vincristine	rs10504361	NKAIN3	A	Toxicity	increased	Adverse_Event	Healthy		L01CA02	rs10504361:A
simvastatin	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA01	rs4149056:C
atenolol	rs340874	PROX1	C	Toxicity	increased	Adverse_Event	Disease:C0020538		C07AB03	rs340874:C
tacrolimus	rs35599367	CYP3A4	AA	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs35599367:AA
tacrolimus	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs35599367:AG
abemaciclib, palbociclib, ribociclib	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C1458155		L01EF01|L01EF02|L01EF03	rs1128503:AA
simvastatin	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA01	rs2231142:GT
vincristine	rs3784867	ABCC1	T	Toxicity	increased	Adverse_Event	Healthy		L01CA02	rs3784867:T
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs4244285:AG
opioids	rs4680	COMT	AA	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs4680:AA
opioids	rs4680	COMT	AG	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs4680:AG
opioids	rs1800795	IL6	CG	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs1800795:CG
opioids	rs1800795	IL6	GG	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs1800795:GG
fluorouracil	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Healthy		L01BC02	rs67376798:A
sunitinib	rs776746	CYP3A5	CT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs776746:CT
sunitinib	rs776746	CYP3A5	TT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs776746:TT
abemaciclib, palbociclib, ribociclib	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01EF01|L01EF02|L01EF03	rs35599367:AG
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	Healthy		L01CA02	rs924607:TT
metoprolol	rs1065852	CYP2D6	GG	Efficacy	decreased	Efficacy_Response	Healthy		C07AB02	rs1065852:GG
conjugated estrogens, medroxyprogesterone	rs1544410	VDR	TT	Efficacy	increased	Other	Healthy		G03CA57|L02AB02	rs1544410:TT
verapamil	rs2357928	CACNB2	GG	Efficacy, Toxicity	increased	Adverse_Event	Other:C1956346		C08DA01	rs2357928:GG
metformin	rs2252281	SLC47A1	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs2252281:CC
tacrolimus	rs4646450	CYP3A5	A	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs4646450:A
metformin	rs2252281	SLC47A1	CC	Efficacy	increased	Efficacy_Response	Healthy		A10BA02	rs2252281:CC
trazodone	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		N06AX05	rs1045642:AA
interferons, ribavirin	rs1800477	BCL2	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB	rs1800477:T
cetuximab, fluorouracil, irinotecan, oxaliplatin	rs112445441	KRAS	T	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01XA03	rs112445441:T
fluorouracil, leucovorin, oxaliplatin	rs3136228	MSH6	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs3136228:GG
fluorouracil, leucovorin, oxaliplatin	rs1799794	XRCC3	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs1799794:CC
none	rs7643645	NR1I2	GG	Other	increased	Adverse_Event	Other:C0860195		A03DA02	rs7643645:GG
platinum compounds	rs9344	CCND1	AA	Toxicity	increased	Adverse_Event	Other:C0024121		L01XA	rs9344:AA
verapamil	rs11014166	CACNB2	AT	Efficacy, Toxicity	increased	Adverse_Event	Other:C1956346		C08DA01	rs11014166:AT
verapamil	rs11014166	CACNB2	TT	Efficacy, Toxicity	increased	Adverse_Event	Other:C1956346		C08DA01	rs11014166:TT
fluorouracil, leucovorin, oxaliplatin	rs2074087	ABCC1	C	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs2074087:C
fluorouracil	rs2960436	__INTRONIC__	AA	Efficacy	Indeterminado	Other	Disease:C0026640		L01BC02	rs2960436:AA
fluorouracil, leucovorin, oxaliplatin	rs1885301	ABCC2	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs1885301:AA
fluorouracil	rs2854744	IGFBP3	TT	Efficacy	Indeterminado	Other	Disease:C0026640		L01BC02	rs2854744:TT
fluorouracil, leucovorin, oxaliplatin	rs717620	ABCC2	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs717620:TT
fluorouracil, leucovorin, oxaliplatin	rs3740066	ABCC2	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs3740066:TT
cocaine	rs1125394	DRD2	C	Toxicity	increased	Adverse_Event	Healthy		N01BC01	rs1125394:C
cocaine	rs1076560	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		N01BC01	rs1076560:A
cocaine	rs2283265	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		N01BC01	rs2283265:A
mycophenolate mofetil(mycophenolic acid)	rs4149015	SLCO1B1	A	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs4149015:A
tacrolimus	rs4646453	CYP3A5	CC	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs4646453:CC
tacrolimus	rs776746	CYP3A5	CC	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs776746:CC
mycophenolate mofetil(mycophenolic acid)	rs4149056	SLCO1B1	TT	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs4149056:TT
opioids	rs4633	COMT	CC	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs4633:CC
mycophenolate mofetil(mycophenolic acid)	rs4149056	SLCO1B1	C	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs4149056:C
acetaminophen / tramadol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs1799971:AG
acetaminophen / tramadol	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs1799971:GG
opioids	rs4633	COMT	CT	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs4633:CT
capecitabine	rs1128503	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs1128503:AA
opioids	rs1799971	OPRM1	G	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs1799971:G
capecitabine	rs2032582	ABCB1	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2032582:CC
opioids	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs1799971:AG
opioids	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs1799971:GG
fluorouracil	rs1045642	ABCB1	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02	rs1045642:GG
capecitabine	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1045642:GG
warfarin	rs7900194	CYP2C9	A	Dosage, Metabolism/PK	Indeterminado	Other	Healthy		B01AA03	rs7900194:A
sunitinib	rs3814055	NR1I2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs3814055:TT
amphetamine	rs510769	OPRM1	TT	Other	decreased	Other	Healthy		No_ATC	rs510769:TT
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0020473		C10AA01	rs4149056:CC
simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0020473		C10AA01	rs4149056:CT
sunitinib	rs2231137	ABCG2	CT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs2231137:CT
cisplatin	rs11265375	NHLH1	CT	Efficacy	increased	Efficacy_Response	Other:C0007134|Other:C0024121		L01XA01	rs11265375:CT
cisplatin	rs11265375	NHLH1	TT	Efficacy	increased	Efficacy_Response	Other:C0007134|Other:C0024121		L01XA01	rs11265375:TT
bortezomib	rs915854	CBS	TT	Toxicity	increased	Adverse_Event	Other:Multiple_Myeloma		L01XG01	rs915854:TT
none	rs3100	UGT2B15	AA	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs3100:AA
amphetamine	rs2281617	OPRM1	CC	Other	increased	Other	Healthy		No_ATC	rs2281617:CC
warfarin	rs6130615	HNF4A	CC	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs6130615:CC
cisplatin	rs3806915	SEMA6A	A	Efficacy	increased	Efficacy_Response	Other:C0007134|Other:C0024121		L01XA01	rs3806915:A
aspirin, clopidogrel	rs1045642	ABCB1	AA	Efficacy, Other	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs1045642:AA
warfarin	rs1884613	HNF4A	GG	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1884613:GG
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
aspirin, clopidogrel	rs5918	ITGB3	CC	Efficacy, Other	decreased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs5918:CC
aspirin, clopidogrel	rs5918	ITGB3	CT	Efficacy, Other	decreased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs5918:CT
warfarin	rs3212191	HNF4A	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs3212191:TT
ondansetron	rs1042173	SLC6A4	AA	Efficacy	increased	Efficacy_Response	Disease:C0085762		A04AA01	rs1042173:AA
warfarin	rs61162043	__INTRONIC__	G	Other	increased	Adverse_Event	Healthy		B01AA03	rs61162043:G
risperidone	rs6313	HTR2A	GG	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AX08	rs6313:GG
heroin	rs2075572	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2075572:G
risperidone	rs1805054	__INTRONIC__	TT	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AX08	rs1805054:TT
antihypertensives	rs4149601	NEDD4L	AA	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs4149601:AA
antihypertensives	rs1801252	ADRB1	GG	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs1801252:GG
fluorouracil	rs1801133	MTHFR	AA	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs1801133:AA
fluorouracil	rs1801133	MTHFR	AG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs1801133:AG
risperidone	rs3813929	HTR2C	CT	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AX08	rs3813929:CT
risperidone	rs3813929	HTR2C	TT	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AX08	rs3813929:TT
heroin	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:G
bleomycin, cyclophosphamide, doxorubicin, prednisone, rituximab, vincristine, vindesine	rs2229109	ABCB1	CT	Toxicity	increased	Adverse_Event	Disease:C0024299		H02AB07|L01AA01|L01CA02|L01CA03|L01DB01|L01DC01|L01FA01	rs2229109:CT
cyclophosphamide	rs4802101	CYP2B6	C	Toxicity	decreased	Adverse_Event	Disease:C0409974		L01AA01	rs4802101:C
antihypertensives	rs776746	CYP3A5, ZSCAN25	CC	Efficacy	decreased	Adverse_Event	Other:C0020538		C02	rs776746:CC
cisplatin	rs2228001	XPC	GG	Toxicity	increased	Adverse_Event	Disease:C0877645		L01XA01	rs2228001:GG
cisplatin	rs2228001	XPC	GT	Toxicity	increased	Adverse_Event	Disease:C0877645		L01XA01	rs2228001:GT
methadone	rs1799971	OPRM1	G	Other	decreased	Adverse_Event	Disease:C0028043		N07BC02	rs1799971:G
sufentanil	rs2242480	CYP3A4	TT	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N01AH03	rs2242480:TT
none	rs3750625	ADRA2A	A	Other	increased	Adverse_Event	Other:C0032961		A03DA02	rs3750625:A
none	rs11195418	ADRA2A	G	Other	decreased	Adverse_Event	Other:C0032961		A03DA02	rs11195418:G
muraglitazar	rs2368564	REN	TT	Toxicity	decreased	Adverse_Event	Disease:C0011849		No_ATC	rs2368564:TT
chloroquine, primaquine	rs12422149	SLCO2B1	GG	Efficacy	increased	Adverse_Event	Disease:C0024530		P01BA01|P01BA03	rs12422149:GG
aspirin	rs2243250	IL4	TT	Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs2243250:TT
antipsychotics	rs806374	CNR1	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs806374:CC
warfarin	rs1057910	CYP2C9	AC	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs1057910:AC
warfarin	rs1057910	CYP2C9	CC	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs1057910:CC
methotrexate	rs3763980	SLC16A7	A	Efficacy	increased	Adverse_Event	Disease:C0003873		L04AX03	rs3763980:A
metformin	rs784892	AMHR2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs784892:G
acetaminophen, aspirin, diclofenac, propionic acid derivatives, pyrazolones	rs12746200	PLA2G4A	G	Toxicity	increased	Adverse_Event	Healthy		M01AE|N02BB|N02BE01|S01BC03	rs12746200:G
antipsychotics	rs806374	CNR1	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs806374:CC
warfarin	rs9923231	VKORC1	TT	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
fluorouracil	rs75017182	DPYD	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs75017182:C
ethanol	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:AA
nevirapine	rs3099844	CYCSP5	A	Toxicity, Other	increased	Adverse_Event	Disease:C0001175		J05AG01	rs3099844:A
acetaminophen, aspirin, diclofenac, propionic acid derivatives, pyrazolones	rs2228246	PLCG1	G	Toxicity	increased	Adverse_Event	Healthy		M01AE|N02BB|N02BE01|S01BC03	rs2228246:G
acetaminophen, aspirin, diclofenac, propionic acid derivatives, pyrazolones	rs1805034	TNFRSF11A	C	Toxicity	increased	Adverse_Event	Healthy		M01AE|N02BB|N02BE01|S01BC03	rs1805034:C
antihypertensives	rs1799983	NOS3	G	Efficacy	increased	Adverse_Event	Disease:C0032914		C02	rs1799983:G
antihypertensives	rs2070744	NOS3	C	Efficacy	increased	Adverse_Event	Disease:C0032914		C02	rs2070744:C
methotrexate	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1045642:AG
none	rs1800038	ADRA2A	A	Other	increased	Adverse_Event	Other:C0032961		A03DA02	rs1800038:A
tacrolimus	rs776746	CYP3A5	T	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs776746:T
cisplatin	rs683369	SLC22A1	CG	Efficacy	increased	Efficacy_Response	Other:Neoplasm_of_esophagus		L01XA01	rs683369:CG
cisplatin	rs683369	SLC22A1	GG	Efficacy	increased	Efficacy_Response	Other:Neoplasm_of_esophagus		L01XA01	rs683369:GG
nicotine	rs4887074	__INTRONIC__	G	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs4887074:G
fluorouracil, irinotecan, leucovorin	rs10937158	ABCC5	T	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs10937158:T
fluorouracil, irinotecan, leucovorin	rs3749438	ABCC5	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs3749438:A
fluorouracil, irinotecan, leucovorin	rs225440	ABCG1	T	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs225440:T
clopidogrel	rs854552	PON1	CC	Efficacy	increased	Efficacy_Response	Other:C1956346		B01AC04	rs854552:CC
fluorouracil, irinotecan, leucovorin	rs2292997	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs2292997:A
cisplatin	rs2038067	PPARD	AG	Efficacy	decreased	Efficacy_Response	Other:Neoplasm_of_esophagus		L01XA01	rs2038067:AG
cisplatin	rs2038067	PPARD	GG	Efficacy	decreased	Efficacy_Response	Other:Neoplasm_of_esophagus		L01XA01	rs2038067:GG
tacrolimus	rs6977165	CYP3A5	C	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs6977165:C
cyclophosphamide	rs4244285	CYP2C19	A	Toxicity	decreased	Adverse_Event	Disease:C0409974		L01AA01	rs4244285:A
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	T	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:T
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT
fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:TT
none	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1799971:AA
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT
fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:TT
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT
fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:TT
fluorouracil	rs17376848	DPYD	G	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs17376848:G
opioids	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs776746:CC
opioids	rs776746	CYP3A5	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs776746:CT
acetaminophen / tramadol	rs2296616	MIR107	AA	Toxicity	decreased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs2296616:AA
acetaminophen / tramadol	rs2296616	MIR107	AG	Toxicity	decreased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs2296616:AG
lithium	rs334558	GSK3B	AA	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs334558:AA
cyclophosphamide, doxorubicin, epirubicin, fluorouracil, methotrexate	rs1800566	NQO1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01|L01DB03|L04AX03	rs1800566:AA
acetaminophen / tramadol	rs1011784	MIR23B	GG	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs1011784:GG
acetaminophen / tramadol	rs1011784	MIR23B	CG	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs1011784:CG
acetaminophen / tramadol	rs1011784	MIR23B	GG	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs1011784:GG
opioids	rs2069514	CYP1A2	AA	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs2069514:AA
opioids	rs2069514	CYP1A2	AG	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs2069514:AG
opioids	rs2654754	DRD3	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2654754:AA
opioids	rs2654754	DRD3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2654754:AG
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC
opioids	rs324029	DRD3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs324029:AG
opioids	rs324029	DRD3	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs324029:GG
methamphetamine	rs324420	FAAH	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs324420:A
opioids	rs2740574	CYP3A4	CC	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs2740574:CC
opioids	rs2740574	CYP3A4	CT	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs2740574:CT
risperidone	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs2231142:GT
risperidone	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs2231142:TT
aspirin	rs1105879	UGT1A6	AC	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs1105879:AC
aspirin	rs1105879	UGT1A6	CC	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs1105879:CC
acetaminophen / tramadol	rs677830	OPRM1	CT	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs677830:CT
acetaminophen / tramadol	rs677830	OPRM1	TT	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs677830:TT
opioids	rs15524	CYP3A5	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs15524:AA
opioids	rs15524	CYP3A5	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs15524:AG
regorafenib	rs4864950	KDR	A	Toxicity	increased	Adverse_Event	Other:C0027651		L01EX05	rs4864950:A
efavirenz, ethambutol, isoniazid, rifampin	rs2472677	NR1I2	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease|Disease:C0041296		J04AC01|J04AK02|J05AG03	rs2472677:TT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	rs9923231:TT
efavirenz, ethambutol, isoniazid, rifampin	rs2472677	NR1I2	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease|Disease:C0041296		J04AC01|J04AK02|J05AG03	rs2472677:TT
cyclophosphamide, doxorubicin	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs2032582:AA
cyclophosphamide, doxorubicin	rs2032582	ABCB1	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs2032582:TT
taxanes	rs11584174	NR1I3	CC	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD	rs11584174:CC
atazanavir, ritonavir	rs8330	UGT1A1	G	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs8330:G
cyclophosphamide, doxorubicin	rs2032582	ABCB1	AC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs2032582:AC
cyclophosphamide, doxorubicin	rs2032582	ABCB1	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs2032582:CT
efavirenz	rs28399499	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs28399499:TT
nevirapine	rs10276036	ABCB1	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs10276036:TT
taxanes	rs7438284	UGT2B7	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD	rs7438284:AA
atazanavir, ritonavir	rs10929303	UGT1A1	T	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs10929303:T
taxanes	rs7439366	UGT2B7	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD	rs7439366:TT
atazanavir, ritonavir	rs1042640	UGT1A1	G	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs1042640:G
taxanes	rs7662029	UGT2B7	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD	rs7662029:AA
taxanes	rs7668258	UGT2B7	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD	rs7668258:TT
efavirenz	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
antipsychotics	rs1468412	GRM3	TT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1468412:TT
aspirin, clopidogrel	rs662	PON1	CT	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	rs662:CT
aspirin, clopidogrel	rs662	PON1	TT	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	rs662:TT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	rs9923231:TT
risperidone	rs6265	BDNF	TT	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AX08	rs6265:TT
corticosteroids	rs28364072	FCER2	G	Efficacy	increased	Adverse_Event	Disease:C0004096		S02BA	rs28364072:G
fluorouracil, radiotherapy	rs4073	CXCL8	AA	Efficacy	decreased	Adverse_Event	Disease:C0022665		L01BC02	rs4073:AA
methotrexate	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1045642:AA
methotrexate	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1045642:AG
fluorouracil, radiotherapy	rs1870377	KDR	AA	Toxicity	Indeterminado	Adverse_Event	Disease:C0022665		L01BC02	rs1870377:AA
peginterferon alfa-2b, ribavirin	rs1800795	IL6	CC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs1800795:CC
atorvastatin	rs3808607	CYP7A1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020473		C10AA05	rs3808607:TT
cangrelor	rs6787801	P2RY12	G	Other	Indeterminado	Other	Healthy		B01AC25	rs6787801:G
none	rs445925	APOC1, APOE	A	Metabolism/PK	Indeterminado	LADME	Disease:C0679403		A03DA02	rs445925:A
sunitinib	rs2981582	FGFR2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2981582:AA
sulfamethoxazole / trimethoprim	rs1799931	NAT2	A	Toxicity	increased	Adverse_Event	Disease:C0032285		J01EE01	rs1799931:A
sunitinib	rs307826	FLT4	CC	Efficacy	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs307826:CC
sunitinib	rs307826	FLT4	CT	Efficacy	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs307826:CT
heroin	rs1799971	OPRM1	AG	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs1799971:AG
heroin	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs1799971:GG
sunitinib	rs2307424	NR1I3	AA	Efficacy	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs2307424:AA
sunitinib	rs2307424	NR1I3	AG	Efficacy	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs2307424:AG
none	rs174541	FADS1, FEN1, MIR611, TMEM258	T	Metabolism/PK	Indeterminado	LADME	Disease:C0679403		A03DA02	rs174541:T
none	rs258494	__INTRONIC__	C	Metabolism/PK	Indeterminado	LADME	Disease:C0679403		A03DA02	rs258494:C
none	rs6511720	LDLR	T	Other	Indeterminado	LADME	Disease:C0679403		A03DA02	rs6511720:T
none	rs2934965	PNMT	T	Other	decreased	Adverse_Event	Other:C0002895		A03DA02	rs2934965:T
fluorouracil, leucovorin, levamisole, radiotherapy	rs1695	GSTP1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0022665		L01BC02	rs1695:GG
dexamethasone, lenalidomide	rs2229109	ABCB1	CT	Efficacy	increased	Adverse_Event	Disease:Multiple_Myeloma		L04AX04|S02BA06	rs2229109:CT
azathioprine	rs1127354	DDRGK1, ITPA	AC	Efficacy	increased	Adverse_Event	Disease:C0021390		L04AX01	rs1127354:AC
none	rs2941523	PNMT	GG	Other	decreased	Adverse_Event	Other:C0002895		A03DA02	rs2941523:GG
mycophenolic acid	rs4149117	SLCO1B3	GT	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:GT
mycophenolic acid	rs4149117	SLCO1B3	TT	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:TT
none	rs876493	PNMT	AA	Other	decreased	Adverse_Event	Other:C0002895		A03DA02	rs876493:AA
none	rs876493	PNMT	AG	Other	decreased	Adverse_Event	Other:C0002895		A03DA02	rs876493:AG
atenolol, bisoprolol	rs2514036	ACY3	C	Efficacy	decreased	Adverse_Event	Disease:C0020538		C07AB03|C07AB07	rs2514036:C
losartan	rs3814995	KIRREL2, NPHS1	T	Efficacy	decreased	Adverse_Event	Disease:C0020538		C09CA01	rs3814995:T
aspirin	rs16851030	ADORA1	TT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs16851030:TT
antineoplastic agents	rs1544105	FPGS	TT	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs1544105:TT
sunitinib	rs4073054	NR1I3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs4073054:AA
sunitinib	rs307821	FLT4	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs307821:AA
sunitinib	rs307821	FLT4	AC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs307821:AC
alprazolam	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:C0085762|Other:C0003469		N05BA12	rs35599367:AG
mycophenolic acid	rs7311358	SLCO1B3	AG	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs7311358:AG
mycophenolic acid	rs7311358	SLCO1B3	GG	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs7311358:GG
mycophenolic acid	rs7311358	SLCO1B3	AG	Efficacy	decreased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs7311358:AG
mycophenolic acid	rs7311358	SLCO1B3	GG	Efficacy	decreased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs7311358:GG
sunitinib	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs1128503:AG
sunitinib	rs1128503	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs1128503:GG
olanzapine	rs2472297	CYP1A1	T	Metabolism/PK	Indeterminado	LADME	Disease:C0033975		N05AH03	rs2472297:T
mycophenolic acid	rs4149117	SLCO1B3	GT	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:GT
mycophenolic acid	rs4149117	SLCO1B3	TT	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:TT
bevacizumab, capecitabine, cetuximab, oxaliplatin	rs885036	MGAT4A	G	Efficacy	increased	Adverse_Event	Disease:C0023055		L01BC06|L01FG01|L01XA03	rs885036:G
opioids	rs2366929	ADGRV1	C	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2366929:C
bevacizumab, capecitabine, oxaliplatin	rs885036	MGAT4A	G	Efficacy	decreased	Adverse_Event	Disease:C0023055		L01BC06|L01FG01|L01XA03	rs885036:G
clopidogrel	rs1736557	FMO3	AA	Efficacy	decreased	Adverse_Event	Efficacy:C1956346		B01AC04	rs1736557:AA
mycophenolic acid	rs4149117	SLCO1B3	GT	Efficacy	decreased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:GT
mycophenolic acid	rs4149117	SLCO1B3	TT	Efficacy	decreased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:TT
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs10929302:AA
aspirin, clopidogrel	rs2644592	PEAR1	G	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	rs2644592:G
aspirin, clopidogrel	rs11264580	PEAR1	C	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	rs11264580:C
bupropion, nicotine	rs429358	APOE	CC	Other	increased	Adverse_Event	Disease:C0039338		N06AX12|N07BA01	rs429358:CC
bupropion, nicotine	rs429358	APOE	CT	Other	increased	Adverse_Event	Disease:C0039338		N06AX12|N07BA01	rs429358:CT
aspirin, clopidogrel	rs57731889	PEAR1	TT	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	rs57731889:TT
alendronate, ibandronate, risedronate, zoledronate	rs932658	SIRT1	A	Toxicity	decreased	Adverse_Event	Other:C0027651		No_ATC	rs932658:A
valproic acid	rs1137101	LEPR	AG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs1137101:AG
valproic acid	rs1137101	LEPR	GG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs1137101:GG
antineoplastic agents	rs3754446	GSTM5	C	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs3754446:C
atorvastatin, bezafibrate	rs449647	APOE	AT	Efficacy	increased	Efficacy_Response	Disease:C0020473		C10AA05|C10AB02	rs449647:AT
atorvastatin, bezafibrate	rs449647	APOE	TT	Efficacy	increased	Efficacy_Response	Disease:C0020473		C10AA05|C10AB02	rs449647:TT
haloperidol	rs2298826	SLC6A5	AA	Toxicity	Indeterminado	Adverse_Event	Disease:C0036341		N05AD01	rs2298826:AA
olanzapine	rs4410790	AHR	T	Metabolism/PK	Indeterminado	LADME	Disease:C0033975		N05AH03	rs4410790:T
clopidogrel	rs6785930	P2RY12	AA	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs6785930:AA
clopidogrel	rs6785930	P2RY12	AG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs6785930:AG
aspirin, clopidogrel	rs3737224	PEAR1	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	rs3737224:T
aspirin, clopidogrel	rs3093135	CYP4F2	T	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs3093135:T
ethanol	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:G
venlafaxine	rs5030655	CYP2D6	del	Metabolism/PK	Indeterminado	LADME	Disease:C0011581		N06AX16	rs5030655:del
aspirin, ticagrelor	rs3093135	CYP4F2	T	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC24	rs3093135:T
clopidogrel	rs6809699	P2RY12	AA	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs6809699:AA
clopidogrel	rs6809699	P2RY12	AC	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs6809699:AC
cisplatin, doxorubicin	rs2720376	CASP3	C	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01DB01|L01XA01	rs2720376:C
ace inhibitors, plain	rs3788853	XPNPEP2	A	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs3788853:A
hmg coa reductase inhibitors	rs59502379	SLCO1B1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs59502379:C
capecitabine	rs2244613	CES1	GG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GG
capecitabine	rs2244613	CES1	GT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GT
nevirapine	rs1265112	CCHCR1	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs1265112:C
cisplatin, doxorubicin	rs4646437	CYP3A4	A	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01DB01|L01XA01	rs4646437:A
none	rs2228226	GLI1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0024121		A03DA02	rs2228226:CC
nicotine	rs1800497	ANKK1, DRD2	AA	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AA
nicotine	rs1800497	ANKK1, DRD2	AG	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AG
valproic acid	rs2070959	UGT1A6	AG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs2070959:AG
valproic acid	rs2070959	UGT1A6	GG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs2070959:GG
escitalopram	rs4646425	CYP1A2	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs4646425:T
clozapine	rs2814778	ACKR1	CC	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs2814778:CC
escitalopram	rs2069521	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs2069521:A
aspirin, clopidogrel	rs41273215	PEAR1	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	rs41273215:T
escitalopram	rs4646427	CYP1A2	C	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs4646427:C
escitalopram	rs2069521	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs2069521:A
escitalopram	rs4646425	CYP1A2	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs4646425:T
escitalopram	rs4646427	CYP1A2	C	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs4646427:C
allopurinol	rs3099844	CYCSP5	AA	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:AA
allopurinol	rs3099844	CYCSP5	AC	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:AC
clopidogrel	rs762551	CYP1A2	AA	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Other:cigarette_smokers		B01AC04	rs762551:AA
clopidogrel	rs762551	CYP1A2	AC	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Other:cigarette_smokers		B01AC04	rs762551:AC
ethanol	rs6473797	OPRK1	CC	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs6473797:CC
ethanol	rs6473797	OPRK1	CT	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs6473797:CT
cyclophosphamide, doxorubicin	rs1800566	NQO1	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs1800566:A
heroin	rs274618	GRM3	T	Other	increased	Adverse_Event	Healthy		No_ATC	rs274618:T
thiazolidinediones	rs296766	AQP2	T	Toxicity	increased	Adverse_Event	Disease:C0011849		A10BG	rs296766:T
ethanol	rs578776	CHRNA3	G	Toxicity, Other	decreased	Adverse_Event	Healthy		V03AB16	rs578776:G
cisplatin, doxorubicin	rs939338	ABCC5	G	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01DB01|L01XA01	rs939338:G
cisplatin, doxorubicin	rs763110	FASLG	T	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01DB01|L01XA01	rs763110:T
cisplatin, doxorubicin	rs4638843	MSH2	C	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01DB01|L01XA01	rs4638843:C
selective serotonin reuptake inhibitors	rs3087879	SLC1A1	C	Efficacy	increased	Adverse_Event	Disease:C0028768		N06AB	rs3087879:C
cocaine	rs684513	CHRNA5	G	Other	increased	Adverse_Event	Healthy		N01BC01	rs684513:G
ace inhibitors, plain	rs3788853	XPNPEP2	A	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs3788853:A
allopurinol	rs2734583	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs2734583:AG
allopurinol	rs2734583	__INTRONIC__	GG	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs2734583:GG
methotrexate	rs717620	ABCC2	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs717620:CT
methotrexate	rs717620	ABCC2	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs717620:TT
allopurinol	rs9263726	PSORS1C1	AA	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263726:AA
allopurinol	rs9263726	PSORS1C1	AG	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263726:AG
fexofenadine	rs2306168	SLCO2B1	T	Metabolism/PK	decreased	LADME	Healthy		R06AX26	rs2306168:T
antineoplastic agents	rs17343066	SLC28A3	AA	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs17343066:AA
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
clozapine	rs116982346	TRAT1	C	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs116982346:C
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:CT
efavirenz	rs8192726	CYP2A6	AC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs8192726:AC
efavirenz	rs8192726	CYP2A6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs8192726:CC
cyclophosphamide, doxorubicin, fluorouracil	rs2740574	CYP3A4	CC	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2740574:CC
cyclophosphamide, doxorubicin, fluorouracil	rs2740574	CYP3A4	CT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2740574:CT
none	rs1789891	ADH1B	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs1789891:A
antineoplastic agents	rs12067645	DCTD	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs12067645:AA
efavirenz	rs7439366	UGT2B7	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs7439366:CC
efavirenz	rs7439366	UGT2B7	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs7439366:CT
mercaptopurine	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs1051266:TT
fluorouracil, leucovorin, oxaliplatin	rs13181	ERCC2	G	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs13181:G
clozapine	rs377360	TRAC	A	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs377360:A
nevirapine	rs746647	CCHCR1	G	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs746647:G
none	rs2245964	FGFBP1	CC	Other	increased	Other	Healthy		A03DA02	rs2245964:CC
acenocoumarol	rs9923231	VKORC1	CT	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AA07	rs9923231:CT
acenocoumarol	rs9923231	VKORC1	TT	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AA07	rs9923231:TT
none	rs16892645	FGFBP1	TT	Other	increased	Other	Healthy		A03DA02	rs16892645:TT
atorvastatin	rs2306283	SLCO1B1	GG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2306283:GG
none	rs2824292	__INTRONIC__	G	Other	increased	Adverse_Event	Disease:C0027051		A03DA02	rs2824292:G
nevirapine	rs6545803	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs6545803:G
nicotine	rs10912675	FMO1	C	Other	increased	Adverse_Event	Healthy		N07BA01	rs10912675:C
nevirapine	rs2562519	POLR3G	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs2562519:T
nicotine	rs7877	FMO1	T	Other	increased	Adverse_Event	Healthy		N07BA01	rs7877:T
asparaginase	rs4958381	GRIA1	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	rs4958381:T
paclitaxel	rs743572	CYP17A1	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01CD01	rs743572:AG
paclitaxel	rs743572	CYP17A1	GG	Toxicity	increased	Adverse_Event	Other:C1458155		L01CD01	rs743572:GG
acenocoumarol	rs1057910	CYP2C9	C	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AA07	rs1057910:C
cisplatin, fluorouracil	rs3212986	ERCC1	AA	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs3212986:AA
cisplatin, fluorouracil	rs3212986	ERCC1	AC	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs3212986:AC
doxorubicin	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AA
doxorubicin	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AG
anastrozole, letrozole	rs2073618	TNFRSF11B	CC	Toxicity	increased	Adverse_Event	Other:C1458155		L02BG03|L02BG04	rs2073618:CC
carboplatin, docetaxel, paclitaxel	rs139887	SOX10	CG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD01|L01CD02|L01XA02	rs139887:CG
anastrozole, letrozole	rs2073618	TNFRSF11B	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L02BG03|L02BG04	rs2073618:CC
anastrozole, letrozole	rs7984870	TNFSF11	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L02BG03|L02BG04	rs7984870:CC
antineoplastic agents	rs12067645	CTPS1	A	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs12067645:A
doxorubicin	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AA
doxorubicin	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AG
antineoplastic agents	rs12067645	CTPS1	A	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs12067645:A
capecitabine	rs11075646	CES2	CG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs11075646:CG
capecitabine	rs11075646	CES2	GG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs11075646:GG
warfarin	rs9923231	VKORC1	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004238		B01AA03	rs9923231:T
anastrozole, letrozole	rs7984870	TNFSF11	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L02BG03|L02BG04	rs7984870:CC
drugs for treatment of tuberculosis	rs4880	SOD2	AG	Toxicity	increased	Adverse_Event	Healthy		J04A	rs4880:AG
drugs for treatment of tuberculosis	rs4880	SOD2	GG	Toxicity	increased	Adverse_Event	Healthy		J04A	rs4880:GG
"""analgesics and anesthetics"", ""antibiotics"", ""antiepileptics"", ""antifungals for systemic use"", ""antiinflammatory and antirheumatic products, non-steroids"", ""antimycobacterials"", ""antithyroid preparations"""	rs4880	SOD2	AG	Toxicity	increased	Adverse_Event	Healthy		D01BA|H03B|J04|M01|N03A|S01AA|S02DA	rs4880:AG
"""analgesics and anesthetics"", ""antibiotics"", ""antiepileptics"", ""antifungals for systemic use"", ""antiinflammatory and antirheumatic products, non-steroids"", ""antimycobacterials"", ""antithyroid preparations"""	rs4880	SOD2	GG	Toxicity	increased	Adverse_Event	Healthy		D01BA|H03B|J04|M01|N03A|S01AA|S02DA	rs4880:GG
doxorubicin	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AA
doxorubicin	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AG
metformin	rs1801282	PPARG	G	Other	increased	Adverse_Event	Healthy		A10BA02	rs1801282:G
mitotane	rs3745274	CYP2B6	GT	Metabolism/PK	Indeterminado	LADME	Disease:C1370740		L01XX23	rs3745274:GT
mitotane	rs3745274	CYP2B6	TT	Metabolism/PK	Indeterminado	LADME	Disease:C1370740		L01XX23	rs3745274:TT
bortezomib, melphalan, prednisone	rs4553808	CTLA4	GG	Toxicity	Indeterminado	Adverse_Event	Disease:Multiple_Myeloma		H02AB07|L01AA03|L01XG01	rs4553808:GG
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
none	rs1876828	CRHR1	TT	Metabolism/PK	decreased	LADME	Disease:C0004096		A03DA02	rs1876828:TT
efavirenz	rs3745274	CYP2B6	TT	Toxicity, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
valproic acid	rs4880	SOD2	AG	Toxicity	decreased	Adverse_Event	Other:C0014544		N03AG01	rs4880:AG
valproic acid	rs4880	SOD2	GG	Toxicity	decreased	Adverse_Event	Other:C0014544		N03AG01	rs4880:GG
none	rs1045642	ABCB1	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs1045642:AA
valproic acid	rs1137101	LEPR	AG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs1137101:AG
valproic acid	rs1137101	LEPR	GG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs1137101:GG
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Other	Healthy		B01AC04	rs4244285:A
capecitabine	rs10916825	CDA	AG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs10916825:AG
capecitabine	rs10916825	CDA	GG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs10916825:GG
antineoplastic agents	rs4148737	ABCB1	CC	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs4148737:CC
antineoplastic agents	rs4148737	ABCB1	CT	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs4148737:CT
hmg coa reductase inhibitors	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:C
clopidogrel, ticagrelor	rs3093135	CYP4F2	TT	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04|B01AC24	rs3093135:TT
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT
deferasirox	rs3806596	UGT1A3	CC	Efficacy	decreased	Adverse_Event	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs3806596:CC
capecitabine, cisplatin, docetaxel, epirubicin, gemcitabine	rs13181	ERCC2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05|L01BC06|L01CD02|L01DB03|L01XA01	rs13181:GG
deferasirox	rs887829	UGT1A1	TT	Efficacy	decreased	Adverse_Event	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs887829:TT
metformin	rs12943590	SLC47A2	AA	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs12943590:AA
metformin	rs12943590	SLC47A2	AG	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs12943590:AG
metformin	rs12943590	SLC47A2	AA	Efficacy	decreased	Efficacy_Response	Healthy		A10BA02	rs12943590:AA
capecitabine	rs2244613	CES1	GG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GG
capecitabine	rs2244613	CES1	GT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GT
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	decreased	LADME	Disease:C0028754		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	decreased	LADME	Disease:C0028754		C10AA05	rs4149056:CT
capecitabine	rs2244613	CES1	GG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GG
capecitabine	rs2244613	CES1	GT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GT
deferasirox	rs762551	CYP1A2	AA	Efficacy	decreased	Adverse_Event	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs762551:AA
antineoplastic agents	rs776746	CYP3A5	T	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs776746:T
capecitabine, cisplatin, docetaxel, epirubicin, gemcitabine	rs13181	ERCC2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05|L01BC06|L01CD02|L01DB03|L01XA01	rs13181:GG
deferasirox	rs2606345	CYP1A1	CC	Efficacy	decreased	Adverse_Event	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs2606345:CC
heroin	rs274622	GRM3	C	Other	increased	Adverse_Event	Healthy		No_ATC	rs274622:C
efavirenz	rs3842	ABCB1	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3842:CC
efavirenz	rs3842	ABCB1	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3842:CT
ethanol	rs1044394	CHRNA4	G	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1044394:G
hormonal contraceptives for systemic use	rs1799963	F2	AG	Toxicity	increased	Adverse_Event	Healthy		G03A	rs1799963:AG
opioids	rs2249015	ENPP2	AA	Efficacy	increased	Adverse_Event	Other:C0027651		N02A	rs2249015:AA
hormonal contraceptives for systemic use	rs6025	F5	CT	Toxicity	increased	Adverse_Event	Healthy		G03A	rs6025:CT
capecitabine, cisplatin, docetaxel, epirubicin, gemcitabine	rs25487	XRCC1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05|L01BC06|L01CD02|L01DB03|L01XA01	rs25487:CT
capecitabine, cisplatin, docetaxel, epirubicin, gemcitabine	rs25487	XRCC1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05|L01BC06|L01CD02|L01DB03|L01XA01	rs25487:TT
aspirin	rs2228079	ADORA1	GG	Toxicity	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs2228079:GG
aspirin	rs2228079	ADORA1	GT	Toxicity	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs2228079:GT
lovastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA02	rs4149056:CC
methotrexate	rs1801131	MTHFR	GG	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1801131:GG
methotrexate	rs1801131	MTHFR	GT	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1801131:GT
methotrexate	rs1801394	FASTKD3, MTRR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801394:AG
methotrexate	rs1801394	FASTKD3, MTRR	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801394:GG
fluorouracil	rs56038477	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs56038477:T
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AG
propranolol	rs1065852	CYP2D6	AA	Metabolism/PK	increased	LADME	Healthy		C07AA05	rs1065852:AA
capecitabine, fluorouracil	rs6668296	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs6668296:T
clozapine	rs113332494	HLA-DQB1	G	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs113332494:G
capecitabine, cisplatin, docetaxel, epirubicin, gemcitabine	rs1799793	ERCC2	CC	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05|L01BC06|L01CD02|L01DB03|L01XA01	rs1799793:CC
none	rs7412	APOE	CT	Other	increased	Other	Other:C0010068|Other:C0020538		A03DA02	rs7412:CT
none	rs7412	APOE	TT	Other	increased	Other	Other:C0010068|Other:C0020538		A03DA02	rs7412:TT
capecitabine, fluorouracil	rs115349832	DPYD	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs115349832:C
metformin	rs1801282	PPARG	G	Other	increased	Adverse_Event	Healthy		A10BA02	rs1801282:G
none	rs429358	APOE	CC	Other	increased	Other	Other:C0010068|Other:C0020538		A03DA02	rs429358:CC
none	rs429358	APOE	CT	Other	increased	Other	Other:C0010068|Other:C0020538		A03DA02	rs429358:CT
clozapine	rs113332494	HLA-DQB1	G	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs113332494:G
simvastatin	rs429358	APOE	C	Efficacy	increased	Adverse_Event	Healthy		C10AA01	rs429358:C
clozapine, haloperidol, olanzapine, risperidone	rs518147	HTR2C	G	Other	increased	Adverse_Event	Disease:C0036341		N05AD01|N05AH02|N05AH03|N05AX08	rs518147:G
amisulpride, clozapine, haloperidol, iloperidone, olanzapine, quetiapine, risperidone, ziprasidone	rs3813929	HTR2C	C	Other	increased	Adverse_Event	Healthy		N05AD01|N05AE04|N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	rs3813929:C
heroin	rs5746136	SOD2	TT	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs5746136:TT
opioids	rs7832704	ENPP2	A	Efficacy	increased	Adverse_Event	Other:C0027651		N02A	rs7832704:A
carboplatin, docetaxel, paclitaxel	rs2849380	BCL2	TT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD01|L01CD02|L01XA02	rs2849380:TT
carboplatin, docetaxel, paclitaxel	rs544093	OPRM1	TT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD01|L01CD02|L01XA02	rs544093:TT
carboplatin, docetaxel, paclitaxel	rs879207	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD01|L01CD02|L01XA02	rs879207:AG
tolcapone	rs4680	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Other:abstinent_smokers		N04BX01	rs4680:GG
dolasetron, granisetron	rs10494366	NOS1AP	GT	Toxicity	increased	Adverse_Event	Other:surgery_as_part_of_anesthetic_management		A04AA02|A04AA04	rs10494366:GT
dolasetron, granisetron	rs10494366	NOS1AP	TT	Toxicity	increased	Adverse_Event	Other:surgery_as_part_of_anesthetic_management		A04AA02|A04AA04	rs10494366:TT
sunitinib	rs2032582	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs2032582:A
capecitabine, fluorouracil	rs56276561	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs56276561:T
clozapine	rs73482673	ELAVL2	A	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs73482673:A
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
fluorouracil	rs2297595	DPYD	CC	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs2297595:CC
fluorouracil	rs2297595	DPYD	CT	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs2297595:CT
docetaxel	rs4149118	SLCO1B3	G	Other, Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs4149118:G
nevirapine	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT
tolcapone	rs4680	COMT	AG	Efficacy	decreased	Efficacy_Response	Other:abstinent_smokers		N04BX01	rs4680:AG
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
heroin	rs2758339	SOD2	AC	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs2758339:AC
heroin	rs2758339	SOD2	CC	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs2758339:CC
docetaxel	rs11045585	SLCO1B3	G	Other, Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs11045585:G
docetaxel	rs7311358	SLCO1B3	A	Other, Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs7311358:A
irinotecan	rs6072262	TOP1	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs6072262:GG
warfarin	rs679899	APOB	G	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs679899:G
erlotinib	rs712829	EGFR	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EB02	rs712829:GG
erlotinib	rs2622604	ABCG2	CC	Other, Metabolism/PK	decreased	LADME	Healthy		L01EB02	rs2622604:CC
warfarin	rs1367117	APOB	G	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs1367117:G
capecitabine, fluorouracil	rs56038477	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs56038477:T
morphine	rs1799971	OPRM1	AA	Efficacy	increased	Efficacy_Response	Disease:C0027651		N02AA01	rs1799971:AA
morphine	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0027651		N02AA01	rs1045642:AA
phenytoin	rs1045642	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0014544		N03AB02	rs1045642:G
atorvastatin, fluvastatin, hmg coa reductase inhibitors, pravastatin, rosuvastatin, simvastatin	rs4149056	SLCO1B1	C	Toxicity	Indeterminado	Adverse_Event	Healthy		C10AA|C10AA01|C10AA03|C10AA04|C10AA05|C10AA07	rs4149056:C
aspirin, clopidogrel	rs1061781	B4GALT2	CT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs1061781:CT
aspirin, clopidogrel	rs1061781	B4GALT2	TT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs1061781:TT
leflunomide	rs1790834	CYB5A	AA	Efficacy	decreased	Efficacy_Response	Other:C0003873		No_ATC	rs1790834:AA
leflunomide	rs1790834	CYB5A	AG	Efficacy	decreased	Efficacy_Response	Other:C0003873		No_ATC	rs1790834:AG
hormonal contraceptives for systemic use	rs6025	F5	CT	Toxicity	increased	Adverse_Event	Healthy		G03A	rs6025:CT
nevirapine	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs28399499:CT
nevirapine	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:T
cetuximab, panitumumab	rs61764370	KRAS	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0001418		No_ATC	rs61764370:C
edoxaban	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs4149056:CC
edoxaban	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs4149056:CT
cyclosporine	rs1045642	ABCB1	GG	Efficacy, Metabolism/PK	decreased	LADME	Disease:C0277631		L04AD01	rs1045642:GG
bleomycin	rs1050565	BLMH	CC	Efficacy	decreased	Efficacy_Response	Disease:C0039591		L01DC01	rs1050565:CC
cisplatin	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Disease:C0039591		L01XA01	rs1695:AA
cisplatin	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Disease:C0039591		L01XA01	rs1695:AG
citalopram	rs4713916	FKBP5	A	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB04	rs4713916:A
opioids	rs10770141	TH	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs10770141:AA
opioids	rs10770141	TH	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs10770141:AG
disulfiram	rs1611115	DBH	CC	Efficacy	decreased	Adverse_Event	Other:C0278080|Other:C0036502		N07BB01	rs1611115:CC
opioids	rs4680	COMT	AA	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N02A	rs4680:AA
none	rs2010963	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0027651		A03DA02	rs2010963:CC
none	rs2010963	VEGFA	CG	Efficacy	increased	Efficacy_Response	Disease:C0027651		A03DA02	rs2010963:CG
sofosbuvir, velpatasvir, voxilaprevir	rs12979860	IFNL3, IFNL4	CT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP08|J05AP55|J05AP56	rs12979860:CT
sofosbuvir, velpatasvir, voxilaprevir	rs12979860	IFNL3, IFNL4	TT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP08|J05AP55|J05AP56	rs12979860:TT
opioids	rs10770140	TH	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs10770140:CT
opioids	rs10770140	TH	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs10770140:TT
phenytoin	rs1128503	ABCB1	A	Other, Metabolism/PK	increased	LADME	Other:C0024198		N03AB02	rs1128503:A
phenytoin	rs1045642	ABCB1	A	Other, Metabolism/PK	increased	LADME	Other:C0024198		N03AB02	rs1045642:A
anthracyclines and related substances	rs1056892	CBR3	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01DB	rs1056892:GG
dexmedetomidine	rs9922316	PRKCB	T	Other	increased	Other	Healthy		N05CM18	rs9922316:T
prasugrel	rs12248560	CYP2C19	T	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC22	rs12248560:T
cyclosporine	rs2229109	ABCB1	CC	Efficacy, Metabolism/PK	increased	LADME	Disease:C0277631		L04AD01	rs2229109:CC
prasugrel	rs12248560	CYP2C19	T	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC22	rs12248560:T
hmg coa reductase inhibitors	rs10455872	LPA	G	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs10455872:G
efavirenz	rs28399499	CYP2B6	C	Toxicity, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C
prasugrel	rs12248560	CYP2C19	T	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC22	rs12248560:T
nicotine	rs686	DRD1	A	Efficacy, Toxicity, Other	increased	Adverse_Event	Other:smokers		N07BA01	rs686:A
prasugrel	rs12248560	CYP2C19	T	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC22	rs12248560:T
antipsychotics	rs1799732	DRD2	del	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1799732:del
mitotane	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:C1370740		L01XX23	rs3745274:GT
mitotane	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:C1370740		L01XX23	rs3745274:TT
nicotine	rs4532	DRD1	T	Efficacy, Toxicity, Other	increased	Adverse_Event	Other:smokers		N07BA01	rs4532:T
repaglinide	rs16889462	SLC30A8	AG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs16889462:AG
atazanavir, ritonavir	rs17863778	UGT1A7	AA	Toxicity, Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs17863778:AA
bevacizumab	rs5370	EDN1	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01FG01	rs5370:TT
mycophenolate mofetil(mycophenolic acid)	rs2278294	IMPDH1	T	Efficacy	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs2278294:T
atazanavir, ritonavir	rs3806596	UGT1A3	CC	Toxicity, Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs3806596:CC
gefitinib	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01EB01	rs1128503:AA
mycophenolate mofetil(mycophenolic acid)	rs2278294	IMPDH1	T	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs2278294:T
atazanavir, ritonavir	rs7586110	UGT1A7	GG	Toxicity, Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs7586110:GG
oxaliplatin	rs13181	ERCC2, KLC3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs13181:GG
oxaliplatin	rs13181	ERCC2, KLC3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs13181:GT
aprepitant, olanzapine	rs6766410	HTR3C	CC	Efficacy	increased	Adverse_Event	Other:C0027651		A04AD12|N05AH03	rs6766410:CC
atazanavir, ritonavir	rs17868323	UGT1A7	GG	Toxicity, Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs17868323:GG
bevacizumab	rs3025039	VEGFA	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01FG01	rs3025039:TT
aprepitant, olanzapine	rs1801131	MTHFR	TT	Efficacy	decreased	Adverse_Event	Other:C0027651		A04AD12|N05AH03	rs1801131:TT
aprepitant, olanzapine	rs7943062	HTR3B	GG	Efficacy	decreased	Adverse_Event	Other:C0027651		A04AD12|N05AH03	rs7943062:GG
tafenoquine	rs62103056	__INTRONIC__	A	Efficacy	increased	Adverse_Event	Other:C0024530|Vivax		No_ATC	rs62103056:A
methotrexate	rs719235	GGH	CC	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs719235:CC
timolol	rs1801252	ADRB1	AA	Other	increased	Other	Healthy		S01ED01	rs1801252:AA
cisplatin	rs2228171	LRP2	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs2228171:G
disulfiram	rs1611115	DBH	CT	Toxicity	increased	Adverse_Event	Other:C0085762		N07BB01	rs1611115:CT
disulfiram	rs1611115	DBH	TT	Toxicity	increased	Adverse_Event	Other:C0085762		N07BB01	rs1611115:TT
fentanyl, propofol, remifentanil, sevoflurane	rs1042718	ADRB2	AA	Toxicity	increased	Adverse_Event	Healthy		N01AB08|N01AH06|N01AX10|N02AB03	rs1042718:AA
rosuvastatin	rs2231142	ABCG2	T	Efficacy	Indeterminado	Adverse_Event	Healthy		C10AA07	rs2231142:T
none	rs13266634	SLC30A8	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs13266634:C
thiazides, plain	rs34550074	SLCO2A1	T	Toxicity	increased	Adverse_Event	Disease:C0020538		A03B|C03A	rs34550074:T
rosuvastatin	rs1736557	FMO3	A	Efficacy	Indeterminado	Adverse_Event	Healthy		C10AA07	rs1736557:A
warfarin	rs699664	GGCX	C	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs699664:C
cisplatin	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Disease:C0017636		L01XA01	rs1695:AG
cisplatin	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Disease:C0017636		L01XA01	rs1695:GG
warfarin	rs11676382	GGCX	G	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs11676382:G
methylphenidate	rs4680	COMT	A	Toxicity	increased	Adverse_Event	Other:C1263846|Other:C0015923		N06BA04	rs4680:A
antiepileptics	rs2304016	SCN2A	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03A	rs2304016:A
warfarin	rs11676382	GGCX	G	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs11676382:G
warfarin	rs1800566	NQO1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1800566:AA
warfarin	rs1800566	NQO1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1800566:AG
antithyroid preparations, methimazole, propylthiouracil	rs2734565	KLRC4	C	Toxicity	increased	Adverse_Event	Other:C0242656		H03B|H03BA02	rs2734565:C
oxaliplatin	rs11615	ERCC1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs11615:AA
fluorouracil	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs1801133:AA
fluorouracil	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs1801133:AG
ace inhibitors, plain	rs4267385	__INTRONIC__	CC	Other	Indeterminado	Other	Other:homozygous_GG_genotype_for_rs4343		A03B|C09A	rs4267385:CC
ace inhibitors, plain	rs4267385	__INTRONIC__	CT	Other	Indeterminado	Other	Other:homozygous_GG_genotype_for_rs4343		A03B|C09A	rs4267385:CT
ace inhibitors, plain	rs4459610	__INTRONIC__	AA	Other	Indeterminado	Other	Other:homozygous_GG_genotype_for_rs4343		A03B|C09A	rs4459610:AA
ace inhibitors, plain	rs4459610	__INTRONIC__	AT	Other	Indeterminado	Other	Other:homozygous_GG_genotype_for_rs4343		A03B|C09A	rs4459610:AT
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AG
ace inhibitors, plain	rs8016905	BDKRB2	AG	Toxicity	Indeterminado	Adverse_Event	Healthy		A03B|C09A	rs8016905:AG
none	rs6025	F5	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs6025:C
carboplatin, paclitaxel	rs7950311	TRIM5	C	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01CD01|L01XA02	rs7950311:C
none	rs1801131	MTHFR	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs1801131:G
antineoplastic agents	rs6674079	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01	rs6674079:G
none	rs1801133	MTHFR	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs1801133:G
carboplatin, paclitaxel	rs2549714	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01CD01|L01XA02	rs2549714:C
none	rs2227631	SERPINE1	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs2227631:A
antineoplastic agents	rs4910232	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01	rs4910232:G
warfarin	rs2108622	CYP4F2	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2108622:TT
aspirin	rs3856806	PPARG	TT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3856806:TT
cyclosporine	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs1045642:AA
antineoplastic agents	rs3795247	ZNF100	C	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01	rs3795247:C
warfarin	rs9923231	VKORC1	T	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:T
aspirin	rs1126510	PTGIR	AG	Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs1126510:AG
aspirin	rs1126510	PTGIR	GG	Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs1126510:GG
warfarin	rs9923231	VKORC1	CT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
aspirin	rs1131882	TBXA2R	GG	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1131882:GG
aspirin	rs7551789	PTGER3	A	Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7551789:A
warfarin	rs9923231	VKORC1	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
aspirin	rs1353411	PTGER2	GG	Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1353411:GG
aspirin	rs2075797	PTGER2	G	Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs2075797:G
docetaxel, paclitaxel	rs2740574	CYP3A4	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01|L01CD02	rs2740574:CC
doxorubicin	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Other:C1458155		L01DB01	rs1045642:AA
doxorubicin	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Other:C1458155		L01DB01	rs1045642:AG
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:TT
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AG
clopidogrel	rs4244285	CYP2C19	GG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:GG
aspirin	rs3856806	PPARG	TT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3856806:TT
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	Indeterminado	Efficacy_Response	Other:undergoing_scheduled_percutaneous_coronary_intervention		B01AC04	rs4986893:AG
clopidogrel	rs4986893	CYP2C19	GG	Efficacy	Indeterminado	Efficacy_Response	Other:undergoing_scheduled_percutaneous_coronary_intervention		B01AC04	rs4986893:GG
aspirin, clopidogrel	rs74569896	NECAB1	G	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs74569896:G
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	Indeterminado	Efficacy_Response	Other:undergoing_scheduled_percutaneous_coronary_intervention		B01AC04	rs4244285:AG
clopidogrel	rs4244285	CYP2C19	GG	Efficacy	Indeterminado	Efficacy_Response	Other:undergoing_scheduled_percutaneous_coronary_intervention		B01AC04	rs4244285:GG
warfarin	rs9923231	VKORC1	T	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:T
warfarin	rs1799853	CYP2C9	T	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1799853:T
aspirin, clopidogrel	rs4736529	EFR3A	G	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs4736529:G
docetaxel, paclitaxel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01|L01CD02	rs1045642:AA
gemcitabine	rs2242046	SLC28A1	GG	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01BC05	rs2242046:GG
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T
warfarin	rs1057910	CYP2C9	C	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1057910:C
gemcitabine	rs1048977	CDA	CC	Other, Metabolism/PK	increased	LADME	Disease:C0027651		L01BC05	rs1048977:CC
gemcitabine	rs1048977	CDA	CT	Other, Metabolism/PK	increased	LADME	Disease:C0027651		L01BC05	rs1048977:CT
paclitaxel	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Other:C1458155		L01CD01	rs1045642:AA
paclitaxel	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Other:C1458155		L01CD01	rs1045642:AG
hmg coa reductase inhibitors	rs10455872	LPA	AG	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs10455872:AG
hmg coa reductase inhibitors	rs10455872	LPA	GG	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs10455872:GG
hmg coa reductase inhibitors	rs10455872	LPA	AG	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs10455872:AG
hmg coa reductase inhibitors	rs10455872	LPA	GG	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs10455872:GG
cytarabine	rs1128503	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs1128503:GG
hmg coa reductase inhibitors	rs10455872	LPA	AG	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA	rs10455872:AG
hmg coa reductase inhibitors	rs10455872	LPA	GG	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA	rs10455872:GG
ethambutol, isoniazid / pyrazinamide / rifampin	rs1799930	NAT2	AA	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1799930:AA
hmg coa reductase inhibitors	rs10455872	LPA	AG	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA	rs10455872:AG
hmg coa reductase inhibitors	rs10455872	LPA	GG	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA	rs10455872:GG
pravastatin	rs2032582	ABCB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03	rs2032582:CC
gemcitabine	rs1044457	CMPK1	CC	Other, Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC05	rs1044457:CC
aspirin, clopidogrel	rs11640115	WDR24	G	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs11640115:G
gemcitabine	rs4655226	CDA	CC	Other, Metabolism/PK	increased	LADME	Disease:C0027651		L01BC05	rs4655226:CC
carboplatin, paclitaxel	rs1801368	MAD1L1	CT	Other	decreased	Other	Disease:C0919267		L01CD01|L01XA02	rs1801368:CT
carboplatin, paclitaxel	rs1801368	MAD1L1	TT	Other	decreased	Other	Disease:C0919267		L01CD01|L01XA02	rs1801368:TT
varenicline	rs901886	ICAM5	T	Toxicity	increased	Adverse_Event	Other:C0039338|Other:C0558401		N07BA03	rs901886:T
methotrexate	rs2238476	ABCC1	AG	Toxicity	increased	Adverse_Event	Other:C0235763		L04AX03	rs2238476:AG
mitoxantrone	rs1128503	ABCB1	AA	Other	increased	Other	Healthy		L01DB07	rs1128503:AA
mercaptopurine, methotrexate	rs61886492	FOLH1	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs61886492:A
cytarabine	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs2032582:CC
ethambutol, isoniazid / pyrazinamide / rifampin	rs1041983	NAT2	TT	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1041983:TT
nevirapine	rs28399499	CYP2B6	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs28399499:C
none	rs135561	PPARA	AA	Other	decreased	Adverse_Event	Disease:C0027051		A03DA02	rs135561:AA
none	rs135561	PPARA	AG	Other	decreased	Adverse_Event	Disease:C0027051		A03DA02	rs135561:AG
clozapine	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		N05AH02	rs1045642:AA
drugs for treatment of tuberculosis, isoniazid	rs1495741	__INTRONIC__	AA	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A|J04AC01	rs1495741:AA
methotrexate	rs4673993	ATIC	C	Efficacy	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs4673993:C
drugs for treatment of tuberculosis, isoniazid	rs1495741	__INTRONIC__	AA	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A|J04AC01	rs1495741:AA
antivirals for treatment of hiv infections, combinations	rs5128	APOC3	CG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs5128:CG
antivirals for treatment of hiv infections, combinations	rs5128	APOC3	GG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs5128:GG
fluticasone propionate	rs35599367	CYP3A4	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004096		R03BA05	rs35599367:AA
fluticasone propionate	rs35599367	CYP3A4	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004096		R03BA05	rs35599367:AG
allopurinol	rs9263745	CCHCR1	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263745:A
letrozole	rs74418677	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Other:C1458155		L02BG04	rs74418677:C
ace inhibitors, plain	rs5186	AGTR1	C	Toxicity	increased	Adverse_Event	Disease:C1956346		A03B|C09A	rs5186:C
cytarabine, daunorubicin, etoposide, mitoxantrone	rs2291075	SLCO1B1	CT	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01CB01|L01DB02|L01DB07	rs2291075:CT
cytarabine, daunorubicin, etoposide, mitoxantrone	rs2291075	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01CB01|L01DB02|L01DB07	rs2291075:TT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:CC
cyclosporine	rs35599367	CYP3A4	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs35599367:AA
cyclosporine	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs35599367:AG
allopurinol	rs3099844	CYCSP5	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:A
methotrexate	rs3761548	FOXP3	GT	Toxicity	increased	Adverse_Event	Other:C0235763		L04AX03	rs3761548:GT
none	rs1880676	CHAT	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs1880676:G
antivirals for treatment of hiv infections, combinations	rs139961185	SIK3	AA	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs139961185:AA
antivirals for treatment of hiv infections, combinations	rs139961185	SIK3	AG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs139961185:AG
oxaliplatin	rs25487	XRCC1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs25487:TT
cyclosporine	rs35599367	CYP3A4	AA	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs35599367:AA
cyclosporine	rs35599367	CYP3A4	AG	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs35599367:AG
metformin	rs622342	SLC22A1	AA	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs622342:AA
allopurinol	rs9263733	PSORS1C2	T	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263733:T
cyclosporine	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs1045642:AA
cyclosporine	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs1045642:AG
methotrexate	rs13120400	ABCG2	CT	Toxicity	increased	Adverse_Event	Other:C0235763		L04AX03	rs13120400:CT
methotrexate	rs13120400	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0235763		L04AX03	rs13120400:TT
allopurinol	rs9263726	PSORS1C1, PSORS1C2	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263726:A
drugs for treatment of tuberculosis	rs1495741	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs1495741:AA
exemestane, letrozole	rs912571	__INTRONIC__	G	Toxicity	decreased	Adverse_Event	Other:C1458155		L02BG04|L02BG06	rs912571:G
antivirals for treatment of hiv infections, combinations	rs964184	APOA5	CG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs964184:CG
antivirals for treatment of hiv infections, combinations	rs964184	APOA5	GG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs964184:GG
valproic acid	rs2307441	POLG	C	Toxicity	increased	Adverse_Event	Healthy		N03AG01	rs2307441:C
cisplatin, cyclophosphamide	rs698	ADH1C	CT	Efficacy	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs698:CT
exemestane, letrozole	rs79048288	CCDC148	T	Toxicity	increased	Adverse_Event	Other:C1458155		L02BG04|L02BG06	rs79048288:T
oxaliplatin	rs1695	GSTP1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1695:GG
atorvastatin, lovastatin, simvastatin	rs35599367	CYP3A4	AA	Dosage, Metabolism/PK	decreased	Other	Healthy		C10AA01|C10AA02|C10AA05	rs35599367:AA
atorvastatin, lovastatin, simvastatin	rs35599367	CYP3A4	AG	Dosage, Metabolism/PK	decreased	Other	Healthy		C10AA01|C10AA02|C10AA05	rs35599367:AG
valproic acid	rs3087374	POLG	A	Toxicity	increased	Adverse_Event	Healthy		N03AG01	rs3087374:A
edoxaban	rs2306283	SLCO1B1	GG	Toxicity	decreased	Adverse_Event	Healthy		B01AF03	rs2306283:GG
edoxaban	rs3842	ABCB1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs3842:CC
hydrochlorothiazide	rs4961	ADD1	TT	Other	increased	Other	Disease:C0020538		C03AA03	rs4961:TT
edoxaban	rs999278	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs999278:AA
edoxaban	rs999278	SLCO1B1	AC	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs999278:AC
levodopa	rs6280	DRD3	TT	Toxicity	increased	Adverse_Event	Disease:C0030567		N04BA02	rs6280:TT
levodopa	rs1799732	DRD2	GG	Toxicity	increased	Adverse_Event	Side_Effect:C0030567		N04BA02	rs1799732:GG
busulfan, cyclophosphamide	rs1021737	CTH	TT	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01|L01AB01	rs1021737:TT
furosemide, spironolactone	rs1799998	CYP11B2	AA	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs1799998:AA
furosemide, spironolactone	rs1799998	CYP11B2	AG	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs1799998:AG
edoxaban	rs4149057	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs4149057:CC
edoxaban	rs4149057	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs4149057:CT
simvastatin	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs2032582:AA
simvastatin	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs2032582:AC
furosemide, spironolactone	rs4341	ACE	CG	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs4341:CG
furosemide, spironolactone	rs4341	ACE	GG	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs4341:GG
simvastatin	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs1045642:AA
atorvastatin	rs2070744	NOS3	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs2070744:CC
atorvastatin	rs2070744	NOS3	CC	Other	increased	Other	Healthy		C10AA05	rs2070744:CC
paroxetine	rs2472304	CYP1A2	A	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB05	rs2472304:A
furosemide, spironolactone	rs4961	ADD1	GT	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs4961:GT
furosemide, spironolactone	rs4961	ADD1	TT	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs4961:TT
paroxetine	rs4646425	CYP1A2	T	Efficacy	decreased	Adverse_Event	Disease:C0011581		N06AB05	rs4646425:T
atorvastatin	rs2032582	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA05	rs2032582:AA
cisplatin, doxorubicin	rs11615	ERCC1	AA	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01|L01XA01	rs11615:AA
methamphetamine	rs4790694	ARRB2	C	Other	increased	Adverse_Event	Healthy		No_ATC	rs4790694:C
methotrexate	rs2231142	ABCG2	GT	Toxicity	decreased	Adverse_Event	Other:C0029463		L04AX03	rs2231142:GT
paroxetine	rs2470890	CYP1A2	T	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB05	rs2470890:T
peginterferon alfa-2a, ribavirin	rs10846744	SCARB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs10846744:GG
platinum compounds, radiotherapy	rs1829346	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA	rs1829346:AA
cisplatin, doxorubicin	rs4673	CYBA	AA	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01|L01XA01	rs4673:AA
cisplatin, doxorubicin	rs4673	CYBA	AG	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01|L01XA01	rs4673:AG
atorvastatin	rs1128503	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA05	rs1128503:AA
clozapine	rs4244285	CYP2C19	AA	Other, Metabolism/PK	increased	LADME	Healthy		N05AH02	rs4244285:AA
atorvastatin	rs1045642	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA05	rs1045642:AA
prasugrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC22	rs4244285:A
irinotecan	rs2306283	SLCO1B1	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs2306283:GG
platinum compounds, radiotherapy	rs2027701	__INTRONIC__	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01XA	rs2027701:AG
platinum compounds, radiotherapy	rs2027701	__INTRONIC__	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01XA	rs2027701:GG
simvastatin	rs1128503	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA01	rs1128503:AA
prasugrel	rs4244285	CYP2C19	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC22	rs4244285:A
antipsychotics	rs363341	SLC18A2	TT	Toxicity	increased	Adverse_Event	Disease:C0033975		N05A	rs363341:TT
platinum compounds, radiotherapy	rs1059698	__INTRONIC__	CC	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01XA	rs1059698:CC
antipsychotics	rs1334802	GRIK3	CT	Toxicity	increased	Adverse_Event	Disease:C0033975		N05A	rs1334802:CT
platinum compounds, radiotherapy	rs73594404	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA	rs73594404:AA
platinum compounds, radiotherapy	rs73594404	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA	rs73594404:AG
paroxetine	rs4646427	CYP1A2	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AB05	rs4646427:TT
methotrexate	rs1979277	SHMT1	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1979277:AG
methotrexate	rs1979277	SHMT1	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1979277:GG
paroxetine	rs762551	CYP1A2	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB05	rs762551:A
antipsychotics	rs9567733	HTR2A	AG	Toxicity	increased	Adverse_Event	Disease:C0033975		N05A	rs9567733:AG
antipsychotics	rs9567733	HTR2A	GG	Toxicity	increased	Adverse_Event	Disease:C0033975		N05A	rs9567733:GG
platinum compounds, radiotherapy	rs36080650	__INTRONIC__	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA	rs36080650:CC
methotrexate	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs1045642:AG
methotrexate	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs1045642:GG
antipsychotics	rs1124491	DRD2	AA	Toxicity	decreased	Adverse_Event	Disease:C0033975		N05A	rs1124491:AA
antipsychotics	rs1124491	DRD2	AG	Toxicity	decreased	Adverse_Event	Disease:C0033975		N05A	rs1124491:AG
platinum compounds, radiotherapy	rs10132552	MEG3	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA	rs10132552:CC
warfarin	rs2108622	CYP4F2	CT	Metabolism/PK	increased	LADME	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Metabolism/PK	increased	LADME	Healthy		B01AA03	rs2108622:TT
mycophenolate mofetil(mycophenolic acid)	rs72551330	UGT1A9	C	Toxicity	Indeterminado	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs72551330:C
methotrexate	rs17222723	ABCC2	AT	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs17222723:AT
methotrexate	rs17222723	ABCC2	TT	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs17222723:TT
methamphetamine	rs2486001	SLC6A9	T	Toxicity, Other	increased	Adverse_Event	Healthy		No_ATC	rs2486001:T
mycophenolate mofetil(mycophenolic acid)	rs72551330	UGT1A9	C	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs72551330:C
antipsychotics, clozapine, olanzapine, risperidone	rs1414334	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A|N05AH02|N05AH03|N05AX08	rs1414334:C
none	rs1805123	KCNH2	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs1805123:T
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:TT
methamphetamine	rs2036657	ARRB2	A	Other	increased	Adverse_Event	Healthy		No_ATC	rs2036657:A
methotrexate	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L04AX03	rs1801133:AG
aspirin	rs1065776	P2RY1	CT	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs1065776:CT
rosuvastatin	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Disease:C1956346		C10AA07	rs4149056:C
none	rs110402	CRHR1	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs110402:AA
nicotine	rs4790694	ARRB2	A	Other	increased	Adverse_Event	Healthy		N07BA01	rs4790694:A
warfarin	rs7900194	CYP2C9	A	Dosage	decreased	Efficacy_Response	Healthy		B01AA03	rs7900194:A
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs1801133:AG
atorvastatin	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:C1956346		C10AA05	rs1045642:A
capecitabine	rs1801133	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1801133:GG
carvedilol	rs1042714	ADRB2	C	Efficacy	increased	Efficacy_Response	Healthy		C07AG02	rs1042714:C
clopidogrel	rs662	PON1	CC	Efficacy	increased	Adverse_Event	Other:C0236036		B01AC04	rs662:CC
clopidogrel	rs662	PON1	CT	Efficacy	increased	Adverse_Event	Other:C0236036		B01AC04	rs662:CT
antidepressants	rs1439050	NTRK2	G	Toxicity	increased	Adverse_Event	Disease:C0011581		N06A	rs1439050:G
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs10929302:AA
bevacizumab	rs1478947	__INTRONIC__	CT	Toxicity	increased	Adverse_Event	Other:C0033578		L01FG01	rs1478947:CT
bevacizumab	rs1478947	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Other:C0033578		L01FG01	rs1478947:TT
aspirin	rs4523	TBXA2R	AA	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs4523:AA
methamphetamine	rs1045280	ARRB2	T	Other	increased	Adverse_Event	Healthy		No_ATC	rs1045280:T
aspirin	rs6065	GP1BA	CC	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs6065:CC
olanzapine	rs7973796	PMCH	G	Other	increased	Adverse_Event	Disease:C0036341		N05AH03	rs7973796:G
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs10929302:AA
warfarin	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:AA
aspirin	rs1800469	TGFB1	AA	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1800469:AA
aspirin	rs1800469	TGFB1	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1800469:AG
warfarin	rs6046	F7	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs6046:AA
warfarin	rs6046	F7	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs6046:AA
carboplatin, cisplatin, docetaxel, gemcitabine, paclitaxel, vinorelbine	rs1801133	MTHFR	AA	Efficacy	increased	Adverse_Event	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA01|L01XA02	rs1801133:AA
aspirin, clopidogrel	rs201441480	KRTAP10-4, TSPEAR	A	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs201441480:A
capecitabine, fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs3918290:CT
methotrexate	rs2236225	MTHFD1	AA	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs2236225:AA
methotrexate	rs2236225	MTHFD1	AG	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs2236225:AG
paclitaxel	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C1458155		L01CD01	rs1128503:AA
methotrexate	rs1801131	MTHFR	GT	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs1801131:GT
methotrexate	rs1801131	MTHFR	TT	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs1801131:TT
atorvastatin	rs2070744	NOS3	CC	Other	decreased	Other	Healthy		C10AA05	rs2070744:CC
warfarin	rs7900194	CYP2C9	A	Metabolism/PK	decreased	LADME	Healthy		B01AA03	rs7900194:A
aspirin, clopidogrel	rs140410716	ECHS1	T	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs140410716:T
cyclophosphamide, epirubicin, fluorouracil	rs12050587	PIGB	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs12050587:G
atorvastatin, fluvastatin, lovastatin, pitavastatin, simvastatin	rs4149035	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA02|C10AA04|C10AA05|C10AA08	rs4149035:CT
atorvastatin, fluvastatin, lovastatin, pitavastatin, simvastatin	rs4149035	SLCO1B1	TT	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA02|C10AA04|C10AA05|C10AA08	rs4149035:TT
aspirin, clopidogrel	rs75750968	AGAP3	A	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs75750968:A
atorvastatin, fluvastatin, lovastatin, pitavastatin, simvastatin	rs11045818	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA02|C10AA04|C10AA05|C10AA08	rs11045818:AA
atorvastatin, fluvastatin, lovastatin, pitavastatin, simvastatin	rs11045818	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA02|C10AA04|C10AA05|C10AA08	rs11045818:AG
gemcitabine	rs11854484	SLC28A2	CC	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01BC05	rs11854484:CC
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC
acetaminophen	rs1927911	TLR4	AA	Toxicity	increased	Adverse_Event	Healthy		N02BE01	rs1927911:AA
acetaminophen	rs1927911	TLR4	AG	Toxicity	increased	Adverse_Event	Healthy		N02BE01	rs1927911:AG
timolol	rs16947	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Disease:Open-angle_glaucoma		S01ED01	rs16947:AA
timolol	rs16947	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Disease:Open-angle_glaucoma		S01ED01	rs16947:AG
cyclophosphamide, epirubicin, fluorouracil	rs11636687	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs11636687:C
gemcitabine	rs1060896	SLC28A2	CC	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01BC05	rs1060896:CC
atorvastatin, fluvastatin, lovastatin, pitavastatin, simvastatin	rs2622629	ABCG2	TT	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA02|C10AA04|C10AA05|C10AA08	rs2622629:TT
pravastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA03	rs4149056:CC
pravastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA03	rs4149056:CT
aspirin, clopidogrel	rs3749187	ZDHHC3	A	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs3749187:A
venlafaxine	rs3892097	CYP2D6	CT	Metabolism/PK	increased	LADME	Disease:C0011581		N06AX16	rs3892097:CT
venlafaxine	rs3892097	CYP2D6	TT	Metabolism/PK	increased	LADME	Disease:C0011581		N06AX16	rs3892097:TT
none	rs5996696	ADORA2A	AC	Other	decreased	Adverse_Event	Healthy		A03DA02	rs5996696:AC
none	rs5996696	ADORA2A	CC	Other	decreased	Adverse_Event	Healthy		A03DA02	rs5996696:CC
none	rs71651683	ADORA2A	CT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs71651683:CT
none	rs12252	IFITM3	GG	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs12252:GG
methotrexate	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:Precursor_T-Cell_Lymphoblastic_Leukemia-Lymphoma|Other:C0029463|Other:C0024299		L04AX03	rs1128503:AG
methotrexate	rs1128503	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:Precursor_T-Cell_Lymphoblastic_Leukemia-Lymphoma|Other:C0029463|Other:C0024299		L04AX03	rs1128503:GG
caffeine	rs762551	CYP1A2	CC	Other	decreased	Adverse_Event	Other:coffee_consumption		N06BC01	rs762551:CC
caffeine	rs2470890	CYP1A2	CC	Other	decreased	Adverse_Event	Other:coffee_consumption		N06BC01	rs2470890:CC
clozapine	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N05AH02	rs1045642:AA
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC
warfarin	rs9934438	VKORC1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9934438:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs1127354	ITPA	CC	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs1127354:CC
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
atorvastatin, simvastatin	rs374113543	SLCO1B1	A	Efficacy	increased	Adverse_Event	Healthy		C10AA01|C10AA05	rs374113543:A
atorvastatin, simvastatin	rs373327528	SLCO1B1	A	Efficacy	increased	Adverse_Event	Healthy		C10AA01|C10AA05	rs373327528:A
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs6051702	DNAAF9	AA	Efficacy	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs6051702:AA
dexamethasone	rs6092	SERPINE1	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		S02BA06	rs6092:AA
dexamethasone	rs6092	SERPINE1	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		S02BA06	rs6092:AG
gemcitabine	rs2072671	CDA	AA	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs2072671:AA
gemcitabine	rs2072671	CDA	AC	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs2072671:AC
nicotine	rs2072661	CHRNB2	GG	Efficacy, Toxicity, Other	increased	Other	Other:smokers		N07BA01	rs2072661:GG
peginterferon alfa-2a, peginterferon alfa-2b	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB10|L03AB11	rs12979860:CC
anthracyclines and related substances	rs7853758	SLC28A3	A	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01DB	rs7853758:A
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, simeprevir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10|L03AB11	rs8099917:TT
clozapine	rs2069514	CYP1A2	A	Other	increased	Adverse_Event	Disease:C0036341		N05AH02	rs2069514:A
cisplatin, doxorubicin, methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1801133:AA
cisplatin, doxorubicin, methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1801133:AG
cisplatin, doxorubicin, methotrexate	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1695:AG
cisplatin, doxorubicin, methotrexate	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1695:GG
everolimus	rs2024627	MTOR	C	Efficacy	decreased	Adverse_Event	Other:C1458155|Other:C0005967|Other:Neuroendocrine_Tumors		L01EG02	rs2024627:C
capecitabine	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01BC06	rs3918290:CT
cisplatin, doxorubicin, methotrexate	rs13181	ERCC2	GG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs13181:GG
cisplatin, doxorubicin, methotrexate	rs13181	ERCC2	GT	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs13181:GT
nicotine	rs324650	CHRM2	T	Toxicity, Other	increased	Adverse_Event	Healthy		N07BA01	rs324650:T
cetuximab, panitumumab	rs712829	EGFR	GT	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs712829:GT
cetuximab, panitumumab	rs712829	EGFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs712829:TT
clozapine	rs35694136	CYP1A2	del	Other	increased	Adverse_Event	Disease:C0036341		N05AH02	rs35694136:del
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
cetuximab, panitumumab	rs9996584	AREG	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs9996584:AA
cetuximab, panitumumab	rs9996584	AREG	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs9996584:AG
bevacizumab, irinotecan	rs1570360	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01CE02|L01FG01	rs1570360:GG
clopidogrel	rs662	PON1	CT	Other	increased	Other	Healthy		B01AC04	rs662:CT
clopidogrel	rs662	PON1	TT	Other	increased	Other	Healthy		B01AC04	rs662:TT
proton pump inhibitors	rs3750425	TRPM6	T	Toxicity	increased	Adverse_Event	Healthy		A02BC	rs3750425:T
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02	rs3918290:CT
none	rs1360780	FKBP5	CC	Efficacy	increased	Adverse_Event	Disease:C0011581		A03DA02	rs1360780:CC
none	rs1360780	FKBP5	CT	Efficacy	increased	Adverse_Event	Disease:C0011581		A03DA02	rs1360780:CT
clozapine, olanzapine, quetiapine, risperidone	rs12836771	HTR2C, MIR1264, MIR1912	GG	Toxicity	increased	Adverse_Event	Disease:C0033975|Disease:C0036341		N05AH02|N05AH03|N05AH04|N05AX08	rs12836771:GG
methotrexate	rs3758149	GGH	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs3758149:AA
halothane, succinylcholine	rs193922803	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01	rs193922803:T
cetuximab, panitumumab	rs11942466	AREG	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		No_ATC	rs11942466:AA
simvastatin	rs1045642	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA01	rs1045642:AA
proton pump inhibitors	rs2274924	TRPM6	C	Toxicity	increased	Adverse_Event	Healthy		A02BC	rs2274924:C
doxorubicin	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01	rs1695:AG
doxorubicin	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01	rs1695:GG
doxorubicin	rs3212986	ERCC1	AA	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01	rs3212986:AA
doxorubicin	rs3212986	ERCC1	AC	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01	rs3212986:AC
clozapine, olanzapine, quetiapine, risperidone	rs518147	HTR2C	CC	Toxicity	increased	Adverse_Event	Disease:C0033975|Disease:C0036341		N05AH02|N05AH03|N05AH04|N05AX08	rs518147:CC
simvastatin	rs2032582	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA01	rs2032582:AA
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs118192172	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs118192172:T
nevirapine	rs2054675	CYP2B6	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs2054675:C
asunaprevir, daclatasvir, direct acting antivirals, ledipasvir / sofosbuvir, ombitasvir / paritaprevir / ritonavir	rs8099917	IFNL3, IFNL4	GG	Toxicity	increased	Adverse_Event	Disease:C0019372		J05A|J05AE03|J05AP07|J05AP08|J05AP51|J05AP53	rs8099917:GG
asunaprevir, daclatasvir, direct acting antivirals, ledipasvir / sofosbuvir, ombitasvir / paritaprevir / ritonavir	rs8099917	IFNL3, IFNL4	GT	Toxicity	increased	Adverse_Event	Disease:C0019372		J05A|J05AE03|J05AP07|J05AP08|J05AP51|J05AP53	rs8099917:GT
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs118192176	RYR1	A	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs118192176:A
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs118192177	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs118192177:T
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs121918593	RYR1	A	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs121918593:A
nevirapine	rs3786547	CYP2B6	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs3786547:C
capecitabine	rs1801160	DPYD	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1801160:CC
capecitabine	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1801160:CT
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs121918592	RYR1	A	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs121918592:A
capecitabine	rs1801159	DPYD	C	Toxicity	increased	Adverse_Event	Other:C1458155		L01BC06	rs1801159:C
methylphenidate	rs6280	DRD3	CT	Toxicity	increased	Adverse_Event	Disease:C1510586		N06BA04	rs6280:CT
methylphenidate	rs6280	DRD3	TT	Toxicity	increased	Adverse_Event	Disease:C1510586		N06BA04	rs6280:TT
cisplatin	rs1872328	ACYP2	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1872328:AA
cisplatin	rs1872328	ACYP2	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1872328:AG
clopidogrel	rs662	PON1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs662:CT
clopidogrel	rs662	PON1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs662:TT
doxorubicin	rs2228001	XPC	GG	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01	rs2228001:GG
doxorubicin	rs2228001	XPC	GT	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01	rs2228001:GT
peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs12979860:CC
heroin	rs9479757	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs9479757:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
naltrexone	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Healthy		N07BB04	rs1799971:AG
naltrexone	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Healthy		N07BB04	rs1799971:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs8099917:TT
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs1125338	FTO	CC	Efficacy	increased	Adverse_Event	Other:C0027651		No_ATC	rs1125338:CC
beta-lactam antibacterials, penicillins	rs71542416	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		J01C|J01D	rs71542416:T
irinotecan	rs425215	ABCG1	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs425215:GG
xelox	rs2271862	ABCA2	AA	Toxicity	decreased	Adverse_Event	Other:C0023055|Other:C2939419		No_ATC	rs2271862:AA
irinotecan	rs562	ABCC5	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs562:CC
opioids	rs6715729	TACR1	AG	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs6715729:AG
opioids	rs6715729	TACR1	GG	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs6715729:GG
opioids	rs4436578	DRD2	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs4436578:CT
opioids	rs4436578	DRD2	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs4436578:TT
opioids	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs776746:CC
opioids	rs776746	CYP3A5	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs776746:CT
irinotecan	rs2306283	SLCO1B1	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs2306283:AG
tramadol	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Healthy		N02AX02	rs1045642:AA
none	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Healthy		A03DA02	rs2032582:CC
none	rs2032582	ABCB1	TT	Efficacy	decreased	Efficacy_Response	Healthy		A03DA02	rs2032582:TT
carboplatin, paclitaxel	rs7311358	SLCO1B3	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CD01|L01XA02	rs7311358:AA
methotrexate	rs10106	FPGS	CC	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs10106:CC
methotrexate	rs10106	FPGS	CT	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs10106:CT
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:T
none	rs11549467	HIF1A	AG	Efficacy	decreased	Efficacy_Response	Healthy		A03DA02	rs11549467:AG
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12596638	FTO	GG	Efficacy	increased	Adverse_Event	Other:C0027651		No_ATC	rs12596638:GG
coumarin, nicotine	rs28399433	CYP2A6	C	Other, Metabolism/PK	decreased	Other	Healthy		N07BA01	rs28399433:C
sunitinib	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:TT
antibiotics	rs11125	LGALS3	AT	Toxicity	increased	Adverse_Event	Disease:C0699744		S01AA	rs11125:AT
antibiotics	rs11125	LGALS3	TT	Toxicity	increased	Adverse_Event	Disease:C0699744		S01AA	rs11125:TT
sunitinib	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:TT
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12600192	__INTRONIC__	CG	Toxicity	increased	Adverse_Event	Other:C0027651		No_ATC	rs12600192:CG
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12600192	__INTRONIC__	GG	Toxicity	increased	Adverse_Event	Other:C0027651		No_ATC	rs12600192:GG
sunitinib	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:TT
none	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs9934438:AA
none	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs9934438:AG
sunitinib	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:TT
methotrexate	rs1650723	DHFR	T	Toxicity	increased	Adverse_Event	Disease:C0029463		L04AX03	rs1650723:T
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12600192	__INTRONIC__	CC	Efficacy	increased	Adverse_Event	Other:C0027651		No_ATC	rs12600192:CC
methotrexate	rs2231135	ABCG2	AG	Toxicity	increased	Adverse_Event	Disease:C0029463		L04AX03	rs2231135:AG
nicotine	rs3852209	HINT1	CC	Other	increased	Adverse_Event	Other:C0039338		N07BA01	rs3852209:CC
methotrexate	rs1051266	SLC19A1	TT	Efficacy	increased	Adverse_Event	Disease:C0029463		L04AX03	rs1051266:TT
none	rs1544410	VDR	CC	Other	decreased	Adverse_Event	Other:C0032961		A03DA02	rs1544410:CC
ethambutol, isoniazid / pyrazinamide / rifampin	rs352139	ALAS1	AA	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs352139:AA
ethambutol, isoniazid / pyrazinamide / rifampin	rs352139	ALAS1	AG	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs352139:AG
risperidone	rs3813034	SLC6A4	AA	Other	increased	Adverse_Event	Disease:C0036341		N05AX08	rs3813034:AA
isoniazid, rifampin	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs1695:AA
cyclophosphamide, doxorubicin	rs3764435	ALDH1A1	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs3764435:A
cyclophosphamide, doxorubicin	rs168351	ALDH1A1	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs168351:A
methotrexate	rs1801133	MTHFR	A	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:A
carboplatin, paclitaxel	rs4149117	SLCO1B3	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CD01|L01XA02	rs4149117:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs117648444	IFNL3, IFNL4	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs117648444:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs117648444	IFNL3, IFNL4	AG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs117648444:AG
ethanol, naltrexone	rs1799971	OPRM1	AG	Efficacy	increased	Adverse_Event	Healthy		N07BB04|V03AB16	rs1799971:AG
ethanol, naltrexone	rs1799971	OPRM1	GG	Efficacy	increased	Adverse_Event	Healthy		N07BB04|V03AB16	rs1799971:GG
isoniazid, rifampin	rs1799929	NAT2	TT	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01	rs1799929:TT
opioids	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs4680:AG
isoniazid, rifampin	rs1799930	NAT2	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01	rs1799930:AA
methotrexate	rs1051266	SLC19A1	CC	Efficacy	increased	Efficacy_Response	Disease:C0029463		L04AX03	rs1051266:CC
methotrexate	rs1053129	DHFR	CC	Toxicity	increased	Adverse_Event	Disease:C0029463		L04AX03	rs1053129:CC
methotrexate	rs1801133	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0029463		L04AX03	rs1801133:GG
tamoxifen	rs118042719	HS6ST3	A	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs118042719:A
phenytoin	rs2229107	ABCB1	A	Other, Metabolism/PK	increased	LADME	Other:C0024198		N03AB02	rs2229107:A
"""3,4-methylenedioxymethamphetamine"", ""cocaine"", ""ethanol"", ""opioids"""	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:AG
trastuzumab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Disease:C1458155		No_ATC	rs396991:CC
mycophenolic acid, tacrolimus	rs717620	ABCC2	C	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AA06|L04AD02	rs717620:C
methadone	rs1038376	CYP2B6	TT	Toxicity	increased	Adverse_Event	"""Other:C0030193|Postoperative""|""Other:C0036439"		N07BC02	rs1038376:TT
trastuzumab	rs1801274	FCGR2A	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		No_ATC	rs1801274:AA
methotrexate	rs1051266	SLC19A1	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1051266:CC
methotrexate	rs1051266	SLC19A1	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1051266:CT
succinylcholine	rs1799807	BCHE	C	Metabolism/PK	Indeterminado	Adverse_Event	Healthy		No_ATC	rs1799807:C
succinylcholine	rs1803274	BCHE	T	Metabolism/PK	Indeterminado	Adverse_Event	Healthy		No_ATC	rs1803274:T
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT
clopidogrel	rs1042192	CYP2C18	A	Efficacy	increased	Efficacy_Response	Other:C0007222		B01AC04	rs1042192:A
clozapine	rs2737385	HNMT	GG	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02	rs2737385:GG
fluorouracil	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs1801160:CT
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Other:C0007222		B01AC04	rs4244285:A
methadone	rs2279343	CYP2B6	AG	Toxicity	increased	Adverse_Event	"""Other:C0030193|Postoperative""|""Other:C0036439"		N07BC02	rs2279343:AG
methadone	rs2279343	CYP2B6	GG	Toxicity	increased	Adverse_Event	"""Other:C0030193|Postoperative""|""Other:C0036439"		N07BC02	rs2279343:GG
clopidogrel	rs12572897	NOC3L	A	Efficacy	increased	Efficacy_Response	Other:C0007222		B01AC04	rs12572897:A
tamoxifen	rs6790761	LPP	A	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs6790761:A
ethambutol, isoniazid / pyrazinamide / rifampin	rs1799929	NAT2	T	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1799929:T
sunitinib	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1128503:AA
sunitinib	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1128503:AG
nicotine	rs16969968	CHRNA5	A	Toxicity, Other	increased	Adverse_Event	Healthy		N07BA01	rs16969968:A
clopidogrel	rs1058932	CYP2C8	A	Efficacy	increased	Efficacy_Response	Other:C0007222		B01AC04	rs1058932:A
sunitinib	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs2032582:AA
sunitinib	rs2032582	ABCB1	AC	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs2032582:AC
nicotine	rs578776	CHRNA3	A	Toxicity, Other	decreased	Adverse_Event	Healthy		N07BA01	rs578776:A
tamoxifen	rs77693286	LPP	A	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs77693286:A
anthracyclines and related substances	rs17863783	UGT1A6	T	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C1261473|Other:C0206624|Other:C0029463|Other:C0024299		L01DB	rs17863783:T
tacrolimus	rs776746	CYP3A5	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
rifampicin	rs10946739	RIPOR2	C	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs10946739:C
anthracyclines and related substances	rs2229774	RARG	A	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C1261473|Other:C0206624|Other:C0029463|Other:C0024299		L01DB	rs2229774:A
none	rs763317	EGFR	AA	Efficacy	increased	Adverse_Event	Other:C0024121		A03DA02	rs763317:AA
none	rs948854	GAL	C	Other	increased	Adverse_Event	Disease:C0003469		A03DA02	rs948854:C
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CT
carbamazepine	rs3869066	ZNRD1-AS1	AG	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs3869066:AG
carbamazepine	rs3869066	ZNRD1-AS1	GG	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs3869066:GG
atazanavir	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		J05AE08	rs2032582:AA
hmg coa reductase inhibitors	rs1337512	EYS	G	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA	rs1337512:G
rifampicin	rs393994	AGBL4	A	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs393994:A
atazanavir	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		J05AE08	rs1045642:AA
phenytoin	rs1799853	CYP2C9	T	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	rs1799853:T
hmg coa reductase inhibitors, other combinations	rs9342288	EYS	A	Toxicity	increased	Adverse_Event	Disease:C0007222		B03AE|C10AA	rs9342288:A
aspirin	rs1047626	SLC30A9	A	Toxicity, Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs1047626:A
escitalopram, nortriptyline	rs962369	BDNF	C	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA10|N06AB10	rs962369:C
ace inhibitors, plain	rs2253201	KCNMA1	G	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs2253201:G
hmg coa reductase inhibitors, other combinations	rs3857532	EYS	A	Toxicity	increased	Adverse_Event	Disease:C0007222		B03AE|C10AA	rs3857532:A
aspirin	rs7862221	TSC1	C	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7862221:C
rifampicin	rs320003	AGBL4	G	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs320003:G
aspirin	rs11819745	THRA	G	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs11819745:G
rifampicin	rs7958375	CUX2	G	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs7958375:G
anthracyclines and related substances	rs7853758	SLC28A3	A	Toxicity	decreased	Adverse_Event	Other:C0023449|Other:C1261473|Other:C0206624|Other:C0029463|Other:C0024299		L01DB	rs7853758:A
hmg coa reductase inhibitors	rs9806699	GATM	A	Toxicity	decreased	Adverse_Event	Disease:C0007222		C10AA	rs9806699:A
hmg coa reductase inhibitors	rs4363657	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA	rs4363657:CC
hmg coa reductase inhibitors	rs4363657	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA	rs4363657:CT
aspirin	rs3818822	CHIA	A	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3818822:A
atazanavir	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		J05AE08	rs1128503:AA
aspirin	rs1074373	__INTRONIC__	C	Toxicity, Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs1074373:C
phenytoin	rs1799853	CYP2C9	T	Toxicity, Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	rs1799853:T
phenytoin	rs1057910	CYP2C9	C	Toxicity, Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	rs1057910:C
heroin	rs1990040	GRM3	A	Other	increased	Adverse_Event	Healthy		No_ATC	rs1990040:A
aspirin	rs3130100	ZBTB22	C	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3130100:C
cyclosporine, sirolimus, tacrolimus	rs7903146	TCF7L2	T	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01|L04AD02	rs7903146:T
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA	rs4149056:CC
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA	rs4149056:CT
phenytoin	rs1057910	CYP2C9	C	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	rs1057910:C
clopidogrel	rs4244285	CYP2C19	AA	Efficacy, Toxicity	increased	Adverse_Event	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy, Toxicity	increased	Adverse_Event	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	rs4244285:AG
aspirin	rs3097671	HLA-DPB1	C	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3097671:C
aspirin	rs3129294	HLA-DPB2	C	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3129294:C
aspirin	rs1042151	HLA-DPB1	G	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1042151:G
aspirin	rs1042136	HLA-DPB1	C	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1042136:C
atorvastatin, simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	rs4149056:CC
atorvastatin, simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	rs4149056:CT
rifampicin	rs10946737	RIPOR2	A	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs10946737:A
prednisolone	rs3824662	GATA3	AA	PD	increased	Adverse_Event	Other:C0023449		S02BA03	rs3824662:AA
rifampicin	rs319952	AGBL4	A	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs319952:A
nicotine	rs10485057	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs10485057:AA
ethanol	rs2533200	DPP6	C	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs2533200:C
cisplatin, cyclophosphamide	rs1051740	EPHX1	CT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1051740:CT
carbamazepine	rs192543598	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs192543598:G
ethanol	rs7900002	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs7900002:T
ethanol	rs2582405	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs2582405:T
cisplatin, cyclophosphamide	rs1801280	NAT2	CT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1801280:CT
ethanol	rs56722963	__INTRONIC__	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs56722963:T
cisplatin, cyclophosphamide	rs3219484	MUTYH	CT	Toxicity	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs3219484:CT
carbamazepine	rs187926838	ALK	G	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs187926838:G
ethanol	rs576859	MED19, TMX2	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs576859:A
methotrexate	rs7563206	ATIC	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs7563206:CC
enzymes	rs669	A2M	TT	Toxicity	increased	Adverse_Event	Disease:C0018839		M09AB	rs669:TT
methotrexate	rs3821353	ATIC	GT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs3821353:GT
methotrexate	rs3821353	ATIC	TT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs3821353:TT
chop, rituximab	rs1883112	NCF4	AA	Efficacy	decreased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1883112:AA
enzymes	rs1801020	F12	GG	Toxicity	increased	Adverse_Event	Disease:C0018839		M09AB	rs1801020:GG
sunitinib	rs1128503	ABCB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs1128503:A
methotrexate	rs2372536	ATIC	CG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2372536:CG
methotrexate	rs2372536	ATIC	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2372536:GG
ethanol	rs6589386	__INTRONIC__	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs6589386:T
ethanol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:AG
ethanol	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:GG
ethanol	rs13125415	ADH1C	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs13125415:A
methotrexate	rs12995526	ATIC	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs12995526:CC
cisplatin, cyclophosphamide	rs11226	RAD52	AG	Toxicity	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs11226:AG
ethanol	rs13135092	SLC39A8	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs13135092:A
cisplatin, cyclophosphamide	rs1052536	LIG3	CC	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1052536:CC
abiraterone, prednisolone	rs3828743	TSPYL1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0033578		L02BX03|S02BA03	rs3828743:AA
opioids	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs4680:AA
opioids	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs4680:AG
cisplatin, fluorouracil, radiotherapy	rs1799782	XRCC1	AA	Efficacy	increased	Adverse_Event	Other:C0007097|Squamous_Cell		L01BC02|L01XA01	rs1799782:AA
cisplatin, fluorouracil, radiotherapy	rs1799782	XRCC1	AG	Efficacy	increased	Adverse_Event	Other:C0007097|Squamous_Cell		L01BC02|L01XA01	rs1799782:AG
indinavir	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Other:HIV		J05AE02	rs4148323:AG
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
ethanol	rs1229984	ADH1B	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1229984:T
methotrexate	rs10760502	FPGS	AA	Efficacy, Toxicity, Other	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs10760502:AA
methotrexate	rs10106	FPGS	TT	Efficacy, Toxicity, Other	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs10106:TT
capecitabine, fluorouracil, tegafur	rs55886062	DPYD	AC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs55886062:AC
capecitabine, fluorouracil, tegafur	rs55886062	DPYD	CC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs55886062:CC
methotrexate	rs10106	FPGS	TT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs10106:TT
ethanol	rs9679319	__INTRONIC__	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs9679319:T
ethanol	rs1402398	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1402398:A
ethanol	rs13382553	THSD7B	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs13382553:A
peginterferon alfa-2a, ribavirin	rs4273729	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4273729:GG
peginterferon alfa-2a, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12980275:AA
methotrexate	rs868755	ABCB1	TT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs868755:TT
ethanol	rs2673136	__INTRONIC__	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs2673136:A
ethanol	rs13129401	__INTRONIC__	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs13129401:A
methotrexate	rs10280623	ABCB1	TT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs10280623:TT
ethanol	rs62250713	CADM2	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs62250713:A
ethanol	rs75967634	ADH1B	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs75967634:T
carboplatin, cyclophosphamide, etoposide, lomustine, methotrexate, vincristine	rs1139130	METTL3	AA	Toxicity	increased	Adverse_Event	Other:C0017636|Other:C0017636|Other:C0004114|Other:C0006118		L01AA01|L01AD02|L01CA02|L01CB01|L01XA02|L04AX03	rs1139130:AA
carboplatin, cyclophosphamide, etoposide, lomustine, methotrexate, vincristine	rs1139130	METTL3	AG	Toxicity	increased	Adverse_Event	Other:C0017636|Other:C0017636|Other:C0004114|Other:C0006118		L01AA01|L01AD02|L01CA02|L01CB01|L01XA02|L04AX03	rs1139130:AG
heroin	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:AG
heroin	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4273729	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs4273729:GG
none	rs56113850	CYP2A6	T	Other	decreased	Adverse_Event	Other:C0039338		A03DA02	rs56113850:T
ethanol	rs6421482	PDE4B	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs6421482:A
ethanol	rs61767420	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs61767420:A
ethanol	rs1260326	GCKR	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1260326:T
ethanol	rs494904	__INTRONIC__	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs494904:T
none	rs503464	CHRNA5	AA	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs503464:AA
none	rs503464	CHRNA5	AT	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs503464:AT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Healthy		J05AP01|L03AB10|L03AB11	rs12979860:CC
methotrexate	rs72783407	SPATA9	A	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs72783407:A
methotrexate	rs9904341	BIRC5	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs9904341:GG
protein kinase inhibitors	rs324011	STAT6	TT	Toxicity	increased	Adverse_Event	Other:C0007131		L01E	rs324011:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Healthy		J05AP01|L03AB10|L03AB11	rs8099917:TT
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT
fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:TT
capecitabine, fluorouracil, tegafur	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs3918290:CT
capecitabine, fluorouracil, tegafur	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs3918290:TT
opioids	rs1800497	ANKK1, DRD2	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1800497:AA
opioids	rs1800497	ANKK1, DRD2	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1800497:AG
tamoxifen	rs114557570	C1QTNF6	C	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs114557570:C
none	rs637137	CHRNA5	AA	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs637137:AA
none	rs637137	CHRNA5	AT	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs637137:AT
docetaxel	rs833061	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02	rs833061:CC
docetaxel	rs13207351	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02	rs13207351:GG
docetaxel	rs35864111	VEGFA	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02	rs35864111:GG
asparaginase, cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, leucovorin, mercaptopurine, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs3824662	GATA3	A	Efficacy	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX02|L01XX24|L04AX03|S02BA06	rs3824662:A
asparaginase, cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, leucovorin, mercaptopurine, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs3824662	GATA3	A	Efficacy	increased	Efficacy_Response	Disease:C0023449		H02AB07|L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX02|L01XX24|L04AX03|S02BA06	rs3824662:A
docetaxel	rs699947	VEGFA	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02	rs699947:AA
exemestane	rs62293499	__INTRONIC__	C	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BG06	rs62293499:C
aspirin, clopidogrel	rs2108622	CYP4F2	CT	Other	increased	Other	Disease:C0027051		B01AC04	rs2108622:CT
fluorouracil	rs4294451	DPYD	AT	Efficacy	decreased	Adverse_Event	Healthy		L01BC02	rs4294451:AT
fluorouracil	rs4294451	DPYD	TT	Efficacy	decreased	Adverse_Event	Healthy		L01BC02	rs4294451:TT
citalopram	rs17135437	COL26A1	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	rs17135437:T
citalopram	rs16965962	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	rs16965962:A
allopurinol	rs9263726	PSORS1C1, PSORS1C2	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263726:A
aspirin	rs4292	ACE	CC	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs4292:CC
aspirin	rs4292	ACE	CT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs4292:CT
clopidogrel	rs6809699	P2RY12	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		B01AC04	rs6809699:AA
anthracyclines and related substances	rs4982753	SLC22A17	T	Toxicity	decreased	Adverse_Event	Other:C0019829|Other:C1261473		L01DB	rs4982753:T
tacrolimus	rs776746	CYP3A5	T	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs776746:T
fluorouracil	rs4294451	DPYD	AT	Toxicity	decreased	Adverse_Event	Healthy		L01BC02	rs4294451:AT
fluorouracil	rs4294451	DPYD	TT	Toxicity	decreased	Adverse_Event	Healthy		L01BC02	rs4294451:TT
none	rs2074192	ACE2	T	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs2074192:T
clopidogrel	rs6809699	P2RY12	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs6809699:AA
aspirin, clopidogrel	rs168753	F2R	T	Efficacy	decreased	Efficacy_Response	Other:C0007787|Other:C0018839		B01AC04	rs168753:T
clopidogrel	rs6809699	P2RY12	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs6809699:AA
aspirin	rs1065776	P2RY1	CT	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs1065776:CT
mercaptopurine	rs1127354	ITPA	AC	Metabolism/PK	increased	LADME	Disease:C0023449		L01BB02	rs1127354:AC
none	rs1219648	FGFR2	G	Toxicity, Other	increased	Adverse_Event	Disease:C0019829		A03DA02	rs1219648:G
anastrozole	rs6735923	__INTRONIC__	T	Efficacy	increased	Adverse_Event	Other:C1458155		L02BG03	rs6735923:T
acenocoumarol	rs1799853	CYP2C9	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs1799853:CT
acenocoumarol	rs1799853	CYP2C9	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs1799853:TT
aspirin, clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Other:C0007787|Other:C0018839		B01AC04	rs4244285:A
anthracyclines and related substances	rs7319981	SLC10A2	A	Toxicity	increased	Adverse_Event	Other:C0019829|Other:C1261473		L01DB	rs7319981:A
none	rs699	AGT	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs699:AG
anastrozole	rs1877193	__INTRONIC__	C	Efficacy	increased	Adverse_Event	Other:C1458155		L02BG03	rs1877193:C
capecitabine	rs2786783	DPYD	A	Toxicity	increased	Adverse_Event	Healthy		L01BC06	rs2786783:A
none	rs4818	COMT	CC	Other	increased	Adverse_Event	Other:C0011334|Other:C0040435|Other:C0040460		A03DA02	rs4818:CC
none	rs4818	COMT	CG	Other	increased	Adverse_Event	Other:C0011334|Other:C0040435|Other:C0040460		A03DA02	rs4818:CG
drugs for treatment of tuberculosis	rs7662029	UGT2B7	G	Toxicity	increased	Adverse_Event	Healthy		J04A	rs7662029:G
drugs for treatment of tuberculosis	rs7439366	UGT2B7	C	Toxicity	increased	Adverse_Event	Healthy		J04A	rs7439366:C
clopidogrel	rs4244285	CYP2C19	AA	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:AG
cefaclor	rs62242178	LIMD1	C	Toxicity	increased	Adverse_Event	Healthy		J01DC04	rs62242178:C
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:TT
cefaclor	rs62242177	LIMD1	G	Toxicity	increased	Adverse_Event	Healthy		J01DC04	rs62242177:G
repaglinide	rs4149056	SLCO1B1	CC	Other, Metabolism/PK	increased	LADME	Healthy		A10BX02	rs4149056:CC
dihydropyridine derivatives	rs1048101	ADRA1A	AG	Efficacy	decreased	Adverse_Event	Healthy		C08CA	rs1048101:AG
dihydropyridine derivatives	rs1048101	ADRA1A	GG	Efficacy	decreased	Adverse_Event	Healthy		C08CA	rs1048101:GG
thalidomide	rs1051685	XRCC5	AG	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02	rs1051685:AG
thalidomide	rs735482	ERCC1	AC	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02	rs735482:AC
thalidomide	rs735482	ERCC1	CC	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02	rs735482:CC
clozapine, olanzapine	rs13429709	GCG	C	Other	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03	rs13429709:C
clozapine, olanzapine	rs2268639	GLP1R	T	Other	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03	rs2268639:T
nicotine	rs1799971	OPRM1	AA	Dosage	increased	Other	Healthy		N07BA01	rs1799971:AA
nicotine	rs1799971	OPRM1	AG	Dosage	increased	Other	Healthy		N07BA01	rs1799971:AG
nicotine	rs1799971	OPRM1	AG	Dosage	increased	Other	Healthy		N07BA01	rs1799971:AG
nicotine	rs1799971	OPRM1	GG	Dosage	increased	Other	Healthy		N07BA01	rs1799971:GG
tolcapone	rs4680	COMT	AA	Efficacy	increased	Adverse_Event	Other:C0221016		N04BX01	rs4680:AA
nicotine	rs112561475	UGT2B10	AG	Metabolism/PK	increased	LADME	Healthy		N07BA01	rs112561475:AG
nicotine	rs112561475	UGT2B10	GG	Metabolism/PK	increased	LADME	Healthy		N07BA01	rs112561475:GG
nicotine	rs61750900	UGT2B10	T	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs61750900:T
clozapine, olanzapine	rs13429709	GCG	CC	Other	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03	rs13429709:CC
dihydropyridine derivatives	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Healthy		C08CA	rs776746:TT
methamphetamine	rs878567	HTR1A	A	Toxicity, Other	Indeterminado	Adverse_Event	Disease:C0036502		No_ATC	rs878567:A
methotrexate	rs1801133	MTHFR	A	Toxicity	increased	Adverse_Event	Other:C0024299|Other:C0029463|Other:C0023449		L04AX03	rs1801133:A
cisplatin, fluorouracil, mitoxantrone	rs9679162	GALNT14	TT	Efficacy	increased	Adverse_Event	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs9679162:TT
captopril	rs4291	ACE	AA	Efficacy	decreased	Adverse_Event	Disease:C0002395		C09AA01	rs4291:AA
antiepileptics	rs4471527	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		N03A	rs4471527:T
antipsychotics	rs1137101	LEPR	G	Other	increased	Adverse_Event	Healthy		N05A	rs1137101:G
anthracyclines and related substances	rs2232228	HAS3	A	Toxicity	decreased	Adverse_Event	Other:C0019829|Other:C1261473		L01DB	rs2232228:A
ethanol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:AG
ethanol	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:GG
antiepileptics	rs77542827	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		N03A	rs77542827:T
stavudine	rs8124728	SAMHD1	A	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AF04	rs8124728:A
carvedilol	rs1801253	ADRB1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0085605		C07AG02	rs1801253:CC
irinotecan	rs1800469	TGFB1	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs1800469:AG
irinotecan	rs1800469	TGFB1	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs1800469:GG
anthracyclines and related substances	rs2229774	RARG	A	Toxicity	increased	Adverse_Event	Other:C0019829|Other:C1261473		L01DB	rs2229774:A
cytarabine, daunorubicin, mitoxantrone	rs4643786	DCK	CT	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB02|L01DB07	rs4643786:CT
antiepileptics	rs199755581	NIPAL2	A	Toxicity	increased	Adverse_Event	Healthy		N03A	rs199755581:A
oxaliplatin, paclitaxel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055		L01CD01|L01XA03	rs1045642:AA
oxaliplatin, paclitaxel	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055		L01CD01|L01XA03	rs1045642:AG
amlodipine, chlorthalidone, lisinopril	rs4291	ACE	AA	Other	decreased	Adverse_Event	Disease:C0020538		C03BA04|C08CA01|C09AA03	rs4291:AA
amlodipine, chlorthalidone, lisinopril	rs4291	ACE	AT	Other	decreased	Adverse_Event	Disease:C0020538		C03BA04|C08CA01|C09AA03	rs4291:AT
sorafenib	rs1870377	KDR	T	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs1870377:T
irinotecan	rs3087465	TGFBR2	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs3087465:GG
sorafenib	rs1870377	KDR	T	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs1870377:T
sunitinib	rs307826	FLT4	CT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007134		L01EX01	rs307826:CT
sunitinib	rs776746	CYP3A5	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs776746:TT
ritodrine	rs17128809	PDE4B	AA	Toxicity	increased	Adverse_Event	Healthy		G02CA01	rs17128809:AA
cyclophosphamide, docetaxel, epirubicin	rs246221	ABCC1	CC	Toxicity	increased	Adverse_Event	Other:C1458155		L01AA01|L01CD02|L01DB03	rs246221:CC
sunitinib	rs307821	FLT4	AC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs307821:AC
beta blocking agents	rs1042713	ADRB2	AG	Efficacy	increased	Adverse_Event	Other:C0085605		S01ED	rs1042713:AG
beta blocking agents	rs1042713	ADRB2	GG	Efficacy	increased	Adverse_Event	Other:C0085605		S01ED	rs1042713:GG
salbutamol	rs9552679	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs9552679:C
salbutamol	rs6988229	COL22A1	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs6988229:T
salbutamol	rs17495520	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs17495520:T
aspirin, clopidogrel	rs72819363	CDH15	C	Efficacy	increased	Adverse_Event	Other:C0010068		B01AC04	rs72819363:C
antiepileptics	rs77491650	DDX12P	C	Toxicity	decreased	Adverse_Event	Healthy		N03A	rs77491650:C
salbutamol	rs1663332	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs1663332:T
salbutamol	rs1663330	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs1663330:G
salbutamol	rs17701271	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs17701271:A
salbutamol	rs518350	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs518350:T
salbutamol	rs10511905	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs10511905:G
sorafenib	rs717620	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX02	rs717620:CC
salbutamol	rs1522113	CLOCK	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs1522113:A
salbutamol	rs1423515	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs1423515:A
salbutamol	rs1419555	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs1419555:T
salbutamol	rs6002674	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs6002674:C
none	rs2106809	ACE2	A	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs2106809:A
doxorubicin	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs1695:AG
doxorubicin	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs1695:GG
methotrexate	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Other:C0024299|Other:C0029463|Other:C0023449		L04AX03	rs1045642:A
aspirin, clopidogrel	rs11859453	CDH13	AA	Efficacy	decreased	Adverse_Event	Other:C0010068		B01AC04	rs11859453:AA
aspirin, clopidogrel	rs11859453	CDH13	AG	Efficacy	decreased	Adverse_Event	Other:C0010068		B01AC04	rs11859453:AG
allopurinol	rs3099844	CYCSP5	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:A
allopurinol	rs1634776	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs1634776:T
paclitaxel	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055		L01CD01	rs1128503:AA
paclitaxel	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055		L01CD01	rs1128503:AG
salbutamol	rs11252394	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs11252394:A
sorafenib	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs4149056:CT
sorafenib	rs4149056	SLCO1B1	TT	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs4149056:TT
cocaine	rs11503014	GABRA2	G	Toxicity	increased	Adverse_Event	Healthy		N01BC01	rs11503014:G
cocaine	rs2236256	OPRM1	C	Toxicity	decreased	Adverse_Event	Healthy		N01BC01	rs2236256:C
sorafenib	rs2306283	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs2306283:AG
sorafenib	rs2306283	SLCO1B1	GG	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs2306283:GG
sorafenib	rs2306283	SLCO1B1	AG	Toxicity	decreased	Adverse_Event	Healthy		L01EX02	rs2306283:AG
sorafenib	rs2306283	SLCO1B1	GG	Toxicity	decreased	Adverse_Event	Healthy		L01EX02	rs2306283:GG
methotrexate	rs1128503	ABCB1	A	Toxicity	increased	Adverse_Event	Other:C0024299|Other:C0029463|Other:C0023449		L04AX03	rs1128503:A
none	rs699	AGT	A	Other	decreased	Adverse_Event	Other:COVID-19		A03DA02	rs699:A
cangrelor	rs9859552	P2RY12	TT	Other	Indeterminado	Other	Healthy		B01AC25	rs9859552:TT
sorafenib	rs2070744	NOS3	TT	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2070744:TT
radiotherapy	rs10497203	TANC1	C	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs10497203:C
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:T
sorafenib	rs1799983	NOS3	GG	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs1799983:GG
sorafenib	rs1799983	NOS3	GG	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs1799983:GG
glucocorticoids	rs37973	GLCCI1	GG	Efficacy	increased	Adverse_Event	Disease:C0004096		R03BA	rs37973:GG
fluorouracil, irinotecan, leucovorin	rs7699188	ABCG2	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02	rs7699188:A
sorafenib	rs2070744	NOS3	TT	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2070744:TT
azathioprine	rs116855232	NUDT15	T	Toxicity	decreased	Adverse_Event	Disease:C0023530		L04AX01	rs116855232:T
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3087243	CTLA4	AG	Toxicity	decreased	Adverse_Event	Disease:C0235763		No_ATC	rs3087243:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3087243	CTLA4	GG	Toxicity	decreased	Adverse_Event	Disease:C0235763		No_ATC	rs3087243:GG
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Other	Healthy		B01AA03	rs8050894:G
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0010346		L01BB02|L04AX01	rs116855232:T
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10782001	FBXL19	GG	Toxicity	increased	Adverse_Event	Disease:C0235763		No_ATC	rs10782001:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11209026	IL23R	AG	Toxicity	increased	Adverse_Event	Disease:C0235763		No_ATC	rs11209026:AG
azathioprine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0010346		L04AX01	rs116855232:TT
methotrexate	rs1801133	MTHFR	A	Metabolism/PK	increased	Adverse_Event	Disease:C0023418		L04AX03	rs1801133:A
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Other	Healthy		B01AA03	rs8050894:G
ethanol	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:G
morphine	rs2032582	ABCB1	CC	Toxicity	decreased	Adverse_Event	Disease:C0030193|Postoperative		N02AA01	rs2032582:CC
colistimethate	rs2257212	SLC15A2	T	Toxicity	increased	Adverse_Event	Other:C0004623		No_ATC	rs2257212:T
heroin	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:G
asparaginase, daunorubicin, methotrexate, prednisolone, vincristine	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02|L01DB02|L01XX02|L04AX03|S02BA03	rs1801133:AA
asparaginase, daunorubicin, methotrexate, prednisolone, vincristine	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02|L01DB02|L01XX02|L04AX03|S02BA03	rs1801133:AG
asparaginase, daunorubicin, methotrexate, prednisolone, vincristine	rs1801131	MTHFR	GT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02|L01DB02|L01XX02|L04AX03|S02BA03	rs1801131:GT
asparaginase, daunorubicin, methotrexate, prednisolone, vincristine	rs1801131	MTHFR	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02|L01DB02|L01XX02|L04AX03|S02BA03	rs1801131:TT
warfarin	rs699664	GGCX	CT	Dosage	decreased	Other	Healthy		B01AA03	rs699664:CT
warfarin	rs699664	GGCX	TT	Dosage	decreased	Other	Healthy		B01AA03	rs699664:TT
cetuximab	rs396991	FCGR3A	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs396991:A
warfarin	rs28371685	CYP2C9	CT	Dosage	decreased	Other	Healthy		B01AA03	rs28371685:CT
cetuximab	rs9344	CCND1	G	Efficacy	decreased	Efficacy_Response	Disease:C0023055		No_ATC	rs9344:G
warfarin	rs510335	F7	GT	Dosage	decreased	Other	Healthy		B01AA03	rs510335:GT
warfarin	rs510335	F7	TT	Dosage	decreased	Other	Healthy		B01AA03	rs510335:TT
tacrolimus	rs1800871	IL10	AA	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs1800871:AA
escitalopram	rs11568817	HTR1B	AC	Toxicity	increased	Adverse_Event	Disease:C0003469		N06AB10	rs11568817:AC
escitalopram	rs11568817	HTR1B	CC	Toxicity	increased	Adverse_Event	Disease:C0003469		N06AB10	rs11568817:CC
cetuximab	rs9344	CCND1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		No_ATC	rs9344:AA
methotrexate	rs1051266	SLC19A1	TT	Toxicity	decreased	Adverse_Event	Other:C0003873		L04AX03	rs1051266:TT
fluvoxamine, milnacipran, paroxetine	rs1160351	MDGA2	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB05|N06AB08|N06AX17	rs1160351:A
"""antivirals for treatment of hiv infections, combinations"", ""ritonavir"""	rs429358	APOC1, APOE, TOMM40	CC	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AP|S02DA30	rs429358:CC
"""antivirals for treatment of hiv infections, combinations"", ""ritonavir"""	rs429358	APOC1, APOE, TOMM40	CT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AP|S02DA30	rs429358:CT
escitalopram	rs6311	HTR2A	CT	Toxicity	increased	Adverse_Event	Disease:C0003469		N06AB10	rs6311:CT
escitalopram	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Disease:C0003469		N06AB10	rs6311:TT
tacrolimus	rs1800872	IL10	TT	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs1800872:TT
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:AG
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:GG
levodopa	rs4704559	HOMER1	AG	Toxicity	decreased	Adverse_Event	Disease:C0030567		N04BA02	rs4704559:AG
levodopa	rs4704559	HOMER1	GG	Toxicity	decreased	Adverse_Event	Disease:C0030567		N04BA02	rs4704559:GG
cyclophosphamide, docetaxel, epirubicin	rs4880	SOD2	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01AA01|L01CD02|L01DB03	rs4880:AG
cyclophosphamide, docetaxel, epirubicin	rs4880	SOD2	GG	Toxicity	increased	Adverse_Event	Other:C1458155		L01AA01|L01CD02|L01DB03	rs4880:GG
levodopa	rs4704559	HOMER1	AG	Toxicity	decreased	Adverse_Event	Disease:C0030567		N04BA02	rs4704559:AG
levodopa	rs4704559	HOMER1	GG	Toxicity	decreased	Adverse_Event	Disease:C0030567		N04BA02	rs4704559:GG
estradiol	rs6721961	NFE2L2	T	Toxicity	increased	Adverse_Event	Healthy		G03CA03	rs6721961:T
hydrochlorothiazide	rs7297610	YEATS4	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs7297610:CC
capecitabine	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs3918290:CT
warfarin	rs5896	F2	CT	Dosage	decreased	Other	Healthy		B01AA03	rs5896:CT
warfarin	rs5896	F2	TT	Dosage	decreased	Other	Healthy		B01AA03	rs5896:TT
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	Other:C0024299		L01CA02	rs924607:TT
cisplatin, paclitaxel	rs1042522	TP53	CG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01CD01|L01XA01	rs1042522:CG
cisplatin, paclitaxel	rs1042522	TP53	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01CD01|L01XA01	rs1042522:GG
azathioprine	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs1127354:AC
clopidogrel	rs71647871	CES1	CT	PD	increased	Adverse_Event	Healthy		B01AC04	rs71647871:CT
none	rs1800797	IL6	AG	Other	increased	Adverse_Event	Other:C0027651		A03DA02	rs1800797:AG
none	rs1800797	IL6	GG	Other	increased	Adverse_Event	Other:C0027651		A03DA02	rs1800797:GG
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:A
ethanol	rs1229984	ADH1B	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1229984:T
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:AG
none	rs10965219	CDKN2B-AS1	G	Other	increased	Other	Healthy		A03DA02	rs10965219:G
morphine	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Healthy		N02AA01	rs4680:AA
ethanol	rs61826952	RABGAP1L	G	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs61826952:G
morphine	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Healthy		N02AA01	rs4680:AA
none	rs10965219	CDKN2B-AS1	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs10965219:G
tramadol	rs1058172	CYP2D6	CC	Toxicity	increased	Adverse_Event	Other:C0277589		N02AX02	rs1058172:CC
clozapine	rs16947	CYP2D6	GG	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs16947:GG
tramadol	rs4803419	CYP2B6	CC	Toxicity	increased	Adverse_Event	Other:C0277589		N02AX02	rs4803419:CC
none	rs4240157	ACE2	CC	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs4240157:CC
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
none	rs4240157	ACE2	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs4240157:C
clozapine	rs1065852	CYP2D6	AA	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs1065852:AA
clozapine	rs1065852	CYP2D6	AA	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs1065852:AA
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1051266:TT
clozapine	rs16947	CYP2D6	GG	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs16947:GG
hmg coa reductase inhibitors	rs10849757	COQ5	AA	Efficacy	increased	Adverse_Event	Other:C0018839		C10AA	rs10849757:AA
hmg coa reductase inhibitors	rs10849757	COQ5	AG	Efficacy	increased	Adverse_Event	Other:C0018839		C10AA	rs10849757:AG
azathioprine	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs1127354:AC
zoledronic acid	rs2297480	FDPS	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		M05BA08	rs2297480:TT
hmg coa reductase inhibitors	rs11548336	COQ3	TT	Efficacy	increased	Adverse_Event	Other:C0018839		C10AA	rs11548336:TT
imatinib	rs3745274	CYP2B6	GG	Toxicity	increased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs3745274:GG
hmg coa reductase inhibitors	rs4693075	COQ2	CG	Efficacy	increased	Adverse_Event	Other:C0018839		C10AA	rs4693075:CG
hmg coa reductase inhibitors	rs4693075	COQ2	GG	Efficacy	increased	Adverse_Event	Other:C0018839		C10AA	rs4693075:GG
cyclophosphamide, doxorubicin	rs2032582	ABCB1	CT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs2032582:CT
cyclophosphamide, doxorubicin	rs2032582	ABCB1	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs2032582:TT
cyclophosphamide, doxorubicin	rs3211371	CYP2B6	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs3211371:T
atorvastatin, pravastatin, simvastatin	rs8014194	CLMN	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA01|C10AA03|C10AA05	rs8014194:A
cyclophosphamide, doxorubicin	rs12721655	CYP2B6	AG	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs12721655:AG
nintedanib	rs2076295	DSP	TT	Efficacy	decreased	Efficacy_Response	Other:C0034069		L01EX09	rs2076295:TT
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:TT
cyclophosphamide, doxorubicin	rs8192709	CYP2B6	CT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs8192709:CT
fluorouracil, leucovorin	rs1801133	MTHFR	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02	rs1801133:GG
warfarin	rs5896	F2	CT	Dosage	decreased	Other	Healthy		B01AA03	rs5896:CT
warfarin	rs5896	F2	TT	Dosage	decreased	Other	Healthy		B01AA03	rs5896:TT
busulfan	rs12248560	CYP2C19	CC	Metabolism/PK	increased	LADME	Disease:hemopoietic_stem_cell_transplant		L01AB01	rs12248560:CC
capecitabine	rs1801131	MTHFR	TT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs1801131:TT
warfarin	rs510317	F7	GG	Dosage	decreased	Other	Healthy		B01AA03	rs510317:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1135216	TAP1	CT	Toxicity	decreased	Adverse_Event	Disease:C0235763		No_ATC	rs1135216:CT
olanzapine, quetiapine, risperidone	rs1800497	ANKK1	AA	Toxicity	increased	Adverse_Event	Healthy		N05AH03|N05AH04|N05AX08	rs1800497:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs651630	SLC12A8	AA	Toxicity	decreased	Adverse_Event	Disease:C0235763		No_ATC	rs651630:AA
radiotherapy	rs264588	TANC1	A	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs264588:A
efavirenz	rs3745274	CYP2B6	TT	Toxicity, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
radiotherapy	rs264631	TANC1	G	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs264631:G
busulfan	rs1799853	CYP2C9	CT	Metabolism/PK	increased	LADME	Disease:hemopoietic_stem_cell_transplant		L01AB01	rs1799853:CT
busulfan	rs1799853	CYP2C9	TT	Metabolism/PK	increased	LADME	Disease:hemopoietic_stem_cell_transplant		L01AB01	rs1799853:TT
cyclophosphamide, doxorubicin	rs714368	SLC22A16	C	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs714368:C
radiotherapy	rs7582141	TANC1	T	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs7582141:T
fluorouracil, irinotecan, leucovorin	rs7699188	ABCG2	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs7699188:A
radiotherapy	rs6432512	TANC1	T	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs6432512:T
radiotherapy	rs264663	TANC1	T	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs264663:T
fluorouracil, irinotecan, leucovorin	rs2032582	ABCB1	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02	rs2032582:CC
radiotherapy	rs264651	TANC1	G	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs264651:G
cyclophosphamide, doxorubicin	rs3745274	CYP2B6	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs3745274:T
cyclophosphamide, doxorubicin	rs8192709	CYP2B6	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs8192709:T
platinum compounds	rs2228000	XPC	AA	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA	rs2228000:AA
platinum compounds	rs2228000	XPC	AG	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA	rs2228000:AG
secukinumab	rs2248374	ERAP2	GG	Efficacy	increased	Adverse_Event	Other:C0235763		L04AC10	rs2248374:GG
cyclophosphamide, doxorubicin	rs12210538	SLC22A16	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs12210538:G
cyclophosphamide, doxorubicin	rs723685	SLC22A16	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs723685:G
cyclophosphamide, doxorubicin	rs6907567	SLC22A16	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs6907567:G
aspirin	rs730012	LTC4S	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs730012:C
atorvastatin, rosuvastatin	rs4693075	COQ2	G	Toxicity	increased	Adverse_Event	Disease:C0342882		C10AA05|C10AA07	rs4693075:G
atezolizumab, avelumab, durvalumab, ipilimumab, nivolumab, pembrolizumab	rs35719165	SEMA5A	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs35719165:A
methotrexate	rs2236225	MTHFD1	AA	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs2236225:AA
methotrexate	rs2236225	MTHFD1	AG	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs2236225:AG
warfarin	rs2884737	VKORC1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs2884737:CC
efavirenz, nelfinavir	rs1045642	ABCB1	AA	Efficacy, Other	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AE04|J05AG03	rs1045642:AA
efavirenz	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs1045642:AA
atezolizumab, avelumab, durvalumab, ipilimumab, nivolumab, pembrolizumab	rs1862167	EDIL3	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1862167:T
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
doxorubicin	rs17222723	ABCC2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0024299		L01DB01	rs17222723:A
amitriptyline, citalopram, paroxetine, venlafaxine	rs2032583	ABCB1	AG	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs2032583:AG
amitriptyline, citalopram, paroxetine, venlafaxine	rs2032583	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs2032583:GG
azathioprine	rs2295475	XDH	AA	Toxicity	increased	Adverse_Event	Other:C0021390|Other:C0024141|Other:C0030353		L04AX01	rs2295475:AA
azathioprine	rs2295475	XDH	AG	Toxicity	increased	Adverse_Event	Other:C0021390|Other:C0024141|Other:C0030353		L04AX01	rs2295475:AG
azathioprine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0021390|Other:C0024141|Other:C0030353		L04AX01	rs116855232:CT
azathioprine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Other:C0021390|Other:C0024141|Other:C0030353		L04AX01	rs116855232:TT
none	rs10421558	ATP8B3	G	Toxicity	decreased	Adverse_Event	Other:C0004096		A03DA02	rs10421558:G
none	rs1045642	ABCB1	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs1045642:AA
isoniazid, pyrazinamide, rifampin	rs1799929	NAT2	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	rs1799929:T
isoniazid, pyrazinamide, rifampin	rs1799930	NAT2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	rs1799930:A
anthracyclines and related substances, doxorubicin, epirubicin	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01DB|L01DB01|L01DB03	rs1045642:GG
ritonavir	rs2854117	APOC3	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03	rs2854117:T
none	rs5186	AGTR1	CC	Other	increased	Adverse_Event	Disease:C1956346		A03DA02	rs5186:CC
imatinib	rs10821936	ARID5B	TT	Efficacy	increased	Adverse_Event	Other:C0023473|BCR-ABL1_positive		L01EA01	rs10821936:TT
isoniazid, pyrazinamide, rifampin	rs1041983	NAT2	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	rs1041983:T
isoniazid, pyrazinamide, rifampin	rs1801280	NAT2	C	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	rs1801280:C
fexofenadine	rs1045642	ABCB1	AA	Dosage, Metabolism/PK	decreased	LADME	Healthy		R06AX26	rs1045642:AA
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C
efavirenz	rs4803419	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs4803419:T
imatinib	rs2372536	ATIC	G	Efficacy	increased	Adverse_Event	Other:C0023473|BCR-ABL1_positive		L01EA01	rs2372536:G
atorvastatin, simvastatin	rs2740574	CYP3A4	CC	Other	decreased	Adverse_Event	Healthy		C10AA01|C10AA05	rs2740574:CC
atorvastatin, simvastatin	rs2740574	CYP3A4	CT	Other	decreased	Adverse_Event	Healthy		C10AA01|C10AA05	rs2740574:CT
fexofenadine	rs2032582	ABCB1	AA	Dosage, Metabolism/PK	decreased	LADME	Healthy		R06AX26	rs2032582:AA
ritodrine	rs7625907	KCNMB2	GG	Toxicity	decreased	Adverse_Event	Healthy		G02CA01	rs7625907:GG
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
doxorubicin	rs45511401	ABCC1	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0024299		L01DB01	rs45511401:T
doxorubicin	rs8187710	ABCC2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0024299		L01DB01	rs8187710:A
capecitabine, folfox, tegafur	rs4939827	SMAD7	CC	Efficacy	decreased	Efficacy_Response	Other:C0023055		L01BC03|L01BC06	rs4939827:CC
doxorubicin	rs1883112	NCF4	AA	Toxicity	increased	Adverse_Event	Disease:C0024299		L01DB01	rs1883112:AA
none	rs10403288	ATP8B3	A	Toxicity	decreased	Adverse_Event	Other:C0004096		A03DA02	rs10403288:A
simvastatin	rs1128503	ABCB1	A	Efficacy	decreased	Adverse_Event	Disease:C0020443		C10AA01	rs1128503:A
none	rs2074192	ACE2	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs2074192:T
doxorubicin	rs4673	CYBA	A	Toxicity	increased	Adverse_Event	Disease:C0024299		L01DB01	rs4673:A
simvastatin	rs1045642	ABCB1	A	Efficacy	decreased	Adverse_Event	Disease:C0020443		C10AA01	rs1045642:A
doxorubicin	rs13058338	RAC2	T	Toxicity	increased	Adverse_Event	Disease:C0024299		L01DB01	rs13058338:T
simvastatin	rs2032582	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0020443		C10AA01	rs2032582:C
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
atorvastatin, simvastatin	rs705379	PON1	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020443		C10AA01|C10AA05	rs705379:AA
atorvastatin, simvastatin	rs705379	PON1	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020443		C10AA01|C10AA05	rs705379:AG
atorvastatin, simvastatin	rs662	PON1	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020443		C10AA01|C10AA05	rs662:CC
atorvastatin, simvastatin	rs662	PON1	CT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020443		C10AA01|C10AA05	rs662:CT
atorvastatin	rs705379	PON1	GG	Other	decreased	Other	Disease:C0020443		C10AA05	rs705379:GG
clozapine	rs58933792	TACR1	C	Toxicity	increased	Adverse_Event	Healthy		N05AH02	rs58933792:C
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
fluconazole, tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	LADME	Disease:C0277631		J02AC01|L04AD02	rs776746:CC
fluconazole, tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	LADME	Disease:C0277631		J02AC01|L04AD02	rs776746:CC
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	LADME	Disease:C0277631		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	LADME	Disease:C0277631		L04AD02	rs776746:TT
tamoxifen	rs10841795	SLCO1A2	AG	Toxicity	decreased	Adverse_Event	Other:C1458155		L02BA01	rs10841795:AG
tamoxifen	rs10841795	SLCO1A2	GG	Toxicity	decreased	Adverse_Event	Other:C1458155		L02BA01	rs10841795:GG
clozapine	rs3942465	ERBB4	C	Toxicity	increased	Adverse_Event	Healthy		N05AH02	rs3942465:C
diazepam	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:C0085762		N05BA01	rs4244285:AA
diazepam	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Other:C0085762		N05BA01	rs4244285:AG
"""ace inhibitors, plain"", ""angiotensin ii antagonists"", ""beta blocking agents"", ""digoxin"", ""diuretics"", ""spironolactone"""	rs1042713	ADRB2	GG	Other	increased	Adverse_Event	Disease:C0085605		C03|C03DA01|C09A|S01ED	rs1042713:GG
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	AA	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP01|L03AB10	rs1127354:AA
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	AC	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP01|L03AB10	rs1127354:AC
l-asparagine, prednisone, vincristine	rs1049674	ASNS	AT	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	rs1049674:AT
"""ace inhibitors, plain"", ""angiotensin ii antagonists"", ""beta blocking agents"", ""digoxin"", ""diuretics"", ""spironolactone"""	rs1799983	NOS3	TT	Other	increased	Adverse_Event	Disease:C0085605		C03|C03DA01|C09A|S01ED	rs1799983:TT
efavirenz, lopinavir, nucleoside and nucleotide reverse transcriptase inhibitors, ritonavir	rs2853826	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AF|J05AG03|J05AR10	rs2853826:G
diazepam	rs12248560	CYP2C19	CT	Toxicity	decreased	Adverse_Event	Other:C0085762		N05BA01	rs12248560:CT
diazepam	rs12248560	CYP2C19	TT	Toxicity	decreased	Adverse_Event	Other:C0085762		N05BA01	rs12248560:TT
"""ace inhibitors, plain"", ""angiotensin ii antagonists"", ""beta blocking agents"", ""digoxin"", ""diuretics"", ""spironolactone"""	rs1801253	ADRB1	GG	Other	decreased	Adverse_Event	Disease:C0085605		C03|C03DA01|C09A|S01ED	rs1801253:GG
l-asparagine, prednisone, vincristine	rs9282564	ABCB1	CT	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	rs9282564:CT
olanzapine	rs2011425	UGT1A4	GG	Toxicity	decreased	Adverse_Event	Other:C0036341		N05AH03	rs2011425:GG
olanzapine	rs2011425	UGT1A4	GT	Toxicity	decreased	Adverse_Event	Other:C0036341		N05AH03	rs2011425:GT
olanzapine	rs2740574	CYP3A4	CC	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs2740574:CC
olanzapine	rs2740574	CYP3A4	CT	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs2740574:CT
cabazitaxel	rs17327624	ABCB1	T	Toxicity	increased	Adverse_Event	Other:C2939419|Other:C0033578		L01CD04	rs17327624:T
simvastatin	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs1128503:AA
olanzapine	rs2011425	UGT1A4	GG	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs2011425:GG
olanzapine	rs2011425	UGT1A4	GT	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs2011425:GT
cyclosporine	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs1045642:AG
tacrolimus	rs776746	CYP3A5	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
clopidogrel	rs6785930	P2RY12	AA	Efficacy	increased	Adverse_Event	Other:C0010068		B01AC04	rs6785930:AA
clopidogrel	rs6785930	P2RY12	AG	Efficacy	increased	Adverse_Event	Other:C0010068		B01AC04	rs6785930:AG
cabazitaxel	rs2235040	ABCB1	T	Toxicity	decreased	Adverse_Event	Other:C2939419|Other:C0033578		L01CD04	rs2235040:T
tacrolimus	rs2066844	NOD2	CC	Other	increased	Other	Disease:Kidney_Transplantation		L04AD02	rs2066844:CC
tacrolimus	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
cyclosporine, tacrolimus	rs2740574	CYP3A4	CT	Toxicity	increased	Adverse_Event	Healthy		L04AD01|L04AD02	rs2740574:CT
warfarin	rs2359612	VKORC1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2359612:AA
warfarin	rs2359612	VKORC1	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2359612:AG
azathioprine, mercaptopurine	rs16952570	FTO	CC	Toxicity	decreased	Adverse_Event	Other:C0009324|Other:C0010346		L01BB02|L04AX01	rs16952570:CC
oseltamivir	rs121912777	CES1	CT	Metabolism/PK	Indeterminado	LADME	Healthy		J05AH02	rs121912777:CT
oseltamivir	rs121912777	CES1	TT	Metabolism/PK	Indeterminado	LADME	Healthy		J05AH02	rs121912777:TT
azathioprine, mercaptopurine	rs16952570	FTO	CT	Toxicity	increased	Adverse_Event	Other:C0009324|Other:C0010346		L01BB02|L04AX01	rs16952570:CT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
cabazitaxel	rs11572093	CYP2C8	T	Toxicity	increased	Adverse_Event	Other:C2939419|Other:C0033578		L01CD04	rs11572093:T
warfarin	rs9923231	VKORC1	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
citalopram	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	rs4244285:A
warfarin	rs9934438	VKORC1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:AG
nortriptyline	rs5443	GNB3	TT	Toxicity	Indeterminado	Adverse_Event	Disease:C0011581		N06AA10	rs5443:TT
warfarin	rs8050894	VKORC1	CG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs8050894:CG
warfarin	rs8050894	VKORC1	GG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs8050894:GG
nortriptyline	rs5443	GNB3	TT	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AA10	rs5443:TT
warfarin	rs2884737	VKORC1	AC	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2884737:AC
warfarin	rs2884737	VKORC1	CC	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2884737:CC
nortriptyline	rs5443	GNB3	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AA10	rs5443:TT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
warfarin	rs9934438	VKORC1	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:A
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
none	rs1051266	SLC19A1	C	Other	increased	Adverse_Event	Other:C0032961		A03DA02	rs1051266:C
digoxin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		C01AA05	rs1045642:AA
olanzapine	rs7997012	HTR2A	AA	Toxicity	increased	Adverse_Event	Other:C0033975		N05AH03	rs7997012:AA
capecitabine, fluorouracil, tegafur	rs3918290	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs3918290:T
capecitabine, fluorouracil, tegafur	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs67376798:A
olanzapine	rs1045642	ABCB1	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		N05AH03	rs1045642:A
olanzapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Other:C0033975		N05AH03	rs762551:AA
nicotine	rs1799971	OPRM1	AA	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs1799971:AA
olanzapine	rs6275	DRD2	A	Other, Metabolism/PK	increased	Other	Healthy		N05AH03	rs6275:A
anthracyclines and related substances	rs9024	CBR1	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01DB	rs9024:GG
olanzapine	rs6279	DRD2	G	Other, Metabolism/PK	increased	Other	Healthy		N05AH03	rs6279:G
cephalexin	rs34545984	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs34545984:T
olanzapine	rs1124493	DRD2	T	Other, Metabolism/PK	increased	Other	Healthy		N05AH03	rs1124493:T
olanzapine	rs2734841	DRD2	A	Other, Metabolism/PK	increased	Other	Healthy		N05AH03	rs2734841:A
aspirin	rs115346678	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs115346678:A
methotrexate	rs2236225	MTHFD1	A	Efficacy	decreased	Adverse_Event	Disease:C0023449		L04AX03	rs2236225:A
simvastatin	rs4253728	PPARA	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs4253728:AA
methotrexate	rs1801133	MTHFR	A	Efficacy	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:A
codeine	rs9620007	WBP2NL	G	Toxicity	decreased	Adverse_Event	Healthy		R05DA04	rs9620007:G
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:A
codeine, hydrocodone, oxycodone, tramadol	rs62436463	OPRM1	T	Toxicity	decreased	Adverse_Event	Healthy		N02AA05|N02AX02|R05DA03|R05DA04	rs62436463:T
metformin	rs316009	SLC22A2	CC	Toxicity	increased	Adverse_Event	Other:C0011849		A10BA02	rs316009:CC
metformin	rs316019	SLC22A2	CC	Toxicity	increased	Adverse_Event	Other:C0011849		A10BA02	rs316019:CC
simvastatin	rs4823613	PPARA	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs4823613:GG
none	rs1800497	ANKK1	GG	Efficacy	increased	Adverse_Event	Healthy		A03DA02	rs1800497:GG
nicotine	rs4680	COMT	GG	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs4680:GG
escitalopram	rs6311	HTR2A	CT	Toxicity	increased	Adverse_Event	Other:C0235876|Other:C0003469	intermediate metabolizer	N06AB10	rs6311:CT
escitalopram	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Other:C0235876|Other:C0003469	intermediate metabolizer	N06AB10	rs6311:TT
nicotine	rs1800497	ANKK1	AA	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AA
nicotine	rs1800497	ANKK1	AG	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AG
amiodarone, antibiotics, antipsychotics, diuretics, quinidine, sotalol	rs1805128	KCNE1	T	Toxicity	increased	Adverse_Event	Healthy		C01BA01|C01BD01|C03|C07AA07|N05A|S01AA	rs1805128:T
nicotine	rs1799971	OPRM1	GG	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs1799971:GG
nicotine	rs1799971	OPRM1	AG	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs1799971:AG
bupropion	rs1800497	ANKK1	GG	Efficacy	increased	Adverse_Event	Healthy		N06AX12	rs1800497:GG
olanzapine	rs2734842	DRD2	G	Other, Metabolism/PK	increased	Other	Healthy		N05AH03	rs2734842:G
methotrexate	rs1801133	MTHFR	A	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:A
pyrimidine analogues	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Healthy		L01BC	rs1801160:CT
pyrimidine analogues	rs1801160	DPYD	TT	Toxicity	increased	Adverse_Event	Healthy		L01BC	rs1801160:TT
rosuvastatin	rs2231142	ABCG2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA07	rs2231142:GG
amitriptyline	rs4244285	CYP2C19	AA	Other, Metabolism/PK	increased	LADME	Healthy		N06AA09	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A
rosuvastatin	rs4149056	SLCO1B1	TT	Metabolism/PK	decreased	LADME	Disease:C0020443		C10AA07	rs4149056:TT
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:A
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0020443		C10AA07	rs2231142:TT
clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1045642:AA
clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:C0085096		B01AC04	rs1045642:AA
cisplatin, docetaxel, fluorouracil	rs1024611	CCL2	GG	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs1024611:GG
none	rs7242	SERPINE1	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs7242:T
none	rs2227684	SERPINE1	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs2227684:G
methotrexate	rs1801131	MTHFR	G	Efficacy	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801131:G
gemcitabine	rs60369023	CDA	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0027651		L01BC05	rs60369023:A
methotrexate	rs3758149	GGH	AA	Toxicity	increased	Adverse_Event	Other:C0024299|Other:C0023449		L04AX03	rs3758149:AA
bisphosphonates	rs16944	IL1B	GG	Efficacy	increased	Adverse_Event	Disease:C0015230		M05BA	rs16944:GG
clodronate	rs1544410	VDR	C	Efficacy	increased	Adverse_Event	Disease:C0015230		No_ATC	rs1544410:C
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
clodronate	rs731236	VDR	A	Efficacy	increased	Adverse_Event	Disease:C0015230		No_ATC	rs731236:A
cytarabine, idarubicin	rs3750117	NT5C3A	GG	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs3750117:GG
atorvastatin, lovastatin, simvastatin	rs662799	APOA5	AG	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA01|C10AA02|C10AA05	rs662799:AG
atorvastatin, lovastatin, simvastatin	rs662799	APOA5	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA01|C10AA02|C10AA05	rs662799:GG
citalopram, sertraline	rs6311	HTR2A	T	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB04|N06AB06	rs6311:T
cisplatin, docetaxel, fluorouracil	rs1800796	IL6	CC	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs1800796:CC
citalopram	rs6313	HTR2A	AA	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB04	rs6313:AA
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0024299|Other:C0023449		L04AX03	rs1801133:AA
buprenorphine / naloxone	rs648893	OPRM1	AG	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs648893:AG
buprenorphine / naloxone	rs648893	OPRM1	GG	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs648893:GG
methotrexate	rs2267076	ADORA2A	T	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2267076:T
methotrexate	rs2236624	ADORA2A	T	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2236624:T
methotrexate	rs2298383	ADORA2A	T	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2298383:T
tacrolimus	rs776746	CYP3A5	CT	Other	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Other	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
methotrexate	rs3761422	ADORA2A	T	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs3761422:T
cisplatin, docetaxel, fluorouracil	rs1799964	TNF	CC	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs1799964:CC
cisplatin, docetaxel, fluorouracil	rs1799964	TNF	CT	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs1799964:CT
clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Other:C0018839		B01AC04	rs1045642:AA
aspirin, clopidogrel	rs12041331	PEAR1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs12041331:AA
aspirin, clopidogrel	rs12041331	PEAR1	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs12041331:AG
cisplatin, docetaxel, fluorouracil	rs717620	ABCC2	CT	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs717620:CT
cisplatin, docetaxel, fluorouracil	rs717620	ABCC2	TT	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs717620:TT
hydrochlorothiazide	rs12279250	NELL1	C	Metabolism/PK	increased	Adverse_Event	Disease:C0020538		C03AA03	rs12279250:C
buprenorphine / naloxone	rs678849	OPRD1	TT	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs678849:TT
aripiprazole	rs2391191	DAOA	A	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX12	rs2391191:A
buprenorphine / naloxone	rs569356	OPRD1	A	Efficacy	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs569356:A
olanzapine	rs6318	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	rs6318:C
tacrolimus	rs776746	CYP3A5	T	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:T
tacrolimus	rs776746	CYP3A5	CC	Efficacy, Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
simvastatin	rs4673	CYBA	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA01	rs4673:AA
simvastatin	rs4673	CYBA	AG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA01	rs4673:AG
bupropion	rs3211371	CYP2B6	CT	Efficacy	increased	Adverse_Event	Other:female_gender		N06AX12	rs3211371:CT
aspirin	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Other:C0018839		No_ATC	rs1045642:AG
aspirin	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Other:C0018839		No_ATC	rs1045642:GG
olanzapine	rs6280	DRD3	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH03	rs6280:CC
azathioprine, mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0010346		L01BB02|L04AX01	rs116855232:CT
azathioprine, mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0010346		L01BB02|L04AX01	rs116855232:TT
olanzapine	rs951439	RGS4	CT	Efficacy	increased	Adverse_Event	Disease:C0036341		N05AH03	rs951439:CT
cabazitaxel	rs151352	TUBB1	G	Efficacy	increased	Efficacy_Response	Other:C2939419|Other:C0033578		L01CD04	rs151352:G
risperidone	rs951439	RGS4	TT	Efficacy	increased	Adverse_Event	Disease:C0036341		N05AX08	rs951439:TT
olanzapine, perphenazine	rs951439	RGS4	CC	Efficacy	increased	Adverse_Event	Disease:C0036341		N05AB03|N05AH03	rs951439:CC
cabazitaxel	rs1341164	CYP2C8	C	Efficacy	increased	Efficacy_Response	Other:C2939419|Other:C0033578		L01CD04	rs1341164:C
olanzapine	rs4731426	LEP	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	rs4731426:GG
heroin	rs13242038	GRM3	T	Other	increased	Adverse_Event	Healthy		No_ATC	rs13242038:T
amitriptyline, citalopram, paroxetine, venlafaxine	rs2235015	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs2235015:A
none	rs4343	ACE	G	Metabolism/PK	increased	Other	Disease:C0020538		A03DA02	rs4343:G
antidepressants	rs6295	HTR1A	GG	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs6295:GG
opioids	rs9282564	ABCB1	CC	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N02A	rs9282564:CC
opioids	rs9282564	ABCB1	CT	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N02A	rs9282564:CT
anthracyclines and related substances, taxanes	rs1045642	ABCB1	AA	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:C1458155		L01CD|L01DB	rs1045642:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
paroxetine, sertraline	rs6295	HTR1A	CC	Efficacy	increased	Adverse_Event	Disease:C0030319		N06AB05|N06AB06	rs6295:CC
opioids	rs2070995	KCNJ6	TT	Efficacy	increased	Efficacy_Response	Disease:C0030193		N02A	rs2070995:TT
warfarin	rs8050894	VKORC1	G	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs8050894:G
warfarin	rs9923231	VKORC1	T	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs9923231:T
nevirapine	rs28399499	CYP2B6	CT	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs28399499:CT
nevirapine	rs776746	CYP3A5	CC	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs776746:CC
nevirapine	rs776746	CYP3A5	CT	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs776746:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3849942	C9orf72	T	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs3849942:T
methamphetamine	rs3213207	DTNBP1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3213207:C
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2814707	MOB3B	T	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs2814707:T
methamphetamine	rs2076369	PICK1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2076369:T
nevirapine	rs12721646	CYP2B6	CT	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs12721646:CT
nevirapine	rs12721646	CYP2B6	TT	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs12721646:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs928655	GBP6	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs928655:A
fluorouracil	rs1801265	DPYD	AG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs1801265:AG
fluorouracil	rs1801265	DPYD	GG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs1801265:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs774359	C9orf72	C	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs774359:C
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs983332	CSRP3	T	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs983332:T
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs868856	MOB3B	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs868856:A
methotrexate	rs1801131	MTHFR	G	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801131:G
methotrexate	rs1801131	MTHFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:TT
methotrexate	rs1051266	SLC19A1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:TT
gefitinib	rs712829	EGFR	GT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs712829:GT
gefitinib	rs712829	EGFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs712829:TT
antiandrogens	rs12529	AKR1C3	CC	Efficacy	increased	Adverse_Event	Disease:C0033578		G03H	rs12529:CC
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:AG
cisplatin, cyclophosphamide	rs11615	ERCC1	AG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs11615:AG
cisplatin, cyclophosphamide	rs1042522	TP53	GG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1042522:GG
paclitaxel	rs11572080	CYP2C8	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CD01	rs11572080:TT
methotrexate	rs2238476	ABCC1	GG	Toxicity	increased	Adverse_Event	Disease:C0235763		L04AX03	rs2238476:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6028945	MAFB	T	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs6028945:T
olanzapine	rs3813929	HTR2C	T	Toxicity	decreased	Adverse_Event	Disease:C0011581|Disease:C0036341		N05AH03	rs3813929:T
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6071980	MAFB	C	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs6071980:C
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT
olanzapine	rs3813929	HTR2C	T	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH03	rs3813929:T
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6138150	CST5	T	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs6138150:T
olanzapine	rs3813929	HTR2C	T	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH03	rs3813929:T
cisplatin, cyclophosphamide	rs1695	GSTP1	AA	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:C0919267		L01AA01|L01XA01	rs1695:AA
antipsychotics	rs1801133	CLCN6, MTHFR	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1801133:A
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs854548	PON1	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs854548:A
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs854555	PON1	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs854555:A
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs7046653	MOB3B	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs7046653:A
buprenorphine	rs2740574	CYP3A4	CC	Efficacy	increased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs2740574:CC
buprenorphine	rs2740574	CYP3A4	CT	Efficacy	increased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs2740574:CT
warfarin	rs9934438	VKORC1	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:AG
docetaxel	rs11185648	__INTRONIC__	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs11185648:CT
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T
docetaxel	rs11185647	RXRA	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs11185647:AG
cisplatin	rs12201199	TPMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs12201199:T
docetaxel	rs2234753	RXRA	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs2234753:AG
docetaxel	rs6413517	RXRA	GT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs6413517:GT
docetaxel	rs62576288	RXRA	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs62576288:GG
none	rs2298771	SCN1A	CT	Other	increased	Adverse_Event	Healthy		A03DA02	rs2298771:CT
methotrexate	rs9345389	__INTRONIC__	G	Toxicity	Indeterminado	Adverse_Event	Healthy		L04AX03	rs9345389:G
docetaxel	rs6130615	HNF4A	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs6130615:TT
antipsychotics	rs7997012	HTR2A	GG	Efficacy	increased	Adverse_Event	Other:C0036341		N05A	rs7997012:GG
simvastatin	rs76103438	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs76103438:A
diazepam	rs35599367	CYP3A4	GG	Toxicity	increased	Adverse_Event	Other:C0085762		N05BA01	rs35599367:GG
antipsychotics	rs6314	HTR2A	AG	Efficacy	increased	Adverse_Event	Other:C0036341		N05A	rs6314:AG
docetaxel	rs2273618	HNF4A	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs2273618:CT
docetaxel	rs3746574	HNF4A	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3746574:CT
warfarin	rs9934438	VKORC1	A	Dosage, Efficacy	Indeterminado	Other	Healthy		B01AA03	rs9934438:A
docetaxel	rs3732360	NR1I2	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3732360:TT
none	rs985919	NRXN1	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs985919:C
"""beta blocking agents, selective"", ""diuretics"""	rs4149601	NEDD4L	AG	Efficacy	decreased	Adverse_Event	Disease:C0020538		C03|S01ED	rs4149601:AG
"""beta blocking agents, selective"", ""diuretics"""	rs4149601	NEDD4L	GG	Efficacy	decreased	Adverse_Event	Disease:C0020538		C03|S01ED	rs4149601:GG
meperidine	rs185462714	SERINC5	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs185462714:C
cisplatin, cyclophosphamide	rs3957357	GSTA1	AA	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01AA01|L01XA01	rs3957357:AA
docetaxel	rs3732359	NR1I2	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3732359:AA
none	rs17408276	CHRNA5	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs17408276:C
beta blocking agents	rs139945292	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Other:C0020538		S01ED	rs139945292:T
nicotine	rs4680	COMT	AA	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs4680:AA
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC
simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CT
penicillin g, penicillin v	rs115200108	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs115200108:A
nicotine	rs4680	COMT	AG	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs4680:AG
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:A
docetaxel	rs3814058	NR1I2	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3814058:CC
docetaxel	rs3814058	NR1I2	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3814058:TT
none	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs16969968:A
none	rs1882296	NRXN1	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs1882296:C
docetaxel	rs10538494	NR1I3	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs10538494:TT
codeine, hydrocodone, oxycodone, tramadol	rs739296	SEPTIN3, WBP2NL	A	Toxicity	decreased	Adverse_Event	Healthy		N02AA05|N02AX02|R05DA03|R05DA04	rs739296:A
meperidine	rs113100019	FIP1L1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs113100019:G
docetaxel	rs75114882	NR1I3	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs75114882:AG
none	rs10865246	NRXN1	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs10865246:C
cisplatin	rs9332377	COMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs9332377:T
docetaxel	rs2501873	NR1I3	CC	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CD02	rs2501873:CC
cisplatin, cyclophosphamide	rs1799793	ERCC2	CT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1799793:CT
cisplatin, cyclophosphamide	rs3212986	ERCC1	AC	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs3212986:AC
cisplatin, cyclophosphamide	rs25487	XRCC1	CC	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs25487:CC
meperidine	rs11049274	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs11049274:A
docetaxel	rs1536475	RXRA	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs1536475:AG
cisplatin	rs2228001	XPC	G	Toxicity	increased	Adverse_Event	Disease:C0029463		L01XA01	rs2228001:G
docetaxel	rs2502815	NR1I3	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs2502815:GG
docetaxel	rs9725457	NR1I3	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs9725457:AA
cisplatin	rs13181	ERCC2, KLC3	G	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01XA01	rs13181:G
ethanol	rs6088638	ACSS2	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs6088638:T
capecitabine, fluorouracil	rs17376848	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs17376848:AG
ethanol	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:G
angiotensin ii antagonists	rs1058164	CYP2D6	C	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs1058164:C
cisplatin	rs11615	ERCC1	G	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01XA01	rs11615:G
none	rs429358	APOE	CC	Other	increased	Adverse_Event	Healthy		A03DA02	rs429358:CC
clopidogrel	rs4986893	CYP2C19	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:A
angiotensin ii antagonists	rs1985842	CYP2D6	T	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs1985842:T
none	rs1801280	NAT2	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs1801280:T
angiotensin ii antagonists	rs1135840	CYP2D6	G	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs1135840:G
clopidogrel	rs28399504	CYP2C19	G	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs28399504:G
angiotensin ii antagonists	rs28371713	CYP2D6	G	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs28371713:G
none	rs1208	NAT2	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs1208:A
amoxicillin, clavulanate, flucloxacillin	rs72631546	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	rs72631546:C
gefitinib	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01EB01	rs2231142:GT
angiotensin ii antagonists	rs112568578	CYP2D6	G	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs112568578:G
capecitabine, fluorouracil	rs895819	MIR23A, MIR24-2, MIR27A	C	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs895819:C
fluorouracil	rs3918290	DPYD	CT	Toxicity	Indeterminado	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT
amoxicillin, clavulanate	rs2476601	PTPN22	A	Toxicity	increased	Adverse_Event	Healthy		J01CA04	rs2476601:A
morphine	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs1799971:AA
cocaine	rs6454674	CNR1	GT	Other	increased	Adverse_Event	Healthy		N01BC01	rs6454674:GT
cocaine	rs6454674	CNR1	TT	Other	increased	Adverse_Event	Healthy		N01BC01	rs6454674:TT
atenolol, beta blocking agents, carvedilol, metoprolol	rs4253778	PPARA	GG	Efficacy	decreased	Other	Disease:C0027051		C07AB02|C07AB03|C07AG02|S01ED	rs4253778:GG
doxorubicin	rs2229774	RARG	AG	Toxicity	increased	Adverse_Event	Healthy		L01DB01	rs2229774:AG
fluvastatin	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		C10AA04	rs2231142:GT
fluvastatin	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		C10AA04	rs2231142:TT
aspirin	rs9886152	TMEM196	T	Toxicity	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs9886152:T
pazopanib	rs11549467	HIF1A	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs11549467:AG
none	rs1801260	CLOCK	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs1801260:AA
none	rs1801260	CLOCK	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs1801260:AG
mercaptopurine, methotrexate	rs7270101	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs7270101:CC
cocaine	rs6454674	CNR1	GT	Other	increased	Adverse_Event	Healthy		N01BC01	rs6454674:GT
cocaine	rs6454674	CNR1	TT	Other	increased	Adverse_Event	Healthy		N01BC01	rs6454674:TT
rituximab	rs396991	FCGR3A	C	Efficacy	increased	Efficacy_Response	Disease:C0024299|Large_B-Cell|Diffuse		L01FA01	rs396991:C
mercaptopurine, methotrexate	rs2278293	IMPDH1	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs2278293:CT
cocaine	rs806368	CNR1	C	Other	decreased	Adverse_Event	Healthy		N01BC01	rs806368:C
mercaptopurine, methotrexate	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1127354:CC
alendronate, raloxifene	rs1544410	VDR	CC	Efficacy	increased	Efficacy_Response	Disease:C0029456|Postmenopausal		G03XC01	rs1544410:CC
asparaginase, dexamethasone, methotrexate	rs7142143	PYGL	CC	Dosage	increased	Adverse_Event	Disease:C0023449		L01XX02|L04AX03|S02BA06	rs7142143:CC
asparaginase, dexamethasone, methotrexate	rs7142143	PYGL	CT	Dosage	increased	Adverse_Event	Disease:C0023449		L01XX02|L04AX03|S02BA06	rs7142143:CT
interferons	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB	rs12979860:CC
pazopanib	rs4073	CXCL8	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs4073:AA
erlotinib	rs121434569	EGFR	T	Efficacy	decreased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB02	rs121434569:T
erlotinib, gefitinib	rs121434569	EGFR	T	Efficacy	decreased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01|L01EB02	rs121434569:T
interferons	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB	rs8099917:TT
capecitabine, irinotecan, oxaliplatin	rs17376848	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06|L01CE02|L01XA03	rs17376848:AG
methotrexate	rs4888024	__INTRONIC__	G	Toxicity	Indeterminado	Adverse_Event	Healthy		L04AX03	rs4888024:G
tacrolimus	rs1128503	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1128503:AG
tacrolimus	rs2032582	ABCB1	AC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:AC
tacrolimus	rs2032582	ABCB1	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:CT
methotrexate	rs3784862	ABCC1	AA	Toxicity	increased	Adverse_Event	Disease:C0235763		L04AX03	rs3784862:AA
ethanol	rs1799971	OPRM1	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:A
capecitabine	rs2297595	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2297595:CT
clopidogrel	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs1045642:A
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs945665113	CTBP2	A	Efficacy	increased	Efficacy_Response	Other:C0024121		No_ATC	rs945665113:A
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Other:PCI-scheduled_patients		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Other:PCI-scheduled_patients		B01AC04	rs4244285:AG
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
capecitabine, fluorouracil, leucovorin, oxaliplatin	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06|L01XA03	rs1801133:AG
antidepressants	rs6313	HTR2A	AA	Toxicity	decreased	Adverse_Event	Other:C0005586|Other:C0235876|Other:C0011581		N06A	rs6313:AA
antidepressants	rs6313	HTR2A	AG	Toxicity	decreased	Adverse_Event	Other:C0005586|Other:C0235876|Other:C0011581		N06A	rs6313:AG
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
sunitinib	rs2631367	SLC22A5	C	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EX01	rs2631367:C
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB02	rs121434568:G
clopidogrel	rs4244285	CYP2C19	AA	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AA
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0001418		L01EB02	rs121434568:G
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0001418		L01EB02	rs121434568:G
sunitinib	rs2631370	SLC22A5	C	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EX01	rs2631370:C
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs376695472	CTBP2	G	Efficacy	increased	Efficacy_Response	Other:C0024121		No_ATC	rs376695472:G
antidepressants	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Other:C0005586|Other:C0235876|Other:C0011581		N06A	rs6311:CC
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs4244285:A
beta blocking agents	rs1042713	ADRB2	GG	Efficacy	decreased	Adverse_Event	Other:C0027051		S01ED	rs1042713:GG
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Other:C0027051|Other:C0027051		C10AA	rs4149056:CC
fluorouracil	rs2959023	DPYS	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs2959023:G
sunitinib	rs1805015	IL4R	C	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EX01	rs1805015:C
omega-3 polyunsaturated fatty acids	rs20417	PTGS2	CG	Other	increased	Adverse_Event	Healthy		No_ATC	rs20417:CG
omega-3 polyunsaturated fatty acids	rs20417	PTGS2	GG	Other	increased	Adverse_Event	Healthy		No_ATC	rs20417:GG
none	rs20417	PTGS2	CG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs20417:CG
none	rs20417	PTGS2	GG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs20417:GG
fluorouracil	rs2669429	DPYS	G	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs2669429:G
methotrexate	rs1801133	CLCN6, MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0085136		L04AX03	rs1801133:AG
capecitabine, fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs3918290:CT
sunitinib	rs2631372	SLC22A5	C	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EX01	rs2631372:C
capecitabine, fluorouracil, leucovorin, oxaliplatin	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06|L01XA03	rs1801131:GG
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB02	rs121434568:G
sunitinib	rs1801275	IL4R	G	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EX01	rs1801275:G
aminoglycoside antibacterials	rs267606619	MT-RNR1	T	Toxicity	increased	Adverse_Event	Healthy		J01G	rs267606619:T
tenofovir	rs1751034	ABCC4	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs1751034:CC
tenofovir	rs1751034	ABCC4	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs1751034:CT
azithromycin, erythromycin	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0004623|Other:C0948873		S01AA17|S01AA26	rs1045642:AA
azithromycin, erythromycin	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0004623|Other:C0948873		S01AA17|S01AA26	rs1045642:AG
corticosteroids	rs35514893	DTNBP1	T	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs35514893:T
none	rs1056836	CYP1B1	CC	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1056836:CC
none	rs1056836	CYP1B1	CG	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1056836:CG
thiotepa	rs1138272	GSTP1	T	Other	increased	LADME	Healthy		L01AC01	rs1138272:T
tenofovir	rs1751034	ABCC4	TT	Other	increased	LADME	Healthy		J05AF07	rs1751034:TT
fluorouracil	rs2786783	DPYD	A	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02	rs2786783:A
none	rs72554664	G6PD	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs72554664:T
opioids	rs12442183	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		N02A	rs12442183:T
corticosteroids	rs450789	KL	G	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs450789:G
interferon beta-1a, interferon beta-1b	rs2205986	IRF6	G	Toxicity	increased	Adverse_Event	Disease:C0026769		L03AB07|L03AB08	rs2205986:G
methotrexate	rs3814058	NR1I2	C	Toxicity	decreased	Adverse_Event	Disease:C0029463		L04AX03	rs3814058:C
methotrexate	rs2273697	ABCC2	A	Toxicity	increased	Adverse_Event	Disease:C0029463		L04AX03	rs2273697:A
fluorouracil	rs2010851	WNT5B	CC	Efficacy	decreased	Other	Disease:C0024121		L01BC02	rs2010851:CC
corticosteroids	rs2125362	ME3	A	Efficacy	increased	Adverse_Event	Disease:C0004096		S02BA	rs2125362:A
methotrexate	rs6785049	NR1I2	G	Toxicity	decreased	Adverse_Event	Disease:C0029463		L04AX03	rs6785049:G
corticosteroids	rs7851998	LHX2	A	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs7851998:A
fluorouracil	rs2811178	DPYD	C	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02	rs2811178:C
corticosteroids	rs61585310	LHFPL3	G	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs61585310:G
asparaginase, corticosteroids, cyclophosphamide, cytarabine, mercaptopurine, methotrexate, vincristine	rs1800896	IL10	CC	Efficacy	increased	Efficacy_Response	Other:C0023449		L01AA01|L01BB02|L01BC01|L01CA02|L01XX02|L04AX03|S02BA	rs1800896:CC
methotrexate	rs3732361	GSK3B	A	Metabolism/PK	decreased	Adverse_Event	Disease:C0029463		L04AX03	rs3732361:A
morphine	rs12208357	SLC22A1	T	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs12208357:T
corticosteroids	rs4897302	TRDN	T	Efficacy	increased	Adverse_Event	Disease:C0004096		S02BA	rs4897302:T
nicotine	rs55781567	CHRNA5	G	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs55781567:G
heroin	rs4654327	OPRD1	AA	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs4654327:AA
olanzapine	rs10423928	GIPR	AA	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	rs10423928:AA
olanzapine	rs10423928	GIPR	AT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	rs10423928:AT
nicotine	rs16969968	CHRNA5	A	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs16969968:A
nicotine	rs503464	CHRNA5	A	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs503464:A
allopurinol	rs9469003	CYCSP5	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9469003:C
fluorouracil	rs1801265	DPYD	G	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02	rs1801265:G
daunorubicin, doxorubicin	rs4982753	SLC22A17	T	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01DB01|L01DB02	rs4982753:T
warfarin	rs9923231	VKORC1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
allopurinol, carbamazepine, phenytoin	rs9469003	CYCSP5	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs9469003:C
nicotine	rs55853698	CHRNA5	G	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs55853698:G
amantadine, anticholinergics, dopamine agonists, levodopa, selegiline	rs622342	SLC22A1	C	Dosage, Efficacy, Toxicity	increased	Adverse_Event	Disease:C0030567		N04BA02|N04BC|N04BD01|S01FA	rs622342:C
melphalan	rs967591	POLR1G	A	Efficacy, Toxicity	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01AA03	rs967591:A
corticosteroids	rs11121611	ACOT7	G	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs11121611:G
peginterferon alfa-2b, ribavirin, telaprevir	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs1127354:CC
morphine	rs3804100	TLR2	CC	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs3804100:CC
morphine	rs3804100	TLR2	CT	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs3804100:CT
daunorubicin, doxorubicin	rs4149178	SLC22A7	G	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01DB01|L01DB02	rs4149178:G
rosuvastatin	rs12487736	SCAP	CC	Efficacy	decreased	Adverse_Event	Disease:C0524620		C10AA07	rs12487736:CC
rosuvastatin	rs12487736	SCAP	CT	Efficacy	decreased	Adverse_Event	Disease:C0524620		C10AA07	rs12487736:CT
allopurinol	rs3094188	PSORS1C3	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3094188:A
corticosteroids	rs5995653	APOBEC3B	A	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs5995653:A
allopurinol, carbamazepine, phenytoin	rs3094188	PSORS1C3	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs3094188:A
morphine	rs4680	COMT	AA	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs4680:AA
morphine	rs4680	COMT	AG	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs4680:AG
gemcitabine, paclitaxel	rs2072671	CDA	CC	Toxicity	increased	Adverse_Event	Other:C0030297		L01BC05|L01CD01	rs2072671:CC
montelukast	rs119774	ABCC1	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03DC03	rs119774:CT
triamcinolone	rs2523864	HCG22	T	Toxicity	increased	Adverse_Event	Disease:C0231303		S01BA05	rs2523864:T
antidepressants	rs7569963	CREB1, METTL21A	GG	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	rs7569963:GG
morphine	rs10499563	IL6	CC	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs10499563:CC
allopurinol	rs3130501	POU5F1	G	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3130501:G
allopurinol, carbamazepine, phenytoin	rs3130501	POU5F1	G	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs3130501:G
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs184278615	HLA-DRB5	A	Efficacy	decreased	Efficacy_Response	Other:C0024121		No_ATC	rs184278615:A
citalopram	rs4675690	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	rs4675690:T
citalopram	rs7569963	CREB1, METTL21A	A	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AB04	rs7569963:A
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs201469165	HLA-DRB5	T	Efficacy	decreased	Efficacy_Response	Other:C0024121		No_ATC	rs201469165:T
"""antivirals for treatment of hiv infections, combinations"", ""ritonavir"""	rs7412	APOE	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AP|S02DA30	rs7412:T
allopurinol	rs3130931	POU5F1	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3130931:C
triamcinolone	rs3873352	HCG22	G	Toxicity	increased	Adverse_Event	Disease:C0231303		S01BA05	rs3873352:G
allopurinol, carbamazepine, phenytoin	rs3815087	PSORS1C1	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs3815087:A
morphine	rs2228145	IL6R	AC	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs2228145:AC
morphine	rs2228145	IL6R	CC	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs2228145:CC
allopurinol, carbamazepine, phenytoin	rs3130931	POU5F1	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs3130931:C
morphine	rs6265	BDNF	TT	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs6265:TT
allopurinol	rs3815087	PSORS1C1	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3815087:A
morphine	rs2069762	IL2	AC	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs2069762:AC
morphine	rs2069762	IL2	CC	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs2069762:CC
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs1071748	HLA-DRB5	C	Efficacy	decreased	Efficacy_Response	Other:C0024121		No_ATC	rs1071748:C
aspirin, clopidogrel	rs1061781	B4GALT2	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1061781:CT
aspirin, clopidogrel	rs1061781	B4GALT2	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1061781:TT
methotrexate	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1128503:AA
methotrexate	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1128503:AG
allopurinol	rs2844665	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs2844665:C
mercaptopurine, methotrexate	rs2413775	SLC28A2	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs2413775:AA
chlorthalidone	rs5065	NPPA	G	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03BA04	rs5065:G
methotrexate	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1045642:AA
methotrexate	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1045642:AG
mercaptopurine, methotrexate	rs2413775	SLC28A2	AT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs2413775:AT
cyclophosphamide	rs4880	SOD2	G	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01	rs4880:G
cyclophosphamide	rs2740574	CYP3A4	C	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01	rs2740574:C
doxorubicin	rs714368	SLC22A16	CC	Toxicity, Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs714368:CC
mercaptopurine, methotrexate	rs747199	SLC29A1	CC	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs747199:CC
allopurinol, carbamazepine, phenytoin	rs2844665	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs2844665:C
cyclophosphamide	rs2279343	CYP2B6	AG	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:recipients_of_HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs2279343:AG
cyclophosphamide	rs2279343	CYP2B6	GG	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:recipients_of_HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs2279343:GG
cyclophosphamide	rs8192709	CYP2B6	CT	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:recipients_of_HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs8192709:CT
cyclophosphamide	rs8192709	CYP2B6	TT	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:recipients_of_HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs8192709:TT
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs973541788	KIR3DL2	G	Efficacy	decreased	Efficacy_Response	Other:C0024121		No_ATC	rs973541788:G
amoxicillin, clavulanate, flucloxacillin	rs3129880	HLA-DRA	T	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	rs3129880:T
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AG
cyclophosphamide	rs3745274	CYP2B6	GT	Toxicity, Metabolism/PK	decreased	Adverse_Event	Other:HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs3745274:GT
cyclophosphamide	rs3745274	CYP2B6	TT	Toxicity, Metabolism/PK	decreased	Adverse_Event	Other:HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs3745274:TT
angiotensin ii antagonists	rs28371725	CYP2D6	C	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs28371725:C
opioids	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs1799971:GG
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AG
cyclosporine, methotrexate	rs1801133	MTHFR	A	Other	Indeterminado	Adverse_Event	Other:recipients_of_HLA-identical_hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs1801133:A
carboplatin, cisplatin, gemcitabine	rs1695	GSTP1	AG	Efficacy	increased	Adverse_Event	Other:C0005695		L01BC05|L01XA01|L01XA02	rs1695:AG
carboplatin, cisplatin, gemcitabine	rs1695	GSTP1	GG	Efficacy	increased	Adverse_Event	Other:C0005695		L01BC05|L01XA01|L01XA02	rs1695:GG
angiotensin ii antagonists	rs2004511	CYP2D6	T	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs2004511:T
mercaptopurine, methotrexate	rs2274407	ABCC4	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs2274407:CC
doxorubicin	rs8133052	CBR3	G	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01DB01	rs8133052:G
doxorubicin	rs8133052	CBR3	G	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C1458155		L01DB01	rs8133052:G
doxorubicin	rs1056892	CBR3	A	Dosage, Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs1056892:A
antihypertensives	rs1401982	ATP2B1	AA	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs1401982:AA
antihypertensives	rs1401982	ATP2B1	AG	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs1401982:AG
angiotensin ii antagonists	rs28371702	CYP2D6	A	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs28371702:A
morphine	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AA01	rs1799971:AA
mercaptopurine, methotrexate	rs10868138	SLC28A3	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs10868138:CC
mercaptopurine, methotrexate	rs10868138	SLC28A3	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs10868138:CT
heroin	rs724226	GRM3	A	Other	increased	Adverse_Event	Healthy		No_ATC	rs724226:A
acenocoumarol	rs7294	VKORC1	T	Other	decreased	Adverse_Event	Disease:C0004238|Disease:C0004239|Disease:C0042487		B01AA07	rs7294:T
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AG
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T
corticosteroids	rs242941	CRHR1	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		S02BA	rs242941:AA
methotrexate	rs1801133	CLCN6, MTHFR	AA	Efficacy	increased	Adverse_Event	Disease:C0029463		L04AX03	rs1801133:AA
corticosteroids	rs4713916	FKBP5	AA	Efficacy	increased	Adverse_Event	Disease:C0010346		S02BA	rs4713916:AA
corticosteroids	rs4713916	FKBP5	AG	Efficacy	increased	Adverse_Event	Disease:C0010346		S02BA	rs4713916:AG
budesonide, fluticasone propionate	rs242941	CRHR1	AA	Efficacy	Indeterminado	LADME	Disease:C0004096		R03BA02|R03BA05	rs242941:AA
opioids	rs1045642	ABCB1	G	Toxicity	increased	Adverse_Event	Other:C0024031		N02A	rs1045642:G
corticosteroids	rs1876828	CRHR1	TT	Efficacy	increased	Efficacy_Response	Disease:C0004096		S02BA	rs1876828:TT
gemcitabine	rs1155463	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		L01BC05	rs1155463:C
efavirenz	rs3745274	CYP2B6	GT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
antineoplastic and immunomodulating agents	rs212090	ABCC1	AA	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs212090:AA
antineoplastic and immunomodulating agents	rs212090	ABCC1	AT	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs212090:AT
budesonide, fluticasone propionate	rs1876828	CRHR1	TT	Efficacy	Indeterminado	LADME	Disease:C0004096		R03BA02|R03BA05	rs1876828:TT
antineoplastic and immunomodulating agents	rs4149171	SLC22A6	CC	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs4149171:CC
antineoplastic and immunomodulating agents	rs4149171	SLC22A6	CT	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs4149171:CT
antineoplastic and immunomodulating agents	rs955434	__INTRONIC__	AA	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs955434:AA
antineoplastic and immunomodulating agents	rs955434	__INTRONIC__	AG	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs955434:AG
chlorothiazide, hydrochlorothiazide	rs61824877	__INTRONIC__	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03|C03EA01	rs61824877:A
warfarin	rs9923231	VKORC1	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
antineoplastic and immunomodulating agents	rs4149170	SLC22A6	CT	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs4149170:CT
antineoplastic and immunomodulating agents	rs4149170	SLC22A6	TT	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs4149170:TT
tramadol	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Healthy		N02AX02	rs1799971:GG
chlorothiazide, hydrochlorothiazide	rs9943291	HMGCS2	G	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03|C03EA01	rs9943291:G
methotrexate	rs1801133	CLCN6, MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AG
methadone	rs55944529	DAO	TT	Efficacy	increased	Adverse_Event	Other:C0028043		N07BC02	rs55944529:TT
antineoplastic and immunomodulating agents	rs4148579	ABCC5	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs4148579:CC
none	rs11739136	KCNIP1, KCNMB1	CT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs11739136:CT
none	rs11739136	KCNIP1, KCNMB1	TT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs11739136:TT
infliximab	rs1143634	IL1B	GG	Efficacy	decreased	Adverse_Event	Other:C0010346		L04AB02	rs1143634:GG
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs10929302:AA
atazanavir	rs2032582	ABCB1	AT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	rs2032582:AT
dabigatran	rs4148738	ABCB1	CC	Toxicity	increased	Adverse_Event	Other:C0018839		B01AE07	rs4148738:CC
dabigatran	rs4148738	ABCB1	CT	Toxicity	increased	Adverse_Event	Other:C0018839		B01AE07	rs4148738:CT
nicotine	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Healthy		N07BA01	rs16969968:A
antineoplastic and immunomodulating agents	rs212087	ABCC1	AA	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs212087:AA
antineoplastic and immunomodulating agents	rs212087	ABCC1	AG	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs212087:AG
infliximab	rs10489629	IL23R	TT	Efficacy	decreased	Adverse_Event	Other:C0010346		L04AB02	rs10489629:TT
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs10929302:AA
antineoplastic and immunomodulating agents	rs4148580	ABCC5	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs4148580:CC
infliximab	rs3794271	SLCO1C1	GG	Efficacy	decreased	Adverse_Event	Other:C0010346		L04AB02	rs3794271:GG
nicotine	rs578776	CHRNA3	A	Other	decreased	Adverse_Event	Healthy		N07BA01	rs578776:A
carvedilol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AG02	rs1801253:CC
peginterferon alfa-2a	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Healthy		L03AB11	rs1045642:AA
peginterferon alfa-2a	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Healthy		L03AB11	rs1045642:AG
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs16906115	IL7	A	Toxicity	increased	Adverse_Event	Other:C0027651		No_ATC	rs16906115:A
irinotecan	rs3743527	ABCC1	CT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs3743527:CT
irinotecan	rs3743527	ABCC1	TT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs3743527:TT
nicotine	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Healthy		N07BA01	rs1051730:A
irinotecan	rs12720066	ABCB1	AC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs12720066:AC
irinotecan	rs12720066	ABCB1	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs12720066:CC
nicotine	rs3743078	CHRNA3	C	Other	decreased	Adverse_Event	Healthy		N07BA01	rs3743078:C
antineoplastic and immunomodulating agents	rs4148575	ABCC5	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs4148575:GG
nicotine	rs3813567	CHRNB4	G	Other	decreased	Adverse_Event	Healthy		N07BA01	rs3813567:G
irinotecan	rs17501331	ABCC1	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs17501331:AG
irinotecan	rs17501331	ABCC1	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs17501331:GG
carvedilol	rs1801253	ADRB1	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0085605		C07AG02	rs1801253:CC
peginterferon alfa-2a	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Adverse_Event	Healthy		L03AB11	rs12979860:CC
peginterferon alfa-2a	rs8099917	IFNL4	TT	Efficacy	increased	Adverse_Event	Healthy		L03AB11	rs8099917:TT
none	rs4148323	UGT1A1	AA	Efficacy	increased	Adverse_Event	Other:C0020433		A03DA02	rs4148323:AA
peginterferon alfa-2a	rs10883841	NT5C2	CT	Efficacy	decreased	Adverse_Event	Healthy		L03AB11	rs10883841:CT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
infliximab	rs10929587	ADAM17	TT	Efficacy	decreased	Adverse_Event	Other:C0010346		L04AB02	rs10929587:TT
clopidogrel	rs10935838	MED12L, P2RY12	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs10935838:AG
none	rs4961280	AGO2	AA	Other	decreased	Other	Other:C0007134		A03DA02	rs4961280:AA
none	rs4961280	AGO2	AC	Other	decreased	Other	Other:C0007134		A03DA02	rs4961280:AC
stavudine	rs1799964	TNF	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF04	rs1799964:C
clopidogrel	rs2046934	MED12L, P2RY12	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs2046934:AG
clopidogrel	rs6809699	MED12L, P2RY12	AC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs6809699:AC
antineoplastic and immunomodulating agents	rs3749442	ABCC5	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs3749442:AA
nicotine	rs684513	CHRNA5	G	Other	decreased	Adverse_Event	Healthy		N07BA01	rs684513:G
aminoglycoside antibacterials	rs267606618	MT-RNR1	C	Toxicity	increased	Adverse_Event	Healthy		J01G	rs267606618:C
antineoplastic and immunomodulating agents	rs1132776	ABCC5	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs1132776:GG
nicotine	rs637137	CHRNA5	A	Other	decreased	Adverse_Event	Healthy		N07BA01	rs637137:A
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
none	rs1800587	IL1A	A	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs1800587:A
fluticasone / salmeterol	rs242941	CRHR1	CC	Efficacy	increased	Efficacy_Response	Disease:C0024117		R03AK06	rs242941:CC
propranolol	rs4680	COMT	G	Efficacy	increased	Adverse_Event	Efficacy:C0030193|Disease:C0155943		C07AA05	rs4680:G
antineoplastic and immunomodulating agents	rs939338	ABCC5	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs939338:AA
peginterferon alfa-2a	rs10877012	CYP27B1, METTL1	GT	Efficacy	decreased	Adverse_Event	Disease:C0019372		L03AB11	rs10877012:GT
peginterferon alfa-2a	rs10877012	CYP27B1, METTL1	TT	Efficacy	decreased	Adverse_Event	Disease:C0019372		L03AB11	rs10877012:TT
propranolol	rs4818	COMT	G	Efficacy	increased	Adverse_Event	Efficacy:C0030193|Disease:C0155943		C07AA05	rs4818:G
corticosteroids	rs6001366	APOBEC3B	T	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs6001366:T
peginterferon alfa-2a	rs12979860	IFNL3	TT	Efficacy	increased	Adverse_Event	Disease:C0019372		L03AB11	rs12979860:TT
corticosteroids	rs2278992	KCNN1	C	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs2278992:C
peginterferon alfa-2a	rs7975232	VDR	AA	Efficacy	decreased	Adverse_Event	Disease:C0019372		L03AB11	rs7975232:AA
corticosteroids	rs12959468	ANKRD30B	A	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs12959468:A
rosuvastatin	rs1205	CRP	CT	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs1205:CT
rosuvastatin	rs1205	CRP	TT	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs1205:TT
propranolol	rs6269	COMT	G	Efficacy	increased	Adverse_Event	Efficacy:C0030193|Disease:C0155943		C07AA05	rs6269:G
antineoplastic and immunomodulating agents	rs129081	ABCC1	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs129081:CC
antineoplastic and immunomodulating agents	rs129081	ABCC1	CG	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs129081:CG
risperidone	rs6311	HTR2A	TT	Toxicity	decreased	Adverse_Event	Healthy		N05AX08	rs6311:TT
heroin	rs2189814	GRM3	T	Other	increased	Adverse_Event	Healthy		No_ATC	rs2189814:T
rosuvastatin	rs2808630	__INTRONIC__	CC	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs2808630:CC
rosuvastatin	rs2808630	__INTRONIC__	CT	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs2808630:CT
methadone	rs204076	OPRD1	AT	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	rs204076:AT
methadone	rs204076	OPRD1	TT	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	rs204076:TT
rosuvastatin	rs1169288	HNF1A	AC	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs1169288:AC
rosuvastatin	rs1169288	HNF1A	CC	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs1169288:CC
metoprolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AB02	rs1801253:CC
propranolol	rs4633	COMT	C	Efficacy	increased	Adverse_Event	Efficacy:C0030193|Disease:C0155943		C07AA05	rs4633:C
bucindolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085605		No_ATC	rs1801253:CC
erythromycin	rs35599367	CYP3A4	AA	Toxicity	increased	Adverse_Event	Other:C0004623|Other:C0948873		S01AA17	rs35599367:AA
erythromycin	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:C0004623|Other:C0948873		S01AA17	rs35599367:AG
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:A
aspirin	rs12041331	PEAR1	AA	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs12041331:AA
aspirin	rs12041331	PEAR1	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs12041331:AG
none	rs11739136	KCNIP1, KCNMB1	CT	Other	decreased	Other	Healthy		A03DA02	rs11739136:CT
none	rs11739136	KCNIP1, KCNMB1	TT	Other	decreased	Other	Healthy		A03DA02	rs11739136:TT
tacrolimus	rs2032582	ABCB1	A	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2032582:A
caffeine, isoflurane	rs118192162	RYR1	AC	Toxicity	Indeterminado	Adverse_Event	Healthy		N01AB06|N06BC01	rs118192162:AC
risperidone	rs7643645	NR1I2	GG	Metabolism/PK	decreased	LADME	Disease:C0033975		N05AX08	rs7643645:GG
repaglinide	rs2306283	SLCO1B1	GG	Other, Metabolism/PK	decreased	LADME	Healthy		A10BX02	rs2306283:GG
halothane	rs118192161	RYR1	CT	Toxicity	Indeterminado	Adverse_Event	Healthy		N01AB01	rs118192161:CT
risperidone	rs7643645	NR1I2	GG	Metabolism/PK	decreased	LADME	Disease:C0033975		N05AX08	rs7643645:GG
clopidogrel	rs4244285	CYP2C19	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A
tacrolimus	rs1045642	ABCB1	G	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs1045642:G
gefitinib	rs1065852	CYP2D6	AA	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01EB01	rs1065852:AA
gefitinib	rs1065852	CYP2D6	AG	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01EB01	rs1065852:AG
dalcetrapib	rs1967309	ADCY9	AA	Efficacy	decreased	Adverse_Event	Disease:C0027051		No_ATC	rs1967309:AA
egfr inhibitors	rs6443624	PIK3CA	C	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01EB	rs6443624:C
egfr inhibitors	rs2677760	PIK3CA	T	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01EB	rs2677760:T
misoprostol	rs4149087	SLCO1B1	GG	Toxicity	increased	Adverse_Event	Disease:C0032797		G02AD06	rs4149087:GG
misoprostol	rs11568658	ABCC4	AA	Toxicity	increased	Adverse_Event	Disease:C0032797|Disease:Therapeutic_abortion		G02AD06	rs11568658:AA
aspirin, clopidogrel	rs12041331	PEAR1	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs12041331:A
ethambutol, isoniazid, pyrazinamide, rifampin	rs2031920	CYP2E1	TT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs2031920:TT
carboplatin, cisplatin, docetaxel, gemcitabine, paclitaxel	rs11710163	RAF1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CD01|L01CD02|L01XA01|L01XA02	rs11710163:AG
clopidogrel	rs12248560	CYP2C19	T	Toxicity	decreased	Adverse_Event	Disease:C1956346		B01AC04	rs12248560:T
aspirin, clopidogrel	rs12041331	PEAR1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs12041331:AA
aspirin, clopidogrel	rs12041331	PEAR1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs12041331:AG
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:CT
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:TT
olanzapine	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH03	rs1695:AG
olanzapine	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH03	rs1695:GG
aspirin, clopidogrel	rs12041331	PEAR1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs12041331:AA
aspirin, clopidogrel	rs12041331	PEAR1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs12041331:AG
antiinflammatory agents, non-steroids	rs3892408	ALOX15	C	Toxicity	increased	Adverse_Event	Disease:C0004096		M01A|V10A	rs3892408:C
methadone	rs1129844	CCL11	A	Toxicity	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs1129844:A
egfr inhibitors	rs2699905	PIK3CA	C	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01EB	rs2699905:C
fluoxetine	rs2433320	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB03	rs2433320:GG
antipsychotics	rs1801133	MTHFR	G	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs1801133:G
asparaginase, cyclophosphamide, cytarabine, daunorubicin, mercaptopurine, prednisolone, vincristine	rs738409	PNPLA3	CG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01AA01|L01BB02|L01BC01|L01CA02|L01DB02|L01XX02|S02BA03	rs738409:CG
asparaginase, cyclophosphamide, cytarabine, daunorubicin, mercaptopurine, prednisolone, vincristine	rs738409	PNPLA3	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01AA01|L01BB02|L01BC01|L01CA02|L01DB02|L01XX02|S02BA03	rs738409:GG
antiinflammatory agents, non-steroids	rs5789	PTGS1	C	Toxicity	decreased	Adverse_Event	Disease:C0004096		M01A|V10A	rs5789:C
clozapine, olanzapine	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03	rs1801131:GG
drugs for treatment of tuberculosis	rs1799929	NAT2	CT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs1799929:CT
cyclophosphamide, cytarabine, daunorubicin, doxorubicin, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine	rs738409	PNPLA3	G	Toxicity	increased	Adverse_Event	Other:C0023449		L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03	rs738409:G
leucovorin, tegafur	rs1801019	UMPS	CC	Toxicity	increased	Adverse_Event	Other:C0022665		L01BC03	rs1801019:CC
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	T	Efficacy	decreased	Efficacy_Response	Other:EGFR_mutation_negative_non-small-cell_lung_cancer		L01EB01	rs121434568:T
carboplatin, cisplatin, docetaxel, paclitaxel	rs726501	MAP3K1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs726501:AA
carboplatin, cisplatin, docetaxel, paclitaxel	rs726501	MAP3K1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs726501:AG
ethambutol, isoniazid, pyrazinamide, rifampin	rs9332096	CYP2C9	CT	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs9332096:CT
ethambutol, isoniazid, pyrazinamide, rifampin	rs9332096	CYP2C9	TT	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs9332096:TT
anthracyclines and related substances, cyclophosphamide, fluorouracil, taxanes	rs17102977	CYP4X1	AA	Efficacy	increased	Efficacy_Response	Other:C1458155		L01AA01|L01BC02|L01CD|L01DB	rs17102977:AA
cyclophosphamide, cytarabine, daunorubicin, doxorubicin, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine	rs1142345	TPMT	C	Toxicity	decreased	Adverse_Event	Other:C0023449		L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03	rs1142345:C
ethambutol, isoniazid, pyrazinamide, rifampin	rs4986893	CYP2C19	AA	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs4986893:AA
ethambutol, isoniazid, pyrazinamide, rifampin	rs4986893	CYP2C19	AG	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs4986893:AG
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC
antiinflammatory agents, non-steroids	rs10306135	PTGS1	A	Toxicity	increased	Adverse_Event	Disease:C0004096		M01A|V10A	rs10306135:A
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G
imatinib	rs683369	SLC22A1	CG	Efficacy	decreased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CG
imatinib	rs683369	SLC22A1	GG	Efficacy	decreased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:GG
antipsychotics	rs2061051	GABRG3	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs2061051:A
gemcitabine	rs642990	__INTRONIC__	CT	Toxicity	decreased	Adverse_Event	Healthy		L01BC05	rs642990:CT
gemcitabine	rs642990	__INTRONIC__	TT	Toxicity	decreased	Adverse_Event	Healthy		L01BC05	rs642990:TT
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G
carboplatin, cisplatin, docetaxel, paclitaxel	rs16886403	MAP3K1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs16886403:CC
carboplatin, cisplatin, docetaxel, paclitaxel	rs16886403	MAP3K1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs16886403:CT
gemcitabine	rs1042858	RRM1	A	Dosage	decreased	Adverse_Event	Disease:C1458155		L01BC05	rs1042858:A
carboplatin, cisplatin, docetaxel, paclitaxel	rs17661089	__INTRONIC__	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs17661089:AG
carboplatin, cisplatin, docetaxel, paclitaxel	rs17661089	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs17661089:GG
carboplatin, cisplatin, docetaxel, gemcitabine, paclitaxel	rs17309872	ACSS2	AT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01CD01|L01CD02|L01XA01|L01XA02	rs17309872:AT
methotrexate	rs246240	ABCC1	AG	Toxicity	decreased	Adverse_Event	Disease:C0235763		L04AX03	rs246240:AG
methotrexate	rs246240	ABCC1	GG	Toxicity	decreased	Adverse_Event	Disease:C0235763		L04AX03	rs246240:GG
bupropion, nicotine	rs6702335	EPB41	AA	Efficacy	increased	Efficacy_Response	Disease:C0039338		N06AX12|N07BA01	rs6702335:AA
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G
drugs for treatment of tuberculosis	rs62328061	METTL14	G	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs62328061:G
none	rs763780	IL17F	CC	Other	increased	Adverse_Event	Other:C0032961		A03DA02	rs763780:CC
daunorubicin	rs1799983	NOS3	GG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01DB02	rs1799983:GG
none	rs2275913	IL17A	AA	Other	increased	Adverse_Event	Other:C0032961		A03DA02	rs2275913:AA
ace inhibitors, plain	rs145489027	KCNIP4	A	Other	increased	Adverse_Event	Healthy		A03B|C09A	rs145489027:A
pemetrexed	rs12995526	ATIC	C	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BA04	rs12995526:C
opioids	rs910080	PDYN	A	Toxicity	increased	Adverse_Event	Healthy		N02A	rs910080:A
irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0042065|Disease:C0030297		L01CE02	rs4148323:AA
irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0042065|Disease:C0030297		L01CE02	rs4148323:AG
ace inhibitors, plain	rs1495509	KCNIP4	C	Other	increased	Adverse_Event	Healthy		A03B|C09A	rs1495509:C
folfiri, folfox, xelox	rs1801131	MTHFR	GG	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs1801131:GG
gemcitabine	rs1705772	ALG10	AA	Toxicity	decreased	Adverse_Event	Healthy		L01BC05	rs1705772:AA
gemcitabine	rs1705772	ALG10	AG	Toxicity	decreased	Adverse_Event	Healthy		L01BC05	rs1705772:AG
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:CT
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:TT
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G
cyclophosphamide, cytarabine, daunorubicin, doxorubicin, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine	rs887829	UGT1A1	T	Toxicity	increased	Adverse_Event	Other:C0023449		L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03	rs887829:T
ritonavir	rs2854116	APOC3	C	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03	rs2854116:C
pemetrexed	rs16930092	GGH	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BA04	rs16930092:CT
pemetrexed	rs16930092	GGH	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BA04	rs16930092:TT
anastrozole	rs3732218	UGT1A4	GG	Metabolism/PK	increased	LADME	Other:human_liver_microsomes		L02BG03	rs3732218:GG
haloperidol	rs3892097	CYP2D6	CT	Toxicity	increased	Adverse_Event	Other:C0236663		N05AD01	rs3892097:CT
folfiri, folfox, xelox	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs1045642:GG
ace inhibitors, plain	rs7675300	KCNIP4	A	Other	increased	Adverse_Event	Healthy		A03B|C09A	rs7675300:A
cyclophosphamide	rs2010963	VEGFA	CC	Efficacy	decreased	Efficacy_Response	Disease:C0033578		L01AA01	rs2010963:CC
nicotine	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Other:smokers_who_are_pregnant		N07BA01	rs1051730:A
nevirapine	rs76228616	TRAF3IP2	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs76228616:C
gemcitabine	rs4769060	ALOX5AP	AG	Metabolism/PK	decreased	LADME	Healthy		L01BC05	rs4769060:AG
gemcitabine	rs4769060	ALOX5AP	GG	Metabolism/PK	decreased	LADME	Healthy		L01BC05	rs4769060:GG
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB02	rs121434568:G
sufentanil	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N01AH03	rs1799971:AG
ipilimumab, nivolumab, pembrolizumab	rs16906115	IL7	AA	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs16906115:AA
ipilimumab, nivolumab, pembrolizumab	rs16906115	IL7	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs16906115:AG
gemtuzumab ozogamicin	rs1803254	CD33	CC	Toxicity	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		No_ATC	rs1803254:CC
gemtuzumab ozogamicin	rs1803254	CD33	CG	Toxicity	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		No_ATC	rs1803254:CG
folfiri, folfox, xelox	rs113488022	BRAF	T	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs113488022:T
methotrexate	rs1801133	CLCN6, MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AG
methotrexate	rs1801133	CLCN6, MTHFR	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:GG
opioids	rs2070762	TH	G	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2070762:G
gemtuzumab ozogamicin	rs35112940	CD33	GG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		No_ATC	rs35112940:GG
isoniazid, rifampin	rs6413432	CYP2E1, DUX1	AT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs6413432:AT
cisplatin	rs316019	SLC22A2	A	Toxicity	decreased	Adverse_Event	Healthy		L01XA01	rs316019:A
antineoplastic agents, fluorouracil, leucovorin	rs1059829	SPARC	AG	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01|L01BC02	rs1059829:AG
antineoplastic agents, fluorouracil, leucovorin	rs1059829	SPARC	GG	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01|L01BC02	rs1059829:GG
opioids	rs1611131	DBH	G	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs1611131:G
antipsychotics	rs2445142	HSPG2	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs2445142:C
folfiri, folfox, xelox	rs1801265	DPYD	AG	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs1801265:AG
folfiri, folfox, xelox	rs1801265	DPYD	GG	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs1801265:GG
antipsychotics	rs878949	HSPG2	T	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs878949:T
quetiapine	rs502046	RIMS1	CC	Efficacy, Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH04	rs502046:CC
quetiapine	rs502046	RIMS1	CT	Efficacy, Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH04	rs502046:CT
ethanol	rs846664	TAS2R16	C	Other	increased	Adverse_Event	Healthy		V03AB16	rs846664:C
drugs for treatment of tuberculosis	rs1139130	METTL3	G	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs1139130:G
methotrexate	rs1801131	C1orf167, CLCN6, MTHFR	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801131:GG
methotrexate	rs1801131	C1orf167, CLCN6, MTHFR	GT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801131:GT
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB02	rs121434568:G
hormonal contraceptives for systemic use	rs6025	F5	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs6025:T
sorafenib	rs2239702	KDR	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2239702:CT
sorafenib	rs2239702	KDR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2239702:TT
fluorouracil	rs3812718	SCN1A	CC	Other	decreased	Other	Disease:C0023055		L01BC02	rs3812718:CC
efavirenz	rs3745274	CYP2B6	GT	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
"""acetaminophen"", ""antiepileptics"", ""antiinflammatory agents, non-steroids"", ""opioids"""	rs510769	OPRM1	CT	Efficacy	decreased	Adverse_Event	Other:C0023055|Other:C2939419		N02BE01|N03A|V10A	rs510769:CT
"""acetaminophen"", ""antiepileptics"", ""antiinflammatory agents, non-steroids"", ""opioids"""	rs510769	OPRM1	TT	Efficacy	decreased	Adverse_Event	Other:C0023055|Other:C2939419		N02BE01|N03A|V10A	rs510769:TT
warfarin	rs9934438	VKORC1	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:A
opioids	rs1076560	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1076560:A
efavirenz	rs2472677	NR1I2	TT	Efficacy	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs2472677:TT
efavirenz	rs3745274	CYP2B6	TT	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
cetuximab	rs112445441	KRAS	T	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs112445441:T
cisplatin, cyclophosphamide, dactinomycin, doxorubicin, methotrexate, vincristine	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DA01|L01DB01|L01XA01|L04AX03	rs1801133:AA
sorafenib	rs2010963	VEGFA	CG	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX02	rs2010963:CG
sorafenib	rs2010963	VEGFA	GG	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX02	rs2010963:GG
cisplatin, cyclophosphamide, dactinomycin, doxorubicin, methotrexate, vincristine	rs1805087	MTR	GG	Toxicity	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DA01|L01DB01|L01XA01|L04AX03	rs1805087:GG
sorafenib	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX02	rs1045642:AA
sorafenib	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX02	rs1045642:AG
sorafenib	rs1570360	VEGFA	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs1570360:AA
sorafenib	rs1570360	VEGFA	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs1570360:AG
atorvastatin	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs2231142:GT
atorvastatin	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs2231142:TT
cocaine, heroin	rs62638690	OPRM1	T	Toxicity	decreased	Adverse_Event	Healthy		N01BC01	rs62638690:T
sorafenib	rs2239702	KDR	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2239702:CT
sorafenib	rs2239702	KDR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2239702:TT
efavirenz	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs1045642:AA
cetuximab, panitumumab	rs112445441	KRAS	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs112445441:A
hormonal contraceptives for systemic use	rs1799853	CYP2C9	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs1799853:T
none	rs1805087	MTR	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs1805087:GG
methotrexate	rs1805087	MTR	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1805087:GG
"""acetaminophen"", ""antiepileptics"", ""antiinflammatory agents, non-steroids"", ""opioids"""	rs2236861	OPRD1	AG	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		N02BE01|N03A|V10A	rs2236861:AG
"""acetaminophen"", ""antiepileptics"", ""antiinflammatory agents, non-steroids"", ""opioids"""	rs2236861	OPRD1	GG	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		N02BE01|N03A|V10A	rs2236861:GG
pravastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:CT
hormonal contraceptives for systemic use	rs1799963	F2	A	Toxicity	increased	Adverse_Event	Healthy		G03A	rs1799963:A
efavirenz	rs3745274	CYP2B6	TT	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
fluorouracil	rs3812718	SCN1A	TT	Other	decreased	Other	Disease:C0023055		L01BC02	rs3812718:TT
atazanavir	rs887829	UGT1A1	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	rs887829:T
simvastatin	rs4363657	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0027051		C10AA01	rs4363657:CC
efavirenz	rs28399499	CYP2B6	CC	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC
efavirenz	rs28399499	CYP2B6	CT	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
tacrolimus	rs776746	CYP3A5	CT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0027051		C10AA01	rs4149056:CC
efavirenz	rs4803419	CYP2B6	CT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs4803419:CT
efavirenz	rs4803419	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs4803419:TT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
fluorouracil	rs1801160	DPYD	CT	Metabolism/PK	decreased	LADME	Healthy		L01BC02	rs1801160:CT
allopurinol	rs3131003	PSORS1C1	AG	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3131003:AG
allopurinol	rs3131003	PSORS1C1	GG	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3131003:GG
fluorouracil	rs1801133	MTHFR	GG	Efficacy	increased	Adverse_Event	Disease:C0022665		L01BC02	rs1801133:GG
opioids	rs1997794	PDYN	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1997794:CT
opioids	rs1997794	PDYN	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1997794:TT
ondansetron	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		A04AA01	rs1045642:GG
dexmedetomidine	rs8192733	CYP2A6	GG	Toxicity	increased	Adverse_Event	Other:C0549433		N05CM18	rs8192733:GG
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
"""acetaminophen"", ""antiepileptics"", ""antiinflammatory agents, non-steroids"", ""opioids"""	rs1799971	OPRM1	AA	Efficacy	increased	Adverse_Event	Other:C0023055|Other:C2939419		N02BE01|N03A|V10A	rs1799971:AA
opioids	rs1022563	PDYN	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1022563:CC
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
risperidone	rs7799039	LEP	GG	Toxicity	increased	Adverse_Event	Disease:C0233523|Disease:C0004936		N05AX08	rs7799039:GG
perindopril	rs5182	AGTR1	TT	Efficacy	decreased	Adverse_Event	Disease:C1956346		C09AA04	rs5182:TT
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
gemcitabine	rs2072671	CDA	AC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC05	rs2072671:AC
gemcitabine	rs2072671	CDA	CC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC05	rs2072671:CC
cytarabine	rs602950	CDA	GG	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:C0023418|Myeloid		L01BC01	rs602950:GG
haloperidol	rs3892097	CYP2D6	CC	Toxicity	decreased	Adverse_Event	Disease:C0033936|Disease:C0085762|Disease:C0221016		N05AD01	rs3892097:CC
cytarabine	rs532545	CDA	TT	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:C0023418|Myeloid		L01BC01	rs532545:TT
allopurinol	rs3099844	CYCSP5	AA	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:AA
allopurinol	rs3099844	CYCSP5	AC	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:AC
bisphosphonates	rs17024608	RBMS3	A	Toxicity	increased	Adverse_Event	Healthy		M05BA	rs17024608:A
none	rs4149601	NEDD4L	AG	Other	increased	Adverse_Event	Disease:C0020538		A03DA02	rs4149601:AG
fluorouracil	rs55886062	DPYD	AC	Metabolism/PK	decreased	LADME	Healthy		L01BC02	rs55886062:AC
antipsychotics	rs17587100	INSIG2	C	Other	increased	Adverse_Event	Disease:C0036341		N05A	rs17587100:C
ondansetron	rs2032582	ABCB1	CC	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		A04AA01	rs2032582:CC
none	rs3087243	CTLA4	A	Other	decreased	Adverse_Event	Healthy		A03DA02	rs3087243:A
epirubicin, fluorouracil, oxaliplatin	rs780094	GCKR	CC	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs780094:CC
epirubicin, fluorouracil, oxaliplatin	rs780094	GCKR	CT	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs780094:CT
fluorouracil	rs115232898	DPYD	CT	Metabolism/PK	decreased	LADME	Healthy		L01BC02	rs115232898:CT
ribavirin, sofosbuvir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:Liver_Cirrhosis		J05AP01|J05AP08	rs12979860:CC
tenofovir	rs1059751	ABCC4	G	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF07	rs1059751:G
epirubicin, fluorouracil, oxaliplatin	rs6769511	IGF2BP2	C	Efficacy	increased	Adverse_Event	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs6769511:C
warfarin	rs9934438	VKORC1	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:A
cytarabine	rs2072671	CDA	CC	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:C0023418|Myeloid		L01BC01	rs2072671:CC
warfarin	rs9934438	VKORC1	A	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:A
allopurinol	rs367398	NOTCH4	AA	Toxicity	decreased	Adverse_Event	Healthy		M04AA01	rs367398:AA
allopurinol	rs367398	NOTCH4	AG	Toxicity	decreased	Adverse_Event	Healthy		M04AA01	rs367398:AG
epirubicin, fluorouracil, oxaliplatin	rs163182	KCNQ1	CC	Efficacy	decreased	Adverse_Event	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs163182:CC
epirubicin, fluorouracil, oxaliplatin	rs163182	KCNQ1	GG	Efficacy	decreased	Adverse_Event	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs163182:GG
none	rs1800566	NQO1	AA	Other	decreased	Adverse_Event	Disease:C1458155		A03DA02	rs1800566:AA
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
epirubicin, fluorouracil, oxaliplatin	rs4402960	IGF2BP2	G	Efficacy	decreased	Adverse_Event	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs4402960:G
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:chemorefractory_advanced_non-small-cell_lung_cancer_patients		L01EB01	rs121434568:G
erlotinib, gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01|L01EB02	rs121434568:G
efavirenz	rs3745274	CYP2B6	GG	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:GG
azathioprine, mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:CT
azathioprine, mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:TT
cyclophosphamide, epirubicin, fluorouracil	rs1800566	NQO1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs1800566:AA
methotrexate	rs2306283	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs2306283:AG
methotrexate	rs2306283	SLCO1B1	GG	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs2306283:GG
efavirenz	rs3745274	CYP2B6	GT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
sunitinib	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1045642:AA
verapamil	rs1051375	CACNA1C	AA	Efficacy	decreased	Adverse_Event	Disease:C1956346		C08DA01	rs1051375:AA
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AA
cisplatin, irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AG
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
sunitinib	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1045642:AA
sunitinib	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1045642:AG
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AA
cisplatin, irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AG
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
efavirenz	rs28399433	CYP2A6	AC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399433:AC
efavirenz	rs28399433	CYP2A6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399433:CC
none	rs1800497	DRD2	AA	Toxicity	increased	Adverse_Event	Disease:C0085762		A03DA02	rs1800497:AA
none	rs1800497	DRD2	AG	Toxicity	increased	Adverse_Event	Disease:C0085762		A03DA02	rs1800497:AG
efavirenz	rs28399499	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
verapamil	rs1051375	CACNA1C	GG	Efficacy	increased	Adverse_Event	Disease:C1956346		C08DA01	rs1051375:GG
epirubicin, fluorouracil, oxaliplatin	rs780093	GCKR	CC	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs780093:CC
epirubicin, fluorouracil, oxaliplatin	rs780093	GCKR	CT	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs780093:CT
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs121434568:G
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CT
carboplatin, cisplatin, gemcitabine	rs12118636	__INTRONIC__	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01|L01XA02	rs12118636:AG
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:T
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AA
cisplatin, irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AG
azathioprine, mercaptopurine	rs116855232	NUDT15	TT	Toxicity	Indeterminado	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:TT
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
antineoplastic agents	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01	rs1045642:AG
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
carboplatin, cisplatin, gemcitabine	rs1065634	NRAS	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01|L01XA02	rs1065634:CT
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
carboplatin, cisplatin, gemcitabine	rs451774	GPX5	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01|L01XA02	rs451774:AG
carboplatin, cisplatin, gemcitabine	rs451774	GPX5	GG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01|L01XA02	rs451774:GG
vincristine	rs1135989	ACTG1	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs1135989:A
acenocoumarol, warfarin	rs9923231	VKORC1	T	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03|B01AA07	rs9923231:T
methadone	rs3745274	CYP2B6	GG	Toxicity	increased	Adverse_Event	Healthy		N07BC02	rs3745274:GG
carboplatin, taxanes	rs1801249	ATP7B	AA	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs1801249:AA
vincristine	rs3770102	CAPG	T	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs3770102:T
valproic acid	rs1800012	COL1A1	AA	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AG01	rs1800012:AA
valproic acid	rs1800012	COL1A1	AC	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AG01	rs1800012:AC
vincristine	rs4728709	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs4728709:A
doxorubicin	rs1937840	AKR1C3	GG	Other	decreased	Other	Disease:C1458155		L01DB01	rs1937840:GG
methadone	rs2279343	CYP2B6	AA	Toxicity	increased	Adverse_Event	Healthy		N07BC02	rs2279343:AA
ketoprofen	rs1799853	CYP2C9	CC	Toxicity	decreased	Adverse_Event	Other:C0030193|Postoperative		M02AA10	rs1799853:CC
acenocoumarol, warfarin	rs9923231	VKORC1	T	Efficacy	increased	Other	Disease:C1861172		B01AA03|B01AA07	rs9923231:T
mycophenolate mofetil(mycophenolic acid)	rs4149117	SLCO1B3	GG	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		L04AA06	rs4149117:GG
remifentanil	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Disease:C0030193|Postoperative		N01AH06	rs1799971:GG
warfarin	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:AG
mercaptopurine	rs1127354	ITPA	AA	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0023418		L01BB02	rs1127354:AA
mercaptopurine	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0023418		L01BB02	rs1127354:AC
carboplatin, taxanes	rs3594	GSR	CC	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs3594:CC
acenocoumarol, warfarin	rs429358	APOE	C	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03|B01AA07	rs429358:C
ethanol	rs4251417	SLC6A4	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs4251417:T
carboplatin, taxanes	rs6900017	VEGFA	TT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs6900017:TT
acenocoumarol, warfarin	rs1057910	CYP2C9	C	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03|B01AA07	rs1057910:C
methylphenidate	rs4680	COMT	AA	Toxicity	decreased	Adverse_Event	Other:C1263846		N06BA04	rs4680:AA
methylphenidate	rs4680	COMT	AG	Toxicity	decreased	Adverse_Event	Other:C1263846		N06BA04	rs4680:AG
naloxone	rs1799971	OPRM1	G	Efficacy	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:G
ethanol	rs25531	SLC6A4	C	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs25531:C
interferons, ribavirin	rs2228570	VDR	AG	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB	rs2228570:AG
interferons, ribavirin	rs2228570	VDR	GG	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB	rs2228570:GG
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T
egfr inhibitors	rs2677760	PIK3CA	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EB	rs2677760:C
cetuximab	rs2227983	EGFR	AA	Efficacy	decreased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		No_ATC	rs2227983:AA
cetuximab	rs2227983	EGFR	AG	Efficacy	decreased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		No_ATC	rs2227983:AG
egfr inhibitors	rs2459693	PIK3CA	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EB	rs2459693:T
irinotecan	rs7187684	CES1	CC	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030297|Other:C0023055|Other:C0919267|Other:C0026640		L01CE02	rs7187684:CC
methotrexate	rs2372536	ATIC	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2372536:GG
ethanol	rs2066713	SLC6A4	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs2066713:A
corticosteroids, salmeterol	rs1042713	ADRB2	AA	Efficacy	increased	Adverse_Event	Disease:C0004096		R03AC12|S02BA	rs1042713:AA
antipsychotics	rs4849127	IL1B	AA	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs4849127:AA
antipsychotics	rs4849127	IL1B	AG	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs4849127:AG
beta blocking agents	rs1065852	CYP2D6	GG	Toxicity	increased	Adverse_Event	Other:C0027051		S01ED	rs1065852:GG
fluorouracil	rs1801265	DPYD	GG	Metabolism/PK	increased	LADME	Other:without_the_rs115232898_A>G_variant_(DPYD_Y186C)		L01BC02	rs1801265:GG
egfr inhibitors	rs6443624	PIK3CA	C	Efficacy	decreased	Efficacy_Response	Disease:C0027651		L01EB	rs6443624:C
antipsychotics	rs16944	IL1B	AG	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs16944:AG
daunorubicin, doxorubicin	rs885004	SLC28A3	A	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01DB01|L01DB02	rs885004:A
cyclosporine	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation|Disease:Kidney_Transplantation|Disease:Liver_transplantation|Disease:C0277631		L04AD01	rs1045642:AA
egfr inhibitors	rs2677760	PIK3CA	T	Efficacy	decreased	Efficacy_Response	Disease:C0027651		L01EB	rs2677760:T
corticosteroids	rs1042713	ADRB2	AA	Efficacy	increased	Adverse_Event	Disease:C0004096		S02BA	rs1042713:AA
irinotecan	rs2244614	CES1	AA	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030297|Other:C0023055|Other:C0919267|Other:C0026640		L01CE02	rs2244614:AA
irinotecan	rs2244614	CES1	AG	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030297|Other:C0023055|Other:C0919267|Other:C0026640		L01CE02	rs2244614:AG
exemestane, letrozole	rs6493497	CYP19A1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04|L02BG06	rs6493497:AA
antipsychotics	rs1143634	IL1B	AA	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs1143634:AA
antipsychotics	rs6265	BDNF	CT	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs6265:CT
antipsychotics	rs6265	BDNF	TT	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs6265:TT
methylphenidate	rs2345039	ADGRL3	CG	Toxicity	increased	Adverse_Event	Other:C1263846		N06BA04	rs2345039:CG
methylphenidate	rs2345039	ADGRL3	GG	Toxicity	increased	Adverse_Event	Other:C1263846		N06BA04	rs2345039:GG
daunorubicin, doxorubicin	rs7853758	SLC28A3	A	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01DB01|L01DB02	rs7853758:A
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0023418		L01BB02	rs116855232:CT
warfarin	rs1799853	CYP2C9	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs1799853:T
carboplatin, taxanes	rs1061472	ATP7B	TT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs1061472:TT
irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs4148323:AG
hmg coa reductase inhibitors	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:C
hormonal contraceptives for systemic use	rs4379368	SUGCT	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs4379368:T
none	rs2266780	FMO3	AG	Other	decreased	Adverse_Event	Disease:C0039338		A03DA02	rs2266780:AG
none	rs2266780	FMO3	GG	Other	decreased	Adverse_Event	Disease:C0039338		A03DA02	rs2266780:GG
hormonal contraceptives for systemic use	rs710446	KNG1	C	Toxicity	increased	Adverse_Event	Healthy		G03A	rs710446:C
fluorouracil	rs1801265	DPYD	AA	Efficacy	increased	Efficacy_Response	Disease:C0023449		L01BC02	rs1801265:AA
irinotecan	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030297|Other:C0023055|Other:C0919267|Other:C0026640		L01CE02	rs2231142:GT
irinotecan	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030297|Other:C0023055|Other:C0919267|Other:C0026640		L01CE02	rs2231142:TT
aspirin	rs3798220	LPA	CT	Efficacy	decreased	Adverse_Event	Healthy		No_ATC	rs3798220:CT
methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1051266:TT
boceprevir, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|J05AP03|L03AB10	rs12979860:CC
warfarin	rs3814637	CYP2C19	T	Toxicity	Indeterminado	Adverse_Event	Healthy		B01AA03	rs3814637:T
fluorouracil	rs72728438	DPYD	CT	Metabolism/PK	decreased	LADME	Healthy		L01BC02	rs72728438:CT
fluorouracil	rs7194667	ABCC11	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs7194667:GG
fluorouracil	rs7194667	ABCC11	GT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs7194667:GT
egfr inhibitors	rs2699905	PIK3CA	C	Efficacy	decreased	Efficacy_Response	Disease:C0027651		L01EB	rs2699905:C
fluorouracil	rs115632870	DPYD	CT	Metabolism/PK	decreased	LADME	Healthy		L01BC02	rs115632870:CT
hormonal contraceptives for systemic use	rs56392308	ABO	del	Toxicity	decreased	Adverse_Event	Healthy		G03A	rs56392308:del
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT
ethanol	rs6350	SLC6A3	AG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs6350:AG
capecitabine, fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:AT
hormonal contraceptives for systemic use	rs8176719	ABO	C	Toxicity	increased	Adverse_Event	Healthy		G03A	rs8176719:C
methotrexate	rs4149056	SLCO1B1	TT	Toxicity	decreased	Adverse_Event	Disease:C0027651		L04AX03	rs4149056:TT
hormonal contraceptives for systemic use	rs9574	PROCR	G	Toxicity	increased	Adverse_Event	Healthy		G03A	rs9574:G
hormonal contraceptives for systemic use	rs2289252	F11	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs2289252:T
methotrexate	rs2306283	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L04AX03	rs2306283:AG
methotrexate	rs2306283	SLCO1B1	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L04AX03	rs2306283:GG
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BC02	rs3918290:CT
dexmedetomidine	rs3814057	NR1I2	CC	Toxicity	increased	Adverse_Event	Other:C0549433		N05CM18	rs3814057:CC
none	rs1137070	MAOA	TT	Toxicity	decreased	Adverse_Event	Healthy		A03DA02	rs1137070:TT
none	rs1799836	MAOB	CC	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1799836:CC
capecitabine	rs9936750	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs9936750:C
fluorouracil	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BC02	rs1801265:AG
fluorouracil	rs1801265	DPYD	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BC02	rs1801265:GG
doxorubicin	rs1045642	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01DB01	rs1045642:A
doxorubicin	rs1056892	CBR3	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01DB01	rs1056892:A
capecitabine	rs3918290	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01BC06	rs3918290:T
folfiri	rs4124874	UGT1A1	GG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs4124874:GG
capecitabine	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01BC06	rs67376798:A
cetuximab	rs4444903	EGF	GG	Efficacy	increased	Adverse_Event	Disease:C0022665		No_ATC	rs4444903:GG
afatinib, erlotinib, gefitinib	rs2261988	UHRF1	TT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01EB01|L01EB02|L01EB03	rs2261988:TT
none	rs10515746	HAVCR2	AA	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		A03DA02	rs10515746:AA
none	rs10515746	HAVCR2	AC	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		A03DA02	rs10515746:AC
none	rs1036199	HAVCR2	AC	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		A03DA02	rs1036199:AC
none	rs1036199	HAVCR2	CC	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		A03DA02	rs1036199:CC
afatinib, erlotinib, gefitinib	rs2074216	DVL2	AA	Efficacy	decreased	Adverse_Event	Other:C0024121		L01EB01|L01EB02|L01EB03	rs2074216:AA
glatiramer acetate	rs12459996	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0026769		L03AX13	rs12459996:T
warfarin	rs9923231	VKORC1	T	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:T
warfarin	rs9923231	VKORC1	T	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:T
fluorouracil	rs10876844	OR10AE3P, PSMB3P	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs10876844:A
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Healthy		L04AX03	rs1801133:AA
heroin	rs6265	BDNF	TT	Other	increased	Adverse_Event	Healthy		No_ATC	rs6265:TT
methamphetamine	rs6265	BDNF	T	Other	increased	Adverse_Event	Healthy		No_ATC	rs6265:T
doxorubicin, paclitaxel, trastuzumab	rs2235047	ABCB1	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01|L01DB01	rs2235047:C
doxorubicin, paclitaxel, trastuzumab	rs1056892	CBR3	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01|L01DB01	rs1056892:A
fentanyl	rs540825	OPRM1	T	Toxicity	increased	Adverse_Event	Disease:C0030193|Postoperative		N02AB03	rs540825:T
aspirin, ticagrelor	rs3093135	CYP4F2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027051|Disease:C0027051		B01AC24	rs3093135:AA
clopidogrel	rs2032582	ABCB1	T	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs2032582:T
afatinib, erlotinib, gefitinib	rs9523	NUP62	CC	Efficacy	decreased	Adverse_Event	Other:C0024121		L01EB01|L01EB02|L01EB03	rs9523:CC
none	rs2207418	__INTRONIC__	GG	Other	increased	Adverse_Event	Disease:C0085605		A03DA02	rs2207418:GG
alfentanil	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Healthy		N01AH02	rs1799971:GG
warfarin	rs9332197	CYP2C9	C	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs9332197:C
warfarin	rs1057910	CYP2C9	C	Toxicity	Indeterminado	Adverse_Event	Healthy		B01AA03	rs1057910:C
warfarin	rs2901783	CYP2C18	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs2901783:AG
warfarin	rs2901783	CYP2C18	GG	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs2901783:GG
warfarin	rs6018	F5	G	Toxicity	Indeterminado	Adverse_Event	Healthy		B01AA03	rs6018:G
warfarin	rs8178607	PROS1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs8178607:AA
none	rs2165870	CHRM3	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs2165870:GG
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
cisplatin, gemcitabine	rs2072671	CDA	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BC05|L01XA01	rs2072671:AA
capecitabine	rs1801265	DPYD	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01BC06	rs1801265:G
doxorubicin	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Healthy		L01DB01	rs1695:GG
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
methotrexate	rs1801131	MTHFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0023449		L04AX03	rs1801131:TT
methotrexate	rs1801133	MTHFR	GG	Efficacy	increased	Efficacy_Response	Disease:C0023449		L04AX03	rs1801133:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs1801274:AG
none	rs7626962	SCN5A	GT	Other	increased	Adverse_Event	Healthy		A03DA02	rs7626962:GT
none	rs7626962	SCN5A	TT	Other	increased	Adverse_Event	Healthy		A03DA02	rs7626962:TT
carboplatin, taxanes	rs879825	VEGFA	GG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs879825:GG
exemestane, letrozole	rs4870061	ESR1	CT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04|L02BG06	rs4870061:CT
exemestane, letrozole	rs4870061	ESR1	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04|L02BG06	rs4870061:TT
methotrexate	rs1801394	MTRR	AG	Metabolism/PK	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1801394:AG
methotrexate	rs1801394	MTRR	GG	Metabolism/PK	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1801394:GG
carboplatin, taxanes	rs9825762	SCN10A	TT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs9825762:TT
carboplatin, taxanes	rs9369421	VEGFA	CC	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs9369421:CC
letrozole	rs4870061	ESR1	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04	rs4870061:TT
warfarin	rs1057910	CYP2C9	CC	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1057910:CC
methotrexate	rs2273697	ABCC2	AA	Metabolism/PK	increased	Adverse_Event	Other:C0023449		L04AX03	rs2273697:AA
methotrexate	rs2273697	ABCC2	AG	Metabolism/PK	increased	Adverse_Event	Other:C0023449		L04AX03	rs2273697:AG
exemestane, letrozole	rs9322335	ESR1	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04|L02BG06	rs9322335:TT
letrozole	rs9322335	ESR1	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04	rs9322335:TT
cisplatin, etoposide	rs1800566	NQO1	AA	Other	decreased	Other	Disease:C0007131		L01CB01|L01XA01	rs1800566:AA
cisplatin	rs316019	SLC22A2	AC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs316019:AC
letrozole	rs10140457	ESR2	CC	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04	rs10140457:CC
exemestane	rs2813543	ESR1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG06	rs2813543:AA
exemestane	rs6493497	CYP19A1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG06	rs6493497:AA
methotrexate	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CC
methotrexate	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CT
methotrexate	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CC
methotrexate	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CT
bisphosphonates	rs2736308	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Other:C0027651		M05BA	rs2736308:C
methotrexate	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CC
methotrexate	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CT
bisphosphonates	rs2736308	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Other:C0029456		M05BA	rs2736308:C
antiinflammatory agents, non-steroids	rs10306135	PTGS1	TT	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs10306135:TT
bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin, trastuzumab	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0026640		L01BC06|L01CD02|L01DB03|L01FG01|L01XA01|L01XA03	rs67376798:AT
carboplatin, gemcitabine	rs1800629	TNF	A	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs1800629:A
sorafenib	rs2305948	KDR	CC	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs2305948:CC
none	rs4680	COMT	AG	Other	decreased	Other	Disease:C0270276		A03DA02	rs4680:AG
none	rs4680	COMT	GG	Other	decreased	Other	Disease:C0270276		A03DA02	rs4680:GG
carboplatin, gemcitabine	rs11229	PRRC2A	G	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs11229:G
carboplatin, gemcitabine	rs10885	PRRC2A	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs10885:T
methadone, morphine	rs4680	COMT	AG	Other	decreased	Adverse_Event	Other:C0270276		N02AA01|N07BC02	rs4680:AG
methadone, morphine	rs4680	COMT	GG	Other	decreased	Adverse_Event	Other:C0270276		N02AA01|N07BC02	rs4680:GG
sorafenib	rs664393	FLT1	TT	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs664393:TT
sorafenib	rs2071559	KDR	AA	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2071559:AA
carboplatin, gemcitabine	rs3115672	MSH5	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs3115672:T
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs13959	ALDH1A1	AA	Efficacy	increased	Adverse_Event	Other:C1458155		L01AA01|L01BC02|L01DB01	rs13959:AA
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs13959	ALDH1A1	AG	Efficacy	increased	Adverse_Event	Other:C1458155		L01AA01|L01BC02|L01DB01	rs13959:AG
hmg coa reductase inhibitors	rs17381194	ATP2B1	T	Toxicity	increased	Adverse_Event	Disease:C0020473		C10AA	rs17381194:T
carboplatin, gemcitabine	rs10491684	DOCK8	A	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs10491684:A
hmg coa reductase inhibitors	rs4693570	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C0020473		C10AA	rs4693570:C
none	rs1617640	EPO	A	Other	increased	Other	Healthy		A03DA02	rs1617640:A
hmg coa reductase inhibitors	rs672348	DMPK	G	Toxicity	increased	Adverse_Event	Disease:C0020473		C10AA	rs672348:G
aspirin	rs12678747	EYA1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs12678747:T
carboplatin, gemcitabine	rs1058932	CYP2C8	A	Toxicity	decreased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs1058932:A
carboplatin, gemcitabine	rs11572078	CYP2C8	A	Toxicity	decreased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs11572078:A
azithromycin, chlorpromazine, cilostazol, ciprofloxacin, citalopram, clarithromycin, dofetilide, donepezil, dronedarone, erythromycin, escitalopram, flecainide, fluconazole, haloperidol, hydroxychloroquine, levofloxacin, methadone, moxifloxacin, ondansetron, oxaliplatin, papaverine, pentamidine, procainamide, propofol, quinidine, sotalol	rs1805128	KCNE1	T	Toxicity	increased	Adverse_Event	Healthy		A04AA01|B01AC23|C01BA01|C01BA02|C01BC04|C01BD04|C01BD07|C07AA07|G04BE02|J01FA09|J01MA12|J02AC01|L01XA03|N01AX10|N05AA01|N05AD01|N06AB04|N06AB10|N06DA02|N07BC02|P01BA02|P01CX01|S01AA17|S01AA26|S01AE07|S03AA07	rs1805128:T
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
carboplatin, gemcitabine	rs2233980	C6orf15	A	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs2233980:A
carboplatin, gemcitabine	rs3130985	CDSN	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs3130985:T
etoposide, platinum compounds	rs716274	DYNC2H1	AG	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CB01|L01XA	rs716274:AG
etoposide, platinum compounds	rs716274	DYNC2H1	GG	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CB01|L01XA	rs716274:GG
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:bronchioloalveolar_carcinoma_and_adenocarcinoma_patients		L01EB02	rs121434568:G
methadone, morphine	rs1799971	OPRM1	AG	Other	decreased	Adverse_Event	Disease:C0270276		N02AA01|N07BC02	rs1799971:AG
methadone, morphine	rs1799971	OPRM1	GG	Other	decreased	Adverse_Event	Disease:C0270276		N02AA01|N07BC02	rs1799971:GG
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs1800566	NQO1	AA	Efficacy	decreased	Adverse_Event	Other:C1458155		L01AA01|L01BC02|L01DB01	rs1800566:AA
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs1800566	NQO1	AG	Efficacy	decreased	Adverse_Event	Other:C1458155		L01AA01|L01BC02|L01DB01	rs1800566:AG
etoposide, platinum compounds	rs10895256	YAP1	GT	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CB01|L01XA	rs10895256:GT
etoposide, platinum compounds	rs10895256	YAP1	TT	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CB01|L01XA	rs10895256:TT
hmg coa reductase inhibitors	rs6535454	COQ2	A	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs6535454:A
hmg coa reductase inhibitors	rs4693075	COQ2	G	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4693075:G
carboplatin, gemcitabine	rs1049709	HLA-C	C	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs1049709:C
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:bronchioloalveolar_carcinoma_and_adenocarcinoma_patients		L01EB02	rs121434568:G
carboplatin, gemcitabine	rs3130907	HCP5	G	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs3130907:G
lenalidomide	rs4135385	CTNNB1	AA	Toxicity	increased	Adverse_Event	Disease:Multiple_Myeloma		L04AX04	rs4135385:AA
carboplatin, erlotinib, paclitaxel	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01EB02|L01XA02	rs121434568:G
carboplatin, gemcitabine	rs5877	SERPINC1	C	Toxicity	decreased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs5877:C
ibrutinib	rs2237895	KCNQ1	AA	Toxicity	increased	Adverse_Event	"""Other:C0023418|Lymphocytic|Chronic|B-Cell""|""Other:Waldenstrom_Macroglobulinemia""|""Other:C0334634"		L01EL01	rs2237895:AA
tamoxifen	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs4149056:CC
tamoxifen	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs4149056:CT
methotrexate	rs1051266	SLC19A1	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1051266:CC
none	rs7626962	SCN5A	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs7626962:GG
lenalidomide	rs4533622	CTNNB1	AA	Toxicity	increased	Adverse_Event	Disease:Multiple_Myeloma		L04AX04	rs4533622:AA
carboplatin, gemcitabine	rs886423	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs886423:C
carboplatin, gemcitabine	rs886424	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs886424:T
beta blocking agents	rs1801252	ADRB1	AG	Efficacy	increased	Adverse_Event	Healthy		S01ED	rs1801252:AG
beta blocking agents	rs1801252	ADRB1	GG	Efficacy	increased	Adverse_Event	Healthy		S01ED	rs1801252:GG
carboplatin, gemcitabine	rs9262132	ATAT1	C	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs9262132:C
sorafenib	rs2010963	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2010963:GG
sorafenib	rs2010963	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2010963:GG
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs121434568:G
none	rs495828	ABO	GG	Metabolism/PK	increased	Other	Disease:C0020538		A03DA02	rs495828:GG
carboplatin, gemcitabine	rs9262143	PPP1R18	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs9262143:T
none	rs1799971	OPRM1	AG	Other	decreased	Other	Disease:C0270276		A03DA02	rs1799971:AG
none	rs1799971	OPRM1	GG	Other	decreased	Other	Disease:C0270276		A03DA02	rs1799971:GG
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs121434568:G
sorafenib	rs4604006	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs4604006:CC
ibrutinib	rs163182	KCNQ1	GG	Toxicity	increased	Adverse_Event	"""Other:C0023418|Lymphocytic|Chronic|B-Cell""|""Other:Waldenstrom_Macroglobulinemia""|""Other:C0334634"		L01EL01	rs163182:GG
carboplatin, gemcitabine	rs3094086	MUCL3	A	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs3094086:A
olanzapine	rs10423928	GIPR	AA	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	rs10423928:AA
sorafenib	rs4604006	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs4604006:CC
sorafenib	rs25648	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs25648:CC
anthracyclines and related substances	rs28714259	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01DB	rs28714259:A
cyclosporine	rs231775	CTLA4	A	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs231775:A
sorafenib	rs833061	VEGFA	CC	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs833061:CC
sorafenib	rs699947	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs699947:CC
sorafenib	rs25648	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs25648:CC
fentanyl	rs9397685	OPRM1	AG	Toxicity	decreased	Adverse_Event	Disease:C0030193|Postoperative		N02AB03	rs9397685:AG
sorafenib	rs833061	VEGFA	CC	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs833061:CC
tacrolimus	rs776746	CYP3A5	CT	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
none	rs2274407	ABCC4	AA	Efficacy	decreased	Adverse_Event	Disease:C0023449		A03DA02	rs2274407:AA
none	rs2274407	ABCC4	AC	Efficacy	decreased	Adverse_Event	Disease:C0023449		A03DA02	rs2274407:AC
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:people_with_EGFR_mutation_positive_advanced_non-small-cell_lung_cancer		L01EB01	rs121434568:G
erlotinib, gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer_patients		L01EB01|L01EB02	rs121434568:G
erlotinib, gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer_patients		L01EB01|L01EB02	rs121434568:G
warfarin	rs9923231	VKORC1	TT	Dosage, Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
pazopanib	rs2858996	HFE	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX03	rs2858996:TT
paclitaxel	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs1128503:AA
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AG
none	rs2207418	__INTRONIC__	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs2207418:GG
tacrolimus	rs776746	CYP3A5	CT	Efficacy, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Efficacy, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
glatiramer acetate	rs75041078	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0026769		L03AX13	rs75041078:A
glatiramer acetate	rs1056854	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0026769		L03AX13	rs1056854:A
methamphetamine	rs2236418	GAD2	AG	Other	increased	Adverse_Event	Healthy		No_ATC	rs2236418:AG
methamphetamine	rs2236418	GAD2	GG	Other	increased	Adverse_Event	Healthy		No_ATC	rs2236418:GG
gliclazide, glyburide	rs757110	ABCC8, KCNJ11	CC	Efficacy	increased	Adverse_Event	Other:C0011849		A10BB09	rs757110:CC
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB02	rs121434568:G
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4803217	IFNL3	AA	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs4803217:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4803217	IFNL3	AC	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs4803217:AC
tacrolimus	rs2229109	ABCB1	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs2229109:CT
tacrolimus	rs2229109	ABCB1	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs2229109:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4803217	IFNL3	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs4803217:CC
tacrolimus	rs776746	CYP3A5	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
fentanyl	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0030193|Postoperative		N02AB03	rs1045642:AA
tacrolimus	rs776746	CYP3A5	CT	Efficacy, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Efficacy, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
afatinib, erlotinib, gefitinib	rs11541557	ARF1	GT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01EB01|L01EB02|L01EB03	rs11541557:GT
afatinib, erlotinib, gefitinib	rs11541557	ARF1	TT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01EB01|L01EB02|L01EB03	rs11541557:TT
drugs for treatment of tuberculosis	rs2031920	CYP2E1	CT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs2031920:CT
drugs for treatment of tuberculosis	rs2031920	CYP2E1	TT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs2031920:TT
oseltamivir	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0035222|Other:suspected_influenza_A/H1N1_infection		J05AH02	rs1045642:AG
oseltamivir	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0035222|Other:suspected_influenza_A/H1N1_infection		J05AH02	rs1045642:GG
methotrexate	rs9895420	ABCC3	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0023449		L04AX03	rs9895420:AA
methotrexate	rs9895420	ABCC3	AT	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0023449		L04AX03	rs9895420:AT
methotrexate	rs9895420	ABCC3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs9895420:AA
methotrexate	rs9895420	ABCC3	AT	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs9895420:AT
cocaine	rs678849	OPRD1	T	Toxicity	decreased	Adverse_Event	Healthy		N01BC01	rs678849:T
cerivastatin	rs2819742	RYR2	AA	Toxicity	decreased	Adverse_Event	Healthy		C10AA06	rs2819742:AA
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs1891059	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs1891059:A
antiepileptics	rs2273697	ABCC2	A	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs2273697:A
methotrexate	rs9895420	ABCC3	AA	Efficacy	increased	Adverse_Event	Disease:C0023449		L04AX03	rs9895420:AA
methotrexate	rs9895420	ABCC3	AT	Efficacy	increased	Adverse_Event	Disease:C0023449		L04AX03	rs9895420:AT
none	rs35694136	CYP1A2	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs35694136:T
antithymocyte globulin	rs396991	FCGR3A	AC	Other	increased	Other	Disease:Kidney_Transplantation		No_ATC	rs396991:AC
antithymocyte globulin	rs396991	FCGR3A	CC	Other	increased	Other	Disease:Kidney_Transplantation		No_ATC	rs396991:CC
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs141059755	LINC00251	G	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs141059755:G
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs17021408	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs17021408:C
pegaspargase	rs9958628	ARHGAP28	T	Toxicity	increased	Adverse_Event	Healthy		L01XX24	rs9958628:T
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs117532069	DOK5	A	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs117532069:A
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs80223967	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs80223967:G
carboplatin, etoposide, ifosfamide	rs3114020	ABCG2	CT	Efficacy	increased	Adverse_Event	Other:C0266453		L01AA06|L01CB01|L01XA02	rs3114020:CT
carboplatin, etoposide, ifosfamide	rs3114020	ABCG2	TT	Efficacy	increased	Adverse_Event	Other:C0266453		L01AA06|L01CB01|L01XA02	rs3114020:TT
theophylline	rs35694136	CYP1A2	T/del	Efficacy	increased	Adverse_Event	Disease:C0024117		R03DA04	rs35694136:T/del
theophylline	rs35694136	CYP1A2	TT	Efficacy	increased	Adverse_Event	Disease:C0024117		R03DA04	rs35694136:TT
theophylline	rs35694136	CYP1A2	T	Efficacy, Metabolism/PK	decreased	LADME	Disease:C0024117		R03DA04	rs35694136:T
none	rs762551	CYP1A2	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs762551:C
ethambutol, isoniazid / pyrazinamide / rifampin	rs1061472	ATP7B	CC	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1061472:CC
verapamil	rs2279238	NR1H3	T	Efficacy	increased	Adverse_Event	Disease:C1956346|Disease:C0020538		C08DA01	rs2279238:T
verapamil	rs12221497	NR1H3	A	Efficacy	decreased	Adverse_Event	Disease:C1956346|Disease:C0020538		C08DA01	rs12221497:A
atenolol, verapamil	rs11039149	NR1H3	G	Efficacy	decreased	Adverse_Event	Disease:C1956346|Disease:C0020538		C07AB03|C08DA01	rs11039149:G
sevoflurane	rs6686529	KCNK2	CC	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs6686529:CC
sevoflurane	rs6686529	KCNK2	CG	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs6686529:CG
chop, rituximab	rs74832512	SLC35F4	CC	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs74832512:CC
protease inhibitors	rs2854116	APOC3	CC	Efficacy	decreased	Adverse_Event	Healthy		J05AE	rs2854116:CC
protease inhibitors	rs2854116	APOC3	CT	Efficacy	decreased	Adverse_Event	Healthy		J05AE	rs2854116:CT
varenicline	rs2302764	CHRNB1, ZBTB4	C	Toxicity	increased	Adverse_Event	Disease:C0039338		N07BA03	rs2302764:C
protease inhibitors	rs2854117	APOC3	CT	Toxicity	decreased	Adverse_Event	Healthy		J05AE	rs2854117:CT
protease inhibitors	rs2854117	APOC3	TT	Toxicity	decreased	Adverse_Event	Healthy		J05AE	rs2854117:TT
varenicline	rs2072661	CHRNB2	A	Toxicity	increased	Adverse_Event	Disease:C0039338		N07BA03	rs2072661:A
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs79085477	BMP7	T	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs79085477:T
varenicline	rs4292956	CHRNB2	T	Toxicity	increased	Adverse_Event	Disease:C0039338		N07BA03	rs4292956:T
varenicline	rs2072660	CHRNB2	C	Toxicity	increased	Adverse_Event	Disease:C0039338		N07BA03	rs2072660:C
carboplatin, etoposide, ifosfamide	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Other:C0266453		L01AA06|L01CB01|L01XA02	rs1045642:AA
carboplatin, etoposide, ifosfamide	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Other:C0266453		L01AA06|L01CB01|L01XA02	rs1045642:AG
azathioprine	rs1127354	DDRGK1, ITPA	A	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs1127354:A
morphine	rs324420	FAAH	AA	Toxicity	increased	Adverse_Event	Disease:C0022821|Disease:C0036439		N02AA01	rs324420:AA
chop, rituximab	rs11721010	OXNAD1	TT	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs11721010:TT
morphine	rs11576941	FAAH	TT	Toxicity	increased	Adverse_Event	Disease:C0022821|Disease:C0036439		N02AA01	rs11576941:TT
protease inhibitors	rs5128	APOC3	CG	Toxicity	decreased	Adverse_Event	Healthy		J05AE	rs5128:CG
protease inhibitors	rs5128	APOC3	GG	Toxicity	decreased	Adverse_Event	Healthy		J05AE	rs5128:GG
sunitinib	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs2032582:AC
docetaxel	rs11045585	SLCO1B3	G	Toxicity	increased	Adverse_Event	Healthy		L01CD02	rs11045585:G
apixaban	rs4148738	ABCB1	CT	Toxicity	decreased	Adverse_Event	Healthy		B01AF02	rs4148738:CT
apixaban	rs4148738	ABCB1	TT	Toxicity	decreased	Adverse_Event	Healthy		B01AF02	rs4148738:TT
docetaxel	rs12762549	ABCC2	G	Toxicity	increased	Adverse_Event	Healthy		L01CD02	rs12762549:G
aspirin	rs5918	ITGB3	CT	Other	increased	Other	Healthy		No_ATC	rs5918:CT
chop, rituximab	rs75614943	CIDEA	TT	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs75614943:TT
cytarabine	rs3215400	CDA	C/del	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs3215400:C/del
cytarabine	rs3215400	CDA	del/del	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs3215400:del/del
methamphetamine	rs6265	BDNF	CC	Other	increased	Adverse_Event	Healthy		No_ATC	rs6265:CC
chop, rituximab	rs77241831	NOS1	GG	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs77241831:GG
methamphetamine	rs6265	BDNF	CC	Other	decreased	Adverse_Event	Disease:C0036502		No_ATC	rs6265:CC
cytarabine	rs2072671	CDA	AC	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs2072671:AC
cytarabine	rs2072671	CDA	CC	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs2072671:CC
antipsychotics	rs9346455	__INTRONIC__	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs9346455:GG
antipsychotics	rs9346455	__INTRONIC__	GT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs9346455:GT
sufentanil	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative		N01AH03	rs1045642:GG
cytarabine	rs602950	CDA	AG	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs602950:AG
cytarabine	rs602950	CDA	GG	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs602950:GG
heroin	rs2236857	OPRD1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2236857:C
cytarabine	rs532545	CDA	CT	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs532545:CT
cytarabine	rs532545	CDA	TT	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs532545:TT
heroin	rs2236855	OPRD1	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2236855:A
sunitinib	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs1128503:AG
rivaroxaban	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Healthy		B01AF01	rs1045642:AA
rivaroxaban	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Healthy		B01AF01	rs1045642:AG
heroin	rs3766951	OPRD1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3766951:C
nicotine	rs2193225	NRXN1	C	Other	Indeterminado	Other	Other:smokers		N07BA01	rs2193225:C
heroin	rs2298897	OPRD1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2298897:C
nicotine	rs2193225	NRXN1	C	Other	Indeterminado	Other	Other:smokers		N07BA01	rs2193225:C
nicotine	rs6721498	NRXN1	A	Other	Indeterminado	Other	Other:smokers		N07BA01	rs6721498:A
sunitinib	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs1045642:AG
chop, rituximab	rs1607795	__INTRONIC__	CC	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1607795:CC
sufentanil	rs4680	COMT	AA	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative		N01AH03	rs4680:AA
ethanol	rs492602	FUT2	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs492602:A
ethanol	rs9937709	FTO	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs9937709:A
platinum	rs6878291	RICTOR	GG	Toxicity	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs6878291:GG
antidepressants	rs852977	NR3C1	G	Efficacy	increased	LADME	Healthy		N06A	rs852977:G
cerivastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA06	rs4149056:CC
paroxetine	rs1176744	HTR3B	AA	Toxicity	increased	Adverse_Event	Disease:C0004936		N06AB05	rs1176744:AA
ethanol	rs1783835	__INTRONIC__	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1783835:A
chop, rituximab	rs116665727	TNIP3	CC	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs116665727:CC
cisplatin, fluorouracil, radiotherapy	rs1760944	APEX1	GG	Efficacy	decreased	Adverse_Event	Other:C0007097|Squamous_Cell		L01BC02|L01XA01	rs1760944:GG
chop, rituximab	rs1800871	IL10	AG	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1800871:AG
chop, rituximab	rs1800871	IL10	GG	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1800871:GG
sunitinib	rs2032582	ABCB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2032582:A
cisplatin, fluorouracil, radiotherapy	rs3219489	MUTYH	CG	Efficacy	decreased	Adverse_Event	Other:C0007097|Squamous_Cell		L01BC02|L01XA01	rs3219489:CG
cisplatin, fluorouracil, radiotherapy	rs3219489	MUTYH	GG	Efficacy	decreased	Adverse_Event	Other:C0007097|Squamous_Cell		L01BC02|L01XA01	rs3219489:GG
ethanol	rs12296477	SLC4A8	C	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs12296477:C
aspirin	rs5918	ITGB3	CC	Other	Indeterminado	Other	Healthy		No_ATC	rs5918:CC
aspirin	rs5918	ITGB3	CT	Other	Indeterminado	Other	Healthy		No_ATC	rs5918:CT
escitalopram	rs9316233	HTR2A	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10	rs9316233:C
ethanol	rs61974485	ARID4A	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs61974485:T
ethanol	rs8008020	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs8008020:T
nicotine	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1799971:AG
ethanol	rs72768626	TNRC6A	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs72768626:A
glimepiride, glipizide, glyburide	rs10494366	NOS1AP	T	Toxicity	increased	Adverse_Event	Other:C0011849		A10BB07|A10BB12	rs10494366:T
ketorolac	rs2562456	__INTRONIC__	CC	Efficacy	Indeterminado	Efficacy_Response	Healthy		S01BC05	rs2562456:CC
opioids	rs1799971	OPRM1	AG	Dosage	decreased	Adverse_Event	Healthy		N02A	rs1799971:AG
opioids	rs1799971	OPRM1	GG	Dosage	decreased	Adverse_Event	Healthy		N02A	rs1799971:GG
azathioprine	rs2074087	ABCC1	CC	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs2074087:CC
azathioprine	rs2074087	ABCC1	CG	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs2074087:CG
fluvastatin	rs60282872	SREBF1	CC	Efficacy	increased	Efficacy_Response	Disease:C1956346		C10AA04	rs60282872:CC
bevacizumab, pemetrexed	rs1051298	SLC19A1	G	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01BA04|L01FG01	rs1051298:G
cisplatin, radiotherapy	rs1042522	TP53	CG	Efficacy	increased	Efficacy_Response	Other:C0007869		L01XA01	rs1042522:CG
none	rs13266634	SLC30A8	C	Other, Metabolism/PK	increased	Other	Other:suspected_increased_risk_of_diabetes		A03DA02	rs13266634:C
opioids	rs1799971	OPRM1	AG	Dosage	decreased	Adverse_Event	Other:C0030193|Postoperative		N02A	rs1799971:AG
opioids	rs1799971	OPRM1	GG	Dosage	decreased	Adverse_Event	Other:C0030193|Postoperative		N02A	rs1799971:GG
antiinflammatory agents, non-steroids	rs943580	AGT	GG	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs943580:GG
antiinflammatory agents, non-steroids	rs2071230	MMP1, MMP10	AG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs2071230:AG
antiinflammatory agents, non-steroids	rs2071230	MMP1, MMP10	GG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs2071230:GG
levonorgestrel	rs7255721	ADAMTS10	CG	Toxicity	decreased	Adverse_Event	Healthy		G03AD01	rs7255721:CG
antiinflammatory agents, non-steroids	rs7945189	MMP1, MMP10	CT	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs7945189:CT
antiinflammatory agents, non-steroids	rs7945189	MMP1, MMP10	TT	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs7945189:TT
citalopram	rs6313	HTR2A	AA	Toxicity	decreased	Adverse_Event	Disease:C0235876		N06AB04	rs6313:AA
antiinflammatory agents, non-steroids	rs12353214	PTGS1	TT	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs12353214:TT
antiinflammatory agents, non-steroids	rs211247	KL	CG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs211247:CG
antiinflammatory agents, non-steroids	rs211247	KL	GG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs211247:GG
antiinflammatory agents, non-steroids	rs1205	CRP	CT	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs1205:CT
antiinflammatory agents, non-steroids	rs1205	CRP	TT	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs1205:TT
nicotine	rs1044396	CHRNA4	AG	Other	increased	Adverse_Event	Healthy		N07BA01	rs1044396:AG
antiinflammatory agents, non-steroids	rs10757274	CDKN2B-AS1	AA	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs10757274:AA
antiinflammatory agents, non-steroids	rs10757274	CDKN2B-AS1	AG	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs10757274:AG
nicotine	rs1044396	CHRNA4	GG	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1044396:GG
antiinflammatory agents, non-steroids	rs699	AGT	GG	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs699:GG
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
nicotine	rs1044397	CHRNA4	CC	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1044397:CC
coxibs	rs20417	PTGS2	CG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01AH	rs20417:CG
coxibs	rs20417	PTGS2	GG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01AH	rs20417:GG
coxibs	rs4648276	PTGS2	AG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01AH	rs4648276:AG
coxibs	rs4648276	PTGS2	GG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01AH	rs4648276:GG
sevoflurane	rs3733784	FASTKD3, MTRR	CC	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs3733784:CC
sevoflurane	rs3733784	FASTKD3, MTRR	CT	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs3733784:CT
heroin	rs524731	OPRM1	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs524731:A
heroin	rs511435	OPRM1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs511435:T
heroin	rs495491	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs495491:G
azathioprine	rs10824095	ADK	TT	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs10824095:TT
heroin	rs510769	OPRM1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs510769:T
cisplatin	rs1872328	ACYP2	A	Toxicity	increased	Adverse_Event	Disease:C0006118		L01XA01	rs1872328:A
azathioprine	rs747199	SLC29A1	CG	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs747199:CG
azathioprine	rs747199	SLC29A1	GG	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs747199:GG
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AG
azathioprine	rs11706052	IMPDH2	AG	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs11706052:AG
azathioprine	rs11706052	IMPDH2	GG	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs11706052:GG
heroin	rs3778151	OPRM1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3778151:C
azathioprine	rs2278294	IMPDH1	CT	Toxicity	decreased	Adverse_Event	Disease:C0021390		L04AX01	rs2278294:CT
azathioprine	rs2278294	IMPDH1	TT	Toxicity	decreased	Adverse_Event	Disease:C0021390		L04AX01	rs2278294:TT
clozapine, olanzapine, risperidone	rs2228622	SLC1A1	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs2228622:A
heroin	rs3823010	OPRM1	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3823010:A
clozapine, olanzapine, risperidone	rs3780413	SLC1A1	G	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs3780413:G
clozapine, olanzapine, risperidone	rs3780412	SLC1A1	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs3780412:C
heroin	rs9478495	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs9478495:A
aspirin, clopidogrel	rs1062535	ITGA2	AA	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1062535:AA
aspirin, clopidogrel	rs1062535	ITGA2	AG	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1062535:AG
none	rs1187075	ITGB1	AA	Efficacy	increased	Adverse_Event	Disease:C0023055		A03DA02	rs1187075:AA
heroin	rs562859	OPRM1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs562859:C
fluorouracil	rs3918290	DPYD	T	Toxicity	increased	Adverse_Event	Healthy		L01BC02	rs3918290:T
letrozole	rs1324052	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Other:C1458155		L02BG04	rs1324052:A
platinum, vinorelbine	rs182455	STMN1	AA	Efficacy	decreased	Efficacy_Response	Healthy		L01CA04|L01XA	rs182455:AA
tegafur	rs1801159	DPYD	TT	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC03	rs1801159:TT
none	rs2230395	ITGB1	GG	Efficacy	increased	Adverse_Event	Disease:C0023055		A03DA02	rs2230395:GG
heroin	rs3778150	OPRM1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3778150:C
bevacizumab, pemetrexed	rs3780126	GGH	G	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01BA04|L01FG01	rs3780126:G
none	rs1843809	TPH2	TT	Other	decreased	Adverse_Event	Disease:C0085762		A03DA02	rs1843809:TT
aspirin, clopidogrel	rs1126643	ITGA2	CT	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1126643:CT
aspirin, clopidogrel	rs1126643	ITGA2	TT	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1126643:TT
heroin	rs9384169	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs9384169:C
antipsychotics	rs762551	CYP1A2	AC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs762551:AC
antipsychotics	rs762551	CYP1A2	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs762551:CC
platinum compounds	rs316019	SLC22A2	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs316019:AA
platinum compounds	rs316019	SLC22A2	AC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs316019:AC
platinum compounds	rs316019	SLC22A2	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs316019:AA
platinum compounds	rs316019	SLC22A2	AC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs316019:AC
antidepressants, antipsychotics, benzodiazepine derivatives, opioids, sympathomimetics	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Other:C1963951		N02A|N05A|N05CD|N06A|R01BA	rs1799971:G
bevacizumab, pemetrexed	rs11545077	GGH	CT	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01BA04|L01FG01	rs11545077:CT
digoxin	rs10494366	NOS1AP	GG	Toxicity	increased	Adverse_Event	Healthy		C01AA05	rs10494366:GG
sunitinib	rs2032582	ABCB1	CC	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2032582:CC
aspirin, clopidogrel	rs1126643	ITGA2	CT	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs1126643:CT
aspirin, clopidogrel	rs1126643	ITGA2	TT	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs1126643:TT
fentanyl	rs1799971	OPRM1	GG	Dosage	Indeterminado	Efficacy_Response	Healthy		N02AB03	rs1799971:GG
cannabinoids, cocaine, ethanol, nicotine, opioids	rs1799971	OPRM1	G	Toxicity	decreased	Adverse_Event	Healthy		N01BC01|N02A|N02BG10|N07BA01|V03AB16	rs1799971:G
capecitabine, fluorouracil	rs895819	MIR27A	CT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs895819:CT
sunitinib	rs7993418	FLT1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs7993418:GG
cisplatin	rs6721961	NFE2L2	GG	Toxicity	increased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01	rs6721961:GG
cisplatin	rs6721961	NFE2L2	GT	Toxicity	increased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01	rs6721961:GT
sunitinib	rs9582036	FLT1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs9582036:CC
fentanyl	rs1799971	OPRM1	AG	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		N02AB03	rs1799971:AG
fentanyl	rs1799971	OPRM1	GG	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		N02AB03	rs1799971:GG
fluvoxamine	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB08	rs6311:CC
fluvoxamine	rs6311	HTR2A	CT	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB08	rs6311:CT
fentanyl	rs1799971	OPRM1	AG	Efficacy	Indeterminado	Efficacy_Response	Healthy		N02AB03	rs1799971:AG
fentanyl	rs1799971	OPRM1	GG	Efficacy	Indeterminado	Efficacy_Response	Healthy		N02AB03	rs1799971:GG
olanzapine	rs2266780	FMO3	GG	Metabolism/PK	decreased	LADME	Healthy		N05AH03	rs2266780:GG
metoprolol	rs3892097	CYP2D6	T	Efficacy, Metabolism/PK	increased	LADME	Healthy		C07AB02	rs3892097:T
sunitinib	rs9554320	FLT1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs9554320:AA
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs4244285:A
platinum compounds	rs10956697	CCN4	AA	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs10956697:AA
platinum compounds	rs10956697	CCN4	AC	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs10956697:AC
aspirin	rs5918	ITGB3	CC	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs5918:CC
aspirin	rs5918	ITGB3	CT	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs5918:CT
sunitinib	rs9554320	FLT1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs9554320:AA
olanzapine	rs12720462	FMO1	AA	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs12720462:AA
olanzapine	rs12720462	FMO1	AC	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs12720462:AC
clopidogrel	rs4244285	CYP2C19	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	rs4244285:A
platinum compounds	rs3212986	ERCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01XA	rs3212986:CC
aripiprazole	rs2514218	DRD2	CC	Toxicity	increased	Adverse_Event	Other:C0033975|Other:C0036337|Other:C0036341		N05AX12	rs2514218:CC
platinum compounds, taxanes	rs1695	GSTP1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA	rs1695:AA
platinum, taxanes	rs2032582	ABCB1	CC	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0919267		L01CD|L01XA	rs2032582:CC
clopidogrel	rs4986893	CYP2C19	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	rs4986893:A
sunitinib	rs9582036	FLT1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs9582036:CC
olanzapine	rs7877	FMO1	CT	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs7877:CT
olanzapine	rs7877	FMO1	TT	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs7877:TT
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs4986893:A
bumetanide, furosemide, torasemide	rs1529927	SLC12A3	C	Efficacy	increased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs1529927:C
amphetamine, cannabinoids, cocaine, opioids	rs9829896	KAT2B	C	Toxicity	decreased	Adverse_Event	Healthy		N01BC01|N02A|N02BG10	rs9829896:C
paclitaxel	rs7349683	EPHA5	TT	Toxicity	increased	Adverse_Event	Other:C1458155		L01CD01	rs7349683:TT
imatinib	rs2231142	ABCG2	TT	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs2231142:TT
aspirin	rs4271002	NAT2	C	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs4271002:C
opioids	rs1799971	OPRM1	AG	Toxicity	decreased	Adverse_Event	"""Other:C0030193|""Other:C0030193|Postoperative"""		N02A	rs1799971:AG
opioids	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	"""Other:C0030193|""Other:C0030193|Postoperative"""		N02A	rs1799971:GG
methadone	rs3786047	ARRB2	AA	Efficacy	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs3786047:AA
bumetanide, furosemide, torasemide	rs5723	SCNN1G	G	Efficacy	decreased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5723:G
platinum compounds	rs2929973	CCN4	GG	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2929973:GG
platinum compounds	rs2929973	CCN4	GT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2929973:GT
enalapril	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0085580		C09AA02	rs4149056:CC
enalapril	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0085580		C09AA02	rs4149056:CT
antipsychotics	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs6311:TT
methadone	rs1045280	ARRB2	CC	Efficacy	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs1045280:CC
methadone	rs1714984	MYOCD	AA	Efficacy	Indeterminado	Efficacy_Response	Healthy		N07BC02	rs1714984:AA
methadone	rs1714984	MYOCD	AG	Efficacy	Indeterminado	Efficacy_Response	Healthy		N07BC02	rs1714984:AG
methadone	rs2036657	ARRB2	GG	Efficacy	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs2036657:GG
bumetanide, furosemide, torasemide	rs5729	SCNN1G	A	Efficacy	decreased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5729:A
antipsychotics	rs762551	CYP1A2	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs762551:CC
antipsychotics	rs1065852	CYP2D6	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1065852:A
olanzapine	rs518147	HTR2C	C	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH03	rs518147:C
pravastatin	rs708272	CETP	AG	Efficacy	decreased	Adverse_Event	Other:C1956346		C10AA03	rs708272:AG
atorvastatin	rs20455	KIF6	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA05	rs20455:AG
atorvastatin	rs20455	KIF6	GG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA05	rs20455:GG
aspirin	rs5918	ITGB3	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		No_ATC	rs5918:TT
aspirin	rs5985	F13A1	AA	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs5985:AA
aspirin	rs5985	F13A1	AC	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs5985:AC
verapamil	rs1801253	ADRB1	CC	Efficacy	increased	Adverse_Event	Disease:C1956346		C08DA01	rs1801253:CC
verapamil	rs1801253	ADRB1	CG	Efficacy	increased	Adverse_Event	Disease:C1956346		C08DA01	rs1801253:CG
azathioprine	rs1127354	ITPA	C	Efficacy	decreased	Adverse_Event	Other:Liver_transplantation		L04AX01	rs1127354:C
chop, rituximab	rs1883112	NCF4	GG	Efficacy	decreased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1883112:GG
ivacaftor	rs75527207	CFTR	AA	Efficacy	decreased	Adverse_Event	Disease:C0156318		R07AX02	rs75527207:AA
ivacaftor	rs75527207	CFTR	AG	Efficacy	decreased	Adverse_Event	Disease:C0156318		R07AX02	rs75527207:AG
chop, rituximab	rs2231137	ABCG2	CC	Efficacy	decreased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs2231137:CC
pravastatin	rs708272	CETP	GG	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C10AA03	rs708272:GG
amiodarone, diuretics, sotalol	rs10800397	NOS1AP	T	Toxicity	Indeterminado	Adverse_Event	Healthy		C01BD01|C03|C07AA07	rs10800397:T
antipsychotics	rs6977820	__INTRONIC__	CT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs6977820:CT
antipsychotics	rs6977820	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs6977820:TT
amiodarone	rs10800397	NOS1AP	T	Toxicity	Indeterminado	Adverse_Event	Healthy		C01BD01	rs10800397:T
warfarin	rs17880887	VKORC1	T	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs17880887:T
amiodarone	rs10919035	NOS1AP	T	Toxicity	Indeterminado	Adverse_Event	Healthy		C01BD01	rs10919035:T
aspirin	rs1050891	HNMT	G	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs1050891:G
amiodarone	rs10919035	NOS1AP	T	Toxicity	Indeterminado	Adverse_Event	Healthy		C01BD01	rs10919035:T
aspirin	rs730012	LTC4S	AC	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs730012:AC
aspirin	rs730012	LTC4S	CC	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs730012:CC
antipsychotics	rs2485914	SMYD3	T	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs2485914:T
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799929	NAT2	TT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799929:TT
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799929	NAT2	CC	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799929:CC
cytarabine, idarubicin	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs1045642:GG
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Other	Healthy		B01AA03	rs1057910:AC
levonorgestrel	rs1042522	TP53	CG	Toxicity	increased	Adverse_Event	Healthy		G03AD01	rs1042522:CG
aspirin	rs1613662	GP6	AG	Efficacy	increased	Adverse_Event	Disease:C1956346		No_ATC	rs1613662:AG
cisplatin, doxorubicin, ifosfamide, methotrexate	rs1799793	ERCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01AA06|L01DB01|L01XA01|L04AX03	rs1799793:CT
cisplatin, doxorubicin, ifosfamide, methotrexate	rs1799793	ERCC2	TT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01AA06|L01DB01|L01XA01|L04AX03	rs1799793:TT
cytarabine, idarubicin	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs1045642:GG
cisplatin, doxorubicin, ifosfamide, methotrexate	rs13181	ERCC2, KLC3	GG	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01AA06|L01DB01|L01XA01|L04AX03	rs13181:GG
acenocoumarol, phenprocoumon, warfarin	rs2108622	CYP4F2	CT	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03|B01AA04|B01AA07	rs2108622:CT
acenocoumarol, phenprocoumon, warfarin	rs2108622	CYP4F2	TT	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03|B01AA04|B01AA07	rs2108622:TT
aspirin	rs5918	ITGB3	CT	Toxicity	increased	Adverse_Event	Disease:C1956346		No_ATC	rs5918:CT
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0024299		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0024299		L04AX03	rs1801133:AG
sunitinib	rs2305948	KDR	C	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs2305948:C
capecitabine, epirubicin, platinum	rs1695	GSTP1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC06|L01DB03|L01XA	rs1695:GG
clopidogrel	rs662	PON1	CT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs662:CT
clopidogrel	rs662	PON1	TT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs662:TT
none	rs5918	ITGB3	CC	Other	Indeterminado	Other	Healthy		A03DA02	rs5918:CC
none	rs5918	ITGB3	CT	Other	Indeterminado	Other	Healthy		A03DA02	rs5918:CT
beta blocking agents	rs2230345	GRK5	AA	Other	increased	Adverse_Event	Other:C0085605		S01ED	rs2230345:AA
fentanyl, hydromorphone, oxycodone	rs1799971	OPRM1	AG	Efficacy	increased	Adverse_Event	Other:C0027651		N02AA03|N02AA05|N02AB03	rs1799971:AG
fentanyl, hydromorphone, oxycodone	rs1799971	OPRM1	GG	Efficacy	increased	Adverse_Event	Other:C0027651		N02AA03|N02AA05|N02AB03	rs1799971:GG
clopidogrel	rs662	PON1	CT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs662:CT
clopidogrel	rs662	PON1	TT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs662:TT
bevacizumab	rs2228014	CXCR4	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01FG01	rs2228014:AA
bevacizumab	rs2228014	CXCR4	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01FG01	rs2228014:AG
beta blocking agents	rs1801253	ADRB1	CC	Other	decreased	Adverse_Event	Other:C0085605		S01ED	rs1801253:CC
docetaxel, fec100, gemcitabine, trastuzumab, zoledronate	rs147451859	PPCDC	G	Toxicity	decreased	Adverse_Event	Other:C1458155		L01BC05|L01CD02	rs147451859:G
sunitinib	rs6877011	FLT4	GG	Efficacy	decreased	Adverse_Event	Disease:C0238198		L01EX01	rs6877011:GG
haloperidol	rs17143212	ABCB5	CT	Toxicity	increased	Adverse_Event	Disease:C0033975		N05AD01	rs17143212:CT
docetaxel, fec100, gemcitabine, trastuzumab, zoledronate	rs17587029	__INTRONIC__	G	Toxicity	decreased	Adverse_Event	Other:C1458155		L01BC05|L01CD02	rs17587029:G
sunitinib	rs2231142	ABCG2	T	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:T
opioids	rs10799590	CNIH3	A	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs10799590:A
azathioprine, mercaptopurine	rs7270101	ITPA	AC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX01	rs7270101:AC
azathioprine, mercaptopurine	rs7270101	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX01	rs7270101:CC
sunitinib	rs3025039	VEGFA	CT	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EX01	rs3025039:CT
sunitinib	rs3025039	VEGFA	TT	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EX01	rs3025039:TT
antipsychotics	rs762551	CYP1A2	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs762551:CC
methotrexate	rs1801133	MTHFR	A	Efficacy	decreased	Adverse_Event	Disease:C0024299		L04AX03	rs1801133:A
cisplatin	rs316019	SLC22A2	A	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs316019:A
sunitinib	rs4646437	CYP3A4	AA	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs4646437:AA
sunitinib	rs4646437	CYP3A4	AG	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs4646437:AG
atorvastatin	rs2032582	ABCB1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs2032582:C
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs6025	F5	CT	Toxicity	increased	Adverse_Event	Healthy		C09A	rs6025:CT
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs6025	F5	TT	Toxicity	increased	Adverse_Event	Healthy		C09A	rs6025:TT
cisplatin	rs6721961	NFE2L2	T	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs6721961:T
carvedilol	rs1042714	ADRB2	CC	Efficacy	decreased	Adverse_Event	Disease:C0085605		C07AG02	rs1042714:CC
tacrolimus	rs3761548	FOXP3	GT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs3761548:GT
tacrolimus	rs3761548	FOXP3	TT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs3761548:TT
tacrolimus	rs2740574	CYP3A4	CC	Toxicity	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2740574:CC
tacrolimus	rs2740574	CYP3A4	CT	Toxicity	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2740574:CT
methotrexate	rs72675408	RAVER2	A	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs72675408:A
phenytoin	rs1057910	CYP2C9	C	Efficacy	increased	Adverse_Event	Other:C0014544		N03AB02	rs1057910:C
phenytoin	rs1799853	CYP2C9	T	Efficacy	increased	Adverse_Event	Other:C0014544		N03AB02	rs1799853:T
capecitabine, fluorouracil	rs2016520	PPARD	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs2016520:T
efavirenz	rs8192719	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs8192719:CT
efavirenz	rs8192719	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs8192719:TT
none	rs1801030	SULT1A1, SULT1A2	CC	Other	increased	Adverse_Event	Other:C0025320		A03DA02	rs1801030:CC
none	rs1801030	SULT1A1, SULT1A2	CT	Other	increased	Adverse_Event	Other:C0025320		A03DA02	rs1801030:CT
opioids	rs116181528	MCOLN1	A	Toxicity	increased	Adverse_Event	Healthy		N02A	rs116181528:A
cerivastatin, hmg coa reductase inhibitors, rosuvastatin, simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA|C10AA01|C10AA06|C10AA07	rs4149056:CC
cerivastatin, hmg coa reductase inhibitors, rosuvastatin, simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA|C10AA01|C10AA06|C10AA07	rs4149056:CT
none	rs2494732	AKT1	CC	Other	increased	Adverse_Event	Disease:Marijuana_Abuse		A03DA02	rs2494732:CC
capecitabine	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0017185		L01BC06	rs1801131:GG
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Other	Healthy		B01AA03	rs8050894:G
bevacizumab	rs6770663	KCNAB1	G	Toxicity	increased	Adverse_Event	Other:C0027651		L01FG01	rs6770663:G
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:A
cyclophosphamide, epirubicin	rs1695	GSTP1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB03	rs1695:AA
cyclophosphamide, epirubicin	rs1695	GSTP1	AG	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB03	rs1695:AG
aspirin	rs7572857	CEP68	AA	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7572857:AA
opioids	rs114077267	MCOLN1	T	Toxicity	increased	Adverse_Event	Healthy		N02A	rs114077267:T
acenocoumarol	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA07	rs9923231:TT
platinum compounds	rs2279744	MDM2	GT	Toxicity	increased	Adverse_Event	Other:C0007131		L01XA	rs2279744:GT
platinum compounds	rs2279744	MDM2	TT	Toxicity	increased	Adverse_Event	Other:C0007131		L01XA	rs2279744:TT
sunitinib	rs1933437	FLT3	AG	Toxicity	decreased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1933437:AG
sunitinib	rs1933437	FLT3	GG	Toxicity	decreased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1933437:GG
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
aspirin	rs5918	ITGB3	CT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		No_ATC	rs5918:CT
none	rs62293298	SLC2A9	AG	Other	decreased	Adverse_Event	Other:C1956346		A03DA02	rs62293298:AG
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG
aspirin	rs3775291	TLR3	CT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3775291:CT
aspirin	rs3775291	TLR3	TT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3775291:TT
efavirenz	rs2279345	CYP2B6	CC	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CC
efavirenz	rs2279345	CYP2B6	CT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CT
opioids	rs115208233	MCOLN1	G	Toxicity	increased	Adverse_Event	Healthy		N02A	rs115208233:G
tacrolimus	rs2740574	CYP3A4	CC	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2740574:CC
tacrolimus	rs2740574	CYP3A4	CT	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2740574:CT
nicotine	rs1800497	DRD2	AA	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AA
nicotine	rs1800497	DRD2	AG	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AG
nicotine	rs1800497	DRD2	GG	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1800497:GG
warfarin	rs2884737	VKORC1	CC	Dosage	decreased	Other	Healthy		B01AA03	rs2884737:CC
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs1800795	IL6	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs1800795:CC
none	rs2231142	ABCG2	GT	Other	increased	Adverse_Event	Other:C1956346		A03DA02	rs2231142:GT
none	rs2231142	ABCG2	TT	Other	increased	Adverse_Event	Other:C1956346		A03DA02	rs2231142:TT
acenocoumarol, warfarin	rs72558189	CYP2C9	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AA03|B01AA07	rs72558189:AG
telbivudine	rs3826160	TK2	CC	Toxicity	increased	Adverse_Event	Other:C0019163|Chronic		J05AF11	rs3826160:CC
telbivudine	rs3826160	TK2	CT	Toxicity	increased	Adverse_Event	Other:C0019163|Chronic		J05AF11	rs3826160:CT
sunitinib	rs9582036	FLT1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs9582036:CC
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T
none	rs3825017	SLC22A12	CT	Other	increased	Adverse_Event	Other:C1956346		A03DA02	rs3825017:CT
acenocoumarol, warfarin	rs2108622	CYP4F2	CT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03|B01AA07	rs2108622:CT
acenocoumarol, warfarin	rs2108622	CYP4F2	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03|B01AA07	rs2108622:TT
sunitinib	rs1048943	CYP1A1	C	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1048943:C
olanzapine	rs2440390	DRD2	T	Toxicity	increased	Adverse_Event	Disease:C0004936		N05AH03	rs2440390:T
pravastatin	rs428785	ADAMTS1	GG	Efficacy	decreased	Adverse_Event	Healthy		C10AA03	rs428785:GG
olanzapine	rs6318	HTR2C	G	Toxicity	increased	Adverse_Event	Disease:C0004936		N05AH03	rs6318:G
caffeine	rs762551	CYP1A2	AA	Toxicity	increased	Adverse_Event	Other:who_are_pregnant		N06BC01	rs762551:AA
olanzapine	rs2497538	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0004936		N05AH03	rs2497538:C
olanzapine	rs1414334	HTR2C	G	Toxicity	increased	Adverse_Event	Disease:C0004936		N05AH03	rs1414334:G
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs924607:TT
pioglitazone	rs328	LPL	CG	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BG03	rs328:CG
pioglitazone	rs328	LPL	GG	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BG03	rs328:GG
paclitaxel	rs7349683	EPHA5	CT	Toxicity	increased	Adverse_Event	Healthy		L01CD01	rs7349683:CT
paclitaxel	rs7349683	EPHA5	TT	Toxicity	increased	Adverse_Event	Healthy		L01CD01	rs7349683:TT
none	rs3812718	SCN1A	T	Other	increased	Adverse_Event	Disease:C0014544		A03DA02	rs3812718:T
none	rs4148323	UGT1A1	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs4148323:AA
none	rs4148323	UGT1A1	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs4148323:AG
none	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs16969968:A
paclitaxel	rs3213619	ABCB1	AG	Toxicity	decreased	Adverse_Event	Healthy		L01CD01	rs3213619:AG
paclitaxel	rs3213619	ABCB1	GG	Toxicity	decreased	Adverse_Event	Healthy		L01CD01	rs3213619:GG
verapamil	rs10494366	NOS1AP	GG	Toxicity	increased	Adverse_Event	Healthy		C08DA01	rs10494366:GG
mercaptopurine	rs2413739	PACSIN2	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs2413739:TT
none	rs1051730	__INTRONIC__	A	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs1051730:A
none	rs12794714	CYP2R1	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs12794714:A
olanzapine	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0033975		N05AH03	rs1045642:AA
peginterferon alfa-2b, ribavirin, simeprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10	rs12979860:CC
ethambutol, isoniazid / pyrazinamide / rifampin	rs1799930	NAT2	A	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1799930:A
none	rs10741657	CYP2R1	A	Other	decreased	Adverse_Event	Healthy		A03DA02	rs10741657:A
ethambutol, isoniazid / pyrazinamide / rifampin	rs1799929	NAT2	T	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1799929:T
atorvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CT
paroxetine	rs6295	HTR1A	GG	Efficacy	increased	Efficacy_Response	Disease:C0030319		N06AB05	rs6295:GG
tamoxifen	rs310786	E2F7	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L02BA01	rs310786:CC
alendronate	rs2241529	DKK1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0005944|Disease:C0029456		No_ATC	rs2241529:AA
clopidogrel	rs8192950	CES1	G	Efficacy	decreased	Adverse_Event	Other:C0007820		B01AC04	rs8192950:G
antipsychotics	rs1799732	DRD2	GG	Toxicity	increased	Adverse_Event	Healthy		N05A	rs1799732:GG
sunitinib	rs2305948	KDR	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2305948:CC
warfarin	rs4918758	CYP2C9	C	Dosage	decreased	Other	Healthy		B01AA03	rs4918758:C
sunitinib	rs3025039	VEGFA	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs3025039:CC
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC
simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CT
olanzapine	rs1800497	ANKK1	GG	Other	decreased	LADME	Healthy		N05AH03	rs1800497:GG
exemestane	rs9322336	ESR1	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L02BG06	rs9322336:CC
warfarin	rs9332096	CYP2C9	T	Dosage	decreased	Other	Healthy		B01AA03	rs9332096:T
olanzapine	rs1800497	ANKK1	GG	Other	decreased	Other	Healthy		N05AH03	rs1800497:GG
sunitinib	rs2010963	VEGFA	G	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2010963:G
sunitinib	rs6877011	FLT4	C	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs6877011:C
olanzapine	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs1695:AA
sunitinib	rs2276707	NR1I2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2276707:TT
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:AG
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:GG
anthracyclines and related substances	rs2232228	HAS3	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01DB	rs2232228:AA
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T
sunitinib	rs1933437	FLT3	AG	Toxicity	decreased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1933437:AG
sunitinib	rs1933437	FLT3	GG	Toxicity	decreased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1933437:GG
nortriptyline	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA10	rs1045642:AA
warfarin	rs2359612	VKORC1	A	Dosage	decreased	Other	Healthy		B01AA03	rs2359612:A
morphine, oxycodone	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Other:C0024121		N02AA01|N02AA05	rs1799971:GG
morphine, oxycodone	rs4680	COMT	GG	Toxicity	increased	Adverse_Event	Other:C0024121		N02AA01|N02AA05	rs4680:GG
carbamazepine	rs2071197	HNF4A	GG	Efficacy	increased	LADME	Disease:C0014544		N03AF01	rs2071197:GG
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Other	Healthy		B01AA03	rs8050894:G
pravastatin	rs1801133	MTHFR	GG	Efficacy	decreased	Adverse_Event	Disease:C0020538		C10AA03	rs1801133:GG
sunitinib	rs1128503	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs1128503:AA
sunitinib	rs833061	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs833061:CC
sunitinib	rs833061	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs833061:CT
cyclosporine, mycophenolate mofetil	rs11706052	IMPDH2	AG	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs11706052:AG
cyclosporine, mycophenolate mofetil	rs11706052	IMPDH2	GG	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs11706052:GG
cyclosporine, mycophenolate mofetil	rs1800629	TNF	AA	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs1800629:AA
cyclosporine, mycophenolate mofetil	rs1800629	TNF	AG	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs1800629:AG
methotrexate	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs1801131:GG
cyclosporine, mycophenolate mofetil	rs1800872	IL10	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs1800872:TT
sunitinib	rs2032582	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2032582:AA
sunitinib	rs2032582	ABCB1	AT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2032582:AT
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Adverse_Event	Other:C0007820		B01AC04	rs4986893:A
sunitinib	rs2010963	VEGFA	G	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs2010963:G
nicotine	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Other:Schizophrenia_who_are_smokers		N07BA01	rs16969968:A
nicotine	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Other:C0008301		N07BA01	rs16969968:A
none	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs16969968:A
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs1801133:AA
clopidogrel	rs2254638	N6AMT1	GG	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs2254638:GG
methotrexate	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs1801133:AA
nicotine	rs2717162	GALR1	CT	Other	increased	Adverse_Event	Disease:C0039338		N07BA01	rs2717162:CT
nicotine	rs2717162	GALR1	TT	Other	increased	Adverse_Event	Disease:C0039338		N07BA01	rs2717162:TT
capecitabine, fluorouracil	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:A
capecitabine, fluorouracil	rs3918290	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs3918290:T
erythromycin	rs4149056	SLCO1B1	C	Metabolism/PK	decreased	LADME	Disease:C0027651		S01AA17	rs4149056:C
pazopanib, simvastatin	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Disease:C0027651		C10AA01|L01EX03	rs2231142:GT
pazopanib, simvastatin	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		C10AA01|L01EX03	rs2231142:TT
gentamicin	rs267606617	MT-RNR1	G	Toxicity	increased	Adverse_Event	Healthy		S02AA14	rs267606617:G
cyclosporine, tacrolimus	rs2167270	LEP	A	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01|L04AD02	rs2167270:A
erlotinib	rs1045642	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0007131		L01EB02	rs1045642:AA
mercaptopurine	rs73189762	NUDT15	GT	Dosage	increased	Adverse_Event	Other:C0023449		L01BB02	rs73189762:GT
ethanol	rs1176744	HTR3B	C	Other	increased	Adverse_Event	Healthy		V03AB16	rs1176744:C
clopidogrel	rs12248560	CYP2C19	T	Toxicity	decreased	Adverse_Event	Disease:C0027051		B01AC04	rs12248560:T
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AX03	rs1801133:AA
methotrexate	rs5760410	ADORA2A, SPECC1L	G	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs5760410:G
calcium channel blockers, nitrendipine	rs1137617	KCNH2	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C08|C08CA08	rs1137617:AA
calcium channel blockers, nitrendipine	rs1137617	KCNH2	AG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C08|C08CA08	rs1137617:AG
clopidogrel	rs7667298	KDR	CC	Toxicity	decreased	Adverse_Event	Disease:C0010068		B01AC04	rs7667298:CC
methotrexate	rs1801131	MTHFR	G	Efficacy	increased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L04AX03	rs1801131:G
methotrexate	rs1801133	MTHFR	AA	Efficacy	decreased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L04AX03	rs1801133:AA
nicotine	rs2717162	GALR1	CT	Other	increased	Adverse_Event	Disease:C0039338		N07BA01	rs2717162:CT
nicotine	rs2717162	GALR1	TT	Other	increased	Adverse_Event	Disease:C0039338		N07BA01	rs2717162:TT
antineoplastic agents	rs1801133	CLCN6, MTHFR	GG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		L01	rs1801133:GG
irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs4148323:AG
none	rs1801131	MTHFR	G	Efficacy	increased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		A03DA02	rs1801131:G
busulfan, cyclophosphamide, methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Healthy		L01AA01|L01AB01|L04AX03	rs1801133:AA
erlotinib	rs1128503	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0007131		L01EB02	rs1128503:AA
methotrexate	rs1801131	MTHFR	GG	Efficacy	decreased	Adverse_Event	Other:allogeneic_hematopoietic_cell_transplantation_for_chronic_myelogenous_leukemia.		L04AX03	rs1801131:GG
clopidogrel	rs2305948	KDR	TT	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	rs2305948:TT
methotrexate	rs1128503	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1128503:GG
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L04AX03	rs1801133:AA
methotrexate	rs1801131	MTHFR	GG	Toxicity	decreased	Adverse_Event	Other:hematopoietic-cell-transplantation		L04AX03	rs1801131:GG
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023418		L04AX03	rs1801133:AA
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	rs9923231:TT
erlotinib	rs2032582	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0007131		L01EB02	rs2032582:AA
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	rs9923231:TT
paclitaxel	rs9657362	ARHGEF10	C	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CD01	rs9657362:C
none	rs3800373	FKBP5	AA	Other	increased	Adverse_Event	Other:history_of_Child_Abuse		A03DA02	rs3800373:AA
none	rs3800373	FKBP5	AC	Other	increased	Adverse_Event	Other:history_of_Child_Abuse		A03DA02	rs3800373:AC
paclitaxel	rs9657362	ARHGEF10	C	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CD01	rs9657362:C
none	rs2296840	PSMB4	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs2296840:T
metformin	rs34059508	SLC22A1	A	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BA02	rs34059508:A
metformin	rs12208357	SLC22A1	C	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BA02	rs12208357:C
clopidogrel	rs12248560	CYP2C19	T	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs12248560:T
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A
none	rs680244	CHRNA5	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs680244:C
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:A
methotrexate	rs2476601	PTPN22	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2476601:AA
methotrexate	rs6920220	TNFAIP3	A	Toxicity	increased	Adverse_Event	Disease:C0235889		L04AX03	rs6920220:A
sunitinib	rs2231142	ABCG2	TT	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:TT
risperidone	rs1045642	ABCB1	AA	Metabolism/PK	increased	Adverse_Event	Disease:C0005586|Disease:C0036337|Disease:C0036341		N05AX08	rs1045642:AA
carbamazepine, phenobarbital, phenytoin, valproic acid	rs2606345	CYP1A1	A	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:C0014544		N03AA02|N03AB02|N03AF01|N03AG01	rs2606345:A
none	rs2417940	SLCO1B3	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs2417940:C
sertraline	rs13432159	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB06	rs13432159:G
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CT
tamoxifen	rs3892097	CYP2D6	TT	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	rs3892097:TT
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC
simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CT
tamoxifen	rs3892097	CYP2D6	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs3892097:TT
tamoxifen	rs3892097	CYP2D6	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs3892097:TT
none	rs20455	KIF6	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs20455:AG
none	rs20455	KIF6	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs20455:GG
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	A	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs1127354:A
rosuvastatin	rs9806699	GATM	AA	Toxicity	decreased	Adverse_Event	Healthy		C10AA07	rs9806699:AA
rosuvastatin	rs9806699	GATM	AG	Toxicity	decreased	Adverse_Event	Healthy		C10AA07	rs9806699:AG
tamoxifen	rs3892097	CYP2D6	T	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs3892097:T
hmg coa reductase inhibitors	rs4363657	SLCO1B1	CC	Toxicity	decreased	Adverse_Event	Healthy		C10AA	rs4363657:CC
hmg coa reductase inhibitors	rs4363657	SLCO1B1	CT	Toxicity	decreased	Adverse_Event	Healthy		C10AA	rs4363657:CT
peginterferon alfa-2b, ribavirin	rs7270101	ITPA	C	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs7270101:C
irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs4148323:AA
fluorouracil, irinotecan, oxaliplatin	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02|L01XA03	rs1695:AA
pravastatin	rs16944	IL1B	GG	Other	increased	Other	Healthy		C10AA03	rs16944:GG
hmg coa reductase inhibitors	rs116561224	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs116561224:G
none	rs3815459	KCNH2	T	Other	increased	Other	Healthy		A03DA02	rs3815459:T
fenofibrate, sertraline, terbinafine, ticlopidine	rs114577328	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		B01AC05|C10AB05|D01BA02|N06AB06	rs114577328:C
antidepressants	rs17288723	HTR2A	CC	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	rs17288723:CC
none	rs3807375	KCNH2	CT	Other	increased	Other	Healthy		A03DA02	rs3807375:CT
none	rs3807375	KCNH2	TT	Other	increased	Other	Healthy		A03DA02	rs3807375:TT
citalopram	rs1954787	GRIK4	C	Efficacy	decreased	Adverse_Event	Disease:C0235876		N06AB04	rs1954787:C
none	rs1805123	KCNH2	GT	Other	increased	Other	Healthy		A03DA02	rs1805123:GT
none	rs1805123	KCNH2	TT	Other	increased	Other	Healthy		A03DA02	rs1805123:TT
cyclosporine	rs2276707	NR1I2	C	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs2276707:C
drugs for treatment of tuberculosis	rs1799929	NAT2	CT	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799929:CT
drugs for treatment of tuberculosis	rs1799929	NAT2	TT	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799929:TT
drugs for treatment of tuberculosis	rs1799930	NAT2	AA	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799930:AA
drugs for treatment of tuberculosis	rs1799930	NAT2	AG	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799930:AG
platinum compounds	rs1695	GSTP1	G	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0007131		L01XA	rs1695:G
clozapine	rs149104283	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs149104283:T
drugs for treatment of tuberculosis	rs1799931	NAT2	AA	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799931:AA
drugs for treatment of tuberculosis	rs1799931	NAT2	AG	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799931:AG
none	rs1805123	KCNH2	G	Other	decreased	Other	Healthy		A03DA02	rs1805123:G
asparaginase, cyclophosphamide, daunorubicin, prednisolone, vincristine	rs738409	PNPLA3	CG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01AA01|L01CA02|L01DB02|L01XX02|S02BA03	rs738409:CG
asparaginase, cyclophosphamide, daunorubicin, prednisolone, vincristine	rs738409	PNPLA3	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01AA01|L01CA02|L01DB02|L01XX02|S02BA03	rs738409:GG
none	rs3807375	KCNH2	T	Other	increased	Other	Healthy		A03DA02	rs3807375:T
oxaliplatin	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA03	rs1695:GG
none	rs757092	KCNQ1	G	Other	increased	Other	Healthy		A03DA02	rs757092:G
none	rs3815459	KCNH2	T	Other	increased	Other	Healthy		A03DA02	rs3815459:T
pravastatin	rs16944	IL1B	GG	Other	increased	Other	Healthy		C10AA03	rs16944:GG
none	rs2010963	VEGFA	CG	Other	increased	Adverse_Event	Healthy		A03DA02	rs2010963:CG
none	rs2010963	VEGFA	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs2010963:GG
none	rs1805123	KCNH2	GG	Other	decreased	Other	Healthy		A03DA02	rs1805123:GG
none	rs757092	KCNQ1	G	Other	increased	Other	Healthy		A03DA02	rs757092:G
oxaliplatin	rs1695	GSTP1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0017185		L01XA03	rs1695:AA
methotrexate	rs4149056	SLCO1B1	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:TT
cyclosporine	rs2276707	NR1I2	T	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs2276707:T
rifampicin	rs3814055	NR1I2	TT	Other	increased	LADME	Healthy		J04AB02	rs3814055:TT
platinum compounds	rs2977549	CCN4	CC	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2977549:CC
platinum compounds	rs2977549	CCN4	CT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2977549:CT
citalopram	rs7997012	HTR2A	AA	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AB04	rs7997012:AA
tacrolimus	rs2740574	CYP3A4	CC	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs2740574:CC
tacrolimus	rs2740574	CYP3A4	TT	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs2740574:TT
citalopram	rs7997012	HTR2A	A	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AB04	rs7997012:A
tacrolimus	rs776746	CYP3A5	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:T
cyclosporine	rs3814055	NR1I2	C	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs3814055:C
aspirin, clopidogrel	rs17064642	MYOM2	CC	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs17064642:CC
aspirin, clopidogrel	rs17064642	MYOM2	CT	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs17064642:CT
antidepressants	rs7997012	HTR2A	G	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	rs7997012:G
citalopram	rs7997012	HTR2A	A	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AB04	rs7997012:A
sufentanil	rs4680	COMT	AA	Dosage	increased	Adverse_Event	Other:C0032961		N01AH03	rs4680:AA
sufentanil	rs4680	COMT	AG	Dosage	increased	Adverse_Event	Other:C0032961		N01AH03	rs4680:AG
antidepressants	rs1954787	GRIK4	CC	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	rs1954787:CC
sufentanil	rs1799971	OPRM1	AG	Dosage	decreased	Adverse_Event	Other:C0032961		N01AH03	rs1799971:AG
sufentanil	rs1799971	OPRM1	GG	Dosage	decreased	Adverse_Event	Other:C0032961		N01AH03	rs1799971:GG
antidepressants	rs12800734	GRIK4	GG	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	rs12800734:GG
pravastatin	rs20455	KIF6	AG	Efficacy	decreased	Adverse_Event	Healthy		C10AA03	rs20455:AG
pravastatin	rs20455	KIF6	GG	Efficacy	decreased	Adverse_Event	Healthy		C10AA03	rs20455:GG
none	rs20455	KIF6	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs20455:AG
none	rs20455	KIF6	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs20455:GG
pravastatin	rs2306283	SLCO1B1	G	Metabolism/PK	decreased	LADME	Healthy		C10AA03	rs2306283:G
pravastatin	rs4149015	SLCO1B1	AG	Other, Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149015:AG
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:CT
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:TT
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:CT
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:TT
platinum compounds	rs2977551	CCN4	CC	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2977551:CC
platinum compounds	rs2977551	CCN4	CT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2977551:CT
clopidogrel	rs1045642	ABCB1	AA	Efficacy	decreased	Adverse_Event	Other:C0027051		B01AC04	rs1045642:AA
fluorouracil	rs1042522	TP53	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02	rs1042522:GG
peginterferon alfa-2a, ribavirin	rs6051702	ITPA	AC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB11	rs6051702:AC
peginterferon alfa-2a, ribavirin	rs6051702	ITPA	CC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB11	rs6051702:CC
nicotine	rs578776	CHRNA3, CHRNA5	GG	Toxicity	increased	Adverse_Event	Other:C0024121		N07BA01	rs578776:GG
nicotine	rs1044396	CHRNA4	AA	Toxicity	increased	Adverse_Event	Other:C0024121		N07BA01	rs1044396:AA
nicotine	rs2229959	CHRNA4	CC	Toxicity	increased	Adverse_Event	Other:C0024121		N07BA01	rs2229959:CC
selective serotonin reuptake inhibitors	rs13306278	COMT, TXNRD2	T	Efficacy	decreased	Adverse_Event	Disease:C0011581		N06AB	rs13306278:T
pravastatin	rs4986790	TLR4	AG	Efficacy	decreased	Adverse_Event	Disease:C1956346		C10AA03	rs4986790:AG
pravastatin	rs4986790	TLR4	GG	Efficacy	decreased	Adverse_Event	Disease:C1956346		C10AA03	rs4986790:GG
phenprocoumon	rs9923231	VKORC1	TT	Efficacy	increased	Adverse_Event	Healthy		B01AA04	rs9923231:TT
aminoglycoside antibacterials	rs267606617	MT-RNR1	G	Toxicity	increased	Adverse_Event	Healthy		J01G	rs267606617:G
peginterferon alfa-2a, ribavirin	rs1544410	VDR	TT	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB11	rs1544410:TT
phenprocoumon	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9923231:TT
acenocoumarol	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:CT
acenocoumarol	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:TT
fluorouracil	rs2854746	IGFBP3	CC	Efficacy	Indeterminado	Other	Disease:C0026640		L01BC02	rs2854746:CC
phenprocoumon	rs9923231	VKORC1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA04	rs9923231:TT
platinum compounds	rs1695	GSTP1	AA	Efficacy	increased	Adverse_Event	Disease:C0023055		L01XA	rs1695:AA
platinum compounds	rs13181	ERCC2, KLC3	GG	Efficacy	increased	Adverse_Event	Disease:C0023055		L01XA	rs13181:GG
phenprocoumon	rs1051740	EPHX1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs1051740:CC
platinum compounds	rs11615	ERCC1	AA	Efficacy	increased	Adverse_Event	Disease:C0023055		L01XA	rs11615:AA
clopidogrel	rs2032582	ABCB1	AA	Efficacy	decreased	Adverse_Event	Other:C0027051		B01AC04	rs2032582:AA
platinum compounds	rs1695	GSTP1	AA	Efficacy	increased	Adverse_Event	Disease:C0023055		L01XA	rs1695:AA
carboplatin, paclitaxel	rs1523130	NR1I2	TT	Toxicity	decreased	Adverse_Event	Disease:C0024121|Disease:C1153706|Disease:C0027651|Disease:C0919267|Disease:C0042138		L01CD01|L01XA02	rs1523130:TT
azathioprine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0021390|Disease:C0023449		L04AX01	rs116855232:T
cetuximab	rs4444903	EGF	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs4444903:AA
carboplatin, paclitaxel	rs1523127	NR1I2	CC	Toxicity	decreased	Adverse_Event	Disease:C0024121|Disease:C1153706|Disease:C0027651|Disease:C0919267|Disease:C0042138		L01CD01|L01XA02	rs1523127:CC
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs10929302:AA
irinotecan	rs10929302	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs10929302:AG
carboplatin, paclitaxel	rs4149117	SLCO1B3	GT	Toxicity	decreased	Adverse_Event	Disease:C0024121|Disease:C1153706|Disease:C0027651|Disease:C0919267|Disease:C0042138		L01CD01|L01XA02	rs4149117:GT
carboplatin, paclitaxel	rs4149117	SLCO1B3	TT	Toxicity	decreased	Adverse_Event	Disease:C0024121|Disease:C1153706|Disease:C0027651|Disease:C0919267|Disease:C0042138		L01CD01|L01XA02	rs4149117:TT
nicotine	rs1044396	CHRNA4	G	Other	increased	Adverse_Event	Healthy		N07BA01	rs1044396:G
cisplatin	rs2075252	LRP2	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs2075252:T
cetuximab	rs4444903	EGF	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		No_ATC	rs4444903:AA
capecitabine	rs3215400	CDA	C/del	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC06	rs3215400:C/del
capecitabine	rs3215400	CDA	CC	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC06	rs3215400:CC
clopidogrel	rs2286823	POR	GG	Efficacy	decreased	Adverse_Event	Other:C0027051		B01AC04	rs2286823:GG
sunitinib	rs1057868	POR	TT	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EX01	rs1057868:TT
sunitinib	rs4149117	SLCO1B3	GG	Efficacy	decreased	Efficacy_Response	Efficacy:C0238198		L01EX01	rs4149117:GG
methotrexate	rs1051266	SLC19A1	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CC
methotrexate	rs1051266	SLC19A1	CT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CT
phenprocoumon	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9923231:TT
capecitabine	rs532545	CDA	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs532545:T
clopidogrel	rs3785161	CES1P1	AC	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs3785161:AC
clopidogrel	rs3785161	CES1P1	CC	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs3785161:CC
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
leucovorin, tegafur	rs1801394	FASTKD3, MTRR	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03	rs1801394:GG
capecitabine	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs67376798:A
leucovorin, tegafur	rs1801019	UMPS	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03	rs1801019:CC
leucovorin, tegafur	rs1801019	UMPS	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03	rs1801019:CC
aspirin, clopidogrel	rs5985	F13A1	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs5985:AA
aspirin, clopidogrel	rs5985	F13A1	AC	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs5985:AC
pazopanib	rs1126647	CXCL8	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs1126647:TT
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT
nicotine	rs2236196	CHRNA4	G	Other	increased	Adverse_Event	Healthy		N07BA01	rs2236196:G
angiotensin ii antagonists	rs111564371	CYP2D6	CT	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs111564371:CT
methotrexate	rs1051266	SLC19A1	CT	Toxicity	decreased	Adverse_Event	Other:C0029463		L04AX03	rs1051266:CT
methotrexate	rs1051266	SLC19A1	TT	Toxicity	decreased	Adverse_Event	Other:C0029463		L04AX03	rs1051266:TT
nicotine	rs1051730	CHRNA3	AA	Toxicity	decreased	Adverse_Event	Disease:C0039338		N07BA01	rs1051730:AA
nicotine	rs1051730	CHRNA3	AG	Toxicity	decreased	Adverse_Event	Disease:C0039338		N07BA01	rs1051730:AG
cyclophosphamide, fluorouracil	rs1801133	MTHFR	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02	rs1801133:A
ledipasvir, sofosbuvir	rs12979860	IFNL3, IFNL4	TT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP08|J05AP51	rs12979860:TT
carbamazepine	rs1043620	HSPA1A	T	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	rs1043620:T
aspirin, clopidogrel	rs5985	F13A1	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs5985:AA
aspirin, clopidogrel	rs5985	F13A1	AC	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs5985:AC
ledipasvir, sofosbuvir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP08|J05AP51	rs8099917:TT
carbamazepine	rs506770	HSPA1A	G	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	rs506770:G
aspirin, clopidogrel	rs5985	F13A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs5985:AA
cyclophosphamide, fluorouracil	rs1042522	TP53	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02	rs1042522:G
carbamazepine	rs2227956	HSPA1L	G	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	rs2227956:G
clopidogrel	rs6787801	P2RY12	AG	Efficacy	Indeterminado	Efficacy_Response	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	rs6787801:AG
clopidogrel	rs6787801	P2RY12	GG	Efficacy	Indeterminado	Efficacy_Response	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	rs6787801:GG
clozapine	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1045642:AG
clozapine	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1045642:GG
ribavirin	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01	rs1127354:CC
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
clozapine	rs212090	ABCC1	AT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs212090:AT
clozapine	rs212090	ABCC1	TT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs212090:TT
carbamazepine	rs2894342	MLN	A	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs2894342:A
efavirenz	rs28399499	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT
clozapine	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1045642:AG
clozapine	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1045642:GG
clozapine	rs212090	ABCC1	AT	Toxicity	increased	Adverse_Event	Healthy		N05AH02	rs212090:AT
clozapine	rs212090	ABCC1	TT	Toxicity	increased	Adverse_Event	Healthy		N05AH02	rs212090:TT
caffeine	rs5751876	ADORA2A	TT	Toxicity	increased	Adverse_Event	Other:C0024198		N06BC01	rs5751876:TT
caffeine	rs2298383	ADORA2A	CC	Toxicity	increased	Adverse_Event	Other:C0024198		N06BC01	rs2298383:CC
caffeine	rs4822492	__INTRONIC__	CC	Toxicity	increased	Adverse_Event	Other:C0024198		N06BC01	rs4822492:CC
none	rs267606617	MT-RNR1	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs267606617:G
carbamazepine	rs3130690	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs3130690:T
caffeine	rs5751876	ADORA2A	CC	Efficacy	increased	Adverse_Event	Healthy		N06BC01	rs5751876:CC
caffeine	rs5751876	ADORA2A	CC	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs5751876:CC
ethanol, heroin, methamphetamine	rs2133896	ANKS1B	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs2133896:T
carbamazepine	rs2848716	MICA	C	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs2848716:C
"""antiinflammatory agents, non-steroids"", ""aspirin"""	rs2965667	__INTRONIC__	TT	Other	decreased	Adverse_Event	Healthy		V10A	rs2965667:TT
caffeine	rs5751876	ADORA2A	TT	Dosage	decreased	Other	Healthy		N06BC01	rs5751876:TT
carbamazepine	rs750332	BAG6, PRRC2A	C	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs750332:C
"""antiinflammatory agents, non-steroids"", ""aspirin"""	rs16973225	__INTRONIC__	AA	Other	decreased	Adverse_Event	Healthy		V10A	rs16973225:AA
none	rs588765	CHRNA5	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		A03DA02	rs588765:T
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:AG
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:GG
ribavirin	rs7270101	ITPA	AA	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01	rs7270101:AA
simvastatin	rs1137101	LEPR	GG	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA01	rs1137101:GG
alendronate	rs1234612	SOST	CC	Efficacy	increased	Efficacy_Response	Disease:C0005944|Disease:C0029456		No_ATC	rs1234612:CC
cytarabine, daunorubicin	rs1128503	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB02	rs1128503:GG
cytarabine, daunorubicin	rs532545	CDA	CC	Toxicity	decreased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB02	rs532545:CC
cytarabine, daunorubicin	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB02	rs1045642:GG
clopidogrel	rs4244285	CYP2C19	A	Efficacy	Indeterminado	Efficacy_Response	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	rs4244285:A
alendronate	rs865429	SOST	GG	Efficacy	decreased	Efficacy_Response	Disease:C0005944|Disease:C0029456		No_ATC	rs865429:GG
ribavirin	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01	rs1127354:CC
cytarabine	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs1128503:AA
cytarabine	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs1128503:AG
clopidogrel	rs6801273	MED12L, P2RY12	T	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs6801273:T
cytarabine	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs2032582:AA
cytarabine	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs2032582:AC
clopidogrel	rs6798347	MED12L	G	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs6798347:G
erlotinib, gefitinib	rs121434569	EGFR	T	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01EB01|L01EB02	rs121434569:T
cytarabine	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs1045642:AA
cytarabine	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs1045642:AG
sevoflurane	rs1128503	ABCB1	GG	Other	decreased	Adverse_Event	Other:tonsillectomy		N01AB08	rs1128503:GG
tacrolimus	rs5219	KCNJ11	CT	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation|Disease:Kidney_Transplantation		L04AD02	rs5219:CT
tacrolimus	rs5219	KCNJ11	TT	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation|Disease:Kidney_Transplantation		L04AD02	rs5219:TT
ace inhibitors, plain	rs2724635	ETV6	GG	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs2724635:GG
erlotinib, gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01|L01EB02	rs121434568:G
sunitinib	rs1128503	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1128503:AA
aspirin	rs2071888	TAPBP	CC	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs2071888:CC
aspirin	rs2071888	TAPBP	CG	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs2071888:CG
drugs for treatment of tuberculosis	rs3740065	ABCC2	AG	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs3740065:AG
drugs for treatment of tuberculosis	rs3740065	ABCC2	GG	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs3740065:GG
escitalopram	rs6311	HTR2A	CT	Toxicity	increased	Adverse_Event	Other:C0003469		N06AB10	rs6311:CT
escitalopram	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Other:C0003469		N06AB10	rs6311:TT
clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AA
hydrochlorothiazide	rs12795437	KCNJ1	C	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs12795437:C
phenprocoumon	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9934438:AA
phenprocoumon	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9934438:AG
valproic acid	rs1137101	LEPR	AA	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AG01	rs1137101:AA
valproic acid	rs1137101	LEPR	AG	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AG01	rs1137101:AG
phenytoin	rs78239784	CFHR4	G	Toxicity	increased	Adverse_Event	Healthy		N03AB02	rs78239784:G
hydrochlorothiazide	rs11600347	KCNJ1	A	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs11600347:A
cabazitaxel	rs2032582	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01CD04	rs2032582:A
valproic acid	rs1800497	ANKK1	AG	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AG01	rs1800497:AG
valproic acid	rs1800497	ANKK1	GG	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AG01	rs1800497:GG
hydrochlorothiazide	rs658903	KCNJ1	A	Toxicity	decreased	Adverse_Event	Disease:C0020538		C03AA03	rs658903:A
cabazitaxel	rs1045642	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01CD04	rs1045642:A
clopidogrel	rs6787801	P2RY12	G	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs6787801:G
cabazitaxel	rs776746	CYP3A5	T	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01CD04	rs776746:T
ace inhibitors, plain	rs500766	PRKCQ	CT	Toxicity	decreased	Adverse_Event	Healthy		A03B|C09A	rs500766:CT
ace inhibitors, plain	rs500766	PRKCQ	TT	Toxicity	decreased	Adverse_Event	Healthy		A03B|C09A	rs500766:TT
hydrochlorothiazide	rs675388	KCNJ1	A	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs675388:A
doxorubicin	rs1695	GSTP1	GG	Efficacy	decreased	Adverse_Event	Disease:C1458155		L01DB01	rs1695:GG
cabazitaxel	rs1128503	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01CD04	rs1128503:A
propofol	rs2283265	DRD2	AA	Other	decreased	Other	Healthy		N01AX10	rs2283265:AA
propofol	rs2283265	DRD2	AC	Other	decreased	Other	Healthy		N01AX10	rs2283265:AC
nicotine	rs2236196	CHRNA4	A	Other	increased	Adverse_Event	Healthy		N07BA01	rs2236196:A
acetaminophen	rs1042640	UGT1A	CG	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs1042640:CG
acetaminophen	rs1042640	UGT1A	GG	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs1042640:GG
clopidogrel	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AA
acetaminophen	rs8330	UGT1A	CG	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs8330:CG
acetaminophen	rs8330	UGT1A	GG	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs8330:GG
gefitinib	rs121434569	EGFR	T	Efficacy	decreased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434569:T
hydrochlorothiazide	rs59172778	KCNJ1	AG	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs59172778:AG
ethanol	rs1034936	CACNA1C	TT	Toxicity	increased	Adverse_Event	Other:C0005586		V03AB16	rs1034936:TT
doxorubicin, methotrexate, prednisolone, vincristine	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02|L01DB01|L04AX03|S02BA03	rs1045642:AA
clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AA
warfarin	rs114504854	EPHA7	A	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs114504854:A
acetaminophen	rs10929303	UGT1A	CT	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs10929303:CT
acetaminophen	rs10929303	UGT1A	TT	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs10929303:TT
ace inhibitors, plain	rs2050011	XPNPEP2	T	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs2050011:T
ethambutol, isoniazid, pyrazinamide, rifampin	rs1800629	TNF	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1800629:AA
ethambutol, isoniazid, pyrazinamide, rifampin	rs1800629	TNF	AG	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1800629:AG
nicotine	rs2271339	ADGRL3	AG	Toxicity	increased	Adverse_Event	Other:C1263846		N07BA01	rs2271339:AG
nicotine	rs1456862	ADGRL3	AT	Toxicity	increased	Adverse_Event	Other:C1263846		N07BA01	rs1456862:AT
gefitinib	rs2293347	EGFR	CC	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs2293347:CC
gefitinib	rs2293347	EGFR	CC	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs2293347:CC
ethanol	rs2159140	MAP2K4	CT	Toxicity	increased	Adverse_Event	Other:C1263846		V03AB16	rs2159140:CT
sunitinib	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs1045642:GG
sorafenib	rs17868320	UGT1A9	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EX02	rs17868320:T
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G
gefitinib	rs712829	EGFR	GT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs712829:GT
gefitinib	rs712829	EGFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs712829:TT
acenocoumarol	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9934438:AA
acenocoumarol	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9934438:AG
morphine	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs1799971:AA
ace inhibitors, plain	rs3788853	XPNPEP2	A	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs3788853:A
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01CA02	rs924607:TT
clopidogrel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AA
clopidogrel	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AG
docetaxel	rs2125739	ABCC10	CT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01CD02	rs2125739:CT
none	rs2228099	ARNT	CG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs2228099:CG
none	rs2228099	ARNT	GG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs2228099:GG
ethambutol, isoniazid, pyrazinamide, rifampin	rs3813867	CYP2E1	GG	Toxicity	increased	Adverse_Event	Disease:C0745744		J04AC01|J04AK01|J04AK02	rs3813867:GG
clopidogrel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AA
clopidogrel	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AG
none	rs4871827	DEPTOR	AA	Other	increased	Other	Other:C0011849		A03DA02	rs4871827:AA
none	rs4871827	DEPTOR	AG	Other	increased	Other	Other:C0011849		A03DA02	rs4871827:AG
cisplatin, irinotecan	rs8020368	SYNE3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs8020368:CC
none	rs4871827	DEPTOR	AG	Other	decreased	Adverse_Event	Other:C0011849		A03DA02	rs4871827:AG
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection		J04A|J05AP|S02DA30	rs3745274:TT
none	rs4871827	DEPTOR	AG	Other	decreased	Adverse_Event	Other:C0011849		A03DA02	rs4871827:AG
losartan	rs6749447	STK39	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09CA01	rs6749447:GG
losartan	rs6749447	STK39	GT	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09CA01	rs6749447:GT
clopidogrel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AA
none	rs2066853	AHR	AA	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption		A03DA02	rs2066853:AA
none	rs2066853	AHR	AG	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption		A03DA02	rs2066853:AG
risperidone	rs9659997	HTR6	CC	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs9659997:CC
risperidone	rs9659997	HTR6	CT	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs9659997:CT
cisplatin, irinotecan	rs17574269	DCBLD1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs17574269:AG
cisplatin, irinotecan	rs7186128	__INTRONIC__	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs7186128:AG
cisplatin, irinotecan	rs7186128	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs7186128:GG
risperidone	rs3786362	TYMS	A	Toxicity	increased	Adverse_Event	Disease:C1510586		N05AX08	rs3786362:A
none	rs1800630	TNF	C	Efficacy	increased	Adverse_Event	Other:C0023449		A03DA02	rs1800630:C
cisplatin, irinotecan	rs2166219	__INTRONIC__	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs2166219:TT
risperidone	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs6311:CC
cisplatin, irinotecan	rs4655567	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs4655567:CC
antineoplastic agents, corticosteroids	rs1127354	ITPA	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L01|S02BA	rs1127354:AA
antineoplastic agents, corticosteroids	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01|S02BA	rs1127354:AC
cisplatin, irinotecan	rs2018683	__INTRONIC__	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs2018683:TT
risperidone	rs6265	BDNF	CT	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs6265:CT
risperidone	rs6265	BDNF	TT	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs6265:TT
antineoplastic agents, corticosteroids	rs2236624	ADORA2A	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01|S02BA	rs2236624:CC
leucovorin, methotrexate	rs717620	ABCC2	CT	Metabolism/PK	increased	LADME	Disease:C0024299		L04AX03	rs717620:CT
leucovorin, methotrexate	rs717620	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:C0024299		L04AX03	rs717620:TT
cisplatin, irinotecan	rs2018683	__INTRONIC__	TT	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CE02|L01XA01	rs2018683:TT
none	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1799971:G
cisplatin, irinotecan	rs8020368	SYNE3	CC	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CE02|L01XA01	rs8020368:CC
cisplatin, irinotecan	rs4655567	__INTRONIC__	CC	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CE02|L01XA01	rs4655567:CC
methotrexate	rs7317112	ABCC4	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs7317112:AA
risperidone	rs1976391	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C1510586		N05AX08	rs1976391:AG
risperidone	rs6318	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs6318:C
cyclosporine	rs2275913	__INTRONIC__	GG	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD01	rs2275913:GG
lenalidomide	rs2032582	ABCB1	AA	Toxicity	decreased	Adverse_Event	Other:C0334634		L04AX04	rs2032582:AA
heroin	rs1611114	DBH	TT	Toxicity	decreased	Adverse_Event	Other:C0028043		No_ATC	rs1611114:TT
diltiazem	rs12946454	PLCD3	T	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08DB01	rs12946454:T
capecitabine, fluorouracil, oxaliplatin	rs1801131	MTHFR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01XA03	rs1801131:GG
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	AC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs1127354:AC
docetaxel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		L01CD02	rs1045642:AA
"""beta blocking agents"", ""thiazides, plain"""	rs11191548	__INTRONIC__	C	Efficacy	increased	Efficacy_Response	Disease:C0020538		S01ED	rs11191548:C
nicotine	rs4680	COMT	GG	Other	increased	Adverse_Event	Disease:C0039338		N07BA01	rs4680:GG
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
morphine	rs9282564	ABCB1	CC	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs9282564:CC
morphine	rs9282564	ABCB1	CT	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs9282564:CT
antineoplastic agents, corticosteroids	rs246240	ABCC1	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01|S02BA	rs246240:GG
lenalidomide	rs1883112	NCF4	AA	Toxicity	decreased	Adverse_Event	Other:C0334634		L04AX04	rs1883112:AA
lenalidomide	rs1883112	NCF4	AG	Toxicity	decreased	Adverse_Event	Other:C0334634		L04AX04	rs1883112:AG
nicotine	rs4680	COMT	GG	Other	increased	Other	Disease:C0039338		N07BA01	rs4680:GG
lenalidomide	rs1695	GSTP1	GG	Toxicity	decreased	Adverse_Event	Other:C0334634		L04AX04	rs1695:GG
cisplatin, irinotecan	rs16950650	ABCC4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs16950650:CT
aspirin, clopidogrel	rs1126643	ITGA2	CT	Other	increased	Other	Other:patients_undergoing_coronary_stenting		B01AC04	rs1126643:CT
aspirin, clopidogrel	rs1126643	ITGA2	TT	Other	increased	Other	Other:patients_undergoing_coronary_stenting		B01AC04	rs1126643:TT
mycophenolate mofetil(mycophenolic acid)	rs4149117	SLCO1B3	TT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs4149117:TT
efavirenz, lamivudine, tenofovir	rs1045642	ABCB1	GG	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AF05|J05AF07|J05AG03	rs1045642:GG
gemcitabine	rs780668	SLC29A3	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs780668:CT
gemcitabine	rs780668	SLC29A3	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs780668:TT
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	A	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs1127354:A
mycophenolate mofetil(mycophenolic acid)	rs4149117	SLCO1B3	TT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs4149117:TT
atorvastatin	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:C
peginterferon alfa-2b, ribavirin	rs7270101	ITPA	C	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs7270101:C
caffeine	rs762551	CYP1A2	AC	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs762551:AC
caffeine	rs762551	CYP1A2	CC	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs762551:CC
gemcitabine	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BC05	rs2231142:GT
gemcitabine	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BC05	rs2231142:TT
platinum compounds	rs11615	ERCC1	AA	Efficacy	increased	Adverse_Event	Disease:C0919267		L01XA	rs11615:AA
capecitabine	rs1048977	CDA	CT	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs1048977:CT
capecitabine	rs1048977	CDA	TT	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs1048977:TT
clopidogrel	rs1799853	CYP2C9	CT	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs1799853:CT
clopidogrel	rs1799853	CYP2C9	TT	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs1799853:TT
atorvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CT
allopurinol	rs1594	CFLAR	A	Toxicity	Indeterminado	Adverse_Event	Healthy		M04AA01	rs1594:A
oxycodone	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA05	rs1045642:AA
oxycodone	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA05	rs1045642:AG
capecitabine	rs11075646	CES2	CG	Efficacy	increased	Efficacy_Response	Disease:C0027651		L01BC06	rs11075646:CG
capecitabine	rs11075646	CES2	GG	Efficacy	increased	Efficacy_Response	Disease:C0027651		L01BC06	rs11075646:GG
platinum compounds	rs11615	ERCC1	AA	Efficacy	increased	Adverse_Event	Disease:C0919267		L01XA	rs11615:AA
clopidogrel	rs1799853	CYP2C9	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1799853:CT
clopidogrel	rs1799853	CYP2C9	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1799853:TT
platinum compounds	rs430397	HSPA5	TT	Efficacy	decreased	Other	Disease:C0007131		L01XA	rs430397:TT
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:A
aspirin	rs5050	AGT	GG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs5050:GG
sunitinib	rs6785049	NR1I2	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EX01	rs6785049:A
bupropion	rs2251954	SACM1L	C	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2251954:C
rosuvastatin	rs9806699	GATM	AA	Toxicity	decreased	Adverse_Event	Other:C1956346		C10AA07	rs9806699:AA
clopidogrel	rs4244285	CYP2C19	A	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs4244285:A
bupropion	rs2742421	SACM1L	G	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2742421:G
ethambutol, isoniazid / pyrazinamide / rifampin	rs28371759	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs28371759:AG
rosuvastatin	rs4149081	SLCO1B1	AG	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA07	rs4149081:AG
bupropion	rs2742423	SACM1L	G	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2742423:G
efavirenz	rs3745274	CYP2B6	TT	Toxicity	Indeterminado	Adverse_Event	Healthy		J05AG03	rs3745274:TT
clopidogrel	rs1057910	CYP2C9	AC	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs1057910:AC
clopidogrel	rs1057910	CYP2C9	CC	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs1057910:CC
bupropion	rs1969624	SACM1L	T	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs1969624:T
efavirenz	rs2307424	NR1I3	GG	Toxicity	Indeterminado	Adverse_Event	Healthy		J05AG03	rs2307424:GG
bupropion	rs2245705	SACM1L	C	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2245705:C
bupropion	rs2742435	SACM1L	G	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2742435:G
clopidogrel	rs1057910	CYP2C9	AC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1057910:AC
clopidogrel	rs1057910	CYP2C9	CC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1057910:CC
bupropion	rs2742390	SACM1L	A	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2742390:A
simvastatin	rs4149081	SLCO1B1	AG	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA01	rs4149081:AG
platinum compounds	rs430397	HSPA5	TT	Efficacy	increased	Adverse_Event	Disease:C0007131		L01XA	rs430397:TT
simvastatin	rs4149081	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA01	rs4149081:AA
pemetrexed	rs442767	DHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BA04	rs442767:GG
fluorouracil	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs1801131:GG
bupropion	rs2742417	SACM1L	T	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2742417:T
temsirolimus	rs3814055	NR1I2	T	Toxicity	decreased	Adverse_Event	Disease:C0877645		L01EG01	rs3814055:T
phenprocoumon	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9923231:CT
phenprocoumon	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9923231:TT
sunitinib	rs1933437	FLT3	AA	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs1933437:AA
capecitabine	rs71647871	CES1	CT	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs71647871:CT
capecitabine	rs71647871	CES1	TT	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs71647871:TT
rosuvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA07	rs4149056:CC
rosuvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA07	rs4149056:CT
gemcitabine	rs2231142	ABCG2	GT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs2231142:GT
gemcitabine	rs2231142	ABCG2	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs2231142:TT
platinum compounds	rs430397	HSPA5	TT	Efficacy	increased	Adverse_Event	Disease:C0007131		L01XA	rs430397:TT
rosuvastatin	rs4149081	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA07	rs4149081:AA
naltrexone	rs4654327	OPRD1	A	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs4654327:A
irinotecan	rs11563250	UGT1A	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs11563250:AG
irinotecan	rs11563250	UGT1A	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs11563250:GG
atorvastatin, simvastatin	rs2819742	RYR2	A	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA01|C10AA05	rs2819742:A
capecitabine, fluorouracil, gemcitabine	rs2347128	SPARC	GG	Efficacy	increased	Other	Disease:C0030297		L01BC02|L01BC05|L01BC06	rs2347128:GG
none	rs40239	MET	AG	Other	increased	Other	Disease:C0026640		A03DA02	rs40239:AG
none	rs40239	MET	GG	Other	increased	Other	Disease:C0026640		A03DA02	rs40239:GG
azathioprine	rs7270101	ITPA	AC	Toxicity	increased	Adverse_Event	Other:C0010346		L04AX01	rs7270101:AC
azathioprine	rs7270101	ITPA	CC	Toxicity	increased	Adverse_Event	Other:C0010346		L04AX01	rs7270101:CC
capecitabine, fluorouracil, gemcitabine	rs17718347	SPARC	TT	Efficacy	increased	Other	Disease:C0030297		L01BC02|L01BC05|L01BC06	rs17718347:TT
none	rs40239	MET	AG	Other	increased	Other	Disease:C0026640		A03DA02	rs40239:AG
none	rs40239	MET	GG	Other	increased	Other	Disease:C0026640		A03DA02	rs40239:GG
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	rs1045642	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection		J04A|J05AP|S02DA30	rs1045642:AA
efavirenz	rs3745274	CYP2B6	T	Other, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
efavirenz	rs3745274	CYP2B6	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs112563513	RYR1	A	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs112563513:A
efavirenz	rs2740574	CYP3A4	C	Other, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2740574:C
fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs67376798:AT
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AG
efavirenz	rs776746	CYP3A5	C	Metabolism/PK	decreased	LADME	PK:HIV		J05AG03	rs776746:C
clopidogrel	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1045642:GG
clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:AA
clopidogrel	rs4986893	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:A
ace inhibitors, plain	rs989692	MME	CT	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs989692:CT
ace inhibitors, plain	rs989692	MME	TT	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs989692:TT
hmg coa reductase inhibitors	rs12975366	LILRB5	TT	Dosage, Toxicity	increased	Adverse_Event	Healthy		C10AA	rs12975366:TT
escitalopram, fluoxetine, paroxetine, sertraline, venlafaxine	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB03|N06AB05|N06AB06|N06AB10|N06AX16	rs6311:TT
cabazitaxel	rs776746	CYP3A5	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CD04	rs776746:CT
clopidogrel	rs4986893	CYP2C19	AA	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:AA
citalopram, escitalopram, fluoxetine, paroxetine, sertraline	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Other:C0235876		N06AB03|N06AB04|N06AB05|N06AB06|N06AB10	rs6311:CC
cabazitaxel	rs463312	TUBB1	AC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CD04	rs463312:AC
clopidogrel	rs28399504	CYP2C19	G	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs28399504:G
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AA
clopidogrel	rs4986893	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:AA
nevirapine	rs28399499	CYP2B6	C	Metabolism/PK	increased	Other	Disease:HIV_infectious_disease		J05AG01	rs28399499:C
none	rs16890979	SLC2A9	T	Metabolism/PK	decreased	LADME	Healthy		A03DA02	rs16890979:T
cyclophosphamide	rs9908694	IKZF3	CC	Efficacy	increased	Adverse_Event	Disease:C0206624		L01AA01	rs9908694:CC
methotrexate	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs1045642:AG
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs118192122	RYR1	A	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs118192122:A
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs193922816	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs193922816:T
methamphetamine	rs1800955	DRD4	CC	Toxicity	decreased	Adverse_Event	Other:Methamphetamine_dependence		No_ATC	rs1800955:CC
methamphetamine	rs1800955	DRD4	CT	Toxicity	decreased	Adverse_Event	Other:Methamphetamine_dependence		No_ATC	rs1800955:CT
bevacizumab	rs4588	GC	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C2939419		L01FG01	rs4588:TT
cetuximab	rs4588	GC	TT	Efficacy	increased	Efficacy_Response	Disease:C0023055|Disease:C2939419		No_ATC	rs4588:TT
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs28933397	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs28933397:T
aspirin	rs1059288	TAPBP	AG	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1059288:AG
aspirin	rs1059288	TAPBP	GG	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1059288:GG
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs140530655	F5	CT	Toxicity	increased	Adverse_Event	Healthy		C09A	rs140530655:CT
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:AG
gefitinib	rs2272733	IKBKB	CC	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2272733:CC
"""metformin"", ""sulfonamides, urea derivatives"""	rs628031	SLC22A1	AA	Efficacy	increased	Adverse_Event	Other:C0011849		A10BA02|S01AB	rs628031:AA
"""metformin"", ""sulfonamides, urea derivatives"""	rs628031	SLC22A1	AG	Efficacy	increased	Adverse_Event	Other:C0011849		A10BA02|S01AB	rs628031:AG
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:AA
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs193922772	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs193922772:T
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:AG
fenoterol	rs12208357	SLC22A1	T	Toxicity	increased	Adverse_Event	Healthy		R03CC04	rs12208357:T
fenoterol	rs34130495	SLC22A1	A	Toxicity	increased	Adverse_Event	Healthy		R03CC04	rs34130495:A
ace inhibitors, plain	rs699	AGT	GG	Efficacy	decreased	Adverse_Event	Disease:C0020538		A03B|C09A	rs699:GG
none	rs2046934	P2RY12	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs2046934:G
gefitinib	rs11227247	RELA	CC	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs11227247:CC
fenoterol	rs55918055	SLC22A1	C	Toxicity	increased	Adverse_Event	Healthy		R03CC04	rs55918055:C
irinotecan	rs9351963	KCNQ5	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs9351963:C
fenoterol	rs34059508	SLC22A1	A	Toxicity	increased	Adverse_Event	Healthy		R03CC04	rs34059508:A
none	rs2046934	P2RY12	G	Other	increased	Efficacy_Response	Healthy		A03DA02	rs2046934:G
gefitinib	rs2151222	IKBKE	AG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2151222:AG
gefitinib	rs2151222	IKBKE	GG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2151222:GG
isoniazid, phenytoin	rs1801280	NAT2	C	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1801280:C
isoniazid, phenytoin	rs1799931	NAT2	A	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1799931:A
tamoxifen	rs28371725	CYP2D6	T	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	rs28371725:T
tamoxifen	rs3892097	CYP2D6	C	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	rs3892097:C
tamoxifen	rs1065852	CYP2D6	A	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	rs1065852:A
paroxetine	rs6314	HTR2A	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0235876		N06AB05	rs6314:AG
gabapentin, pregabalin	rs4240803	SLC7A5	AG	Toxicity	increased	Adverse_Event	Other:C0522067		N02BF02	rs4240803:AG
bevacizumab, cyclophosphamide	rs2230054	CXCR2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01AA01|L01FG01	rs2230054:TT
paroxetine	rs6314	HTR2A	AG	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AB05	rs6314:AG
tamoxifen	rs12248560	CYP2C19	T	Efficacy	decreased	Adverse_Event	Disease:C1458155		L02BA01	rs12248560:T
gemcitabine	rs4149086	SLCO1B1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05	rs4149086:AG
gemcitabine	rs4149086	SLCO1B1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05	rs4149086:GG
paroxetine	rs6313	HTR2A	GG	Toxicity	increased	Adverse_Event	Disease:C0235876		N06AB05	rs6313:GG
hydrochlorothiazide	rs5443	CDCA3, GNB3, USP5	TT	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs5443:TT
beta blocking agents	rs2230345	GRK5	AT	Other	decreased	Adverse_Event	Disease:C0085605		S01ED	rs2230345:AT
beta blocking agents	rs2230345	GRK5	TT	Other	decreased	Adverse_Event	Disease:C0085605		S01ED	rs2230345:TT
acenocoumarol, warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	rs9923231:CT
acenocoumarol, warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	rs9923231:TT
none	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Other:who_have_ever_been_smokers		A03DA02	rs1051730:A
citalopram	rs2518224	GRIK2	CC	Toxicity	increased	Adverse_Event	Disease:C0235876		N06AB04	rs2518224:CC
acenocoumarol, warfarin	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	rs9934438:AA
acenocoumarol, warfarin	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	rs9934438:AG
irinotecan	rs7586110	UGT1A9	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs7586110:G
acenocoumarol, warfarin	rs2108622	CYP4F2	CT	Toxicity	decreased	Adverse_Event	Healthy		B01AA03|B01AA07	rs2108622:CT
acenocoumarol, warfarin	rs2108622	CYP4F2	TT	Toxicity	decreased	Adverse_Event	Healthy		B01AA03|B01AA07	rs2108622:TT
none	rs8034191	HYKK	C	Other	increased	Adverse_Event	Other:who_have_ever_been_smokers		A03DA02	rs8034191:C
isoniazid, phenytoin	rs1041983	NAT2	T	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1041983:T
tacrolimus	rs290487	TCF7L2	CC	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	rs290487:CC
tacrolimus	rs290487	TCF7L2	CT	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	rs290487:CT
ace inhibitors, plain	rs699	AGT	GG	Efficacy	decreased	Adverse_Event	Disease:C0020538		A03B|C09A	rs699:GG
gemcitabine	rs2228130	POLR2A	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BC05	rs2228130:CC
valproic acid	rs1057910	CYP2C9	AC	Other, Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs1057910:AC
citalopram	rs4825476	GRIA3	G	Toxicity	increased	Adverse_Event	Disease:C0235876		N06AB04	rs4825476:G
imatinib	rs274558	SLC22A5	AA	Toxicity	decreased	Adverse_Event	Disease:C0238198		L01EA01	rs274558:AA
imatinib	rs274558	SLC22A5	AG	Toxicity	decreased	Adverse_Event	Disease:C0238198		L01EA01	rs274558:AG
isoniazid, phenytoin	rs1208	NAT2	G	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1208:G
antipsychotics	rs4818	COMT	CC	Toxicity	increased	Adverse_Event	Other:C0036341		N05A	rs4818:CC
antipsychotics	rs4818	COMT	CG	Toxicity	increased	Adverse_Event	Other:C0036341		N05A	rs4818:CG
none	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1051730:A
none	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1051730:A
dacarbazine, procarbazine	rs1800734	EPM2AIP1	AA	Toxicity	increased	Adverse_Event	Disease:C0019829		L01AX04|L01XB01	rs1800734:AA
dacarbazine, procarbazine	rs1800734	EPM2AIP1	AG	Toxicity	increased	Adverse_Event	Disease:C0019829		L01AX04|L01XB01	rs1800734:AG
isoniazid, phenytoin	rs1799930	NAT2	A	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1799930:A
none	rs1051730	CHRNA3	A	Other	increased	Other	Disease:C0039338		A03DA02	rs1051730:A
isoniazid, phenytoin	rs1799929	NAT2	T	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1799929:T
imatinib	rs2235040	ABCB1	CT	Toxicity	decreased	Adverse_Event	Disease:C0238198		L01EA01	rs2235040:CT
dexamethasone, doxorubicin, vincristine	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01CA02|L01DB01|S02BA06	rs2032582:AA
dexamethasone, doxorubicin, vincristine	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01CA02|L01DB01|S02BA06	rs2032582:AC
dacarbazine, procarbazine	rs1800734	EPM2AIP1	AA	Toxicity	increased	Adverse_Event	Disease:C0019829		L01AX04|L01XB01	rs1800734:AA
dacarbazine, procarbazine	rs1800734	EPM2AIP1	AG	Toxicity	increased	Adverse_Event	Disease:C0019829		L01AX04|L01XB01	rs1800734:AG
imatinib	rs10258429	EGFR	CT	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs10258429:CT
imatinib	rs10258429	EGFR	TT	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs10258429:TT
antipsychotics	rs165599	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0036341		N05A	rs165599:AG
imatinib	rs683369	SLC22A1	CG	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs683369:CG
imatinib	rs683369	SLC22A1	GG	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs683369:GG
risperidone	rs1065852	CYP2D6	AA	Toxicity	increased	Adverse_Event	Disease:C0233523|Disease:C0004936		N05AX08	rs1065852:AA
daclatasvir, sofosbuvir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP07|J05AP08	rs8099917:TT
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs6305	HTR2A	A	Other	increased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs6305:A
aspirin	rs4523	TBXA2R	AA	Efficacy	increased	Adverse_Event	Other:off-pump_coronary_artery_bypass_grafting		No_ATC	rs4523:AA
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs1611115	DBH	T	Other	decreased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs1611115:T
risperidone	rs1799978	DRD2	CT	Toxicity	increased	Adverse_Event	Disease:C0233523|Disease:C0004936		N05AX08	rs1799978:CT
paclitaxel	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CD01	rs2032582:AA
paclitaxel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CD01	rs1045642:AA
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs1799971	OPRM1	G	Other	increased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs1799971:G
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs6265	BDNF	T	Other	decreased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs6265:T
antipsychotics	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0036341		N05A	rs4680:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs4680	COMT	AA	Other	decreased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs4680:AA
risperidone	rs1065852	CYP2D6	AA	Toxicity	increased	Adverse_Event	Disease:C0233523|Disease:C0004936		N05AX08	rs1065852:AA
tacrolimus	rs5030952	CAPN10	CT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs5030952:CT
warfarin	rs2901783	CYP2C18	G	Dosage	Indeterminado	Other	Healthy		B01AA03	rs2901783:G
idarubicin	rs13058338	RAC2	AA	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01DB06	rs13058338:AA
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs6275	DRD2	AA	Other	decreased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs6275:AA
idarubicin	rs1883112	NCF4	AA	Toxicity	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01DB06	rs1883112:AA
opioids	rs9479757	OPRM1	AG	Other	decreased	Adverse_Event	Healthy		N02A	rs9479757:AG
tacrolimus	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs776746:CC
peginterferon alfa-2b, protease inhibitors, ribavirin	rs1127354	ITPA	AA	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AE|J05AP01|L03AB10	rs1127354:AA
peginterferon alfa-2b, protease inhibitors, ribavirin	rs1127354	ITPA	AC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AE|J05AP01|L03AB10	rs1127354:AC
opioids	rs948854	GAL	CC	Other	increased	Adverse_Event	Healthy		N02A	rs948854:CC
opioids	rs1045642	ABCB1	GG	Other	decreased	Adverse_Event	Healthy		N02A	rs1045642:GG
opioids	rs2236861	OPRD1	A	Other	decreased	Adverse_Event	Healthy		N02A	rs2236861:A
idarubicin	rs4673	CYBA	AG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01DB06	rs4673:AG
idarubicin	rs4673	CYBA	GG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01DB06	rs4673:GG
hydrochlorothiazide	rs1799983	NOS3	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs1799983:GG
idarubicin	rs4673	CYBA	AA	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01DB06	rs4673:AA
idarubicin	rs4673	CYBA	AG	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01DB06	rs4673:AG
pravastatin	rs708272	CETP	A	Efficacy	increased	Adverse_Event	Disease:C1956346		C10AA03	rs708272:A
peginterferon alfa-2b, protease inhibitors, ribavirin	rs11854484	SLC28A2	TT	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AE|J05AP01|L03AB10	rs11854484:TT
daclatasvir, sofosbuvir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP07|J05AP08	rs12979860:CC
diuretics	rs702553	PDE4D	TT	Efficacy	decreased	Efficacy_Response	Disease:C0027719		C03	rs702553:TT
citalopram, fluvoxamine, paroxetine, sertraline, venlafaxine	rs2235040	ABCB1	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04|N06AB05|N06AB06|N06AB08|N06AX16	rs2235040:T
escitalopram	rs1805127	KCNE1	C	Toxicity	increased	Adverse_Event	Healthy		N06AB10	rs1805127:C
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A
escitalopram	rs4817668	KCNE1	TT	Toxicity	increased	Adverse_Event	Healthy		N06AB10	rs4817668:TT
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Other:coronary_artery_disease_undergoing_stent_implantation		B01AC04	rs4244285:A
drugs used in nicotine dependence	rs588765	CHRNA5	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		N07BA	rs588765:T
none	rs1051730	CHRNA3	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		A03DA02	rs1051730:A
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Other:C0004364|Other:C0021390		L01BB02|L04AX01	rs116855232:T
drugs used in nicotine dependence	rs1051730	CHRNA3	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		N07BA	rs1051730:A
citalopram, fluvoxamine, paroxetine, sertraline, venlafaxine	rs2032583	ABCB1	G	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04|N06AB05|N06AB06|N06AB08|N06AX16	rs2032583:G
fluorouracil	rs1801159	DPYD	CC	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0027651		L01BC02	rs1801159:CC
fluorouracil	rs1801159	DPYD	CC	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0027651		L01BC02	rs1801159:CC
cisplatin, cyclophosphamide, doxorubicin, methotrexate, vincristine	rs4148737	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DB01|L01XA01|L04AX03	rs4148737:C
cisplatin, cyclophosphamide, doxorubicin, methotrexate, vincristine	rs4148416	ABCC3	T	Efficacy	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DB01|L01XA01|L04AX03	rs4148416:T
none	rs4946936	FOXO3	TT	Efficacy	decreased	Efficacy_Response	Other:Rhabdomyosarcoma		A03DA02	rs4946936:TT
nevirapine	rs1045642	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs1045642:A
none	rs17069665	FOXO3	GG	Efficacy	decreased	Efficacy_Response	Other:Rhabdomyosarcoma		A03DA02	rs17069665:GG
none	rs3215133	ARNT	T/del	Other	decreased	Adverse_Event	Healthy		A03DA02	rs3215133:T/del
none	rs3215133	ARNT	del/del	Other	decreased	Adverse_Event	Healthy		A03DA02	rs3215133:del/del
methadone	rs2036657	ARRB2	GG	Efficacy	increased	Adverse_Event	Other:C0027651		N07BC02	rs2036657:GG
cyclophosphamide, epirubicin, paclitaxel	rs2032582	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs2032582:A
ethanol	rs2232165	GHSR	AG	Other	Indeterminado	Other	Healthy		V03AB16	rs2232165:AG
cyclophosphamide, epirubicin, paclitaxel	rs1045642	ABCB1	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs1045642:G
cisplatin, cyclophosphamide, doxorubicin, methotrexate, vincristine	rs10276036	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DB01|L01XA01|L04AX03	rs10276036:C
antipsychotics	rs1379357	NEFM	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05A	rs1379357:G
cisplatin, cyclophosphamide, doxorubicin, methotrexate, vincristine	rs1128503	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DB01|L01XA01|L04AX03	rs1128503:G
antipsychotics	rs1457266	NEFM	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05A	rs1457266:G
none	rs12410394	ARNT	AA	Other	decreased	Adverse_Event	Healthy		A03DA02	rs12410394:AA
none	rs12410394	ARNT	AG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs12410394:AG
celecoxib	rs7518660	IL23R	A	Toxicity	increased	Adverse_Event	Disease:C0023055		M01AH01	rs7518660:A
celecoxib	rs11078659	ALOX12	A	Toxicity	increased	Adverse_Event	Disease:C0023055		M01AH01	rs11078659:A
none	rs2470890	CYP1A2	CT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs2470890:CT
none	rs2470890	CYP1A2	TT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs2470890:TT
none	rs11072508	__INTRONIC__	CT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs11072508:CT
none	rs11072508	__INTRONIC__	TT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs11072508:TT
celecoxib	rs2302821	PTGES	C	Toxicity	increased	Adverse_Event	Disease:C0023055		M01AH01	rs2302821:C
none	rs4886410	CSK	CG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs4886410:CG
none	rs4886410	CSK	GG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs4886410:GG
celecoxib	rs4133101	PTGER4	T	Toxicity	increased	Adverse_Event	Disease:C0023055		M01AH01	rs4133101:T
carboplatin, cyclophosphamide, thiotepa	rs2228100	ALDH3A1	CC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01AA01|L01AC01|L01XA02	rs2228100:CC
carboplatin, cyclophosphamide, thiotepa	rs2228100	ALDH3A1	CG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01AA01|L01AC01|L01XA02	rs2228100:CG
tamoxifen	rs3740065	ABCC2	AA	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:C1458155		L02BA01	rs3740065:AA
caffeine	rs762551	CYP1A2	AA	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs762551:AA
dexamethasone, doxorubicin, vincristine	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:Multiple_Myeloma		L01CA02|L01DB01|S02BA06	rs1045642:GG
farglitazar, insulins and analogues	rs34241435	SCNN1B	A	Toxicity	Indeterminado	Adverse_Event	Disease:C0011849		A10A	rs34241435:A
hydrochlorothiazide	rs5723	SCNN1G	CC	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C03AA03	rs5723:CC
farglitazar, glyburide	rs889299	SCNN1B	A	Toxicity	Indeterminado	Adverse_Event	Disease:C0011849		No_ATC	rs889299:A
hydrochlorothiazide	rs5729	SCNN1G	TT	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C03AA03	rs5729:TT
gefitinib	rs12142086	IKBKE	CC	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs12142086:CC
nicotine	rs680244	CHRNA5	C	Other	decreased	Adverse_Event	Disease:C0039338		N07BA01	rs680244:C
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AG
methadone	rs1045280	ARRB2	CC	Efficacy	increased	Adverse_Event	Other:C0027651		N07BC02	rs1045280:CC
tacrolimus	rs776746	CYP3A5	CT	Efficacy	decreased	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
lorazepam	rs1902023	UGT2B15	AA	Metabolism/PK	increased	LADME	Healthy		N05BA06	rs1902023:AA
cyclophosphamide, epirubicin, paclitaxel	rs3213619	ABCB1	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs3213619:G
cyclophosphamide, epirubicin, paclitaxel	rs9501929	TUBB2A	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs9501929:C
naloxone, oxycodone	rs4680	COMT	GG	Toxicity	increased	Adverse_Event	Other:C0030193		N02AA05|V03AB15	rs4680:GG
tacrolimus	rs2740574	CYP3A4	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2740574:CT
nicotine	rs16969968	CHRNA5	A	Other	decreased	Adverse_Event	Disease:C0039338		N07BA01	rs16969968:A
methadone	rs3786047	ARRB2	AA	Efficacy	increased	Adverse_Event	Other:C0027651		N07BC02	rs3786047:AA
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AG
bisoprolol	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Other:C0027051		C07AB07	rs776746:TT
naloxone, oxycodone	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:C0030193		N02AA05|V03AB15	rs1799971:AA
pazopanib	rs2010963	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX03	rs2010963:CC
hydrochlorothiazide	rs1159744	WNK1	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs1159744:GG
tamoxifen	rs12248560	CYP2C19	T	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	rs12248560:T
cyclophosphamide	rs3745274	CYP2B6	TT	Toxicity	decreased	Adverse_Event	Other:C0027697		L01AA01	rs3745274:TT
none	rs2504938	SLC22A3	TT	Efficacy	decreased	Efficacy_Response	Disease:C0030297		A03DA02	rs2504938:TT
naloxone, oxycodone	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0030193		N02AA05|V03AB15	rs4680:AA
cyclophosphamide	rs3745274	CYP2B6	GT	Toxicity	increased	Adverse_Event	Other:C0027697		L01AA01	rs3745274:GT
fluorouracil, leucovorin	rs1801019	UMPS	CC	Toxicity, Metabolism/PK	Indeterminado	Adverse_Event	Disease:C0001418		L01BC02	rs1801019:CC
fluorouracil, leucovorin	rs1801019	UMPS	CG	Toxicity, Metabolism/PK	Indeterminado	Adverse_Event	Disease:C0001418		L01BC02	rs1801019:CG
fluorouracil, leucovorin	rs1801019	UMPS	CC	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0001418		L01BC02	rs1801019:CC
buprenorphine, methadone	rs4680	COMT	AG	Efficacy	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01|N07BC02	rs4680:AG
buprenorphine, methadone	rs4680	COMT	GG	Efficacy	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01|N07BC02	rs4680:GG
capecitabine, fluorouracil	rs56038477	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs56038477:T
none	rs512077	SLC22A3	AA	Efficacy	increased	Efficacy_Response	Disease:C0030297		A03DA02	rs512077:AA
buprenorphine, methadone	rs1799971	OPRM1	AG	Efficacy	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01|N07BC02	rs1799971:AG
buprenorphine, methadone	rs1799971	OPRM1	GG	Efficacy	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01|N07BC02	rs1799971:GG
capecitabine, fluorouracil	rs2297595	DPYD	CC	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C2931822		L01BC02|L01BC06	rs2297595:CC
capecitabine, fluorouracil	rs2297595	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C2931822		L01BC02|L01BC06	rs2297595:CT
glucarpidase	rs7317112	ABCC4	AG	Toxicity	increased	Adverse_Event	Other:C0023449		V03AF09	rs7317112:AG
glucarpidase	rs7317112	ABCC4	GG	Toxicity	increased	Adverse_Event	Other:C0023449		V03AF09	rs7317112:GG
hydrochlorothiazide	rs2400707	ADRB2	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs2400707:AA
hydrochlorothiazide	rs2400707	ADRB2	AG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs2400707:AG
cyclophosphamide	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Other:C0027697		L01AA01	rs3745274:TT
nicotine	rs16969968	CHRNA5	GG	Other	increased	Other	Other:C0028043		N07BA01	rs16969968:GG
hydrochlorothiazide	rs1159744	WNK1	CC	Other	increased	Adverse_Event	Disease:C0085580		C03AA03	rs1159744:CC
heroin	rs1076560	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1076560:A
sufentanil	rs1128503	ABCB1	GG	Efficacy	decreased	Adverse_Event	"""Other:C0549433|""Other:C0016658|Bone"""		N01AH03	rs1128503:GG
hydrochlorothiazide	rs2107614	WNK1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs2107614:CC
hydrochlorothiazide	rs2107614	WNK1	CT	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs2107614:CT
hydrochlorothiazide	rs2277869	RAD52, WNK1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs2277869:CC
asparaginase, cyclophosphamide, cytarabine, doxorubicin, mercaptopurine, prednisone, vincristine	rs1799782	XRCC1	AA	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01AA01|L01BB02|L01BC01|L01CA02|L01DB01|L01XX02	rs1799782:AA
asparaginase, cyclophosphamide, cytarabine, doxorubicin, mercaptopurine, prednisone, vincristine	rs1799782	XRCC1	AG	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01AA01|L01BB02|L01BC01|L01CA02|L01DB01|L01XX02	rs1799782:AG
metformin	rs34399035	SLC47A2	T	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs34399035:T
oxaliplatin	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1128503:AA
anlotinib, apatinib, axitinib, bevacizumab, sorafenib, sunitinib	rs1870377	KDR	A	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0919267|Other:C2239176|Other:C0007131|Other:C0029463|Other:C0027651		L01EH01|L01EK01|L01EX01|L01EX02|L01FG01	rs1870377:A
cytarabine, idarubicin	rs8133052	CBR3	GG	Toxicity	decreased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs8133052:GG
warfarin	rs16871327	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs16871327:T
warfarin	rs78132896	EPHA7	C	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs78132896:C
fenofibrate	rs2241883	FABP1	CC	Toxicity	increased	Adverse_Event	Disease:C0020557		C10AB05	rs2241883:CC
fenofibrate	rs2241883	FABP1	CT	Toxicity	increased	Adverse_Event	Disease:C0020557		C10AB05	rs2241883:CT
antipsychotics	rs1051312	SNAP25	TT	Toxicity	decreased	Adverse_Event	Healthy		N05A	rs1051312:TT
gefitinib	rs577001	TAB2	CT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs577001:CT
gefitinib	rs577001	TAB2	TT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs577001:TT
peginterferon alfa-2b, ribavirin	rs304478	IFIT1	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs304478:TT
peginterferon alfa-2b, ribavirin	rs12819210	OASL	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12819210:T
oxaliplatin	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1045642:AG
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
pazopanib	rs833061	VEGFA	TT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX03	rs833061:TT
cocaine	rs6347	SLC6A3	TT	Toxicity	increased	Adverse_Event	Disease:C0278080		N01BC01	rs6347:TT
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0001418		L01EB01	rs121434568:G
atorvastatin	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs1045642:AA
cyclophosphamide, epirubicin, paclitaxel	rs8187710	ABCC2	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs8187710:A
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0001418		L01EB01	rs121434568:G
cocaine	rs1076560	DRD2	A	Toxicity	increased	Adverse_Event	Disease:C0278080		N01BC01	rs1076560:A
antiinflammatory agents, non-steroids	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	rs9923231:CT
antiinflammatory agents, non-steroids	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	rs9923231:TT
cyclophosphamide, epirubicin, paclitaxel	rs17222723	ABCC2	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs17222723:A
cyclophosphamide, epirubicin, paclitaxel	rs1056836	CYP1B1	C	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs1056836:C
anlotinib, apatinib, axitinib, bevacizumab, sorafenib, sunitinib	rs1870377	KDR	A	Efficacy	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0919267|Other:C2239176|Other:C0007131|Other:C0029463|Other:C0027651		L01EH01|L01EK01|L01EX01|L01EX02|L01FG01	rs1870377:A
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0001418		L01EB01	rs121434568:G
gefitinib	rs2233407	NFKBIA	AA	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233407:AA
gefitinib	rs2233407	NFKBIA	AT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233407:AT
cyclophosphamide, epirubicin, paclitaxel	rs6473187	SPIDR	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs6473187:G
gefitinib	rs2695121	NR1H2	CT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2695121:CT
gefitinib	rs2695121	NR1H2	TT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2695121:TT
cyclophosphamide, epirubicin, paclitaxel	rs3829306	SLCO1B1	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs3829306:T
sunitinib	rs2010963	VEGFA	CG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs2010963:CG
sunitinib	rs2010963	VEGFA	GG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs2010963:GG
cyclophosphamide, epirubicin, paclitaxel	rs301927	EPHA6	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs301927:G
warfarin	rs115112393	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs115112393:G
antipsychotics	rs6318	HTR2C	GG	Toxicity	increased	Adverse_Event	Healthy		N05A	rs6318:GG
antipsychotics	rs3813929	HTR2C	CC	Toxicity	increased	Adverse_Event	Healthy		N05A	rs3813929:CC
antipsychotics	rs518147	HTR2C	GG	Toxicity	increased	Adverse_Event	Healthy		N05A	rs518147:GG
atorvastatin	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs2032582:AA
cocaine	rs2283265	DRD2	A	Toxicity	increased	Adverse_Event	Disease:C0278080		N01BC01	rs2283265:A
anlotinib, apatinib, axitinib, bevacizumab, sorafenib, sunitinib	rs2305948	KDR	CT	Efficacy	decreased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0919267|Other:C2239176|Other:C0007131|Other:C0029463|Other:C0027651		L01EH01|L01EK01|L01EX01|L01EX02|L01FG01	rs2305948:CT
anlotinib, apatinib, axitinib, bevacizumab, sorafenib, sunitinib	rs2305948	KDR	TT	Efficacy	decreased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0919267|Other:C2239176|Other:C0007131|Other:C0029463|Other:C0027651		L01EH01|L01EK01|L01EX01|L01EX02|L01FG01	rs2305948:TT
antipsychotics	rs6275	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		N05A	rs6275:A
antipsychotics	rs7131056	DRD2	CC	Toxicity	decreased	Adverse_Event	Healthy		N05A	rs7131056:CC
antipsychotics	rs17047764	INSIG2	C	Toxicity	increased	Adverse_Event	Healthy		N05A	rs17047764:C
antipsychotics	rs5443	GNB3	TT	Toxicity	increased	Adverse_Event	Healthy		N05A	rs5443:TT
antipsychotics	rs489693	MC4R	AA	Toxicity	increased	Adverse_Event	Healthy		N05A	rs489693:AA
tianeptine	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:C0011581		N06AX14	rs1799971:AA
atorvastatin	rs1128503	ABCB1	A	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs1128503:A
antipsychotics	rs6265	BDNF, BDNF-AS	CC	Toxicity	increased	Adverse_Event	Healthy		N05A	rs6265:CC
antipsychotics	rs1800544	ADRA2A	G	Toxicity	increased	Adverse_Event	Healthy		N05A	rs1800544:G
anlotinib, apatinib, axitinib, bevacizumab, sorafenib, sunitinib	rs2071559	KDR	G	Efficacy	decreased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0919267|Other:C2239176|Other:C0007131|Other:C0029463|Other:C0027651		L01EH01|L01EK01|L01EX01|L01EX02|L01FG01	rs2071559:G
theophylline	rs2069514	CYP1A2	GG	Metabolism/PK	increased	LADME	Disease:C0004096		R03DA04	rs2069514:GG
antipsychotics	rs1799732	DRD2	del	Toxicity	increased	Adverse_Event	Healthy		N05A	rs1799732:del
gefitinib	rs2233409	NFKBIA	AG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233409:AG
gefitinib	rs2233409	NFKBIA	GG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233409:GG
gefitinib	rs8904	NFKBIA	AG	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs8904:AG
gefitinib	rs8904	NFKBIA	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs8904:GG
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Adverse_Event	Other:patients_who_underwent_successful_percutaneous_coronary_intervention		B01AC04	rs4986893:A
gefitinib	rs2053071	NFKBIB	CC	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2053071:CC
levodopa	rs6280	DRD3	CT	Toxicity	increased	Adverse_Event	Other:C0030567		N04BA02	rs6280:CT
levodopa	rs6280	DRD3	TT	Toxicity	increased	Adverse_Event	Other:C0030567		N04BA02	rs6280:TT
gefitinib	rs2233406	NFKBIA	AG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233406:AG
gefitinib	rs2233406	NFKBIA	GG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233406:GG
clopidogrel	rs5918	ITGB3	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		B01AC04	rs5918:C
clopidogrel	rs5918	ITGB3	CT	Efficacy	decreased	Efficacy_Response	Other:patients_undergoing_coronary_stent_implantation		B01AC04	rs5918:CT
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs2070673	CYP2E1	A	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs2070673:A
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs2515641	CYP2E1	T	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs2515641:T
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs4149056:C
perindopril	rs275651	AGTR1	TT	Efficacy	decreased	Adverse_Event	Disease:C1956346		C09AA04	rs275651:TT
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs2302948	SULT2B1	T	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs2302948:T
escitalopram	rs3807372	KCNH2	AA	Toxicity	increased	Adverse_Event	Healthy		N06AB10	rs3807372:AA
heroin	rs1799971	OPRM1	AA	Other	decreased	Adverse_Event	Healthy		No_ATC	rs1799971:AA
heroin	rs1799971	OPRM1	AG	Other	decreased	Adverse_Event	Healthy		No_ATC	rs1799971:AG
gefitinib	rs9694958	IKBKB	AA	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs9694958:AA
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs11231825	SLC22A12	TT	Toxicity	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs11231825:TT
gefitinib	rs3748022	IKBKE	CC	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs3748022:CC
gefitinib	rs3748022	IKBKE	CT	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs3748022:CT
aspirin	rs7179742	FSIP1	G	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7179742:G
aspirin	rs10306114	PTGS1	G	Efficacy	increased	Adverse_Event	Disease:C1956346		No_ATC	rs10306114:G
drugs for treatment of tuberculosis	rs4430924	XPO1	AA	Toxicity	increased	Adverse_Event	Other:C0041296		J04A	rs4430924:AA
aspirin	rs7572857	CEP68	AA	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7572857:AA
aspirin	rs7572857	CEP68	AG	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7572857:AG
cyclosporine, mycophenolate mofetil	rs2032582	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs2032582:A
paroxetine	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB05	rs6311:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10945919	__INTRONIC__	G	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs10945919:G
amisulpride, clozapine, haloperidol, olanzapine, quetiapine, risperidone, ziprasidone, zuclopenthixol	rs5030655	CYP2D6	A/DELA	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0005586|Other:C0031212|Other:C0033975|Other:C0028768		N05AD01|N05AE04|N05AF05|N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	rs5030655:A/DELA
daunorubicin, doxorubicin, epirubicin	rs7853758	SLC28A3	AA	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02|L01DB03	rs7853758:AA
daunorubicin, doxorubicin, epirubicin	rs7853758	SLC28A3	AG	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02|L01DB03	rs7853758:AG
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799930	NAT2	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799930:AA
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799931	NAT2	AG	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799931:AG
cetuximab, panitumumab	rs61764370	KRAS	AC	Efficacy	increased	Adverse_Event	Disease:C0023055		No_ATC	rs61764370:AC
cetuximab, panitumumab	rs61764370	KRAS	CC	Efficacy	increased	Adverse_Event	Disease:C0023055		No_ATC	rs61764370:CC
ethambutol, isoniazid, pyrazinamide, rifampin	rs1041983	NAT2	TT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1041983:TT
cyclophosphamide, fluorouracil, methotrexate	rs351855	FGFR4	GG	Efficacy	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L04AX03	rs351855:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs13393173	CERS6	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs13393173:A
clopidogrel	rs71647871	CES1	CT	Metabolism/PK	increased	LADME	Healthy		B01AC04	rs71647871:CT
clopidogrel	rs71647871	CES1	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs71647871:CT
clopidogrel	rs71647871	CES1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0010068		B01AC04	rs71647871:CT
clopidogrel	rs4986893	CYP2C19	A	Efficacy	decreased	LADME	Healthy		B01AC04	rs4986893:A
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	LADME	Healthy		B01AC04	rs4244285:A
carboplatin, pemetrexed	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BA04|L01XA02	rs1801133:AA
vemurafenib	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0859290		L01EC01	rs1045642:AA
vemurafenib	rs35599367	CYP3A4	AA	Toxicity	increased	Adverse_Event	Other:C0859290		L01EC01	rs35599367:AA
vemurafenib	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:C0859290		L01EC01	rs35599367:AG
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs4244285:A
citalopram, escitalopram, fluoxetine, paroxetine, sertraline	rs7997012	HTR2A	AA	Toxicity	increased	Adverse_Event	Healthy		N06AB03|N06AB04|N06AB05|N06AB06|N06AB10	rs7997012:AA
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs4986893:A
warfarin	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
fluorouracil, irinotecan, leucovorin	rs861539	KLC1, XRCC3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02	rs861539:GG
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
opioids	rs363332	SLC18A2	A	Other	increased	Adverse_Event	Healthy		N02A	rs363332:A
opioids	rs363334	SLC18A2	G	Other	increased	Adverse_Event	Healthy		N02A	rs363334:G
opioids	rs363338	SLC18A2	C	Other	increased	Adverse_Event	Healthy		N02A	rs363338:C
cyclophosphamide, epirubicin, paclitaxel	rs8110536	MISP	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs8110536:G
clopidogrel	rs4986893	CYP2C19	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007820		B01AC04	rs4986893:AA
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007820		B01AC04	rs4986893:AG
paclitaxel	rs7349683	EPHA5	TT	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0919267		L01CD01	rs7349683:TT
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A
sunitinib	rs699947	VEGFA	AA	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs699947:AA
sunitinib	rs699947	VEGFA	AC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs699947:AC
pazopanib	rs699947	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX03	rs699947:CC
cytarabine, idarubicin	rs1143684	NQO2	CC	Toxicity	increased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs1143684:CC
paclitaxel	rs301927	EPHA6	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0919267		L01CD01	rs301927:G
tacrolimus	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:A
warfarin	rs35410204	VEGFA	CC	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs35410204:CC
paclitaxel	rs209709	EPHA8	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0919267		L01CD01	rs209709:G
ursodeoxycholic acid	rs661899	MGAT5	TT	Toxicity	increased	Adverse_Event	Other:C0008311		A05AA02	rs661899:TT
glucocorticoids, methotrexate, radiotherapy	rs1944294	CDH2	AT	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03|R03BA	rs1944294:AT
glucocorticoids, methotrexate, radiotherapy	rs1944294	CDH2	TT	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03|R03BA	rs1944294:TT
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A
mycophenolate mofetil(mycophenolic acid)	rs11706052	IMPDH2	AG	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs11706052:AG
paclitaxel	rs7349683	EPHA5	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD01	rs7349683:TT
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007820		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007820		B01AC04	rs4244285:AG
cytarabine, idarubicin	rs1800566	NQO1	AA	Toxicity	increased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs1800566:AA
warfarin	rs866236	VEGFA	AA	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs866236:AA
paclitaxel	rs492338	ABCG1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs492338:AA
cisplatin	rs1049305	AQP1	CC	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CC
cisplatin	rs1049305	AQP1	CG	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CG
oxaliplatin	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1128503:AG
paclitaxel	rs301927	EPHA6	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD01	rs301927:AA
none	rs1042028	SULT1A1	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs1042028:T
none	rs1042028	SULT1A1	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs1042028:T
none	rs1042028	SULT1A1	T	Other	increased	Adverse_Event	Disease:C1458155		A03DA02	rs1042028:T
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:AG
amitriptyline, clomipramine, doxepin, imipramine, maprotiline, nortriptyline, opipramol	rs3892097	CYP2D6	TT	Toxicity	increased	Adverse_Event	Disease:C0235876		N06AA02|N06AA04|N06AA09|N06AA10|N06AA12|N06AA21	rs3892097:TT
calcium	rs731236	VDR	G	Efficacy	increased	Adverse_Event	Healthy		A12AA	rs731236:G
none	rs1042028	SULT1A1	T	Other	decreased	Adverse_Event	Healthy		A03DA02	rs1042028:T
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:AG
none	rs1042028	SULT1A1	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs1042028:T
amitriptyline, citalopram, paroxetine, venlafaxine	rs2235040	ABCB1	T	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs2235040:T
amitriptyline, citalopram, paroxetine, venlafaxine	rs12720067	ABCB1	T	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs12720067:T
aspirin, clopidogrel	rs13431554	IRS1	AG	Efficacy	increased	Efficacy_Response	"""Disease:C1956346|""Disease:C0011849"""		B01AC04	rs13431554:AG
aspirin, clopidogrel	rs13431554	IRS1	GG	Efficacy	increased	Efficacy_Response	"""Disease:C1956346|""Disease:C0011849"""		B01AC04	rs13431554:GG
docetaxel	rs875858	VAC14	T	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02	rs875858:T
clopidogrel	rs2242480	CYP3A4	CT	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		B01AC04	rs2242480:CT
clopidogrel	rs2242480	CYP3A4	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		B01AC04	rs2242480:TT
amitriptyline, citalopram, paroxetine, venlafaxine	rs10280101	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs10280101:C
direct factor xa inhibitors, direct thrombin inhibitors	rs1800792	FGG	CC	Toxicity	increased	Adverse_Event	Healthy		B01AE|B01AF	rs1800792:CC
amitriptyline, citalopram, paroxetine, venlafaxine	rs7787082	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs7787082:A
opioids	rs6269	COMT	AG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs6269:AG
opioids	rs6269	COMT	GG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs6269:GG
fluindione	rs9934438	VKORC1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1861172		No_ATC	rs9934438:AA
fluindione	rs9934438	VKORC1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1861172		No_ATC	rs9934438:AA
osimertinib	rs121434569	EGFR	T	Efficacy	increased	Adverse_Event	Other:C0007131		L01EB04	rs121434569:T
amitriptyline, citalopram, paroxetine, venlafaxine	rs4148739	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs4148739:C
fluindione	rs9934438	VKORC1	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C1861172		No_ATC	rs9934438:AA
opioids	rs4680	COMT	AG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4680:AG
opioids	rs4680	COMT	GG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4680:GG
ethanol	rs1229984	ADH1B	TT	Metabolism/PK	increased	LADME	Healthy		V03AB16	rs1229984:TT
amitriptyline, citalopram, paroxetine, venlafaxine	rs11983225	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs11983225:C
fluindione	rs9934438	VKORC1	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C1861172		No_ATC	rs9934438:AA
opioids	rs4818	COMT	CG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4818:CG
opioids	rs4818	COMT	GG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4818:GG
fluindione	rs9934438	VKORC1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1861172		No_ATC	rs9934438:AA
opioids	rs4633	COMT	CC	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4633:CC
opioids	rs4633	COMT	CT	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4633:CT
amitriptyline, citalopram, paroxetine, venlafaxine	rs10248420	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs10248420:G
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799931	NAT2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799931:A
antineoplastic agents	rs6744284	UGT1A	TT	Efficacy	increased	Efficacy_Response	Other:C0023449|Side_Effect:C0020433		L01	rs6744284:TT
direct factor xa inhibitors, direct thrombin inhibitors	rs5896	F2	TT	Toxicity	increased	Adverse_Event	Healthy		B01AE|B01AF	rs5896:TT
bortezomib	rs2839629	PKNOX1	A	Toxicity	increased	Adverse_Event	Other:Multiple_Myeloma		L01XG01	rs2839629:A
antineoplastic agents	rs6744284	UGT1A	T	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs6744284:T
sunitinib	rs699947	VEGFA	A	Toxicity	increased	Adverse_Event	Healthy		L01EX01	rs699947:A
amitriptyline, citalopram, paroxetine, venlafaxine	rs2235067	ABCB1	T	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs2235067:T
atenolol	rs9940629	FTO	G	Other	Indeterminado	Adverse_Event	Disease:C0020538		C07AB03	rs9940629:G
sunitinib	rs833061	VEGFA	C	Toxicity	increased	Adverse_Event	Healthy		L01EX01	rs833061:C
alfentanil, fentanyl	rs1799971	OPRM1	AG	Efficacy	increased	Adverse_Event	Other:tonsillectomy		N01AH02|N02AB03	rs1799971:AG
alfentanil, fentanyl	rs1799971	OPRM1	GG	Efficacy	increased	Adverse_Event	Other:tonsillectomy		N01AH02|N02AB03	rs1799971:GG
sunitinib	rs2010963	VEGFA	G	Toxicity	increased	Adverse_Event	Healthy		L01EX01	rs2010963:G
amitriptyline, citalopram, paroxetine, venlafaxine	rs4148740	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs4148740:G
atenolol	rs10267099	ABCB1	G	Other	increased	Adverse_Event	Disease:C0020538		C07AB03	rs10267099:G
clopidogrel	rs4244285	CYP2C19	AA	Other	decreased	Other	Disease:C0027051		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Other	decreased	Other	Disease:C0027051		B01AC04	rs4244285:AG
atenolol	rs3213619	ABCB1	G	Other	increased	Adverse_Event	Disease:C0020538		C07AB03	rs3213619:G
corticosteroids	rs7160796	DCAF4	CC	Efficacy	increased	Efficacy_Response	Disease:C0004096		S02BA	rs7160796:CC
sunitinib	rs2070744	NOS3	CC	Toxicity	increased	Adverse_Event	Healthy		L01EX01	rs2070744:CC
sunitinib	rs2070744	NOS3	CT	Toxicity	increased	Adverse_Event	Healthy		L01EX01	rs2070744:CT
atenolol	rs11649514	PRKCB	GT	Toxicity, Other	increased	Adverse_Event	Disease:C0085580		C07AB03	rs11649514:GT
atenolol	rs11649514	PRKCB	TT	Toxicity, Other	increased	Adverse_Event	Disease:C0085580		C07AB03	rs11649514:TT
atenolol	rs12595985	FTO	AA	Other	increased	Adverse_Event	Disease:C0020538		C07AB03	rs12595985:AA
cyclophosphamide	rs8187996	ALDH1A1	CT	Toxicity	decreased	Adverse_Event	Other:C1458155|Other:C0027651		L01AA01	rs8187996:CT
cyclophosphamide	rs8187996	ALDH1A1	TT	Toxicity	decreased	Adverse_Event	Other:C1458155|Other:C0027651		L01AA01	rs8187996:TT
clopidogrel	rs2046934	P2RY12	AG	Other	decreased	Other	Disease:C0027051		B01AC04	rs2046934:AG
clopidogrel	rs2046934	P2RY12	GG	Other	decreased	Other	Disease:C0027051		B01AC04	rs2046934:GG
atenolol	rs2144297	GALNT2	T	Other	Indeterminado	Adverse_Event	Disease:C0020538		C07AB03	rs2144297:T
atenolol	rs2144300	GALNT2	C	Other	Indeterminado	Adverse_Event	Disease:C0020538		C07AB03	rs2144300:C
ethanol	rs1800497	ANKK1, DRD2	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1800497:A
warfarin	rs1057910	CYP2C9	AC	Dosage, Metabolism/PK	decreased	LADME	Healthy		B01AA03	rs1057910:AC
atenolol	rs10157410	PLA2G4A	C	Other	increased	Adverse_Event	Disease:C0020538		C07AB03	rs10157410:C
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AG
atenolol	rs4648287	PTGS2	G	Other	increased	Adverse_Event	Disease:C0020538		C07AB03	rs4648287:G
isoniazid, rifampin	rs11080344	NOS2	CC	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs11080344:CC
enalapril	rs2306283	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Other:C0020538		C09AA02	rs2306283:AA
isoniazid, rifampin	rs2070401	BACH1	GG	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs2070401:GG
clopidogrel	rs12248560	CYP2C19	CT	Efficacy	decreased	Efficacy_Response	Efficacy:C1956346		B01AC04	rs12248560:CT
clopidogrel	rs12248560	CYP2C19	TT	Efficacy	decreased	Efficacy_Response	Efficacy:C1956346		B01AC04	rs12248560:TT
isoniazid, rifampin	rs4720833	MAFK	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs4720833:AA
isoniazid, rifampin	rs4720833	MAFK	AG	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs4720833:AG
isoniazid, rifampin	rs11125883	XPO1	AC	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01	rs11125883:AC
isoniazid, rifampin	rs11125883	XPO1	CC	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01	rs11125883:CC
clopidogrel	rs12248560	CYP2C19	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		B01AC04	rs12248560:CC
isoniazid	rs1041983	NAT2	T	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs1041983:T
isoniazid	rs1495741	NAT2	G	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs1495741:G
clopidogrel	rs1057910	CYP2C9	C	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs1057910:C
capecitabine, fluorouracil	rs1801158	DPYD	CT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs1801158:CT
capecitabine, fluorouracil	rs1801158	DPYD	TT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs1801158:TT
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Adverse_Event	Disease:C0010068		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Adverse_Event	Disease:C0010068		B01AC04	rs4244285:AG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs7270101	ITPA	AA	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs7270101:AA
anastrozole, letrozole	rs9340799	ESR1	A	Other	increased	Adverse_Event	Other:C0235653		L02BG03|L02BG04	rs9340799:A
clopidogrel	rs776746	CYP3A5	CT	Efficacy	decreased	Adverse_Event	Disease:C0010068		B01AC04	rs776746:CT
clopidogrel	rs776746	CYP3A5	TT	Efficacy	decreased	Adverse_Event	Disease:C0010068		B01AC04	rs776746:TT
anastrozole, letrozole	rs2234693	ESR1	C	Other	increased	Adverse_Event	Other:C0235653		L02BG03|L02BG04	rs2234693:C
clopidogrel	rs2046934	P2RY12	AG	Efficacy	increased	Adverse_Event	Disease:C0010068		B01AC04	rs2046934:AG
clopidogrel	rs2046934	P2RY12	GG	Efficacy	increased	Adverse_Event	Disease:C0010068		B01AC04	rs2046934:GG
none	rs2740574	CYP3A4	CC	Other	increased	Adverse_Event	Other:C0007222|Other:C0020473		A03DA02	rs2740574:CC
opioids	rs1799971	OPRM1	AA	Other	decreased	Adverse_Event	Healthy		N02A	rs1799971:AA
opioids	rs1799971	OPRM1	AG	Other	decreased	Adverse_Event	Healthy		N02A	rs1799971:AG
capecitabine, fluorouracil	rs75017182	DPYD	C	Dosage, Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs75017182:C
repaglinide	rs1801262	NEUROD1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1801262:CT
repaglinide	rs1801262	NEUROD1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1801262:TT
repaglinide	rs114202595	PAX4	AA	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs114202595:AA
repaglinide	rs114202595	PAX4	AG	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs114202595:AG
none	rs2740574	CYP3A4	CT	Other	increased	Adverse_Event	Healthy		A03DA02	rs2740574:CT
vincristine	rs1045644	COCH	CG	Toxicity	decreased	Adverse_Event	Other:C0023449		L01CA02	rs1045644:CG
vincristine	rs1045644	COCH	GG	Toxicity	decreased	Adverse_Event	Other:C0023449		L01CA02	rs1045644:GG
cetuximab, irinotecan, leucovorin, tegafur	rs712830	EGFR	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03|L01CE02	rs712830:CC
tamoxifen	rs2740574	CYP3A4	CT	Other	increased	Adverse_Event	Disease:C1458155		L02BA01	rs2740574:CT
vincristine	rs7963521	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs7963521:C
repaglinide	rs1801262	NEUROD1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1801262:CT
repaglinide	rs1801262	NEUROD1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1801262:TT
none	rs3782905	VDR	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs3782905:G
opioids	rs6090043	OPRL1	C	Toxicity	increased	Adverse_Event	Healthy		N02A	rs6090043:C
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_undergoing_elective_coronary_stent_placement		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_undergoing_elective_coronary_stent_placement		B01AC04	rs4244285:AG
clopidogrel	rs6785930	P2RY12	A	Efficacy	increased	Adverse_Event	Disease:C0085096		B01AC04	rs6785930:A
opioids	rs165599	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs165599:AA
opioids	rs165599	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs165599:AG
docetaxel, paclitaxel	rs2032582	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD01|L01CD02	rs2032582:A
cisplatin	rs1049305	AQP1	CC	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CC
cisplatin	rs1049305	AQP1	CG	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CG
clopidogrel	rs4986893	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4986893:AA
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4986893:AG
calcitriol	rs2228570	VDR	A	Efficacy	increased	Adverse_Event	Healthy		D05AX03	rs2228570:A
cisplatin	rs1049305	AQP1	CC	Toxicity	decreased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CC
cisplatin	rs1049305	AQP1	CG	Toxicity	decreased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CG
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A
perindopril	rs12050217	BDKRB1	AA	Efficacy	decreased	Adverse_Event	Disease:C1956346		C09AA04	rs12050217:AA
cisplatin	rs1049305	AQP1	CC	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CC
atenolol, verapamil	rs1801058	GRK4	TT	Efficacy, Toxicity, Other	increased	Adverse_Event	Other:hypertension_and_coronory_artery_disease		C07AB03|C08DA01	rs1801058:TT
clozapine	rs762551	CYP1A2	AA	Toxicity	increased	Adverse_Event	Disease:C0036341|Disease:C0039338		N05AH02	rs762551:AA
mycophenolate mofetil(mycophenolic acid)	rs2278294	IMPDH1	CT	Toxicity	decreased	Adverse_Event	Other:C1262018		L04AA06	rs2278294:CT
mycophenolate mofetil(mycophenolic acid)	rs2278294	IMPDH1	TT	Toxicity	decreased	Adverse_Event	Other:C1262018		L04AA06	rs2278294:TT
platinum compounds	rs2071554	HLA-DOB	CT	Efficacy	increased	Adverse_Event	Disease:C0024121		L01XA	rs2071554:CT
platinum compounds	rs2071554	HLA-DOB	TT	Efficacy	increased	Adverse_Event	Disease:C0024121		L01XA	rs2071554:TT
platinum compounds	rs2900420	__INTRONIC__	AA	Efficacy	decreased	Adverse_Event	Disease:C0024121		L01XA	rs2900420:AA
platinum compounds	rs2900420	__INTRONIC__	AG	Efficacy	decreased	Adverse_Event	Disease:C0024121		L01XA	rs2900420:AG
clozapine	rs762551	CYP1A2	AA	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH02	rs762551:AA
cyclophosphamide, cytarabine, daunorubicin, mercaptopurine, methotrexate, prednisone, vincristine	rs639174	DROSHA	T	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB02|L01BC01|L01CA02|L01DB02|L04AX03	rs639174:T
opioids	rs6275	DRD2	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs6275:AG
opioids	rs6275	DRD2	GG	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs6275:GG
cisplatin	rs12201199	TPMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs12201199:T
isoniazid, pyrazinamide, rifampin	rs6413432	CYP2E1	A	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	rs6413432:A
cisplatin	rs3746444	__INTRONIC__	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA01	rs3746444:AG
cisplatin	rs3746444	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA01	rs3746444:GG
acenocoumarol, warfarin	rs1057910	CYP2C9	CC	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03|B01AA07	rs1057910:CC
aspirin	rs20417	PTGS2	G	Other	decreased	Adverse_Event	Healthy		No_ATC	rs20417:G
cisplatin	rs28362731	AQP1	AG	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs28362731:AG
ethambutol, isoniazid, pyrazinamide, rifampin	rs2031920	CYP2E1	CC	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs2031920:CC
aspirin	rs20417	PTGS2	G	Other	increased	Adverse_Event	Healthy		No_ATC	rs20417:G
clopidogrel	rs4986893	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4986893:A
folfiri	rs17501011	ABCC1	AA	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs17501011:AA
folfiri	rs17501011	ABCC1	AG	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs17501011:AG
opioids	rs6090041	OPRL1	G	Toxicity	increased	Adverse_Event	Healthy		N02A	rs6090041:G
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:AG
antidepressants	rs365836	CUX1	G	Efficacy	Indeterminado	Adverse_Event	Disease:C0011581		N06A	rs365836:G
none	rs1042028	SULT1A1	CT	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1042028:CT
none	rs1042028	SULT1A1	TT	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1042028:TT
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:A
none	rs1042028	SULT1A1	CT	Other	decreased	Adverse_Event	Other:at_least_three_pregnancies_and_premenopausal		A03DA02	rs1042028:CT
none	rs1042028	SULT1A1	TT	Other	decreased	Adverse_Event	Other:at_least_three_pregnancies_and_premenopausal		A03DA02	rs1042028:TT
clozapine	rs1137101	LEPR	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1137101:AG
clozapine	rs1137101	LEPR	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1137101:GG
acenocoumarol, warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03|B01AA07	rs9923231:TT
antidepressants	rs201522	CUX1	A	Efficacy	Indeterminado	Adverse_Event	Disease:C0011581		N06A	rs201522:A
bortezomib	rs2839629	PKNOX1	AA	Toxicity	increased	Adverse_Event	Other:Multiple_Myeloma		L01XG01	rs2839629:AA
cisplatin	rs9332377	COMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs9332377:T
warfarin	rs9923231	VKORC1	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
cisplatin	rs4646316	COMT	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs4646316:C
capecitabine	rs2741171	ENOSF1	T	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2741171:T
capecitabine	rs2612091	ENOSF1	C	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2612091:C
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Healthy		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Healthy		L04AX03	rs1801133:AG
cisplatin	rs1051640	ABCC3	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1051640:G
capecitabine	rs12022243	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs12022243:T
folfiri	rs9921399	CES1	CC	Efficacy	increased	Efficacy_Response	Other:C0023055		No_ATC	rs9921399:CC
dextroamphetamine, methylphenidate	rs4532	DRD1	CC	Toxicity	increased	Adverse_Event	Disease:C1263846		N06BA04	rs4532:CC
cisplatin	rs1142345	TPMT	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1142345:C
methamphetamine	rs1126442	GRIN1	GG	Toxicity	increased	Adverse_Event	Disease:Methamphetamine_dependence		No_ATC	rs1126442:GG
folfiri	rs1113193	UGT1A10, UGT1A8	AA	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs1113193:AA
cisplatin	rs1800460	TPMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1800460:T
capecitabine	rs2741171	ENOSF1	T	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2741171:T
capecitabine	rs2612091	ENOSF1	C	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2612091:C
capecitabine	rs12022243	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs12022243:T
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
iodine (131i) compounds, radiotherapy	rs1800469	TGFB1	AA	Toxicity	increased	Adverse_Event	Other:C0030521		V10XA01	rs1800469:AA
nicotine	rs588765	CHRNA5	CT	Efficacy	increased	Adverse_Event	Other:smokers		N07BA01	rs588765:CT
nicotine	rs588765	CHRNA5	TT	Efficacy	increased	Adverse_Event	Other:smokers		N07BA01	rs588765:TT
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs8099917:GG
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs8099917:GT
capecitabine	rs76387818	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs76387818:A
capecitabine	rs12132152	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs12132152:A
capecitabine	rs76387818	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs76387818:A
atenolol	rs2669429	DPYS	AG	Toxicity	increased	Adverse_Event	Disease:C0020538		C07AB03	rs2669429:AG
atenolol	rs2669429	DPYS	GG	Toxicity	increased	Adverse_Event	Disease:C0020538		C07AB03	rs2669429:GG
lenalidomide	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:Multiple_Myeloma|Other:C0024299|Other:C0026986		L04AX04	rs1045642:AA
lenalidomide	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:Multiple_Myeloma|Other:C0024299|Other:C0026986		L04AX04	rs1045642:AG
capecitabine	rs12132152	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs12132152:A
none	rs12979860	IFNL3, IFNL4	CC	Other	increased	Other	Disease:C0019372		A03DA02	rs12979860:CC
risperidone	rs7799039	LEP	G	Other	increased	Adverse_Event	Disease:C1510586		N05AX08	rs7799039:G
warfarin	rs9923231	VKORC1	T	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:T
iodine (131i) compounds, radiotherapy	rs10514231	ATG10	CC	Toxicity	increased	Adverse_Event	Other:C0030521		V10XA01	rs10514231:CC
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs924607:TT
carboplatin, paclitaxel	rs1656402	EIF4E2, TIGD1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA02	rs1656402:CC
iodine (131i) compounds, radiotherapy	rs11212570	ATM	AG	Toxicity	decreased	Adverse_Event	Other:C0030521		V10XA01	rs11212570:AG
nicotine	rs2056527	__INTRONIC__	CT	Efficacy	decreased	Adverse_Event	Other:smokers		N07BA01	rs2056527:CT
nicotine	rs2056527	__INTRONIC__	TT	Efficacy	decreased	Adverse_Event	Other:smokers		N07BA01	rs2056527:TT
nicotine	rs2056527	__INTRONIC__	CT	Efficacy	decreased	Adverse_Event	Other:smokers		N07BA01	rs2056527:CT
nicotine	rs2056527	__INTRONIC__	TT	Efficacy	decreased	Adverse_Event	Other:smokers		N07BA01	rs2056527:TT
capecitabine, fluorouracil	rs67376798	DPYD	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:AA
capecitabine, fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:AT
pirfenidone	rs5743890	TOLLIP	CC	Efficacy	increased	Efficacy_Response	Other:C0034069		L04AX05	rs5743890:CC
pirfenidone	rs5743890	TOLLIP	CT	Efficacy	increased	Efficacy_Response	Other:C0034069		L04AX05	rs5743890:CT
capecitabine, fluorouracil	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs1801160:CT
capecitabine, fluorouracil	rs1801160	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs1801160:TT
warfarin	rs9923231	VKORC1	T	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:T
imatinib	rs1045642	ABCB1	GG	Toxicity	decreased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:GG
platinum compounds	rs2269577	XBP1	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs2269577:GG
imatinib	rs683369	SLC22A1	CC	Toxicity	decreased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CC
carboplatin, paclitaxel	rs9981861	DSCAM	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA02	rs9981861:TT
carboplatin, paclitaxel	rs1209950	ETS2	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA02	rs1209950:CT
carboplatin, paclitaxel	rs1209950	ETS2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA02	rs1209950:TT
iodine (131i) compounds, radiotherapy	rs10514231	ATG10	CC	Toxicity	increased	Adverse_Event	Other:C0030521		V10XA01	rs10514231:CC
iodine (131i) compounds, radiotherapy	rs1800469	TGFB1	AA	Toxicity	increased	Adverse_Event	Other:C0030521		V10XA01	rs1800469:AA
warfarin	rs9923231	VKORC1	T	Efficacy	increased	Adverse_Event	Healthy		B01AA03	rs9923231:T
iodine (131i) compounds, radiotherapy	rs1864183	ATG10	TT	Toxicity	increased	Adverse_Event	Other:C0030521		V10XA01	rs1864183:TT
mercaptopurine	rs186364861	NUDT15	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs186364861:A
amisulpride, clozapine, olanzapine, paliperidone, quetiapine, risperidone	rs17782313	MC4R	CC	Other	increased	Adverse_Event	Healthy		N05AH02|N05AH03|N05AH04|N05AL05|N05AX08|N05AX13	rs17782313:CC
amisulpride, aripiprazole, clozapine, haloperidol, quetiapine, risperidone, ziprasidone	rs489693	MC4R	A	Other	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AD01|N05AE04|N05AH02|N05AH04|N05AL05|N05AX08|N05AX12	rs489693:A
mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:T
amisulpride, aripiprazole, clozapine, haloperidol, quetiapine, risperidone, ziprasidone	rs489693	MC4R	AA	Other	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AD01|N05AE04|N05AH02|N05AH04|N05AL05|N05AX08|N05AX12	rs489693:AA
atenolol, verapamil	rs11124945	PLEKHH2	G	Toxicity	decreased	Adverse_Event	Disease:C0020538		C07AB03|C08DA01	rs11124945:G
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C0002962|Disease:C0027051		B01AC04	rs4244285:AG
regadenoson	rs17602729	AMPD1	AA	Efficacy	increased	Adverse_Event	Healthy		C01EB21	rs17602729:AA
regadenoson	rs17602729	AMPD1	AG	Efficacy	increased	Adverse_Event	Healthy		C01EB21	rs17602729:AG
efavirenz	rs3745274	CYP2B6	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Other	Disease:C1956346		B01AC04	rs4244285:AA
capecitabine, fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs3918290:CT
capecitabine, fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs3918290:TT
none	rs2952768	__INTRONIC__	CC	Efficacy	decreased	Adverse_Event	Other:Methamphetamine_dependence|Other:C0085762|Other:C0013473		A03DA02	rs2952768:CC
cisplatin, cyclophosphamide	rs1799793	ERCC2	CT	Efficacy	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1799793:CT
acenocoumarol, warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Disease:C0004238|Disease:C1861172		B01AA03|B01AA07	rs9923231:CT
acenocoumarol, warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Disease:C0004238|Disease:C1861172		B01AA03|B01AA07	rs9923231:TT
nicotine	rs1541333	DBH	CC	Efficacy	decreased	Adverse_Event	Other:smokers_with_low_dependency		N07BA01	rs1541333:CC
regadenoson	rs17602729	AMPD1	AA	Toxicity	increased	Adverse_Event	Healthy		C01EB21	rs17602729:AA
regadenoson	rs17602729	AMPD1	AG	Toxicity	increased	Adverse_Event	Healthy		C01EB21	rs17602729:AG
risperidone	rs806378	CNR1	T	Other	increased	Adverse_Event	Disease:C1510586		N05AX08	rs806378:T
risperidone	rs1049353	CNR1	C	Other	increased	Adverse_Event	Disease:C1510586		N05AX08	rs1049353:C
mercaptopurine	rs3765534	ABCC4	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs3765534:T
asparaginase	rs6021191	NFATC2	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	rs6021191:T
asparaginase	rs17885382	HLA-DRB1	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	rs17885382:T
cyclophosphamide, epirubicin	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB03	rs1695:AA
ivacaftor	rs75527207	CFTR	A	Efficacy	decreased	Adverse_Event	Disease:C0156318		R07AX02	rs75527207:A
vancomycin	rs2789047	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		J01XA01	rs2789047:A
lisinopril	rs35068180	MMP3	AA	Efficacy	increased	Adverse_Event	Disease:C0020538		C09AA03	rs35068180:AA
carboplatin, gemcitabine	rs6113	SERPINA5	C	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs6113:C
clopidogrel	rs4244285	CYP2C19	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:A
carboplatin, gemcitabine	rs6118	SERPINA5	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs6118:T
carboplatin, gemcitabine	rs6504649	XYLT2	G	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs6504649:G
carboplatin, gemcitabine	rs6119	SERPINA5	G	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs6119:G
ethanol	rs1001179	CAT	T	Other	increased	Adverse_Event	Healthy		V03AB16	rs1001179:T
carboplatin, gemcitabine	rs73450548	ETS2	A	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs73450548:A
bevacizumab, pegaptanib, ranibizumab	rs2010963	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:Choroidal_Neovascularization		L01FG01|S01LA03|S01LA04	rs2010963:CC
clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Other	Disease:C0027051		B01AC04	rs1045642:AA
methotrexate	rs1801133	MTHFR	AA	Efficacy	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA
doxorubicin	rs3957357	GSTA1	AA	Efficacy	increased	Efficacy_Response	Disease:C1261473		L01DB01	rs3957357:AA
amisulpride, clozapine, olanzapine, paliperidone, quetiapine, risperidone	rs489693	MC4R	AA	Other	increased	Adverse_Event	Healthy		N05AH02|N05AH03|N05AH04|N05AL05|N05AX08|N05AX13	rs489693:AA
ethanol	rs1001179	CAT	T	Other	increased	Adverse_Event	Disease:C0085762		V03AB16	rs1001179:T
none	rs3212986	ERCC1	AC	Other	decreased	Other	Disease:C0007131		A03DA02	rs3212986:AC
dexmedetomidine	rs279847	GABRA2	GG	Toxicity	decreased	Adverse_Event	Healthy		N05CM18	rs279847:GG
tamoxifen	rs9340799	ESR1	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L02BA01	rs9340799:AG
tamoxifen	rs9340799	ESR1	GG	Toxicity	increased	Adverse_Event	Other:C1458155		L02BA01	rs9340799:GG
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs149389480	F5	AG	Toxicity	increased	Adverse_Event	Healthy		C09A	rs149389480:AG
morphine	rs3766246	FAAH	AA	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs3766246:AA
morphine	rs3766246	FAAH	AG	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs3766246:AG
clozapine, olanzapine	rs9852	TBC1D1	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03	rs9852:CC
fluorouracil	rs67376798	DPYD	AT	Efficacy	decreased	Efficacy_Response	Other:C0023055		L01BC02	rs67376798:AT
morphine	rs4141964	FAAH	CT	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs4141964:CT
morphine	rs4141964	FAAH	TT	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs4141964:TT
none	rs2287622	ABCB11	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs2287622:GG
hydrocodone	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:AG
hydrocodone	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:GG
hydrocodone	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:AG
hydrocodone	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:GG
none	rs1800497	DRD2	AA	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1800497:AA
none	rs1800497	DRD2	AG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1800497:AG
opioids	rs5443	GNB3	CT	Toxicity, Other	increased	Adverse_Event	Side_Effect:withdrawal_from_opioid_addiction		N02A	rs5443:CT
opioids	rs5443	GNB3	TT	Toxicity, Other	increased	Adverse_Event	Side_Effect:withdrawal_from_opioid_addiction		N02A	rs5443:TT
aripiprazole, clozapine, haloperidol, olanzapine, quetiapine, risperidone	rs324420	FAAH	A	Toxicity	increased	Adverse_Event	Disease:C0033975		N05AD01|N05AH02|N05AH03|N05AH04|N05AX08|N05AX12	rs324420:A
morphine	rs2295632	FAAH	GT	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs2295632:GT
morphine	rs2295632	FAAH	TT	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs2295632:TT
caffeine	rs762551	CYP1A2	AC	Other	decreased	Adverse_Event	Other:BRCA1_mutations		N06BC01	rs762551:AC
caffeine	rs762551	CYP1A2	CC	Other	decreased	Adverse_Event	Other:BRCA1_mutations		N06BC01	rs762551:CC
morphine	rs324420	FAAH	AA	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs324420:AA
morphine	rs324420	FAAH	AC	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs324420:AC
peginterferon alfa-2b, ribavirin	rs2228570	VDR	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs2228570:AA
peginterferon alfa-2b, ribavirin	rs2228570	VDR	AG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs2228570:AG
none	rs2287622	ABCB11	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs2287622:GG
peginterferon alfa-2b, ribavirin, simeprevir	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01|J05AP05|L03AB10	rs1127354:CC
docetaxel	rs3003593	NR1I3	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3003593:AA
antithyroid preparations	rs652888	EHMT2	G	Toxicity	increased	Adverse_Event	Healthy		H03B	rs652888:G
iodine (131i) compounds, radiotherapy	rs1800629	TNF	AG	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs1800629:AG
hydrocodone	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:AG
hydrocodone	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:GG
hmg coa reductase inhibitors	rs1063320	HLA-G	G	Other	decreased	Adverse_Event	Disease:C0004096		C10AA	rs1063320:G
hydrocodone	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:AG
hydrocodone	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:GG
dexmedetomidine	rs28399433	CYP2A6	C	Efficacy	increased	Efficacy_Response	Healthy		N05CM18	rs28399433:C
deferiprone	rs6759892	UGT1A6	GG	Toxicity	increased	Adverse_Event	Disease:Beta-thalassemia_and_related_diseases		V03AC02	rs6759892:GG
deferiprone	rs6759892	UGT1A6	GG	Toxicity	increased	Adverse_Event	Disease:Beta-thalassemia_and_related_diseases		V03AC02	rs6759892:GG
antithyroid preparations	rs111618861	__INTRONIC__	del	Toxicity	increased	Adverse_Event	Healthy		H03B	rs111618861:del
antithyroid preparations	rs1071816	HLA-B	C	Toxicity	increased	Adverse_Event	Healthy		H03B	rs1071816:C
iodine (131i) compounds, radiotherapy	rs11212570	ATM	AA	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs11212570:AA
iodine (131i) compounds, radiotherapy	rs11212570	ATM	AG	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs11212570:AG
efavirenz	rs1800896	IL10	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs1800896:TT
ethanol	rs1800497	ANKK1, DRD2	A	Other	increased	Adverse_Event	Healthy		V03AB16	rs1800497:A
iodine (131i) compounds, radiotherapy	rs230493	NFKB1	AT	Toxicity	decreased	Adverse_Event	Disease:C0030521		V10XA01	rs230493:AT
opioids	rs1799971	OPRM1	G	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs1799971:G
ethanol	rs1800497	DRD2	A	Other	increased	Adverse_Event	Healthy		V03AB16	rs1800497:A
iodine (131i) compounds, radiotherapy	rs2241716	TGFB1	TT	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs2241716:TT
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:CT
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:TT
iodine (131i) compounds, radiotherapy	rs1800469	TGFB1	GG	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs1800469:GG
antithyroid preparations	rs199564443	FOXF2	del	Toxicity	increased	Adverse_Event	Healthy		H03B	rs199564443:del
capecitabine	rs7187684	CES1P1	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs7187684:T
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs6977967	__INTRONIC__	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs6977967:GG
capecitabine	rs11861118	CES1P1	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs11861118:G
platinum	rs25487	XRCC1	TT	Efficacy	Indeterminado	Other	Disease:C0007131		L01XA	rs25487:TT
platinum	rs11615	ERCC1	AG	Efficacy	increased	Adverse_Event	Disease:C0007131		L01XA	rs11615:AG
platinum	rs11615	ERCC1	GG	Efficacy	increased	Adverse_Event	Disease:C0007131		L01XA	rs11615:GG
capecitabine	rs2244613	CES1	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs2244613:G
platinum	rs3212986	ERCC1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs3212986:AA
platinum	rs3212986	ERCC1	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs3212986:AC
clozapine, ethanol	rs2069514	CYP1A2	GG	Toxicity	increased	Adverse_Event	Other:C0033975		N05AH02|V03AB16	rs2069514:GG
mercaptopurine, methotrexate	rs2413739	PACSIN2	CT	Efficacy	increased	Adverse_Event	Other:C0023449		L01BB02|L04AX03	rs2413739:CT
mercaptopurine, methotrexate	rs2413739	PACSIN2	TT	Efficacy	increased	Adverse_Event	Other:C0023449		L01BB02|L04AX03	rs2413739:TT
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs4674470	MIR4268	CC	Toxicity	decreased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs4674470:CC
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs4674470	MIR4268	CT	Toxicity	decreased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs4674470:CT
capecitabine	rs2244614	CES1	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs2244614:G
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CT
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:TT
citalopram	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Other:C0085762|Other:C0011581		N06AB04	rs4244285:AG
iodine (131i) compounds, radiotherapy	rs620815	ATM	TT	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs620815:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	TT	Efficacy	increased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs12979860:TT
tenofovir	rs17222723	ABCC2	A	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AF07	rs17222723:A
tenofovir	rs2273697	ABCC2	A	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF07	rs2273697:A
fluorouracil	rs1801160	DPYD	CT	Efficacy	decreased	Efficacy_Response	Other:C0023055		L01BC02	rs1801160:CT
cytarabine, idarubicin	rs12036333	__INTRONIC__	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs12036333:AA
cytarabine, idarubicin	rs12036333	__INTRONIC__	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs12036333:AG
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs8667	ATF5	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs8667:AA
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs8667	ATF5	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs8667:AG
nevirapine	rs28399499	CYP2B6	CC	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs28399499:CC
nevirapine	rs28399499	CYP2B6	CT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs28399499:CT
peginterferon alfa-2b, ribavirin	rs10741657	CYP2R1	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10741657:AA
peginterferon alfa-2b, ribavirin	rs10741657	CYP2R1	AG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10741657:AG
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs12402181	MIR3117	AA	Toxicity	decreased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs12402181:AA
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs12402181	MIR3117	AG	Toxicity	decreased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs12402181:AG
nevirapine	rs3745274	CYP2B6	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs3745274:T
tenofovir disoproxil fumarate	rs2248359	CYP24A1	TT	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AF07	rs2248359:TT
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L04AX03	rs1801133:AG
cyclophosphamide	rs4244285	CYP2C19	GG	Toxicity	increased	Adverse_Event	Disease:C0024141		L01AA01	rs4244285:GG
peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs8099917:TT
tenofovir disoproxil fumarate	rs4646536	CYP27B1	GG	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AF07	rs4646536:GG
nicotine	rs2060761	DDC	C	Other	increased	Adverse_Event	Other:smokers		N07BA01	rs2060761:C
drugs for treatment of tuberculosis	rs10946737	RIPOR2	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs10946737:AA
drugs for treatment of tuberculosis	rs10946737	RIPOR2	AG	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs10946737:AG
nicotine	rs12718541	DDC	A	Other	increased	Adverse_Event	Other:smokers		N07BA01	rs12718541:A
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
imipramine	rs12248560	CYP2C19	CT	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	rs12248560:CT
imipramine	rs12248560	CYP2C19	TT	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	rs12248560:TT
imipramine	rs11188072	CYP2C19	CT	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	rs11188072:CT
imipramine	rs11188072	CYP2C19	TT	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	rs11188072:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12980275:AA
none	rs352046	CXCL5	GG	Other	increased	Adverse_Event	Disease:C0027051		A03DA02	rs352046:GG
nevirapine	rs28399499	CYP2B6	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs28399499:C
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
warfarin	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:AG
capecitabine	rs602950	CDA	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs602950:G
capecitabine	rs532545	CDA	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs532545:T
tenofovir disoproxil fumarate	rs717620	ABCC2	TT	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AF07	rs717620:TT
capecitabine	rs6690069	CDA	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs6690069:A
tenofovir	rs717620	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF07	rs717620:CC
methylphenidate	rs4532	DRD1	CC	Toxicity	increased	Adverse_Event	Disease:C1263846		N06BA04	rs4532:CC
capecitabine, fluorouracil	rs67376798	DPYD	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:AA
capecitabine, fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:AT
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_undergoing_drug-eluting_stent_(DES)_implantation		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_undergoing_drug-eluting_stent_(DES)_implantation		B01AC04	rs4244285:AG
capecitabine	rs3217164	CES1	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs3217164:G
capecitabine	rs10916825	CDA	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs10916825:A
capecitabine, fluorouracil	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs1801160:CT
capecitabine, fluorouracil	rs1801160	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs1801160:TT
tenofovir disoproxil fumarate	rs11854484	SLC28A2	CT	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AF07	rs11854484:CT
tenofovir disoproxil fumarate	rs11854484	SLC28A2	TT	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AF07	rs11854484:TT
selective serotonin reuptake inhibitors	rs6311	HTR2A	CC	Toxicity	decreased	Adverse_Event	Other:C0011581		N06AB	rs6311:CC
capecitabine	rs144470777	NSUN3	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs144470777:C
capecitabine	rs187805828	PHC1	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs187805828:C
alendronate	rs1544410	VDR	CC	Efficacy	decreased	Efficacy_Response	Disease:C0029456		No_ATC	rs1544410:CC
aspirin	rs5918	ITGB3	TT	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs5918:TT
capecitabine	rs116134453	FAT1	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs116134453:T
cisplatin	rs2228001	XPC	GG	Toxicity	increased	Adverse_Event	Disease:C0877645		L01XA01	rs2228001:GG
cisplatin	rs2228001	XPC	GT	Toxicity	increased	Adverse_Event	Disease:C0877645		L01XA01	rs2228001:GT
capecitabine	rs141531882	TENM4	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs141531882:C
ticagrelor	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0027051		B01AC24	rs1045642:AA
ticagrelor	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0027051		B01AC24	rs1045642:AG
warfarin	rs2108622	CYP4F2	T	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs2108622:T
amoxicillin, clavulanate	rs9274407	HLA-DQB1	A	Toxicity	increased	Adverse_Event	Disease:C0013221		J01CA04	rs9274407:A
capecitabine	rs77475703	CD96	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs77475703:C
methotrexate	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1045642:AA
cyclophosphamide, docetaxel, doxorubicin, epirubicin, fluorouracil, goserelin	rs4149056	SLCO1B1	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01CD02|L01DB01|L01DB03|L02AE03	rs4149056:TT
warfarin	rs1800566	NQO1	A	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs1800566:A
capecitabine	rs117484357	ZMIZ1	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs117484357:C
capecitabine	rs138385713	VPS13D	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs138385713:G
cetuximab	rs2236947	RASSF1	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs2236947:CC
paroxetine	rs4646425	CYP1A2	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	rs4646425:CC
capecitabine	rs141213385	CCDC77	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs141213385:G
antipsychotics	rs4606	RGS2	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs4606:C
pravastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:C
dexmedetomidine	rs5758550	WBP2NL	AA	Efficacy	increased	Adverse_Event	Other:C0549433		N05CM18	rs5758550:AA
capecitabine	rs117308378	ADGRG7	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs117308378:T
carboplatin, cisplatin	rs1130214	AKT1	AA	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs1130214:AA
carboplatin, cisplatin	rs1130214	AKT1	AC	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs1130214:AC
cyclosporine, mycophenolic acid, prednisone	rs2280055	NFATC1	CC	Efficacy	Indeterminado	Efficacy_Response	Other:Kidney_Transplantation		H02AB07|L04AA06|L04AD01	rs2280055:CC
aspirin, clopidogrel	rs41273215	PEAR1	T	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs41273215:T
carboplatin, cisplatin	rs2498804	__INTRONIC__	AA	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs2498804:AA
carboplatin, cisplatin	rs2498804	__INTRONIC__	AC	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs2498804:AC
clozapine, olanzapine, risperidone	rs4436578	DRD2	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs4436578:CC
peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs8099917:TT
vincristine	rs12826	ABCC2	T	Toxicity	decreased	Adverse_Event	Other:C0023449		L01CA02	rs12826:T
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
nicotine	rs10121600	GRIN3A	C	Other	increased	Adverse_Event	Healthy		N07BA01	rs10121600:C
aspirin, clopidogrel	rs762551	CYP1A2	C	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs762551:C
warfarin	rs9923231	VKORC1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
aspirin, clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs4244285:A
citalopram	rs6296	HTR1B	CC	Toxicity	increased	Adverse_Event	Disease:C0003469|Disease:C0011581		N06AB04	rs6296:CC
pravastatin	rs2230806	ABCA1	TT	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA03	rs2230806:TT
aspirin, clopidogrel	rs662	PON1	T	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs662:T
dexmedetomidine	rs2231142	ABCG2	GG	Efficacy	increased	Adverse_Event	Other:C0549433		N05CM18	rs2231142:GG
peginterferon alfa-2b, ribavirin, simeprevir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10	rs8099917:TT
"""antiinflammatory agents, non-steroids"", ""celecoxib"", ""diclofenac"", ""ibuprofen"", ""naproxen"", ""piroxicam"""	rs1057910	CYP2C9	C	Toxicity	increased	Adverse_Event	Healthy		M01AH01|M02AA07|M02AA13|S01BC03|V10A	rs1057910:C
capecitabine	rs75267292	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs75267292:A
nicotine	rs11788456	GRIN3A	G	Other	Indeterminado	Adverse_Event	Healthy		N07BA01	rs11788456:G
efavirenz	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
"""antiinflammatory agents, non-steroids"", ""celecoxib"", ""diclofenac"""	rs1057910	CYP2C9	C	Toxicity	increased	Adverse_Event	Healthy		M01AH01|S01BC03|V10A	rs1057910:C
efavirenz	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
pravastatin	rs20455	KIF6	AG	Efficacy	decreased	Adverse_Event	Other:C0085096		C10AA03	rs20455:AG
pravastatin	rs20455	KIF6	GG	Efficacy	decreased	Adverse_Event	Other:C0085096		C10AA03	rs20455:GG
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1801133:AA
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs368967198	F5	AG	Toxicity	increased	Adverse_Event	Healthy		C09A	rs368967198:AG
capecitabine	rs146898897	SSU72	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs146898897:C
aspirin, clopidogrel	rs168753	F2R	T	Efficacy	decreased	Adverse_Event	Other:C0027051		B01AC04	rs168753:T
beta blocking agents	rs5443	GNB3	CT	Other	decreased	Other	Healthy		S01ED	rs5443:CT
beta blocking agents	rs5443	GNB3	TT	Other	decreased	Other	Healthy		S01ED	rs5443:TT
carboplatin, cisplatin	rs2699887	PIK3CA	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs2699887:CC
beta blocking agents	rs5443	GNB3	CT	Other	decreased	Other	Healthy		S01ED	rs5443:CT
beta blocking agents	rs5443	GNB3	TT	Other	decreased	Other	Healthy		S01ED	rs5443:TT
carboplatin, cisplatin	rs2299939	PTEN	AC	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs2299939:AC
carboplatin, cisplatin	rs2299939	PTEN	CC	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs2299939:CC
capecitabine	rs185346775	MAN1A1	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs185346775:A
carboplatin, cisplatin	rs3803304	AKT1	C	Efficacy	Indeterminado	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs3803304:C
cocaine	rs1803274	BCHE	TT	Other	Indeterminado	Adverse_Event	Healthy		N01BC01	rs1803274:TT
pravastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:CC
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11506105	EGFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11506105:AA
cisplatin, fluorouracil	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs1045642:GG
aspirin, clopidogrel	rs2046934	P2RY12	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs2046934:AG
aspirin, clopidogrel	rs2046934	P2RY12	GG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs2046934:GG
hmg coa reductase inhibitors	rs7574865	STAT4	T	Toxicity	increased	Adverse_Event	Disease:C0860207		C10AA	rs7574865:T
cisplatin, fluorouracil	rs1045642	ABCB1	AA	Efficacy	decreased	Adverse_Event	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs1045642:AA
cisplatin, fluorouracil	rs1045642	ABCB1	AG	Efficacy	decreased	Adverse_Event	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs1045642:AG
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:CT
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:TT
heroin	rs671	ALDH2	AA	Other	increased	Adverse_Event	Healthy		No_ATC	rs671:AA
heroin	rs671	ALDH2	AG	Other	increased	Adverse_Event	Healthy		No_ATC	rs671:AG
fentanyl	rs145837941	CALCA	GG	Dosage	decreased	Adverse_Event	"""Other:C0030193|Postoperative""|""Other:C0699744"		N02AB03	rs145837941:GG
"""metformin"", ""sulfonamides, urea derivatives"""	rs5219	KCNJ11	T	Efficacy	increased	Adverse_Event	Disease:C0011849		A10BA02|S01AB	rs5219:T
antihypertensives, beta blocking agents, diuretics	rs1801253	ADRB1	CC	Efficacy	increased	Adverse_Event	Other:C0020538		C02|C03|S01ED	rs1801253:CC
nicotine	rs17189632	GRIN3A	T	Other	Indeterminado	Adverse_Event	Healthy		N07BA01	rs17189632:T
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT
fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:TT
hmg coa reductase inhibitors	rs4149000	SLCO1A2	T	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149000:T
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_undergoing_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_undergoing_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4244285:AG
tramadol	rs35167514	SLC22A1	del	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs35167514:del
efavirenz	rs3745274	CYP2B6	TT	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
sevoflurane	rs2307116	FASTKD3, MTRR	AA	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs2307116:AA
sevoflurane	rs2307116	FASTKD3, MTRR	AG	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs2307116:AG
aspirin, clopidogrel	rs2046934	P2RY12	AG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs2046934:AG
aspirin, clopidogrel	rs2046934	P2RY12	GG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs2046934:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
methotrexate	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1045642:AA
tramadol	rs34130495	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs34130495:A
tramadol	rs12208357	SLC22A1	T	Metabolism/PK	Indeterminado	LADME	Healthy		N02AX02	rs12208357:T
methadone	rs2070995	KCNJ6	TT	Toxicity	decreased	Adverse_Event	Disease:C0028043		N07BC02	rs2070995:TT
imatinib	rs3764043	SLCO1A2	CC	Metabolism/PK	decreased	LADME	Healthy		L01EA01	rs3764043:CC
imatinib	rs4148978	SLCO1A2	CC	Metabolism/PK	increased	LADME	Healthy		L01EA01	rs4148978:CC
vincristine	rs3740066	ABCC2	T	Toxicity	decreased	Adverse_Event	Other:C0023449		L01CA02	rs3740066:T
imatinib	rs4148977	SLCO1A2	CC	Metabolism/PK	increased	LADME	Healthy		L01EA01	rs4148977:CC
fluorouracil	rs55886062	DPYD	AC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs55886062:AC
flucloxacillin	rs3814055	NR1I2	CC	Toxicity	increased	Adverse_Event	Healthy		J01CF05	rs3814055:CC
cyclosporine, mycophenolic acid, prednisone	rs3894049	NFATC1	CC	Efficacy	decreased	Adverse_Event	Disease:Kidney_Transplantation		H02AB07|L04AA06|L04AD01	rs3894049:CC
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
sevoflurane	rs1801394	FASTKD3, MTRR	AG	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs1801394:AG
sevoflurane	rs1801394	FASTKD3, MTRR	GG	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs1801394:GG
fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs67376798:AT
efavirenz	rs28399499	CYP2B6	CC	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs143509841	F5	GT	Toxicity	increased	Adverse_Event	Healthy		C09A	rs143509841:GT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	G	Efficacy	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:G
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs200157005	F5	AG	Toxicity	increased	Adverse_Event	Healthy		C09A	rs200157005:AG
paroxetine	rs4646427	CYP1A2	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AB05	rs4646427:TT
carbamazepine	rs3812718	SCN1A	CC	Other	increased	Other	Healthy		N03AF01	rs3812718:CC
methotrexate	rs2114358	MIR1206	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs2114358:GG
paroxetine	rs4646425	CYP1A2	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	rs4646425:CC
atorvastatin	rs2306283	SLCO1B1	G	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs2306283:G
atorvastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:C
folic acid, methotrexate	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:C0003873		B03BB01|L04AX03	rs1045642:A
cytarabine, idarubicin	rs10758713	BRD10	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs10758713:AA
cytarabine, idarubicin	rs10758713	BRD10	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs10758713:AG
hmg coa reductase inhibitors	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:C
sorafenib	rs4864950	KDR	A	Toxicity	increased	Adverse_Event	Other:C0027651		L01EX02	rs4864950:A
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	T	Efficacy	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:T
sorafenib	rs444904	PIK3R5	T	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs444904:T
irinotecan	rs17868323	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs17868323:G
cytarabine, idarubicin	rs2897047	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs2897047:AG
methotrexate	rs2273697	ABCC2	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2273697:AA
cytarabine, idarubicin	rs6550826	__INTRONIC__	GG	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs6550826:GG
methotrexate	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1128503:AG
azathioprine, mercaptopurine	rs3765534	ABCC4	CT	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs3765534:CT
azathioprine, mercaptopurine	rs3765534	ABCC4	TT	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs3765534:TT
methotrexate	rs4148396	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs4148396:CC
methotrexate	rs4148396	ABCC2	CT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs4148396:CT
methotrexate	rs4148396	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs4148396:CC
cytarabine, idarubicin	rs9883101	__INTRONIC__	CC	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs9883101:CC
folic acid, methotrexate	rs4986790	TLR4	G	Toxicity	increased	Adverse_Event	Disease:C0003873		B03BB01|L04AX03	rs4986790:G
rosuvastatin	rs2231142	ABCG2	T	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:T
rosuvastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs4149056:C
fluorouracil, leucovorin	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs67376798:AT
pravastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:C
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12980275:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT
hydrochlorothiazide	rs10792367	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03	rs10792367:G
irinotecan	rs17868323	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	G	Dosage	increased	Adverse_Event	Disease:C0027651		L01CE02	rs17868323:G
none	rs12654264	HMGCR	AT	Other	increased	Other	Healthy		A03DA02	rs12654264:AT
none	rs12654264	HMGCR	TT	Other	increased	Other	Healthy		A03DA02	rs12654264:TT
doxorubicin	rs7853758	SLC28A3	AA	Toxicity	decreased	Adverse_Event	"""Other:C0027651|""Other:Wilms_Tumor""|""Other:C1261473|Ewing's""|""Other:C0019829|""Other:C0024299|""Other:C0029463|""Other:C0206624"		L01DB01	rs7853758:AA
doxorubicin	rs7853758	SLC28A3	AG	Toxicity	decreased	Adverse_Event	"""Other:C0027651|""Other:Wilms_Tumor""|""Other:C1261473|Ewing's""|""Other:C0019829|""Other:C0024299|""Other:C0029463|""Other:C0206624"		L01DB01	rs7853758:AG
hmg coa reductase inhibitors	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs1045642:AA
nicotine	rs3743075	CHRNA3	T	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs3743075:T
nicotine	rs7178270	CHRNB4	G	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs7178270:G
vincristine	rs2272653	NDRG1	G	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs2272653:G
nicotine	rs1948	CHRNB4	A	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs1948:A
platinum compounds	rs1052555	ERCC2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1052555:AA
platinum compounds	rs1052555	ERCC2	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1052555:AG
hmg coa reductase inhibitors, simvastatin	rs1719247	__INTRONIC__	T	Toxicity	decreased	Adverse_Event	Healthy		C10AA|C10AA01	rs1719247:T
hmg coa reductase inhibitors	rs2306283	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs2306283:AA
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC
hmg coa reductase inhibitors, simvastatin	rs1346268	__INTRONIC__	C	Toxicity	decreased	Adverse_Event	Healthy		C10AA|C10AA01	rs1346268:C
pravastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:CT
cyclophosphamide, doxorubicin, fluorouracil	rs3740066	ABCC2	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs3740066:CT
cyclophosphamide, doxorubicin, fluorouracil	rs3740066	ABCC2	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs3740066:TT
imatinib	rs11249454	UGT2A1	CC	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs11249454:CC
anthracyclines and related substances	rs11155012	ECT2L	A	Efficacy	increased	Adverse_Event	Disease:C1458155		L01DB	rs11155012:A
hmg coa reductase inhibitors	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs1128503:AA
cyclophosphamide, doxorubicin, fluorouracil	rs1801516	ATM	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1801516:AA
gemcitabine	rs3825876	SLC28A1	AA	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs3825876:AA
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CC
gemcitabine	rs2072671	CDA	AC	Toxicity	decreased	Adverse_Event	Disease:C0030297		L01BC05	rs2072671:AC
gemcitabine	rs2072671	CDA	CC	Toxicity	decreased	Adverse_Event	Disease:C0030297		L01BC05	rs2072671:CC
risperidone	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	rs1045642:AA
risperidone	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	rs1045642:AG
pitavastatin	rs2306283	SLCO1B1	AG	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs2306283:AG
pitavastatin	rs2306283	SLCO1B1	GG	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs2306283:GG
sorafenib	rs2330951	EGFR	C	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs2330951:C
rosuvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs4149056:CC
hmg coa reductase inhibitors	rs9806699	GATM	A	Toxicity	decreased	Adverse_Event	Healthy		C10AA	rs9806699:A
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:A
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:A
everolimus	rs2032582	ABCB1	A	Toxicity, Other	increased	Adverse_Event	Disease:C1458155		L01EG02	rs2032582:A
cyclophosphamide, doxorubicin, fluorouracil	rs1056836	CYP1B1	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1056836:CC
azathioprine, mercaptopurine	rs2647087	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs2647087:C
everolimus	rs9906827	RPTOR	T	Toxicity, Other	decreased	Adverse_Event	Disease:C1458155		L01EG02	rs9906827:T
radiotherapy	rs2228001	XPC	G	Toxicity	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms		No_ATC	rs2228001:G
everolimus	rs1045642	ABCB1	A	Toxicity, Other	increased	Adverse_Event	Disease:C1458155		L01EG02	rs1045642:A
cyclophosphamide, doxorubicin, fluorouracil	rs1801516	ATM	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1801516:AA
cyclophosphamide, doxorubicin, fluorouracil	rs1801516	ATM	AG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1801516:AG
azathioprine, mercaptopurine	rs116855232	NUDT15	C	Toxicity	increased	Adverse_Event	Disease:C0022104		L01BB02|L04AX01	rs116855232:C
platelet aggregation inhibitors excl. heparin	rs12041331	PEAR1	AA	Efficacy	increased	Adverse_Event	Other:C1956346		B01AC	rs12041331:AA
platelet aggregation inhibitors excl. heparin	rs12041331	PEAR1	AG	Efficacy	increased	Adverse_Event	Other:C1956346		B01AC	rs12041331:AG
sunitinib	rs833061	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs833061:CC
sunitinib	rs833061	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs833061:CT
azacitidine	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0026986		L01BC07	rs1801133:AA
clopidogrel	rs4986893	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_treated_with_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4986893:AA
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_treated_with_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4986893:AG
platelet aggregation inhibitors excl. heparin	rs2768759	PEAR1	AA	Efficacy	increased	Adverse_Event	Other:C1956346		B01AC	rs2768759:AA
cyclophosphamide, doxorubicin, fluorouracil	rs3212986	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs3212986:AA
imatinib	rs628031	SLC22A1	GG	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs628031:GG
acetaminophen, ibuprofen, loxoprofen, salicylamide	rs6500265	__INTRONIC__	CT	Toxicity	increased	Adverse_Event	Healthy		M02AA13|N02BA05|N02BE01	rs6500265:CT
acetaminophen, ibuprofen, loxoprofen, salicylamide	rs6500265	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Healthy		M02AA13|N02BA05|N02BE01	rs6500265:TT
imatinib	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs1051266:TT
selective serotonin reuptake inhibitors	rs1994862	GRIA1	CC	Other	decreased	Adverse_Event	Disease:C0235876		N06AB	rs1994862:CC
everolimus	rs9906827	RPTOR	CT	Efficacy	increased	Adverse_Event	Disease:C1458155		L01EG02	rs9906827:CT
everolimus	rs9906827	RPTOR	TT	Efficacy	increased	Adverse_Event	Disease:C1458155		L01EG02	rs9906827:TT
imatinib	rs9787901	CHST1	AA	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs9787901:AA
imatinib	rs9787901	CHST1	AG	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs9787901:AG
imatinib	rs305968	CYP2F1	AA	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs305968:AA
acetaminophen, ibuprofen, loxoprofen, salicylamide	rs9933632	__INTRONIC__	GT	Toxicity	increased	Adverse_Event	Healthy		M02AA13|N02BA05|N02BE01	rs9933632:GT
acetaminophen, ibuprofen, loxoprofen, salicylamide	rs9933632	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Healthy		M02AA13|N02BA05|N02BE01	rs9933632:TT
cyclophosphamide, doxorubicin, fluorouracil	rs20572	CBR1	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs20572:TT
cyclophosphamide, doxorubicin, fluorouracil	rs1042522	TP53	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1042522:GG
sorafenib	rs11125039	PRKCE	G	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs11125039:G
cyclophosphamide, doxorubicin, fluorouracil	rs714368	SLC22A16	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs714368:CC
cyclophosphamide, doxorubicin, fluorouracil	rs714368	SLC22A16	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs714368:CT
antiinflammatory agents, non-steroids	rs1800896	IL10	C	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	rs1800896:C
cyclophosphamide, doxorubicin, fluorouracil	rs25487	XRCC1	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs25487:CT
cyclophosphamide, doxorubicin, fluorouracil	rs25487	XRCC1	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs25487:TT
antiinflammatory agents, non-steroids	rs231775	CTLA4	G	Toxicity	decreased	Adverse_Event	Healthy		M01A|V10A	rs231775:G
none	rs971074	ADH7	CT	Other	increased	Adverse_Event	Other:C0002895		A03DA02	rs971074:CT
none	rs971074	ADH7	TT	Other	increased	Adverse_Event	Other:C0002895		A03DA02	rs971074:TT
sorafenib	rs1346563	ADAMTS18	A	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs1346563:A
platinum compounds	rs25487	XRCC1	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:CT
platinum compounds	rs25487	XRCC1	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:TT
cyclophosphamide, doxorubicin, fluorouracil	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1695:AA
cyclophosphamide, doxorubicin, fluorouracil	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1695:AG
cisplatin	rs10981694	SLC31A1	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA01	rs10981694:GG
cisplatin	rs10981694	SLC31A1	GT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA01	rs10981694:GT
cyclophosphamide, doxorubicin, fluorouracil	rs12248560	CYP2C19	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs12248560:CC
cyclophosphamide, doxorubicin, fluorouracil	rs3740066	ABCC2	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs3740066:TT
dexmedetomidine	rs11046209	ABCC9	AA	Efficacy	increased	Adverse_Event	Other:C0549433		N05CM18	rs11046209:AA
cyclophosphamide, doxorubicin, fluorouracil	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1045642:GG
vincristine	rs12522955	CEP72	A	Toxicity	increased	Adverse_Event	Other:C0017636|Other:C0017638|Other:C0006118		L01CA02	rs12522955:A
capecitabine	rs72765700	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs72765700:T
cyclophosphamide, doxorubicin, fluorouracil	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2231142:GT
antineoplastic agents, mercaptopurine, methotrexate	rs2274407	ABCC4	AC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01|L01BB02|L04AX03	rs2274407:AC
azathioprine, mercaptopurine	rs79206939	FTO	A	Toxicity	increased	Adverse_Event	Disease:C0022104		L01BB02|L04AX01	rs79206939:A
cyclophosphamide, doxorubicin, fluorouracil	rs2228100	ALDH3A1	CG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2228100:CG
cyclophosphamide, doxorubicin, fluorouracil	rs2228100	ALDH3A1	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2228100:GG
antineoplastic agents, mercaptopurine, methotrexate	rs2274407	ABCC4	AC	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L01|L01BB02|L04AX03	rs2274407:AC
pravastatin	rs17238540	HMGCR	GT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs17238540:GT
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_treated_with_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_treated_with_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4244285:AG
cyclophosphamide, doxorubicin, fluorouracil	rs2273697	ABCC2	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2273697:GG
cyclophosphamide, doxorubicin, fluorouracil	rs6907567	SLC22A16	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs6907567:AA
everolimus	rs351855	FGFR4	A	Toxicity, Other	decreased	Adverse_Event	Disease:C1458155		L01EG02	rs351855:A
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	"""Other:C0017636|""Other:C0017638|""Other:C0006118|""Other:C0023449|""Other:C0024299|B-Cell""|""Other:C0023418|""Other:C1261473|Ewing's""|""Other:C0024299"		L01CA02	rs924607:TT
azathioprine, mercaptopurine	rs2834826	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0022104		L01BB02|L04AX01	rs2834826:T
cyclophosphamide, doxorubicin, fluorouracil	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs4244285:AA
cyclophosphamide, doxorubicin, fluorouracil	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs4244285:AG
imatinib	rs12659	SLC19A1	AG	Toxicity	decreased	Adverse_Event	Disease:C0238198		L01EA01	rs12659:AG
imatinib	rs12659	SLC19A1	GG	Toxicity	decreased	Adverse_Event	Disease:C0238198		L01EA01	rs12659:GG
azathioprine, mercaptopurine	rs16952570	FTO	C	Toxicity	increased	Adverse_Event	Disease:C0022104		L01BB02|L04AX01	rs16952570:C
azacitidine	rs25487	XRCC1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0026986		L01BC07	rs25487:CC
imatinib	rs10517	NQO1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EA01	rs10517:GG
everolimus	rs10515074	PIK3R1	G	Toxicity, Other	decreased	Adverse_Event	Disease:C1458155		L01EG02	rs10515074:G
desloratadine	rs901865	HRH1	CC	Toxicity	increased	Adverse_Event	Other:C0042109		R06AX27	rs901865:CC
imatinib	rs2273697	ABCC2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EA01	rs2273697:GG
cytarabine, doxorubicin, leucovorin, methotrexate, prednisone, vincristine	rs1799983	NOS3	TT	Toxicity	decreased	Adverse_Event	Disease:C0023449		H02AB07|L01BC01|L01CA02|L01DB01|L04AX03	rs1799983:TT
imatinib	rs1202283	ABCB4	AA	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs1202283:AA
imatinib	rs1202283	ABCB4	AG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs1202283:AG
everolimus	rs10515074	PIK3R1	G	Toxicity, Other	increased	Adverse_Event	Disease:C1458155		L01EG02	rs10515074:G
capecitabine	rs10024471	MIR2054	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs10024471:A
azathioprine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0004364|Disease:C0024141|Disease:C1527336		L04AX01	rs116855232:CT
azathioprine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0004364|Disease:C0024141|Disease:C1527336		L04AX01	rs116855232:TT
methotrexate	rs1105525	DHFR	CT	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs1105525:CT
methotrexate	rs1105525	DHFR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs1105525:TT
antipsychotics, clozapine, olanzapine	rs3766522	PRKAB2	TT	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A|N05AH02|N05AH03	rs3766522:TT
methadone	rs11265549	NECTIN4	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC02	rs11265549:AA
capecitabine	rs117876855	SPRY2	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs117876855:A
azathioprine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0004364|Disease:C0024141|Disease:C1527336		L04AX01	rs116855232:T
capecitabine	rs139544515	SPRY2	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs139544515:A
hmg coa reductase inhibitors	rs12654264	HMGCR	AA	Efficacy	decreased	Adverse_Event	Healthy		C10AA	rs12654264:AA
rivaroxaban	rs2246709	CYP3A4	AA	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AF01	rs2246709:AA
methotrexate	rs11545078	GGH	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs11545078:A
capecitabine	rs185217050	NCOA7	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs185217050:T
capecitabine	rs139368788	CCDC70	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs139368788:A
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs1801133:AG
none	rs12654264	HMGCR	AT	Other	increased	Other	Healthy		A03DA02	rs12654264:AT
none	rs12654264	HMGCR	TT	Other	increased	Other	Healthy		A03DA02	rs12654264:TT
cyclophosphamide, doxorubicin, fluorouracil	rs11615	ERCC1	AG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs11615:AG
cyclophosphamide, doxorubicin, fluorouracil	rs11615	ERCC1	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs11615:GG
capecitabine	rs117412990	TMEM131L	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs117412990:G
pravastatin	rs17244841	HMGCR	AT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs17244841:AT
hmg coa reductase inhibitors	rs12654264	HMGCR	TT	Efficacy	decreased	Adverse_Event	Healthy		C10AA	rs12654264:TT
capecitabine	rs191934521	SIRPA	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs191934521:G
antipsychotics, clozapine, olanzapine	rs10789038	PRKAA2	AA	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A|N05AH02|N05AH03	rs10789038:AA
rivaroxaban	rs3735451	CYP3A4	TT	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AF01	rs3735451:TT
capecitabine	rs146644707	LMNTD1	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs146644707:T
methotrexate	rs1801133	MTHFR	GG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L04AX03	rs1801133:GG
antineoplastic agents	rs6500843	RBFOX1	G	Efficacy	increased	Adverse_Event	Disease:C1458155		L01	rs6500843:G
hmg coa reductase inhibitors	rs12654264	HMGCR	AA	Efficacy	decreased	Adverse_Event	Healthy		C10AA	rs12654264:AA
platinum	rs1051685	XRCC5	G	Toxicity	decreased	Adverse_Event	Disease:C0024121		L01XA	rs1051685:G
clozapine, olanzapine, risperidone	rs7799039	LEP	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs7799039:AG
clozapine, olanzapine, risperidone	rs7799039	LEP	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs7799039:GG
irinotecan	rs17287570	ABCC1	A	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CE02	rs17287570:A
sorafenib	rs1868089	EPAS1	C	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs1868089:C
platinum	rs6941	XRCC5	A	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs6941:A
cyclophosphamide	rs143731390	CYP2A6	A	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs143731390:A
irinotecan	rs2622604	ABCG2	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs2622604:T
folic acid	rs2236225	MTHFD1	AA	Other	decreased	Adverse_Event	Other:C0032961		B03BB01	rs2236225:AA
methotrexate	rs442767	DHFR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs442767:GG
irinotecan	rs11692021	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	CT	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CE02	rs11692021:CT
irinotecan	rs11692021	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	TT	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CE02	rs11692021:TT
platinum	rs10875989	AQP2	T	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs10875989:T
apixaban, rivaroxaban	rs3114018	ABCG2	AA	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01|B01AF02	rs3114018:AA
apixaban, rivaroxaban	rs3114018	ABCG2	AC	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01|B01AF02	rs3114018:AC
irinotecan	rs7977213	SLCO1B3	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs7977213:G
methotrexate	rs408626	DHFR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs408626:TT
cyclophosphamide	rs3745274	CYP2B6	T	Toxicity	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs3745274:T
platinum	rs3759125	AQP2	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs3759125:AA
platinum	rs3759125	AQP2	AC	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs3759125:AC
irinotecan	rs10841661	SLCO1B3	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs10841661:T
methotrexate	rs1650697	DHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs1650697:AA
apixaban, rivaroxaban	rs2622604	ABCG2	CT	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01|B01AF02	rs2622604:CT
apixaban, rivaroxaban	rs2622604	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01|B01AF02	rs2622604:TT
platinum	rs461872	AQP2	A	Toxicity	decreased	Adverse_Event	Disease:C0024121		L01XA	rs461872:A
platinum	rs7305534	AQP2	CC	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs7305534:CC
platinum	rs7305534	AQP2	CT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs7305534:CT
mephenytoin, tolbutamide	rs41291556	CYP2C19	C	Metabolism/PK	Indeterminado	LADME	Healthy		A10BB03|N03AB02	rs41291556:C
platinum	rs2748249	CD74	A	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs2748249:A
aspirin	rs6962291	TBXAS1	AA	Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs6962291:AA
platinum	rs1560661	CD74	C	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA	rs1560661:C
cytarabine	rs2072671	CDA	AA	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01	rs2072671:AA
warfarin	rs12777823	__INTRONIC__	A	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs12777823:A
warfarin	rs12777823	__INTRONIC__	A	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs12777823:A
none	rs12915901	ALDH1A2	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs12915901:A
raloxifene, tamoxifen	rs10030044	__INTRONIC__	G	Efficacy	increased	Adverse_Event	Disease:C1458155		G03XC01|L02BA01	rs10030044:G
capecitabine, fluorouracil	rs2297595	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs2297595:CT
capecitabine, fluorouracil	rs2297595	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs2297595:TT
none	rs841844	SLC2A1	CG	Toxicity	increased	Adverse_Event	Disease:C0024121		A03DA02	rs841844:CG
none	rs841844	SLC2A1	GG	Toxicity	increased	Adverse_Event	Disease:C0024121		A03DA02	rs841844:GG
capecitabine, fluorouracil	rs2297595	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs2297595:TT
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_undergoing_elective_coronary_stent_implantation		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_undergoing_elective_coronary_stent_implantation		B01AC04	rs4244285:AG
dasatinib	rs121913459	ABL1	CT	Other, Metabolism/PK	decreased	LADME	Disease:C0023418		L01EA02	rs121913459:CT
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	decreased	Adverse_Event	Healthy		J05AP01|L03AB10	rs8099917:TT
hydrochlorothiazide	rs5051	AGT	T	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs5051:T
hydrochlorothiazide	rs5186	AGTR1	A	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs5186:A
tamoxifen	rs4986938	ESR2	CC	Other	increased	Adverse_Event	Healthy		L02BA01	rs4986938:CC
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:T
ondansetron	rs1045642	ABCB1	AA	Efficacy	decreased	Adverse_Event	Healthy		A04AA01	rs1045642:AA
tamoxifen	rs9340799	ESR1	GG	Other	decreased	Adverse_Event	Healthy		L02BA01	rs9340799:GG
talinolol	rs2273697	ABCC2	A	Other	increased	LADME	Healthy		No_ATC	rs2273697:A
clozapine, olanzapine, risperidone	rs1414334	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03|N05AX08	rs1414334:C
doxorubicin	rs8133052	CBR3	G	Toxicity, Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs8133052:G
ondansetron	rs2032582	ABCB1	AA	Efficacy	decreased	Adverse_Event	Healthy		A04AA01	rs2032582:AA
clozapine, olanzapine, risperidone	rs518147	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03|N05AX08	rs518147:C
bevacizumab, cyanocobalamin, folic acid, pemetrexed	rs1801131	MTHFR	GG	Efficacy	increased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		B03BA01|B03BB01|L01BA04|L01FG01	rs1801131:GG
bevacizumab, cyanocobalamin, folic acid, pemetrexed	rs1801131	MTHFR	GT	Efficacy	increased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		B03BA01|B03BB01|L01BA04|L01FG01	rs1801131:GT
artesunate, primaquine, pyrimethamine, sulfadoxine	rs1050828	G6PD, IKBKG	CT	Toxicity	increased	Adverse_Event	Healthy		P01BA03|P01BD01|P01BE03	rs1050828:CT
raloxifene, tamoxifen	rs8060157	ZNF423	A	Efficacy	decreased	Adverse_Event	Disease:C1458155		G03XC01|L02BA01	rs8060157:A
tacrolimus	rs1045642	ABCB1	AA	Efficacy	Indeterminado	Efficacy_Response	Other:Kidney_Transplantation		L04AD02	rs1045642:AA
tacrolimus	rs1045642	ABCB1	AG	Efficacy	Indeterminado	Efficacy_Response	Other:Kidney_Transplantation		L04AD02	rs1045642:AG
carbamazepine	rs2273697	ABCC2	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0014544		N03AF01	rs2273697:AA
carbamazepine	rs2273697	ABCC2	AG	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0014544		N03AF01	rs2273697:AG
artesunate, primaquine, pyrimethamine, sulfadoxine	rs1050828	G6PD, IKBKG	TT	Other	increased	Adverse_Event	Healthy		P01BA03|P01BD01|P01BE03	rs1050828:TT
sorafenib	rs12366035	VEGFB	T	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs12366035:T
cytarabine	rs532545	CDA	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs532545:TT
cytarabine	rs532545	CDA	TT	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01	rs532545:TT
vincristine	rs71585289	CEP72	C	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs71585289:C
cyclosporine, tacrolimus	rs1128503	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:Heart_transplantation		L04AD01|L04AD02	rs1128503:AA
cyclosporine, tacrolimus	rs1128503	ABCB1	AG	Efficacy	increased	Adverse_Event	Disease:Heart_transplantation		L04AD01|L04AD02	rs1128503:AG
clopidogrel	rs2046934	P2RY12	GG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs2046934:GG
vincristine	rs35650931	MIR6076	CC	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs35650931:CC
vincristine	rs35650931	MIR6076	CG	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs35650931:CG
sorafenib	rs9927200	WWOX	A	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs9927200:A
doxepin	rs4244285	CYP2C19	AA	Metabolism/PK	decreased	LADME	Healthy		N06AA12	rs4244285:AA
anthracyclines and related substances	rs2229774	RARG	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01DB	rs2229774:A
vincristine	rs7896283	MIR4481	G	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs7896283:G
clomipramine	rs4244285	CYP2C19	AG	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA04	rs4244285:AG
capecitabine, fluorouracil	rs2297595	DPYD	CC	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06	rs2297595:CC
methotrexate	rs1051266	SLC19A1	CT	Efficacy	increased	Adverse_Event	Other:C0023449		L04AX03	rs1051266:CT
corticosteroids	rs11553746	ACP1	TT	Toxicity	increased	Adverse_Event	Other:C0023449		S02BA	rs11553746:TT
sorafenib	rs11651488	MAP2K6	C	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs11651488:C
methotrexate	rs1801131	MTHFR	GT	Efficacy	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1801131:GT
sorafenib	rs17682789	CDH13	C	Toxicity	decreased	Adverse_Event	Other:C0007134		L01EX02	rs17682789:C
tacrolimus	rs776746	CYP3A5	CC	Efficacy	decreased	Adverse_Event	Other:C0027726		L04AD02	rs776746:CC
clomipramine	rs4244285	CYP2C19	AA	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA04	rs4244285:AA
paroxetine	rs1360780	FKBP5	T	Other	increased	Adverse_Event	Disease:C0235876		N06AB05	rs1360780:T
clomipramine, liothyronine, lithium, nefazodone, paroxetine, venlafaxine	rs1360780	FKBP5	T	Other	increased	Adverse_Event	Disease:C0235876		H03AA02|N05AN01|N06AA04|N06AB05|N06AX06|N06AX16	rs1360780:T
iloperidone	rs1065852	CYP2D6	GG	Other	increased	Adverse_Event	Disease:C0036341		No_ATC	rs1065852:GG
gemcitabine	rs12148896	SLC28A1	A	Toxicity	decreased	Adverse_Event	Disease:C0030297		L01BC05	rs12148896:A
methotrexate	rs1801133	MTHFR	AA	Efficacy	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AA
clomipramine, liothyronine, lithium, nefazodone, venlafaxine	rs130058	HTR1B	A	Efficacy	decreased	Adverse_Event	Disease:C0235876		H03AA02|N05AN01|N06AA04|N06AX06|N06AX16	rs130058:A
paroxetine	rs130058	HTR1B	A	Other	increased	Adverse_Event	Disease:C0235876		N06AB05	rs130058:A
gemcitabine	rs471760	CDA	A	Toxicity	decreased	Adverse_Event	Disease:C0030297		L01BC05	rs471760:A
cannabidiol	rs3749442	ABCC5	AA	Toxicity	increased	Adverse_Event	Other:C0014544		No_ATC	rs3749442:AA
cannabidiol	rs3749442	ABCC5	AG	Toxicity	increased	Adverse_Event	Other:C0014544		No_ATC	rs3749442:AG
cisplatin	rs1872328	ACYP2	AG	Toxicity	increased	Adverse_Event	Disease:C0029463		L01XA01	rs1872328:AG
clomipramine, liothyronine, lithium, nefazodone, paroxetine, venlafaxine	rs2032582	ABCB1	A	Other	increased	Adverse_Event	Disease:C0235876		H03AA02|N05AN01|N06AA04|N06AB05|N06AX06|N06AX16	rs2032582:A
melphalan	rs4240803	SLC7A5	AA	Toxicity	decreased	Adverse_Event	Disease:Multiple_Myeloma		L01AA03	rs4240803:AA
melphalan	rs4240803	SLC7A5	AG	Toxicity	decreased	Adverse_Event	Disease:Multiple_Myeloma		L01AA03	rs4240803:AG
antipsychotics	rs17782313	MC4R	CC	Other	increased	Adverse_Event	Healthy		N05A	rs17782313:CC
antipsychotics	rs17782313	MC4R	CT	Other	increased	Adverse_Event	Healthy		N05A	rs17782313:CT
platinum	rs3738514	SLC2A1	T	Toxicity	decreased	Adverse_Event	Disease:C0024121		L01XA	rs3738514:T
doxorubicin	rs2229774	RARG	AA	Toxicity	increased	Adverse_Event	"""Other:C0027651|""Other:Wilms_Tumor""|""Other:C1261473|Ewing's""|""Other:C0019829|""Other:C0024299|""Other:C0029463|""Other:C0206624"		L01DB01	rs2229774:AA
vincristine	rs1049402	GARS1	G	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs1049402:G
sorafenib	rs917881	EGFR	A	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs917881:A
vincristine	rs12823621	FGD4	A	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs12823621:A
carboplatin, cisplatin	rs7851395	SLC31A1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA01|L01XA02	rs7851395:AA
vincristine	rs12402181	MIR3117	AA	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs12402181:AA
vincristine	rs12402181	MIR3117	AG	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs12402181:AG
fluorouracil, oxaliplatin	rs13181	ERCC2, KLC3	GT	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs13181:GT
platinum	rs4658	SLC2A1	CC	Toxicity	decreased	Adverse_Event	Healthy		L01XA	rs4658:CC
peginterferon alfa-2b, ribavirin, telaprevir	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs1127354:CC
fluorouracil, oxaliplatin	rs1695	GSTP1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1695:AG
fluorouracil, oxaliplatin	rs1695	GSTP1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1695:GG
none	rs4961	ADD1	GT	Other	increased	Other	Disease:C0020538		A03DA02	rs4961:GT
none	rs4961	ADD1	TT	Other	increased	Other	Disease:C0020538		A03DA02	rs4961:TT
bleomycin, cisplatin, etoposide	rs238406	ERCC2	GT	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs238406:GT
bleomycin, cisplatin, etoposide	rs238406	ERCC2	TT	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs238406:TT
atorvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CT
clopidogrel	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Disease:C0018839		B01AC04	rs776746:CC
clopidogrel	rs776746	CYP3A5	CT	Toxicity	increased	Adverse_Event	Disease:C0018839		B01AC04	rs776746:CT
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CT
none	rs2277869	RAD52, WNK1	CC	Other	increased	Other	Disease:C0020538		A03DA02	rs2277869:CC
fentanyl, morphine, opioids, oxycodone	rs13422094	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs13422094:C
sunitinib	rs1800925	IL13	TT	Other	increased	Adverse_Event	Disease:C0007134		L01EX01	rs1800925:TT
fentanyl, morphine, opioids, oxycodone	rs12211463	__INTRONIC__	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs12211463:G
fentanyl, morphine, opioids, oxycodone	rs7757130	__INTRONIC__	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs7757130:A
fentanyl	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		N02AB03	rs1799971:AG
fentanyl	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		N02AB03	rs1799971:GG
fentanyl, morphine, opioids, oxycodone	rs2473967	__INTRONIC__	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs2473967:G
thiazides, plain	rs4961	ADD1	GG	Efficacy	decreased	Adverse_Event	Disease:C0020538		A03B|C03A	rs4961:GG
bleomycin, cisplatin, etoposide	rs1799793	ERCC2	TT	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1799793:TT
sunitinib	rs1800925	IL13	TT	Other	increased	Adverse_Event	Disease:C0007134		L01EX01	rs1800925:TT
fentanyl	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Healthy		N02AB03	rs4680:AG
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC
simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CT
fentanyl, morphine, opioids, oxycodone	rs12948783	RHBDF2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs12948783:AA
fentanyl, morphine, opioids, oxycodone	rs12948783	RHBDF2	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs12948783:AG
ace inhibitors, plain	rs192613545	SH2B1	T	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs192613545:T
radiotherapy	rs1239344	OSMR	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1239344:T
bleomycin, cisplatin, etoposide	rs1050565	BLMH	CC	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1050565:CC
radiotherapy	rs10711	CDK1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs10711:G
bleomycin, cisplatin, etoposide	rs1050565	BLMH	CC	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1050565:CC
celecoxib	rs1799853	CYP2C9	CT	Metabolism/PK	Indeterminado	LADME	Healthy		M01AH01	rs1799853:CT
hydrochlorothiazide	rs11240688	REN	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs11240688:GG
hydrochlorothiazide	rs7297610	YEATS4	C	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs7297610:C
ace inhibitors, plain	rs62063838	RBFOX3	C	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs62063838:C
hydrochlorothiazide	rs4961	ADD1	GT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:GT
hydrochlorothiazide	rs4961	ADD1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:TT
radiotherapy	rs940052	PRKCE	G	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs940052:G
ace inhibitors, plain	rs10946364	MBOAT1	T	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs10946364:T
radiotherapy	rs11125035	PRKCE	T	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs11125035:T
rofecoxib	rs3842787	PTGS1	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		M01AH02	rs3842787:T
bleomycin, cisplatin, etoposide	rs11615	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs11615:AA
radiotherapy	rs11795343	RIGI	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs11795343:C
cisplatin	rs12201199	TPMT	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01XA01	rs12201199:T
drugs for treatment of tuberculosis	rs1495741	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1495741:AA
ace inhibitors, plain	rs56044629	RBFOX3	G	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs56044629:G
hydrochlorothiazide	rs880054	WNK1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03	rs880054:TT
radiotherapy	rs7259857	__INTRONIC__	C	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs7259857:C
celecoxib	rs3842787	PTGS1	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		M01AH01	rs3842787:T
hydrochlorothiazide	rs4961	ADD1	T	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:T
ace inhibitors, plain	rs77370934	GABRG2	G	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs77370934:G
vincristine	rs3803357	BAHD1	AA	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs3803357:AA
vincristine	rs3803357	BAHD1	AC	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs3803357:AC
ace inhibitors, plain	rs56209714	RBFOX3	G	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs56209714:G
capecitabine, fluorouracil	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02|L01BC06	rs1801160:CT
capecitabine, fluorouracil	rs1801160	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02|L01BC06	rs1801160:TT
methylprednisolone, prednisolone	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		H02AB04|S02BA03	rs1045642:AA
bleomycin, cisplatin, etoposide	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1695:GG
anastrozole, letrozole, tamoxifen	rs8113308	ZNF613	C	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01|L02BG03|L02BG04	rs8113308:C
pirfenidone	rs762551	CYP1A2	AA	Toxicity	decreased	Adverse_Event	Other:C0034069		L04AX05	rs762551:AA
bleomycin, cisplatin, etoposide	rs13181	ERCC2	GG	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs13181:GG
bleomycin, cisplatin, etoposide	rs13181	ERCC2	GT	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs13181:GT
cisplatin	rs2291767	OTOS	CC	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs2291767:CC
cisplatin	rs2291767	OTOS	CT	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs2291767:CT
ace inhibitors, plain	rs2061538	RBFOX3	G	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs2061538:G
selective serotonin reuptake inhibitors	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB	rs6311:CC
citalopram	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB04	rs6311:CC
tacrolimus	rs776746	CYP3A5	CT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
mercaptopurine, methotrexate	rs1801131	MTHFR	GG	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1801131:GG
sunitinib	rs1126647	CXCL8	TT	Other	increased	Adverse_Event	Disease:C0007134		L01EX01	rs1126647:TT
bevacizumab, fluorouracil, irinotecan, leucovorin	rs2302273	PDGFRB	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs2302273:AA
bevacizumab, fluorouracil, irinotecan, leucovorin	rs2302273	PDGFRB	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs2302273:AG
ethanol	rs738409	PNPLA3	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs738409:GG
bevacizumab, fluorouracil, irinotecan, leucovorin	rs2661280	RGS5	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs2661280:CC
bevacizumab, fluorouracil, irinotecan, leucovorin	rs2661280	RGS5	CG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs2661280:CG
sorafenib	rs9973653	EPAS1	T	Toxicity	decreased	Adverse_Event	Other:C0007134		L01EX02	rs9973653:T
none	rs16754	WT1	CC	Other	increased	Adverse_Event	Healthy		A03DA02	rs16754:CC
none	rs16754	WT1	CT	Other	increased	Adverse_Event	Healthy		A03DA02	rs16754:CT
tacrolimus	rs776746	CYP3A5	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
mercaptopurine	rs1127354	ITPA	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs1127354:A
cannabinoids	rs324420	FAAH	AA	Toxicity	decreased	Adverse_Event	Healthy		N02BG10	rs324420:AA
sorafenib	rs315498	__INTRONIC__	C	Toxicity	decreased	Adverse_Event	Other:C0007134		L01EX02	rs315498:C
cyclophosphamide	rs3957357	GSTA1	A	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs3957357:A
vincristine	rs10513762	MRPL47	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs10513762:CT
vincristine	rs10513762	MRPL47	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs10513762:TT
fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02	rs67376798:AT
vincristine	rs2781377	SYNE2	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs2781377:A
sorafenib	rs4035887	EPAS1	A	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs4035887:A
antipsychotics	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Healthy		N05A	rs4680:AA
antipsychotics	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Healthy		N05A	rs4680:AG
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AA
methotrexate	rs408626	DHFR	CC	Efficacy	decreased	Other	Disease:C0023449		L04AX03	rs408626:CC
methotrexate	rs1801131	MTHFR	G	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801131:G
cyclophosphamide	rs1051775	GSTA1	C	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs1051775:C
efavirenz	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs1045642:A
doxorubicin	rs9679162	GALNT14	TT	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01DB01	rs9679162:TT
aspirin	rs28360521	CYP2D6	CC	Toxicity, Other	increased	Adverse_Event	Healthy		No_ATC	rs28360521:CC
desflurane, propofol	rs45574836	ATP8B3	CT	Toxicity	increased	Adverse_Event	Other:C0549433		N01AB07|N01AX10	rs45574836:CT
desflurane, propofol	rs45574836	ATP8B3	TT	Toxicity	increased	Adverse_Event	Other:C0549433		N01AB07|N01AX10	rs45574836:TT
losartan	rs10752271	CAMK1D	AG	Efficacy	decreased	Adverse_Event	Disease:C0085580		C09CA01	rs10752271:AG
losartan	rs10752271	CAMK1D	GG	Efficacy	decreased	Adverse_Event	Disease:C0085580		C09CA01	rs10752271:GG
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0235889|Psoriatic		L04AX03	rs1801133:AA
methotrexate	rs408626	DHFR	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs408626:TT
losartan	rs10737062	CAMK1D	AG	Efficacy	decreased	Adverse_Event	Disease:C0085580		C09CA01	rs10737062:AG
losartan	rs10737062	CAMK1D	GG	Efficacy	decreased	Adverse_Event	Disease:C0085580		C09CA01	rs10737062:GG
cyclophosphamide	rs1051775	GSTA1	C	Toxicity	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs1051775:C
methotrexate	rs1801131	MTHFR	T	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801131:T
methotrexate	rs442767	DHFR	GT	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs442767:GT
celecoxib	rs1057910	CYP2C9	C	Efficacy	decreased	Adverse_Event	Disease:C0003126		M01AH01	rs1057910:C
mercaptopurine	rs1051266	SLC19A1	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs1051266:CT
mercaptopurine	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs1051266:TT
bleomycin, cisplatin, etoposide	rs2740574	CYP3A4	CT	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs2740574:CT
mercaptopurine	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs1801133:AA
mercaptopurine	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs1801133:AG
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AG
efavirenz	rs1045642	ABCB1	A	Efficacy	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs1045642:A
bevacizumab, fluorouracil, irinotecan, leucovorin	rs1127648	CSPG4	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs1127648:AG
sorafenib	rs10958704	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs10958704:G
methotrexate	rs1979277	SHMT1	AG	Toxicity	decreased	Adverse_Event	Disease:C0023449		L04AX03	rs1979277:AG
methotrexate	rs1801394	FASTKD3, MTRR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801394:AG
sorafenib	rs7557402	EPAS1	G	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs7557402:G
methotrexate	rs1801131	MTHFR	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801131:TT
cyclophosphamide	rs3211371	CYP2B6	T	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs3211371:T
apixaban, rivaroxaban	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01|B01AF02	rs1045642:AA
efavirenz	rs2032582	ABCB1	A	Efficacy	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs2032582:A
cyclophosphamide, docetaxel	rs1570360	VEGFA	AA	Efficacy	decreased	Efficacy_Response	Disease:C0033578		L01AA01|L01CD02	rs1570360:AA
carboplatin, gemcitabine	rs1453542	OR4D6	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BC05|L01XA02	rs1453542:CC
sorafenib	rs12948059	MAP2K6	G	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs12948059:G
carboplatin, gemcitabine	rs5925720	DDX53	T	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01BC05|L01XA02	rs5925720:T
methotrexate	rs2236225	MTHFD1	AA	Other	increased	LADME	Disease:C0003873		L04AX03	rs2236225:AA
methotrexate	rs1801394	FASTKD3, MTRR	AA	Other	increased	LADME	Disease:C0003873		L04AX03	rs1801394:AA
irinotecan	rs11979430	SEMA3C	T	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs11979430:T
antipsychotics	rs1800497	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		N05A	rs1800497:A
clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AG
antipsychotics	rs4680	COMT	AA	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05A	rs4680:AA
antipsychotics	rs4680	COMT	AG	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05A	rs4680:AG
irinotecan	rs7779029	SEMA3C	C	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs7779029:C
antiepileptics	rs2032582	ABCB1	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03A	rs2032582:C
antipsychotics	rs1800497	DRD2	G	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1800497:G
antiepileptics	rs2032582	ABCB1	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03A	rs2032582:C
antipsychotics	rs1800497	DRD2	G	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1800497:G
irinotecan	rs1661167	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs1661167:G
antiepileptics	rs2032582	ABCB1	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03A	rs2032582:C
amisulpride, clozapine, olanzapine, quetiapine, risperidone	rs498207	HTR2C	AA	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	rs498207:AA
cisplatin, cyclophosphamide	rs6413432	CYP2E1	TT	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01AA01|L01XA01	rs6413432:TT
budesonide	rs28364072	FCER2	G	Other	Indeterminado	Other	Disease:C0004096		R03BA02	rs28364072:G
cyclophosphamide	rs1799983	NOS3	TT	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01	rs1799983:TT
amisulpride, clozapine, olanzapine, quetiapine, risperidone	rs3813928	HTR2C	GG	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	rs3813928:GG
mycophenolate mofetil(mycophenolic acid)	rs568408	IL12A	A	Toxicity	increased	Adverse_Event	Healthy		L04AA06	rs568408:A
irinotecan	rs2745761	PLCB1	C	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs2745761:C
cyclophosphamide	rs2070744	NOS3	CC	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01	rs2070744:CC
amisulpride, clozapine, olanzapine, quetiapine, risperidone	rs3813929	HTR2C	CC	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	rs3813929:CC
cyclophosphamide, doxorubicin, fluorouracil, methotrexate	rs1799983	NOS3	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB01|L04AX03	rs1799983:GG
cyclophosphamide, doxorubicin, fluorouracil, methotrexate	rs1799983	NOS3	GT	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB01|L04AX03	rs1799983:GT
irinotecan	rs11128347	PDZRN3	C	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs11128347:C
methadone	rs4554144	UGT2B7	TT	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs4554144:TT
dapsone	rs201929247	HLA-DRB1	A	Toxicity	increased	Adverse_Event	Healthy		J04BA02	rs201929247:A
olanzapine	rs1801282	PPARG	CG	Other	increased	Adverse_Event	Disease:C0036341		N05AH03	rs1801282:CG
methadone	rs11940316	UGT2B7	CC	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs11940316:CC
corticosteroids	rs2241843	BCL2L11	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		S02BA	rs2241843:AA
methadone	rs7438135	UGT2B7	AA	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs7438135:AA
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
methadone	rs7662029	UGT2B7	GG	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs7662029:GG
cisplatin, cyclophosphamide	rs3957357	GSTA1	AA	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs3957357:AA
cisplatin, cyclophosphamide	rs3957357	GSTA1	AG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs3957357:AG
oxaliplatin	rs2233678	PIN1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs2233678:CC
oxaliplatin	rs2233678	PIN1	CG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs2233678:CG
methadone	rs7668258	UGT2B7	CC	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs7668258:CC
ethambutol, isoniazid, pyrazinamide, rifampin	rs9332096	CYP2C9	CT	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs9332096:CT
ethambutol, isoniazid, pyrazinamide, rifampin	rs9332096	CYP2C9	TT	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs9332096:TT
methotrexate	rs2231142	ABCG2	TT	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs2231142:TT
methotrexate	rs17602729	AMPD1	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs17602729:AG
antiepileptics	rs1045642	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs1045642:A
methadone	rs7439366	UGT2B7	CC	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs7439366:CC
antiepileptics	rs1128503	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs1128503:A
antiepileptics	rs3789243	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs3789243:G
methadone	rs4292394	UGT2B7	GG	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs4292394:GG
ethambutol, isoniazid, pyrazinamide, rifampin	rs4986893	CYP2C19	AA	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs4986893:AA
ethambutol, isoniazid, pyrazinamide, rifampin	rs4986893	CYP2C19	AG	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs4986893:AG
cisplatin, cyclophosphamide	rs2070676	CYP2E1	CG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs2070676:CG
antiepileptics	rs3789243	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs3789243:G
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT
thiazides, plain	rs5443	GNB3	CC	Toxicity	increased	Adverse_Event	Healthy		A03B|C03A	rs5443:CC
amlodipine	rs877087	RYR3	TT	Efficacy	increased	Adverse_Event	Disease:C0020538		C08CA01	rs877087:TT
fluorouracil	rs1695	GSTP1	GG	Toxicity	decreased	Adverse_Event	Disease:C0022665		L01BC02	rs1695:GG
methadone	rs6600879	UGT2B7	GG	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs6600879:GG
methadone	rs6600880	UGT2B7	AA	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs6600880:AA
platinum compounds	rs10510050	EIF3A	A	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs10510050:A
capecitabine	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01BC06	rs67376798:AT
thiazides, plain	rs5186	AGTR1	AA	Toxicity	increased	Adverse_Event	Healthy		A03B|C03A	rs5186:AA
thiazides, plain	rs5186	AGTR1	AC	Toxicity	increased	Adverse_Event	Healthy		A03B|C03A	rs5186:AC
thiazides, plain	rs4341	ACE	GG	Toxicity	increased	Adverse_Event	Healthy		A03B|C03A	rs4341:GG
atorvastatin, rifampin	rs4149056	SLCO1B1	TT	Metabolism/PK	Indeterminado	LADME	Healthy		C10AA05	rs4149056:TT
capecitabine, fluorouracil	rs895819	MIR27A	C	Toxicity	Indeterminado	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs895819:C
atorvastatin	rs2297480	FDPS	TT	Toxicity	increased	Adverse_Event	Disease:C0010068		C10AA05	rs2297480:TT
none	rs3740066	ABCC2	C	Metabolism/PK	Indeterminado	Other	Healthy		A03DA02	rs3740066:C
cisplatin	rs560018	GSTM4	CC	Efficacy, Toxicity	increased	Efficacy_Response	Healthy		L01XA01	rs560018:CC
atorvastatin	rs11264359	FDPS	AA	Toxicity	increased	Adverse_Event	Disease:C0010068		C10AA05	rs11264359:AA
irinotecan	rs1517114	C8orf34	C	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs1517114:C
dicloxacillin, probenecid	rs1045642	ABCB1	GG	Other, Metabolism/PK	increased	LADME	Healthy		J01CF01|M04AB01	rs1045642:GG
antipsychotics, clozapine, olanzapine, risperidone	rs1414334	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A|N05AH02|N05AH03|N05AX08	rs1414334:C
ethanol	rs1799971	OPRM1	G	Other	Indeterminado	Adverse_Event	Healthy		V03AB16	rs1799971:G
cyclosporine, dicloxacillin	rs2032582	ABCB1	CC	Other, Metabolism/PK	increased	LADME	Healthy		J01CF01|L04AD01	rs2032582:CC
ethambutol, isoniazid, pyrazinamide, rifampin	rs2031920	CYP2E1	CT	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs2031920:CT
ethambutol, isoniazid, pyrazinamide, rifampin	rs2031920	CYP2E1	TT	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs2031920:TT
platinum compounds	rs1690924	MDM2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1690924:CC
methotrexate	rs1051266	SLC19A1	TT	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs1051266:TT
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A
sevoflurane	rs1806201	GRIN2B	AA	Other	increased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1806201:AA
sevoflurane	rs1806201	GRIN2B	AG	Other	increased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1806201:AG
clopidogrel	rs28399504	CYP2C19	G	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs28399504:G
drugs for obstructive airway diseases	rs1042714	ADRB2	GG	Efficacy	increased	Other	Disease:C0004096		R03	rs1042714:GG
methotrexate	rs9344	CCND1	AA	Toxicity	decreased	Adverse_Event	Disease:C0023449		L04AX03	rs9344:AA
risperidone	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	rs1045642:A
methotrexate	rs1801133	MTHFR	AA	Toxicity	decreased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity	decreased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AG
paclitaxel	rs4880	SOD2	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs4880:AA
mercaptopurine, methotrexate	rs1051266	SLC19A1	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1051266:CT
mercaptopurine, methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1051266:TT
methylphenidate	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1263846		N06BA04	rs2032582:AA
docetaxel	rs13181	ERCC2	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD02	rs13181:TT
cyclosporine, tacrolimus	rs8450	CRTC2	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01|L04AD02	rs8450:AA
docetaxel	rs11615	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD02	rs11615:AA
clopidogrel	rs12248560	CYP2C19	T	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs12248560:T
metformin	rs2683511	SP1	C	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs2683511:C
acenocoumarol	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:CT
acenocoumarol	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:TT
nicotine	rs16969968	CHRNA3, CHRNA5	A	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs16969968:A
metformin	rs10747673	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs10747673:G
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs4244285:AG
metformin	rs10747673	__INTRONIC__	G	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs10747673:G
acenocoumarol	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:CT
acenocoumarol	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:TT
methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1051266:TT
clopidogrel	rs12913988	ATP10A	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs12913988:AA
clopidogrel	rs12913988	ATP10A	AG	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs12913988:AG
platinum compounds	rs4752220	EIF3A	A	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs4752220:A
chop, rituximab	rs1883112	NCF4	AG	Toxicity	decreased	Adverse_Event	Disease:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1883112:AG
chop, rituximab	rs1883112	NCF4	GG	Toxicity	decreased	Adverse_Event	Disease:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1883112:GG
clopidogrel	rs1057910	CYP2C9	AC	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs1057910:AC
clopidogrel	rs1057910	CYP2C9	CC	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs1057910:CC
platinum compounds	rs1409314	EIF3A	A	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1409314:A
platinum compounds	rs4752219	EIF3A	C	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs4752219:C
clopidogrel	rs1057910	CYP2C9	AC	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs1057910:AC
clopidogrel	rs1057910	CYP2C9	CC	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs1057910:CC
mercaptopurine, methotrexate	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1695:GG
clozapine	rs3813929	HTR2C	T	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH02	rs3813929:T
acenocoumarol	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs1045642:GG
acenocoumarol	rs1045642	ABCB1	GT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs1045642:GT
risperidone	rs2032582	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	rs2032582:A
methotrexate	rs1051266	SLC19A1	TT	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs1051266:TT
sevoflurane	rs1275988	KCNK3	CT	Other	increased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1275988:CT
sevoflurane	rs1275988	KCNK3	TT	Other	increased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1275988:TT
leucovorin, mercaptopurine, methotrexate	rs1051266	SLC19A1	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1051266:CC
leucovorin, mercaptopurine, methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1051266:TT
docetaxel	rs2740574	CYP3A4	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD02	rs2740574:CC
docetaxel	rs2740574	CYP3A4	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD02	rs2740574:CT
metformin	rs784888	SP1	G	Efficacy	decreased	Adverse_Event	Disease:C0011849		A10BA02	rs784888:G
platinum compounds	rs1805087	MTR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1805087:AA
platinum compounds	rs1805087	MTR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1805087:AG
sevoflurane	rs279858	GABRA2	CC	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs279858:CC
sevoflurane	rs279858	GABRA2	CT	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs279858:CT
leucovorin, mercaptopurine, methotrexate	rs1051266	SLC19A1	TT	Efficacy	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1051266:TT
acenocoumarol	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:CT
acenocoumarol	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:TT
platinum compounds	rs7091672	EIF3A	T	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs7091672:T
paclitaxel	rs1113129	CYP2C8	CG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs1113129:CG
paclitaxel	rs1113129	CYP2C8	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs1113129:GG
metformin	rs149711321	PPARA	T	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs149711321:T
acenocoumarol	rs2108622	CYP4F2	CT	Toxicity	decreased	Adverse_Event	Healthy		B01AA07	rs2108622:CT
acenocoumarol	rs2108622	CYP4F2	TT	Toxicity	decreased	Adverse_Event	Healthy		B01AA07	rs2108622:TT
platinum compounds	rs1051266	SLC19A1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1051266:TT
paclitaxel	rs1934951	CYP2C8	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs1934951:CT
paclitaxel	rs1934951	CYP2C8	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs1934951:TT
lenalidomide	rs699947	VEGFA	AA	Efficacy	decreased	Efficacy_Response	Other:C0334634		L04AX04	rs699947:AA
metformin	rs2683511	SP1	C	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2683511:C
sevoflurane	rs1801394	FASTKD3, MTRR	AG	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1801394:AG
sevoflurane	rs1801394	FASTKD3, MTRR	GG	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1801394:GG
clopidogrel	rs28399504	CYP2C19	G	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs28399504:G
bupropion, nicotine	rs2168631	DRD1	A	Efficacy	increased	Adverse_Event	Disease:C0039338		N06AX12|N07BA01	rs2168631:A
simvastatin	rs17238540	HMGCR	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs17238540:TT
none	rs9324918	NR3C1	C	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs9324918:C
clopidogrel	rs4986893	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:A
sevoflurane	rs2307116	FASTKD3, MTRR	AA	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs2307116:AA
sevoflurane	rs2307116	FASTKD3, MTRR	AG	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs2307116:AG
paclitaxel	rs3212986	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs3212986:AA
paclitaxel	rs3212986	ERCC1	AC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs3212986:AC
morphine	rs1978153	ABCC3	C	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs1978153:C
clopidogrel	rs12248560	CYP2C19	T	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs12248560:T
bupropion, nicotine	rs11749035	DRD1	T	Efficacy	increased	Adverse_Event	Disease:C0039338		N06AX12|N07BA01	rs11749035:T
clopidogrel	rs12248560	CYP2C19	T	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs12248560:T
pazopanib, sunitinib	rs1126647	CXCL8	T	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01|L01EX03	rs1126647:T
none	rs2963155	NR3C1	G	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs2963155:G
morphine	rs733392	ABCC3	G	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs733392:G
methadone	rs6600893	UGT2B7	CC	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs6600893:CC
fentanyl	rs6853	MYD88	G	Toxicity	decreased	Adverse_Event	Disease:C0027651		N02AB03	rs6853:G
methotrexate, prednisone	rs1051266	SLC19A1	TT	Efficacy	increased	Adverse_Event	Disease:C0003873		H02AB07|L04AX03	rs1051266:TT
bupropion, nicotine	rs11746641	DRD1	G	Efficacy	increased	Adverse_Event	Disease:C0039338		N06AX12|N07BA01	rs11746641:G
none	rs33389	NR3C1	T	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs33389:T
spironolactone	rs4343	ACE	AA	Efficacy	Indeterminado	Efficacy_Response	Other:C0745744		C03DA01	rs4343:AA
spironolactone	rs4343	ACE	AG	Efficacy	Indeterminado	Efficacy_Response	Other:C0745744		C03DA01	rs4343:AG
simvastatin	rs17244841	HMGCR	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs17244841:AA
docetaxel	rs3212986	ERCC1	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD02	rs3212986:CC
sevoflurane	rs3813867	CYP2E1	CC	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs3813867:CC
sevoflurane	rs3813867	CYP2E1	CG	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs3813867:CG
cyclophosphamide, doxorubicin, prednisone, rituximab, vincristine	rs3957357	GSTA1	AA	Efficacy	increased	Adverse_Event	Disease:C0024299|Large_B-Cell|Diffuse		H02AB07|L01AA01|L01CA02|L01DB01|L01FA01	rs3957357:AA
cyclophosphamide, doxorubicin, prednisone, rituximab, vincristine	rs3957357	GSTA1	AG	Efficacy	increased	Adverse_Event	Disease:C0024299|Large_B-Cell|Diffuse		H02AB07|L01AA01|L01CA02|L01DB01|L01FA01	rs3957357:AG
sevoflurane	rs2031920	CYP2E1, DUX1	CT	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs2031920:CT
sevoflurane	rs2031920	CYP2E1, DUX1	TT	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs2031920:TT
antihypertensives, diuretics	rs2070744	NOS3	CC	Efficacy	increased	Adverse_Event	Disease:C0020538		C02|C03	rs2070744:CC
cyclophosphamide, doxorubicin, prednisone, rituximab, vincristine	rs4673	CYBA	AA	Efficacy	decreased	Adverse_Event	Disease:C0024299|Large_B-Cell|Diffuse		H02AB07|L01AA01|L01CA02|L01DB01|L01FA01	rs4673:AA
ibuprofen	rs20417	PTGS2	CG	Efficacy	increased	Efficacy_Response	Healthy		M02AA13	rs20417:CG
ibuprofen	rs20417	PTGS2	GG	Efficacy	increased	Efficacy_Response	Healthy		M02AA13	rs20417:GG
diflomotecan	rs2231142	ABCG2	T	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs2231142:T
cyclosporine	rs2032582	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:C0009324		L04AD01	rs2032582:AA
cyclosporine, tacrolimus	rs8450	CRTC2	AA	Toxicity	increased	Adverse_Event	Disease:C0277631		L04AD01|L04AD02	rs8450:AA
rofecoxib	rs20417	PTGS2	CC	Efficacy	increased	Efficacy_Response	Healthy		M01AH02	rs20417:CC
fentanyl, morphine, opioids, oxycodone	rs2884129	__INTRONIC__	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs2884129:G
hmg coa reductase inhibitors	rs13210472	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs13210472:C
fentanyl, morphine, opioids, oxycodone	rs7104613	__INTRONIC__	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs7104613:T
pazopanib, sunitinib	rs4073	CXCL8	A	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01|L01EX03	rs4073:A
bleomycin, cisplatin, etoposide	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1695:GG
fentanyl, morphine, opioids, oxycodone	rs10413396	__INTRONIC__	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs10413396:T
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:A
methotrexate	rs9344	CCND1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs9344:AA
bleomycin, cisplatin, etoposide	rs3212986	ERCC1	AC	Toxicity	decreased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs3212986:AC
bleomycin, cisplatin, etoposide	rs3212986	ERCC1	CC	Toxicity	decreased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs3212986:CC
aspirin	rs10306114	PTGS1	AA	Efficacy	increased	Adverse_Event	Other:C0007785		No_ATC	rs10306114:AA
aspirin	rs10306114	PTGS1	AG	Efficacy	increased	Adverse_Event	Other:C0007785		No_ATC	rs10306114:AG
fluorouracil	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02	rs67376798:A
anthracyclines and related substances	rs2032582	ABCB1	CC	Efficacy	increased	Adverse_Event	Disease:C1458155		L01DB	rs2032582:CC
cyclosporine, tacrolimus	rs8450	CRTC2	AA	Toxicity	increased	Adverse_Event	Disease:C0277631		L04AD01|L04AD02	rs8450:AA
cyclosporine, tacrolimus	rs8450	CRTC2	AG	Toxicity	increased	Adverse_Event	Disease:C0277631		L04AD01|L04AD02	rs8450:AG
clopidogrel	rs4244285	CYP2C19	A	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs4244285:A
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Efficacy_Response	Disease:C0004238		B01AA07	rs9923231:TT
fluorouracil	rs1801160	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0024121|Disease:C0023055		L01BC02	rs1801160:T
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A
morphine	rs886493	ABCC3	G	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs886493:G
bleomycin, cisplatin, etoposide	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1045642:AA
morphine	rs7216383	ABCC3	T	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs7216383:T
methotrexate	rs1045642	ABCB1	A	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1045642:A
ethanol	rs10516440	__INTRONIC__	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs10516440:A
tramadol	rs1045642	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0016658|Bone		N02AX02	rs1045642:A
citalopram	rs12248560	CYP2C19	TT	Metabolism/PK	decreased	LADME	Healthy		N06AB04	rs12248560:TT
tramadol	rs2032582	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0016658|Bone		N02AX02	rs2032582:A
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	A	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs1127354:A
clopidogrel	rs4244285	CYP2C19	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A
methotrexate	rs17222723	ABCC2	A	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs17222723:A
risperidone	rs887829	UGT1A1	CT	Toxicity	increased	Adverse_Event	Disease:C1510586		N05AX08	rs887829:CT
fluoxetine	rs242941	CRHR1	CC	Efficacy	increased	Efficacy_Response	Other:C0338908		N06AB03	rs242941:CC
risperidone	rs10929302	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C1510586		N05AX08	rs10929302:AG
sarilumab	rs11265618	IL6R	CC	Efficacy	increased	Adverse_Event	Other:C0003873		L04AC14	rs11265618:CC
cisplatin	rs1799793	ERCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01XA01	rs1799793:CT
cisplatin	rs1799793	ERCC2	TT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01XA01	rs1799793:TT
cisplatin	rs1138272	GSTP1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01XA01	rs1138272:CT
cisplatin	rs1138272	GSTP1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01XA01	rs1138272:TT
sarilumab	rs4845625	IL6R	TT	Efficacy	increased	Adverse_Event	Other:C0003873		L04AC14	rs4845625:TT
vitamin k antagonists	rs2108622	CYP4F2	TT	Efficacy	increased	Adverse_Event	Disease:C0004238		B01AA	rs2108622:TT
risperidone	rs6318	HTR2C	GG	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs6318:GG
warfarin	rs1205	CRP	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1205:CT
warfarin	rs1205	CRP	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1205:TT
hydrochlorothiazide	rs4132670	TCF7L2	A	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs4132670:A
hydrochlorothiazide	rs7917983	TCF7L2	T	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs7917983:T
atorvastatin, cerivastatin, fluvastatin, pravastatin, rosuvastatin, simvastatin	rs17238540	HMGCR	GT	Efficacy	decreased	Adverse_Event	Disease:C0011849		C10AA01|C10AA03|C10AA04|C10AA05|C10AA06|C10AA07	rs17238540:GT
hydrochlorothiazide	rs4506565	TCF7L2	T	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs4506565:T
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:C0018839		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:C0018839		B01AC04	rs4244285:AG
citalopram	rs4244285	CYP2C19	AA	Metabolism/PK	increased	LADME	Healthy		N06AB04	rs4244285:AA
lenalidomide	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Other:C0334634		L04AX04	rs2032582:CC
fluorouracil, leucovorin, oxaliplatin	rs25487	XRCC1	CC	Other	Indeterminado	Other	Disease:C0024121		L01BC02|L01XA03	rs25487:CC
docetaxel, thalidomide	rs4148950	CHST3	A	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs4148950:A
irinotecan	rs3832043	UGT1A9	T/del	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	rs3832043:T/del
irinotecan	rs3832043	UGT1A9	del/del	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	rs3832043:del/del
buprenorphine, fentanyl, tramadol	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs4680:AA
sarilumab	rs4537545	IL6R	CC	Efficacy	increased	Adverse_Event	Other:C0003873		L04AC14	rs4537545:CC
calcium, etidronic acid	rs1544410	VDR	TT	Efficacy	increased	Efficacy_Response	Disease:C0029456|Postmenopausal		A12AA|M05BA01	rs1544410:TT
sarilumab	rs2228145	IL6R	AA	Efficacy	increased	Adverse_Event	Other:C0003873		L04AC14	rs2228145:AA
buprenorphine, fentanyl, tramadol	rs2234918	OPRD1	CT	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs2234918:CT
valproic acid	rs4880	SOD2	AA	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AG01	rs4880:AA
valproic acid	rs4880	SOD2	AG	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AG01	rs4880:AG
sarilumab	rs4329505	IL6R	TT	Efficacy	increased	Adverse_Event	Other:C0003873		L04AC14	rs4329505:TT
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
buprenorphine, fentanyl, tramadol	rs1045280	ARRB2	TT	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1045280:TT
peginterferon alfa-2a, ribavirin	rs4273729	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4273729:GG
bisphosphonates	rs1934951	CYP2C8	TT	Toxicity	increased	Adverse_Event	Disease:Multiple_Myeloma		M05BA	rs1934951:TT
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:AG
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:GG
buprenorphine, fentanyl, tramadol	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs4680:AG
peginterferon alfa-2a, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12980275:AA
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:AA
buprenorphine, fentanyl, tramadol	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs4680:AA
buprenorphine, fentanyl, tramadol	rs4680	COMT	GG	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs4680:GG
none	rs12979860	IFNL3, IFNL4	CC	Other	increased	Adverse_Event	Disease:C0019372		A03DA02	rs12979860:CC
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:AA
fluorouracil, leucovorin, oxaliplatin	rs717620	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02|L01XA03	rs717620:CC
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:AA
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:AG
lenalidomide	rs1705814	CRBN	CC	Dosage, Toxicity	increased	Adverse_Event	Other:C0334634		L04AX04	rs1705814:CC
buprenorphine, fentanyl, tramadol	rs4680	COMT	AG	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs4680:AG
fluorouracil, leucovorin, oxaliplatin	rs11615	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02|L01XA03	rs11615:AA
fluorouracil, leucovorin, oxaliplatin	rs25487	XRCC1	CC	Toxicity	decreased	Adverse_Event	Disease:C0024121		L01BC02|L01XA03	rs25487:CC
rifampicin	rs2472677	NR1I2	T	Other, Metabolism/PK	decreased	LADME	Healthy		J04AB02	rs2472677:T
carbamazepine, lamotrigine, oxcarbazepine, phenytoin, topiramate	rs2304016	SCN2A	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AB02|N03AF01|N03AF02|N03AX09|N03AX11	rs2304016:A
capecitabine, oxaliplatin	rs5275	PTGS2	AA	Efficacy	increased	Other	Disease:C0023055		L01BC06|L01XA03	rs5275:AA
hmg coa reductase inhibitors	rs708272	CETP	A	Efficacy	decreased	Adverse_Event	Disease:C1956346		C10AA	rs708272:A
diuretics	rs4961	ADD1	GT	Efficacy	decreased	Adverse_Event	Disease:C0020538		C03	rs4961:GT
diuretics	rs4961	ADD1	TT	Efficacy	decreased	Adverse_Event	Disease:C0020538		C03	rs4961:TT
warfarin	rs9923231	VKORC1	CT	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
ethanol	rs1076560	DRD2	A	Other	increased	Adverse_Event	Healthy		V03AB16	rs1076560:A
clopidogrel	rs2046934	P2RY12	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs2046934:AG
clopidogrel	rs2046934	P2RY12	GG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs2046934:GG
methotrexate	rs717620	ABCC2	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs717620:CT
methotrexate	rs717620	ABCC2	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs717620:TT
hydrochlorothiazide	rs4961	ADD1	GT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:GT
hydrochlorothiazide	rs4961	ADD1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:TT
fluorouracil, leucovorin, oxaliplatin	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02|L01XA03	rs1801133:AA
bromperidol, nemonapride	rs1799732	DRD2	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs1799732:GG
thiazides, plain	rs13306673	SLC12A3	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		A03B|C03A	rs13306673:CC
valproic acid	rs3789243	ABCB1	GG	Efficacy	decreased	Adverse_Event	Other:C0014544		N03AG01	rs3789243:GG
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
azathioprine	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs1127354:AC
valproic acid	rs3789243	ABCB1	GG	Efficacy	increased	Adverse_Event	Other:C0014544		N03AG01	rs3789243:GG
atorvastatin, rosuvastatin	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Disease:C0011849|Disease:C0020473|Disease:C0020538|Disease:C0028754		C10AA05|C10AA07	rs776746:CC
methotrexate	rs4149056	SLCO1B1	CC	Efficacy	decreased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CC
methotrexate	rs4149056	SLCO1B1	CT	Efficacy	decreased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CT
thiazides, plain	rs4994	ADRB3	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		A03B|C03A	rs4994:AA
trastuzumab	rs1801274	FCGR2A	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		No_ATC	rs1801274:AA
irinotecan	rs3832043	UGT1A9	T/del	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	rs3832043:T/del
irinotecan	rs3832043	UGT1A9	del/del	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	rs3832043:del/del
asparaginase	rs199695765	CPA2	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	rs199695765:T
peginterferon alfa-2a, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12980275:AA
peginterferon alfa-2a, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12980275:AA
dapsone	rs701829	HLA-DRB1	T	Toxicity	increased	Adverse_Event	Healthy		J04BA02	rs701829:T
tacrolimus	rs1057868	POR	CT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT
tacrolimus	rs1057868	POR	TT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT
warfarin	rs1042580	THBD	CC	Toxicity	decreased	Adverse_Event	Healthy		B01AA03	rs1042580:CC
warfarin	rs1042580	THBD	CT	Toxicity	decreased	Adverse_Event	Healthy		B01AA03	rs1042580:CT
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:TT
methylphenidate	rs3815583	CES1	AC	Toxicity	increased	Adverse_Event	Disease:C1263846		N06BA04	rs3815583:AC
methylphenidate	rs3815583	CES1	CC	Toxicity	increased	Adverse_Event	Disease:C1263846		N06BA04	rs3815583:CC
ace inhibitors, plain	rs8012552	BDKRB2	C	Toxicity	increased	Adverse_Event	Disease:C0020538		A03B|C09A	rs8012552:C
corticosteroids	rs724710	BCL2L11	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		S02BA	rs724710:CC
ace inhibitors, plain	rs2016848	MME	A	Toxicity	increased	Adverse_Event	Disease:C0020538		A03B|C09A	rs2016848:A
irinotecan	rs2233678	PIN1	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01CE02	rs2233678:CC
irinotecan	rs2233678	PIN1	CG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01CE02	rs2233678:CG
peginterferon alfa-2a, ribavirin	rs4273729	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4273729:GG
hydrochlorothiazide	rs4961	ADD1	GT	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs4961:GT
acenocoumarol	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9934438:AA
acenocoumarol	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9934438:AG
aspirin	rs4291	ACE	AT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs4291:AT
aspirin	rs4291	ACE	TT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs4291:TT
mycophenolate mofetil(mycophenolic acid)	rs11572103	CYP2C8	A	Toxicity	increased	Adverse_Event	Healthy		L04AA06	rs11572103:A
hydrochlorothiazide	rs4961	ADD1	GT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:GT
hydrochlorothiazide	rs4961	ADD1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:TT
mycophenolate mofetil(mycophenolic acid)	rs11572076	CYP2C8	T	Toxicity	increased	Adverse_Event	Healthy		L04AA06	rs11572076:T
ace inhibitors, plain	rs11209716	PTGER3	C	Toxicity	decreased	Adverse_Event	Disease:C0020538		A03B|C09A	rs11209716:C
mycophenolate mofetil(mycophenolic acid)	rs1056663	HUS1	T	Toxicity	decreased	Adverse_Event	Healthy		L04AA06	rs1056663:T
dapsone	rs17211071	HLA-DRB1	A	Toxicity	increased	Adverse_Event	Healthy		J04BA02	rs17211071:A
tacrolimus	rs4253728	PPARA	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs4253728:AA
tacrolimus	rs4253728	PPARA	AG	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs4253728:AG
mycophenolate mofetil(mycophenolic acid)	rs2037483	HUS1	A	Toxicity	decreased	Adverse_Event	Healthy		L04AA06	rs2037483:A
none	rs4961	ADD1	GT	Other	increased	Adverse_Event	Healthy		A03DA02	rs4961:GT
none	rs4961	ADD1	TT	Other	increased	Adverse_Event	Healthy		A03DA02	rs4961:TT
fluorouracil	rs2032582	ABCB1	C	Toxicity	decreased	Adverse_Event	Other:C0023055		L01BC02	rs2032582:C
fluorouracil	rs2306283	SLCO1B1	A	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02	rs2306283:A
none	rs2781666	ARG1	TT	Other	increased	Adverse_Event	Healthy		A03DA02	rs2781666:TT
tacrolimus	rs2740574	CYP3A4	TT	Efficacy	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2740574:TT
epirubicin	rs246221	ABCC1	CT	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB03	rs246221:CT
levodopa	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0030567		N04BA02	rs4680:AA
methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1051266:TT
daunorubicin, doxorubicin	rs8187710	ABCC2	A	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs8187710:A
folfox	DPYD c.1129-5923C>G, c.1236G>A (HapB3)	DPYD	c.1129-5923C>G, c.1236G>A (HapB3)	Efficacy	decreased	Adverse_Event	Other:C0022665		No_ATC	c.1129-5923C>G, c.1236G>A (HapB3)
daunorubicin, doxorubicin	rs1799945	HFE	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs1799945:G
daunorubicin, doxorubicin	rs12468485	GPR35	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs12468485:T
daunorubicin, doxorubicin	rs17863783	UGT1A6	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs17863783:T
daunorubicin, doxorubicin	rs2180314	GSTA2	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs2180314:G
daunorubicin, doxorubicin	rs79338777	ETFB	A	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs79338777:A
daunorubicin, doxorubicin	rs17583889	HNMT	A	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs17583889:A
daunorubicin, doxorubicin	rs7627754	ABCC5	AA	Toxicity	decreased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs7627754:AA
daunorubicin, doxorubicin	rs7627754	ABCC5	AT	Toxicity	decreased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs7627754:AT
cefazolin, cefdinir, ceftriaxone, cefuroxime, cephalexin	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		J01DB04|J01DD04|J01DD15|S01AA27	*02:01
tacrolimus	rs3745274	CYP2B6	GT	Efficacy	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs3745274:GT
corticosteroids	rs73175102	WNT7B	A	Toxicity	increased	Adverse_Event	Other:C0023418|Other:C0024299		S02BA	rs73175102:A
corticosteroids	rs115587273	POGK	A	Toxicity	increased	Adverse_Event	Other:C0023418|Other:C0024299		S02BA	rs115587273:A
corticosteroids	rs78233573	FAM240C	A	Toxicity	increased	Adverse_Event	Other:C0023418|Other:C0024299		S02BA	rs78233573:A
corticosteroids	rs376867011	ZNF37A	A	Toxicity	increased	Adverse_Event	Other:C0023418|Other:C0024299		S02BA	rs376867011:A
codeine, hydrocodone, tramadol	intermediate metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:C0030193	intermediate metabolizer and poor metabolizer	N02AX02|R05DA03|R05DA04	__UNKNOWN__
valproic acid	rs758109	ACOT1	T	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs758109:T
tacrolimus	rs2306283	SLCO1B1	AA	Toxicity	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2306283:AA
tacrolimus	rs2306283	SLCO1B1	AG	Toxicity	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2306283:AG
azathioprine	rs73430958	MOCOS	GT	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs73430958:GT
valproic acid	rs59288687	GABPA	CC	Toxicity	decreased	Adverse_Event	Other:C0014544		N03AG01	rs59288687:CC
valproic acid	rs10517	NQO1	GG	Toxicity	decreased	Adverse_Event	Other:C0014544		N03AG01	rs10517:GG
valproic acid	rs881740	PPARA	G	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs881740:G
methotrexate	rs7311358	SLCO1B3	AA	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs7311358:AA
methotrexate	rs4149117	SLCO1B3	GG	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs4149117:GG
methotrexate	rs2306283	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs2306283:AA
methotrexate	rs2306283	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs2306283:AG
apixaban	rs7412	APOE	C	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF02	rs7412:C
apixaban	rs429358	APOE	C	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF02	rs429358:C
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs8099917	IFNL3	GG	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0039338		No_ATC	rs8099917:GG
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12980275	IFNL3	GG	Toxicity	increased	Adverse_Event	Other:C0024121		No_ATC	rs12980275:GG
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12979860	IFNL3	TT	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0039338		No_ATC	rs12979860:TT
tacrolimus	rs9282564	ABCB1	TT	Efficacy	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs9282564:TT
tacrolimus	rs2273697	ABCC2	GG	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2273697:GG
tacrolimus	rs4149056	SLCO1B1	TT	Efficacy	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs4149056:TT
tacrolimus	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs4244285:AA
azathioprine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs116855232:CT
azathioprine	rs1735053	RRM1	AG	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs1735053:AG
azathioprine	rs1735053	RRM1	GG	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs1735053:GG
azathioprine	rs9465102	TPMT	GT	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs9465102:GT
azathioprine	rs9465102	TPMT	TT	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs9465102:TT
cisplatin	rs920829	TRPA1	TT	Toxicity	decreased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0007097|""Other:C0001418"		L01XA01	rs920829:TT
folfox, xelox	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	rs1801265:AG
folfox, xelox	rs1801265	DPYD	GG	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	rs1801265:GG
fluoxetine	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Efficacy, Toxicity	increased	Adverse_Event	Healthy	poor metabolizer and ultrarapid metabolizer	N06AB03	__UNKNOWN__
cyclosporine	rs693955	SLC29A1	AA	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation|Other:C0023418		L04AD01	rs693955:AA
afatinib, erlotinib, gefitinib	rs2494750	AKT1	CC	Efficacy	increased	Adverse_Event	Other:C0007131		L01EB01|L01EB02|L01EB03	rs2494750:CC
sulfamethoxazole / trimethoprim	HLA-B*44:03	HLA-B	*44:03	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*44:03
sulfamethoxazole / trimethoprim	HLA-B*38:01	HLA-B	*38:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*38:01
sulfamethoxazole / trimethoprim	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*04:01
folfox, xelox	rs1695	GSTP1	GG	Toxicity	decreased	Adverse_Event	Other:C0023055		No_ATC	rs1695:GG
folfox, xelox	rs11280056	TYMS	TTA/TTA	Toxicity	decreased	Adverse_Event	Other:C0023055		No_ATC	rs11280056:TTA/TTA
folfox, xelox	rs11280056	TYMS	TTA/TTAAAGTTA	Toxicity	decreased	Adverse_Event	Other:C0023055		No_ATC	rs11280056:TTA/TTAAAGTTA
folfox, xelox	rs45445694	TYMS	(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3/(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	rs45445694:(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3/(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3
folfox, xelox	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	rs1695:GG
azathioprine	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*02:01
azathioprine	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*07:01
hmg coa reductase inhibitors	rs2231142	ABCG2	T	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs2231142:T
amitriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09	*1/*4
amitriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*4	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09	*2/*4
amitriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*5	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09	*2/*5
amitriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09	*4/*41
amitriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09	*4/*10
omeprazole	CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC01	*2/*2
omeprazole	CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC01	*2/*3
omeprazole	CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC01	*3/*3
azathioprine, mercaptopurine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3A	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*3A
azathioprine, mercaptopurine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3B	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*3B
azathioprine, mercaptopurine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3C	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*3C
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*4
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*3/*4	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*3/*4
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*3/*5	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*3/*5
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*4xN	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*4xN
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*6	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*6
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*5/*41	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*5/*41
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*29	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*29
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*17	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*17
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*5/*10	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*5/*10
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*3/*41	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*3/*41
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*9	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*9
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*41	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*41
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*10	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*10
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*5/*17	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*5/*17
codeine, morphine, oxycodone	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030193		N02AA01|N02AA05|R05DA04	rs1799971:AA
folfiri, folfirinox, irinotecan	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0022665|Other:C0030297		L01CE02	rs2231142:GT
folfiri, folfirinox, irinotecan	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0022665|Other:C0030297		L01CE02	rs2231142:TT
folfiri, folfirinox, irinotecan	rs3785161	CES1P1	AC	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0022665|Other:C0030297		L01CE02	rs3785161:AC
folfiri, folfirinox, irinotecan	rs3785161	CES1P1	CC	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0022665|Other:C0030297		L01CE02	rs3785161:CC
sacituzumab govitecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*28/*28
sacituzumab govitecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Efficacy	increased	Adverse_Event	Healthy		No_ATC	*28/*28
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0027051	poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0027051	poor metabolizer	B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0027051	poor metabolizer	B01AC04	*3/*3
none	rs4820268	TMPRSS6	AG	Other	decreased	Adverse_Event	Other:C0002895|Other:C0274435		A03DA02	rs4820268:AG
none	rs747302	DRD4	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs747302:C
dipeptidyl peptidase 4 (dpp-4) inhibitors	HLA-DQB1*03:01	HLA-DQB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*03:01
rosuvastatin	rs2231142	ABCG2	GT	Efficacy, Toxicity	increased	Adverse_Event	Healthy		C10AA07	rs2231142:GT
rosuvastatin	rs2231142	ABCG2	TT	Efficacy, Toxicity	increased	Adverse_Event	Healthy		C10AA07	rs2231142:TT
valganciclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*2	Toxicity	increased	Adverse_Event	Other:Lung_transplantation		J05AB14	*1/*2
valganciclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:Lung_transplantation		J05AB14	*1/*3
valganciclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*5	Toxicity	increased	Adverse_Event	Other:Lung_transplantation		J05AB14	*1/*5
valganciclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*3/*3	Toxicity	increased	Adverse_Event	Other:Lung_transplantation		J05AB14	*3/*3
valganciclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*3/*5	Toxicity	increased	Adverse_Event	Other:Lung_transplantation		J05AB14	*3/*5
cefaclor	rs765144578	TPSAB1	T	Toxicity	increased	Adverse_Event	Healthy		J01DC04	rs765144578:T
sitagliptin	rs2909451	DPP4	TT	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01	rs2909451:TT
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
sitagliptin	rs2285676	KCNJ11	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01	rs2285676:GG
sitagliptin	rs163184	KCNQ1	GG	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01	rs163184:GG
efavirenz	CYP2B6*1, CYP2B6*18	CYP2B6	*1/*18	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*18
sitagliptin	rs4664443	DPP4	GG	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01	rs4664443:GG
sitagliptin	rs1799853	CYP2C9	TT	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01	rs1799853:TT
sitagliptin	rs3765467	GLP1R	AG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01	rs3765467:AG
ivacaftor / lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX30	rs113993960:del/del
fluoxetine	intermediate metabolizer	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0011581	intermediate metabolizer	N06AB03	__UNKNOWN__
paroxetine	ultrarapid metabolizer	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0011581	ultrarapid metabolizer	N06AB05	__UNKNOWN__
sitagliptin	rs6923761	GLP1R	AA	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01	rs6923761:AA
exenatide, liraglutide	rs3765467	GLP1R	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ01|A10BJ02	rs3765467:GG
citalopram, fluoxetine, paroxetine, sertraline	poor metabolizer	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0011581	poor metabolizer	N06AB03|N06AB04|N06AB05|N06AB06	__UNKNOWN__
albiglutide, dulaglutide, glp-1 receptor agonists	rs6923761	GLP1R	A	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BJ04|A10BJ05	rs6923761:A
exenatide	rs7903146	TCF7L2	CT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ01	rs7903146:CT
exenatide	rs7903146	TCF7L2	TT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ01	rs7903146:TT
lansoprazole	CYP2C19*1	CYP2C19	*1/*1	Metabolism/PK	decreased	LADME	Other:history_of_gastric_bypass_surgery		A02BC03	*1/*1
albiglutide, dulaglutide, glp-1 receptor agonists	rs140226575	ARRB1	A	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ04|A10BJ05	rs140226575:A
propafenone	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C0018824		C01BC03	*10/*10
propafenone	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Efficacy_Response	Disease:C0018824		C01BC03	*10/*10
albiglutide, dulaglutide, glp-1 receptor agonists	rs78979036	ARRB1	A	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ04|A10BJ05	rs78979036:A
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*2xN	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	*1/*2xN
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*2/*2xN	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	*2/*2xN
lurbinectedin	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*1	Metabolism/PK	decreased	LADME	Other:C0027651		No_ATC	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	*1/*3
albiglutide, dulaglutide, glp-1 receptor agonists	rs78052828	ARRB1	T	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ04|A10BJ05	rs78052828:T
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Metabolism/PK	increased	LADME	Disease:Severe_Cutaneous_Adverse_Reactions		N03AB02	*3
albiglutide, dulaglutide, glp-1 receptor agonists	rs58428187	ARRB1	C	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ04|A10BJ05	rs58428187:C
raloxifene 6-glucuronide, raloxifene-4-glucuronide	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	increased	LADME	Disease:C0029456		G03XC01	*28/*28
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs8099917:TT
dextromethorphan	CYP2D6*41	CYP2D6	*41	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*41
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*4
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*5
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*1/*9	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*9
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*10
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*10
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*5/*10
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*10/*10
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*10/*17	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*10/*17
aripiprazole	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N05AX12	__UNKNOWN__
lurbinectedin	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:C0027651		No_ATC	*1/*1
lurbinectedin	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:C0027651		No_ATC	*1/*1
leflunomide	rs705379	PON1	GG	Efficacy	increased	Efficacy_Response	Other:C0003873		No_ATC	rs705379:GG
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*4
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*6
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Dosage	decreased	Dosage	Disease:C0023055		L01CE02	*1/*28
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Dosage	decreased	Dosage	Disease:C0023055		L01CE02	*28/*28
dabigatran	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Healthy		B01AE07	*1/*1
levomethadone	CYP2B6*1, CYP2B6*5, CYP2B6*6, CYP2B6*7	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		N07BC05	*6/*6
antiepileptics	rs2298771	SCN1A	C	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs2298771:C
antiepileptics	rs10167228	SCN1A	T	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs10167228:T
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*5	CYP2C9	*1/*5	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*5
warfarin	CYP2C9*1, CYP2C9*11	CYP2C9	*1/*11	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*11
methadone	low activity	__INTRONIC__	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	low activity	N07BC02	
telmisartan	UGT1A3*1, UGT1A3*2	UGT1A3	*2	Metabolism/PK	decreased	LADME	Healthy		C09CA07	*2
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*28/*28
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*1/*28
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*28/*28
carvedilol	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Metabolism/PK	increased	LADME	Other:C0002962		C07AG02	*28
lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Healthy		R07AX30	rs113993960:del/del
olanzapine	rs36120609	GSTM3	TCCTC/TCCTC	Metabolism/PK	decreased	LADME	Healthy		N05AH03	rs36120609:TCCTC/TCCTC
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
olanzapine	rs36120609	GSTM3	TCCTC/TCCTC	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs36120609:TCCTC/TCCTC
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*17, CYP2D6*29	CYP2D6	*17/*17	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*17/*17
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*17, CYP2D6*29	CYP2D6	*29/*29	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*29/*29
liraglutide	rs1049353	CNR1	CT	Efficacy	increased	Efficacy_Response	"""Other:C0011849""|""Other:C0028754"		A10BJ02	rs1049353:CT
liraglutide	rs1049353	CNR1	TT	Efficacy	increased	Efficacy_Response	"""Other:C0011849""|""Other:C0028754"		A10BJ02	rs1049353:TT
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	decreased	LADME	Healthy		M04AA01	*58:01
fluvoxamine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08	
clonidine	rs11269124	ADRA2C	GGGGAGCTTTCCCAGAGACCC/del	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		S01EA04	rs11269124:GGGGAGCTTTCCCAGAGACCC/del
clonidine	rs11269124	ADRA2C	del/del	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		S01EA04	rs11269124:del/del
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*1/*10
dextromethorphan	CYP2D6*1, CYP2D6*10, CYP2D6*14	CYP2D6	*14	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*14
simvastatin acid	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0242339		C10AA01	rs4149056:CC
simvastatin acid	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0242339		C10AA01	rs4149056:CT
dextromethorphan	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	R05DA09	__UNKNOWN__
simvastatin acid	rs2306283	SLCO1B1	AG	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0242339		C10AA01	rs2306283:AG
simvastatin acid	rs2306283	SLCO1B1	GG	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0242339		C10AA01	rs2306283:GG
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*3/*4
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*4/*4
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*4/*5
aspirin	rs1371097	P2RY1	T	Efficacy	decreased	Efficacy_Response	Other:C0018839		No_ATC	rs1371097:T
aspirin	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Other:C0018839		No_ATC	rs1045642:GG
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Metabolism/PK	increased	LADME	Other:C0024121		L01CE02	*28
dextromethorphan	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	R05DA09	__UNKNOWN__
ribavirin, sofosbuvir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP01|J05AP08	rs11322783:TT/TT
rifampicin	rs4149032	SLCO1B1	TT	Metabolism/PK	increased	LADME	Other:C0041296		J04AB02	rs4149032:TT
modafinil	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Other:Methamphetamine_dependence		N06BA07	rs4680:GG
isoniazid	rs1495741	__INTRONIC__	AA	Metabolism/PK	increased	LADME	Other:C0041296		J04AC01	rs1495741:AA
valsartan	rs699	AGT	GG	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA03	rs699:GG
meloxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*1/*3
naltrexone	rs1799971	OPRM1	G	Efficacy	increased	Efficacy_Response	Other:C0085762		N07BB04	rs1799971:G
ivacaftor	rs113993960	CFTR	del	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs113993960:del
ivacaftor	rs113993960	CFTR	del	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs113993960:del
elexacaftor	deficiency	CFTR	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0156318	deficiency	No_ATC	
atorvastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15	Metabolism/PK	increased	LADME	Healthy		C10AA05	*15
remifentanil	rs1800544	ADRA2A	CG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH06	rs1800544:CG
remifentanil	rs1800544	ADRA2A	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH06	rs1800544:GG
warfarin	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Dosage	increased	Dosage	Other:C0040038		B01AA03	*1/*28
warfarin	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Dosage	increased	Dosage	Other:C0040038		B01AA03	*28/*28
remifentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH06	rs1799971:AG
remifentanil	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH06	rs1799971:GG
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	*1/*3
posaconazole, tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		J02AC04|L04AD02	rs1045642:GG
tacrolimus	CYP3A5*1, CYP3A5*6	CYP3A5	*6	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*6
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*2/*2
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*2/*3
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*7	CYP3A5	*7	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*7
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*1/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*1/*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*17
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*1/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*1/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*17
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Dosage	Disease:Organ_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Dosage	Disease:Organ_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*7
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Healthy		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0009324		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0009324		L04AD02	*1/*3
coumarin	CYP2A6*1, CYP2A6*4, CYP2A6*10	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*4/*4
coumarin	CYP2A6*1, CYP2A6*4, CYP2A6*10	CYP2A6	*4/*10	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*4/*10
nicotine	CYP2A6*1, CYP2A6*2	CYP2A6	*1/*2	Dosage	decreased	Dosage	Disease:C0039338		N07BA01	*1/*2
nicotine	CYP2A6*1, CYP2A6*2	CYP2A6	*2/*2	Dosage	decreased	Dosage	Disease:C0039338		N07BA01	*2/*2
moxifloxacin	UGT1A1*1, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	*1/*36	Metabolism/PK	decreased	LADME	Disease:C0041296		S01AE07	*1/*36
dextromethorphan	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C1458155	poor metabolizer	R05DA09	__UNKNOWN__
nicotine	CYP2A6*1, CYP2A6*46	CYP2A6	*46/*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*46/*46
buprenorphine	rs149319538	SLC39A10	C	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs149319538:C
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Dosage, Efficacy	decreased	Dosage	Disease:C0271093		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	*1/*3
simvastatin, warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03|C10AA01	*3
dextromethorphan	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*4/*4
dextromethorphan	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*7	CYP2D6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*6/*6
dextromethorphan	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*7	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*3/*4
dextromethorphan	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*7	CYP2D6	*3/*3	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*3/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Disease:C0004238		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
dextromethorphan	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*4
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*1/*1	Metabolism/PK	decreased	LADME	Disease:C1458155	normal metabolizer	L02BG04	*1/*1
dextromethorphan	CYP2D6*1, CYP2D6*2	CYP2D6	*1/*2	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Other:Heart_valve_replacement|Other:C0004238|Other:C0018839|Other:C0034065|Other:C0042487		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Other:Heart_valve_replacement|Other:C0004238|Other:C0018839|Other:C0034065|Other:C0042487		B01AA03	*3
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Other:Heart_valve_replacement|Other:C0004238|Other:C0018839|Other:C0034065|Other:C0042487		B01AA03	rs9923231:T
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
rivaroxaban	rs4148738	ABCB1	CC	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs4148738:CC
rivaroxaban	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs1128503:AA
diazepam	poor metabolizer	CYP2B6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05BA01	__UNKNOWN__
methotrexate	rs2853542	TYMS	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs2853542:GG
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*2	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*2
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3A
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*2	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*2
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*3A
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*3C	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*3C
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*9	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*9
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*21	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*21
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*33	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*33
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*34	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*34
methotrexate	rs4673993	ATIC	TT	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AX03	rs4673993:TT
fluoxetine	rs6295	HTR1A	GG	Efficacy	increased	Efficacy_Response	Efficacy:C0011581		N06AB03	rs6295:GG
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0011581	poor metabolizer	N05AX08	*4/*4
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0011581	poor metabolizer	N05AX08	*4/*5
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*3	Efficacy	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0011581	poor metabolizer	N05AX08	*4/*3
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*5	Efficacy	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0011581	poor metabolizer	N05AX08	*5/*5
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*6/*6	Efficacy	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0011581	poor metabolizer	N05AX08	*6/*6
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*60	UGT1A1	*6/*60	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*6/*60
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*60	UGT1A1	*6/*28	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*6/*28
dihydropyridine derivatives	rs10898815	NUMA1	AA	Other	increased	Adverse_Event	Healthy		C08CA	rs10898815:AA
dihydropyridine derivatives	rs10898815	NUMA1	AG	Other	increased	Adverse_Event	Healthy		C08CA	rs10898815:AG
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03	rs2108622:CC
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Heart_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Heart_transplantation		L04AD02	*1/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*2/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*2/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*2/*17
sulfonamides, urea derivatives	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Other:C0011849	poor metabolizer	S01AB	*2/*2
sulfonamides, urea derivatives	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Other:C0011849	poor metabolizer	S01AB	*2/*3
sulfonamides, urea derivatives	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Other:C0011849	poor metabolizer	S01AB	*3/*3
corticosteroids	rs10482634	NR3C1	GG	Efficacy	increased	Efficacy_Response	Other:C0027726		S02BA	rs10482634:GG
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*10, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*10, CYP2C9*11	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*10, CYP2C9*11	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*10, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*10, CYP2C9*11	CYP2C9	*6	Dosage	decreased	Dosage	Healthy		B01AA03	*6
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Dosage	Disease:Heart_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Dosage	Disease:Heart_transplantation		L04AD02	*1/*3
valproic acid	rs6759892	UGT1A6	TT	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs6759892:TT
nicotine	CYP2A6*1, CYP2A6*46	CYP2A6	*46/*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*46/*46
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3
methylphenidate	rs2251214	SYT1	AA	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA04	rs2251214:AA
methylphenidate	rs2251214	SYT1	AG	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA04	rs2251214:AG
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	J02AC03	*1/*17
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*2
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
chop, rituximab	rs8133052	CBR3	AA	Efficacy	decreased	Efficacy_Response	Other:C0024299		L01FA01	rs8133052:AA
chop, rituximab	rs8133052	CBR3	AG	Efficacy	decreased	Efficacy_Response	Other:C0024299		L01FA01	rs8133052:AG
chop, rituximab	rs8187710	ABCC2	AA	Efficacy	decreased	Efficacy_Response	Other:C0024299		L01FA01	rs8187710:AA
chop, rituximab	rs8187710	ABCC2	AG	Efficacy	decreased	Efficacy_Response	Other:C0024299		L01FA01	rs8187710:AG
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*11	CYP2C9	*1/*11	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*11
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*11	CYP2C9	*2/*11	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*2/*11
n-desmethyltamoxifen	rs11914200	SEPTIN3	AG	Metabolism/PK	decreased	LADME	Healthy		L02BA01	rs11914200:AG
fentanyl	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0027651|Disease:C0030193		N02AB03	*3/*3
citalopram	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		N06AB04	*1/*10
citalopram	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06AB04	*10/*10
n-desmethyltamoxifen	rs133290	SREBF2	AC	Metabolism/PK	decreased	LADME	Healthy		L02BA01	rs133290:AC
hydroxyphenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*11	CYP2C9	*1/*11	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*1/*11
hydroxyphenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*11	CYP2C9	*2/*11	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*2/*11
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	*2
n-desmethyltamoxifen	rs5751251	TCF20	GG	Metabolism/PK	increased	LADME	Healthy		L02BA01	rs5751251:GG
n-desmethyltamoxifen	rs2267439	SREBF2	TT	Metabolism/PK	increased	LADME	Healthy		L02BA01	rs2267439:TT
piroxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M02AA07	*1/*3
piroxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		M02AA07	*3/*3
n-desmethyltamoxifen	rs9607850	SREBF2	TT	Metabolism/PK	increased	LADME	Healthy		L02BA01	rs9607850:TT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage, Metabolism/PK	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	*3/*3
n-desmethyltamoxifen	rs8140869	CENPM, SMIM45	AG	Metabolism/PK	decreased	LADME	Healthy		L02BA01	rs8140869:AG
ribavirin, sofosbuvir	rs11322783	IFNL4	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP08	rs11322783:GG
varenicline	high activity	CYP2A6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0039338	high activity	N07BA03	__UNKNOWN__
etoposide	rs446112	__INTRONIC__	AA	Other	increased	Efficacy_Response	Healthy		L01CB01	rs446112:AA
rosuvastatin	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Other:C0011849|Other:C0020443		C10AA07	rs2231142:GT
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Other:C0011849|Other:C0020443		C10AA07	rs2231142:TT
fluvoxamine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08	
meloxicam	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*1/*3
meloxicam	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*2/*2
opioids	poor and ultrarapid metabolizers	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Disease:C0030193	poor metabolizer and ultrarapid metabolizer	N02A	__UNKNOWN__
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	J02AC03	*1/*17
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0030319		N06AB05	
ivacaftor, lumacaftor	rs113993960	CFTR	del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del
paroxetine	SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Healthy		N06AB05	
afatinib	rs28929495	EGFR	GG	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01EB03	rs28929495:GG
ivacaftor, lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del/del
3-aminoisobutyrate	rs3918290	DPYD	TT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs3918290:TT
hydralazine	rapid acetylator	NAT2	__UNKNOWN__	Dosage, Efficacy	increased	Dosage	Other:C0020538	rapid acetylator	C02DB02	__UNKNOWN__
mexiletine	CYP2D6*41	CYP2D6	*41	Efficacy	decreased	Efficacy_Response	Other:C0221260|Other:Nondystrophic_myotonia		C01BB02	*41
3-aminoisobutyrate	rs143493067	UPB1	AA	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs143493067:AA
3-aminoisobutyrate	rs114286107	AGXT2	TT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs114286107:TT
meloxicam	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*3
meloxicam	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*2
meloxicam	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	PD, Metabolism/PK	decreased	LADME	Healthy		M01AC06	*1/*13
fentanyl	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0030193|Postoperative		N02AB03	*3/*3
uracil	rs3918290	DPYD	TT	Metabolism/PK	increased	LADME	Healthy		H03BA	rs3918290:TT
2-aminoheptanoate, 2-aminooctanoic acid, 2-hydroxylaurate	rs41272317	ACAD11	AA	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs41272317:AA
cysteine-s-sulfate, l-ornithine	rs140130028	NPC2	TT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs140130028:TT
5,6-dihydrothymine	rs143493067	UPB1	AA	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs143493067:AA
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
10-monohydroxy oxcarbazepine	rs2273697	ABCC2	G	Metabolism/PK	increased	LADME	Other:C0014544		N03AF02	rs2273697:G
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*5/*10
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*1/*10
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Healthy		J05AG03	*6
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10
rivaroxaban	rs776746	CYP3A5	TT	Toxicity	decreased	LADME	Other:C1861172		B01AF01	rs776746:TT
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1057910:AC
praziquantel	CYP1A2*1, CYP1A2*30	CYP1A2	*1/*30	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*30
praziquantel	CYP1A2*1, CYP1A2*30	CYP1A2	*30/*30	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*30/*30
praziquantel	CYP2C9*1, CYP2C9*9	CYP2C9	*1/*9	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*9
praziquantel	CYP2C9*1, CYP2C9*9	CYP2C9	*9/*9	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*9/*9
aripiprazole	rs1065852	CYP2D6	AA	Efficacy	increased	Efficacy_Response	Other:C0038354		N05AX12	rs1065852:AA
aripiprazole	rs1065852	CYP2D6	AG	Efficacy	increased	Efficacy_Response	Other:C0038354		N05AX12	rs1065852:AG
aripiprazole	rs1080989	CYP2D6	CT	Efficacy	increased	Efficacy_Response	Other:C0038354		N05AX12	rs1080989:CT
aripiprazole	rs1080989	CYP2D6	TT	Efficacy	increased	Efficacy_Response	Other:C0038354		N05AX12	rs1080989:TT
quinapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Healthy		C09AA06	rs1799752:del/del
aripiprazole	rs1080989	CYP2D6	CT	Efficacy	decreased	LADME	Other:C0038354		N05AX12	rs1080989:CT
aripiprazole	rs1080989	CYP2D6	TT	Efficacy	decreased	LADME	Other:C0038354		N05AX12	rs1080989:TT
cyclophosphamide	rs2740574	CYP3A4	CC	Efficacy	decreased	Efficacy_Response	Other:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01	rs2740574:CC
cyclophosphamide	rs2740574	CYP3A4	CT	Efficacy	decreased	Efficacy_Response	Other:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01	rs2740574:CT
cyclophosphamide	CYP3A5*1, CYP3A5*3	CYP3A5	*3	Efficacy	decreased	Efficacy_Response	Other:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01	*3
esomeprazole, pantoprazole	CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Healthy		A02BC02|A02BC05	*17/*17
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Dosage, Efficacy, Toxicity	decreased	Dosage	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3A
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Dosage, Efficacy, Toxicity	decreased	Dosage	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3C
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*2
meloxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*3/*3
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs776746:TT
tacrolimus	rs2011425	UGT1A4	TT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs2011425:TT
tacrolimus	rs35599367	CYP3A4	GG	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs35599367:GG
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		J05AG03	*6/*6
rosuvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0011849|Other:C0020443		C10AA07	rs4149056:CC
rosuvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0011849|Other:C0020443		C10AA07	rs4149056:CT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	Dosage	Disease:Liver_transplantation		L04AD02	*3/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*3/*3
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
alogliptin	rs738409	PNPLA3	CG	Efficacy	increased	Efficacy_Response	"""Other:C0011849""|""Other:C0860195|""Other:C2732728"		A10BH04	rs738409:CG
alogliptin	rs738409	PNPLA3	GG	Efficacy	increased	Efficacy_Response	"""Other:C0011849""|""Other:C0860195|""Other:C2732728"		A10BH04	rs738409:GG
amlodipine	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:C0020538		C08CA01	*1/*22
amlodipine	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Other:C0020538		C08CA01	*22/*22
ivacaftor, lumacaftor	rs113993960	CFTR	CTT/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:CTT/del
sertraline	rs167770	DRD3	AG	Efficacy	increased	Efficacy_Response	Other:C0028768		N06AB06	rs167770:AG
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*2
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*3
sertraline	rs11721264	DRD3	AG	Efficacy	increased	Efficacy_Response	Other:C0028768		N06AB06	rs11721264:AG
iloperidone, iloperidone metabolite p88	rs1065852	CYP2D6	AA	Metabolism/PK	increased	LADME	Other:C0036341		No_ATC	rs1065852:AA
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*3
ivacaftor, lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del/del
efavirenz	CYP2B6*1, CYP2B6*4	CYP2B6	*1/*4	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*4
ivacaftor, lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del/del
valproic acid	rs3751664	CACNA1H	T	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs3751664:T
fluvoxamine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB08	
penicillin g	rs1861494	IFNG	CC	Efficacy	decreased	Efficacy_Response	Other:C0039128		No_ATC	rs1861494:CC
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2
penicillin g	rs2430561	IFNG	TT	Efficacy	decreased	Efficacy_Response	Other:C0039128		No_ATC	rs2430561:TT
ivacaftor, lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del/del
imipramine	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*1xN	Dosage	increased	Dosage	Disease:C0011581	ultrarapid metabolizer	N06AA02	*1/*1xN
imipramine	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*2xN	Dosage	increased	Dosage	Disease:C0011581	ultrarapid metabolizer	N06AA02	*1/*2xN
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*6	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*6
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*7	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*7
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*7/*7	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*7/*7
simvastatin	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:C0020443		C10AA01	*1/*22
fluvoxamine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB08	
fluvoxamine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB08	
rivaroxaban	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Healthy		B01AF01	rs2231142:GT
rivaroxaban	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		B01AF01	rs2231142:TT
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage, Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*3/*3
atomoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06BA09	*10/*10
atomoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		N06BA09	*1/*10
ivacaftor, lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del/del
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*3
avatrombopag	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*3	Dosage	Indeterminado	Dosage	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*5	Dosage	Indeterminado	Dosage	Healthy		B01AA03	*5
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*2	Dosage	Indeterminado	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*1	Dosage	Indeterminado	Dosage	Healthy		B01AA03	*1
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
avatrombopag	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1128503:AA
avatrombopag	rs1128503	ABCB1	AG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1128503:AG
venetoclax	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:C0023418|Myeloid|Acute		L01XX52	rs776746:CC
clozapine	rs28379954	NFIB	CT	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs28379954:CT
atomoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		N06BA09	*10/*10
atomoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Healthy		N06BA09	*1/*10
pitavastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15	Metabolism/PK	increased	LADME	Healthy		C10AA08	*15
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
tacrolimus	rs2740574	CYP3A4	TT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs2740574:TT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*3/*3
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC01	*1/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC01	*1/*3
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC01	*1/*1
methylphenidate	rs998424	SLC6A2	GG	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA04	rs998424:GG
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		J02AC03	*2/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		J02AC03	*2/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0027697		L04AD02	*3/*3
lithium	rs7405404	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs7405404:T
3,4-methylenedioxymethamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Efficacy_Response	Healthy		V04CX05	*4/*4
3,4-methylenedioxymethamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*5	Efficacy	increased	Efficacy_Response	Healthy		V04CX05	*3/*5
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease	poor metabolizer	J05AG03	rs28399499:C
fentanyl	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Dosage	increased	Dosage	"""Other:C0017185|""Other:C0030193|Postoperative"""		N02AB03	*10/*10
varenicline	rs7164594	HYKK	CT	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs7164594:CT
varenicline	rs7164594	HYKK	TT	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs7164594:TT
sirolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		No_ATC	*3/*3
4-hydroxytamoxifen(tamoxifen)	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*10/*10
captopril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C0011849		C09AA01	rs1799752:del/del
3,4-methylenedioxymethamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		V04CX05	*4/*4
3,4-methylenedioxymethamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*5	Metabolism/PK	decreased	LADME	Healthy		V04CX05	*3/*5
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*1	Metabolism/PK	increased	LADME	Disease:C0023449	high activity	L01BB02	*1/*1
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease	poor metabolizer	J05AG03	rs3745274:T
enalapril, losartan	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Disease:C0010068		C09AA02|C09CA01	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1
benazepril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA07	rs1799752:del/del
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		A02BC03	*1/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		A02BC03	*1/*3
bupropion	rs8109525	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12	rs8109525:GG
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC03	*1/*1
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5	NUDT15	*1/*1	Dosage	increased	Dosage	Disease:C0023449	high activity	L01BB02	*1/*1
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0027726		L04AD02	*3/*3
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*10/*10
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*10/*41
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*5
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*5
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5/*10
atomoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06BA09	*10/*10
mesalazine, thioguanine	NAT1*3, NAT1*4, NAT1*10	NAT1	*10	Metabolism/PK	decreased	LADME	Disease:C0009324|Disease:C0010346|Disease:C0021390		A07EC02|L01BB03	*10
pioglitazone	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		A10BG03	*1/*3
tacrolimus	rs776746	CYP3A5	CC	Dosage	increased	LADME	Disease:C0009324		L04AD02	rs776746:CC
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Organ_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Organ_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Organ_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Organ_Transplantation		L04AD02	*1/*3
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	*4/*5
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	*4/*6
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	*3/*4
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	*4/*4
exemestane	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:C1458155		L02BG06	*1/*22
warfarin	CYP4F2*1, CYP4F2*3	CYP4F2	*3	Dosage	increased	Dosage	Healthy		B01AA03	*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	*3/*3
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*4
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*5
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*4
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*5
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*10
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*14	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*14
metoprolol	CYP2D6*4	CYP2D6	*4	Dosage	decreased	Dosage	Disease:C0085605		C07AB02	*4
cetuximab	rs144854329	VEGFA	del/del	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs144854329:del/del
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*1/*28
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*28/*28
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1
ibuprofen	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*3
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*1/*1
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*1/*1
ibuprofen	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*2
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:C0003873|Disease:C0009324		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:C0003873|Disease:C0009324		L04AD02	*1/*3
tacrolimus	rs776746	CYP3A5	CC	Dosage	increased	LADME	Disease:C0009324		L04AD02	rs776746:CC
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*1/*28
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*28/*28
lornoxicam	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	decreased	LADME	Healthy		M01AC05	*1/*13
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*1
pilocarpine	CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4/*7	Metabolism/PK	decreased	LADME	Healthy		S01EB01	*4/*7
pilocarpine	CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4/*9	Metabolism/PK	decreased	LADME	Healthy		S01EB01	*4/*9
pilocarpine	CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4/*10	Metabolism/PK	decreased	LADME	Healthy		S01EB01	*4/*10
pilocarpine	CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*7/*9	Metabolism/PK	decreased	LADME	Healthy		S01EB01	*7/*9
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*3
lornoxicam	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	decreased	LADME	Healthy		M01AC05	*1/*13
lornoxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC05	*1/*3
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1
lornoxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC05	*1/*3
atenolol	rs1801253	ADRB1	C	Efficacy	increased	Efficacy_Response	Healthy		C07AB03	rs1801253:C
warfarin	CYP2C9*1, CYP2C9*6	CYP2C9	*1/*6	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*6
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Healthy		N06AX16	*3/*4
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AX16	*4/*4
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N06AX16	*4/*5
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Other:total_knee_or_hip_arthroplasty		B01AA03	*3
propofol	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N01AX10	*1/*1
propofol	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Metabolism/PK	decreased	LADME	Healthy		N01AX10	*1/*2
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	Indeterminado	LADME	Disease:C0271093		B01AA03	*1/*3
lansoprazole, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03	*1/*2
lansoprazole, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03	*1/*3
noroxycodone, oxycodone	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AA05	__UNKNOWN__
citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Dosage, Efficacy	decreased	Dosage	Disease:C0235876		N06AB03|N06AB04|N06AB05|N06AB06|N06AB08|N06AB10	*4/*4
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
disulfiram	rs28363170	SLC6A3	GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT/GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs28363170:GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT/GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage	increased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Other:total_knee_or_hip_arthroplasty		B01AA03	*2
benazepril, perindopril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA04|C09AA07	rs1799752:del/del
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0033975	poor metabolizer	N05AX08	*4/*4
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
thioguanine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Metabolism/PK	increased	LADME	Disease:C0010346		L01BB03	*1/*3A
thioguanine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Metabolism/PK	increased	LADME	Disease:C0010346		L01BB03	*1/*3C
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:C0009324		L04AD02	rs776746:CC
proguanil	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0024530		P01BB01	*2/*2
proguanil	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0024530		P01BB01	*2/*3
proguanil	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0024530		P01BB01	*3/*3
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3A
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3C
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*3A/*3A
artemether	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		P01BE02	*6/*6
fluoxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB03	__UNKNOWN__
fluoxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB03	__UNKNOWN__
n-desmethylclozapine(clozapine)	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Metabolism/PK	increased	LADME	Disease:C0036337|Disease:C0036341		N05AH02	*17
clozapine	CYP2C19*17	CYP2C19	*17/*17	Efficacy	increased	Efficacy_Response	Disease:C0036337|Disease:C0036341		N05AH02	*17/*17
efavirenz	rs36118214	CYP2B6	GG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs36118214:GG
cyclophosphamide	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Disease:C0024299		L01AA01	*6
cyclophosphamide	CYP2B6*1, CYP2B6*30	CYP2B6	*1/*30	Metabolism/PK	decreased	LADME	Disease:C0024299		L01AA01	*1/*30
cyclophosphamide	CYP2B6*1, CYP2B6*29	CYP2B6	*1/*29	Metabolism/PK	decreased	LADME	Disease:C0024299		L01AA01	*1/*29
lansoprazole, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03	*1/*1
rosiglitazone	CYP2C8*3	CYP2C8	*3	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BG02	*3
cyclophosphamide	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0024299		L01AA01	*1/*2
cyclophosphamide	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0024299		L01AA01	*2/*2
quinapril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C09AA06	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del
quinapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C09AA06	rs1799752:del/del
cyclophosphamide	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L01AA01	*1/*2
cyclophosphamide	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L01AA01	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C0004238|Disease:C1861172		B01AA07	*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C0004238|Disease:C1861172		B01AA07	*3
testosterone	UGT1A4*1a, UGT1A4*3a	UGT1A4	*3a	Efficacy, Metabolism/PK	increased	LADME	Healthy		G03BA03	*3a
cyclophosphamide	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0024299		L01AA01	*1/*3
cyclophosphamide	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0024299		L01AA01	*3/*3
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__
acenocoumarol	CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	Indeterminado	Dosage	Healthy		B01AA07	*2
acenocoumarol	CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	Indeterminado	Dosage	Healthy		B01AA07	*3
lamotrigine	UGT1A4*1a, UGT1A4*2, UGT1A4*3a	UGT1A4	*2	Efficacy, Metabolism/PK	decreased	LADME	Healthy		N03AX09	*2
lamotrigine	UGT1A4*1a, UGT1A4*2, UGT1A4*3a	UGT1A4	*3a	Efficacy, Metabolism/PK	decreased	LADME	Healthy		N03AX09	*3a
curcumin, ivacaftor	rs77010898	CFTR	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs77010898:AA
curcumin, ivacaftor	rs77010898	CFTR	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs77010898:AG
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*1/*2
3-hydroxycotinine	CYP2A6*1, CYP2A6*12	CYP2A6	*1/*12	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*1/*12
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0004936		N06AA09	*1/*2
captopril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C0024117		C09AA01	rs1799752:del/del
tacrolimus	CYP3A5*1	CYP3A5	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:Liver_transplantation		L04AD02	*1/*1
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Dosage, Metabolism/PK	increased	LADME	Disease:C0027651	poor metabolizer	J02AC03	*2/*2
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*49	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*49
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*52	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*52
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*49/*52	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*49/*52
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*41
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*5/*5	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*5/*5
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*41/*41	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*41/*41
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*21	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*21
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*18	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*18
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*9	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*9
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*29	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*29
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*45	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*45
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*46	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*46
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*17	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*17
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*10	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*10
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Other:C0010068		B01AC04	*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*1/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*1/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*17/*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*17/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*17/*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*17/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*2/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*2/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*3/*3
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Dosage, Metabolism/PK	decreased	LADME	Disease:C0027651	ultrarapid metabolizer	J02AC03	*17/*17
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
methotrexate	rs371194629	HLA-G	del/del	Efficacy	increased	Efficacy_Response	Efficacy:C0003873		L04AX03	rs371194629:del/del
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*4
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*3
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*5
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*6
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*28/*28
esomeprazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Efficacy	decreased	Efficacy_Response	Other:C0151788		A02BC05	*17
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Dosage, Metabolism/PK	increased	LADME	Disease:C0027651	intermediate metabolizer	J02AC03	*1/*2
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Dosage	decreased	Dosage	Disease:C0027651		L01CE02	*6/*6
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Dosage	decreased	Dosage	Disease:C0027651		L01CE02	*28/*28
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Dosage	decreased	Dosage	Disease:C0027651		L01CE02	*6/*28
captopril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Disease:C0024117		C09AA01	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA04	*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA04	*3
ivacaftor, tezacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX31	rs113993960:del/del
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03	rs9923231:TT
tramadol	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	increased	LADME	Healthy		N02AX02	*1/*1xN
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA01	*1/*2
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA01	*1/*3
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA01	*2/*2
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA01	*2/*3
chiglitazar	rs1800234	PPARA	CC	Efficacy	decreased	Efficacy_Response	Other:C0011849		No_ATC	rs1800234:CC
chiglitazar	rs1800234	PPARA	CT	Efficacy	decreased	Efficacy_Response	Other:C0011849		No_ATC	rs1800234:CT
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6
lamotrigine	UGT1A4*1a, UGT1A4*1b	UGT1A4	*1b	Metabolism/PK	decreased	LADME	Other:C0014544		N03AX09	*1b
haloperidol	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*5
haloperidol	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*10
haloperidol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*3
haloperidol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*4
zuclopenthixol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Other:C0036341		N05AF05	*1/*4
zuclopenthixol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Other:C0036341		N05AF05	*3/*4
azathioprine, mercaptopurine	low activity	TPMT	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	low activity	L01BB02|L04AX01	__UNKNOWN__
risperidone	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	__UNKNOWN__
mercaptopurine	intermediate activity	TPMT	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C0023449	intermediate activity	L01BB02	__UNKNOWN__
fentanyl	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs2242480:T/T
sulfasalazine	slow acetylator	NAT2	__UNKNOWN__	Other	increased	Adverse_Event	Disease:C0003873	slow acetylator	A07EC01	__UNKNOWN__
fentanyl	rs2242480	CYP3A4	T/T	Metabolism/PK	increased	LADME	Disease:C0030193|Postoperative		N02AB03	rs2242480:T/T
ethanol	rs1799971	OPRM1	G	Dosage	increased	Dosage	Healthy		V03AB16	rs1799971:G
sufentanil	rs2242480	CYP3A4	T/T	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		N01AH03	rs2242480:T/T
sufentanil	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Disease:C0030193		N01AH03	rs2242480:T/T
sufentanil	rs2242480	CYP3A4	T/T	Metabolism/PK	decreased	LADME	Disease:C0030193		N01AH03	rs2242480:T/T
tacrolimus	rs2242480	CYP3A4	C/C	Other, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:C/C
fentanyl	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs2242480:T/T
sufentanil	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N01AH03	rs2242480:T/T
fentanyl	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs2242480:T/T
beta blocking agents	rs4752292	GRK5	T	Efficacy	decreased	Efficacy_Response	Other:C1956346		S01ED	rs4752292:T
interferon beta-1a	HLA-B*15:01	HLA-B	*15:01	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AB07	*15:01
rubella vaccines	HLA-B*35:03	HLA-B	*35:03	Efficacy	increased	Efficacy_Response	Healthy		J07BJ	*35:03
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	HLA-B*38:01	HLA-B	*38:01	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	*38:01
highly active antiretroviral therapy (haart)	rs671531	OPRM1	GG	Efficacy	decreased	Efficacy_Response	Other:HIV_infectious_disease		No_ATC	rs671531:GG
tacrolimus	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*18	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*18
cyclosporine	CYP3A4*1, CYP3A4*18	CYP3A4	*18/*18	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*18/*18
ustekinumab	HLA-C*06:02	HLA-C	*06:02	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	*06:02
methotrexate	HLA-C*06:02	HLA-C	*06:02	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AX03	*06:02
fentanyl	CYP3A4*1, CYP3A4*18	CYP3A4	*18/*18	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AB03	*18/*18
rubella vaccines	HLA-C*15:02	HLA-C	*15:02	Efficacy	increased	Efficacy_Response	Healthy		J07BJ	*15:02
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*02:02	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*02:02
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*04:01	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*04:01
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*05:01	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*05:01
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*06:02	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*06:02
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*15:02	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*15:02
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*17:01	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*17:01
measles vaccines	HLA-DQA1*01:04	HLA-DQA1	*01:04	Efficacy	increased	Efficacy_Response	Healthy		J07BD	*01:04
measles vaccines	HLA-DRB1*01:01	HLA-DRB1	*01:01	Efficacy	Indeterminado	Efficacy_Response	Healthy		J07BD	*01:01
cyclosporine	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*1	Metabolism/PK	increased	LADME	Healthy		L04AD01	*1/*1
interferon beta-1a	HLA-DRB1*04:01	HLA-DRB1	*04:01	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07	*04:01
adalimumab, etanercept, infliximab	HLA-DRB1*04:01	HLA-DRB1	*04:01	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04	*04:01
hepatitis vaccines	HLA-DRB1*07:01	HLA-DRB1	*07:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BC	*07:01
influenza vaccines	HLA-DRB1*07:01	HLA-DRB1	*07:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BB	*07:01
measles vaccines	HLA-DRB1*08:01	HLA-DRB1	*08:01	Efficacy	Indeterminado	Efficacy_Response	Healthy		J07BD	*08:01
influenza vaccines	HLA-DRB1*13:01	HLA-DRB1	*13:01	Efficacy	increased	Efficacy_Response	Healthy		J07BB	*13:01
montelukast	CYP2C8*1, CYP2C8*4	CYP2C8	*4	Metabolism/PK	increased	LADME	Healthy		R03DC03	*4
montelukast	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Healthy		R03DC03	*3
tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
methotrexate	rs11545078	GGH	AA	Toxicity	increased	Adverse_Event	Side_Effect:C0003873		L04AX03	rs11545078:AA
methotrexate	rs11545078	GGH	AG	Toxicity	increased	Adverse_Event	Side_Effect:C0003873		L04AX03	rs11545078:AG
ibuprofen	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Dosage	decreased	Dosage	Healthy		M02AA13	*1/*3
rosiglitazone	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A10BG02	*1/*3
ibuprofen	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*3
methadone	CYP2B6*1, CYP2B6*5, CYP2B6*6, CYP2B6*7, CYP2B6*18	CYP2B6	*1/*6	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC02	*1/*6
methadone	CYP2B6*1, CYP2B6*5, CYP2B6*6, CYP2B6*7, CYP2B6*18	CYP2B6	*1/*18	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC02	*1/*18
methadone	CYP2B6*1, CYP2B6*5, CYP2B6*6, CYP2B6*7, CYP2B6*18	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC02	*6/*6
methadone	CYP2B6*1, CYP2B6*5, CYP2B6*6, CYP2B6*7, CYP2B6*18	CYP2B6	*6/*18	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC02	*6/*18
disulfiram	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele) / HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Other:C0278080	low activity	N07BB01	
disulfiram	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele) / L allele-rs25531C	Efficacy	increased	Efficacy_Response	Other:C0278080	low activity	N07BB01	
disulfiram	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531C / L allele-rs25531C	Efficacy	increased	Efficacy_Response	Other:C0278080	low activity	N07BB01	
sertraline	CYP2B6*1, CYP2B6*4	CYP2B6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N06AB06	*1/*4
sertraline	CYP2B6*1, CYP2B6*4	CYP2B6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AB06	*4/*4
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*6	Metabolism/PK	increased	LADME	Healthy		N06AB06	*6
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*9	Metabolism/PK	increased	LADME	Healthy		N06AB06	*9
sertraline	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB06	*1/*17
sertraline	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB06	*17/*17
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*2	Metabolism/PK	increased	LADME	Healthy		N06AB06	*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*3	Metabolism/PK	increased	LADME	Healthy		N06AB06	*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*4	Metabolism/PK	increased	LADME	Healthy		N06AB06	*4
atorvastatin	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Healthy		C10AA05	*1/*3
atorvastatin	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Healthy		C10AA05	*3/*3
atorvastatin	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*1/*5	Metabolism/PK	increased	LADME	Healthy		C10AA05	*1/*5
atorvastatin	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*5/*5	Metabolism/PK	increased	LADME	Healthy		C10AA05	*5/*5
pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*1/*15	Efficacy	decreased	Efficacy_Response	Other:C0020443		C10AA03	*1/*15
rifampin, warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*11	CYP2C9	*2	Efficacy	increased	Efficacy_Response	Other:C0041296		B01AA03	*2
rifampin, warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*11	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Other:C0041296		B01AA03	*3
rifampin, warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*11	CYP2C9	*11	Efficacy	increased	Efficacy_Response	Other:C0041296		B01AA03	*11
pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*15
pitavastatin, pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA03|C10AA08	*15/*15
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*2/*2	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	No_ATC	*2/*2
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*2/*3	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	No_ATC	*2/*3
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*3/*3	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	No_ATC	*3/*3
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*5/*5	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	No_ATC	*5/*5
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs1045642:GG
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
fluvastatin	SLCO1B1*1, SLCO1B1*14	SLCO1B1	*14	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA04	*14
acenocoumarol	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2
methotrexate	SLCO1B1*1, SLCO1B1*31, SLCO1B1*37	SLCO1B1	*31	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	*31
methotrexate	SLCO1B1*1, SLCO1B1*20, SLCO1B1*37	SLCO1B1	*20	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	*20
conjugated estrogens	rs4149056	SLCO1B1	TT	Metabolism/PK	decreased	LADME	Disease:C0025320		G03CA57	rs4149056:TT
methotrexate	SLCO1B1*1, SLCO1B1*23, SLCO1B1*37	SLCO1B1	*23	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	*23
acenocoumarol	rs1998591	CYP2C18	GG	Dosage	increased	Dosage	Healthy		B01AA07	rs1998591:GG
acenocoumarol	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA07	rs9934438:AA
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Other:C0018839		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Other:C0018839		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Other:C0018839		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Other:C0018839		B01AC04	*2/*3
methotrexate	SLCO1B1*1, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	*15
rosuvastatin	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*15	Metabolism/PK	decreased	LADME	Healthy		C10AA07	*15/*15
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	*2/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	*3/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	*2/*3
atorvastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA05	*15/*15
atorvastatin	SLCO1B1*1, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15	Metabolism/PK	increased	LADME	Other:C0020443		C10AA05	*15
atrasentan	SLCO1B1*1, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	No_ATC	*15/*15
atrasentan	SLCO1B1*1, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*1/*15	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	No_ATC	*1/*15
atrasentan	SLCO1B1*1, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*37	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	No_ATC	*15/*37
atrasentan	SLCO1B1*1, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*14/*37	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	No_ATC	*14/*37
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB10	*1/*17
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB10	*17/*17
3,4-dehydrocilostazol	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:C0007785		B01AC23|V04CX05	*1/*1
3,4-dehydrocilostazol	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:C0007785		B01AC23|V04CX05	*1/*3
beta blocking agents	rs61767072	ADRA2C	del	Efficacy	increased	Efficacy_Response	Other:C0878544|Dilated		S01ED	rs61767072:del
hydroxybupropion(bupropion)	CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*3	Metabolism/PK	increased	LADME	Healthy		N05AX12	*3
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4	Metabolism/PK	increased	LADME	Healthy		N05AX12	*4
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4xN	Metabolism/PK	increased	LADME	Healthy		N05AX12	*4xN
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*5	Metabolism/PK	increased	LADME	Healthy		N05AX12	*5
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*6	Metabolism/PK	increased	LADME	Healthy		N05AX12	*6
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*10	Metabolism/PK	increased	LADME	Healthy		N05AX12	*10
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*41	Metabolism/PK	increased	LADME	Healthy		N05AX12	*41
atomoxetine	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C1263846	intermediate metabolizer and poor metabolizer	N06BA09	__UNKNOWN__
docetaxel, thalidomide	rs1402467	SULT1C4	G	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs1402467:G
atomoxetine	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Dosage	decreased	Dosage	Other:C1263846	intermediate metabolizer and poor metabolizer	N06BA09	__UNKNOWN__
atomoxetine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	increased	LADME	Other:C1263846		N06BA09	*2
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*17	CYP2D6	*17	Metabolism/PK	increased	LADME	Healthy		No_ATC	*17
amitriptyline, clomipramine	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Other	increased	Adverse_Event	Other:C0005586		N06AA04|N06AA09	*17/*17
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*2	Dosage	decreased	Dosage	Other:C0023449	intermediate metabolizer	L01BB02	*1/*2
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*3	Dosage	decreased	Dosage	Other:C0023449	intermediate metabolizer	L01BB02	*1/*3
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*5	Dosage	decreased	Dosage	Other:C0023449	intermediate metabolizer	L01BB02	*1/*5
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*6	Dosage	decreased	Dosage	Other:C0023449	intermediate metabolizer	L01BB02	*1/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1
brexpiprazole	CYP2D6*1, CYP2D6*2	CYP2D6	*2	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*2
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*9	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*9
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*10
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*14	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*14
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*17	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*17
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*29	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*29
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*41	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*41
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*3
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*1/*5
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*1/*10
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*5	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*2/*5
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*10	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*2/*10
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*5/*10
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*10/*10
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
venlafaxine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX16	
venlafaxine	SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531T/L allele-rs25531T	Efficacy	increased	Efficacy_Response	Other:C0003469		N06AX16	
venlafaxine	SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531T/L allele-rs25531T	Efficacy	decreased	Efficacy_Response	Other:C0235876		N06AX16	
methotrexate	rs717620	ABCC2	CT	Toxicity	decreased	Adverse_Event	Side_Effect:C0003873		L04AX03	rs717620:CT
methotrexate	rs717620	ABCC2	TT	Toxicity	decreased	Adverse_Event	Side_Effect:C0003873		L04AX03	rs717620:TT
ketorolac	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		S01BC05	*2
ketorolac	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		S01BC05	*3
tramadol	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N02AX02	*4
fluorouracil, leucovorin, oxaliplatin	rs3212948	ERCC1	C	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs3212948:C
sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Other:C0030319		N06AB06	
endoxifen	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	decreased	LADME	Other:C1458155		No_ATC	*22/*22
midazolam	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:C0027651		N05CD08	*1/*1
midazolam	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:C0027651		N05CD08	*1/*3
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*17, CYP2D6*29	CYP2D6	*17/*29	Metabolism/PK	decreased	LADME	Other:C1458155	poor metabolizer	No_ATC	*17/*29
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*17, CYP2D6*29	CYP2D6	*17/*17	Metabolism/PK	decreased	LADME	Other:C1458155	poor metabolizer	No_ATC	*17/*17
liraglutide	rs10305420	GLP1R	TT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ02	rs10305420:TT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*3
oxycodone	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AA05	__UNKNOWN__
oxycodone	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AA05	__UNKNOWN__
oxycodone	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	decreased	LADME	Healthy		N02AA05	*22
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	*1/*3
gliclazide	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	A10BB09	__UNKNOWN__
fluvastatin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		C10AA04	*1/*3
bevacizumab, cyclophosphamide	rs4073	CXCL8	AA	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01AA01|L01FG01	rs4073:AA
bevacizumab, cyclophosphamide	rs4073	CXCL8	AT	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01AA01|L01FG01	rs4073:AT
nicotine	CYP2A6*1, CYP2A6*4	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*4
n-desmethylclozapine(clozapine)	low activity	CYP3A4	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0036341	low activity	N05AH02	__UNKNOWN__
dihydropyridine derivatives	rs776746	CYP3A5	TT	Other	increased	Adverse_Event	Healthy		C08CA	rs776746:TT
n-desmethylclozapine(clozapine)	low activity	CYP1A2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0036341	low activity	N05AH02	__UNKNOWN__
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*35	CYP2A6	*1/*35	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*35
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*35	CYP2A6	*9/*35	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*35
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*35	CYP2A6	*17/*35	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*17/*35
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*2
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*4
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*9
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*1/*12	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*12
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*4/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*9
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*9
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*9/*12	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*12
disulfiram	deficiency	ALDH2	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0085762	deficiency	N07BB01	
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*4
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*1/*7	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*7
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*9
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*10
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*4
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*7/*7	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*7/*7
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*9
nicotine	CYP2A6*1, CYP2A6*46	CYP2A6	*1/*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*1/*46
nicotine	CYP2A6*1, CYP2A6*46	CYP2A6	*46/*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*46/*46
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*2
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*4
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*17
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*20	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*20
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*23	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*23
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*24	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*24
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*25	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*25
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*26	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*26
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*27	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*27
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*28	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*28
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*35	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*35
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*9
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*17/*17	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*17/*17
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*20/*20	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*20/*20
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*35/*35	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*35/*35
rosuvastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15/*15	Metabolism/PK	decreased	LADME	Healthy		C10AA07	*15/*15
fluvastatin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		C10AA04	*1/*3
pitavastatin	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA08	*15/*15
pitavastatin	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*37	Metabolism/PK	increased	LADME	Healthy		C10AA08	*15/*37
warfarin	rs11150606	VKORC1	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs11150606:C
pitavastatin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		C10AA08	*1/*3
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*14, CYP2A6*38, CYP2A6*46	CYP2A6	*1	Metabolism/PK	increased	LADME	Healthy		N07BA01	*1
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*14, CYP2A6*38, CYP2A6*46	CYP2A6	*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*46
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*14, CYP2A6*38, CYP2A6*46	CYP2A6	*9	Metabolism/PK	increased	LADME	Healthy		N07BA01	*9
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*14, CYP2A6*38, CYP2A6*46	CYP2A6	*14	Metabolism/PK	increased	LADME	Healthy		N07BA01	*14
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*14, CYP2A6*38, CYP2A6*46	CYP2A6	*38	Metabolism/PK	increased	LADME	Healthy		N07BA01	*38
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*12, CYP2A6*38, CYP2A6*46	CYP2A6	*1	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*12, CYP2A6*38, CYP2A6*46	CYP2A6	*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*12, CYP2A6*38, CYP2A6*46	CYP2A6	*12	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*12
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*12, CYP2A6*38, CYP2A6*46	CYP2A6	*38	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*38
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
oxaliplatin	rs1801131	MTHFR	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1801131:GG
oxaliplatin	rs1801131	MTHFR	GT	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1801131:GT
alprazolam	low activity	CYP3A4	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0085762|Other:C0003469	low activity	N05BA12	__UNKNOWN__
tacrolimus	rs2242480	CYP3A4	C/C	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs2242480:C/C
tacrolimus	rs2242480	CYP3A4	C/C	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs2242480:C/C
tacrolimus	rs2242480	CYP3A4	C/T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:C/T
tacrolimus	rs2242480	CYP3A4	T/T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:T/T
tacrolimus	rs2242480	CYP3A4	C/C	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:C/C
fentanyl	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs2242480:T/T
endoxifen	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C1458155	intermediate metabolizer	No_ATC	__UNKNOWN__
tacrolimus	intermediate metabolizer and normal metabolizer	CYP3A5	__UNKNOWN__	Dosage	increased	Dosage	Other:Kidney_Transplantation	normal metabolizer and intermediate metabolizer	L04AD02	__UNKNOWN__
diclofenac	CYP2C9*1, CYP2C9*3, CYP2C9*8	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		S01BC03	*1/*3
diclofenac	CYP2C9*1, CYP2C9*3, CYP2C9*8	CYP2C9	*1/*8	Metabolism/PK	decreased	LADME	Healthy		S01BC03	*1/*8
clozapine	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Disease:C0036341		N05AH02	rs2231142:GT
clozapine	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0036341		N05AH02	rs2231142:TT
dolutegravir	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AJ03	*28/*28
dolutegravir	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AJ03	*6/*6
aspirin, clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Other:percutaneous_coronary_interventions_and_drug-eluting_stents		B01AC04	rs4244285:AA
aspirin, clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Other:percutaneous_coronary_interventions_and_drug-eluting_stents		B01AC04	rs4244285:AG
levomethadone	CYP2B6*1, CYP2B6*6, CYP2B6*7, CYP2B6*9, CYP2B6*18	CYP2B6	*6	Metabolism/PK	decreased	LADME	Other:C0036439		N07BC05	*6
levomethadone	CYP2B6*1, CYP2B6*6, CYP2B6*7, CYP2B6*9, CYP2B6*18	CYP2B6	*7	Metabolism/PK	decreased	LADME	Other:C0036439		N07BC05	*7
levomethadone	CYP2B6*1, CYP2B6*6, CYP2B6*7, CYP2B6*9, CYP2B6*18	CYP2B6	*9	Metabolism/PK	decreased	LADME	Other:C0036439		N07BC05	*9
levomethadone	CYP2B6*1, CYP2B6*6, CYP2B6*7, CYP2B6*9, CYP2B6*18	CYP2B6	*18	Metabolism/PK	decreased	LADME	Other:C0036439		N07BC05	*18
mercaptopurine, thioguanine	TPMT*1, TPMT*3C	TPMT	*1/*3C	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*3C
mercaptopurine, thioguanine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*3A
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7	CYP2A6	*4/*4	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*4
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7	CYP2A6	*4/*7	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*7
hydralazine	rapid acetylator	NAT2	__UNKNOWN__	Dosage, Efficacy	increased	Dosage	Other:C0020538	rapid acetylator	C02DB02	__UNKNOWN__
warfarin	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Dosage	decreased	Dosage	Other:C0004238		B01AA03	*1/*13
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	"""Other:C0023449|""Other:C0024299|""Other:C0023418|Myeloid|Acute"""	poor metabolizer	J02AC03	*2/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	"""Other:C0023449|""Other:C0024299|""Other:C0023418|Myeloid|Acute"""	poor metabolizer	J02AC03	*2/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	"""Other:C0023449|""Other:C0024299|""Other:C0023418|Myeloid|Acute"""	poor metabolizer	J02AC03	*3/*3
rosuvastatin	rs11045854	SLCO1B1	A	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs11045854:A
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__
venlafaxine	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Elderly_Adult	intermediate metabolizer	N06AX16	__UNKNOWN__
escitalopram	intermediate metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Elderly_Adult	intermediate metabolizer	N06AB10	__UNKNOWN__
somatropin recombinant	rs1800012	COL1A1	AA	Dosage	decreased	Dosage	Other:C0853662		H01AC01	rs1800012:AA
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*1/*17	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*1/*17
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*20/*23	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*20/*23
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*9/*9
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*1/*4
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*1/*2
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*17/*17	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*17/*17
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*17/*35	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*17/*35
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*2/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*2/*9
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*9/*12	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*9/*12
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*1/*9
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*1/*12	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*1/*12
nicotine	CYP2A6*1, CYP2A6*46	CYP2A6	*1/*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*1/*46
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*2
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*4
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*9
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*12	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*12
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*17	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*17
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*20	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*20
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*23	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*23
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*24	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*24
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*25	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*25
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*26	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*26
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*27	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*27
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*28	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*28
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*35	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*35
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*9/*9
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*17/*17	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*17/*17
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*20/*20	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*20/*20
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*35/*35	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*35/*35
vitamin b-complex, incl. combinations	rs1801133	MTHFR	A	Efficacy	increased	Efficacy_Response	Other:C0011581		A11E|S02DA30	rs1801133:A
rosuvastatin	rs2306283	SLCO1B1	GG	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2306283:GG
warfarin	rs2359612	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:A
vitamin b-complex, incl. combinations	rs1801131	MTHFR	G	Efficacy	increased	Efficacy_Response	Other:C0011581		A11E|S02DA30	rs1801131:G
atomoxetine	rs12708954	SLC6A2	A	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA09	rs12708954:A
cyclosporine, tacrolimus	rs2740574	CYP3A4	C	Metabolism/PK	decreased	LADME	Side_Effect:Kidney_Transplantation		L04AD01|L04AD02	rs2740574:C
rosuvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs4149056:CC
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC
rizatriptan	rs6275	DRD2	AA	Efficacy	decreased	Efficacy_Response	Other:C0338480		N02CC04	rs6275:AA
rizatriptan	rs6275	DRD2	AG	Efficacy	decreased	Efficacy_Response	Other:C0338480		N02CC04	rs6275:AG
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
warfarin	rs61162043	VKORC1	G	Dosage	increased	Dosage	Healthy		B01AA03	rs61162043:G
sulfonamides, urea derivatives	rs1057910	CYP2C9	CC	Efficacy	increased	Efficacy_Response	Healthy		S01AB	rs1057910:CC
nicotine	rs1799971	OPRM1	AG	Efficacy	decreased	Efficacy_Response	Other:C0039338		N07BA01	rs1799971:AG
nicotine	rs1799971	OPRM1	GG	Efficacy	decreased	Efficacy_Response	Other:C0039338		N07BA01	rs1799971:GG
risperidone	rs6280	DRD3	CC	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs6280:CC
risperidone	rs6280	DRD3	CT	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs6280:CT
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT
rosuvastatin	rs16980091	FOXA3	T	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs16980091:T
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
rosuvastatin	rs34671512	SLCO1B1	C	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs34671512:C
sirolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
cysteamine	rs113993960	CFTR	CTT/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		No_ATC	rs113993960:CTT/del
cysteamine	rs113993960	CFTR	del/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		No_ATC	rs113993960:del/del
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0030319		N06AB10	*2/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0030319		N06AB10	*2/*3
dextropropoxyphene	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		N02AC04	*3/*3
felodipine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		C08CA02	*3/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0277631		L04AX01	*1/*3A
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Dosage	decreased	Dosage	Disease:C0277631		L04AX01	*1/*3C
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*3
codeine	CYP2D6*17	CYP2D6	*17	Metabolism/PK	decreased	LADME	Disease:C0002895		R05DA04	*17
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC04	*2/*2
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC04	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
pantoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Healthy		A02BC02	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*1/*17
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*17/*17
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*3
pantoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*2/*2
pantoprazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Metabolism/PK	increased	LADME	Healthy		A02BC02	*17
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA03	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
aripiprazole	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*4
aripiprazole	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*5
aripiprazole	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*6
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC04	*1/*1
lansoprazole, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01|A02BC03	*1/*1
lansoprazole, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01|A02BC03	*1/*17
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*1/*17
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*17/*17
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*1/*2
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC02	*1/*1
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Healthy		A02BC02	*1/*17
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
anthracyclines and related substances, capecitabine, cyclophosphamide, fluorouracil, taxanes	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01BC06|L01CD|L01DB	
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0017168		A02BC03	*2/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0017168		A02BC03	*2/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
tolperisone	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4	Metabolism/PK	increased	LADME	Healthy		No_ATC	*4
tolperisone	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*5	Metabolism/PK	increased	LADME	Healthy		No_ATC	*5
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC03	*1/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC03	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC03	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6
mianserin	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Disease:C0235876		N06AX03	*1/*10
mianserin	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0235876		N06AX03	*5/*10
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		L04AD02	*3/*3
salvianolic acid b	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Other:C0010068		No_ATC	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
mephenytoin	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*1/*2
mephenytoin	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*2/*2
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
valproic acid	UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8	UGT1A6	*1a	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N03AG01	*1a
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0026896		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0026896		L04AD02	*3/*3
mephenytoin, omeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01|N03AB02	*1/*2
valproic acid	UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8	UGT1A6	*1a	Dosage	decreased	Dosage	Disease:C0014544		N03AG01	*1a
warfarin	CYP2C9*1, CYP2C9*8	CYP2C9	*8/*8	Dosage	decreased	Dosage	Healthy		B01AA03	*8/*8
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
cyclosporine	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
sirolimus, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*3
selective serotonin reuptake inhibitors	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Dosage	decreased	Dosage	Disease:C0235876		N06AB	*4/*4
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
tacrolimus	CYP3A4*1, CYP3A4*18	CYP3A4	*18	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*18
tramadol	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Dosage, Efficacy	increased	Dosage	Other:C0030193|Postoperative		N02AX02	*10/*10
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*3
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*4
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*5
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*6
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*3	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*3/*3
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*4
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*5
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*10
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*41
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*41	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*5/*41
endoxifen	normal metabolizer and ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C1458155	normal metabolizer and ultrarapid metabolizer	No_ATC	__UNKNOWN__
imipramine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA02	*2
o-desmethyltramadol	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0024031|Disease:C0022408	poor metabolizer	N02AX02	__UNKNOWN__
rasagiline	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		N04BD02	rs1045642:AA
rasagiline	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		N04BD02	rs1045642:AG
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	
isoniazid	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	__UNKNOWN__
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10	
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	*1/*2
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
omeprazole, pantoprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01|A02BC02|A02BC04	*1/*2
corticosteroids	rs3842689	NR1I2	del/del	Efficacy	increased	Efficacy_Response	Healthy		S02BA	rs3842689:del/del
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11322783:GG
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3
voriconazole	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0026946	intermediate metabolizer and poor metabolizer	J02AC03	__UNKNOWN__
mephenytoin, omeprazole	CYP2C19*1, CYP2C19*26	CYP2C19	*26	Metabolism/PK	decreased	LADME	Healthy		A02BC01|N03AB02	*26
irbesartan	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA04	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*3
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*4
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*5
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*6
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB10	*1/*17
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB10	*17/*17
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*2	Metabolism/PK	increased	LADME	Healthy		N06AB10	*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*3	Metabolism/PK	increased	LADME	Healthy		N06AB10	*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*4	Metabolism/PK	increased	LADME	Healthy		N06AB10	*4
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
sipoglitazar	UGT2B15*1, UGT2B15*2	UGT2B15	*2/*2	Efficacy, Metabolism/PK	increased	Efficacy_Response	Healthy		No_ATC	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	
nortriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*2/*2
nortriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*2/*3
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*6/*9	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB06	*6/*9
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*1/*6	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB06	*1/*6
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB06	*6/*6
metformin	rs72552763	SLC22A1	del/del	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs72552763:del/del
venlafaxine	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		N06AX16	*10/*10
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Disease:C0018839		B01AC04	*2
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*22
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C0079102		B01AA07	*2
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C0079102		B01AA07	*3
tacrolimus	CYP3A5*1	CYP3A5	*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB06	*2/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB06	*2/*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB06	*1/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB06	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0018839		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0018839		B01AC04	*2/*2
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*3/*4
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*4
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*2/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*2/*2
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*4
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*3/*4
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*5
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*6
morphine	rs72552763	SLC22A1	GAT/del	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs72552763:GAT/del
morphine	rs72552763	SLC22A1	del/del	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs72552763:del/del
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*41
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*10
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*17	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*17
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*5/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5/*41
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*4
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*2/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*4
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*5
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*3
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*2/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*5
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*6
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*2/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*3
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*2/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*6
imatinib	GSTT1 non-null, GSTT1 null	GSTT1	null/null	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	
glucocorticoids	rs1047303	HSD3B1	AA	Efficacy	increased	Efficacy_Response	Other:C0004096		R03BA	rs1047303:AA
glucocorticoids	rs1047303	HSD3B1	AC	Efficacy	increased	Efficacy_Response	Other:C0004096		R03BA	rs1047303:AC
lansoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC03	*2/*2
esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02|A02BC03|A02BC04|A02BC05	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Healthy		A02BC03	*17/*17
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*17/*17
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*3/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*3/*9
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*4
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*5
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*10
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*41
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*5/*17	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5/*17
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*5/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5/*41
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*41/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*41/*41
simvastatin	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	Indeterminado	LADME	Healthy		C10AA01	*1/*22
simvastatin	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	Indeterminado	LADME	Healthy		C10AA01	*22/*22
morphine	rs72552763	SLC22A1	del/del	Metabolism/PK	decreased	LADME	Other:adenotonsillectomy		N02AA01	rs72552763:del/del
methotrexate	SLCO1B1*1, SLCO1B1*5, SLCO1B1*37	SLCO1B1	*5	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	*5
nortriptyline	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*10/*10
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC04	*2/*2
fluvoxamine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:C0040435		N06AB05|N06AB08	
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*2
sildenafil	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:C0085605		G04BE03	*1/*22
efavirenz	CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3A
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*28/*28
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*1/*28
efavirenz	CYP2B6*6	CYP2B6	*6	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	*6
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC02	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/3	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC02	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/3
bilirubin	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*1/*6
bilirubin	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*6/*6
methadone	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Healthy		N07BC02	*1/*2
methadone	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		N07BC02	*1/*3
bilirubin	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*1/*28
bilirubin	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*28/*28
methadone	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		N07BC02	*3/*3
methadone	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		N07BC02	*1/*2
methadone	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		N07BC02	*1/*3
losartan	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		C09CA01	*1/*3
methotrexate	SLCO1B1*1, SLCO1B1*14, SLCO1B1*37	SLCO1B1	*14	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	*14
warfarin	CYP2C9*1	CYP2C9	*1/*1	Dosage, Metabolism/PK	increased	Dosage	Healthy		B01AA03	*1/*1
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*6/*6
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*1/*6
rosuvastatin	rs1805343	RXRA	A	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs1805343:A
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*1/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*3
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*3/*9	Dosage	decreased	Dosage	Disease:C0011581		N06AX16	*3/*9
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*17	Dosage	decreased	Dosage	Disease:C0011581		N06AX16	*4/*17
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*41	Dosage	decreased	Dosage	Disease:C0011581		N06AX16	*4/*41
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*10	Dosage	decreased	Dosage	Disease:C0011581		N06AX16	*4/*10
paclitaxel	CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Disease:C1458155		L01CD01	*3
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	Indeterminado	LADME	Healthy		N05BA09	*1/*1
bupropion	CYP2B6*4	CYP2B6	*4	Other, Metabolism/PK	increased	LADME	Healthy		N06AX12	*4
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
glatiramer acetate	rs333	CCR5	del	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AX13	rs333:del
warfarin	CYP2C9*1, CYP2C9*3, CYP2C9*13, CYP2C9*16, CYP2C9*60	CYP2C9	*1/*13	Dosage	decreased	Dosage	Other:C0004238		B01AA03	*1/*13
warfarin	CYP2C9*1, CYP2C9*3, CYP2C9*13, CYP2C9*16, CYP2C9*60	CYP2C9	*1/*16	Dosage	decreased	Dosage	Other:C0004238		B01AA03	*1/*16
warfarin	CYP2C9*1, CYP2C9*3, CYP2C9*13, CYP2C9*16, CYP2C9*60	CYP2C9	*1/*60	Dosage	decreased	Dosage	Other:C0004238		B01AA03	*1/*60
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB06	*2/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB06	*2/*3
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*1	Metabolism/PK	Indeterminado	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0004096	poor metabolizer	A02BC03	*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*3	Metabolism/PK	decreased	LADME	Disease:C0004096	poor metabolizer	A02BC03	*3
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*8	Metabolism/PK	decreased	LADME	Disease:C0004096	poor metabolizer	A02BC03	*8
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*9	Metabolism/PK	decreased	LADME	Disease:C0004096	poor metabolizer	A02BC03	*9
glipizide	rs7903146	TCF7L2	T	Efficacy	increased	Efficacy_Response	Healthy		A10BB07	rs7903146:T
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C0007282		B01AC04	*2
clopidogrel	rs12456693	SLC14A2	T	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs12456693:T
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
cisplatin, fluorouracil	TPMT*3C	TPMT	*3C	Efficacy	decreased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		L01BC02|L01XA01	*3C
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
cavosonstat	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		No_ATC	rs113993960:del/del
bupropion	CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*2/*2
risperidone	CYP2D6*5, CYP2D6*10	CYP2D6	*10	Metabolism/PK	increased	LADME	Disease:C0036341		N05AX08	*10
risperidone	CYP2D6*5, CYP2D6*10	CYP2D6	*5	Metabolism/PK	increased	LADME	Disease:C0036341		N05AX08	*5
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2	Metabolism/PK	increased	LADME	Healthy		J02AC03	*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3	Metabolism/PK	increased	LADME	Healthy		J02AC03	*3
zuclopenthixol	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AF05	*4
nevirapine	rs3842689	NR1I2	GAGAAG/del	Dosage, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3842689:GAGAAG/del
nevirapine	rs3842689	NR1I2	del/del	Dosage, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3842689:del/del
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*4/*4
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*4/*5
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*3/*4
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*4/*6
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*3/*5	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*3/*5
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*4xN	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*4/*4xN
tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		N02AX02	*10/*10
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
voriconazole	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		J02AC03	rs1045642:AA
ivacaftor / lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX30	rs113993960:del/del
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*1
midazolam	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		N05CD08	*1/*22
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	*6
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	*28
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
telmisartan	UGT1A3*1, UGT1A3*3	UGT1A3	*3	Metabolism/PK	decreased	LADME	Healthy		C09CA07	*3
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Dosage	decreased	Dosage	Disease:C0277631		L04AD02	*1/*22
ivacaftor / lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX30	rs113993960:del/del
haloperidol	CYP2D6*1, CYP2D6*5	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*5
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:C0009324		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0009324		L04AD02	*1/*3
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AG
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*8	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*1/*8
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*2/*3
measles vaccines	HLA-B*51:01	HLA-B	*51:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	*51:01
bucindolol	rs61767072	ADRA2C	GGGGCGGGGCCG/GGGGCGGGGCCG	Efficacy	increased	Efficacy_Response	Disease:C0085605		No_ATC	rs61767072:GGGGCGGGGCCG/GGGGCGGGGCCG
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
risperidone	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Dosage	decreased	Dosage	Disease:C0033975	intermediate metabolizer and poor metabolizer	N05AX08	__UNKNOWN__
measles vaccines	HLA-B*07:02	HLA-B	*07:02	Efficacy	increased	Efficacy_Response	Healthy		J07BD	*07:02
measles vaccines	HLA-B*13:01	HLA-B	*13:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	*13:01
measles vaccines	HLA-B*08:01	HLA-B	*08:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	*08:01
rosuvastatin	rs7579275	ABCB11	G	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs7579275:G
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
influenza vaccines	HLA-DQB1*03:03	HLA-DQB1	*03:03	Efficacy	decreased	Efficacy_Response	Healthy		J07BB	*03:03
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*3
omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC04	*1/*1
measles vaccines	HLA-DQA1*02:01	HLA-DQA1	*02:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	*02:01
measles vaccines	HLA-DRB1*03:01	HLA-DRB1	*03:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	*03:01
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A4*1, CYP3A4*20	CYP3A4	*1/*20	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*20
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*22
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Healthy		L04AD02	*22/*22
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1
fluorouracil	poor metabolizer	DPYD	__UNKNOWN__	Dosage	decreased	Dosage	Disease:C0023055|Disease:C0017185|Disease:C0022665	poor metabolizer	L01BC02	__UNKNOWN__
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6
esomeprazole, lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04|A02BC05	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3
esomeprazole, lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04|A02BC05	*1/*2
esomeprazole, lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04|A02BC05	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:heart_transplantation		L04AD02	*1/*3
cisplatin, fluorouracil	TPMT*3B	TPMT	*3B	Efficacy	decreased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		L01BC02|L01XA01	*3B
esomeprazole, lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04|A02BC05	*1/*1
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	*2
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Other:heart_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:heart_transplantation		L04AD02	*1/*3
rosuvastatin	rs2287622	ABCB11	G	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2287622:G
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*1/*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*1/*3
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*2/*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*3/*3
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*2/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:C0009324		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0009324		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3
amitriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA09	*4/*5
amitriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA09	*4/*4
sirolimus, temsirolimus	rs1128503	ABCB1	GG	Metabolism/PK	decreased	LADME	Disease:C0877645		L01EG01	rs1128503:GG
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*3
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		N07BC02	*6/*6
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*3
granisetron	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Healthy		A04AA02	*3/*3
codeine	CYP2D6*1, CYP2D6*40	CYP2D6	*40	Efficacy	decreased	Efficacy_Response	Disease:C0002895		R05DA04	*40
codeine	CYP2D6*1, CYP2D6*17	CYP2D6	*17	Efficacy	decreased	Efficacy_Response	Disease:C0002895		R05DA04	*17
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Other	increased	Adverse_Event	Disease:C0003873		L04AD02	*1/*1
codeine	CYP2D6*1, CYP2D6*6	CYP2D6	*6	Efficacy	decreased	Efficacy_Response	Disease:C0002895		R05DA04	*6
codeine	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Efficacy	decreased	Efficacy_Response	Disease:C0002895		R05DA04	*4
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*1/*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*1/*3
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*2/*17
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*3/*17
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*2/*2
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*2/*3
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*3/*3
codeine	CYP2D6*1, CYP2D6*5	CYP2D6	*5	Efficacy	decreased	Efficacy_Response	Disease:C0002895		R05DA04	*5
granisetron	CYP1A1*1, CYP1A1*2A	CYP1A1	*2A	Metabolism/PK	increased	LADME	Healthy		A04AA02	*2A
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0003873		L04AD02	*3/*3
clomipramine	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0004936		N06AA04	*2/*2
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
hmg coa reductase inhibitors	UGT1A1*28	UGT1A1	*28	Toxicity	decreased	Adverse_Event	Disease:C0020473		C10AA	*28
rocuronium	rs7967354	SLCO1A2	CC	Dosage	decreased	Dosage	Healthy		M03AC09	rs7967354:CC
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA04	*1/*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA04	*2/*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA04	*1/*3
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA04	*2/*3
rosuvastatin	rs8187692	ABCC2	A	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs8187692:A
nortriptyline	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA10	*3
nortriptyline	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA10	*4
nortriptyline	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA10	*5
nortriptyline	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA10	*6
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*2/*2
capecitabine, fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC02|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
capecitabine, fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/CCGCGC(CACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC02|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/CCGCGC(CACTTGGCCTGCCTCCGTCCCG)3
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0004936		N06AA09	*2
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*1/*1
fentanyl	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Healthy		N02AB03	*1/*22
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1
carvedilol	CYP2D6*3, CYP2D6*4, CYP2D6*10	CYP2D6	*3/*10	Dosage	increased	Dosage	Disease:C0085605		C07AG02	*3/*10
carvedilol	CYP2D6*3, CYP2D6*4, CYP2D6*10	CYP2D6	*4/*4	Dosage	increased	Dosage	Disease:C0085605		C07AG02	*4/*4
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*1/*2
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*3
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*3
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*2/*2
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*2/*3
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*3/*3
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11322783:TT/TT
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC03	*2/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC03	*2/*3
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC03	*3/*3
voriconazole	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	increased	LADME	Healthy		J02AC03	*22
haloperidol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N05AD01	*4/*4
rosuvastatin	rs56903885	SLC10A1	T	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs56903885:T
vitamin k1	CYP4F2*1, CYP4F2*3	CYP4F2	*1/*3	Metabolism/PK	increased	LADME	Healthy		B02BA	*1/*3
vitamin k1	CYP4F2*1, CYP4F2*3	CYP4F2	*3/*3	Metabolism/PK	increased	LADME	Healthy		B02BA	*3/*3
tropisetron	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A04AA03	*10/*10
tropisetron	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A04AA03	*5/*10
bumetanide, furosemide, torasemide	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs1799752:del/del
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		J02AC03	*2/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy		J02AC03	*2/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Healthy		J02AC03	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0009324		L04AD02	*3/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		J02AC03	*1/*3
tropisetron	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		A04AA03	*1/*10
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0004936		N06AA09	*2
imipramine	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA02	*2/*2
imipramine	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA02	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*2
morphine	low activity	SLC22A1	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	low activity	N02AA01	
varenicline	normal metabolizer	CYP2A6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C0039338	normal metabolizer	N07BA03	__UNKNOWN__
azathioprine	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Metabolism/PK	increased	Dosage	Disease:C0021390		L04AX01	
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*3
raloxifene	UGT1A8*1a, UGT1A8*2, UGT1A8*3	UGT1A8	*1a/*3	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	G03XC01	*1a/*3
phenazepam	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Efficacy	decreased	Efficacy_Response	Other:C0085762|Other:C0003469		No_ATC	*17
warfarin	CYP2C9*1, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5
warfarin	CYP2C9*1, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*6	Dosage	decreased	Dosage	Healthy		B01AA03	*6
warfarin	CYP2C9*1, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11
rosuvastatin	rs12721616	NR1I2	T	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs12721616:T
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
dimethyl fumarate	rs1695	GSTP1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AX07	rs1695:GG
celecoxib	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*3/*3
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0011581	intermediate metabolizer	N06AX16	*1/*3
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C0011581	intermediate metabolizer	N06AX16	*1/*4
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C0011581	intermediate metabolizer	N06AX16	*1/*5
rosuvastatin	rs11045874	SLCO1B1	C	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs11045874:C
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0009324		L04AD02	*3/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
celecoxib	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*3/*3
celecoxib	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*1/*3
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10	
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Other	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3A
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Other	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3C
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Other	increased	Adverse_Event	Disease:C0023449		L01BB02	*3A/*3A
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, CYP2C9*11	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, CYP2C9*11	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, CYP2C9*11	CYP2C9	*8	Dosage	decreased	Dosage	Healthy		B01AA03	*8
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11
o-desmethyltramadol	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0024031|Disease:C0022408	ultrarapid metabolizer	N02AX02	__UNKNOWN__
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*4/*41
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*6	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*5/*6
clopidogrel	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	Indeterminado	LADME	Healthy	intermediate metabolizer	B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*3
tamoxifen	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*2
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
acenocoumarol	CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	*3
doxepin	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*4/*4
doxepin	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*3/*5
doxepin	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*4/*5
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*9	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*9
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*4
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*41
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*4	Metabolism/PK	increased	LADME	Healthy		No_ATC	*2/*4
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*5
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*10	Metabolism/PK	increased	LADME	Healthy		No_ATC	*2/*10
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*41
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*3	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*3
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*4	Metabolism/PK	increased	LADME	Healthy		No_ATC	*2/*4
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*4
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*1xN/*9	Metabolism/PK	increased	LADME	Healthy		N06AA12	*1xN/*9
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*1xN/*10	Metabolism/PK	increased	LADME	Healthy		N06AA12	*1xN/*10
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*1xN/*41	Metabolism/PK	increased	LADME	Healthy		N06AA12	*1xN/*41
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*2xN/*41	Metabolism/PK	increased	LADME	Healthy		N06AA12	*2xN/*41
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*1xN/*1	Metabolism/PK	increased	LADME	Healthy		N06AA12	*1xN/*1
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*2xN/*1	Metabolism/PK	increased	LADME	Healthy		N06AA12	*2xN/*1
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*1xN/*35	Metabolism/PK	increased	LADME	Healthy		N06AA12	*1xN/*35
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*2xN/*35	Metabolism/PK	increased	LADME	Healthy		N06AA12	*2xN/*35
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*35xN/*1	Metabolism/PK	increased	LADME	Healthy		N06AA12	*35xN/*1
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Other	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2
capecitabine, fluorouracil	rs11479	TYMP	AA	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs11479:AA
capecitabine, fluorouracil	rs11479	TYMP	AG	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs11479:AG
ustekinumab	HLA-C*06:02	HLA-C	*06:02	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	*06:02
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT
phenytoin	CYP2C19*2, CYP2C19*3	CYP2C19	*2	Dosage	Indeterminado	Dosage	Disease:C0014544		N03AB02	*2
phenytoin	CYP2C19*2, CYP2C19*3	CYP2C19	*3	Dosage	Indeterminado	Dosage	Disease:C0014544		N03AB02	*3
clozapine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele)/L allele-rs25531C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH02	
phenytoin	CYP2C9*3	CYP2C9	*3	Dosage	Indeterminado	Dosage	Disease:C0014544		N03AB02	*3
antipsychotics, haloperidol, olanzapine, risperidone	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A|N05AD01|N05AH03|N05AX08	
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*2
folic acid, hydroxychloroquine, methotrexate, sulfasalazine	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Efficacy_Response	Disease:C0003873		A07EC01|B03BB01|L04AX03|P01BA02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
ticagrelor	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Healthy		B01AC24	*1/*22
fluvastatin	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C10AA04	rs1799752:del/del
ondansetron	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	increased	LADME	Healthy		A04AA01	*1/*1xN
"""interferon alfa-2a, recombinant"", ""ribavirin"""	HLA-B*44:02	HLA-B	*44:02	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB04	*44:02
ondansetron, tropisetron	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Efficacy	decreased	Efficacy_Response	Disease:C0027651		A04AA01|A04AA03	*1/*1xN
cyclosporine, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD01|L04AD02	*1
pravastatin	rs1799752	ACE	del/del	Efficacy	Indeterminado	Efficacy_Response	Other:non-hypercholesterolaemic_patients_scheduled_for_angioplasty		C10AA03	rs1799752:del/del
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*2	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*2
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*3	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*4	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*4
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*6	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*6
efavirenz	CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6
efavirenz	CYP2B6*1, CYP2B6*18	CYP2B6	*1/*18	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*18
efavirenz	CYP2B6*1, CYP2B6*9	CYP2B6	*1/*9	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*9
fluoxetine, sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB06	
capecitabine, fluorouracil	rs3918290	DPYD	CT	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs3918290:CT
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*3/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2/*17
rosuvastatin	rs12305884	SLCO1B1	A	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs12305884:A
tamoxifen, endoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*10
levomethadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC05	*6/*6
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3
metoprolol	rs61767072	ADRA2C	del	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AB02	rs61767072:del
endoxifen	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:C1458155		No_ATC	*1/*22
endoxifen	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Disease:C1458155		No_ATC	*22/*22
imatinib	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs2231142:GT
imatinib	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs2231142:TT
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01	*2/*2
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*22
capecitabine, fluorouracil	rs67376798	DPYD	AT	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs67376798:AT
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*22
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC03	*2/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC03	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*2
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*22
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6/*6	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*6/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*7/*7	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*7/*7
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*6	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*3/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*7	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*3/*7
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6/*7	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*6/*7
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*22
vincristine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0023449		L01CA02	*1/*3
endoxifen	CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*9/*4	Metabolism/PK	increased	LADME	Disease:C1458155		No_ATC	*9/*4
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*4
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*5
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*6
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*9/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*9/*41
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*10/*10
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*41/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*41/*41
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA04	*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA04	*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*9
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*10
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*41
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3A
capecitabine, fluorouracil	rs75017182	DPYD	CG	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs75017182:CG
sirolimus, temsirolimus	rs6785049	NR1I2	GG	Metabolism/PK	increased	LADME	Disease:C0877645		L01EG01	rs6785049:GG
fluvastatin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Metabolism/PK	increased	LADME	Healthy		C10AA04	*3
nortriptyline	CYP2D6*1, CYP2D6*2xN, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*4/*4
nortriptyline	CYP2D6*1, CYP2D6*2xN, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*1/*4
nortriptyline	CYP2D6*1, CYP2D6*2xN, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*1/*5
rosuvastatin	rs11045873	SLCO1B1	A	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs11045873:A
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Laparoscopic_sleeve_gastrectomy		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Laparoscopic_sleeve_gastrectomy		L04AD02	*1/*3
tacrolimus	rs4646458	__INTRONIC__	G	Dosage	Indeterminado	Dosage	Disease:Kidney_Transplantation		L04AD02	rs4646458:G
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*2	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*2/*2
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*10	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*2/*10
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*3	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*1/*3
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*4	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*1/*4
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*4	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*2/*4
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*5/*10
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*4	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*4/*4
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*3/*4	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*3/*4
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*1
rocuronium	rs11045995	IAPP, SLCO1A2	CC	Dosage	decreased	Dosage	Healthy		M03AC09	rs11045995:CC
measles vaccines	HLA-B*44:02	HLA-B	*44:02	Efficacy	Indeterminado	Efficacy_Response	Healthy		J07BD	*44:02
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*3
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*6
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Laparoscopic_sleeve_gastrectomy		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Laparoscopic_sleeve_gastrectomy		L04AD02	*1/*3
metoprolol	rs5030655	CYP2D6	del/del	Efficacy	increased	Efficacy_Response	Healthy		C07AB02	rs5030655:del/del
amoxicillin, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|J01CA04	*1/*1
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	Indeterminado	Efficacy_Response	Healthy		M04AA01	*58:01
amoxicillin, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|J01CA04	*1/*2
amoxicillin, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|J01CA04	*1/*3
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3	NUDT15	*2/*3	Toxicity	decreased	Dosage	Disease:C0023449		L01BB02	*2/*3
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*2	Toxicity	decreased	Dosage	Disease:C0023449		L01BB02	*1/*2
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*3	Toxicity	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*5	Toxicity	decreased	Dosage	Disease:C0023449		L01BB02	*1/*5
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3
hmg coa reductase inhibitors	rs352046	CXCL5	CC	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA	rs352046:CC
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06AB05	*10/*10
amoxicillin, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|J01CA04	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28, UGT1A1*36	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03	*28/*28
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Disease:C0004238		B01AA03	*1/*3
celecoxib	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*1/*3
celecoxib	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*1/*13
celecoxib	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*3/*3
dextromethorphan, dextrorphan	rs5758651	TCF20	C	Metabolism/PK	increased	LADME	Healthy		R05DA09	rs5758651:C
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*6	Dosage	decreased	Dosage	Healthy		B01AA03	*6
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*9, CYP2C9*11	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*9, CYP2C9*11	CYP2C9	*6	Dosage	decreased	Dosage	Healthy		B01AA03	*6
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*9, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*9, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11
clopidogrel	CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2
cyclosporine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Healthy		L04AD01	*1/*1
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	Indeterminado	Dosage	Healthy		B01AA03	*1/*3
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*6, CYP2D6*8	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*4
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*6, CYP2D6*8	CYP2D6	*6	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*6
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*6, CYP2D6*8	CYP2D6	*8	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*8
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs11322783:TT/TT
metformin	rs2954625	CSMD1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2954625:CT
metformin	rs2954625	CSMD1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2954625:TT
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*28/*28
estrone	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*5/*5	Efficacy	increased	LADME	Other:C1458155		G03CA07	*5/*5
voriconazole	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		J02AC03	rs1045642:AA
mercaptopurine	rs72846714	NT5C2	AA	Metabolism/PK	decreased	LADME	Other:C0023449		L01BB02	rs72846714:AA
mercaptopurine	rs72846714	NT5C2	AG	Metabolism/PK	decreased	LADME	Other:C0023449		L01BB02	rs72846714:AG
bupropion	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	increased	LADME	Healthy		N06AX12	*2
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*1/*6
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6/*6
haloperidol	CYP2D6*1, CYP2D6*2	CYP2D6	*2/*2	Metabolism/PK	increased	LADME	Disease:C0036341		N05AD01	*2/*2
cyclosporine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*3/*3
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	UGT1A1*60	UGT1A1	*60	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*60
warfarin	CYP2C9*1, CYP2C9*8	CYP2C9	*1/*8	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*8
warfarin	CYP2C9*1, CYP2C9*8	CYP2C9	*8/*8	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*8/*8
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*4
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*41/*4
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*41/*3
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*10/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*10/*4
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*9/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*9/*41
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*17/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*17/*41
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*41/*41
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*9/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*9/*5
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*29	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*29
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*2xN/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2xN/*4
sertraline	rs11188059	CYP2C18	GG	Metabolism/PK	decreased	LADME	Healthy		N06AB06	rs11188059:GG
simvastatin	CYP2D6*1, CYP2D6*14	CYP2D6	*14	Metabolism/PK	increased	LADME	Healthy		C10AA01	*14
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*4
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*7	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*7
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*9	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*9
donepezil	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0002395	poor metabolizer	N06DA02	*4/*4
donepezil	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Disease:C0002395	poor metabolizer	N06DA02	*4/*5
nicotine	high activity	CYP2A6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0039338	high activity	N07BA01	__UNKNOWN__
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*2	Dosage	decreased	Dosage	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*2
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3A
fentanyl	CYP2D6*1, CYP2D6*29	CYP2D6	*29	Metabolism/PK	decreased	LADME	Other:C0006434		N02AB03	*29
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*10x2	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*10x2	CYP2D6	*10/*10x2	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10x2
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*4
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*5
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*4
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*3
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*35/*4
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*6
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*35/*5
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*9/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*9/*5
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*41
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*41
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*35/*41
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*10
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*10
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*35/*10
levonorgestrel	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		G03AD01	rs3745274:GT
levonorgestrel	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		G03AD01	rs3745274:TT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
adalimumab	rs9828223	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AB04	rs9828223:T
dextromethorphan, dextrorphan	rs61740999	IP6K2	AG	Metabolism/PK	increased	LADME	Healthy		R05DA09	rs61740999:AG
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Other:C0023055		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
debrisoquine	CYP2D6*1, CYP2D6*29	CYP2D6	*29/*29	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*29/*29
debrisoquine	CYP2D6*1, CYP2D6*17, CYP2D6*29	CYP2D6	*17/*29	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*17/*29
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10	
progesterone	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		G03DA04	*1/*2
progesterone	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	LADME	Healthy		G03DA04	*2/*17
debrisoquine, metoprolol	CYP2D6*1, CYP2D6*2, CYP2D6*17	CYP2D6	*17/*17	Metabolism/PK	decreased	LADME	Healthy		C07AB02	*17/*17
donepezil	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	increased	LADME	Disease:C0002395	ultrarapid metabolizer	N06DA02	*1/*1xN
donepezil	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1xN/*1xN	Metabolism/PK	increased	LADME	Disease:C0002395	ultrarapid metabolizer	N06DA02	*1xN/*1xN
cyclophosphamide, fludarabine	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01|L01BB05	*1/*6
cyclophosphamide, fludarabine	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01|L01BB05	*6/*6
levonorgestrel	rs4803419	CYP2B6	CT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		G03AD01	rs4803419:CT
atorvastatin	rs12979860	IFNL3, IFNL4	CC	Efficacy	decreased	LADME	Healthy		C10AA05	rs12979860:CC
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	increased	Dosage	Healthy	poor metabolizer	B01AC04	*2
cilostazol	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Metabolism/PK	increased	LADME	Healthy		B01AC23	*2
cilostazol	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Metabolism/PK	increased	LADME	Healthy		B01AC23	*3
codeine, debrisoquine, dextromethorphan, metoprolol	CYP2D6*1, CYP2D6*5, CYP2D6*17	CYP2D6	*5/*17	Metabolism/PK	decreased	LADME	Healthy		C07AB02|R05DA04|R05DA09	*5/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*3
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	increased	LADME	Disease:C0027651		L01EX02	*1/*28
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	increased	LADME	Disease:C0027651		L01EX02	*28/*28
metoprolol	CYP2D6*1, CYP2D6*2, CYP2D6*29	CYP2D6	*29/*29	Metabolism/PK	decreased	LADME	Healthy		C07AB02	*29/*29
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
fluoxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	Dosage	Disease:C0014544		N05BA09	*1/*2
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	Dosage	Disease:C0014544		N05BA09	*1/*3
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	Dosage	Disease:C0014544		N05BA09	*2/*2
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	Dosage	Disease:C0014544		N05BA09	*2/*3
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	decreased	Dosage	Disease:C0014544		N05BA09	*3/*3
dextromethorphan	CYP2D6*1, CYP2D6*17	CYP2D6	*17	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*17
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*2/*2
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*2/*3
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*3/*3
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0017168		A02BC01	*2
atenolol, enalapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0178298		C07AB03|C09AA02	rs1799752:del/del
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3C
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*2	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*2
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3A
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*2/*2
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*2/*3
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*3/*3
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N05BA09	*2/*2
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N05BA09	*2/*3
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N05BA09	*3/*3
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
lopinavir	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AR10	*22/*22
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*1/*1
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0014544		N05BA09	*2/*2
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0014544		N05BA09	*2/*3
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0014544		N05BA09	*3/*3
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*4/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*9
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*9
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	J02AC03	*1/*1
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
efavirenz	rs3842	ABCB1	C	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs3842:C
clobazam	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*1/*2
captopril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Healthy		C09AA01	rs1799752:del/del
citalopram, fluoxetine	rs2227631	SERPINE1	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04	rs2227631:G
phenytoin	rs71486745	CYP2C9	GT/del	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AB02	rs71486745:GT/del
phenytoin	rs71486745	CYP2C9	del/del	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AB02	rs71486745:del/del
atenolol, hydrochlorothiazide, metoprolol	rs201279313	SLC25A31	TTA/del	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03|C07AB02|C07AB03	rs201279313:TTA/del
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Healthy		J02AC03	*1/*17
tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
captopril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA01	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*7
tamoxifen	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*17
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*1	Dosage	increased	Dosage	Healthy		B01AA03	*1/*1
tamoxifen	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:C1458155		L02BA01	*2
captopril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C0085605		C09AA01	rs1799752:del/del
mercaptopurine	rs58700372	CNNM2	CC	Metabolism/PK	decreased	LADME	Other:C0023449		L01BB02	rs58700372:CC
mercaptopurine	rs58700372	CNNM2	CT	Metabolism/PK	decreased	LADME	Other:C0023449		L01BB02	rs58700372:CT
oxycodone	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	increased	Dosage	Disease:C0027651		N02AA05	*3/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0035435		J02AC03	*1/*1
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0035435		J02AC03	*1/*17
montelukast	UGT1A3*1, UGT1A3*2	UGT1A3	*2	Metabolism/PK	decreased	LADME	Healthy		R03DC03	*2
phenytoin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Healthy		N03AB02	*1/*2
fluorouracil	rs11280056	TYMS	TTAAAGTTA/del	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02	rs11280056:TTAAAGTTA/del
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*4/*41
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*1/*4
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*10/*10
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*10/*41
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*4	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*2/*4
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*41/*41	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*41/*41
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		N03AB02	*1/*3
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Metabolism/PK	increased	LADME	Healthy		N03AB02	*2/*2
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	increased	LADME	Healthy		N03AB02	*2/*3
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	increased	LADME	Healthy		N03AB02	*3/*3
sertraline	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB06	rs1799752:del/del
rosuvastatin	rs17216177	ABCC2	C	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs17216177:C
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		N03AB02	*1/*3
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		N03AB02	*2/*2
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		N03AB02	*2/*3
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		N03AB02	*3/*3
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	decreased	LADME	Disease:C0024530		P01BA03	*4/*41
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*6	Metabolism/PK	decreased	LADME	Disease:C0024530		P01BA03	*5/*6
cilostazol	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	B01AC23	*1/*3
endoxifen	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*10/*10
endoxifen	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5/*10
rasagiline	rs12208357	SLC22A1	CT	Metabolism/PK	decreased	LADME	Healthy		N04BD02	rs12208357:CT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
esomeprazole, pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC02|A02BC05	*2/*2
esomeprazole, pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC02|A02BC05	*2/*3
tacrolimus	CYP3A7*1A, CYP3A7*1C	CYP3A7	*1A/*1A	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1A/*1A
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
cotinine, nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*2	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*2
cotinine, nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4
cotinine, nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9
cotinine, nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*12	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*12
ketamine	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Disease:C0027651|Disease:C0030193		N01AX03	*6
debrisoquine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*10/*10
esomeprazole, pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC02|A02BC05	*2/*2
esomeprazole, pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC02|A02BC05	*2/*3
rosuvastatin	rs7899457	ABCC2	T	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs7899457:T
esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02|A02BC03|A02BC04|A02BC05	*1/*2
esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02|A02BC03|A02BC04|A02BC05	*1/*3
esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02|A02BC03|A02BC04|A02BC05	*1/*1
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1
rosuvastatin	rs8187706	ABCC2	A	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs8187706:A
flurbiprofen	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*1	Metabolism/PK	increased	LADME	Healthy		S01BC04	*1/*1
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1
pitavastatin	rs717620	ABCC2	T	Metabolism/PK	decreased	LADME	Healthy		C10AA08	rs717620:T
ethanol	rs28363170	SLC6A3	del	Other	increased	Efficacy_Response	Healthy		V03AB16	rs28363170:del
ethanol	rs1800497	DRD2	A	Dosage	increased	Dosage	Healthy		V03AB16	rs1800497:A
vardenafil	rs776746	CYP3A5	TT	Other, Metabolism/PK	increased	LADME	Healthy		G04BE09	rs776746:TT
sipoglitazar	UGT2B15*1, UGT2B15*2	UGT2B15	*2	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*2
ethanol	rs28363170	SLC6A3	del	Toxicity	increased	LADME	Healthy		V03AB16	rs28363170:del
ethanol	rs1799971	OPRM1	G	Dosage	increased	Dosage	Healthy		V03AB16	rs1799971:G
imatinib	rs683369	SLC22A1	CC	Metabolism/PK	decreased	LADME	Other:C0238198		L01EA01	rs683369:CC
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	increased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*3
acetaminophen	UGT1A6*1a, UGT1A6*2a	UGT1A6	*2a	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		N02BE01	*2a
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C0004238|Disease:C0004239|Disease:C0042487		B01AA07	*3
acetaminophen	UGT1A6*1a, UGT1A6*2a	UGT1A6	*2a/*2a	Metabolism/PK	increased	LADME	Healthy		N02BE01	*2a/*2a
acetaminophen	UGT1A6*1a, UGT1A6*2a	UGT1A6	*1a/*2a	Metabolism/PK	increased	LADME	Healthy		N02BE01	*1a/*2a
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
acetaminophen	UGT2B15*1, UGT2B15*2	UGT2B15	*2	Metabolism/PK	decreased	LADME	Healthy		N02BE01	*2
haloperidol	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*10
methadone	rs3802281	OPRK1	TT	Dosage	decreased	Dosage	Other:C0028043		N07BC02	rs3802281:TT
debrisoquine	CYP2D6*1, CYP2D6*2, CYP2D6*17	CYP2D6	*1/*17	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*1/*17
debrisoquine	CYP2D6*1, CYP2D6*2, CYP2D6*17	CYP2D6	*17/*17	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*17/*17
azathioprine	rs1142345	TPMT	CT	Dosage	decreased	Dosage	Other:C0009324|Other:C0010346		L04AX01	rs1142345:CT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tolterodine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3	Metabolism/PK	decreased	LADME	Healthy		G04BD07	*3
tolterodine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		G04BD07	*4
citalopram, mianserin, mirtazapine, nortriptyline, paroxetine, venlafaxine	CYP2D6*1xN, CYP2D6*2xN	CYP2D6	*1xN	Efficacy	decreased	Efficacy_Response	Disease:C0040435		N06AA10|N06AB04|N06AB05|N06AX03|N06AX11|N06AX16	*1xN
citalopram, mianserin, mirtazapine, nortriptyline, paroxetine, venlafaxine	CYP2D6*1xN, CYP2D6*2xN	CYP2D6	*2xN	Efficacy	decreased	Efficacy_Response	Disease:C0040435		N06AA10|N06AB04|N06AB05|N06AX03|N06AX11|N06AX16	*2xN
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0004364		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0004364		L04AD02	*1/*3
hydroxyurea	rs7166737	SIN3A	GG	Efficacy	decreased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs7166737:GG
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0079487		A02BC04	*2/*2
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0079487		A02BC04	*2/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
fluoxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799964	TNF	TT	Efficacy	increased	Efficacy_Response	Disease:C0038012|Ankylosing		No_ATC	rs1799964:TT
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*1/*3
propafenone	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		C01BC03	*10/*10
venlafaxine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AX16	__UNKNOWN__
tacrolimus	CYP3A5*1, CYP3A5*6	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*6	CYP3A5	*1/*6	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*6
capecitabine, raltitrexed	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BA03|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
tacrolimus	CYP3A5*1, CYP3A5*7	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*7	CYP3A5	*1/*7	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*7
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*1	Dosage	increased	Dosage	Healthy		B01AA03	*1/*1
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*3
venlafaxine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Elderly_Adult	poor metabolizer	N06AX16	__UNKNOWN__
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	G/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:G/TT
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT
venlafaxine	normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Elderly_Adult	normal metabolizer	N06AX16	__UNKNOWN__
rasagiline	rs34059508	SLC22A1	AG	Metabolism/PK	increased	LADME	Healthy		N04BD02	rs34059508:AG
escitalopram	normal metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Elderly_Adult	normal metabolizer	N06AB10	__UNKNOWN__
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	LADME	Disease:C0014544		N03AB02	*1/*3
lovastatin acid	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	*5/*15	Metabolism/PK	increased	LADME	Healthy		C10AA02	*5/*15
lovastatin acid	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA02	*15/*15
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		N03AB02	*1/*3
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	increased	LADME	Healthy		N03AB02	*2/*3
flurbiprofen	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		S01BC04	*1/*3
ambrisentan	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*17	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		C02KX02	*2
ambrisentan	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*17	CYP2C19	*3	Metabolism/PK	decreased	LADME	Healthy		C02KX02	*3
ambrisentan	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*17	CYP2C19	*4	Metabolism/PK	decreased	LADME	Healthy		C02KX02	*4
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		J05AG03	*6/*6
cyclophosphamide	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Disease:C0024299|B-Cell		L01AA01	*6
sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Other:C0033575		N06AB06	
rasagiline	rs2273697	ABCC2	AA	Metabolism/PK	decreased	LADME	Healthy		N04BD02	rs2273697:AA
bupropion	rs2770296	HTR2A	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs2770296:CC
capecitabine, fluorouracil	rs371194629	HLA-G	ATTTGTTCATGCCT/ATTTGTTCATGCCT	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06	rs371194629:ATTTGTTCATGCCT/ATTTGTTCATGCCT
capecitabine, fluorouracil	rs371194629	HLA-G	ATTTGTTCATGCCT/del	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06	rs371194629:ATTTGTTCATGCCT/del
voriconazole	poor metabolizer	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*2
voriconazole	poor metabolizer	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*3
pravastatin	rs20455	KIF6	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03	rs20455:AG
pravastatin	rs20455	KIF6	GG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03	rs20455:GG
fluvoxamine	SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB08	
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		J02AC03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
donepezil	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0002395	poor metabolizer	N06DA02	__UNKNOWN__
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
risperidone	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*10/*10
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*4/*4
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*4/*5
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*4/*6
fluoxetine	rs2032582	ABCB1	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs2032582:A
tamoxifen, endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		L02BA01	*4/*4
tamoxifen, endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		L02BA01	*4/*5
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*3
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		R05DA09	*10/*10
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Healthy		R05DA09	*1/*10
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12	*1/*6
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12	*6/*6
rabeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC04	*2/*2
dipyrone	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*2
fluoxetine, sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB06	
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC03	*1/*4
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC03	*4/*4
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*7	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC03	*4/*7
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*9	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC03	*4/*9
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10	
azathioprine	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0009324|Other:C0010346		L04AX01	
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*4/*10
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*5/*10
nilotinib	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28	UGT1A1	*6/*6	Dosage	decreased	Dosage	Disease:C0023473|BCR-ABL1_positive		L01EA03	*6/*6
nilotinib	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28	UGT1A1	*6/*28	Dosage	decreased	Dosage	Disease:C0023473|BCR-ABL1_positive		L01EA03	*6/*28
cotinine, nicotine	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Metabolism/PK	increased	LADME	Healthy		N07BA01	*1/*6
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*1/*5	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*5
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*2/*5	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*5
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	*6
bupropion	rs2873804	DBH	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs2873804:CC
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0003873|Disease:C0024141		L04AD02	*3/*3
fluorouracil, leucovorin, oxaliplatin	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus|Disease:C0026640		L01BC02|L01XA03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__
paclitaxel, platinum compounds	GSTM1 non-null, GSTM1 null	GSTM1	non-null	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01CD01|L01XA	
bleomycin, dacarbazine, doxorubicin, vinblastine	GSTM1 non-null, GSTM1 null	GSTM1	non-null/non-null	Efficacy	increased	Efficacy_Response	Disease:C0019829		L01AX04|L01CA01|L01DB01|L01DC01	
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB04	*2
enalapril, lisinopril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Other:C0020538		C09AA02|C09AA03	rs1799752:del/del
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3
trimipramine	CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*3/*3
bupropion	rs363225	SLC18A2	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs363225:CC
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*3
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*4
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*5
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*6
methadone	CYP2B6*1, CYP2B6*4, CYP2B6*6	CYP2B6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N07BC02	*1/*4
methadone	CYP2B6*1, CYP2B6*4, CYP2B6*6	CYP2B6	*4/*6	Metabolism/PK	increased	LADME	Healthy		N07BC02	*4/*6
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*1/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*1/*3
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*2/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*2/*3
raltegravir	UGT1A9*3a	UGT1A9	*3a	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AJ01	*3a
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*2/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*2/*3
fluvoxamine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB08	__UNKNOWN__
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Metabolism/PK	decreased	LADME	Healthy		N07BC02	*1/*6
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		N07BC02	*6/*6
fluvoxamine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB08	__UNKNOWN__
sertraline	rs2860840	CYP2C18	TT	Metabolism/PK	decreased	LADME	Healthy		N06AB06	rs2860840:TT
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C2939420		B01AA07	*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C2939420		B01AA07	*3
aripiprazole	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0036337|Disease:C0036341	poor metabolizer	N05AX12	__UNKNOWN__
4-hydroxytamoxifen(tamoxifen)	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	*22
tamoxifen	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	*22
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*1
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Efficacy_Response	Other:C0022665		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Efficacy_Response	Other:C0022665		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*1
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799724	TNF	CC	Efficacy	increased	Efficacy_Response	Disease:C0038012|Ankylosing		No_ATC	rs1799724:CC
hydroxyamitriptyline(amitriptyline)	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06AA09	*10/*10
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AA09	*2/*2
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy		N06AA09	*2/*3
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Healthy		N06AA09	*3/*3
acetylcysteine	poor metabolizer	EPHX1	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C0024117	poor metabolizer	V03AB23	
bupropion	rs363226	SLC18A2	GG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs363226:GG
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
methotrexate	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2
olanzapine	rs1799735	GSTM3	CCT/CCT	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs1799735:CCT/CCT
levodopa, methylphenidate	rs3836790	SLC6A3	ACATACACACTCAGACACACATACCATGCA/ACATACACACTCAGACACACATACCATGCA	Efficacy	increased	Efficacy_Response	Disease:C0030567		N04BA02|N06BA04	rs3836790:ACATACACACTCAGACACACATACCATGCA/ACATACACACTCAGACACACATACCATGCA
atomoxetine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*41	CYP2D6	*4/*4xN	Metabolism/PK	decreased	LADME	Disease:C1263846		N06BA09	*4/*4xN
atomoxetine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1263846		N06BA09	*4/*4
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage, Efficacy	decreased	Dosage	Disease:C0271093		B01AA03	*3/*3
levodopa	rs3836790	SLC6A3	ACATACACACTCAGACACACATACCATGCA/ACATACACACTCAGACACACATACCATGCA	Efficacy	increased	Efficacy_Response	Disease:C0030567		N04BA02	rs3836790:ACATACACACTCAGACACACATACCATGCA/ACATACACACTCAGACACACATACCATGCA
fluorouracil	deficiency	DPYD	__UNKNOWN__	Metabolism/PK	Indeterminado	LADME	Disease:Head_and_Neck_Neoplasms	deficiency	L01BC02	__UNKNOWN__
atomoxetine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*4/*4xN	Metabolism/PK	increased	LADME	Disease:C1263846		N06BA09	*4/*4xN
atomoxetine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C1263846		N06BA09	*4/*4
bupropion	rs17614642	FKBP5	TT	Efficacy	decreased	Efficacy_Response	Other:C0011581		N06AX12	rs17614642:TT
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*3
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*6
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*7	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*7
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage, Efficacy	decreased	Dosage	Disease:C0271093		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage, Efficacy	decreased	Dosage	Disease:C0271093		B01AA03	*1/*2
interferon beta-1a	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AB07	rs1799752:del/del
ethanol	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs1799971:AG
rabeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC04	*1/*1
omeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
warfarin	rs2260863	EPHX1	CG	Dosage	increased	Dosage	Healthy		B01AA03	rs2260863:CG
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	*3/*3
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*2/*2
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*2/*3
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*3/*3
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01	*1/*1
captopril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA01	rs1799752:del/del
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0014868|Disease:C0017168		A02BC01	*1/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0014868|Disease:C0017168		A02BC01	*1/*3
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01	*1/*1
losartan	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09CA01	rs1799752:del/del
tacrolimus	rs35599367	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:GG
thalidomide	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Dosage	increased	Dosage	Disease:C0014743|Disease:Leprosy		L04AX02	*2
carvedilol	CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0002962		C07AG02	*10
efavirenz	CYP2B6*1	CYP2B6	*1/*1	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*1
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Other:C0004238|Other:C0034065|Other:C0042487		B01AA03	*3
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	*1/*17
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	*17/*17
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*6	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*6
nicotine	low activity	CYP2A6	__UNKNOWN__	Dosage	decreased	Dosage	Disease:C0039338	low activity	N07BA01	__UNKNOWN__
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*17
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*17/*17
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
imatinib	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs776746:CC
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*3
paclitaxel	SLCO1B1*5, SLCO1B1*15	SLCO1B1	*5	Metabolism/PK	increased	LADME	Disease:C1458155		L01CD01	*5
paclitaxel	SLCO1B1*5, SLCO1B1*15	SLCO1B1	*15	Metabolism/PK	increased	LADME	Disease:C1458155		L01CD01	*15
imipramine	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	*2/*3
imipramine	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	*2/*2
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC04	*1/*2
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC04	*1/*3
lamotrigine	rs7668258	UGT2B7	CC	Dosage, Metabolism/PK	increased	LADME	Healthy		N03AX09	rs7668258:CC
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC04	*1/*1
buprenorphine	UGT2B7	UGT2B7	*2	Efficacy	decreased	Efficacy_Response	Disease:C0030193		N07BC01	
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Dosage	increased	Dosage	Disease:C0026946		J02AC03	*1/*17
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Dosage	increased	Dosage	Disease:C0026946		J02AC03	*17/*17
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	*2/*2
imatinib	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AG
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*17
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*17/*17
tolbutamide	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A10BB03	*1/*3
tolbutamide	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	decreased	LADME	Healthy		A10BB03	*2/*3
tolbutamide	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		A10BB03	*3/*3
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6/*6
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*6	CYP2B6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N06AX12	*1/*4
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*6	CYP2B6	*4/*6	Metabolism/PK	increased	LADME	Healthy		N06AX12	*4/*6
endoxifen	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Metabolism/PK	Indeterminado	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	__UNKNOWN__
zafirlukast	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		R03DC01	*1/*3
zafirlukast	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	increased	LADME	Healthy		R03DC01	*1/*13
dexlansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC06	*1/*2
dexlansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC06	*1/*3
zafirlukast	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		R03DC01	*1/*3
zafirlukast	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	decreased	LADME	Healthy		R03DC01	*1/*13
nelfinavir	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		J05AE04	*1/*2
hydroxybupropion(bupropion)	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6/*6
nelfinavir	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0030297		J05AE04	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22	CYP2B6	*1/*6	Metabolism/PK	decreased	LADME	Disease:C0039338		N06AX12	*1/*6
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22	CYP2B6	*1/*18	Metabolism/PK	decreased	LADME	Disease:C0039338		N06AX12	*1/*18
ivacaftor, tezacaftor	rs113993960	CFTR	del/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02|R07AX31	rs113993960:del/del
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs11322783:TT/TT
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Disease:C0039338		N06AX12	*6/*6
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22	CYP2B6	*6/*18	Metabolism/PK	decreased	LADME	Disease:C0039338		N06AX12	*6/*18
ivacaftor, tezacaftor	rs113993960	CFTR	CTT/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02|R07AX31	rs113993960:CTT/del
warfarin	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Dosage	increased	Dosage	Disease:C0004238		B01AA03	*1/*2
warfarin	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Dosage	increased	Dosage	Disease:C0004238		B01AA03	*1/*3
warfarin	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Dosage	increased	Dosage	Disease:C0004238		B01AA03	*1/*1
atomoxetine	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06BA09	*10/*10
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*6	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*6
atomoxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Dosage	decreased	Dosage	Disease:C1263846	poor metabolizer	N06BA09	__UNKNOWN__
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*2
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*3
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*1
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*3
gemcitabine	rs60369023	CDA	A	Other, Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC05	rs60369023:A
apixaban, dabigatran, edoxaban, rivaroxaban	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:C0040038		B01AE07|B01AF01|B01AF02|B01AF03	rs1045642:GG
atazanavir	rs2472677	NR1I2	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AE08	rs2472677:TT
imatinib	rs2032582	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs2032582:A
antidepressants	rs1360780	FKBP5	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs1360780:CC
imatinib	rs1128503	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs1128503:A
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
antidepressants	rs5443	GNB3	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs5443:CC
antidepressants	rs5443	GNB3	CT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs5443:CT
imatinib	rs1045642	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:A
antidepressants	rs3800373	FKBP5	AC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs3800373:AC
antidepressants	rs3800373	FKBP5	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs3800373:CC
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
methadone	rs963549	OPRK1	CC	Dosage	decreased	Dosage	Other:C0028043		N07BC02	rs963549:CC
antipsychotics	rs1128503	ABCB1	AA	Dosage, Metabolism/PK	increased	Dosage	Disease:C0036341		N05A	rs1128503:AA
imatinib	rs2231142	ABCG2	T	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs2231142:T
efavirenz	rs3745274	CYP2B6	GT	Efficacy	decreased	Efficacy_Response	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Efficacy	decreased	Efficacy_Response	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
tacrolimus	rs4823613	PPARA	G	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs4823613:G
infliximab	rs3794271	SLCO1C1	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB02	rs3794271:G
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
tacrolimus	rs1057868	POR	T	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs1057868:T
dalcetrapib	rs1967309	ADCY9	AA	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs1967309:AA
antidepressants	rs6265	BDNF	CT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs6265:CT
beta blocking agents, flecainide	rs1801253	ADRB1	G	Efficacy	decreased	Efficacy_Response	Disease:C0039231		C01BC04|S01ED	rs1801253:G
methotrexate	rs717620	ABCC2	T	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs717620:T
rituximab	rs396991	FCGR3A	AA	Efficacy	increased	Efficacy_Response	Other:C0030353		L01FA01	rs396991:AA
efavirenz	CYP2B6*1, CYP2B6*18	CYP2B6	*18	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*18
drugs used in alcohol dependence	rs13273672	GATA4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0085762		N07BB	rs13273672:CC
chorionic gonadotropin	rs6166	FSHR	CC	Dosage	increased	Dosage	Healthy		G03GA01	rs6166:CC
bepridil	CYP2D6*10	CYP2D6	*10	Metabolism/PK	increased	LADME	Disease:C0018824		No_ATC	*10
tacrolimus	rs35599367	CYP3A4	GG	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs35599367:GG
nicardipine, nimodipine	rs2739260	CACNA1B	AG	Efficacy	increased	Efficacy_Response	Other:C0005586		C08CA04|C08CA06	rs2739260:AG
nicardipine, nimodipine	rs2739260	CACNA1B	GG	Efficacy	increased	Efficacy_Response	Other:C0005586		C08CA04|C08CA06	rs2739260:GG
citalopram, escitalopram	rs10975641	GLDC	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB04|N06AB10	rs10975641:G
cortisone acetate	CYP3A7*1A, CYP3A7*1C	CYP3A7	*1C	Dosage	decreased	Dosage	Disease:C0011351|Congenital		S01BA03	*1C
daunorubicin	G6PD A- 202A_376G	G6PD	A-202A_376G	Metabolism/PK	decreased	LADME	Healthy		L01DB02	
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC03	*4/*4
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7	CYP2A6	*4/*7	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC03	*4/*7
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7	CYP2A6	*7/*7	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC03	*7/*7
efavirenz	CYP2A6*2	CYP2A6	*2	Other, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*2
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage, Efficacy	decreased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage, Efficacy	decreased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	*3/*3
metformin	rs11868513	HNF1B	AA	Efficacy	increased	Efficacy_Response	Healthy		A10BA02	rs11868513:AA
metformin	rs11868513	HNF1B	AG	Efficacy	increased	Efficacy_Response	Healthy		A10BA02	rs11868513:AG
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
ibuprofen	CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*3
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
atorvastatin	rs2242480	CYP3A4	C/C	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA05	rs2242480:C/C
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC03	*1/*1
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
glatiramer acetate	HLA-DRB1*15:01	HLA-DRB1	*15:01	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AX13	*15:01
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage, Metabolism/PK	decreased	LADME	Disease:C0007222		B01AA03	*3
warfarin	CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	Dosage	Disease:C0007222		B01AA03	*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*1	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*1/*1
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*1/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*2/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*3/*17
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
caffeine	NAT2*4	NAT2	*4	Metabolism/PK	increased	LADME	Healthy		N06BC01	*4
atorvastatin	rs2242480	CYP3A4	C/C	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA05	rs2242480:C/C
diazepam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Other, Metabolism/PK	decreased	LADME	Healthy		N05BA01	*2
diazepam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Other, Metabolism/PK	decreased	LADME	Healthy		N05BA01	*3
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""interferons"", ""peginterferon alfa-2a"", ""peginterferon alfa-2b"", ""ribavirin"""	rs1946518	IL18	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB|L03AB04|L03AB05|L03AB10|L03AB11	rs1946518:T
fluoxetine, paroxetine	rs57098334	SLC6A4	(CCCACCCGA)12/(CCCACCCGA)12	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB03|N06AB05	rs57098334:(CCCACCCGA)12/(CCCACCCGA)12
ibuprofen	CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*3
venlafaxine	CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AX16	*4/*4
tacrolimus	rs1057868	POR	CC	Metabolism/PK	decreased	LADME	Healthy		L04AD02	rs1057868:CC
acenocoumarol	CYP2C9*2	CYP2C9	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	*2
thioguanosine diphosphate, thioguanosine monophosphate, thioguanosine triphosphate	poor metabolizer	TPMT	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0021390	poor metabolizer	No_ATC	__UNKNOWN__
valproic acid	CYP2A6*1, CYP2A6*4	CYP2A6	*4	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AG01	*4
tegafur	CYP2A6*1, CYP2A6*4	CYP2A6	*4	Metabolism/PK	decreased	LADME	Healthy		L01BC03	*4
nicotine	CYP2A6*1, CYP2A6*7	CYP2A6	*1/*7	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*7
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Other:a_stable_international_normalized_ratio_of_between_two_and_three		B01AA03	*3/*3
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Dosage	decreased	Dosage	Other:a_stable_international_normalized_ratio_of_between_two_and_three		B01AA03	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	*3
warfarin	CYP4F2*1, CYP4F2*3	CYP4F2	*3/*3	Dosage	increased	Dosage	Other:a_stable_international_normalized_ratio_of_between_two_and_three		B01AA03	*3/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Other:a_stable_international_normalized_ratio_of_between_two_and_three		B01AA03	*2/*3
paclitaxel	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD01	*1/*3
paclitaxel	CYP2C8*1, CYP2C8*3	CYP2C8	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD01	*3/*3
caffeine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*1/*4	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	*1/*4
caffeine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*1/*9	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	*1/*9
caffeine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*4/*4	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	*4/*4
caffeine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*4/*9	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	*4/*9
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0040038		B01AA03	*1/*3
tocilizumab	rs4845625	IL6R	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC07	rs4845625:CT
tocilizumab	rs4845625	IL6R	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC07	rs4845625:TT
acenocoumarol	CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	*3
rosuvastatin	rs17216198	ABCC2	T	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs17216198:T
atorvastatin	rs2242480	CYP3A4	T/T	Efficacy	increased	Efficacy_Response	Disease:C0020473		C10AA05	rs2242480:T/T
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007222		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007222		B01AC04	rs4244285:AG
fluvastatin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Metabolism/PK	increased	LADME	Healthy		C10AA04	*2
mirtazapine	CYP2B6*6	CYP2B6	*6/*6	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AX11	*6/*6
sulfapyridine	NAT2*7	NAT2	*7/*7	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*7/*7
methotrexate	rs1051266	SLC19A1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs1051266:CT
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage, Metabolism/PK	decreased	LADME	Disease:C0007222		B01AA03	*2
warfarin	CYP2C9*2	CYP2C9	*2	Metabolism/PK	decreased	Dosage	Disease:C0007222		B01AA03	*2
isoniazid	NAT2*4	NAT2	*4	Metabolism/PK	increased	LADME	Healthy		J04AC01	*4
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""interferons"", ""peginterferon alfa-2a"", ""peginterferon alfa-2b"", ""ribavirin"""	rs187238	IL18	C	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB|L03AB04|L03AB05|L03AB10|L03AB11	rs187238:C
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Other:human_liver_microsomes		J05AG03	*6
acenocoumarol	CYP2C9*1	CYP2C9	*1/*1	Dosage	increased	Dosage	Healthy		B01AA07	*1/*1
isoniazid	NAT2*4	NAT2	*4/*4	Metabolism/PK	increased	LADME	Disease:C0041296		J04AC01	*4/*4
isoniazid	NAT2*4	NAT2	*4/*4	Metabolism/PK	increased	LADME	Disease:C0041296		J04AC01	*4/*4
acenocoumarol	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2
ibuprofen	CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*3
acenocoumarol	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3
acenocoumarol	CYP2C9*1	CYP2C9	*1/*1	Dosage	increased	Dosage	Healthy		B01AA07	*1/*1
acenocoumarol	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0178298		C09CA01	*1/*3
losartan	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		C09CA01	*1/*3
tropisetron	CYP2D6*3	CYP2D6	*3/*3	Efficacy	decreased	LADME	Disease:C0027651		A04AA03	*3/*3
metoprolol	CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		C07AB02	*10
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0178298		C09CA01	*1/*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*3
clopidogrel	CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C0151744		B01AC04	*2
olmesartan	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15	Metabolism/PK	decreased	LADME	Healthy		C09CA08	*15
tacrolimus	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*2/*2
metoprolol	CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		C07AB02	*10
rosuvastatin	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*15	Metabolism/PK	decreased	LADME	Healthy		C10AA07	*15/*15
simvastatin	CYP3A4*1, CYP3A4*4	CYP3A4	*1/*4	Efficacy	increased	Efficacy_Response	Disease:C0020473		C10AA01	*1/*4
losartan	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	decreased	LADME	Healthy		C09CA01	*1/*13
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*3
ondansetron	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN	CYP2D6	*1xN	Efficacy	decreased	Efficacy_Response	Healthy		A04AA01	*1xN
ondansetron	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN	CYP2D6	*2xN	Efficacy	decreased	Efficacy_Response	Healthy		A04AA01	*2xN
nateglinide	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A10BX03	*1/*3
phenprocoumon	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA04	*3
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA04	*2
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA04	*3
risperidone	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*10
haloperidol	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*10
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC03	*1/*1
carvedilol	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C0271093		C07AG02	*1/*4
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1
rosuvastatin	rs3740066	ABCC2	T	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs3740066:T
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC02	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*1
carvedilol	CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Dosage	increased	Dosage	Disease:C0085605		C07AG02	*4/*5
carvedilol	CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Dosage	increased	Dosage	Disease:C0085605		C07AG02	*4/*6
clopidogrel	CYP2C19*1	CYP2C19	*1/*1	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*1
omeprazole, pantoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02	*1/*2
carvedilol	CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C0271093		C07AG02	*10/*10
carvedilol	CYP2D6*1, CYP2D6*5	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C0271093		C07AG02	*1/*5
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Healthy		A02BC04	*2/*2
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Healthy		A02BC04	*3/*3
carvedilol	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		C07AG02	*10/*10
zuclopenthixol	CYP2D6*1, CYP2D6*3	CYP2D6	*3	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AF05	*3
risperidone	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	*4/*4
fluoxetine	rs3892097	CYP2D6	CC	Efficacy	increased	Efficacy_Response	Efficacy:C0085762|Efficacy:C0011581		N06AB03	rs3892097:CC
amitriptyline, clomipramine, doxepin, imipramine, maprotiline, nortriptyline, opipramol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Dosage, Efficacy	decreased	Dosage	Disease:C0235876		N06AA02|N06AA04|N06AA09|N06AA10|N06AA12|N06AA21	*4/*4
sufentanil	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	*1/*3
sufentanil	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	*3/*3
metformin	rs6719578	__INTRONIC__	CG	Efficacy	increased	Efficacy_Response	Healthy		A10BA02	rs6719578:CG
risperidone	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Efficacy, Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*10
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6
mephenytoin, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC01|N03AB02	*2/*3
haloperidol	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*10
risperidone	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*4
methotrexate	rs4673993	ATIC	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs4673993:CC
lornoxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC05	*1/*3
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0041582		A02BC01	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1
rabeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*1
esomeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC05	*1/*1
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*4
clopidogrel	CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0007222		B01AC04	*2/*2
clopidogrel	CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Disease:C0007222		B01AC04	*2/*3
clopidogrel	CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Disease:C0007222		B01AC04	*3/*3
lansoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC03	*1/*2
dexlansoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC06	*2/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1
lovastatin	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		C10AA02	*10
lovastatin	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5	Metabolism/PK	decreased	LADME	Healthy		C10AA02	*5
benzbromarone	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M04AB03	*1/*3
labetalol	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		C07AG01	*2/*2
celecoxib	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Healthy		M01AH01	*1/*2
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1
bupropion	CYP2B6*1, CYP2B6*22	CYP2B6	*1/*22	Metabolism/PK	increased	LADME	Healthy		N06AX12	*1/*22
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		J02AC03	*1/*1
lansoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC03	*2/*2
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
fluoxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Dosage	decreased	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*1/*2
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0030319		N06AB05	
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
fluoxetine, paroxetine	SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB05	
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*17
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*17/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy, Toxicity	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy, Toxicity	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy, Toxicity	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy, Toxicity	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	*2/*3
pioglitazone	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*1	Metabolism/PK	decreased	LADME	Healthy		A10BG03	*1/*1
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	HLA-A*01:01	HLA-A	*01:01	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	*01:01
citalopram, fluoxetine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04|N06AB05	
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
efavirenz	rs70950385	CYP2B6	CA/CA	Metabolism/PK	decreased	LADME	Healthy		J05AG03	rs70950385:CA/CA
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3
mephenytoin	rs28399504	CYP2C19	G	Metabolism/PK	decreased	LADME	Healthy		N03AB02	rs28399504:G
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
tamoxifen, endoxifen	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*10/*10
tamoxifen, endoxifen	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*5/*5
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3
lamivudine, nevirapine, stavudine	HLA-B*40:01	HLA-B	*40:01	Efficacy	Indeterminado	Efficacy_Response	Disease:HIV_infectious_disease		J05AF04|J05AF05|J05AG01	*40:01
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	J02AC03	*2/*2
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*1/*60	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*1/*60
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*60/*60	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*60/*60
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*1/*60	Metabolism/PK	decreased	LADME	Disease:C0027651		No_ATC	*1/*60
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*60/*60	Metabolism/PK	decreased	LADME	Disease:C0027651		No_ATC	*60/*60
doxepin	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*2/*2
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*2/*2
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*10	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*2/*10
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*1/*3
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*1/*4
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*2/*4
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*5/*10
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*4/*4
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*3/*4
boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs11322783	IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|J05AP03|L03AB10|L03AB11	rs11322783:TT
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*6	Dosage	decreased	Dosage	Healthy		B01AA03	*6
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AA09	*2/*2
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy		N06AA09	*2/*3
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		J02AC03	*1/*1
deferasirox	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	decreased	LADME	Disease:C0002871		V03AC03	*1/*28
deferasirox	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Disease:C0002871		V03AC03	*28/*28
clopidogrel, prasugrel, ticagrelor	rs4244285	CYP2C19	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC04|B01AC22|B01AC24	rs4244285:A
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0027051|Disease:C0018839		B01AC04	*2/*2
efavirenz	CYP2B6*1, CYP2B6*11	CYP2B6	*11	Metabolism/PK	decreased	LADME	Healthy		J05AG03	*11
valproic acid	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Disease:C0005586|Disease:C0033975		N03AG01	*1/*2
valproic acid	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Disease:C0005586|Disease:C0033975		N03AG01	*1/*3
warfarin	rs41301394	POR	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs41301394:CT
warfarin	rs41301394	POR	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs41301394:TT
carboplatin, paclitaxel	rs1695	GSTP1	G	Toxicity	decreased	Efficacy_Response	Other:C0919267		L01CD01|L01XA02	rs1695:G
voriconazole	ultrarapid metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0026946	ultrarapid metabolizer	J02AC03	__UNKNOWN__
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*6
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C0004238		B01AA07	*2
tacrolimus	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
cisplatin	rs3807348	MIR335	AA	Efficacy	increased	Efficacy_Response	Other:C0025500		L01XA01	rs3807348:AA
cisplatin	rs3807348	MIR335	AG	Efficacy	increased	Efficacy_Response	Other:C0025500		L01XA01	rs3807348:AG
celecoxib	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*1/*3
cyclophosphamide, doxorubicin	rs6151031	ALDH1A1	CTGGTGAGGAGAGAACC/del	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs6151031:CTGGTGAGGAGAGAACC/del
buprenorphine, methadone	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01|N07BC02	
warfarin	low activity	VKORC1	__UNKNOWN__	Dosage	decreased	Dosage	Healthy	low activity	B01AA03	
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Efficacy	decreased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*2/*17
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*2/*17
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*3/*3
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*3
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*6
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*7	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*7
clozapine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	decreased	LADME	Disease:C0036337|Disease:C0036341		N05AH02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Other:heart_transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	decreased	LADME	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	decreased	LADME	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*3
sirolimus, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
sirolimus, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
nimodipine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	increased	LADME	Healthy		C08CA06	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:C0009324		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:C0009324		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
carbamazepine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	*3/*3
fentanyl	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0027651|Disease:C0030193		N02AB03	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*3/*3
fentanyl	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0030193|Postoperative		N02AB03	*3/*3
midazolam	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0027651		N05CD08	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
cyclosporine	CYP3A5*1, CYP3A5*3	CYP3A5	*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD01	*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1
fentanyl	CYP2D6*1, CYP2D6*9	CYP2D6	*9	Metabolism/PK	decreased	LADME	Other:C0006434		N02AB03	*9
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3
simvastatin	rs3917643	F3	CT	Efficacy	increased	Efficacy_Response	Disease:C0151744		C10AA01	rs3917643:CT
ivacaftor / lumacaftor	rs113993960	CFTR	del/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX30	rs113993960:del/del
acetylcholine, nitroprusside	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Healthy		C02DD01|S01EB09	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC
fluvastatin	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C10AA04	rs1799752:del/del
ivacaftor	rs113993960	CFTR	CTT/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs113993960:CTT/del
enalapril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del	Efficacy	increased	Efficacy_Response	Disease:C0003850		C09AA02	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del
enalapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0003850		C09AA02	rs1799752:del/del
bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin, trastuzumab	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD02|L01DB03|L01FG01|L01XA01|L01XA03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
imatinib	rs776746	CYP3A5	C	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs776746:C
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*22
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	*22/*22
metoclopramide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		A03FA01	*1/*10
metoclopramide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		A03FA01	*10/*10
metoclopramide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy		A03FA01	*5/*10
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*22
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*22/*22
fentanyl, meperidine, midazolam	poor metabolizer	CYP3A5	__UNKNOWN__	Metabolism/PK	decreased	Dosage	Other:C0235195	poor metabolizer	N02AB03|N05CD08	__UNKNOWN__
fentanyl, meperidine, midazolam	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	Dosage	Other:C0235195	intermediate metabolizer and poor metabolizer	N02AB03|N05CD08	__UNKNOWN__
fentanyl, meperidine, midazolam	poor metabolizer	UGT1A1	__UNKNOWN__	Metabolism/PK	decreased	Dosage	Other:C0235195	poor metabolizer	N02AB03|N05CD08	__UNKNOWN__
tacrolimus	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:AG
4-hydroxytamoxifen(tamoxifen)	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	*1/*17
4-hydroxytamoxifen(tamoxifen)	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	*17/*17
tamsulosin	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer	G04CA02	*1/*4
tamsulosin	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer	G04CA02	*4/*10
imatinib	rs2242480	CYP3A4	C	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs2242480:C
fulvestrant	poor metabolizer	CYP2C9	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C1458155|Other:C2939419	intermediate metabolizer and poor metabolizer	L02BA03	__UNKNOWN__
anastrozole	intermediate metabolizer	CYP2C9	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C1458155|Other:C2939419	intermediate metabolizer and poor metabolizer	L02BG03	__UNKNOWN__
anastrozole	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Other:C1458155|Other:C2939419	intermediate metabolizer	L02BG03	*1/*22
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:C0023418	intermediate metabolizer and poor metabolizer	J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Other:C0023418	intermediate metabolizer and poor metabolizer	J02AC03	*1/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0023418	intermediate metabolizer and poor metabolizer	J02AC03	*2/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:C0023418	intermediate metabolizer and poor metabolizer	J02AC03	*2/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:C0023418	intermediate metabolizer and poor metabolizer	J02AC03	*3/*3
abatacept	HLA-DRB1*04:05	HLA-DRB1	*04:05	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*04:05
esomeprazole	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	A02BC05	__UNKNOWN__
esomeprazole	rapid metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	rapid metabolizer	A02BC05	__UNKNOWN__
etanercept	rs3794271	SLCO1C1	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01	rs3794271:G
apatinib	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:C0027651		L01EH01	*1/*1
apatinib	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:C0027651		L01EH01	*1/*3
escitalopram	rapid metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer and rapid metabolizer	N06AB10	__UNKNOWN__
escitalopram	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N06AB10	__UNKNOWN__
sertraline	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N06AB06	__UNKNOWN__
duloxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AX21	__UNKNOWN__
amoxicillin, clarithromycin, omeprazole	rs7975232	VDR	A	Efficacy	increased	Efficacy_Response	Other:C0079487		A02BC01|J01CA04|J01FA09	rs7975232:A
amoxicillin, clarithromycin, omeprazole	rs2228570	VDR	A	Efficacy	increased	Efficacy_Response	Other:C0079487		A02BC01|J01CA04|J01FA09	rs2228570:A
metoprolol	rs1065852	CYP2D6	A	Metabolism/PK	increased	LADME	Healthy		C07AB02	rs1065852:A
bupropion, naltrexone	rs1800497	ANKK1, DRD2	AA	Efficacy	increased	Efficacy_Response	Other:C0028754		N06AX12|N07BB04	rs1800497:AA
bupropion, naltrexone	rs1800497	ANKK1, DRD2	AG	Efficacy	increased	Efficacy_Response	Other:C0028754		N06AX12|N07BB04	rs1800497:AG
alpha-hydroxymetoprolol	rs1065852	CYP2D6	A	Metabolism/PK	decreased	LADME	Healthy		C07AB02	rs1065852:A
tolperisone	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*10/*10
tolperisone	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Other:Heart_transplantation		L04AD02	*3/*3
dapoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	G04BX14	*10/*10
risperidone	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C1510586	intermediate metabolizer	N05AX08	__UNKNOWN__
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*1	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*1
dapoxetine	CYP2D6*1, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	G04BX14	*10/*41
docetaxel, thalidomide	rs6922548	PPARD	G	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs6922548:G
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6	UGT1A1	*6	Metabolism/PK	increased	LADME	Other:C0022665		L01CE02	*6
o-desmethyltramadol	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0030193|Postoperative	intermediate metabolizer and poor metabolizer	N02AX02	__UNKNOWN__
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*22
naldemedine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:C0027651|Other:C0030193|Other:C0009806		No_ATC	*3/*3
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		N07BC02	*6/*6
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*41, CYP2D6*65	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Other:C0036341	intermediate metabolizer	N05AX08	*10/*10
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*41, CYP2D6*65	CYP2D6	*10/*65	Metabolism/PK	increased	LADME	Other:C0036341	intermediate metabolizer	N05AX08	*10/*65
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*41, CYP2D6*65	CYP2D6	*10/*41	Metabolism/PK	increased	LADME	Other:C0036341	intermediate metabolizer	N05AX08	*10/*41
docetaxel, thalidomide	rs7769719	PPARD	G	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs7769719:G
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
warfarin	rs2288344	NEDD4	G	Dosage	increased	Dosage	Healthy		B01AA03	rs2288344:G
quetiapine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Other:C0005586		N05AH04	*3/*3
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
warfarin	rs17126068	DDHD1	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs17126068:G
tacrolimus	intermediate metabolizer	CYP3A5	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	__UNKNOWN__
primaquine 5,6-orthoquinone	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	P01BA03	__UNKNOWN__
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CE02|L01XA01	rs4148323:AA
primaquine	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	P01BA03	__UNKNOWN__
desvenlafaxine, venlafaxine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0011581	poor metabolizer	N06AX16|N06AX23	__UNKNOWN__
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
acenocoumarol	rs9923231	VKORC1	T	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	rs9923231:T
methotrexate	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*22
salbutamol	rs7903366	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs7903366:T
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*2
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*3
paliperidone, risperidone	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		N05AX08|N05AX13	rs1045642:GG
losartan	rs1057910	CYP2C9	C	Metabolism/PK	decreased	LADME	PK:C0024198		C09CA01	rs1057910:C
sulfapyridine	NAT2*5	NAT2	*5/*5	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*5/*5
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0018839	poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Disease:C0018839	poor metabolizer	B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Disease:C0018839	poor metabolizer	B01AC04	*3/*3
risperidone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0005586|Disease:C0235876|Disease:C0033975|Disease:C0036502	poor metabolizer	N05AX08	__UNKNOWN__
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*16/*16
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*16/*6
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*6/*6
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*6/*7
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*7/*7
salbutamol	rs7081864	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs7081864:A
sulfinpyrazone	rs72551330	UGT1A9	T	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs72551330:T
sulfamethoxazole	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*4/*4	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation	rapid acetylator	J01EC01	*4/*4
icotinib	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*1/*2
icotinib	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*1/*3
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1051792	MICA	AA	Efficacy	decreased	Efficacy_Response	Other:C0038012		No_ATC	rs1051792:AA
warfarin	rs9923231	VKORC1	GG	Dosage	increased	Dosage	Other:C0004238|Other:C0034065|Other:C0042487		B01AA03	rs9923231:GG
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*9	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N02AX02	*1/*4
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*9	CYP2D6	*1/*9	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N02AX02	*1/*9
imipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA02	__UNKNOWN__
sulfapyridine	NAT2*4, NAT2*5	NAT2	*5	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*5
3,4-methylenedioxymethamphetamine	ultrarapid metabolizer genotype	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	V04CX05	__UNKNOWN__
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*2xN	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders	ultrarapid metabolizer	N07BC02	*1/*2xN
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*2/*2xN	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders	ultrarapid metabolizer	N07BC02	*2/*2xN
lithium	rs6438552	GSK3B	GG	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs6438552:GG
tacrolimus	rs1045642	ABCB1	AA	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	rs1045642:AA
lithium	rs2071427	NR1D1, THRA	TT	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs2071427:TT
tacrolimus	poor metabolizers	CYP3A5	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation	poor metabolizer	L04AD02	__UNKNOWN__
morphine	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA01	__UNKNOWN__
endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__
sulfapyridine	NAT2*5	NAT2	*5/*5	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*5/*5
aripiprazole	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0033975	poor metabolizer	N05AX12	__UNKNOWN__
atomoxetine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06BA09	__UNKNOWN__
sulfapyridine	NAT2*4, NAT2*6	NAT2	*6	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*6
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:Heart_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:Heart_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Metabolism/PK	decreased	LADME	Other:Heart_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Metabolism/PK	decreased	LADME	Other:Heart_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*7
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*5/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*7
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*5/*5	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*5
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*5/*6	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*6
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*5/*6J	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*6J
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*5/*7G	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*7G
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*6/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*6/*7
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs1045642:GG
infliximab	HLA-DQA1*05	HLA-DQA1	*05	Efficacy	increased	Adverse_Event	Efficacy:C0010346		L04AB02	*05
tacrolimus	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:AA
sulfapyridine	NAT2*6	NAT2	*6/*6	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*6/*6
enzyme inhibitors	rs700518	CYP19A1	CC	Other	Indeterminado	Efficacy_Response	Disease:C1458155		No_ATC	rs700518:CC
tacrolimus	rs1128503	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1128503:AA
corticosteroids	rs28364072	FCER2	G	Dosage	increased	Dosage	Disease:C0004096		S02BA	rs28364072:G
tacrolimus	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:AA
hydrochlorothiazide, olmesartan	rs34059508	SLC22A1	AG	Metabolism/PK	increased	LADME	Healthy		C03AA03|C09CA08	rs34059508:AG
tacrolimus	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs1045642:AG
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs1045642:GG
hydralazine	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*4/*16	Metabolism/PK	increased	LADME	Other:C0020538|Other:C0032961	rapid acetylator	C02DB02	*4/*16
hydralazine	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*4/*6	Metabolism/PK	increased	LADME	Other:C0020538|Other:C0032961	rapid acetylator	C02DB02	*4/*6
hydralazine	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*4/*7	Metabolism/PK	increased	LADME	Other:C0020538|Other:C0032961	rapid acetylator	C02DB02	*4/*7
haloperidol	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0033975	poor metabolizer	N05AD01	__UNKNOWN__
escitalopram	rs12154537	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB10	rs12154537:G
morphine	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs1128503:AG
morphine	rs1128503	ABCB1	GG	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs1128503:GG
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*16/*16
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*5	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*16/*5
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*16/*6
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*6/*6
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*6/*7
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*7/*7
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*19	NAT2	*4/*4	Dosage, Metabolism/PK	increased	Dosage	Disease:C0041296	rapid acetylator	J04AC01	*4/*4
docetaxel	rs11045585	SLCO1B3	G	Other, Metabolism/PK	decreased	LADME	Disease:C0023055		L01CD02	rs11045585:G
sulfapyridine	NAT2*5, NAT2*7	NAT2	*5/*7	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*5/*7
docetaxel	rs7311358	SLCO1B3	A	Other, Metabolism/PK	decreased	LADME	Disease:C0023055		L01CD02	rs7311358:A
docetaxel	rs4149118	SLCO1B3	G	Other, Metabolism/PK	decreased	LADME	Disease:C0023055		L01CD02	rs4149118:G
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*5/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*7
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*5/*5	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*5
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*5/*6	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*6
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*5/*6J	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*6J
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*5/*7G	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*7G
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*6/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*6/*7
sulfapyridine	NAT2*4, NAT2*7	NAT2	*7	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*7
warfarin	rs9934438	VKORC1	A	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs9934438:A
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:Heart_transplantation	poor metabolizer	L04AD02	*1/*22
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Other:Heart_transplantation	poor metabolizer	L04AD02	*22/*22
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*3
midazolam	rs1544410	VDR	C	Metabolism/PK	increased	LADME	Healthy		N05CD08	rs1544410:C
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1154831	KLRC4	GG	Efficacy	increased	Efficacy_Response	Other:C0038012		No_ATC	rs1154831:GG
diazepam	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05BA01	__UNKNOWN__
escitalopram	intermediate metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0235876|Other:C0003469	intermediate metabolizer	N06AB10	__UNKNOWN__
methadone	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0028043	ultrarapid metabolizer	N07BC02	__UNKNOWN__
fluoxetine	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Efficacy:C0011581|Efficacy:C0028768	ultrarapid metabolizer	N06AB03	__UNKNOWN__
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*14	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*16/*14
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*16	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*16/*16
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*6	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*16/*6
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*7	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*16/*7
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*14	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*6/*14
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*6	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*6/*6
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7/*6	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*7/*6
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*14	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*14
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*16	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*16
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*6	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*6
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*7	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*7
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*14	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*14
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*6	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*6
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*7	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*7
sulfapyridine	NAT2*5, NAT2*6	NAT2	*5/*6	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*5/*6
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*14	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*14
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*16	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*16
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*6	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*6
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*7	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*7
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*14	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*14
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*6	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*6
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*7	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*7
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16	Metabolism/PK	decreased	LADME	Healthy	slow acetylator	No_ATC	*16
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Metabolism/PK	decreased	LADME	Healthy	slow acetylator	No_ATC	*6
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Metabolism/PK	decreased	LADME	Healthy	slow acetylator	No_ATC	*7
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Metabolism/PK	decreased	LADME	Healthy	slow acetylator	No_ATC	*14
bupropion	CYP2B6*6	CYP2B6	*6	Metabolism/PK	increased	LADME	Other:C0011581		N06AX12	*6
codeine	CYP2D6*1, CYP2D6*1xN, CYP2D6*41	CYP2D6	*1xN/*41	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	R05DA04	*1xN/*41
warfarin	rs7294	VKORC1	T	Dosage, Metabolism/PK	increased	Dosage	Healthy		B01AA03	rs7294:T
paramethoxymethamphetamine	normal metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0036502	normal metabolizer	No_ATC	__UNKNOWN__
maraviroc	intermediate metabolizers	CYP3A5	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease	intermediate metabolizer	J05AX09	__UNKNOWN__
clopidogrel	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__
codeine	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*2xN	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	R05DA04	*1/*2xN
endoxifen	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__
codeine	CYP2D6*2, CYP2D6*2xN, CYP2D6*41	CYP2D6	*2xN/*41	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	R05DA04	*2xN/*41
codeine	CYP2D6*1, CYP2D6*1xN, CYP2D6*10	CYP2D6	*1xN/*10	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	R05DA04	*1xN/*10
endoxifen	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0026946	intermediate metabolizer	J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0026946	intermediate metabolizer	J02AC03	*1/*3
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04|N06AB10	*1/*2
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		N06AB04|N06AB10	*1/*3
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	LADME	Healthy		N06AB04|N06AB10	*2/*17
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Metabolism/PK	increased	LADME	Healthy		N06AB04|N06AB10	*3/*17
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease	poor metabolizer	J05AG03	rs3745274:TT
nortriptyline	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0011581	ultrarapid metabolizer	N06AA10	__UNKNOWN__
haloperidol, olanzapine, perphenazine, quetiapine, risperidone	rs1799978	DRD2	C	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AB03|N05AD01|N05AH03|N05AH04|N05AX08	rs1799978:C
maraviroc	poor metabolizers	CYP3A5	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease	poor metabolizer	J05AX09	__UNKNOWN__
citalopram, escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Healthy	ultrarapid metabolizer	N06AB04|N06AB10	*17/*17
nortriptyline	intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0011581	intermediate metabolizer	N06AA10	__UNKNOWN__
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation	poor metabolizer	L04AD02	*1/*22
hydrocodone	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	R05DA03	__UNKNOWN__
imipramine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA02	__UNKNOWN__
atomoxetine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06BA09	__UNKNOWN__
imipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA02	__UNKNOWN__
imipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06AA02	__UNKNOWN__
imipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA02	__UNKNOWN__
endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__
risperidone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0033975	poor metabolizer	N05AX08	__UNKNOWN__
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*2	Efficacy, Metabolism/PK	decreased	LADME	Disease:C1956346	poor metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*8	Efficacy, Metabolism/PK	decreased	LADME	Disease:C1956346	poor metabolizer	B01AC04	*1/*8
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*2/*2	Efficacy, Metabolism/PK	decreased	LADME	Disease:C1956346	poor metabolizer	B01AC04	*2/*2
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	R05DA09	*10/*10
tamoxifen	intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	Dosage	Disease:C1458155	intermediate metabolizer	L02BA01	__UNKNOWN__
propafenone	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Other:C0039231	poor metabolizer	C01BC03	*1/*5
propafenone	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	CYP2D6	*2/*36	Metabolism/PK	increased	LADME	Other:C0039231	poor metabolizer	C01BC03	*2/*36
propafenone	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Other:C0039231	poor metabolizer	C01BC03	*5/*10
propafenone	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	CYP2D6	*5/*5	Metabolism/PK	increased	LADME	Other:C0039231	poor metabolizer	C01BC03	*5/*5
imipramine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Dosage	decreased	Dosage	Disease:C0011581	poor metabolizer	N06AA02	*4/*4
imipramine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Dosage	decreased	Dosage	Disease:C0011581	poor metabolizer	N06AA02	*4/*5
citalopram, escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB04|N06AB10	*1/*17
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*2	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C1956346	poor metabolizer	B01AC04	*1/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*8	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C1956346	poor metabolizer	B01AC04	*1/*8
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*2/*2	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C1956346	poor metabolizer	B01AC04	*2/*2
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*4/*10	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*4/*10
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*5/*10
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*5/*14	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*5/*14
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*10/*10
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*10/*18	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*10/*18
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*10/*36	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*10/*36
tolterodine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	G04BD07	__UNKNOWN__
risperidone	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0033975|Other:C0036341	intermediate metabolizer and poor metabolizer	N05AX08	__UNKNOWN__
tamoxifen, endoxifen	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	L02BA01	*2
tamoxifen, endoxifen	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	L02BA01	*3
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX08	*5/*10
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX08	*4/*10
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX08	*10/*10
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX08	*10/*41
venlafaxine	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AX16	__UNKNOWN__
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*2xN	Dosage	increased	Dosage	Other:Opioid-Related_Disorders	ultrarapid metabolizer	N07BC02	*1/*2xN
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*2/*2xN	Dosage	increased	Dosage	Other:Opioid-Related_Disorders	ultrarapid metabolizer	N07BC02	*2/*2xN
desipramine, imipramine	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06AA01|N06AA02	*4/*4
desipramine, imipramine	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06AA01|N06AA02	*4/*5
trans 4-hydroxypraziquantel	rs890293	CYP2J2	AA	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	rs890293:AA
trans 4-hydroxypraziquantel	rs890293	CYP2J2	AC	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	rs890293:AC
venlafaxine	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AX16	__UNKNOWN__
perphenazine	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N05AB03	__UNKNOWN__
tacrolimus	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Dosage, Metabolism/PK	decreased	Dosage	Other:Heart_transplantation	intermediate metabolizer and poor metabolizer	L04AD02	*1/*2
tacrolimus	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Dosage, Metabolism/PK	decreased	Dosage	Other:Heart_transplantation	intermediate metabolizer and poor metabolizer	L04AD02	*1/*3
tacrolimus	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Dosage, Metabolism/PK	decreased	Dosage	Other:Heart_transplantation	intermediate metabolizer and poor metabolizer	L04AD02	*2/*2
tacrolimus	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Dosage, Metabolism/PK	decreased	Dosage	Other:Heart_transplantation	intermediate metabolizer and poor metabolizer	L04AD02	*2/*3
vortioxetine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	N06AX26	*4/*4
fentanyl	poor metabolizers	__INTRONIC__	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0030193	poor metabolizer	N02AB03	
escitalopram	ultrarapid metabolizer phenotype	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0011581	ultrarapid metabolizer	N06AB10	__UNKNOWN__
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8	CYP2C9	*1/*1	Metabolism/PK	increased	Dosage	Healthy	normal metabolizer	B01AA03	*1/*1
nortriptyline	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0011581	poor metabolizer	N06AA10	__UNKNOWN__
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*1/*5
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*5/*10
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*10
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*14	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*14
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*41
escitalopram	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0011581	poor metabolizer	N06AB10	__UNKNOWN__
ethanol	rs2075572	OPRM1	G	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs2075572:G
proton pump inhibitors	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0079487	intermediate metabolizer and poor metabolizer	A02BC	__UNKNOWN__
tramadol	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	N02AX02	__UNKNOWN__
metoprolol	poor metabolizers	CYP2D6	__UNKNOWN__	Dosage	decreased	Dosage	Healthy	poor metabolizer	C07AB02	__UNKNOWN__
ethanol	rs548646	OPRM1	T	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs548646:T
gliclazide	rs2237892	KCNQ1	T	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BB09	rs2237892:T
nicotine	rs1799732	DRD2	G/del	Efficacy	increased	Efficacy_Response	Disease:C0039338		N07BA01	rs1799732:G/del
nicotine	rs1799732	DRD2	del/del	Efficacy	increased	Efficacy_Response	Disease:C0039338		N07BA01	rs1799732:del/del
paroxetine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB05	__UNKNOWN__
desipramine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA01	__UNKNOWN__
linagliptin	rs7903146	TCF7L2	CC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH05	rs7903146:CC
linagliptin	rs7903146	TCF7L2	CT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH05	rs7903146:CT
citalopram, escitalopram	poor metabolizer phenotype	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C0011581	poor metabolizer	N06AB04|N06AB10	__UNKNOWN__
ethanol	rs681243	OPRM1	T	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs681243:T
dextromethorphan	normal metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	R05DA09	__UNKNOWN__
tramadol	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	N02AX02	__UNKNOWN__
hydroxybupropion(bupropion)	poor metabolizer and intermediate metabolizer genotypes	CYP2B6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N06AX12	__UNKNOWN__
tramadol	normal metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	N02AX02	__UNKNOWN__
amoxicillin, clarithromycin, esomeprazole	normal metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Disease:C0017152	normal metabolizer	A02BC05|J01CA04|J01FA09	__UNKNOWN__
dabigatran	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	B01AE07	__UNKNOWN__
escitalopram	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB10	__UNKNOWN__
venlafaxine	poor metabolizers	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Efficacy:C0011581	poor metabolizer	N06AX16	__UNKNOWN__
bupropion	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs4680:AG
bupropion	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs4680:GG
aripiprazole	intermediate metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX12	__UNKNOWN__
codeine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, tramadol	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0027651|Other:C0030193	intermediate metabolizer and poor metabolizer	N02AA01|N02AA03|N02AA05|N02AB03|N02AX02|N07BC02|R05DA03|R05DA04	__UNKNOWN__
venlafaxine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0011581	poor metabolizer	N06AX16	__UNKNOWN__
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*1/*5
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*5/*10
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*10
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*14	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*14
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*41
ethanol	rs1461773	OPRM1	A	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs1461773:A
3,4-methylenedioxymethamphetamine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Efficacy_Response	Healthy		V04CX05	*4/*4
3,4-methylenedioxymethamphetamine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*5	Efficacy	increased	Efficacy_Response	Healthy		V04CX05	*3/*5
endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__
ethanol	rs3778148	OPRM1	T	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs3778148:T
amoxicillin, clarithromycin, lansoprazole	normal metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Efficacy:C0079487	normal metabolizer	A02BC03|J01CA04|J01FA09	__UNKNOWN__
amoxicillin, clarithromycin, omeprazole	normal metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Efficacy:C0079487	normal metabolizer	A02BC01|J01CA04|J01FA09	__UNKNOWN__
midazolam	rs4516035	VDR	T	Metabolism/PK	increased	LADME	Healthy		N05CD08	rs4516035:T
codeine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	*1xN/*1	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	R05DA04	*1xN/*1
oxycodone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N02AA05	__UNKNOWN__
oxymorphone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__
oxymorphone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__
noroxymorphone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__
amitriptyline	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C1328447	poor metabolizer	N06AA09	__UNKNOWN__
noroxymorphone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__
tramadol	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C1328447	poor metabolizer	N02AX02	__UNKNOWN__
tamsulosin	intermediate metabolizer and normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	normal metabolizer and intermediate metabolizer	G04CA02	__UNKNOWN__
noroxycodone	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	ultrarapid metabolizer	No_ATC	__UNKNOWN__
morphine	rs4680	COMT	A	Efficacy	increased	Efficacy_Response	Disease:C0024031		N02AA01	rs4680:A
voriconazole	poor metabolizers	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	J02AC03	__UNKNOWN__
tamsulosin	intermediate metabolizer and normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	normal metabolizer and intermediate metabolizer	G04CA02	__UNKNOWN__
antidepressants	rs3800373	FKBP5	AC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs3800373:AC
antidepressants	rs3800373	FKBP5	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs3800373:CC
tamsulosin	intermediate metabolizer and normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	normal metabolizer and intermediate metabolizer	G04CA02	__UNKNOWN__
venlafaxine	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AX16	__UNKNOWN__
voriconazole	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	J02AC03	__UNKNOWN__
opioids	rs4680	COMT	GG	Dosage	increased	Dosage	Disease:C0030193|Postoperative		N02A	rs4680:GG
atenolol, metoprolol	rs1042714	ADRB2	CC	Efficacy	increased	Efficacy_Response	Other:C0039231		C07AB02|C07AB03	rs1042714:CC
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*3/*3
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*5	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*3/*5
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*4/*4
tamsulosin	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	G04CA02	__UNKNOWN__
gliclazide	rs2237895	KCNQ1	C	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BB09	rs2237895:C
warfarin	normal metabolizers	CYP2C9	__UNKNOWN__	Dosage	increased	Dosage	Healthy	normal metabolizer	B01AA03	__UNKNOWN__
solanidine	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0235876	poor metabolizer	No_ATC	__UNKNOWN__
flecainide	normal metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	Indeterminado	LADME	Disease:C0039231|Supraventricular	normal metabolizer	C01BC04	__UNKNOWN__
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*3/*3
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*5	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*3/*5
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*4/*4
voriconazole	poor metabolizers	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*2
voriconazole	poor metabolizers	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*3
voriconazole	poor metabolizers	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*3/*3
pridopidine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__
morphine	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	N02AA01	__UNKNOWN__
tramadol	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AX02	__UNKNOWN__
rabeprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC04	__UNKNOWN__
bupropion	CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0032961	intermediate metabolizer and poor metabolizer	N06AX12	*2
bupropion	CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3	Metabolism/PK	decreased	LADME	Disease:C0032961	intermediate metabolizer and poor metabolizer	N06AX12	*3
dextromethadone, levomethadone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*1xN	Metabolism/PK	decreased	LADME	Other:C0028043		N07BC02|N07BC05	*1/*1xN
methadone	rs1799971	OPRM1	AA	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	rs1799971:AA
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	N07BA01	*1/*2
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	N07BA01	*1/*9
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*17	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	N07BA01	*1/*17
metronidazole	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	P01AB01	*1/*2
metronidazole	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	P01AB01	*1/*9
metronidazole	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*17	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	P01AB01	*1/*17
arsenic compounds	rs4920037	CBS	AA	Toxicity, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs4920037:AA
arsenic compounds	rs4920037	CBS	AG	Toxicity, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs4920037:AG
dextromethadone, levomethadone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Other:C0028043		N07BC02|N07BC05	*3/*4
dextromethadone, levomethadone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Other:C0028043		N07BC02|N07BC05	*4/*4
dextromethadone, levomethadone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Other:C0028043		N07BC02|N07BC05	*4/*6
morphine	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative	ultrarapid metabolizer	N02AA01	__UNKNOWN__
codeine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	R05DA04	__UNKNOWN__
clomipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA04	__UNKNOWN__
o-desmethyltramadol	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0027651|Other:C0030193	intermediate metabolizer and poor metabolizer	N02AX02	__UNKNOWN__
levomethadone	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders	ultrarapid metabolizer	N07BC05	__UNKNOWN__
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs9934438:GG
voriconazole	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	J02AC03	__UNKNOWN__
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*9	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AX02	*4/*4
methotrexate	rs3761548	FOXP3	G	Other	decreased	Efficacy_Response	Disease:C0235763		L04AX03	rs3761548:G
atenolol, metoprolol	rs1042713	ADRB2	AA	Efficacy	increased	Efficacy_Response	Other:C0039231		C07AB02|C07AB03	rs1042713:AA
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*3
n-desmethyltramadol(tramadol)	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0027651|Other:C0030193	intermediate metabolizer and poor metabolizer	N02AX02	__UNKNOWN__
tamoxifen, endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	L02BA01	__UNKNOWN__
gemcitabine	rs11598702	NT5C2	TT	Metabolism/PK	decreased	LADME	Healthy		L01BC05	rs11598702:TT
gemcitabine	rs1048977	CDA	TT	Metabolism/PK	decreased	LADME	Healthy		L01BC05	rs1048977:TT
omeprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC01	__UNKNOWN__
oxymorphone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*1	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	No_ATC	*1/*1
oxymorphone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*9	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	No_ATC	*1/*9
oxymorphone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*17, CYP2D6*41	CYP2D6	*2/*9	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	No_ATC	*2/*9
oxymorphone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*2	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	No_ATC	*1/*2
oxymorphone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*17, CYP2D6*41	CYP2D6	*2/*2	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	No_ATC	*2/*2
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs7202877	CTRB1, CTRB2	GG	Efficacy	decreased	Efficacy_Response	Other:C0011849		No_ATC	rs7202877:GG
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs7202877	CTRB1, CTRB2	GT	Efficacy	decreased	Efficacy_Response	Other:C0011849		No_ATC	rs7202877:GT
lansoprazole, omeprazole	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0079487	intermediate metabolizer and poor metabolizer	A02BC01|A02BC03	__UNKNOWN__
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB06	*6/*6
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*6/*9	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB06	*6/*9
olanzapine	poor metabolizers	CYP2C9	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N05AH03	__UNKNOWN__
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*3	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*3
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*4
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*5
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*6	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*6
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*9	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*9
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*10
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*17	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*17
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*29	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*29
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*41	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*41
arsenic compounds	rs234709	CBS	CT	Toxicity, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs234709:CT
arsenic compounds	rs234709	CBS	TT	Toxicity, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs234709:TT
3-hydroxycotinine, 3-hydroxycotinine glucuronide	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*10	CYP2A6	*1	Metabolism/PK	increased	LADME	Other:C0039338	normal metabolizer and intermediate metabolizer	No_ATC	*1
3-hydroxycotinine, 3-hydroxycotinine glucuronide	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*10	CYP2A6	*2	Metabolism/PK	increased	LADME	Other:C0039338	normal metabolizer and intermediate metabolizer	No_ATC	*2
risperidone	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0033975	ultrarapid metabolizer	N05AX08	__UNKNOWN__
risperidone	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	__UNKNOWN__
selective beta-2-adrenoreceptor agonists	rs2239179	VDR	C	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC	rs2239179:C
selective beta-2-adrenoreceptor agonists	rs1540339	VDR	C	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC	rs1540339:C
endoxifen	poor metabolizers	CYP2C9	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__
clopidogrel	rs12248560	CYP2C19	CT	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs12248560:CT
clopidogrel	rs12248560	CYP2C19	TT	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs12248560:TT
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0035435|Disease:C0699744	intermediate metabolizer	J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0035435|Disease:C0699744	intermediate metabolizer	J02AC03	*1/*3
endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__
carisoprodol	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	M03BA02	*1/*2
lansoprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC03	__UNKNOWN__
imipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0011581	poor metabolizer	N06AA02	__UNKNOWN__
gemigliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin	rs3765467	GLP1R	AA	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02|A10BH03|A10BH05	rs3765467:AA
gemigliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin	rs3765467	GLP1R	AG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02|A10BH03|A10BH05	rs3765467:AG
methadone	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N07BC02	rs1045642:AA
fentanyl	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AB03	*1/*3
fentanyl	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*6	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AB03	*1/*6
fentanyl	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AB03	*3/*3
fentanyl	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*3/*6	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AB03	*3/*6
fentanyl	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*6/*6	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AB03	*6/*6
gliclazide	intermediate metabolizers	CYP2C9	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	A10BB09	__UNKNOWN__
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
norquetiapine	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	No_ATC	__UNKNOWN__
voriconazole	intermediate metabolizers	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0026946	intermediate metabolizer	J02AC03	*1/*2
voriconazole	intermediate metabolizers	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0026946	intermediate metabolizer	J02AC03	*1/*3
tropisetron	CYP2D6*1, CYP2D6*2xN	CYP2D6	*1/*2xN	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	A04AA03	*1/*2xN
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB04|N06AB10	*2/*2
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB04|N06AB10	*3/*3
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB04|N06AB10	*2/*3
indomethacin	rs2153628	CYP2C9	G	Efficacy	increased	Efficacy_Response	Healthy		S01BC01	rs2153628:G
gemcitabine	rs2072671	CDA	AA	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC05	rs2072671:AA
tacrolimus	poor metabolizer genotype	CYP3A5	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:Liver_transplantation	poor metabolizer	L04AD02	__UNKNOWN__
venlafaxine	rs25531	SLC6A4	TT	Efficacy	increased	Efficacy_Response	Disease:C0003469		N06AX16	rs25531:TT
endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__
omeprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC01	__UNKNOWN__
nimodipine	rs2239128	CACNA1C	CC	Efficacy	increased	Efficacy_Response	Healthy		C08CA06	rs2239128:CC
endoxifen	intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer	No_ATC	__UNKNOWN__
nimodipine	rs2239050	CACNA1C	CG	Efficacy	increased	Efficacy_Response	Healthy		C08CA06	rs2239050:CG
omeprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC01	__UNKNOWN__
tramadol	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	N02AX02	__UNKNOWN__
omeprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC01	__UNKNOWN__
tramadol	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AX02	__UNKNOWN__
maraviroc	poor metabolizers	CYP3A5	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease	poor metabolizer	J05AX09	__UNKNOWN__
venlafaxine	rs3810651	GABRQ	AA	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX16	rs3810651:AA
venlafaxine	rs3810651	GABRQ	AT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX16	rs3810651:AT
metoprolol	normal metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0032961	normal metabolizer	C07AB02	__UNKNOWN__
cytarabine, idarubicin	rs80143932	DCK	G	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs80143932:G
fentanyl, hydromorphone, opioids, oxycodone, tramadol	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Dosage	increased	Dosage	Other:C0549433	ultrarapid metabolizer	N02A|N02AA03|N02AA05|N02AB03|N02AX02	__UNKNOWN__
2-hydroxyatorvastatin, 4-hydroxyatorvastatin, atorvastatin	UGT1A3*1, UGT1A3*2	UGT1A3	*2	Metabolism/PK	decreased	LADME	Healthy		C10AA05	*2
clozapine, n-desmethylclozapine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	
ibogaine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders	poor metabolizer	No_ATC	__UNKNOWN__
atorvastatin, atorvastatin lactone	CYP3A4*1, CYP3A4*2, CYP3A4*22	CYP3A4	*2	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	C10AA05	*2
atorvastatin, atorvastatin lactone	CYP3A4*1, CYP3A4*2, CYP3A4*22	CYP3A4	*22	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	C10AA05	*22
atomoxetine	CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Other:C1263846	intermediate metabolizer	N06BA09	*10/*10
atomoxetine	CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Efficacy_Response	Other:C1263846	intermediate metabolizer	N06BA09	*10/*10
amphetamine, lisdexamfetamine	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C1263846	poor metabolizer	N06BA12	__UNKNOWN__
selective serotonin reuptake inhibitors, venlafaxine	rs502434	GRIA3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB|N06AX16	rs502434:CC
nicotine	CYP2A6*1, CYP2A6*41	CYP2A6	*41	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*41
nicotine	CYP2A6*1, CYP2A6*39	CYP2A6	*39	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*39
isoniazid	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	__UNKNOWN__
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*3
tumor necrosis factor alpha (tnf-alpha) inhibitors	HLA-DQA1*05	HLA-DQA1	*05	Efficacy	decreased	Efficacy_Response	Other:C0021390|Other:C0021368		No_ATC	*05
clopidogrel	rs4244285	CYP2C19	AA	Dosage, Efficacy	Indeterminado	Dosage	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Dosage, Efficacy	Indeterminado	Dosage	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AG
metoprolol	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*95, CYP2D6*97	CYP2D6	*10/*87	Metabolism/PK	increased	LADME	Healthy		C07AB02	*10/*87
metoprolol	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*95, CYP2D6*97	CYP2D6	*10/*95	Metabolism/PK	increased	LADME	Healthy		C07AB02	*10/*95
metoprolol	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*95, CYP2D6*97	CYP2D6	*97/*97	Metabolism/PK	increased	LADME	Healthy		C07AB02	*97/*97
voriconazole	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	J02AC03	__UNKNOWN__
1-hydroxymidazolam, midazolam	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Healthy		N05CD08	*1/*22
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy	ultrarapid metabolizer	J02AC03	*1/*17
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AG
selective serotonin reuptake inhibitors, venlafaxine	rs3761554	GRIA3	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB|N06AX16	rs3761554:TT
warfarin	rs339097	CALU	G	Dosage	increased	Dosage	Healthy		B01AA03	rs339097:G
isoniazid	intermediate acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0041296	intermediate acetylator and rapid acetylator	J04AC01	__UNKNOWN__
dihydroartemisinin	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Other:C0024530|Falciparum		P01BE01	*6/*6
dihydroartemisinin	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*18/*18	Metabolism/PK	decreased	LADME	Other:C0024530|Falciparum		P01BE01	*18/*18
dihydroartemisinin	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*1/*6	Metabolism/PK	decreased	LADME	Other:C0024530|Falciparum		P01BE01	*1/*6
desbutyl lumefantrine	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:C0024530|Falciparum		No_ATC	*1/*3
sertraline	CYP2D6*1, CYP2D6*2	CYP2D6	*2	Metabolism/PK	decreased	LADME	Other:C0036502|Other:C0011581|Other:C0003469|Other:C1704373		N06AB06	*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Other:C0036502|Other:C0011581|Other:C0003469|Other:C1704373	intermediate metabolizer and poor metabolizer	N06AB06	*1/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Other:C0036502|Other:C0011581|Other:C0003469|Other:C1704373	intermediate metabolizer and poor metabolizer	N06AB06	*2/*2
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	decreased	LADME	Other:C0036502|Other:C0011581|Other:C0003469|Other:C1704373	intermediate metabolizer and poor metabolizer	N06AB06	*2/*17
tacrolimus	rs3740066	ABCC2	TT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs3740066:TT
levonorgestrel	poor metabolizer	CYP2B6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease	poor metabolizer	G03AD01	__UNKNOWN__
selective serotonin reuptake inhibitors, venlafaxine	rs3761555	GRIA3	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB|N06AX16	rs3761555:TT
warfarin	rs310279	NKX2-6	AG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs310279:AG
warfarin	rs310279	NKX2-6	GG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs310279:GG
cytarabine, idarubicin	rs2306744	DCK	T	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs2306744:T
venlafaxine	rs7997012	HTR2A	AG	Efficacy	increased	Efficacy_Response	Disease:C0003469		N06AX16	rs7997012:AG
venlafaxine	rs7997012	HTR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0003469		N06AX16	rs7997012:GG
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:therapeutic_drug_monitoring_analyses	poor metabolizer	J02AC03	*2/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:therapeutic_drug_monitoring_analyses	poor metabolizer	J02AC03	*2/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:therapeutic_drug_monitoring_analyses	poor metabolizer	J02AC03	*3/*3
antiepileptics	rs16935279	__INTRONIC__	CC	Metabolism/PK	decreased	LADME	Disease:C0005586|Disease:C0033975		N03A	rs16935279:CC
antiepileptics	rs16935279	__INTRONIC__	CT	Metabolism/PK	decreased	LADME	Disease:C0005586|Disease:C0033975		N03A	rs16935279:CT
follitropin beta, urofollitropin	rs6166	FSHR	CC	Dosage	increased	Dosage	Healthy		G03GA04|G03GA06	rs6166:CC
follitropin beta, urofollitropin	rs6166	FSHR	CT	Dosage	increased	Dosage	Healthy		G03GA04|G03GA06	rs6166:CT
paroxetine	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0011581	ultrarapid metabolizer	N06AB05	__UNKNOWN__
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
warfarin	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Healthy		B01AA03	*1/*17
warfarin	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Healthy		B01AA03	*17/*17
atorvastatin	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*8, CYP2C19*11	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Other:C0007222	poor metabolizer	C10AA05	*2
atorvastatin	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*8, CYP2C19*11	CYP2C19	*4	Efficacy	decreased	Efficacy_Response	Other:C0007222	poor metabolizer	C10AA05	*4
atorvastatin	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*8, CYP2C19*11	CYP2C19	*8	Efficacy	decreased	Efficacy_Response	Other:C0007222	poor metabolizer	C10AA05	*8
cisplatin, irinotecan	rs9597	UBE2I	CG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CE02|L01XA01	rs9597:CG
warfarin	rs4386623	FRAS1	AA	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs4386623:AA
warfarin	rs4386623	FRAS1	AG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs4386623:AG
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*1
warfarin	rs1890109	FAM201A	AG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1890109:AG
warfarin	rs1890109	FAM201A	GG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1890109:GG
methotrexate	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3
valproic acid	rs3812718	SCN1A	T	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs3812718:T
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0041582		A02BC02	*1/*1
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0041582		A02BC02	*1/*2
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0041582		A02BC02	*1/*3
risperidone	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*10
capecitabine	rs1801159	DPYD	CC	Efficacy	increased	Efficacy_Response	Disease:C2931822		L01BC06	rs1801159:CC
capecitabine	rs1801159	DPYD	CT	Efficacy	increased	Efficacy_Response	Disease:C2931822		L01BC06	rs1801159:CT
nicotine	rs6277	DRD2	A	Efficacy	increased	Efficacy_Response	Healthy		N07BA01	rs6277:A
captopril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA01	rs1799752:del/del
apixaban, dabigatran, edoxaban, rivaroxaban	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:C0040038		B01AE07|B01AF01|B01AF02|B01AF03	rs776746:CC
bupropion	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12	
bupropion	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12	
losartan	CYP2C9*1, CYP2C9*5, CYP2C9*6	CYP2C9	*1/*5	Metabolism/PK	decreased	LADME	Healthy		C09CA01	*1/*5
losartan	CYP2C9*1, CYP2C9*5, CYP2C9*6	CYP2C9	*5/*6	Metabolism/PK	decreased	LADME	Healthy		C09CA01	*5/*6
ethanol	rs648007	OPRM1	A	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs648007:A
famotidine, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BA03|A02BC01	*1/*1
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*2
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*3
esomeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC05	*1/*1
midazolam	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		N05CD08	*1/*22
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*1
ethanol	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs1799971:AG
ethanol	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs1799971:GG
tacrolimus	rs776746	CYP3A5	CC	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	increased	LADME	Disease:C0024530		P01BA03	*4/*41
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*6	Metabolism/PK	increased	LADME	Disease:C0024530		P01BA03	*5/*6
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T
nicotine	rs2337980	CHRNA7	CC	Efficacy	increased	Efficacy_Response	Healthy		N07BA01	rs2337980:CC
bupropion	rs1799732	DRD2	GG	Efficacy	increased	Efficacy_Response	Disease:C0039338		N06AX12	rs1799732:GG
warfarin	rs7294	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:CT
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT
simvastatin	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	Indeterminado	LADME	Healthy		C10AA01	*1/*22
simvastatin	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	Indeterminado	LADME	Healthy		C10AA01	*22/*22
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01	*1/*1
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01	*1/*2
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01	*1/*3
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*17
quetiapine	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:C0033975		N05AH04	*1/*22
quetiapine	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Other:C0033975		N05AH04	*22/*22
warfarin	rs1131873	EPHX1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs1131873:A
trimipramine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*2
famotidine, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BA03|A02BC01	*1/*1
metformin	rs8192675	SLC2A2	C	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs8192675:C
warfarin	rs28371686	CYP2C9	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs28371686:G
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:C0026272		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:C0026272		L04AD02	rs776746:TT
warfarin	rs28371685	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs28371685:T
duloxetine	rs3892097	CYP2D6	CC	Efficacy	increased	Efficacy_Response	Other:C0085762|Other:C0011581		N06AX21	rs3892097:CC
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	increased	LADME	Disease:C0027651		L01CE02	*1/*28
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	increased	LADME	Disease:C0027651		L01CE02	*28/*28
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC04	*1/*2
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC04	*1/*3
warfarin	rs9332131	CYP2C9	del	Dosage	decreased	Dosage	Healthy		B01AA03	rs9332131:del
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		L04AD02	*3/*3
hydroxyurea	rs4671393	BCL11A	A	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		No_ATC	rs4671393:A
warfarin	rs7900194	CYP2C9	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs7900194:A
rosiglitazone	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BG02	*3
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	*1/*3
pantoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*1/*2
beta blocking agents	rs36217263	KL	A/del	Efficacy	decreased	Efficacy_Response	Other:C0020538		S01ED	rs36217263:A/del
beta blocking agents	rs36217263	KL	del/del	Efficacy	decreased	Efficacy_Response	Other:C0020538		S01ED	rs36217263:del/del
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*6
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0026946	intermediate metabolizer and poor metabolizer	J02AC03	*2/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0026946	intermediate metabolizer and poor metabolizer	J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0026946	intermediate metabolizer and poor metabolizer	J02AC03	*1/*3
gemcitabine	rs12806698	RRM1	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs12806698:AC
fluoxetine, sertraline	rs57098334	SLC6A4	(CCCACCCGA)12/(CCCACCCGA)12	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB06	rs57098334:(CCCACCCGA)12/(CCCACCCGA)12
bupropion	rs8075924	ACE	TT	Efficacy	decreased	Efficacy_Response	Other:C0011581		N06AX12	rs8075924:TT
lorazepam, valproic acid	rs7438284	UGT2B7	A	Efficacy	increased	Efficacy_Response	Healthy		N03AG01|N05BA06	rs7438284:A
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC04	*1/*1
lorazepam, valproic acid	rs7439366	UGT2B7	T	Efficacy	increased	Efficacy_Response	Healthy		N03AG01|N05BA06	rs7439366:T
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CC
sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB06	
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*3/*3
sunitinib	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Healthy		L01EX01	*1/*22
sunitinib	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	decreased	LADME	Healthy		L01EX01	*22/*22
hydroxychloroquine	rs3735451	CYP3A4	CC	Metabolism/PK	decreased	LADME	Other:C0003873|Other:C0024141		P01BA02	rs3735451:CC
fluorouracil	rs25487	XRCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC02	rs25487:CC
mirtazapine	CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:C0235876		N06AX11	*6/*6
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0014544		N05BA09	*1/*2
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0014544		N05BA09	*1/*3
gemcitabine	rs11030918	RRM1	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs11030918:CT
rosuvastatin	rs3212207	HNF4A	C	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs3212207:C
tacrolimus	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs1045642:AG
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs1045642:GG
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA07	*1/*3
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA07	*2/*3
risperidone	intermediate metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX08	__UNKNOWN__
rosuvastatin	rs8187710	ABCC2	A	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs8187710:A
clopidogrel	rs4244285	CYP2C19	AA	Dosage, Efficacy	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Dosage, Efficacy	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AG
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*1
cyclosporine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Healthy		L04AD01	*1/*3
cyclosporine	rs35599367	CYP3A4	A	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD01	rs35599367:A
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*1/*1	Metabolism/PK	decreased	LADME	Other:C0003469|Other:C0235876|Other:C0011581	normal metabolizer	N06AB03	*1/*1
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Other:C0003469|Other:C0235876|Other:C0011581	normal metabolizer	N06AB03	*10/*10
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Other:C0003469|Other:C0235876|Other:C0011581	normal metabolizer	N06AB03	*1/*4
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Other:C0003469|Other:C0235876|Other:C0011581	normal metabolizer	N06AB03	*1/*10
codeine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0022661		R05DA04	*4/*4
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Other:patients_with_decreased_concentrations_of_voriconazole	ultrarapid metabolizer	J02AC03	*1/*17
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Other:patients_with_decreased_concentrations_of_voriconazole	ultrarapid metabolizer	J02AC03	*17/*17
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation	normal metabolizer and intermediate metabolizer	L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation	normal metabolizer and intermediate metabolizer	L04AD02	rs776746:TT
docetaxel, thalidomide	rs3734254	PPARD	T	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs3734254:T
atenolol, metoprolol	rs17117817	OR10P1	G	PD	decreased	Efficacy_Response	Other:C0020538		C07AB02|C07AB03	rs17117817:G
aripiprazole	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*5
aripiprazole	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*10
aripiprazole	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*41	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*41
trimipramine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*2
pioglitazone	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*1	Metabolism/PK	increased	LADME	Healthy		A10BG03	*1/*1
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*3	Metabolism/PK	increased	LADME	Healthy		N05AX12	*3/*3
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N05AX12	*4/*4
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3
carboplatin, gemcitabine	rs12806698	RRM1	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA02	rs12806698:AC
famotidine, lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		A02BA03|A02BC03	*1/*2
famotidine, lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		A02BA03|A02BC03	*1/*3
famotidine, lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BA03|A02BC03	*1/*1
abatacept	HLA-DRB1*04:01, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:10, HLA-DRB1*10:01	HLA-DRB1	*04:01	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*04:01
abatacept	HLA-DRB1*04:01, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:10, HLA-DRB1*10:01	HLA-DRB1	*04:04	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*04:04
abatacept	HLA-DRB1*04:01, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:10, HLA-DRB1*10:01	HLA-DRB1	*04:05	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*04:05
abatacept	HLA-DRB1*04:01, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:10, HLA-DRB1*10:01	HLA-DRB1	*04:10	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*04:10
abatacept	HLA-DRB1*04:01, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:10, HLA-DRB1*10:01	HLA-DRB1	*10:01	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*10:01
methadone	rs17180299	__INTRONIC__	AG	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs17180299:AG
methadone	rs17180299	__INTRONIC__	GG	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs17180299:GG
warfarin	rs339097	CALU	G	Dosage	increased	Dosage	Healthy		B01AA03	rs339097:G
noscapine	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*9	CYP2C9	*1/*1	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	R05DA07	*1/*1
noscapine	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*9	CYP2C9	*1/*9	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	R05DA07	*1/*9
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*3/*3
atenolol, metoprolol	rs2364349	SNX9	A	PD	decreased	Efficacy_Response	Other:C0020538		C07AB02|C07AB03	rs2364349:A
tacrolimus	rs11265572	__INTRONIC__	GT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs11265572:GT
tacrolimus	rs11265572	__INTRONIC__	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs11265572:TT
warfarin	rs10871454	STX4	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs10871454:T
sirolimus, temsirolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:C0877645		L01EG01	rs776746:CT
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		J02AC03	*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		J02AC03	*3
enalapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA02	rs1799752:del/del
uracil	DPYD c.295_298delTCAT (*7), DPYD Reference	DPYD	c.295_298delTCAT (*7)	Metabolism/PK	increased	LADME	Healthy		H03BA	c.295_298delTCAT (*7)
uracil	DPYD c.2846A>T, DPYD Reference	DPYD	c.2846A>T	Metabolism/PK	increased	LADME	Healthy		H03BA	c.2846A>T
uracil	DPYD c.1679T>G (*13), DPYD Reference	DPYD	c.1679T>G (*13)	Metabolism/PK	increased	LADME	Healthy		H03BA	c.1679T>G (*13)
uracil	DPYD c.1905+1G>A (*2A), DPYD Reference	DPYD	c.1905	Metabolism/PK	increased	LADME	Healthy		H03BA	c.1905
uracil	DPYD c.1905+1G>A (*2A), DPYD Reference	DPYD	1G>A (*2A)	Metabolism/PK	increased	LADME	Healthy		H03BA	1G>A (*2A)
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*29	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*29
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*41
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*2/*41
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*35/*41
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*4
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*5
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*2/*4
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*3
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*35/*4
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*6
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*35/*5
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*2/*9
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*10
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*2/*10
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*35/*10
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*4/*4
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*41/*4
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*41/*3
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*10/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*10/*4
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*9/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*9/*41
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*17/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*17/*41
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*41/*41
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*9/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*9/*5
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*29	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*29
atorvastatin	CYP3A5*3	CYP3A5	*3/*3	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	*3/*3
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	*10/*10
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	*1/*10
escitalopram	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	__UNKNOWN__
escitalopram	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N06AB10	__UNKNOWN__
efavirenz	rs3842	ABCB1	CC	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3842:CC
efavirenz	poor metabolizer	CYP2B6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	J05AG03	__UNKNOWN__
bcr-abl tyrosine kinase inhibitors	HLA-A*03:01	HLA-A	*03:01	Efficacy	decreased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA	*03:01
bcr-abl tyrosine kinase inhibitors	HLA-A*23:17	HLA-A	*23:17	Efficacy	decreased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA	*23:17
bcr-abl tyrosine kinase inhibitors	HLA-B*57:03	HLA-B	*57:03	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA	*57:03
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*7	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*7	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*3
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*2	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*2
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*9	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*9
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*10
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*35	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*35
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*41	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*41
antidepressants	poor metabolizer	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0011581	poor metabolizer	N06A	__UNKNOWN__
methadone	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*6	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders	poor metabolizer	N07BC02	*6
methadone	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*18	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders	poor metabolizer	N07BC02	*18
lamotrigine	UGT1A4*3b	UGT1A4	*3b	Efficacy	decreased	Efficacy_Response	Healthy		N03AX09	*3b
docetaxel, thalidomide	rs2016520	PPARD	C	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs2016520:C
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	*1/*3
infliximab	HLA-DQA1*05	HLA-DQA1	*05	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AB02	*05
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*17	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*17	CYP2C19	*4	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*4
docetaxel, thalidomide	rs1871450	CHST3	A	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs1871450:A
propofol	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Toxicity	decreased	Efficacy_Response	Other:C1140716		N01AX10	*6
tildrakizumab	rs10556657	PDE4D	CT/CT	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AC17	rs10556657:CT/CT
buprenorphine, dihydrocodeine, fentanyl, hydromorphone, methadone, morphine, oxycodone, piritramide, tilidine, tramadol	rs1045642	ABCB1	A	Dosage	decreased	Dosage	Disease:C0030193		N02AA01|N02AA03|N02AA05|N02AA08|N02AB03|N02AX01|N02AX02|N07BC01|N07BC02	rs1045642:A
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	increased	LADME	Other:Hematopoietic_stem_cell_transplantation		L04AD02	*3/*3
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*22
sirolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation	deficiency	No_ATC	*3/*3
docetaxel, thalidomide	rs1883322	PPARD	C	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs1883322:C
phenytoin	intermediate metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N03AB02	__UNKNOWN__
valproic acid	intermediate metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N03AG01	__UNKNOWN__
carbamazepine	poor metabolizer	CYP3A5	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N03AF01	__UNKNOWN__
valproic acid	intermediate metabolizer	CYP2C9	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N03AG01	__UNKNOWN__
valproic acid	UGT1A6*1a, UGT1A6*2a	UGT1A6	*2a	Metabolism/PK	decreased	LADME	Healthy		N03AG01	*2a
phenytoin	intermediate metabolizer	CYP2C9	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N03AB02	__UNKNOWN__
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	increased	LADME	Other:C0023055|Other:C2939419		L01CE02	*1/*28
docetaxel, thalidomide	rs12418	CHST3	A	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs12418:A
folfiri, irinotecan	UGT1A1*1, UGT1A1*28, UGT1A1*60	UGT1A1	*28	Dosage	decreased	Dosage	Other:C0023055		L01CE02	*28
folfiri, irinotecan	UGT1A1*1, UGT1A1*28, UGT1A1*60	UGT1A1	*60	Dosage	decreased	Dosage	Other:C0023055		L01CE02	*60
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Other:C0030920|Other:C0017168|Other:C0014868		A02BC01	*1/*1
mercaptopurine	TPMT*1, TPMT*8	TPMT	*1/*8	Metabolism/PK	decreased	LADME	Healthy		L01BB02	*1/*8
warfarin	CYP2C9*1	CYP2C9	*1/*1	Dosage	increased	Dosage	Healthy		B01AA03	*1/*1
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8	CYP2C9	*8	Dosage	decreased	Dosage	Healthy		B01AA03	*8
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*3	Metabolism/PK	increased	LADME	Healthy		N05AX12	*1/*3
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N05AX12	*1/*4
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Healthy		N05AX12	*1/*5
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*6	Metabolism/PK	increased	LADME	Healthy		N05AX12	*1/*6
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*9	Metabolism/PK	increased	LADME	Healthy		N05AX12	*1/*9
pantoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*1/*2
opioids	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0699744|Other:C0030193		N02A	rs1799971:GG
duloxetine	rs963468	DRD3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003469		N06AX21	rs963468:GG
metformin	rs11212617	C11orf65	C	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs11212617:C
cyclosporine	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	Dosage	Healthy		L04AD01	rs776746:CC
efavirenz, nevirapine	rs2307424	NR1I3	AA	Efficacy	increased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs2307424:AA
efavirenz, nevirapine	rs2307424	NR1I3	AG	Efficacy	increased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs2307424:AG
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Other:C0745761|Other:Hematopoietic_stem_cell_transplantation	normal metabolizer and intermediate metabolizer	J02AC03	*1/*1
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:C0745761|Other:Hematopoietic_stem_cell_transplantation	normal metabolizer and intermediate metabolizer	J02AC03	*1/*2
aripiprazole	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N05AX12	*1/*22
aripiprazole	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N05AX12	*22/*22
aripiprazole, dehydroaripiprazole	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N05AX12	__UNKNOWN__
pimozide	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	decreased	LADME	Disease:C0033975		N05AG02	*22
docetaxel, thalidomide	rs4148943	CHST3	C	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs4148943:C
docetaxel, thalidomide	rs4148945	CHST3	C	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs4148945:C
glyburide	rs4148776	ABCB11	G	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs4148776:G
imatinib	rs7311358	SLCO1B3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs7311358:AA
imatinib	rs7311358	SLCO1B3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs7311358:AG
imatinib	rs4149117	SLCO1B3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs4149117:GG
imatinib	rs4149117	SLCO1B3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs4149117:GT
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*2
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*2/*2
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*3
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*3/*3
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*1/*3
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*1/*4
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*1/*5
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*1/*6
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*9	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*1/*9
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*3	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*3/*3
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*4/*4
fesoterodine	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	G04BD11	__UNKNOWN__
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	"""Other:C0023449|""Other:C0024299|""Other:C0023418|Myeloid|Acute"""	intermediate metabolizer	J02AC03	*1/*2
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	"""Other:C0023449|""Other:C0024299|""Other:C0023418|Myeloid|Acute"""	intermediate metabolizer	J02AC03	*1/*3
glyburide	rs1054097	CHST13	C	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs1054097:C
lacosamide	normal metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0014544	normal metabolizer	N03AX18	__UNKNOWN__
fesoterodine	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	G04BD11	__UNKNOWN__
rosiglitazone	rs10509681	CYP2C8	C	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BG02	rs10509681:C
lacosamide	rs717620	ABCC2	T	Metabolism/PK	decreased	LADME	Other:C0014544		N03AX18	rs717620:T
fesoterodine	intermediate metabolizer	CYP3A4	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	G04BD11	__UNKNOWN__
zuclopenthixol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*3	Metabolism/PK	increased	LADME	Healthy		N05AF05	*1/*3
zuclopenthixol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N05AF05	*1/*4
zuclopenthixol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N05AF05	*4/*4
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*1	Metabolism/PK	decreased	LADME	Other:C0549433	normal metabolizer	N03AB02	*1/*1
clozapine	normal metabolizer	CYP2D6	__UNKNOWN__	Dosage	increased	Dosage	Other:C0036341|Other:C0033975	normal metabolizer	N05AH02	__UNKNOWN__
efavirenz	intermediate metabolizer	CYP2B6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease	intermediate metabolizer and poor metabolizer	J05AG03	__UNKNOWN__
thioguanosine diphosphate, thioguanosine monophosphate, thioguanosine triphosphate	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3A	Metabolism/PK	increased	LADME	Other:C0021390	intermediate metabolizer and poor metabolizer	No_ATC	*3A
thioguanosine diphosphate, thioguanosine monophosphate, thioguanosine triphosphate	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3B	Metabolism/PK	increased	LADME	Other:C0021390	intermediate metabolizer and poor metabolizer	No_ATC	*3B
thioguanosine diphosphate, thioguanosine monophosphate, thioguanosine triphosphate	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3C	Metabolism/PK	increased	LADME	Other:C0021390	intermediate metabolizer and poor metabolizer	No_ATC	*3C
metoprolol	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	C07AB02	__UNKNOWN__
clozapine	rs2535629	ITIH3	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2535629:AA
atomoxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C1263846	poor metabolizer	N06BA09	__UNKNOWN__
cotinine	low activity	CYP2A6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0039338	low activity	No_ATC	__UNKNOWN__
cotinine	low activity	CYP2A6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	low activity	No_ATC	__UNKNOWN__
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*2	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*2
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*4	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*4
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*9	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*9
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*17	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*17
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*20	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*20
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*23	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*23
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*25	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*25
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*26	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*26
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*27	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*27
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*28	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*28
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*35	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*35
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*12	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*12
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*24	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*24
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Other:C0011581		N06AB10	
endoxifen	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	__UNKNOWN__
caffeine	rs10920573	ADORA1	CC	Efficacy	decreased	Efficacy_Response	Other:Apnea_of_prematurity		N06BC01	rs10920573:CC
norquetiapine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		No_ATC	*3/*3
quetiapine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		N05AH04	*3/*3
amlodipine	rs312481	CACNA1D	GG	Efficacy	increased	Efficacy_Response	Other:C0020538		C08CA01	rs312481:GG
peginterferon alfa-2a	rs17289471	ZHX2	C	Efficacy	increased	Efficacy_Response	Other:C0019372		L03AB11	rs17289471:C
berberine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__
clopidogrel	rs12248560	CYP2C19	T	Efficacy, Other	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC04	rs12248560:T
ranibizumab	rs833069	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0024437		S01LA04	rs833069:CC
ranibizumab	rs833069	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:C0024437		S01LA04	rs833069:CT
tacrolimus	rs4646449	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs4646449:CC
ondansetron	poor metabolizer	CYP2D6	__UNKNOWN__	Dosage	increased	Dosage	Other:C0549433	poor metabolizer	A04AA01	__UNKNOWN__
imatinib	rs150929	ABCA3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs150929:GG
imatinib	rs150929	ABCA3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs150929:GT
metformin	rs2301759	CBARP, STK11	TT	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs2301759:TT
metformin	rs3127602	SLC22A3	T	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs3127602:T
metformin	rs11749180	PRKAA1	A	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs11749180:A
metformin	rs10234709	SLC29A4	A	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs10234709:A
metformin	rs4725434	PRKAG2	T	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs4725434:T
metformin	rs2120274	SLC47A1	A	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs2120274:A
metformin	rs2301759	STK11	C	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs2301759:C
metformin	rs4621031	SLC47A2	C	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs4621031:C
alectinib	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:C0007131		L01ED03	*1/*22
alectinib	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Other:C0007131		L01ED03	*22/*22
metformin	rs7903146	TCF7L2	T	Efficacy	increased	Efficacy_Response	Healthy		A10BA02	rs7903146:T
methadone	rs3802279	OPRK1	CC	Dosage	decreased	Dosage	Other:C0028043		N07BC02	rs3802279:CC
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*2/*2
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*2/*3
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*3/*3
n-desmethyltramadol, o-desmethyltramadol	rs41267797	SLC22A1	AG	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs41267797:AG
n,n-didesmethyltramadol	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*41, CYP2D6*45	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	A02A|N02AX02	*4/*6
n,n-didesmethyltramadol	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*41, CYP2D6*45	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	A02A|N02AX02	*4/*5
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0239987		L04AD02	*1/*3
tocilizumab	rs35717427	IL6R	AG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs35717427:AG
tocilizumab	rs35717427	IL6R	GG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs35717427:GG
n-desmethyltramadol, o-desmethyltramadol	rs17216317	ABCC2	CT	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs17216317:CT
tocilizumab	rs6690230	IL6R	CG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs6690230:CG
tocilizumab	rs6690230	IL6R	GG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs6690230:GG
tocilizumab	rs11265621	IL6R	AA	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs11265621:AA
tocilizumab	rs11265621	IL6R	AG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs11265621:AG
tocilizumab	rs10108210	__INTRONIC__	AA	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs10108210:AA
tocilizumab	rs1560011	CLEC2D	GG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC07	rs1560011:GG
tocilizumab	rs703505	KCNMB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs703505:AA
tocilizumab	rs703505	KCNMB1	AG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs703505:AG
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:Elderly_Adult|Other:C0011581	poor metabolizer	N06AB10	*2/*2
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:Elderly_Adult|Other:C0011581	poor metabolizer	N06AB10	*2/*3
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:Elderly_Adult|Other:C0011581	poor metabolizer	N06AB10	*3/*3
morphine	rs17809012	CCL11	AA	Efficacy	decreased	Efficacy_Response	Other:C0027651|Other:C0030193		N02AA01	rs17809012:AA
morphine	rs4778889	IL16	TT	Efficacy	increased	Efficacy_Response	Other:C0027651|Other:C0030193		N02AA01	rs4778889:TT
n-desmethyltramadol, o-desmethyltramadol	rs35235578	SLC22A1	CT	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs35235578:CT
valproic acid	rs7169	SLC16A1	GG	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs7169:GG
n-desmethyltramadol, o-desmethyltramadol	rs9457841	SLC22A1	C	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs9457841:C
n-desmethyltramadol, o-desmethyltramadol	rs34134157	SLC22A1	CC	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs34134157:CC
tenofovir	rs3742106	ABCC4	AC	Toxicity	increased	LADME	Other:HIV_infectious_disease		J05AF07	rs3742106:AC
tenofovir	rs3742106	ABCC4	CC	Toxicity	increased	LADME	Other:HIV_infectious_disease		J05AF07	rs3742106:CC
antidepressants	rs1360780	FKBP5	CT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs1360780:CT
antidepressants	rs1360780	FKBP5	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs1360780:TT
acetaminophen sulfate	CYP2E1*1, CYP2E1*5B	CYP2E1	*1/*5B	Metabolism/PK	increased	LADME	Other:C0013274|Other:C0022876		N02BE01	*1/*5B
fentanyl	rs58572178	ABCC1	(A)14	Metabolism/PK	increased	LADME	Other:C0030193|Other:C0022876		N02AB03	rs58572178:(A)14
voriconazole	CYP2C19*2, CYP2C19*17	CYP2C19	*2	Dosage	Indeterminado	Dosage	Other:Hematopoietic_stem_cell_transplantation		J02AC03	*2
voriconazole	CYP2C19*2, CYP2C19*17	CYP2C19	*17	Dosage	Indeterminado	Dosage	Other:Hematopoietic_stem_cell_transplantation		J02AC03	*17
rosuvastatin	poor metabolizer	ABCG2	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer and reduced metabolizers	C10AA07	
rosuvastatin	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	slow acetylator and intermediate acetylator	C10AA07	__UNKNOWN__
rosuvastatin	intermediate metabolizer	TPMT	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	C10AA07	__UNKNOWN__
doxorubicin	rs20572	CBR1	T	Metabolism/PK	increased	LADME	Other:C1458155		L01DB01	rs20572:T
sunitinib	rs34231037	KDR	AG	Efficacy	increased	Efficacy_Response	Healthy		L01EX01	rs34231037:AG
antidepressants	rs3800373	FKBP5	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs3800373:CC
gliclazide, glimepiride, glipizide, glyburide	rs163184	KCNQ1	GT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BB07|A10BB09|A10BB12	rs163184:GT
gliclazide, glimepiride, glipizide, glyburide	rs163184	KCNQ1	TT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BB07|A10BB09|A10BB12	rs163184:TT
isoniazid	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	__UNKNOWN__
ramipril	low activity	SLCO1B1	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	low activity	C09AA05	__UNKNOWN__
ramipril	poor metabolizer	ABCG2	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer and low activity	C09AA05	
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*3
duloxetine	rs324026	DRD3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003469		N06AX21	rs324026:CC
duloxetine	rs324026	DRD3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003469		N06AX21	rs324026:CT
cytarabine, daunorubicin	rs2299014	RAD50	AA	Efficacy	increased	Efficacy_Response	Other:C0023418|Myeloid|Acute		L01BC01|L01DB02	rs2299014:AA
cytarabine, daunorubicin	rs2299014	RAD50	AC	Efficacy	increased	Efficacy_Response	Other:C0023418|Myeloid|Acute		L01BC01|L01DB02	rs2299014:AC
tenofovir	rs1751034	ABCC4	TT	Toxicity	increased	LADME	Other:HIV_infectious_disease		J05AF07	rs1751034:TT
duloxetine	rs324023	DRD3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003469		N06AX21	rs324023:CT
efavirenz, nevirapine	rs1523127	NR1I2	AA	Efficacy	decreased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs1523127:AA
efavirenz, nevirapine	rs1523127	NR1I2	AC	Efficacy	decreased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs1523127:AC
ezetimibe	deficiency	ABCG8	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0342881	deficiency	C10AX09	
ezetimibe	deficiency	ABCG5	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0342881	deficiency	C10AX09	
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487	intermediate metabolizer and poor metabolizer	A02BC04	*1/*2
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487	intermediate metabolizer and poor metabolizer	A02BC04	*1/*3
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487	intermediate metabolizer and poor metabolizer	A02BC04	*2/*2
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487	intermediate metabolizer and poor metabolizer	A02BC04	*2/*3
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487	intermediate metabolizer and poor metabolizer	A02BC04	*3/*3
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC02	*2/*2
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC02	*2/*3
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC02	*3/*3
duloxetine	rs167770	DRD3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003469		N06AX21	rs167770:AG
risperidone	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0005586|Disease:C0036337|Disease:C0036341	poor metabolizer	N05AX08	__UNKNOWN__
tamsulosin	CYP2D6*10, CYP2D6*41	CYP2D6	*10	Efficacy	increased	Efficacy_Response	Other:C1704272		G04CA02	*10
tamsulosin	CYP2D6*10, CYP2D6*41	CYP2D6	*41	Efficacy	increased	Efficacy_Response	Other:C1704272		G04CA02	*41
hydroxyurea	rs7482144	HBG2	AA	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs7482144:AA
hydroxyurea	rs7482144	HBG2	AG	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs7482144:AG
hydroxyurea	rs7482144	HBG2	AA	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs7482144:AA
hydroxyurea	rs766432	BCL11A	C	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs766432:C
fluorouracil, leucovorin, oxaliplatin	rs1801133	MTHFR	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1801133:A
vortioxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N06AX26	*4/*4
vortioxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*4/*10	Metabolism/PK	increased	LADME	Healthy		N06AX26	*4/*10
antiepileptics	rs121917953	SCN1A	AA	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs121917953:AA
antiepileptics	rs121917953	SCN1A	AT	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs121917953:AT
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		R05DA09	*10/*10
methotrexate	rs1800956	ENG	G	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs1800956:G
methotrexate	rs16954698	PKD1L2	A	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs16954698:A
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4	NUDT15	*1/*2	Dosage	decreased	Dosage	Other:C0023449		L01BB02	*1/*2
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4	NUDT15	*1/*3	Dosage	decreased	Dosage	Other:C0023449		L01BB02	*1/*3
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4	NUDT15	*1/*4	Dosage	decreased	Dosage	Other:C0023449		L01BB02	*1/*4
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4	NUDT15	*2/*4	Dosage	decreased	Dosage	Other:C0023449		L01BB02	*2/*4
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4	NUDT15	*3/*3	Dosage	decreased	Dosage	Other:C0023449		L01BB02	*3/*3
pregabalin	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	slow acetylator	N02BF02	__UNKNOWN__
antidepressants	rs1360780	FKBP5	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs1360780:TT
pitavastatin	poor metabolizer	CYP2C9	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	C10AA08	__UNKNOWN__
efavirenz, nevirapine	rs3003596	NR1I3	AG	Efficacy	decreased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs3003596:AG
efavirenz, nevirapine	rs3003596	NR1I3	GG	Efficacy	decreased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs3003596:GG
antidepressants	rs4713916	FKBP5	AA	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs4713916:AA
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Other:C1458155		No_ATC	*10/*10
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*2/*10	Metabolism/PK	decreased	LADME	Other:C1458155		No_ATC	*2/*10
endoxifen	normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C1458155	normal metabolizer	No_ATC	__UNKNOWN__
clozapine	rs202102799	CYP2D6	C	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0033975		N05AH02	rs202102799:C
clozapine	rs28371726	CYP2D6	G	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0033975		N05AH02	rs28371726:G
clozapine, n-desmethylclozapine	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0036341|Other:C0033975	poor metabolizer	N05AH02	*2/*2
clozapine	rs762502	DRD4	C	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0033975		N05AH02	rs762502:C
nifedipine	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:C0032961		C08CA05	rs776746:CT
nifedipine	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:C0032961		C08CA05	rs776746:TT
clozapine	rs2133251840	DRD4	del	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0033975		N05AH02	rs2133251840:del
clozapine, n-desmethylclozapine	ultrarapid metabolizer	CYP1A2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0033975	ultrarapid metabolizer	N05AH02	__UNKNOWN__
exenatide	rs1416406	SORCS1	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ01	rs1416406:GG
linagliptin, sitagliptin, vildagliptin	rs2285676	KCNJ11	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02|A10BH05	rs2285676:GG
linagliptin, saxagliptin, sitagliptin, vildagliptin	rs57803087	PRKD1	G	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02|A10BH03|A10BH05	rs57803087:G
midazolam	rs2461817	NR1I2	CC	Metabolism/PK	increased	LADME	Other:respiratory_failure_requiring_assisted_ventilation		N05CD08	rs2461817:CC
methadone, r-eddp, s-eddp	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0277589	intermediate metabolizer	N07BC02	__UNKNOWN__
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10
fluorouracil, leucovorin, oxaliplatin	rs1801131	MTHFR	G	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1801131:G
azathioprine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0009324|Disease:C0010346|Disease:C0241910		L04AX01	rs116855232:CT
azathioprine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0009324|Disease:C0010346|Disease:C0241910		L04AX01	rs116855232:TT
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1057910:AA
warfarin	rs7412	APOE	CC	Dosage	increased	Dosage	Other:C0004238|Other:C0034065|Other:C0042487		B01AA03	rs7412:CC
metformin	rs2282143	SLC22A1	CC	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs2282143:CC
metformin	rs316019	SLC22A2	CC	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs316019:CC
methacholine	rs1042713	ADRB2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0004096		No_ATC	rs1042713:AA
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT
temsirolimus	rs3814055	NR1I2	TT	Metabolism/PK	decreased	LADME	Disease:C0877645		L01EG01	rs3814055:TT
temsirolimus	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Disease:C0877645		L01EG01	rs2032582:CC
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs4646457	__INTRONIC__	C	Dosage	Indeterminado	Dosage	Disease:Kidney_Transplantation		L04AD02	rs4646457:C
tacrolimus	rs15524	CYP3A5	G	Dosage	Indeterminado	Dosage	Disease:Kidney_Transplantation		L04AD02	rs15524:G
tacrolimus	rs12333983	CYP3A4	A	Dosage	Indeterminado	Dosage	Disease:Kidney_Transplantation		L04AD02	rs12333983:A
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Disease:C2939420		B01AA07	rs9923231:CT
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Disease:C2939420		B01AA07	rs9923231:TT
atenolol, metoprolol	rs294610	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Other:C0020538		C07AB02|C07AB03	rs294610:A
atenolol, metoprolol	rs45545233	SLC4A1	CC	Efficacy	decreased	Efficacy_Response	Other:C0020538		C07AB02|C07AB03	rs45545233:CC
atenolol, metoprolol	rs45545233	SLC4A1	CT	Efficacy	decreased	Efficacy_Response	Other:C0020538		C07AB02|C07AB03	rs45545233:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3794271	SLCO1C1	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs3794271:G
capecitabine, fluorouracil	rs56038477	DPYD	CT	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs56038477:CT
dichloroacetic acid	rs7975	GSTZ1, POMT2	G	Other, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs7975:G
dichloroacetic acid	rs1046428	GSTZ1, POMT2	C	Other, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1046428:C
dichloroacetic acid	rs7972	GSTZ1, POMT2	G	Other, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs7972:G
sunitinib	rs2032582	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2032582:AA
fluorouracil	rs17376848	DPYD	AG	Metabolism/PK	increased	LADME	Disease:C0023055		L01BC02	rs17376848:AG
fluorouracil	rs17376848	DPYD	GG	Metabolism/PK	increased	LADME	Disease:C0023055		L01BC02	rs17376848:GG
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
hydrochlorothiazide	rs11065987	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs11065987:AA
hydrochlorothiazide	rs11065987	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs11065987:AG
methadone	rs1128503	ABCB1	AA	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs1128503:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
caffeine	rs12720461	CYP1A2	CT	Metabolism/PK	decreased	LADME	Healthy		N06BC01	rs12720461:CT
ethanol	rs553202	OPRM1	T	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs553202:T
ethanol	rs524731	OPRM1	A	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs524731:A
nicotine	rs3852209	HINT1	CT	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA01	rs3852209:CT
nicotine	rs3852209	HINT1	TT	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA01	rs3852209:TT
opioids	rs1799971	OPRM1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0030193|Postoperative		N02A	rs1799971:AG
phenprocoumon	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:CT
phenprocoumon	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:TT
fluoxetine	rs3892097	CYP2D6	CT	Efficacy	increased	LADME	Efficacy:C0085762|Efficacy:C0011581		N06AB03	rs3892097:CT
levodopa	rs1611115	DBH	CT	Efficacy	increased	Efficacy_Response	Disease:C0278080		N04BA02	rs1611115:CT
levodopa	rs1611115	DBH	TT	Efficacy	increased	Efficacy_Response	Disease:C0278080		N04BA02	rs1611115:TT
quetiapine	rs2069514	CYP1A2	AA	Metabolism/PK	increased	LADME	Healthy		N05AH04	rs2069514:AA
venlafaxine	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX16	rs4680:GG
axitinib	rs35305980	OR2B11	A	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs35305980:A
sulfonamides, urea derivatives	rs5219	KCNJ11	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs5219:CT
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AG
sulfonamides, urea derivatives	rs757110	ABCC8	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs757110:AA
sulfonamides, urea derivatives	rs757110	ABCC8	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs757110:CC
tipiracil hydrochloride, trifluridine	rs9394992	SLC29A1	CT	Efficacy	increased	Efficacy_Response	Disease:C0023055		S01AD02	rs9394992:CT
tipiracil hydrochloride, trifluridine	rs9394992	SLC29A1	TT	Efficacy	increased	Efficacy_Response	Disease:C0023055		S01AD02	rs9394992:TT
axitinib	rs3832043	UGT1A10, UGT1A8, UGT1A9	del	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs3832043:del
axitinib	rs17868323	UGT1A7	G	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs17868323:G
risperidone	rs3813928	HTR2C	A	Efficacy	decreased	Efficacy_Response	Disease:C0004352		N05AX08	rs3813928:A
methotrexate	rs1532268	MTRR	CT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1532268:CT
methotrexate	rs1532268	MTRR	TT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1532268:TT
risperidone	rs6311	HTR2A	CT	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs6311:CT
risperidone	rs6311	HTR2A	TT	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs6311:TT
axitinib	rs1045642	ABCB1	A	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs1045642:A
butorphanol	rs6269	COMT	GG	Efficacy	decreased	Efficacy_Response	Healthy		N02AF01	rs6269:GG
axitinib	rs2231142	ABCG2	T	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs2231142:T
axitinib	rs2032582	ABCB1	T	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs2032582:T
voriconazole	rs4244285	CYP2C19	AA	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs4244285:AA
voriconazole	rs4244285	CYP2C19	AG	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs4244285:AG
erlotinib	rs121434568	EGFR	GT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01EB02	rs121434568:GT
erlotinib	rs121434568	EGFR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01EB02	rs121434568:TT
methotrexate	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1045642:AA
cytarabine	rs3734703	SLC29A1	A	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs3734703:A
butorphanol	rs4633	COMT	CC	Efficacy	decreased	Efficacy_Response	Healthy		N02AF01	rs4633:CC
sunitinib	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C0007134|Disease:C2939419		L01EX01	rs1045642:AA
sunitinib	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:C0007134|Disease:C2939419		L01EX01	rs1045642:AG
methotrexate	rs1051266	SLC19A1	CC	Efficacy	decreased	Efficacy_Response	Other:C0023449		L04AX03	rs1051266:CC
methotrexate	rs1051266	SLC19A1	TT	Efficacy	decreased	Efficacy_Response	Other:C0023449		L04AX03	rs1051266:TT
sn-38(irinotecan)	rs3832043	UGT1A9	TT	Dosage	increased	LADME	Disease:C0007131		L01CE02	rs3832043:TT
efavirenz	rs2279345	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CC
efavirenz	rs2279345	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CT
risperidone	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs1128503:AA
risperidone	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs1128503:AG
efavirenz	rs2279345	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CT
glucocorticoids	rs1876828	CRHR1	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA	rs1876828:T
antidepressants	rs11580409	ERICH3	C	Efficacy	increased	Efficacy_Response	Healthy		N06A	rs11580409:C
sn-38(irinotecan)	rs4149056	SLCO1B1	CC	Dosage	increased	Dosage	Disease:C0007131		L01CE02	rs4149056:CC
sn-38(irinotecan)	rs4149056	SLCO1B1	CT	Dosage	increased	Dosage	Disease:C0007131		L01CE02	rs4149056:CT
salmeterol	rs1042713	ADRB2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03AC12	rs1042713:AA
levomethadone	rs2740574	CYP3A4	CT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC05	rs2740574:CT
voriconazole	rs4986893	CYP2C19	AA	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs4986893:AA
voriconazole	rs4986893	CYP2C19	AG	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs4986893:AG
methylphenidate	rs2284411	GRIN2B	CC	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs2284411:CC
fentanyl	rs2740574	CYP3A4	C	Metabolism/PK	decreased	LADME	Other:C0006434		N02AB03	rs2740574:C
salbutamol, selective beta-2-adrenoreceptor agonists	rs7793837	CRHR2	T	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC|R03CC02	rs7793837:T
atorvastatin, rosuvastatin, simvastatin	rs2230806	ABCA1	T	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01|C10AA05|C10AA07	rs2230806:T
salbutamol, selective beta-2-adrenoreceptor agonists	rs7793837	CRHR2	T	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC|R03CC02	rs7793837:T
atorvastatin, rosuvastatin, simvastatin	rs3892097	CYP2D6	T	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01|C10AA05|C10AA07	rs3892097:T
nicardipine, nimodipine	rs2739258	CACNA1B	AG	Efficacy	increased	Efficacy_Response	Other:C0005586		C08CA04|C08CA06	rs2739258:AG
nicardipine, nimodipine	rs2739258	CACNA1B	GG	Efficacy	increased	Efficacy_Response	Other:C0005586		C08CA04|C08CA06	rs2739258:GG
methotrexate	rs1801131	MTHFR	TT	Efficacy	decreased	Efficacy_Response	Other:C0024299|Other:C0023449		L04AX03	rs1801131:TT
imatinib	rs776746	CYP3A5	C	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs776746:C
imatinib	rs683369	SLC22A1	CG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CG
imatinib	rs683369	SLC22A1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:GG
simvastatin	rs662799	APOA5	AA	Efficacy	increased	Efficacy_Response	Disease:C0242339		C10AA01	rs662799:AA
irbesartan	rs1367117	APOB	AG	Efficacy, Metabolism/PK	Indeterminado	Efficacy_Response	Disease:C0020538		C09CA04	rs1367117:AG
irbesartan	rs1367117	APOB	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C09CA04	rs1367117:GG
atorvastatin	rs662799	APOA5	AA	Efficacy	increased	Efficacy_Response	Disease:C0242339		C10AA05	rs662799:AA
efavirenz	rs28399433	CYP2A6	C	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399433:C
methotrexate	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs1801133:AA
benazepril	rs2229437	PRCP	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA07	rs2229437:GG
benazepril	rs2229437	PRCP	GT	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA07	rs2229437:GT
efavirenz	rs28365062	UGT2B7	GG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28365062:GG
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C
clopidogrel	rs4244285	CYP2C19	A	Efficacy, Other	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:A
efavirenz, lamivudine, tenofovir	rs2279343	CYP2B6	AG	Efficacy	increased	Efficacy_Response	Other:HIV_infectious_disease		J05AF05|J05AF07|J05AG03	rs2279343:AG
efavirenz, lamivudine, tenofovir	rs2279343	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Other:HIV_infectious_disease		J05AF05|J05AF07|J05AG03	rs2279343:GG
methotrexate	rs1801131	MTHFR	GG	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs1801131:GG
clopidogrel	rs1045642	ABCB1	G	Efficacy, Other	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC04	rs1045642:G
midazolam	rs11568820	VDR	CT	Metabolism/PK	increased	LADME	Healthy		N05CD08	rs11568820:CT
midazolam	rs11568820	VDR	TT	Metabolism/PK	increased	LADME	Healthy		N05CD08	rs11568820:TT
methyldopa	rs3742879	ARG2	G	Efficacy	increased	Efficacy_Response	Other:C0032961|Other:C0032914		C02AB	rs3742879:G
fluorouracil	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02	rs1801133:AA
fluorouracil	rs1801133	MTHFR	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02	rs1801133:AG
repaglinide	rs10509681	CYP2C8	C	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BX02	rs10509681:C
repaglinide	rs11572080	CYP2C8	T	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BX02	rs11572080:T
aripiprazole	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Other:C0011581		N05AX12	rs1128503:AA
omeprazole	rs12248560	CYP2C19	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		A02BC01	rs12248560:TT
mephenytoin	rs12248560	CYP2C19	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		N03AB02	rs12248560:TT
omeprazole	rs11188072	CYP2C19	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		A02BC01	rs11188072:TT
mephenytoin	rs11188072	CYP2C19	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		N03AB02	rs11188072:TT
methadone	rs3211371	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		N07BC02	rs3211371:TT
mercaptopurine, methotrexate	rs4149056	SLCO1B1	CC	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L04AX03	rs4149056:CC
mercaptopurine, methotrexate	rs4149056	SLCO1B1	CT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L04AX03	rs4149056:CT
gemcitabine	rs1044457	CMPK1	CC	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs1044457:CC
dexmedetomidine	rs1800035	ADRA2A	CG	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs1800035:CG
dexmedetomidine	rs1800035	ADRA2A	GG	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs1800035:GG
budesonide, fluticasone / salmeterol, formoterol, omalizumab	rs3024498	IL10	CC	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03AC12|R03AC13|R03BA02|R03BA05|R03DX05	rs3024498:CC
budesonide, fluticasone / salmeterol, formoterol, omalizumab	rs3024498	IL10	CT	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03AC12|R03AC13|R03BA02|R03BA05|R03DX05	rs3024498:CT
dexmedetomidine	rs775887911	ADRA2A	CT	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs775887911:CT
dexmedetomidine	rs775887911	ADRA2A	TT	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs775887911:TT
dexmedetomidine	rs201376588	ADRA2A	CT	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs201376588:CT
dexmedetomidine	rs201376588	ADRA2A	TT	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs201376588:TT
gemcitabine	rs35687416	CMPK1	GG	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs35687416:GG
gemcitabine	rs12507552	DCTD	CC	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs12507552:CC
beta blocking agents	rs139945292	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Other:C0020538		S01ED	rs139945292:T
rosuvastatin	rs662799	APOA5	AA	Efficacy	increased	Efficacy_Response	Disease:C0242339		C10AA07	rs662799:AA
gemcitabine	rs274713	TENT4A	GG	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs274713:GG
methotrexate	rs1544105	FPGS	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1544105:CT
methotrexate	rs1544105	FPGS	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1544105:TT
gemcitabine	rs992160	CDC5L	CT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs992160:CT
gemcitabine	rs992160	CDC5L	TT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs992160:TT
methotrexate	rs2853539	TYMS	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs2853539:AA
atorvastatin, rosuvastatin, simvastatin	rs662799	APOA5	AA	Other	Indeterminado	Efficacy_Response	Disease:C0242339		C10AA01|C10AA05|C10AA07	rs662799:AA
budesonide, fluticasone / salmeterol, formoterol, omalizumab	rs3819024	IL17A	AG	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03AC12|R03AC13|R03BA02|R03BA05|R03DX05	rs3819024:AG
budesonide, fluticasone / salmeterol, formoterol, omalizumab	rs3819024	IL17A	GG	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03AC12|R03AC13|R03BA02|R03BA05|R03DX05	rs3819024:GG
gemcitabine	rs10916852	SH2D5	GT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs10916852:GT
gemcitabine	rs10916852	SH2D5	TT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs10916852:TT
rosuvastatin	rs708272	CETP	A	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs708272:A
atorvastatin	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Other:C1956346		C10AA05	rs1045642:AA
atorvastatin	rs2306283	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Other:C1956346		C10AA05	rs2306283:AA
repaglinide	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		A10BX02	rs4149056:CT
phenprocoumon	rs9923231	VKORC1	TT	Dosage, Toxicity	decreased	Dosage	Healthy		B01AA04	rs9923231:TT
azathioprine	rs1142345	TPMT	CT	Metabolism/PK	decreased	LADME	Disease:C0021390		L04AX01	rs1142345:CT
azathioprine	rs1127354	ITPA	AC	Metabolism/PK	increased	LADME	Disease:C0021390		L04AX01	rs1127354:AC
repaglinide	rs4149056	SLCO1B1	TT	Metabolism/PK	Indeterminado	LADME	Healthy		A10BX02	rs4149056:TT
buprenorphine	rs2740574	CYP3A4	TT	Efficacy	increased	Efficacy_Response	Disease:C0022116|Disease:C0030193		N07BC01	rs2740574:TT
perindopril	rs5186	AGTR1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA04	rs5186:AA
nitrendipine	rs5186	AGTR1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA08	rs5186:AA
hydromorphone	rs1799971	OPRM1	AG	PD	increased	Efficacy_Response	Healthy		N02AA03	rs1799971:AG
hydromorphone	rs1799971	OPRM1	GG	PD	increased	Efficacy_Response	Healthy		N02AA03	rs1799971:GG
lamotrigine	rs2071197	HNF4A	AA	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AX09	rs2071197:AA
lamotrigine	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs2231142:GT
lamotrigine	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs2231142:TT
lamotrigine	rs3114020	ABCG2	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs3114020:CC
lamotrigine	rs3114020	ABCG2	CT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs3114020:CT
cyclosporine	rs3828743	TSPYL1	AG	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD01	rs3828743:AG
cyclosporine	rs3828743	TSPYL1	GG	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD01	rs3828743:GG
gemcitabine	rs7543016	CMPK1	CC	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs7543016:CC
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
gemcitabine	rs944050	ESR2	TT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs944050:TT
risperidone	rs1799978	DRD2	TT	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs1799978:TT
irinotecan	rs2273697	ABCC2	AA	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs2273697:AA
irinotecan	rs2273697	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs2273697:AG
risperidone	rs1799978	DRD2	T	Other	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs1799978:T
antiepileptics	rs717620	ABCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs717620:CT
antiepileptics	rs717620	ABCC2	TT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs717620:TT
glucose	rs4149056	SLCO1B1	TT	Metabolism/PK	Indeterminado	LADME	Healthy		V06DC01	rs4149056:TT
warfarin	rs12777823	__INTRONIC__	A	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs12777823:A
methotrexate	rs2306283	SLCO1B1	AA	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs2306283:AA
methotrexate	rs2306283	SLCO1B1	AG	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs2306283:AG
ivacaftor	rs75527207	CFTR	AA	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AA
ivacaftor	rs75527207	CFTR	AG	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AG
methotrexate	rs4149056	SLCO1B1	CC	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149056:CC
methotrexate	rs4149056	SLCO1B1	CT	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149056:CT
conjugated estrogens	rs4149056	SLCO1B1	CT	Efficacy	increased	Efficacy_Response	Disease:C0025320		G03CA57	rs4149056:CT
cisplatin	rs3212986	ERCC1	A	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01XA01	rs3212986:A
antipsychotics	rs1045642	ABCB1	GG	Dosage, Metabolism/PK	increased	Dosage	Disease:C0036341		N05A	rs1045642:GG
antipsychotics	rs2032582	ABCB1	AA	Dosage, Metabolism/PK	increased	Dosage	Disease:C0036341		N05A	rs2032582:AA
diazepam	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Other:C0085762		N05BA01	rs4244285:AA
diazepam	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Other:C0085762		N05BA01	rs4244285:AG
alprazolam	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Other:C0085762|Other:C0003469		N05BA12	rs35599367:AG
diazepam	rs12248560	CYP2C19	CT	Efficacy	decreased	Efficacy_Response	Other:C0085762		N05BA01	rs12248560:CT
diazepam	rs12248560	CYP2C19	TT	Efficacy	decreased	Efficacy_Response	Other:C0085762		N05BA01	rs12248560:TT
clozapine	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0039338		N05AH02	rs1057868:CT
clozapine	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0039338		N05AH02	rs1057868:TT
salbutamol	rs8191725	IGF2R	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs8191725:AG
salbutamol	rs77441273	SLC24A4	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs77441273:AG
alprazolam	rs35599367	CYP3A4	AG	Efficacy	decreased	Efficacy_Response	Other:C0085762|Other:C0003469		N05BA12	rs35599367:AG
lansoprazole, omeprazole, rabeprazole	rs16944	IL1B	AG	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	rs16944:AG
lansoprazole, omeprazole, rabeprazole	rs16944	IL1B	AA	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	rs16944:AA
warfarin	rs2359612	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:AA
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
platinum compounds	rs11615	ERCC1	AG	Efficacy	increased	Efficacy_Response	Other:C0919267|Other:Neoplasm_of_esophagus|Other:C0027651		L01XA	rs11615:AG
platinum compounds	rs11615	ERCC1	GG	Efficacy	increased	Efficacy_Response	Other:C0919267|Other:Neoplasm_of_esophagus|Other:C0027651		L01XA	rs11615:GG
ulinastatin	rs243865	MMP2	T	Efficacy	decreased	Efficacy_Response	Other:C0030305		No_ATC	rs243865:T
antipsychotics	rs1128503	ABCB1	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs1128503:G
ulinastatin	rs3918242	MMP9	T	Efficacy	increased	Efficacy_Response	Other:C0030305		No_ATC	rs3918242:T
tacrolimus	rs35599367	CYP3A4	AA	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:AA
tacrolimus	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:AG
tacrolimus	rs2276707	NR1I2	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2276707:CT
tacrolimus	rs2276707	NR1I2	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2276707:TT
antipsychotics	rs1045642	ABCB1	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs1045642:G
irinotecan	rs10934498	NR1I2	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0024121		L01CE02	rs10934498:AA
tacrolimus	rs1800896	IL10	CC	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	rs1800896:CC
olanzapine	rs324026	DRD3	C	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs324026:C
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs6811453	ADH1A	A	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs6811453:A
measles vaccines	rs3775291	TLR3	CT	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	rs3775291:CT
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs1826909	ADH1A	T	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs1826909:T
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
tamoxifen	rs717620	ABCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	rs717620:CT
salbutamol	rs77149876	__INTRONIC__	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs77149876:CT
etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800629	TNF	A	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02	rs1800629:A
carbamazepine	rs3812718	SCN1A	TT	Dosage	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:TT
salbutamol	rs77977790	PAPPA2	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs77977790:CT
norbuprenorphine	rs569356	OPRD1	GG	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		No_ATC	rs569356:GG
tacrolimus	rs2740574	CYP3A4	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2740574:CT
salmeterol	rs1042713	ADRB2	G	Efficacy	increased	Efficacy_Response	Other:C0004096		R03AC12	rs1042713:G
salbutamol	rs116551936	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs116551936:AG
salbutamol	rs115501901	NCOA3	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs115501901:CT
salbutamol	rs74973995	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs74973995:AG
salbutamol	rs73294475	CRHR2	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs73294475:CT
phenprocoumon	rs2740574	CYP3A4	C	Dosage	decreased	Dosage	Healthy		B01AA04	rs2740574:C
salbutamol	rs144315541	ADCY9	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs144315541:AG
perphenazine	rs17570753	MCPH1	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs17570753:A
perphenazine	rs2116971	CDH13	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs2116971:G
perphenazine	rs9952628	SKOR2	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs9952628:G
metformin	rs12943590	SLC47A2	AA	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs12943590:AA
quetiapine	rs35793	KCNMA1	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH04	rs35793:G
perphenazine	rs11100483	MAML3	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs11100483:A
valproic acid	rs7668258	UGT2B7	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs7668258:CC
valproic acid	rs7668258	UGT2B7	CT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs7668258:CT
methacholine	rs11702779	RUNX1	AA	Other	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs11702779:AA
risperidone	rs874295	LRP1B	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AX08	rs874295:G
bevacizumab	rs11200638	HTRA1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01	rs11200638:AA
risperidone	rs9713	PSMD14	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AX08	rs9713:A
risperidone	rs1869295	AGAP1	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AX08	rs1869295:C
bevacizumab	rs10490924	ARMS2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01	rs10490924:TT
valproic acid	rs3816877	APEH	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs3816877:CC
risperidone	rs1315115	NPAS3	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AX08	rs1315115:G
risperidone	rs3738883	TMEFF2	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AX08	rs3738883:G
metformin	rs4810083	PCK1	CT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs4810083:CT
metformin	rs4810083	PCK1	TT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs4810083:TT
ziprasidone	rs4925300	CDH4	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AE04	rs4925300:A
ziprasidone	rs1546519	LYN	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AE04	rs1546519:G
bevacizumab	rs800292	CFH	GG	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01	rs800292:GG
warfarin	rs1799853	CYP2C9	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:CT
ziprasidone	rs9585618	NALCN	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AE04	rs9585618:C
ziprasidone	rs17194378	CNTN4	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AE04	rs17194378:A
opioids	rs4680	COMT	GG	Dosage	increased	Dosage	Disease:C0027651|Disease:C0030193		N02A	rs4680:GG
imatinib	rs4148978	SLCO1A2	CT	Toxicity, Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs4148978:CT
imatinib	rs4148978	SLCO1A2	TT	Toxicity, Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs4148978:TT
imatinib	rs4149117	SLCO1B3	GG	Toxicity, Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs4149117:GG
hydrochlorothiazide	rs4961	ADD1	GT	Efficacy	increased	Efficacy_Response	Healthy		C03AA03	rs4961:GT
hydrochlorothiazide	rs4961	ADD1	TT	Efficacy	increased	Efficacy_Response	Healthy		C03AA03	rs4961:TT
warfarin	rs2290228	CALU	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs2290228:AA
olanzapine	rs12610827	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs12610827:T
remifentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0549433		N01AH06	rs1799971:AG
remifentanil	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0549433		N01AH06	rs1799971:GG
fenofibrate	rs676210	APOB	AA	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs676210:AA
methacholine	rs11702779	RUNX1	AG	Other	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs11702779:AG
methacholine	rs11702779	RUNX1	GG	Other	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs11702779:GG
citalopram, fluoxetine	rs1799889	SERPINE1	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04	rs1799889:G
methotrexate	rs1805087	MTR	G	Metabolism/PK	increased	LADME	Other:C0024299|Other:C0023449		L04AX03	rs1805087:G
citalopram, fluoxetine, mirtazapine, paroxetine, selective serotonin reuptake inhibitors, venlafaxine	rs4713916	FKBP5	A	Efficacy	increased	Efficacy_Response	Disease:C0040435		N06AB|N06AB03|N06AB04|N06AB05|N06AX11|N06AX16	rs4713916:A
olanzapine	rs17070785	CSMD1	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH03	rs17070785:A
olanzapine	rs2247408	PLAGL1	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH03	rs2247408:C
sirolimus	rs15524	CYP3A5	AA	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		No_ATC	rs15524:AA
olanzapine	rs3819811	PLAGL1	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH03	rs3819811:A
sirolimus	rs4646453	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		No_ATC	rs4646453:CC
acetaminophen	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02BE01	rs1799971:AG
acetaminophen	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02BE01	rs1799971:GG
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
olanzapine	rs221253	PTPRN2	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH03	rs221253:C
imatinib	rs628031	SLC22A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs628031:AA
imatinib	rs628031	SLC22A1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs628031:AG
warfarin	rs1800566	NQO1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs1800566:AA
warfarin	rs1800566	NQO1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs1800566:AG
perphenazine	rs2278773	PRKCE	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs2278773:C
perphenazine	rs11774231	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs11774231:C
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A
hydrochlorothiazide	rs2269879	DOT1L	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs2269879:CT
hydrochlorothiazide	rs2269879	DOT1L	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs2269879:TT
paroxetine	rs11042725	ADM	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs11042725:CC
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A
tildrakizumab	rs9373839	ATG5	CT	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AC17	rs9373839:CT
tildrakizumab	rs708567	IL17RC	CC	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AC17	rs708567:CC
citalopram	rs7124442	BDNF	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs7124442:TT
aripiprazole	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		N05AX12	rs2032582:AA
clozapine	rs2740204	OXT	T	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2740204:T
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
diazepam	rs35599367	CYP3A4	GG	Efficacy	increased	Efficacy_Response	Other:C0085762		N05BA01	rs35599367:GG
methotrexate	rs1801133	MTHFR	G	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AX03	rs1801133:G
methotrexate	rs408626	DHFR	C	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AX03	rs408626:C
repaglinide	rs10494366	NOS1AP	T	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs10494366:T
citalopram	rs7103411	BDNF	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs7103411:TT
highly active antiretroviral therapy (haart)	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		No_ATC	rs1045642:AA
highly active antiretroviral therapy (haart)	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		No_ATC	rs1045642:AG
citalopram	rs6265	BDNF	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs6265:CC
lamivudine, lopinavir, ritonavir, zidovudine	rs212091	ABCC1	CC	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AE03|J05AF01|J05AF05|J05AR10	rs212091:CC
lamivudine, lopinavir, ritonavir, zidovudine	rs212091	ABCC1	CT	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AE03|J05AF01|J05AF05|J05AR10	rs212091:CT
fluoxetine	rs6265	BDNF	CT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs6265:CT
tildrakizumab	rs610604	TNFAIP3	GG	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AC17	rs610604:GG
clopidogrel	rs4986893	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4986893:A
antidepressants	rs11580409	ERICH3	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06A	rs11580409:CC
clopidogrel	rs12248560	CYP2C19	CT	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs12248560:CT
aripiprazole	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		N05AX12	rs1045642:AA
ivacaftor	rs77932196	CFTR	A	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs77932196:A
paroxetine	rs6280	DRD3	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	rs6280:CC
paroxetine	rs6280	DRD3	CT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	rs6280:CT
entacapone	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C0030567		N04BX02	rs4680:GG
clozapine	rs1065852	CYP2D6	AA	Metabolism/PK	increased	LADME	Other:C0036341		N05AH02	rs1065852:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
telmisartan	rs60140950	SLCO1B3	C	Metabolism/PK	increased	LADME	Healthy		C09CA07	rs60140950:C
clozapine	rs16947	CYP2D6	GG	Metabolism/PK	increased	LADME	Other:C0036341		N05AH02	rs16947:GG
atorvastatin, simvastatin	rs11887534	ABCG8	CC	Efficacy	decreased	Efficacy_Response	Other:C0242339		C10AA01|C10AA05	rs11887534:CC
atorvastatin, simvastatin	rs11887534	ABCG8	CG	Efficacy	decreased	Efficacy_Response	Other:C0242339		C10AA01|C10AA05	rs11887534:CG
ivacaftor	rs121909011	CFTR	C	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs121909011:C
imatinib	rs2290573	ULK3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2290573:GG
clozapine	rs265976	DRD1	GT	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH02	rs265976:GT
ivacaftor	rs75527207	CFTR	AA	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AA
ivacaftor	rs75527207	CFTR	AG	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AG
interferons	rs4796793	STAT3	GG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L03AB	rs4796793:GG
tamoxifen	rs12422149	SLCO2B1	AA	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	rs12422149:AA
tamoxifen	rs12422149	SLCO2B1	AG	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	rs12422149:AG
warfarin	rs2359612	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:AA
warfarin	rs2359612	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:AG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
warfarin	rs8050894	VKORC1	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:CG
warfarin	rs8050894	VKORC1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:GG
risperidone	rs3787430	HRH3	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs3787430:TT
warfarin	rs12777823	__INTRONIC__	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AA
warfarin	rs12777823	__INTRONIC__	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AG
warfarin	rs2884737	VKORC1	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2884737:AC
warfarin	rs2884737	VKORC1	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2884737:CC
warfarin	rs7294	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:CT
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT
risperidone	rs3787429	HRH3	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs3787429:TT
aripiprazole	rs4305746	TAAR6	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX12	rs4305746:AA
aripiprazole	rs4305746	TAAR6	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX12	rs4305746:AG
peginterferon alfa-2a	rs1800795	IL6	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		L03AB11	rs1800795:G
sulfasalazine	rs2231142	ABCG2	TT	Metabolism/PK	decreased	LADME	Healthy		A07EC01	rs2231142:TT
peginterferon alfa-2a	rs1800796	IL6	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		L03AB11	rs1800796:G
peginterferon alfa-2a	rs1800797	IL6	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		L03AB11	rs1800797:G
rosuvastatin	rs2199936	ABCG2	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs2199936:AA
rosuvastatin	rs2199936	ABCG2	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs2199936:AG
iloperidone	rs1800169	CNTF, ZFP91-CNTF	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs1800169:GG
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A
disulfiram	rs678849	OPRD1	CC	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs678849:CC
erythropoietin	rs1561876	STIM1	AG	Efficacy	increased	Efficacy_Response	Other:C0178298|Other:C0002871		B03XA01	rs1561876:AG
erythropoietin	rs1561876	STIM1	GG	Efficacy	increased	Efficacy_Response	Other:C0178298|Other:C0002871		B03XA01	rs1561876:GG
latanoprost	rs3753380	PTGFR	CC	Efficacy	increased	Efficacy_Response	Healthy		S01EE01	rs3753380:CC
ranibizumab	rs699947	VEGFA	AC	Efficacy	increased	Efficacy_Response	Disease:C0024437		S01LA04	rs699947:AC
ranibizumab	rs699947	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0024437		S01LA04	rs699947:CC
furosemide	rs17268282	ABCC4	T	Efficacy	increased	Efficacy_Response	Disease:C0085605		C03CA01	rs17268282:T
metformin	rs622342	SLC22A1	CC	Efficacy	Indeterminado	Efficacy_Response	Other:genetic_variation_at_rs2289669		A10BA02	rs622342:CC
morphine	rs737866	COMT	T	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs737866:T
morphine	rs2075507	COMT	G	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs2075507:G
antiepileptics	rs2606345	CYP1A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N03A	rs2606345:AA
morphine	rs5746849	COMT	A	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs5746849:A
morphine	rs7287550	COMT, TXNRD2	C	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs7287550:C
morphine	rs6269	COMT	A	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs6269:A
carbamazepine	rs2740574	CYP3A4	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2740574:TT
morphine	rs740603	COMT	A	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs740603:A
morphine	rs4793665	ABCC3	T	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs4793665:T
tacrolimus	rs1057868	POR	T	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs1057868:T
n-desmethyltramadol, o-desmethyltramadol	rs35742686	CYP2D6	DELT/T	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs35742686:DELT/T
n-desmethyltramadol, tramadol	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs35599367:AG
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Other:C1956346		B01AC04	rs4244285:AA
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Other:C1956346		B01AC04	rs4986893:AG
clopidogrel	rs717620	ABCC2	CC	Efficacy	decreased	Efficacy_Response	Other:C1956346		B01AC04	rs717620:CC
atazanavir	rs73208473	SORCS2	A	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AE08	rs73208473:A
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs9304742	ZNF816	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs9304742:CC
carbamazepine	rs28365063	UGT2B7	AA	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs28365063:AA
carbamazepine	rs3814055	NR1I2	T	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs3814055:T
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2916205	PGLYRP4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs2916205:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2916205	PGLYRP4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs2916205:CT
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1801133:AG
sulfonamides, urea derivatives	rs1799853	CYP2C9	TT	Efficacy	increased	Efficacy_Response	Healthy		S01AB	rs1799853:TT
sumatriptan	rs5443	GNB3	CT	Efficacy	increased	Efficacy_Response	Disease:C0009088		N02CC01	rs5443:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2546890	IL12B	AG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs2546890:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2546890	IL12B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs2546890:GG
desethyl hydroxychloroquine	rs1135840	CYP2D6	G	Metabolism/PK	decreased	LADME	Other:C0024141		P01BA01	rs1135840:G
cannabinoids	rs8065080	TRPV1	CC	Efficacy	increased	Efficacy_Response	Other:C0030193		N02BG10	rs8065080:CC
cannabinoids	rs7438135	UGT2B7	AA	Efficacy	increased	Efficacy_Response	Other:C0030193		N02BG10	rs7438135:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11126740	CTNNA2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs11126740:AA
imatinib	rs2231142	ABCG2	GT	Other, Metabolism/PK	decreased	LADME	Disease:C0027651		L01EA01	rs2231142:GT
desethyl hydroxychloroquine	rs1065852	CYP2D6	AA	Metabolism/PK	decreased	LADME	Other:C0024141		P01BA01	rs1065852:AA
repaglinide	rs5219	KCNJ11	T	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs5219:T
tramadol	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		N02AX02	rs1799971:AG
tramadol	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		N02AX02	rs1799971:GG
repaglinide	rs290487	TCF7L2	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs290487:TT
morphine	rs4680	COMT	A	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs4680:A
carbamazepine	rs1051740	EPHX1	TT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs1051740:TT
morphine	rs4818	COMT	C	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs4818:C
erythropoietin	rs12320939	ORAI1	GG	Efficacy	increased	Efficacy_Response	Other:C0178298|Other:C0002871		B03XA01	rs12320939:GG
erythropoietin	rs12320939	ORAI1	GT	Efficacy	increased	Efficacy_Response	Other:C0178298|Other:C0002871		B03XA01	rs12320939:GT
carbamazepine	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs1128503:AA
carbamazepine	rs1128503	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs1128503:AG
morphine	rs2239393	COMT	A	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs2239393:A
mercaptopurine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:CT
morphine	rs165728	ARVCF, COMT	T	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs165728:T
carbamazepine	rs4148740	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs4148740:AG
carbamazepine	rs4148739	ABCB1	TT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs4148739:TT
morphine	rs174699	ARVCF, COMT	T	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs174699:T
antipsychotics	rs1799732	DRD2	del	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1799732:del
hmg coa reductase inhibitors	rs1532624	CETP	AA	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA	rs1532624:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6908425	CDKAL1	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs6908425:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6908425	CDKAL1	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs6908425:TT
carbamazepine	rs2273697	ABCC2	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2273697:AA
carbamazepine	rs2273697	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2273697:AG
hmg coa reductase inhibitors	rs533556	SIK3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA	rs533556:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs12191877	HLA-C	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs12191877:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs12191877	HLA-C	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs12191877:TT
ritodrine	rs7624046	KCNMB2	TT	Efficacy	decreased	Efficacy_Response	Healthy		G02CA01	rs7624046:TT
carbamazepine	rs4148386	ABCC2	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs4148386:AA
carbamazepine	rs4148386	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs4148386:AG
warfarin	rs61742245	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:AA
warfarin	rs61742245	VKORC1	AC	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:AC
carbamazepine	rs3740066	ABCC2	CT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs3740066:CT
carbamazepine	rs3740066	ABCC2	TT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs3740066:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs96844	MAP3K1	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs96844:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs96844	MAP3K1	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs96844:GG
ritodrine	rs9839376	KCNMB2	CC	Efficacy	decreased	Efficacy_Response	Healthy		G02CA01	rs9839376:CC
warfarin	rs11676382	GGCX	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:G
carbamazepine	rs7643645	NR1I2	G	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs7643645:G
morphine	rs2952768	METTL21A	CC	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AA01	rs2952768:CC
carbamazepine	rs4688040	NR1I2	T	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs4688040:T
cannabinoids	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Other:C0030193		N02BG10	rs1045642:AG
cannabinoids	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Other:C0030193		N02BG10	rs1045642:GG
morphine	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AA01	rs1799971:AG
morphine	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AA01	rs1799971:GG
carbamazepine	rs2461817	NR1I2	C	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2461817:C
metoprolol	rs1801252	ADRB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB02	rs1801252:AA
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
warfarin	rs2884737	VKORC1	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2884737:CC
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
citalopram, fluoxetine, paroxetine, sertraline	rs495794	SRP19	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04|N06AB05|N06AB06	rs495794:G
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
citalopram, fluoxetine, paroxetine, sertraline	rs153560	REEP5	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04|N06AB05|N06AB06	rs153560:G
warfarin	rs8050894	VKORC1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:GG
citalopram, fluoxetine, paroxetine, sertraline	rs153549	REEP5	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04|N06AB05|N06AB06	rs153549:A
atazanavir	rs1045642	ABCB1	AA	Dosage	Indeterminado	Dosage	Disease:HIV_infectious_disease		J05AE08	rs1045642:AA
atazanavir	rs1045642	ABCB1	AG	Dosage	Indeterminado	Dosage	Disease:HIV_infectious_disease		J05AE08	rs1045642:AG
atazanavir	rs4149056	SLCO1B1	TT	Dosage	Indeterminado	Dosage	Disease:HIV_infectious_disease		J05AE08	rs4149056:TT
fluorouracil	rs3918290	DPYD	CT	Other, Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs3918290:CT
atazanavir	rs2472677	NR1I2	TT	Dosage	Indeterminado	Dosage	Disease:HIV_infectious_disease		J05AE08	rs2472677:TT
warfarin	rs61742245	VKORC1	AC	Dosage	increased	Dosage	Other:warfarin_maintenance_treatment		B01AA03	rs61742245:AC
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs2227310	CASP7	CG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs2227310:CG
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs2227310	CASP7	GG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs2227310:GG
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs4353229	CASP7	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs4353229:CC
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs4353229	CASP7	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs4353229:CT
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs12415607	CASP7	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs12415607:AA
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs12415607	CASP7	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs12415607:AC
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs7921977	CASP7	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs7921977:CT
olanzapine	rs11240594	SLC26A9	A	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs11240594:A
solanidine	rs28379954	NFIB	CC	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs28379954:CC
solanidine	rs28379954	NFIB	CT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs28379954:CT
ziprasidone	rs286913	EHF	A	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AE04	rs286913:A
clozapine	rs2975226	SLC6A3	A	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2975226:A
olanzapine	rs11677416	IL1A	C	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs11677416:C
cyclosporine	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs1057868:TT
carbamazepine	rs1051740	EPHX1	C	Dosage, Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs1051740:C
fesoterodine	rs10929302	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	AA	Metabolism/PK	increased	LADME	Healthy		G04BD11	rs10929302:AA
pioglitazone	rs17584499	PTPRD	CC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BG03	rs17584499:CC
acenocoumarol, warfarin	rs9923231	VKORC1	CC	Efficacy	increased	Dosage	Healthy		B01AA03|B01AA07	rs9923231:CC
acenocoumarol, warfarin	rs9923231	VKORC1	CT	Efficacy	increased	Dosage	Healthy		B01AA03|B01AA07	rs9923231:CT
ethanol	rs1799971	OPRM1	G	Toxicity	increased	Efficacy_Response	Other:C0085762		V03AB16	rs1799971:G
acamprosate	rs2058878	GRIN2B	A	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB03	rs2058878:A
olanzapine	rs6688363	ATP1A2	T	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AH03	rs6688363:T
risperidone	rs8050896	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs8050896:T
risperidone	rs2980976	TNFRSF11A	A	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AX08	rs2980976:A
risperidone	rs2636697	PPA2	G	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AX08	rs2636697:G
methotrexate	rs1232027	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0235889|Psoriatic		L04AX03	rs1232027:A
fentanyl, hydromorphone, opioids, oxycodone, tramadol	rs1799971	OPRM1	AA	Dosage	increased	Dosage	Other:C0549433		N02A|N02AA03|N02AA05|N02AB03|N02AX02	rs1799971:AA
risperidone	rs2636719	PPA2	A	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AX08	rs2636719:A
repaglinide	rs4402960	IGF2BP2	GT	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs4402960:GT
repaglinide	rs4402960	IGF2BP2	TT	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs4402960:TT
rasagiline	rs4680	COMT	AA	Metabolism/PK	decreased	LADME	Healthy		N04BD02	rs4680:AA
repaglinide	rs1470579	IGF2BP2	AC	Dosage, Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1470579:AC
repaglinide	rs1470579	IGF2BP2	CC	Dosage, Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1470579:CC
disulfiram	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0278080		N07BB01	rs1801133:AA
disulfiram	rs1801133	MTHFR	AG	Efficacy	increased	Efficacy_Response	Disease:C0278080		N07BB01	rs1801133:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	AG	Efficacy	increased	Efficacy_Response	"""Disease:C0235889|Psoriatic""|""Disease:C0010346|""Disease:C0235763|""Disease:C0038012|Ankylosing"""		No_ATC	rs1801274:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	GG	Efficacy	increased	Efficacy_Response	"""Disease:C0235889|Psoriatic""|""Disease:C0010346|""Disease:C0235763|""Disease:C0038012|Ankylosing"""		No_ATC	rs1801274:GG
isoniazid	rs4646244	NAT2	AT	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0041296		J04AC01	rs4646244:AT
platinum compounds	rs11615	ERCC1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01XA	rs11615:AA
isoniazid	rs1799930	NAT2	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0041296		J04AC01	rs1799930:AA
hydrochlorothiazide	rs61747221	BEST3	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs61747221:AA
hydrochlorothiazide	rs61747221	BEST3	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs61747221:AG
deferiprone	rs2070959	UGT1A6	AA	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		V03AC02	rs2070959:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs396991	FCGR3A	C	Efficacy	increased	Efficacy_Response	"""Disease:C0235889|Psoriatic""|""Disease:C0010346|""Disease:C0235763|""Disease:C0038012|Ankylosing"""		No_ATC	rs396991:C
nifedipine	rs1048101	ADRA1A	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA05	rs1048101:AA
nifedipine	rs1048101	ADRA1A	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA05	rs1048101:AG
deferiprone	rs2070959	UGT1A6	AA	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		V03AC02	rs2070959:AA
deferiprone	rs6759892	UGT1A6	GG	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		V03AC02	rs6759892:GG
pioglitazone	rs1801282	PPARG	CG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BG03	rs1801282:CG
paclitaxel, platinum compounds	rs4353229	CASP7	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs4353229:CC
paclitaxel, platinum compounds	rs4353229	CASP7	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs4353229:CT
opioids	rs1800629	TNF	GG	Dosage	increased	Dosage	Other:C0027651|Other:C0030193		N02A	rs1800629:GG
carbamazepine	rs3812718	SCN1A	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:CT
paclitaxel, platinum compounds	rs2227310	CASP7	CG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs2227310:CG
paclitaxel, platinum compounds	rs2227310	CASP7	GG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs2227310:GG
risperidone	rs813676	TJP1	T	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs813676:T
opioids	rs1800797	IL6	A	Dosage	decreased	Dosage	Other:C0027651|Other:C0030193		N02A	rs1800797:A
warfarin	rs9934438	VKORC1	AA	Dosage, Efficacy	decreased	Dosage	Disease:C0027051		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Dosage, Efficacy	decreased	Dosage	Disease:C0027051		B01AA03	rs9934438:AG
methylphenidate	rs734644	ADGRL3	CC	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs734644:CC
methylphenidate	rs734644	ADGRL3	CT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs734644:CT
paclitaxel, platinum compounds	rs1127687	CASP7	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs1127687:AA
paclitaxel, platinum compounds	rs1127687	CASP7	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs1127687:AG
fluticasone propionate, montelukast	rs967676	CA10	CC	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05|R03DC03	rs967676:CC
fluticasone propionate, montelukast	rs967676	CA10	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05|R03DC03	rs967676:CT
carbamazepine	rs1051740	EPHX1	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs1051740:CT
carbamazepine	rs1051740	EPHX1	CC	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs1051740:CC
gemcitabine, platinum compounds	rs1127687	CASP7	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA	rs1127687:AA
gemcitabine, platinum compounds	rs1127687	CASP7	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA	rs1127687:AG
fluticasone propionate, montelukast	rs1786929	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05|R03DC03	rs1786929:AA
fluticasone propionate, montelukast	rs1786929	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05|R03DC03	rs1786929:AG
tacrolimus	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs2032582:AA
carbamazepine	rs3812718	SCN1A	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:TT
rosuvastatin	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:GT
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:TT
methylphenidate	rs1355368	ADGRL3	AG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1355368:AG
methylphenidate	rs1355368	ADGRL3	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1355368:GG
methylphenidate	rs6813183	ADGRL3	CC	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs6813183:CC
methylphenidate	rs6813183	ADGRL3	CG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs6813183:CG
risperidone	rs7395555	__INTRONIC__	C	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs7395555:C
ranibizumab	rs1061170	CFH	TT	Efficacy	increased	Efficacy_Response	Disease:C0024437		S01LA04	rs1061170:TT
olanzapine	rs10170310	SPOPL	C	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AH03	rs10170310:C
quetiapine	rs17382202	PDE4D	T	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH04	rs17382202:T
acenocoumarol	rs9923231	VKORC1	T	Dosage	Indeterminado	Dosage	Healthy		B01AA07	rs9923231:T
quetiapine	rs17742120	PDE4D	G	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH04	rs17742120:G
quetiapine	rs2164660	PDE4D	A	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH04	rs2164660:A
acenocoumarol	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Disease:C0004238|Disease:C1861172		B01AA07	rs9923231:CC
perindopril	rs5182	AGTR1	CC	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs5182:CC
perindopril	rs5182	AGTR1	CT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs5182:CT
risperidone	rs711355	TJP1	T	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs711355:T
risperidone	rs785423	TJP1	A	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs785423:A
tenofovir alafenamide	rs3842	ABCB1	CT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AF13	rs3842:CT
clozapine	rs25531	SLC6A4	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH02	rs25531:T
raloxifene	rs1042597	UGT1A8	CC	Efficacy	increased	Efficacy_Response	Disease:C0025320|Disease:C0036341		G03XC01	rs1042597:CC
esomeprazole	rs1059513	STAT6	CC	Efficacy	increased	Efficacy_Response	Other:C0151788		A02BC05	rs1059513:CC
esomeprazole	rs1059513	STAT6	CT	Efficacy	increased	Efficacy_Response	Other:C0151788		A02BC05	rs1059513:CT
risperidone	rs5758550	WBP2NL	A	Metabolism/PK	decreased	LADME	Healthy		N05AX08	rs5758550:A
paclitaxel, platinum compounds	rs12415607	CASP7	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs12415607:AA
paclitaxel, platinum compounds	rs12415607	CASP7	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs12415607:AC
adalimumab	rs1126535	CD40LG	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs1126535:T
raloxifene	rs11543791	ESR1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0025320|Disease:C0036341		G03XC01	rs11543791:CC
perindopril	rs275651	AGTR1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs275651:AA
perindopril	rs275651	AGTR1	AT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs275651:AT
lithium	rs7959663	MYO1H	C	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs7959663:C
infliximab	rs1801274	FCGR2A	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB02	rs1801274:G
lithium	rs59724122	EPHX2	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs59724122:T
losartan, losartan e-3174	rs17080138	FBXW12	CT	Metabolism/PK	increased	LADME	Healthy		C09CA01	rs17080138:CT
lithium	rs61123830	GRAMD1B	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs61123830:A
warfarin	rs7294	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs7294:T
lithium	rs66486766	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs66486766:A
lithium	rs324899	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs324899:A
lithium	rs1611259	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs1611259:T
lithium	rs6942227	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs6942227:A
nevirapine	rs28371706	CYP2D6	AA	Dosage, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs28371706:AA
nevirapine	rs28371706	CYP2D6	AG	Dosage, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs28371706:AG
nevirapine	rs3745274	CYP2B6	GT	Dosage, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:GT
nevirapine	rs3745274	CYP2B6	TT	Dosage, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT
catecholamines	rs1801253	ADRB1	CC	Dosage	decreased	Dosage	Disease:C1956346		No_ATC	rs1801253:CC
acenocoumarol	rs429358	APOE	CC	Dosage	increased	Dosage	Disease:C0004238|Disease:C1861172		B01AA07	rs429358:CC
losartan, losartan e-3174	rs79707182	ZNF703	CT	Metabolism/PK	increased	LADME	Healthy		C09CA01	rs79707182:CT
perindopril	rs12050217	BDKRB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs12050217:AA
perindopril	rs12050217	BDKRB1	AG	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs12050217:AG
losartan, losartan e-3174	rs11754288	SLC17A4	A	Metabolism/PK	increased	LADME	Healthy		C09CA01	rs11754288:A
warfarin	rs17708472	VKORC1	A	Dosage	increased	Dosage	Healthy		B01AA03	rs17708472:A
drugs used in nicotine dependence	rs680244	CHRNA5	C	Other	increased	Efficacy_Response	Disease:C0039338		N07BA	rs680244:C
adalimumab, etanercept, infliximab	rs3787186	NFATC2	CC	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04	rs3787186:CC
adalimumab, etanercept, infliximab	rs3787186	NFATC2	CT	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04	rs3787186:CT
drugs used in nicotine dependence	rs16969968	CHRNA3, CHRNA5	G	Other	increased	Efficacy_Response	Disease:C0039338		N07BA	rs16969968:G
drugs used in nicotine dependence	rs680244	CHRNA5	T	Other	increased	Efficacy_Response	Disease:C0039338		N07BA	rs680244:T
allopurinol	rs2231142	ABCG2	T	Efficacy	decreased	Efficacy_Response	Other:C0018099		M04AA01	rs2231142:T
lithium	rs79403677	FAM177A1	T	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs79403677:T
clopidogrel	rs2487032	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs2487032:A
metoprolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C07AB02	rs1801253:CC
warfarin	rs9923231	VKORC1	A	Dosage	decreased	Dosage	Other:total_knee_or_hip_arthroplasty		B01AA03	rs9923231:A
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11591741	CHUK	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs11591741:G
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T
lithium	rs1521470	ADCY1	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs1521470:A
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC
repaglinide	rs2237892	KCNQ1	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs2237892:CT
repaglinide	rs2237892	KCNQ1	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs2237892:TT
lithium	rs7588746	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs7588746:A
lithium	rs6728642	FAM178B	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs6728642:A
beta blocking agents	rs2230345	GRK5	AT	Efficacy	increased	Efficacy_Response	Other:C0085605		S01ED	rs2230345:AT
beta blocking agents	rs2230345	GRK5	TT	Efficacy	increased	Efficacy_Response	Other:C0085605		S01ED	rs2230345:TT
zileuton	rs12436663	PRORP	AA	Efficacy	decreased	Efficacy_Response	Disease:C0004096		No_ATC	rs12436663:AA
losartan, losartan e-3174	rs10509680	CYP2C9	GT	Metabolism/PK	increased	LADME	Healthy		C09CA01	rs10509680:GT
lithium	rs62200793	ZNF804A	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs62200793:T
lithium	rs1611255	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs1611255:A
lithium	rs209474	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs209474:A
repaglinide	rs2237895	KCNQ1	AC	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs2237895:AC
repaglinide	rs2237895	KCNQ1	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs2237895:CC
lithium	rs3919583	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs3919583:A
platinum compounds	rs1799782	XRCC1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs1799782:AA
platinum compounds	rs1799782	XRCC1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs1799782:AG
glatiramer acetate	rs1800469	TGFB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AX13	rs1800469:A
antiepileptics	rs3740066	ABCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs3740066:CT
antiepileptics	rs3740066	ABCC2	TT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs3740066:TT
n-desmethyltamoxifen	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	rs2231142:GT
n-desmethyltamoxifen	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	rs2231142:TT
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
glucocorticoids	rs37973	GLCCI1	G	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA	rs37973:G
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG
antiepileptics	rs717620	ABCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs717620:CT
antiepileptics	rs717620	ABCC2	TT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs717620:TT
amlodipine	rs2246709	CYP3A4	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01	rs2246709:AG
amlodipine	rs2246709	CYP3A4	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01	rs2246709:GG
teneligliptin	rs2266780	FMO3	AG	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266780:AG
teneligliptin	rs2266780	FMO3	GG	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266780:GG
drugs used in nicotine dependence	rs16969968	CHRNA3, CHRNA5	A	Other	increased	Efficacy_Response	Disease:C0039338		N07BA	rs16969968:A
quetiapine	rs4818	COMT	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH04	rs4818:C
hydrochlorothiazide	rs3758785	GPR83	GG	Efficacy	decreased	Efficacy_Response	Efficacy:C0085580		C03AA03	rs3758785:GG
quetiapine	rs5993883	COMT	T	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH04	rs5993883:T
teneligliptin	rs909530	FMO3	CT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs909530:CT
teneligliptin	rs909530	FMO3	TT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs909530:TT
quetiapine	rs6269	COMT	A	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH04	rs6269:A
candesartan	rs3758785	GPR83	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09CA06	rs3758785:GG
tacrolimus	rs1800795	IL6	GG	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	rs1800795:GG
teneligliptin	rs2266782	FMO3	AG	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266782:AG
teneligliptin	rs2266782	FMO3	GG	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266782:GG
paclitaxel	rs2032582	ABCB1	CT	Metabolism/PK	increased	LADME	Disease:C0919267		L01CD01	rs2032582:CT
hydrochlorothiazide	rs7553527	HSD3B1	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs7553527:CC
hydrochlorothiazide	rs7553527	HSD3B1	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs7553527:CT
hydrochlorothiazide	rs177852	TTC6	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs177852:CC
hydrochlorothiazide	rs177852	TTC6	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs177852:CT
teneligliptin	rs2242480	CYP3A4	CT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2242480:CT
teneligliptin	rs2242480	CYP3A4	TT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2242480:TT
glatiramer acetate	rs1012335	IFNAR1	G	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AX13	rs1012335:G
5-hydroxyomeprazole, omeprazole	rs12777823	__INTRONIC__	A	Metabolism/PK	increased	LADME	Healthy		A02BC01	rs12777823:A
atorvastatin	rs2740574	CYP3A4	CC	Efficacy	decreased	Efficacy_Response	Other:C0007222|Other:C0020473		C10AA05	rs2740574:CC
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A
6-hydroxy s-warfarin	rs368245720	__INTRONIC__	A	Metabolism/PK	increased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs368245720:A
atorvastatin	rs776746	CYP3A5	CC	Efficacy	increased	Efficacy_Response	Other:C0007222|Other:C0020473		C10AA05	rs776746:CC
citalopram, escitalopram, fluoxetine, sertraline	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03|N06AB04|N06AB06|N06AB10	rs6265:CC
6-hydroxy s-warfarin	rs10433340	PARP14	A	Metabolism/PK	increased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs10433340:A
metoprolol	rs1801253	ADRB1	C	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB02	rs1801253:C
salbutamol	rs1042713	ADRB2	AA	PD	decreased	Efficacy_Response	Healthy		R03CC02	rs1042713:AA
efavirenz	rs3003596	NR1I3	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3003596:GG
imatinib	rs12505410	ABCG2	G	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs12505410:G
imatinib	rs12505410	ABCG2	GG	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs12505410:GG
imatinib	rs12505410	ABCG2	GT	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs12505410:GT
tamoxifen	rs4646	CYP19A1	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	rs4646:AA
tamoxifen	rs4646	CYP19A1	AC	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	rs4646:AC
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
6-hydroxy r-warfarin, 6-hydroxy s-warfarin	rs558364281	GRID2	G	Metabolism/PK	increased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs558364281:G
imatinib	rs13120400	ABCG2	CC	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs13120400:CC
imatinib	rs13120400	ABCG2	CT	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs13120400:CT
methotrexate	rs10841753	SLCO1B1	CT	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs10841753:CT
methotrexate	rs10841753	SLCO1B1	TT	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs10841753:TT
imatinib	rs2725252	ABCG2	AC	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2725252:AC
imatinib	rs2725252	ABCG2	CC	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2725252:CC
lacidipine, nifedipine, nitrendipine	rs2238032	CACNA1C	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA05|C08CA08|C08CA09	rs2238032:TT
lumefantrine	rs2740574	CYP3A4	C	Metabolism/PK	increased	LADME	Disease:C0024530|Other:C0032961		P01BF01	rs2740574:C
quetiapine	rs10042486	HTR1A	TT	Metabolism/PK	increased	LADME	Other:C0036341		N05AH04	rs10042486:TT
amitriptyline, clomipramine, duloxetine, imipramine, milnacipran, venlafaxine	rs6265	BDNF	CT	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AA02|N06AA04|N06AA09|N06AX16|N06AX17|N06AX21	rs6265:CT
amitriptyline, clomipramine, duloxetine, imipramine, milnacipran, venlafaxine	rs6265	BDNF	TT	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AA02|N06AA04|N06AA09|N06AX16|N06AX17|N06AX21	rs6265:TT
chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone, trifluoperazine	rs1415744	EPM2A	C	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AA01|N05AB06|N05AD01|N05AH02|N05AH03|N05AH04|N05AX08	rs1415744:C
amlodipine, felodipine	rs2239050	CACNA1C	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01|C08CA02	rs2239050:GG
warfarin	rs41291550	CYP2C18	A	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs41291550:A
atorvastatin	rs2740574	CYP3A4	TT	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0020473		C10AA05	rs2740574:TT
citalopram, fluoxetine	rs334558	GSK3B	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04	rs334558:GG
ethanol	rs17376019	SRPRB	CT	Metabolism/PK	decreased	LADME	Healthy		V03AB16	rs17376019:CT
warfarin	rs9332241	CYP2C9	T	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs9332241:T
ethanol	rs671	ALDH2	AG	Metabolism/PK	increased	LADME	Healthy		V03AB16	rs671:AG
lumefantrine	rs10264272	CYP3A5	T	Metabolism/PK	increased	LADME	Disease:C0024530|Other:C0032961		P01BF01	rs10264272:T
atorvastatin	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0020473		C10AA05	rs776746:CC
ethanol	rs4643	PGM1	CC	Metabolism/PK	decreased	LADME	Healthy		V03AB16	rs4643:CC
warfarin	rs7856096	FPGS	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs7856096:G
acetaldehyde	rs1229976	ADH1A	CT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1229976:CT
warfarin	rs7856096	FPGS	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs7856096:G
lumefantrine	rs776746	CYP3A5	C	Metabolism/PK	increased	LADME	Disease:C0024530|Other:C0032961		P01BF01	rs776746:C
acetaldehyde	rs671	ALDH2	AG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs671:AG
infliximab	rs396991	FCGR3A	A	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB02	rs396991:A
cetuximab	rs396991	FCGR3A	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs396991:A
acetaldehyde	rs4643	PGM1	CC	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs4643:CC
verapamil	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Healthy		C08DA01	rs1045642:GG
acetaldehyde	rs1229984	ADH1B	CT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1229984:CT
naltrexone	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1799971:AG
naltrexone	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1799971:GG
amlodipine, felodipine	rs2239128	CACNA1C	C	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01|C08CA02	rs2239128:C
fluorouracil	rs3918290	DPYD	CT	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023055		L01BC02	rs3918290:CT
sunitinib	rs776746	CYP3A5	T	Dosage	decreased	Dosage	Disease:C0007134		L01EX01	rs776746:T
n-desmethylclozapine(clozapine)	rs61750900	UGT2B10	GT	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs61750900:GT
lumefantrine	rs2740574	CYP3A4	T	Efficacy	decreased	Efficacy_Response	Disease:C0024530|Disease:C0032961		P01BF01	rs2740574:T
clopidogrel	rs2254638	N6AMT1	G	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs2254638:G
valproic acid	rs6759892	UGT1A6	TT	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs6759892:TT
fentanyl	rs7858836	ASTN2	CT	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs7858836:CT
fentanyl	rs7858836	ASTN2	TT	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs7858836:TT
benazepril, imidapril	rs1799998	CYP11B2	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA07|C09AA16	rs1799998:AA
benazepril, imidapril	rs1799998	CYP11B2	AG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA07|C09AA16	rs1799998:AG
fentanyl	rs958804	ASTN2	CC	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs958804:CC
fentanyl	rs958804	ASTN2	CT	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs958804:CT
valproic acid	rs1105879	UGT1A6	AA	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs1105879:AA
valproic acid	rs2070959	UGT1A6	AA	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs2070959:AA
tacrolimus	rs35599367	CYP3A4	AA	Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs35599367:AA
tacrolimus	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs35599367:AG
verapamil	rs2032582	ABCB1	CC	Metabolism/PK	decreased	LADME	Healthy		C08DA01	rs2032582:CC
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CT
etidronic acid	rs1800012	COL1A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0005944		M05BA01	rs1800012:AA
etidronic acid	rs1800012	COL1A1	AC	Efficacy	decreased	Efficacy_Response	Disease:C0005944		M05BA01	rs1800012:AC
voriconazole	rs13120400	ABCG2	CC	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs13120400:CC
morphine, nortriptyline	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Other:C0030193		N02AA01|N06AA10	rs1045642:GG
risperidone	rs6295	HTR1A	CG	Metabolism/PK	increased	LADME	Other:C0036341		N05AX08	rs6295:CG
risperidone	rs6295	HTR1A	GG	Metabolism/PK	increased	LADME	Other:C0036341		N05AX08	rs6295:GG
duloxetine	rs4858478	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs4858478:G
fluorouracil	rs67376798	DPYD	AT	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023055		L01BC02	rs67376798:AT
valproic acid	rs6759892	UGT1A6	GG	Metabolism/PK	decreased	LADME	Other:C0014544		N03AG01	rs6759892:GG
duloxetine	rs13093500	ZNF385D	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs13093500:T
escitalopram, fluoxetine, paroxetine, sertraline	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03|N06AB05|N06AB06|N06AB10	rs6265:CC
folic acid, hydroxychloroquine, methotrexate, sulfasalazine	rs1051266	SLC19A1	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		A07EC01|B03BB01|L04AX03|P01BA02	rs1051266:T
duloxetine	rs4334661	ZNF385D	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs4334661:T
folic acid, hydroxychloroquine, methotrexate, sulfasalazine	rs1805087	MTR	A	Efficacy	increased	Efficacy_Response	Disease:C0003873		A07EC01|B03BB01|L04AX03|P01BA02	rs1805087:A
duloxetine	rs7625956	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs7625956:G
tacrolimus	rs4646453	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs4646453:CC
tamoxifen	rs1042028	SULT1A1	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs1042028:TT
duloxetine	rs7616119	ZNF385D	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs7616119:G
terbutaline	rs1800888	ADRB2	CT	Efficacy	decreased	Efficacy_Response	Healthy		R03CC03	rs1800888:CT
duloxetine	rs2933304	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs2933304:T
warfarin	rs9923231	VKORC1	CT	Dosage	increased	Dosage	Disease:C0040038		B01AA03	rs9923231:CT
methotrexate	rs1051266	SLC19A1	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:T
duloxetine	rs4971678	NRXN1	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs4971678:T
duloxetine	rs12630569	ZNF385D	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs12630569:G
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Disease:C0040038		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Disease:C0040038		B01AA03	rs2108622:TT
bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin, oxaliplatin	rs699947	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01CE02|L01FG01|L01XA03	rs699947:CC
erythropoietin	rs1800562	HFE	A	Dosage, Metabolism/PK	decreased	Dosage	Other:hemodialysis_treatment		B03XA01	rs1800562:A
duloxetine	rs6700741	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs6700741:C
enalapril	rs1042714	ADRB2	CG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C09AA02	rs1042714:CG
enalapril	rs1042714	ADRB2	GG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C09AA02	rs1042714:GG
atenolol, enalapril	rs1042714	ADRB2	CG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C07AB03|C09AA02	rs1042714:CG
atenolol, enalapril	rs1042714	ADRB2	GG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C07AB03|C09AA02	rs1042714:GG
bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin, oxaliplatin	rs3025039	VEGFA	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01CE02|L01FG01|L01XA03	rs3025039:TT
erythropoietin	rs1799945	HFE	G	Dosage, Metabolism/PK	decreased	Dosage	Other:hemodialysis_treatment		B03XA01	rs1799945:G
duloxetine	rs6479008	TEX10	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs6479008:C
tacrolimus	rs15524	CYP3A5	AA	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs15524:AA
duloxetine	rs7035619	TEX10	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs7035619:A
duloxetine	rs10989064	TEX10	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs10989064:T
digoxin	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs1045642:GG
duloxetine	rs12595802	ATP10A	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs12595802:G
duloxetine	rs7472	TEX10	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs7472:G
duloxetine	rs56229625	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs56229625:G
digoxin	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs2032582:CC
duloxetine	rs61692318	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61692318:G
duloxetine	rs62319299	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs62319299:A
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CC
duloxetine	rs10124893	TEX10	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs10124893:G
duloxetine	rs10123866	INVS	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs10123866:G
abemaciclib, palbociclib, ribociclib	rs1045642	ABCB1	A	Dosage, Toxicity	decreased	Dosage	Other:C1458155		L01EF01|L01EF02|L01EF03	rs1045642:A
amlodipine	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Healthy		C08CA01	rs776746:CC
duloxetine	rs10007051	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs10007051:C
ivacaftor	rs75527207	CFTR	A	Efficacy	increased	Efficacy_Response	Other:C0156318		R07AX02	rs75527207:A
duloxetine	rs9879065	ZNF385D	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9879065:C
duloxetine	rs55881666	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs55881666:C
infliximab	rs2097432	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AB02	rs2097432:CC
infliximab	rs2097432	__INTRONIC__	CT	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AB02	rs2097432:CT
valproic acid	rs4918758	CYP2C9	CC	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs4918758:CC
valproic acid	rs4918758	CYP2C9	CT	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs4918758:CT
duloxetine	rs11933890	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs11933890:A
valproic acid	rs4244285	CYP2C19	AA	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs4244285:AA
valproic acid	rs4244285	CYP2C19	AG	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs4244285:AG
duloxetine	rs9310658	ZNF385D	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9310658:C
duloxetine	rs7653345	ZNF385D	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs7653345:A
valproic acid	rs1731017	ABAT	GG	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs1731017:GG
duloxetine	rs9310657	ZNF385D	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9310657:T
duloxetine	rs9824595	ZNF385D	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9824595:G
duloxetine	rs9873889	ZNF385D	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9873889:C
duloxetine	rs9819548	ZNF385D	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9819548:G
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T
capecitabine	rs532545	CDA	CC	Efficacy	decreased	Efficacy_Response	Other:C1458155		L01BC06	rs532545:CC
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
hydralazine / isosorbide dinitrate	rs1799983	NOS3	GG	Efficacy	increased	Efficacy_Response	Other:C0085605		C05AE02	rs1799983:GG
warfarin	rs56165452	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs56165452:C
tacrolimus	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:GT
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
adalimumab	rs1130864	CRP	AG	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs1130864:AG
adalimumab	rs1130864	CRP	GG	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs1130864:GG
olanzapine	rs472660	CYP3A43	AA	Dosage, Efficacy, Toxicity, Metabolism/PK	increased	LADME	Disease:C0036341		N05AH03	rs472660:AA
glatiramer acetate	rs2371108	EOMES	T	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AX13	rs2371108:T
carvedilol	rs4148323	UGT1A1	A	Metabolism/PK	decreased	LADME	Disease:C0002962		C07AG02	rs4148323:A
etoposide	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:C0023449		L01CB01	rs1045642:GG
adalimumab	rs9373839	ATG5	CC	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs9373839:CC
adalimumab	rs9373839	ATG5	CT	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs9373839:CT
duloxetine	rs56355515	MIEF2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs56355515:G
duloxetine	rs12603700	MIEF2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs12603700:G
adalimumab	rs510432	ATG5	CT	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs510432:CT
adalimumab	rs510432	ATG5	TT	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs510432:TT
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	increased	Dosage	Disease:C0277631		L04AD02	rs1045642:GG
duloxetine	rs3889402	MIEF2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs3889402:G
azathioprine	rs55754655	AOX1	G	Efficacy	decreased	Efficacy_Response	Disease:C0021390		L04AX01	rs55754655:G
azathioprine	rs55754655	AOX1	AG	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AX01	rs55754655:AG
azathioprine	rs55754655	AOX1	GG	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AX01	rs55754655:GG
hydralazine / isosorbide dinitrate	rs1799998	CYP11B2	AA	Efficacy	increased	Efficacy_Response	Other:C0085605		C05AE02	rs1799998:AA
duloxetine	rs58042962	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs58042962:G
tacrolimus	rs2740574	CYP3A4	C	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2740574:C
duloxetine	rs10771997	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs10771997:T
fenofibrate	rs320	LPL	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020557		C10AB05	rs320:GG
duloxetine	rs3124955	FCN2	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs3124955:T
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
fenofibrate	rs2727786	APOA1	CG	Efficacy	decreased	Efficacy_Response	Disease:C0020557		C10AB05	rs2727786:CG
duloxetine	rs3128624	FCN2	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs3128624:A
duloxetine	rs7306991	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs7306991:A
glatiramer acetate	rs6498169	CLEC16A	A	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AX13	rs6498169:A
tacrolimus	rs2740574	CYP3A4	C	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2740574:C
digoxin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		C01AA05	rs1045642:AA
duloxetine	rs10771999	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs10771999:C
duloxetine	rs10771998	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs10771998:A
duloxetine	rs12657120	SKIC3	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs12657120:G
ethosuximide	rs61734410	CACNA1H	T	Efficacy	decreased	Efficacy_Response	Efficacy:C0014544		N03AD01	rs61734410:T
duloxetine	rs4639250	SKIC3	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs4639250:G
duloxetine	rs4437856	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs4437856:A
ethosuximide	rs3747178	CACNA1I	T	Efficacy	decreased	Efficacy_Response	Efficacy:C0014544		N03AD01	rs3747178:T
duloxetine	rs9369266	TREML4	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs9369266:A
azathioprine	rs594445	MOCOS	AA	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AX01	rs594445:AA
azathioprine	rs594445	MOCOS	AC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AX01	rs594445:AC
duloxetine	rs13204353	TREML4	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs13204353:G
lamotrigine	rs2032582	ABCB1	A	Efficacy	decreased	Efficacy_Response	Efficacy:C0014544		N03AX09	rs2032582:A
cyclosporine	rs12885713	CALM1	T	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AD01	rs12885713:T
irbesartan	rs699	AGT	GG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C09CA04	rs699:GG
duloxetine	rs2419128	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs2419128:C
methotrexate	rs1051266	SLC19A1	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:T
duloxetine	rs12502866	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs12502866:G
methotrexate	rs3758149	GGH	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs3758149:AA
methotrexate	rs3758149	GGH	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs3758149:AG
duloxetine	rs12094644	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs12094644:T
capecitabine	rs2072671	CDA	AA	Efficacy	decreased	Efficacy_Response	Other:C1458155		L01BC06	rs2072671:AA
capecitabine	rs2072671	CDA	AC	Efficacy	decreased	Efficacy_Response	Other:C1458155		L01BC06	rs2072671:AC
lamotrigine	rs2753326	CACNA1H	A	Efficacy	increased	Efficacy_Response	Efficacy:C0014544		N03AX09	rs2753326:A
rivaroxaban	rs4728709	ABCB1	GG	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs4728709:GG
atenolol	rs1800545	ADRA2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C07AB03	rs1800545:GG
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
cyclosporine	rs2874116	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AD01	rs2874116:G
irbesartan	rs1801701	APOB	CC	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C09CA04	rs1801701:CC
rivaroxaban	rs4148738	ABCB1	CC	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs4148738:CC
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C
mephenytoin	rs183701923	CYP2C19	T	Metabolism/PK	decreased	LADME	Healthy		N03AB02	rs183701923:T
mephenytoin	rs140278421	CYP2C19	A	Metabolism/PK	decreased	LADME	Healthy		N03AB02	rs140278421:A
efavirenz	rs4803419	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs4803419:T
chlorpromazine	rs1799732	DRD2	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AA01	rs1799732:GG
methotrexate	rs17602729	AMPD1	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs17602729:AA
methotrexate	rs17602729	AMPD1	AG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs17602729:AG
benazepril	rs7079	AGT	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07	rs7079:TT
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
omeprazole	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC01	rs1045642:AA
omeprazole	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC01	rs1045642:AG
opioids	rs1799971	OPRM1	AA	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02A	rs1799971:AA
nelfinavir	rs4244285	CYP2C19	AA	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AE04	rs4244285:AA
tolbutamide	rs771237265	CYP2C9	C	Metabolism/PK	decreased	LADME	Healthy		A10BB03	rs771237265:C
methotrexate	rs1051266	SLC19A1	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:TT
tolbutamide	rs762081829	CYP2C9	T	Metabolism/PK	decreased	LADME	Healthy		A10BB03	rs762081829:T
metformin	rs628031	SLC22A1	A	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs628031:A
mephenytoin	rs145119820	CYP2C19	A	Metabolism/PK	decreased	LADME	Healthy		N03AB02	rs145119820:A
tolbutamide	rs761895497	CYP2C9	C	Metabolism/PK	decreased	LADME	Healthy		A10BB03	rs761895497:C
warfarin	rs510317	F7	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs510317:AA
warfarin	rs510317	F7	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs510317:AG
fluoxetine	rs6295	HTR1A	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs6295:GG
mephenytoin	rs61311738	CYP2C19	T	Metabolism/PK	decreased	LADME	Healthy		N03AB02	rs61311738:T
sulfonamides, urea derivatives	rs7903146	TCF7L2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		S01AB	rs7903146:TT
benazepril	rs4762	AGT	G	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07	rs4762:G
digoxin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		C01AA05	rs1045642:AA
benazepril	rs699	AGT	A	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07	rs699:A
fluorouracil, oxaliplatin	rs1695	GSTP1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1695:AG
fluorouracil, oxaliplatin	rs1695	GSTP1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1695:GG
acenocoumarol	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:CT
acenocoumarol	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:TT
benazepril	rs7079	AGT	T	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07	rs7079:T
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T
fenofibrate	rs3135506	APOA5	CG	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs3135506:CG
fenofibrate	rs3135506	APOA5	GG	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs3135506:GG
pravastatin, simvastatin	rs11716445	RHOA	A	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01|C10AA03	rs11716445:A
efavirenz	rs35303484	CYP2B6	AG	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs35303484:AG
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
citalopram	rs585719	__INTRONIC__	CT	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB04	rs585719:CT
warfarin	rs11676382	GGCX	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:CG
warfarin	rs11676382	GGCX	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:GG
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT
warfarin	rs12777823	__INTRONIC__	A	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs12777823:A
warfarin	rs7900194	CYP2C9	A	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs7900194:A
isoniazid	rs6413432	CYP2E1	A	Metabolism/PK	increased	LADME	Other:C0041296		J04AC01	rs6413432:A
efavirenz	rs4803419	CYP2B6	TT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs4803419:TT
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC
warfarin	rs2645400	GATA4	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2645400:TT
warfarin	rs28371685	CYP2C9	T	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs28371685:T
warfarin	rs4841588	GATA4	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs4841588:TT
mycophenolic acid acyl glucuronide	rs7662029	UGT2B7	GG	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		D08AE03	rs7662029:GG
buprenorphine	rs7439366	UGT2B7	CC	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC01	rs7439366:CC
methotrexate	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs4149056:CC
mycophenolic acid acyl glucuronide	rs7439366	UGT2B7	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		D08AE03	rs7439366:CC
methotrexate	rs2838958	SLC19A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs2838958:AA
warfarin	rs1057910	CYP2C9	AC	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs1057910:AC
warfarin	rs1057910	CYP2C9	CC	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs1057910:CC
sildenafil	rs1570360	VEGFA	AA	Efficacy	decreased	Efficacy_Response	Disease:C0242350		G04BE03	rs1570360:AA
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC
sildenafil	rs699947	VEGFA	AA	Efficacy	decreased	Efficacy_Response	Disease:C0242350		G04BE03	rs699947:AA
sildenafil	rs699947	VEGFA	AC	Efficacy	decreased	Efficacy_Response	Disease:C0242350		G04BE03	rs699947:AC
warfarin	rs2108622	CYP4F2	CT	Metabolism/PK	increased	Dosage	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Metabolism/PK	increased	Dosage	Healthy		B01AA03	rs2108622:TT
captopril	rs2106809	ACE2	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA01	rs2106809:GG
cyclophosphamide, doxorubicin, paclitaxel, trastuzumab	rs1801274	FCGR2A	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01CD01|L01DB01	rs1801274:AA
trastuzumab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Disease:C1458155		No_ATC	rs396991:CC
buprenorphine	rs7662029	UGT2B7	GG	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC01	rs7662029:GG
eculizumab	rs2274567	CR1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024790		No_ATC	rs2274567:AG
eculizumab	rs2274567	CR1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0024790		No_ATC	rs2274567:GG
tacrolimus	rs2740574	CYP3A4	CT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs2740574:CT
mycophenolic acid	rs4148323	UGT1A1	AG	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AA06	rs4148323:AG
mirabegron	rs12708954	SLC6A2	CC	Metabolism/PK	increased	LADME	Healthy		G04BD12	rs12708954:CC
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
phenprocoumon	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:TT
clozapine	rs686	DRD1	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs686:G
mycophenolic acid acyl glucuronide	rs7438135	UGT2B7	AA	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		D08AE03	rs7438135:AA
fluvastatin	rs1057910	CYP2C9	CC	Metabolism/PK	decreased	LADME	Healthy		C10AA04	rs1057910:CC
mirabegron	rs1051266	SLC19A1	TT	Metabolism/PK	decreased	LADME	Healthy		G04BD12	rs1051266:TT
clozapine	rs6280	DRD3	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs6280:TT
mercaptopurine	rs12199316	TPMT	G	Dosage	increased	Dosage	Other:C0023449		L01BB02	rs12199316:G
ticagrelor	rs56324128	CYP3A4	CC	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC24	rs56324128:CC
candesartan	rs5186	AGTR1	AA	Efficacy	increased	Efficacy_Response	Disease:C0085605		C09CA06	rs5186:AA
irbesartan	rs5186	AGTR1	AC	Efficacy	increased	Efficacy_Response	Other:C0020564|Left_Ventricular		C09CA04	rs5186:AC
warfarin	rs2256871	CYP2C9	G	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs2256871:G
docetaxel, paclitaxel	rs776746	CYP3A5	CC	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD01|L01CD02	rs776746:CC
capecitabine, fluorouracil, tegafur / gimeracil / oteracil	rs1801159	DPYD	CC	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01BC03|L01BC06	rs1801159:CC
capecitabine, fluorouracil, tegafur / gimeracil / oteracil	rs1801159	DPYD	CT	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01BC03|L01BC06	rs1801159:CT
candesartan	rs5186	AGTR1	AC	Efficacy	increased	Efficacy_Response	Disease:C0085605		C09CA06	rs5186:AC
ticagrelor	rs113681054	SLCO1B1	C	Metabolism/PK	increased	LADME	Disease:C0027051		B01AC24	rs113681054:C
ticagrelor	rs4149056	SLCO1B1	T	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC24	rs4149056:T
gemcitabine, paclitaxel	rs760370	SLC29A1	A	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01BC05|L01CD01	rs760370:A
citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03|N06AB04|N06AB05|N06AB06|N06AB08|N06AB10	rs6265:CC
warfarin	rs11188082	CYP2C19	T	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs11188082:T
methylphenidate	rs71647871	CES1	CT	Dosage, Metabolism/PK	decreased	Dosage	Disease:C1263846		N06BA04	rs71647871:CT
ticagrelor	rs61361928	UGT2B7	TT	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC24	rs61361928:TT
quetiapine	rs6295	HTR1A	GG	Metabolism/PK	increased	LADME	Other:C0036341		N05AH04	rs6295:GG
ticagrelor	rs62471956	CYP3A43	G	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC24	rs62471956:G
acenocoumarol, warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs9923231:CT
acenocoumarol, warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs9923231:TT
simvastatin	rs1137101	LEPR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA01	rs1137101:GG
lamotrigine	rs2231142	ABCG2	T	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs2231142:T
acetaminophen	rs1042028	SULT1A1	CC	Efficacy	increased	Efficacy_Response	Healthy		N02BE01	rs1042028:CC
opioids	rs2069762	IL2	AA	Dosage	increased	Dosage	Other:C0030193|Other:C0027651		N02A	rs2069762:AA
opioids	rs6265	BDNF	CC	Dosage	increased	Dosage	Other:C0030193|Other:C0027651		N02A	rs6265:CC
acenocoumarol, warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs2108622:CT
acenocoumarol, warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs2108622:TT
voriconazole	rs4646437	CYP3A4	AG	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	rs4646437:AG
opioids	rs1800795	IL6	CC	Dosage	increased	Dosage	Other:C0030193|Other:C0027651		N02A	rs1800795:CC
atenolol, irbesartan	rs4762	AGT	AG	Efficacy	increased	Efficacy_Response	Other:C0020564|Left_Ventricular		C07AB03|C09CA04	rs4762:AG
tenofovir	rs1059751	ABCC4	AA	Metabolism/PK	decreased	LADME	Other:C0019163|Chronic		J05AF07	rs1059751:AA
tenofovir	rs1059751	ABCC4	AG	Metabolism/PK	decreased	LADME	Other:C0019163|Chronic		J05AF07	rs1059751:AG
caffeine	rs2472297	CYP1A1	T	Metabolism/PK	increased	LADME	Healthy		N06BC01	rs2472297:T
docetaxel	rs1570360	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02	rs1570360:GG
opioids	rs1143634	IL1B	AA	Efficacy	decreased	Efficacy_Response	Other:C0030193|Other:C0027651		N02A	rs1143634:AA
opioids	rs1143634	IL1B	AG	Efficacy	decreased	Efficacy_Response	Other:C0030193|Other:C0027651		N02A	rs1143634:AG
fenofibrate	rs4238001	SCARB1	CT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs4238001:CT
fenofibrate	rs4238001	SCARB1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs4238001:TT
tenofovir	rs4149170	SLC22A6	TT	Metabolism/PK	increased	LADME	Other:C0019163|Chronic		J05AF07	rs4149170:TT
nevirapine	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT
opioids	rs678849	OPRD1	CC	Efficacy	decreased	Efficacy_Response	Other:C0030193|Other:C0027651		N02A	rs678849:CC
acenocoumarol, warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs1057910:AC
acenocoumarol, warfarin	rs1057910	CYP2C9	CC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs1057910:CC
irbesartan	rs699	AGT	AG	Efficacy	increased	Efficacy_Response	Other:C0020564|Left_Ventricular		C09CA04	rs699:AG
irbesartan	rs699	AGT	GG	Efficacy	increased	Efficacy_Response	Other:C0020564|Left_Ventricular		C09CA04	rs699:GG
peginterferon alfa-2a, peginterferon alfa-2b	rs56061981	CXCL10	CT	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB10|L03AB11	rs56061981:CT
peginterferon alfa-2a, peginterferon alfa-2b	rs56061981	CXCL10	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB10|L03AB11	rs56061981:TT
atorvastatin	rs2032582	ABCB1	T	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2032582:T
atorvastatin	rs2032582	ABCB1	T	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2032582:T
ataluren	rs113993959	CFTR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs113993959:T
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
ataluren	rs75039782	CFTR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs75039782:T
ataluren	rs77010898	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs77010898:A
platinum compounds	rs1052555	ERCC2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1052555:AA
platinum compounds	rs1052555	ERCC2	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1052555:AG
fenofibrate	rs3135506	APOA5	CC	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs3135506:CC
fenofibrate	rs3135506	APOA5	CG	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs3135506:CG
insulin recombinant, zinc acetate	rs13266634	SLC30A8	CT	Efficacy	increased	Efficacy_Response	Healthy		A16AX05	rs13266634:CT
insulin recombinant, zinc acetate	rs13266634	SLC30A8	TT	Efficacy	increased	Efficacy_Response	Healthy		A16AX05	rs13266634:TT
methylphenidate	rs5326	DRD1	CT	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs5326:CT
methylphenidate	rs5326	DRD1	TT	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs5326:TT
metformin	rs12208357	SLC22A1	T	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs12208357:T
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
fentanyl	rs1045642	ABCB1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs1045642:GG
folic acid, methotrexate	rs2372536	ATIC	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		B03BB01|L04AX03	rs2372536:CC
corticosteroids, selective beta-2-adrenoreceptor agonists	rs2853209	ADAM33	AA	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC|S02BA	rs2853209:AA
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
lithium	rs17026688	GADL1	T	Efficacy	increased	Efficacy_Response	Other:C0005586		N05AN01	rs17026688:T
tacrolimus	rs1057868	POR	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs1057868:CC
folic acid, methotrexate	rs1127354	ITPA	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		B03BB01|L04AX03	rs1127354:CC
methotrexate	rs4673993	ATIC	C	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs4673993:C
warfarin	rs9923231	VKORC1	TT	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
warfarin	rs12714145	GGCX	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs12714145:C
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
methotrexate	rs244076	ADA	C	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs244076:C
methotrexate	rs5751876	ADORA2A	T	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs5751876:T
folic acid, methotrexate	rs17602729	AMPD1	A	Efficacy	increased	Efficacy_Response	Disease:C0003873		B03BB01|L04AX03	rs17602729:A
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
rituximab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs396991:CC
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A
fluorouracil	rs2293347	EGFR	CC	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02	rs2293347:CC
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T
antidepressants	rs12082710	TGFBR3	TT	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06A	rs12082710:TT
warfarin	rs7294	VKORC1	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs7294:C
methotrexate	rs1051266	SLC19A1	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs1051266:TT
allopurinol	rs2231142	ABCG2	T	Dosage	increased	Dosage	Disease:C0018099		M04AA01	rs2231142:T
warfarin	rs2884737	VKORC1	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs2884737:C
warfarin	rs2359612	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:A
rifampicin	rs1803155	AADAC	GG	Metabolism/PK	decreased	LADME	Other:C0041296		J04AB02	rs1803155:GG
abiraterone	rs1077858	SLCO2B1	AA	Metabolism/PK	increased	LADME	Healthy		L02BX03	rs1077858:AA
abiraterone	rs1077858	SLCO2B1	AG	Metabolism/PK	increased	LADME	Healthy		L02BX03	rs1077858:AG
cetuximab, panitumumab	rs9996584	AREG	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs9996584:AA
cetuximab, panitumumab	rs1353295	AREG	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs1353295:GG
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	increased	LADME	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Metabolism/PK	increased	LADME	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1801133:AG
rifampicin	rs3842	ABCB1	CC	Metabolism/PK	increased	LADME	Other:C0041296		J04AB02	rs3842:CC
methotrexate	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1045642:AA
fentanyl	rs1718125	P2RX7	CT	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N02AB03	rs1718125:CT
fentanyl	rs1718125	P2RX7	TT	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N02AB03	rs1718125:TT
methylphenidate	rs4867798	DRD1	CC	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs4867798:CC
methylphenidate	rs4867798	DRD1	CT	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs4867798:CT
methylphenidate	rs6280	DRD3	TT	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs6280:TT
methylphenidate	rs11246226	DRD4	AA	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs11246226:AA
platinum compounds	rs25487	XRCC1	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:CT
platinum compounds	rs25487	XRCC1	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:TT
methylphenidate	rs1800544	ADRA2A	CC	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs1800544:CC
methylphenidate	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs4680:AA
methylphenidate	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs4680:AG
estrone sulfate	rs10841753	SLCO1B1	C	Efficacy	decreased	LADME	Other:C1458155		G03CA07	rs10841753:C
dobutamine	rs62205366	GNAS	CC	Efficacy	increased	Efficacy_Response	Healthy		C01CA07	rs62205366:CC
dobutamine	rs62205366	GNAS	CT	Efficacy	increased	Efficacy_Response	Healthy		C01CA07	rs62205366:CT
warfarin	rs12714145	GGCX	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs12714145:TT
nevirapine	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:GT
nevirapine	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT
cetuximab, panitumumab	rs13104811	AREG	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs13104811:GG
cetuximab, panitumumab	rs11942466	AREG	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		No_ATC	rs11942466:AA
antidepressants	rs28364032	CRHR1	AA	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs28364032:AA
antidepressants	rs28364032	CRHR1	AG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs28364032:AG
topiramate	rs4148324	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GG	Metabolism/PK	increased	LADME	Other:C0014544		N03AX11	rs4148324:GG
topiramate	rs4148324	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GT	Metabolism/PK	increased	LADME	Other:C0014544		N03AX11	rs4148324:GT
cyclosporine	rs1057868	POR	T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs1057868:T
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs760370	SLC29A1	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs760370:GG
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs1801133:AG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
tipiracil hydrochloride, trifluridine	rs760370	SLC29A1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		S01AD02	rs760370:AG
tipiracil hydrochloride, trifluridine	rs760370	SLC29A1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		S01AD02	rs760370:GG
ethanol	rs2018417	ADH1B	A	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs2018417:A
ethanol	rs17033	ADH1B	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs17033:C
ethanol	rs1229985	ADH1B	G	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs1229985:G
phenprocoumon	rs4253728	PPARA	A	Dosage	increased	Dosage	Healthy		B01AA04	rs4253728:A
ethanol	rs931635	ADH1A	A	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs931635:A
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC
ethanol	rs283416	ADH1C	A	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs283416:A
rosiglitazone	rs1801282	PPARG	CG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs1801282:CG
ethanol	rs283411	ADH1C	A	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs283411:A
ethanol	rs1662060	ADH1C	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs1662060:C
tacrolimus	rs237025	SUMO4	AA	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs237025:AA
acenocoumarol	rs17878544	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs17878544:TT
hmg coa reductase inhibitors	rs10455872	LPA	G	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs10455872:G
acenocoumarol	rs7200749	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA07	rs7200749:AA
acenocoumarol	rs7200749	VKORC1	AG	Dosage	increased	Dosage	Healthy		B01AA07	rs7200749:AG
hmg coa reductase inhibitors	rs2231142	ABCG2	G	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs2231142:G
acenocoumarol	rs61742245	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA07	rs61742245:AA
acenocoumarol	rs61742245	VKORC1	AC	Dosage	increased	Dosage	Healthy		B01AA07	rs61742245:AC
warfarin	rs7200749	VKORC1	A	Dosage	increased	Dosage	Healthy		B01AA03	rs7200749:A
acenocoumarol	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA07	rs9923231:CC
warfarin	rs7294	VKORC1	T	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:T
citalopram	rs520210	NEDD4L	A	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB04	rs520210:A
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CT
hmg coa reductase inhibitors	rs2075650	TOMM40	G	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs2075650:G
acenocoumarol	rs55894764	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA07	rs55894764:CT
acenocoumarol	rs55894764	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA07	rs55894764:TT
valproic acid	rs28898617	UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	G	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs28898617:G
ivacaftor	rs78655421	CFTR	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs78655421:AA
ivacaftor	rs78655421	CFTR	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs78655421:AG
methylphenidate	rs17685420	PEBP4	T	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs17685420:T
aripiprazole	rs1128503	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		N05AX12	rs1128503:AA
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs9923231:T
verapamil	rs2230433	ITGAL	C	Efficacy	increased	Efficacy_Response	Other:C0022078		C08DA01	rs2230433:C
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0020443		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0020443		C10AA05	rs4149056:CT
pazopanib	rs34231037	KDR	AG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX03	rs34231037:AG
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
ethanol	rs1154461	ADH7	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs1154461:C
hepatitis vaccines	rs1805015	IL4R	C	Efficacy	increased	Efficacy_Response	Healthy		J07BC	rs1805015:C
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
ethanol	rs1229967	ADH1A	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs1229967:C
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
ethanol	rs2276332	ADH1A	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs2276332:C
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:TT
benazepril, imidapril	rs5051	AGT	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07|C09AA16	rs5051:CC
ethanol	rs1229976	ADH1A	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs1229976:C
ursodeoxycholic acid	rs661899	MGAT5	TT	Efficacy	decreased	Efficacy_Response	Other:C0008311		A05AA02	rs661899:TT
clopidogrel thiol metabolite h4	rs4244285	CYP2C19	A	Metabolism/PK	Indeterminado	LADME	Healthy		B01AC04	rs4244285:A
hepatitis vaccines	rs1295686	IL13	T	Efficacy	decreased	Efficacy_Response	Healthy		J07BC	rs1295686:T
phenprocoumon	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA04	rs9934438:AA
phenprocoumon	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA04	rs9934438:AG
phenprocoumon	rs7294	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA04	rs7294:CT
phenprocoumon	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA04	rs7294:TT
tacrolimus	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C0003873		L04AD02	rs1045642:AA
peginterferon alfa-2b, ribavirin	rs10877012	CYP27B1	GT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10877012:GT
peginterferon alfa-2b, ribavirin	rs10877012	CYP27B1	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10877012:TT
dabigatran	rs8192935	CES1	AA	Metabolism/PK	decreased	LADME	Other:C0004238		B01AE07	rs8192935:AA
dabigatran	rs8192935	CES1	AG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AE07	rs8192935:AG
irinotecan	rs11574077	VDR	TT	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs11574077:TT
methylphenidate	rs1868790	ADGRL3	AA	Efficacy	decreased	Efficacy_Response	Disease:C1263846		N06BA04	rs1868790:AA
methylphenidate	rs3746544	SNAP25	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs3746544:GG
methylphenidate	rs3746544	SNAP25	GT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs3746544:GT
methylphenidate	rs2550948	SLC6A3	CC	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs2550948:CC
methylphenidate	rs2550948	SLC6A3	CT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs2550948:CT
phenprocoumon	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:CT
phenprocoumon	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:TT
atorvastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:C
interferons, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB	rs12979860:CC
morphine	rs34059508	SLC22A1	AA	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs34059508:AA
morphine	rs34059508	SLC22A1	AG	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs34059508:AG
methylphenidate	rs1800544	ADRA2A	G	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:G
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:TT
platinum	rs25487	XRCC1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs25487:CT
platinum	rs25487	XRCC1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs25487:TT
selective serotonin reuptake inhibitors	rs10514475	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB	rs10514475:A
selective serotonin reuptake inhibitors	rs6108160	PLCB1	A	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB	rs6108160:A
warfarin	rs1800139	LRP1	TT	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1800139:TT
warfarin	rs2108622	CYP4F2	T	Dosage, Efficacy	increased	Dosage	Healthy		B01AA03	rs2108622:T
warfarin	rs1800154	LRP1	CC	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1800154:CC
nicotine	rs56113850	CYP2A6	T	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs56113850:T
warfarin	rs9923231	VKORC1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT
interferons, ribavirin	rs8099917	IFNL3	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB	rs8099917:GG
phenprocoumon	rs2359612	VKORC1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AA04	rs2359612:AA
phenprocoumon	rs2359612	VKORC1	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AA04	rs2359612:AG
warfarin	rs2108622	CYP4F2	T	Dosage, Efficacy	increased	Dosage	Healthy		B01AA03	rs2108622:T
platinum compounds	rs1799782	XRCC1	G	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs1799782:G
morphine	rs12208357	SLC22A1	TT	Metabolism/PK	decreased	LADME	Other:adenotonsillectomy		N02AA01	rs12208357:TT
fluorouracil	rs17109924	LGR5	CC	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01BC02	rs17109924:CC
fluorouracil	rs17109924	LGR5	CT	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01BC02	rs17109924:CT
rosuvastatin	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:GT
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:TT
morphine	rs34059508	SLC22A1	AA	Metabolism/PK	decreased	LADME	Other:adenotonsillectomy		N02AA01	rs34059508:AA
acetaminophen	rs1902023	UGT2B15	A	Metabolism/PK	decreased	LADME	Healthy		N02BE01	rs1902023:A
morphine	rs34130495	SLC22A1	AA	Metabolism/PK	decreased	LADME	Other:adenotonsillectomy		N02AA01	rs34130495:AA
acetaminophen	rs1902023	UGT2B15	AA	Metabolism/PK	increased	LADME	Healthy		N02BE01	rs1902023:AA
atorvastatin, pravastatin	rs9462535	KIF6	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs9462535:AA
atorvastatin, pravastatin	rs9462535	KIF6	AC	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs9462535:AC
capecitabine, fluorouracil	rs1801133	MTHFR	AA	Dosage	decreased	Dosage	Other:C0027651		L01BC02|L01BC06	rs1801133:AA
capecitabine, fluorouracil	rs1801133	MTHFR	AG	Dosage	decreased	Dosage	Other:C0027651		L01BC02|L01BC06	rs1801133:AG
pitavastatin, pitavastatin lactone	rs4363657	SLCO1B1	A	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs4363657:A
rosuvastatin	rs1481012	ABCG2	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs1481012:AG
rosuvastatin	rs1481012	ABCG2	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs1481012:GG
somatropin recombinant	rs2069502	CDK4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0041408		H01AC01	rs2069502:CC
atorvastatin, pravastatin	rs9471077	KIF6	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs9471077:AG
atorvastatin, pravastatin	rs9471077	KIF6	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs9471077:GG
metformin	rs7541245	FMO5	A	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs7541245:A
methotrexate	rs1801133	MTHFR	AA	Toxicity	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs1801133:AA
rosuvastatin	rs17111584	USP24	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs17111584:CC
rosuvastatin	rs17111584	USP24	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs17111584:CT
pitavastatin, pitavastatin lactone	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs4149056:C
methylphenidate	rs5569	SLC6A2	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs5569:GG
interferon beta-1a	rs4774388	RORA	TT	Efficacy	increased	Efficacy_Response	Other:C0026769		L03AB07	rs4774388:TT
methylphenidate	rs28386840	SLC6A2	AT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs28386840:AT
methylphenidate	rs28386840	SLC6A2	TT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs28386840:TT
remimazolam	rs71647871	CES1	CT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs71647871:CT
remimazolam	rs71647871	CES1	TT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs71647871:TT
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
nicotine	rs113288603	__INTRONIC__	T	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs113288603:T
rosuvastatin	rs71352238	APOE	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs71352238:CC
rosuvastatin	rs71352238	APOE	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs71352238:CT
methylphenidate	rs1800544	ADRA2A	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:GG
nicotine	rs12461964	__INTRONIC__	A	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs12461964:A
rosuvastatin	rs7412	APOE	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs7412:CT
rosuvastatin	rs7412	APOE	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs7412:TT
methylphenidate	rs1800544	ADRA2A	CG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:CG
methylphenidate	rs1800544	ADRA2A	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:GG
idarubicin	rs1883112	NCF4	AA	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01DB06	rs1883112:AA
simvastatin	rs717620	ABCC2	CT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01	rs717620:CT
simvastatin	rs717620	ABCC2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01	rs717620:TT
idarubicin	rs13058338	RAC2	AT	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01DB06	rs13058338:AT
peginterferon alfa-2a, peginterferon alfa-2b	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0027022		L03AB10|L03AB11	rs12979860:CC
rosuvastatin	rs10455872	LPA	AG	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs10455872:AG
rosuvastatin	rs10455872	LPA	GG	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs10455872:GG
atorvastatin	rs887829	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	T	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs887829:T
methylphenidate	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs6265:CC
efavirenz	rs3745274	CYP2B6	GG	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AG03	rs3745274:GG
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AG03	rs3745274:GT
ivacaftor	rs78655421	CFTR	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs78655421:AA
ivacaftor	rs78655421	CFTR	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs78655421:AG
atorvastatin	rs45446698	CYP3A7	G	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs45446698:G
ataluren	rs77010898	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs77010898:A
pravastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:C
clozapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0039338		N05AH02	rs762551:AA
efavirenz	rs2279343	CYP2B6	G	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs2279343:G
efavirenz	rs2279345	CYP2B6	T	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AG03	rs2279345:T
atorvastatin, pravastatin	rs20455	KIF6	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs20455:AG
atorvastatin, pravastatin	rs20455	KIF6	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs20455:GG
ataluren	rs113993959	CFTR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs113993959:T
methylphenidate	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs4680:GG
efavirenz	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs1045642:AG
somatropin recombinant	rs2270777	CDK4	TT	Efficacy	increased	Efficacy_Response	Disease:C0853662		H01AC01	rs2270777:TT
methylphenidate	rs1800544	ADRA2A	G	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:G
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT
ataluren	rs75039782	CFTR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs75039782:T
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT
metformin	rs254271	PRPF31	C	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs254271:C
gabapentin	rs4240803	SLC7A5	AG	Dosage	increased	Dosage	Other:C0522067		No_ATC	rs4240803:AG
ataluren	rs77010898	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs77010898:A
metformin	rs57081354	NBEA	C	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs57081354:C
sumatriptan	rs12208357	SLC22A1	T	Metabolism/PK	increased	LADME	Healthy	low activity	N02CC01	rs12208357:T
metformin	rs628031	SLC22A1	AA	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs628031:AA
metformin	rs628031	SLC22A1	AG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs628031:AG
fenoterol	rs34130495	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy		R03CC04	rs34130495:A
fenoterol	rs12208357	SLC22A1	T	Metabolism/PK	increased	LADME	Healthy		R03CC04	rs12208357:T
fenoterol	rs55918055	SLC22A1	C	Metabolism/PK	increased	LADME	Healthy		R03CC04	rs55918055:C
sumatriptan	rs34059508	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy	low activity	N02CC01	rs34059508:A
cyclophosphamide	rs3745274	CYP2B6	GT	Efficacy	increased	Efficacy_Response	Other:C0027697		L01AA01	rs3745274:GT
cyclophosphamide	rs3745274	CYP2B6	TT	Efficacy	increased	Efficacy_Response	Other:C0027697		L01AA01	rs3745274:TT
sumatriptan	rs34130495	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy	low activity	N02CC01	rs34130495:A
drugs used in diabetes	rs1801278	IRS1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10	rs1801278:CT
drugs used in diabetes	rs1801278	IRS1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10	rs1801278:TT
sumatriptan	rs55918055	SLC22A1	C	Metabolism/PK	increased	LADME	Healthy	low activity	N02CC01	rs55918055:C
fluorouracil, leucovorin, oxaliplatin	rs25487	XRCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs25487:CC
methotrexate	rs1801394	MTRR	A	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801394:A
fluorouracil, leucovorin, oxaliplatin	rs11615	ERCC1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs11615:GG
fenoterol	rs34059508	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy		R03CC04	rs34059508:A
hydrochlorothiazide	rs4149601	NEDD4L	A	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4149601:A
metformin	rs622342	SLC22A1	AC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs622342:AC
metformin	rs622342	SLC22A1	CC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs622342:CC
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT
peginterferon alfa-2a, peginterferon alfa-2b	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0027022		L03AB10|L03AB11	rs12980275:AA
emtricitabine	rs2273897	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease|Other:C0032961		J05AF09	rs2273897:TT
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG
tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
cycloguanil	rs12208357	SLC22A1	T	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs12208357:T
ataluren	rs113993959	CFTR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs113993959:T
cycloguanil	rs34130495	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs34130495:A
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
gabapentin, pregabalin	rs4240803	SLC7A5	AG	Efficacy	decreased	Efficacy_Response	Other:C0522067		N02BF02	rs4240803:AG
methotrexate	rs1051266	SLC19A1	CT	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CT
methotrexate	rs1051266	SLC19A1	TT	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:TT
morphine	rs4680	COMT	AA	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs4680:AA
metformin	rs2162145	CPA6	T	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs2162145:T
salbutamol	rs881152	DUSP1	G	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs881152:G
ivacaftor	rs75527207	CFTR	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AA
ivacaftor	rs75527207	CFTR	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AG
tacrolimus	rs2242480	CYP3A4	CC	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs2242480:CC
warfarin	rs61742245	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:AA
warfarin	rs61742245	VKORC1	AC	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:AC
tramadol	rs34059508	SLC22A1	A	Dosage	decreased	Dosage	Disease:C0030193		N02AX02	rs34059508:A
tacrolimus	rs4149117	SLCO1B3	GG	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs4149117:GG
tacrolimus	rs4149117	SLCO1B3	GT	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs4149117:GT
escitalopram	rs1126757	IL11	CT	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB10	rs1126757:CT
escitalopram	rs1126757	IL11	TT	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB10	rs1126757:TT
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
clopidogrel	rs2307240	CES1	CT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs2307240:CT
clopidogrel	rs2307240	CES1	TT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs2307240:TT
tacrolimus	rs1499821	SLC2A2	CC	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs1499821:CC
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
abiraterone	rs10493112	YBX1	AC	Efficacy	increased	Efficacy_Response	Other:C0033578		L02BX03	rs10493112:AC
abiraterone	rs10493112	YBX1	CC	Efficacy	increased	Efficacy_Response	Other:C0033578		L02BX03	rs10493112:CC
tacrolimus	rs1955915	NFATC4	CC	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs1955915:CC
tacrolimus	rs1955915	NFATC4	CT	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs1955915:CT
grazoprevir	rs4149056	SLCO1B1	C	PD	increased	LADME	Other:C0019372		J05AP54	rs4149056:C
bisoprolol	rs1080985	CYP2D6	CC	Metabolism/PK	decreased	LADME	Other:C0007222		C07AB07	rs1080985:CC
grazoprevir	rs11045819	SLCO1B1	A	PD	increased	LADME	Other:C0019372		J05AP54	rs11045819:A
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
warfarin	rs9923231	VKORC1	C	Metabolism/PK	increased	Dosage	Healthy		B01AA03	rs9923231:C
warfarin	rs12777823	__INTRONIC__	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AA
warfarin	rs12777823	__INTRONIC__	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AG
methadone	rs7127507	BDNF, BDNF-AS	C	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs7127507:C
o-desmethyltramadol	rs12208357	SLC22A1	T	Metabolism/PK	increased	LADME	Disease:C0030193		N02AX02	rs12208357:T
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
enalapril	rs2070744	NOS3	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs2070744:CC
enalapril	rs2070744	NOS3	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs2070744:CT
methadone	rs11030118	BDNF, BDNF-AS	G	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs11030118:G
warfarin	rs2359612	VKORC1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs2359612:AG
warfarin	rs2359612	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs2359612:GG
warfarin	rs7089580	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs7089580:T
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
methadone	rs1967554	BDNF, BDNF-AS	C	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs1967554:C
warfarin	rs8050894	VKORC1	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:CG
warfarin	rs8050894	VKORC1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:GG
bisoprolol	rs1080985	CYP2D6	G	Metabolism/PK	increased	LADME	Other:C0027051		C07AB07	rs1080985:G
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
warfarin	rs7294	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:CT
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT
methadone	rs2030324	BDNF	G	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs2030324:G
bisoprolol	rs3892097	CYP2D6	CT	Metabolism/PK	increased	LADME	Other:C0027051		C07AB07	rs3892097:CT
bisoprolol	rs3892097	CYP2D6	TT	Metabolism/PK	increased	LADME	Other:C0027051		C07AB07	rs3892097:TT
busulfan	rs3957357	GSTA1	AA	Metabolism/PK	increased	LADME	Disease:C0277631		L01AB01	rs3957357:AA
o-desmethyltramadol	rs34130495	SLC22A1	A	Metabolism/PK	increased	LADME	Disease:C0030193		N02AX02	rs34130495:A
o-desmethyltramadol	rs34059508	SLC22A1	A	Metabolism/PK	increased	LADME	Disease:C0030193		N02AX02	rs34059508:A
enalapril	rs1799722	BDKRB2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA02	rs1799722:TT
methadone	rs988748	BDNF	C	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs988748:C
o-desmethyltramadol	rs55918055	SLC22A1	C	Metabolism/PK	increased	LADME	Disease:C0030193		N02AX02	rs55918055:C
warfarin	rs61742245	VKORC1	A	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:A
tramadol	rs55918055	SLC22A1	C	Dosage	decreased	Dosage	Disease:C0030193		N02AX02	rs55918055:C
celecoxib	rs1057910	CYP2C9	CC	Metabolism/PK	decreased	LADME	Healthy		M01AH01	rs1057910:CC
methadone	rs11030119	BDNF	G	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs11030119:G
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs776746:CC
tramadol	rs12208357	SLC22A1	T	Dosage	decreased	Dosage	Disease:C0030193		N02AX02	rs12208357:T
fentanyl	rs2242480	CYP3A4	T	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs2242480:T
celecoxib	rs1057910	CYP2C9	CC	Metabolism/PK	decreased	LADME	Healthy		M01AH01	rs1057910:CC
bisoprolol	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Other:C0027051		C07AB07	rs776746:TT
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
tramadol	rs34130495	SLC22A1	A	Dosage	decreased	Dosage	Disease:C0030193		N02AX02	rs34130495:A
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4149570	TNFRSF1A	AA	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390		No_ATC	rs4149570:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs5030728	TLR4	AA	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs5030728:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs5030728	TLR4	AG	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs5030728:AG
metformin	rs8065082	SLC47A1	CT	Efficacy	increased	Efficacy_Response	Other:C0016751		A10BA02	rs8065082:CT
metformin	rs8065082	SLC47A1	TT	Efficacy	increased	Efficacy_Response	Other:C0016751		A10BA02	rs8065082:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4696480	TLR2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs4696480:TT
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2430561	IFNG	AA	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390		No_ATC	rs2430561:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2430561	IFNG	AT	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390		No_ATC	rs2430561:AT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs352139	TLR9	TT	Efficacy	decreased	Efficacy_Response	Disease:C0010346|Disease:C0021390		No_ATC	rs352139:TT
warfarin	rs4072879	VKORC1L1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs4072879:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3804099	TLR2	CC	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs3804099:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3804099	TLR2	CT	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs3804099:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1816702	TLR2	CT	Efficacy	increased	Efficacy_Response	Disease:C0010346		No_ATC	rs1816702:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1816702	TLR2	TT	Efficacy	increased	Efficacy_Response	Disease:C0010346		No_ATC	rs1816702:TT
tacrolimus	rs35599367	CYP3A4	A	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:A
sufentanil	rs1799971	OPRM1	G	Dosage	decreased	Dosage	Disease:C0030193		N01AH03	rs1799971:G
opioids	rs2249015	ENPP2	AA	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02A	rs2249015:AA
donepezil, galantamine, rivastigmine	rs429358	APOE	CC	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs429358:CC
donepezil, galantamine, rivastigmine	rs429358	APOE	CT	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs429358:CT
rosiglitazone	rs6467136	PAX4	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs6467136:AA
rosiglitazone	rs6467136	PAX4	AG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs6467136:AG
rosiglitazone	rs6467136	PAX4	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs6467136:AA
rosiglitazone	rs6467136	PAX4	AG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs6467136:AG
atorvastatin	rs429358	APOE	CT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs429358:CT
opioids	rs1045642	ABCB1	AA	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02A	rs1045642:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10499563	IL6	CC	Efficacy	increased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs10499563:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10499563	IL6	CT	Efficacy	increased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs10499563:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2275913	IL17A	AA	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs2275913:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2275913	IL17A	AG	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs2275913:AG
latanoprost	rs11568658	ABCC4	AC	Efficacy	decreased	Efficacy_Response	Disease:Open-angle_glaucoma		S01EE01	rs11568658:AC
adalimumab, etanercept, infliximab, ustekinumab	rs1061622	TNFRSF1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01|L04AB02|L04AB04|L04AC05	rs1061622:GG
adalimumab, etanercept, infliximab, ustekinumab	rs1061622	TNFRSF1B	GT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01|L04AB02|L04AB04|L04AC05	rs1061622:GT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1554973	CNPY4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0021390		No_ATC	rs1554973:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1554973	CNPY4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0021390		No_ATC	rs1554973:CT
botulinum toxin type a	rs3781719	CALCA	G	Efficacy	decreased	Efficacy_Response	Other:C0022078		M03AX01	rs3781719:G
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2569190	CD14	AA	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs2569190:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2569190	CD14	AG	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs2569190:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11938228	TLR2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs11938228:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11938228	TLR2	AC	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs11938228:AC
botulinum toxin type a	rs222749	TRPV1	A	Efficacy	decreased	Efficacy_Response	Other:C0022078		M03AX01	rs222749:A
opioids	rs7832704	ENPP2	AA	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02A	rs7832704:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4848306	IL1B	AA	Efficacy	increased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs4848306:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4848306	IL1B	AG	Efficacy	increased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs4848306:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4251961	IL1RN	CC	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs4251961:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4251961	IL1RN	CT	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs4251961:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6927172	TNFAIP3	CG	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs6927172:CG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6927172	TNFAIP3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs6927172:GG
hmg coa reductase inhibitors	rs429358	APOE	CC	Efficacy	increased	Efficacy_Response	Other:C0002395		C10AA	rs429358:CC
losartan	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA01	rs1045642:AA
losartan	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA01	rs1045642:AG
pemetrexed	rs61734430	FOLR3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs61734430:CT
pemetrexed	rs61734430	FOLR3	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs61734430:TT
peginterferon alfa-2a, ribavirin	rs4803217	IFNL3	AC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4803217:AC
peginterferon alfa-2a, ribavirin	rs4803217	IFNL3	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4803217:CC
metoprolol	rs1801058	GRK4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0848548		C07AB02	rs1801058:CT
highly active antiretroviral therapy (haart)	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		No_ATC	rs12979860:CC
fluoxetine	rs7997012	HTR2A	GG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03	rs7997012:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0021368		No_ATC	rs1800629:GG
direct acting antivirals, elbasvir / grazoprevir, ledipasvir / sofosbuvir	rs8099917	IFNL3, IFNL4	GG	Efficacy	decreased	Efficacy_Response	Other:C0019372		J05A|J05AP08|J05AP51|J05AP54	rs8099917:GG
direct acting antivirals, elbasvir / grazoprevir, ledipasvir / sofosbuvir	rs8099917	IFNL3, IFNL4	GT	Efficacy	decreased	Efficacy_Response	Other:C0019372		J05A|J05AP08|J05AP51|J05AP54	rs8099917:GT
metoprolol	rs2960306	GRK4	GT	Efficacy	decreased	Efficacy_Response	Disease:C0848548		C07AB02	rs2960306:GT
metoprolol	rs2960306	GRK4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0848548		C07AB02	rs2960306:TT
tacrolimus	rs3740066	ABCC2	CT	Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs3740066:CT
tacrolimus	rs3740066	ABCC2	TT	Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs3740066:TT
tacrolimus	rs3740066	ABCC2	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs3740066:CT
tacrolimus	rs3740066	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs3740066:TT
methotrexate	rs717620	ABCC2	CT	Metabolism/PK	increased	LADME	Disease:C0024299		L04AX03	rs717620:CT
methotrexate	rs717620	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:C0024299		L04AX03	rs717620:TT
tacrolimus	rs717620	ABCC2	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs717620:CT
tacrolimus	rs717620	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs717620:TT
metoprolol	rs1024323	GRK4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0848548		C07AB02	rs1024323:CC
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799724	TNF	CC	Efficacy	increased	Efficacy_Response	Disease:C0021368		No_ATC	rs1799724:CC
methadone	rs3762556	GAD1	G	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs3762556:G
infliximab	rs1143634	IL1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		L04AB02	rs1143634:GG
methadone	rs769404	GAD1	TT	Dosage	decreased	Dosage	Other:C0028043		N07BC02	rs769404:TT
rocuronium	rs3834939	SLCO1A2	T/del	Metabolism/PK	decreased	LADME	Healthy		M03AC09	rs3834939:T/del
rocuronium	rs3834939	SLCO1A2	TT	Metabolism/PK	decreased	LADME	Healthy		M03AC09	rs3834939:TT
clozapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs762551:AA
clozapine	rs762551	CYP1A2	AC	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs762551:AC
aripiprazole	rs1058164	CYP2D6	GG	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs1058164:GG
aripiprazole	rs28371699	CYP2D6	AA	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs28371699:AA
ticagrelor	rs2074900	CYP4F2	AA	Metabolism/PK	decreased	LADME	Healthy		B01AC24	rs2074900:AA
acenocoumarol	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA07	rs9934438:GG
capecitabine	rs67376798	DPYD	AT	Dosage	decreased	Dosage	Disease:C0023055		L01BC06	rs67376798:AT
clozapine	rs2011404	UGT1A4	C	Metabolism/PK	increased	LADME	Other:C0036341|Other:C0033975		N05AH02	rs2011404:C
capecitabine	rs3918290	DPYD	CT	Dosage	decreased	Dosage	Disease:C0023055		L01BC06	rs3918290:CT
uric acid	rs1002976	VEGFC	C	Metabolism/PK	increased	LADME	Disease:C0020538		M04AA	rs1002976:C
letermovir	rs4149032	SLCO1B1	TT	Metabolism/PK	decreased	LADME	Healthy		J05AX18	rs4149032:TT
clozapine	rs34946978	UGT1A1	T	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0033975		N05AH02	rs34946978:T
metformin	rs3792269	CAPN10	G	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs3792269:G
letermovir	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		J05AX18	rs4149056:CC
letermovir	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		J05AX18	rs4149056:CT
letermovir	rs4148323	UGT1A1	AA	Metabolism/PK	increased	LADME	Healthy		J05AX18	rs4148323:AA
letermovir	rs4148323	UGT1A1	AG	Metabolism/PK	increased	LADME	Healthy		J05AX18	rs4148323:AG
interferon beta-1a, interferon beta-1b	rs760316	FHIT	C	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs760316:C
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
glyburide	rs7512785	FMO2	T	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs7512785:T
methotrexate	rs1801394	MTRR	AG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801394:AG
methotrexate	rs1801394	MTRR	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801394:GG
propranolol	rs1042713	ADRB2	GG	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		C07AA05	rs1042713:GG
methotrexate	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1128503:AA
methotrexate	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1045642:AA
clozapine	rs10248420	ABCB1	G	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0033975		N05AH02	rs10248420:G
methotrexate	rs3763980	SLC16A7	A	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs3763980:A
peginterferon alfa-2a, peginterferon alfa-2b	rs12979860	IFNL3, IFNL4	C	Efficacy	increased	Efficacy_Response	Disease:C0019163|Chronic		L03AB10|L03AB11	rs12979860:C
methotrexate	rs12231740	SLC16A7	T	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs12231740:T
methotrexate	rs4948496	ARID5B	CC	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs4948496:CC
clozapine	rs4148323	UGT1A1	A	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0033975		N05AH02	rs4148323:A
fenofibrate	rs7412	APOE	CT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs7412:CT
fenofibrate	rs7412	APOE	TT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs7412:TT
methotrexate	rs4149056	SLCO1B1	TT	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149056:TT
peginterferon alfa-2a, peginterferon alfa-2b	rs8099917	IFNL3, IFNL4	T	Efficacy	increased	Efficacy_Response	Disease:C0019163|Chronic		L03AB10|L03AB11	rs8099917:T
methadone	rs3762555	GAD1	G	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs3762555:G
methotrexate	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801133:AA
methadone	rs3749034	GAD1	G	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs3749034:G
clozapine	rs7787082	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0033975		N05AH02	rs7787082:A
iguratimod	rs1495741	NAT2	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs1495741:AG
iguratimod	rs1495741	NAT2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs1495741:GG
interferon beta-1a, interferon beta-1b	rs4278350	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs4278350:T
aripiprazole	rs28371702	CYP2D6	CC	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs28371702:CC
sitagliptin, vildagliptin	rs163184	KCNQ1	GG	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02	rs163184:GG
sitagliptin, vildagliptin	rs163184	KCNQ1	GT	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02	rs163184:GT
iguratimod	rs2231142	ABCG2	GT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2231142:GT
iguratimod	rs2231142	ABCG2	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2231142:TT
desipramine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA01	__UNKNOWN__
interferon beta-1a, interferon beta-1b	rs2291858	GAPVD1	G	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs2291858:G
methadone	rs204047	OPRD1	GG	Dosage	increased	Dosage	Healthy		N07BC02	rs204047:GG
methadone	rs797397	OPRD1	AA	Metabolism/PK	increased	LADME	Healthy		N07BC02	rs797397:AA
methadone	rs204047	OPRD1	GG	Metabolism/PK	increased	LADME	Healthy		N07BC02	rs204047:GG
antipsychotics	rs1344706	ZNF804A	AA	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1344706:AA
platinum compounds	rs25487	XRCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:CC
platinum compounds	rs25487	XRCC1	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:CT
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
interferon beta-1a, interferon beta-1b	rs10819043	GAPVD1	T	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs10819043:T
interferon beta-1a, interferon beta-1b	rs3133084	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs3133084:A
capecitabine, docetaxel	rs1048943	CYP1A1	AG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01BC06|L01CD02	rs1048943:AG
capecitabine, docetaxel	rs1048943	CYP1A1	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01BC06|L01CD02	rs1048943:GG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:TT
glyburide	rs7793861	CYP51A1	G	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs7793861:G
interferon beta-1a, interferon beta-1b	rs1448673	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs1448673:G
glyburide	rs7515157	FMO2	T	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs7515157:T
anastrozole	rs2032582	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C1458155		L02BG03	rs2032582:AA
amisulpride, antipsychotics, olanzapine, quetiapine, risperidone	rs10042486	HTR1A	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A|N05AH03|N05AH04|N05AL05|N05AX08	rs10042486:TT
uric acid	rs950569	BRINP3	T	Metabolism/PK	increased	LADME	Disease:C0020538		M04AA	rs950569:T
glyburide	rs4148269	UGT2B15	G	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs4148269:G
interferon beta-1a, interferon beta-1b	rs10760397	GAPVD1	C	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs10760397:C
uric acid	rs2477134	PADI4	G	Metabolism/PK	increased	LADME	Disease:C0020538		M04AA	rs2477134:G
interferon beta-1a, interferon beta-1b	rs10494227	ZNF697	A	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs10494227:A
doxorubicin	rs1533682	ABCC5	TT	Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs1533682:TT
platinum compounds	rs861539	XRCC3	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs861539:AA
platinum compounds	rs861539	XRCC3	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs861539:AG
glyburide	rs1803545	MAPK1	A	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs1803545:A
glyburide	rs3749442	ABCC5	A	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs3749442:A
aripiprazole	rs1135840	CYP2D6	GG	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs1135840:GG
glyburide	rs2303070	SPINK5	T	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs2303070:T
glyburide	rs5224	BDKRB2	A	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs5224:A
glyburide	rs3729910	MAPK1	G	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs3729910:G
iguratimod	rs2032582	ABCB1	CT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2032582:CT
iguratimod	rs2032582	ABCB1	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2032582:TT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
ethanol	rs11940694	KLB	A	Toxicity	decreased	Dosage	Healthy		V03AB16	rs11940694:A
platinum compounds	rs1799782	XRCC1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs1799782:AA
platinum compounds	rs1799782	XRCC1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs1799782:AG
glyburide	rs2077647	ESR1	T	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs2077647:T
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800629	TNF	G	Efficacy	increased	Efficacy_Response	Other:C0003873|Other:C0004364|Other:C0235763		No_ATC	rs1800629:G
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
antidepressants	rs6265	BDNF	C	Efficacy	increased	Efficacy_Response	Healthy		N06A	rs6265:C
flunisolide	rs2305089	TBXT	TT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA03	rs2305089:TT
granisetron, palonosetron	rs3212986	ERCC1	AC	Efficacy	increased	Efficacy_Response	Side_Effect:C0027497|Side_Effect:C0042963		A04AA02|A04AA05	rs3212986:AC
granisetron, palonosetron	rs3212986	ERCC1	CC	Efficacy	increased	Efficacy_Response	Side_Effect:C0027497|Side_Effect:C0042963		A04AA02|A04AA05	rs3212986:CC
tacrolimus	rs1800795	IL6	GG	Efficacy	decreased	Efficacy_Response	Other:Kidney_Transplantation		L04AD02	rs1800795:GG
valproic acid	rs3892097	CYP2D6	CT	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AG01	rs3892097:CT
valproic acid	rs3892097	CYP2D6	TT	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AG01	rs3892097:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1061622	TNFRSF1B	T	Efficacy	increased	Efficacy_Response	Other:C0235763		No_ATC	rs1061622:T
tacrolimus	rs1800795	IL6	GG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs1800795:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799724	TNF	C	Efficacy	increased	Efficacy_Response	Other:C0235763		No_ATC	rs1799724:C
tacrolimus	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4646437:GG
rasagiline	rs1076560	DRD2	CC	Efficacy	increased	Efficacy_Response	Disease:C0030567		N04BD02	rs1076560:CC
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs2242480	CYP3A4	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:CC
rasagiline	rs2283265	DRD2	CC	Efficacy	increased	Efficacy_Response	Disease:C0030567		N04BD02	rs2283265:CC
tacrolimus	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4646437:GG
tacrolimus	rs4553808	CTLA4	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4553808:AG
tacrolimus	rs4553808	CTLA4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4553808:GG
antidepressants	rs10501087	BDNF-AS	T	Efficacy	increased	Efficacy_Response	Healthy		N06A	rs10501087:T
tacrolimus	rs181781	IL3	AA	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs181781:AA
desipramine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA01	__UNKNOWN__
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
lamotrigine	rs6755571	UGT1A4	CC	Metabolism/PK	decreased	LADME	Other:C0014544		N03AX09	rs6755571:CC
warfarin	rs4917639	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs4917639:C
telaprevir	rs2585428	CYP24A1	C	Metabolism/PK	decreased	LADME	Disease:C0019372		J05AP02	rs2585428:C
tacrolimus	rs4553808	CTLA4	AA	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4553808:AA
tacrolimus	rs2242480	CYP3A4	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:CC
varenicline	rs1044396	CHRNA4	GG	Efficacy	decreased	Efficacy_Response	Disease:C0039338		N07BA03	rs1044396:GG
escitalopram	rs4646425	CYP1A2	T	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	rs4646425:T
escitalopram	rs2069526	CYP1A2	G	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	rs2069526:G
escitalopram	rs4646427	CYP1A2	C	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	rs4646427:C
platinum compounds	rs430397	HSPA5	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs430397:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	A	Efficacy	increased	Efficacy_Response	Other:C0003873		No_ATC	rs1801274:A
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs396991	FCGR3A	C	Efficacy	increased	Efficacy_Response	Other:C0038012		No_ATC	rs396991:C
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG
morphine	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N02AA01	rs1045642:AA
clopidogrel	rs6785930	P2RY12	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs6785930:AA
clopidogrel	rs6785930	P2RY12	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs6785930:AG
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
clopidogrel	rs6809699	P2RY12	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs6809699:AA
clopidogrel	rs6809699	P2RY12	AC	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs6809699:AC
efavirenz	rs2279343	CYP2B6	AG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs361525	TNF	G	Efficacy	increased	Efficacy_Response	Other:C0235763		No_ATC	rs361525:G
fluticasone propionate	rs2872507	ORMDL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs2872507:AA
fluticasone propionate	rs2872507	ORMDL3	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs2872507:AG
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
rituximab	rs396991	FCGR3A	AC	Efficacy	increased	Efficacy_Response	Other:C0003873		L01FA01	rs396991:AC
rituximab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L01FA01	rs396991:CC
abatacept, rituximab, tocilizumab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0003873		L01FA01|L04AA24|L04AC07	rs1801274:AG
abatacept, rituximab, tocilizumab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	GG	Efficacy	increased	Efficacy_Response	Other:C0003873		L01FA01|L04AA24|L04AC07	rs1801274:GG
valproic acid	rs1057910	CYP2C9	AC	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs1057910:AC
tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
warfarin	rs339097	CALU	G	Dosage	increased	Dosage	Healthy		B01AA03	rs339097:G
atazanavir / ritonavir	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs4149056:CC
atazanavir / ritonavir	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs4149056:CT
deferasirox	rs13120400	ABCG2	CT	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs13120400:CT
deferasirox	rs13120400	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs13120400:TT
atazanavir / ritonavir	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs776746:CC
warfarin	rs10509680	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs10509680:T
adalimumab, certolizumab pegol, etanercept, golimumab, infliximab	rs7975232	VDR	AA	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AB06	rs7975232:AA
adalimumab, certolizumab pegol, etanercept, golimumab, infliximab	rs7975232	VDR	AC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AB06	rs7975232:AC
angiotensin ii	rs5186	AGTR1	AA	Efficacy	increased	Efficacy_Response	Healthy		C09CA	rs5186:AA
desipramine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA01	__UNKNOWN__
antiepileptics	rs41423247	NR3C1	GG	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03A	rs41423247:GG
deferasirox	rs2273697	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2273697:AG
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT
fluvastatin	rs7412	APOE	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs7412:CT
metformin	rs2289669	SLC47A1	A	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2289669:A
talinolol	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:AA
lamotrigine	rs7439366	UGT2B7	TT	Metabolism/PK	increased	LADME	Other:C0014544		N03AX09	rs7439366:TT
tacrolimus	rs2740574	CYP3A4	CC	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2740574:CC
tacrolimus	rs2740574	CYP3A4	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2740574:CT
ritodrine	rs598961	PDE4B	AA	Efficacy	decreased	Efficacy_Response	Other:C0022876		G02CA01	rs598961:AA
tacrolimus	rs4986910	CYP3A4	G	Dosage, Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs4986910:G
acenocoumarol, warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03|B01AA07	rs2108622:CT
acenocoumarol, warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03|B01AA07	rs2108622:TT
lamotrigine	rs1902023	UGT2B15	AA	Metabolism/PK	decreased	LADME	Other:C0014544		N03AX09	rs1902023:AA
desipramine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA01	__UNKNOWN__
platinum compounds	rs1800975	XPA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs1800975:CC
aripiprazole, dehydroaripiprazole	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs2032582:CC
aripiprazole, dehydroaripiprazole	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs1045642:GG
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
aripiprazole, dehydroaripiprazole	rs1128503	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs1128503:GG
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
tacrolimus	rs1800871	IL10	AA	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs1800871:AA
antihypertensives, hydralazine, methyldopa, nifedipine	rs3918242	MMP9	CT	Efficacy	decreased	Efficacy_Response	Disease:C0340274		C02|C02AB|C02DB02|C08CA05	rs3918242:CT
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Other:C2939420|Other:C0004238|Other:C0026265|Other:C1956346		B01AA03	rs2108622:T
daclatasvir	rs11568820	VDR	TT	Metabolism/PK	decreased	LADME	Disease:C0019372		J05AP07	rs11568820:TT
morphine	rs4680	COMT	AG	Efficacy	increased	Dosage	Healthy		N02AA01	rs4680:AG
morphine	rs4680	COMT	GG	Efficacy	increased	Dosage	Healthy		N02AA01	rs4680:GG
methyldopa	rs3918242	MMP9	CT	Efficacy	decreased	Efficacy_Response	Disease:C0340274		C02AB	rs3918242:CT
methyldopa	rs3918242	MMP9	TT	Efficacy	decreased	Efficacy_Response	Disease:C0340274		C02AB	rs3918242:TT
daclatasvir	rs2248359	CYP24A1	CT	Metabolism/PK	increased	LADME	Disease:C0019372		J05AP07	rs2248359:CT
daclatasvir	rs2248359	CYP24A1	TT	Metabolism/PK	increased	LADME	Disease:C0019372		J05AP07	rs2248359:TT
tacrolimus	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:AG
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:GG
carbamazepine, oxcarbazepine	rs3812718	SCN1A	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AF01|N03AF02	rs3812718:TT
metoprolol	rs1801252	ADRB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB02	rs1801252:AA
metoprolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB02	rs1801253:CC
calcium channel blockers	rs10898815	NUMA1	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs10898815:GG
carbamazepine, oxcarbazepine	rs3812718	SCN1A	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AF01|N03AF02	rs3812718:TT
calcium channel blockers	rs2429427	TANC2	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs2429427:GG
sibutramine	rs5443	GNB3	CC	Efficacy	increased	Efficacy_Response	Other:C0028754		A08AA10	rs5443:CC
carbamazepine, oxcarbazepine	rs2273697	ABCC2	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AF01|N03AF02	rs2273697:AG
busulfan	rs3957356	GSTA1	T	Metabolism/PK	decreased	LADME	Other:Hematopoietic_stem_cell_transplantation		L01AB01	rs3957356:T
s-eddp	rs8192709	CYP2B6	CT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs8192709:CT
busulfan	rs3957357	GSTA1	A	Metabolism/PK	decreased	LADME	Other:Hematopoietic_stem_cell_transplantation		L01AB01	rs3957357:A
simvastatin	rs12052787	UGT1A9	T	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs12052787:T
tacrolimus	rs776746	CYP3A5	CT	Efficacy, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Efficacy, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
simvastatin	rs2003569	UGT1A9	A	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs2003569:A
platinum compounds	rs1799801	ERCC4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1799801:TT
platinum compounds	rs11615	ERCC1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs11615:AA
platinum compounds	rs11615	ERCC1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs11615:AG
amitriptyline, clomipramine, doxepin, imipramine, maprotiline, nortriptyline, opipramol	rs3892097	CYP2D6	TT	Dosage, Efficacy	decreased	Dosage	Disease:C0235876		N06AA02|N06AA04|N06AA09|N06AA10|N06AA12|N06AA21	rs3892097:TT
platinum compounds	rs3738948	ERCC3	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs3738948:AG
platinum compounds	rs3738948	ERCC3	GG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs3738948:GG
tegafur	rs8192720	CYP2A6	AA	Metabolism/PK	increased	LADME	Healthy		L01BC03	rs8192720:AA
tegafur	rs8192720	CYP2A6	AG	Metabolism/PK	increased	LADME	Healthy		L01BC03	rs8192720:AG
digoxin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	Dosage	Healthy		C01AA05	rs1045642:AA
digoxin	rs1045642	ABCB1	AG	Metabolism/PK	decreased	Dosage	Healthy		C01AA05	rs1045642:AG
antipsychotics, chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone	rs1801133	MTHFR	AG	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05A|N05AA01|N05AD01|N05AH02|N05AH03|N05AH04|N05AX08	rs1801133:AG
oxycodone	rs7439366	UGT2B7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0027651|Disease:C0030193		N02AA05	rs7439366:TT
terbutaline	rs1042714	ADRB2	GG	Metabolism/PK	increased	Efficacy_Response	Healthy		R03CC03	rs1042714:GG
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
bupropion	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Other:C0011581		N06AX12	rs3745274:T
risperidone	rs4483927	HRH4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs4483927:TT
atenolol	rs2960306	GRK4	T	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C07AB03	rs2960306:T
atenolol	rs1024323	GRK4	T	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C07AB03	rs1024323:T
calcium channel blockers	rs588076	PICALM	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs588076:GG
deleobuvir, faldaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		No_ATC	rs12979860:CC
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
propofol	rs11503014	GABRA2	CC	Other	decreased	Efficacy_Response	Healthy		N01AX10	rs11503014:CC
warfarin	rs3212198	HNF4A	T	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs3212198:T
codeine, tramadol	rs1056836	CYP1B1	C	Efficacy	decreased	Efficacy_Response	Other:C0030193		N02AX02|R05DA04	rs1056836:C
erlotinib, gefitinib	rs121434568	EGFR	G	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01EB01|L01EB02	rs121434568:G
warfarin	rs2501873	NR1I3	TT	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2501873:TT
verapamil	rs3733694	PCDHB8	G	Efficacy	decreased	Efficacy_Response	Other:C0022078		C08DA01	rs3733694:G
rivaroxaban	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs1057868:TT
verapamil	rs17844444	PCDHB6	A	Efficacy	decreased	Efficacy_Response	Other:C0022078		C08DA01	rs17844444:A
capecitabine, cetuximab, oxaliplatin	rs61764370	KRAS	AC	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC06|L01XA03	rs61764370:AC
simvastatin acid	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CT
atorvastatin	rs5186	AGTR1	AC	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs5186:AC
atorvastatin	rs1799722	BDKRB2	CT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs1799722:CT
losartan	rs5186	AGTR1	AA	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		C09CA01	rs5186:AA
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
heroin	rs9479757	OPRM1	AG	Dosage	increased	Dosage	Disease:C0028043		No_ATC	rs9479757:AG
5-hydroxyindole-3-acetic acid, serotonin	rs1799836	MAOB	T	Metabolism/PK	increased	LADME	Other:C0011581		A03AE	rs1799836:T
antidepressants	rs1954787	GRIK4	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs1954787:CC
rivaroxaban	rs4148738	ABCB1	CT	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs4148738:CT
5-hydroxyindole-3-acetic acid, serotonin	rs1799836	MAOB	TT	Metabolism/PK	increased	LADME	Other:C0011581		A03AE	rs1799836:TT
apixaban	rs1057868	POR	T	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF02	rs1057868:T
oxcarbazepine	rs2741049	UGT1A9	CC	Efficacy	increased	Efficacy_Response	Disease:Seizures		N03AF02	rs2741049:CC
codeine, tramadol	rs1056837	CYP1B1	A	Efficacy	decreased	Efficacy_Response	Other:C0030193		N02AX02|R05DA04	rs1056837:A
candesartan	rs1799998	CYP11B2	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA06	rs1799998:GG
3-hydroxycotinine	rs4105144	__INTRONIC__	CC	Metabolism/PK	increased	LADME	Other:C0039338		No_ATC	rs4105144:CC
3-hydroxycotinine	rs4105144	__INTRONIC__	CT	Metabolism/PK	increased	LADME	Other:C0039338		No_ATC	rs4105144:CT
hydrocodone, oxycodone	rs35742686	CYP2D6	DELT	Efficacy	increased	Efficacy_Response	Other:C0030193		N02AA05|R05DA03	rs35742686:DELT
3-hydroxycotinine	rs3733829	EGLN2	AA	Metabolism/PK	decreased	LADME	Other:C0039338		No_ATC	rs3733829:AA
3-hydroxycotinine	rs3733829	EGLN2	AG	Metabolism/PK	decreased	LADME	Other:C0039338		No_ATC	rs3733829:AG
hydrocodone, oxycodone	rs76026520	MACROD2	G	Efficacy	increased	Efficacy_Response	Other:C0030193		N02AA05|R05DA03	rs76026520:G
clonidine	rs5443	GNB3	CT	Efficacy	increased	Efficacy_Response	Healthy		S01EA04	rs5443:CT
clonidine	rs5443	GNB3	TT	Efficacy	increased	Efficacy_Response	Healthy		S01EA04	rs5443:TT
benazepril	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07	rs1801133:AA
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
deferasirox	rs2606345	CYP1A1	AC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2606345:AC
deferasirox	rs2606345	CYP1A1	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2606345:CC
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
pitrakinra	rs1029489	IL4R	GG	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs1029489:GG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT
radiotherapy	rs11130424	CACNA2D3	AG	Efficacy	increased	Efficacy_Response	Other:C0023055		No_ATC	rs11130424:AG
radiotherapy	rs11130424	CACNA2D3	GG	Efficacy	increased	Efficacy_Response	Other:C0023055		No_ATC	rs11130424:GG
hydroxyurea	rs9483947	MAP3K5	CC	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs9483947:CC
antihypertensives	rs13144136	CLNK	G	Efficacy	increased	Efficacy_Response	Disease:C0020538		C02	rs13144136:G
hydroxyurea	rs9376230	MAP3K5	CC	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs9376230:CC
imatinib	rs1128503	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1128503:GG
imatinib	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AA
atorvastatin	rs717620	ABCC2	CT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs717620:CT
atorvastatin	rs717620	ABCC2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs717620:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
lenalidomide, thalidomide	rs308395	FGF2	CG	Efficacy	decreased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02|L04AX04	rs308395:CG
lenalidomide, thalidomide	rs308395	FGF2	GG	Efficacy	decreased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02|L04AX04	rs308395:GG
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
methotrexate	rs717620	ABCC2	CT	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs717620:CT
methotrexate	rs717620	ABCC2	TT	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs717620:TT
antidepressants	rs979605	MAOA	AA	Metabolism/PK	decreased	Efficacy_Response	Other:C0011581		N06A	rs979605:AA
methotrexate	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1045642:GG
antidepressants	rs1954787	GRIK4	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs1954787:C
ethanol	rs671	ALDH2	AG	Other	increased	LADME	Healthy		V03AB16	rs671:AG
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
hydrochlorothiazide	rs292449	NEDD4L	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs292449:CC
hydrochlorothiazide	rs292449	NEDD4L	CG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs292449:CG
pitrakinra	rs8832	IL4R	GG	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs8832:GG
tacrolimus	rs776746	CYP3A5	T	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:T
pitrakinra	rs3024530	IL4R	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs3024530:AA
pitrakinra	rs1110470	IL4R	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs1110470:AA
pitrakinra	rs2239347	IL4R	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs2239347:AA
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A
benazepril	rs1805087	MTR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C09AA07	rs1805087:AG
benazepril	rs1805087	MTR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C09AA07	rs1805087:GG
pitrakinra	rs1805010	IL4R	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs1805010:AA
voriconazole	rs717620	ABCC2	CT	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs717620:CT
voriconazole	rs717620	ABCC2	TT	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs717620:TT
acenocoumarol, phenprocoumon	rs9934438	VKORC1	GG	Dosage, Toxicity	increased	Dosage	Healthy		B01AA04|B01AA07	rs9934438:GG
sulindac	rs2266782	FMO3	AA	Metabolism/PK	increased	LADME	Healthy		M01AB02	rs2266782:AA
mycophenolate mofetil(mycophenolic acid)	rs7311358	SLCO1B3	A	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AA06	rs7311358:A
sulindac	rs2266780	FMO3	GG	Metabolism/PK	increased	LADME	Healthy		M01AB02	rs2266780:GG
morphine	rs4793665	ABCC3	CC	Metabolism/PK	increased	LADME	Healthy		N02AA01	rs4793665:CC
peginterferon alfa-2a, ribavirin	rs8105790	IFNL3	C	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8105790:C
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CT
peginterferon alfa-2a, ribavirin	rs8103142	IFNL3	C	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8103142:C
memantine	rs1523130	NR1I2	CT	Metabolism/PK	decreased	LADME	Disease:C0497327		N06DX01	rs1523130:CT
memantine	rs1523130	NR1I2	TT	Metabolism/PK	decreased	LADME	Disease:C0497327		N06DX01	rs1523130:TT
benazepril	rs1042713	ADRB2	AG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA07	rs1042713:AG
benazepril	rs1042713	ADRB2	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA07	rs1042713:GG
peginterferon alfa-2a, ribavirin	rs11881222	IFNL3	G	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11881222:G
peginterferon alfa-2a, ribavirin	rs7248668	IFNL3	A	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs7248668:A
amisulpride	rs7968606	ANKS1B	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AL05	rs7968606:CC
peginterferon alfa-2a, ribavirin	rs28416813	IFNL3	C	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs28416813:C
peginterferon alfa-2a, ribavirin	rs4803219	IFNL3	C	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4803219:C
morphine	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Disease:C0027651		N02AA01	rs1799971:AG
escitalopram	rs2069521	__INTRONIC__	A	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	rs2069521:A
imatinib	rs776746	CYP3A5	CC	Metabolism/PK	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs776746:CC
rosuvastatin	rs4238001	SCARB1	CC	Efficacy	increased	Efficacy_Response	Other:C0151744		C10AA07	rs4238001:CC
imatinib	rs1045642	ABCB1	AA	Metabolism/PK	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AA
imatinib	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs776746:CC
lacosamide	rs2273697	ABCC2	GG	Metabolism/PK	increased	LADME	Other:C0014544		N03AX18	rs2273697:GG
imatinib	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AA
simvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0242339		C10AA01	rs4149056:CC
simvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0242339		C10AA01	rs4149056:CT
olanzapine	rs11960832	SV2C	TT	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH03	rs11960832:TT
corticosteroids	rs2240017	TBX21	CG	Efficacy	increased	Efficacy_Response	Disease:C0004096		S02BA	rs2240017:CG
methotrexate	rs2238476	ABCC1	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AX03	rs2238476:GG
antidepressants	rs6314	HTR2A	AG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs6314:AG
antidepressants	rs6314	HTR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs6314:GG
carbamazepine, lamotrigine, phenytoin, primidone, valproic acid	rs1065852	CYP2D6	A	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA03|N03AB02|N03AF01|N03AG01|N03AX09	rs1065852:A
carbamazepine, lamotrigine, phenytoin, primidone, valproic acid	rs9332120	CYP2C9	C	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA03|N03AB02|N03AF01|N03AG01|N03AX09	rs9332120:C
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:C
carbamazepine, lamotrigine, phenytoin, primidone, valproic acid	rs3892097	CYP2D6	C	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA03|N03AB02|N03AF01|N03AG01|N03AX09	rs3892097:C
carbamazepine, lamotrigine, phenytoin, primidone, valproic acid	rs2740574	CYP3A4	C	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA03|N03AB02|N03AF01|N03AG01|N03AX09	rs2740574:C
carbamazepine, lamotrigine, phenytoin, primidone, valproic acid	rs2687116	CYP3A4	C	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA03|N03AB02|N03AF01|N03AG01|N03AX09	rs2687116:C
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT
duloxetine	rs61908411	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908411:C
duloxetine	rs61908409	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908409:C
duloxetine	rs61908410	ANO2	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908410:T
duloxetine	rs78615940	ANO2	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs78615940:A
duloxetine	rs78482393	ANO2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs78482393:G
duloxetine	rs61908405	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908405:C
duloxetine	rs61908406	ANO2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908406:G
selective beta-2-adrenoreceptor agonists	rs2781659	ARG1	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC	rs2781659:A
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AA
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AG
duloxetine	rs61908404	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908404:C
duloxetine	rs61908408	ANO2	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908408:A
duloxetine	rs61908407	ANO2	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908407:A
duloxetine	rs17786412	ANO2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17786412:G
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
duloxetine	rs17786400	ANO2	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17786400:A
methadone	rs9282564	ABCB1	C	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs9282564:C
duloxetine	rs61908403	ANO2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908403:G
duloxetine	rs61908402	ANO2	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908402:T
dobutamine	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C01CA07	rs1801253:CC
duloxetine	rs17724452	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17724452:C
glatiramer acetate	rs2114358	PVT1	A	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AX13	rs2114358:A
duloxetine	rs7316769	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs7316769:G
duloxetine	rs17724494	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17724494:C
warfarin	rs56165452	CYP2C9	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs56165452:CT
methadone	rs1045642	ABCB1	A	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1045642:A
duloxetine	rs17786394	ANO2	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17786394:T
duloxetine	rs17724464	ANO2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17724464:G
methadone	rs7439366	UGT2B7	CT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs7439366:CT
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A
pemetrexed, platinum compounds	rs9344	CCND1	A	Efficacy	increased	Efficacy_Response	Other:C0024121		L01BA04|L01XA	rs9344:A
warfarin	rs2359612	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:A
metoprolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AB02	rs1801253:CC
warfarin	rs7294	VKORC1	T	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:T
liraglutide	rs10305420	GLP1R	CT	Efficacy	decreased	Efficacy_Response	Disease:C0028754|Disease:Polycystic_Ovary_Syndrome		A10BJ02	rs10305420:CT
liraglutide	rs10305420	GLP1R	TT	Efficacy	decreased	Efficacy_Response	Disease:C0028754|Disease:Polycystic_Ovary_Syndrome		A10BJ02	rs10305420:TT
lamotrigine	rs2753325	CACNA1H	A	Efficacy	increased	Efficacy_Response	Efficacy:C0014544		N03AX09	rs2753325:A
azathioprine	low activity	TPMT	__UNKNOWN__	Metabolism/PK	decreased	Dosage	Healthy	low activity	L04AX01	__UNKNOWN__
fluorouracil	rs3918290	DPYD	CT	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs3918290:CT
fluorouracil	rs2297595	DPYD	CC	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs2297595:CC
fluorouracil	rs2297595	DPYD	CT	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs2297595:CT
aspirin	rs6065	GP1BA	CT	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs6065:CT
aspirin	rs6065	GP1BA	TT	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs6065:TT
fluorouracil	rs1801160	DPYD	CT	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs1801160:CT
fluorouracil	rs1801160	DPYD	TT	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs1801160:TT
fluorouracil	rs1801265	DPYD	GG	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs1801265:GG
lacosamide	rs717620	ABCC2	CC	Metabolism/PK	increased	LADME	Other:C0014544		N03AX18	rs717620:CC
anastrozole	rs11648166	__INTRONIC__	G	Metabolism/PK	increased	LADME	Disease:C1458155		L02BG03	rs11648166:G
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
lacosamide	rs2273697	ABCC2	A	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AX18	rs2273697:A
lacosamide	rs717620	ABCC2	T	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AX18	rs717620:T
anastrozole	rs28845026	__INTRONIC__	T	Metabolism/PK	increased	LADME	Disease:C1458155		L02BG03	rs28845026:T
trazodone	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N06AX05	rs1045642:AA
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1057910:AC
warfarin	rs1057910	CYP2C9	CC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1057910:CC
cyclophosphamide	rs4802101	CYP2B6	C	Metabolism/PK	decreased	LADME	Disease:C0409974		L01AA01	rs4802101:C
dobutamine	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C01CA07	rs1801253:CC
simvastatin acid	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:C
methotrexate	rs10994982	ARID5B	A	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs10994982:A
oxycodone	rs1799971	OPRM1	AG	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N02AA05	rs1799971:AG
oxycodone	rs1799971	OPRM1	GG	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N02AA05	rs1799971:GG
cyclophosphamide	rs4244285	CYP2C19	A	Metabolism/PK	decreased	LADME	Disease:C0409974		L01AA01	rs4244285:A
imatinib	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs1045642:AG
imatinib	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs1045642:GG
fenofibrate	rs4253778	PPARA	GG	Efficacy	increased	Efficacy_Response	Disease:C0011849		C10AB05	rs4253778:GG
methotrexate	rs11231809	SLC22A11	AT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs11231809:AT
methotrexate	rs11231809	SLC22A11	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs11231809:TT
methotrexate	rs246240	ABCC1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs246240:AG
methotrexate	rs246240	ABCC1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs246240:GG
hmg coa reductase inhibitors	rs3846662	HMGCR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0342881		C10AA	rs3846662:AA
methotrexate	rs3784864	ABCC1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs3784864:AG
methotrexate	rs3784864	ABCC1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs3784864:GG
cyclophosphamide	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027697		L01AA01	rs4244285:AG
cyclophosphamide	rs4244285	CYP2C19	GG	Efficacy	decreased	Efficacy_Response	Disease:C0027697		L01AA01	rs4244285:GG
4-hydroxycyclophosphamide	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:C0027697		L01AA01	rs776746:CC
4-hydroxycyclophosphamide	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:C0027697		L01AA01	rs776746:CT
cyclophosphamide	rs7254579	CYP2B6	C	Metabolism/PK	Indeterminado	LADME	Disease:C0409974		L01AA01	rs7254579:C
hmg coa reductase inhibitors	rs445925	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Healthy		C10AA	rs445925:A
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
hmg coa reductase inhibitors	rs10455872	LPA	G	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs10455872:G
fenofibrate	rs1800795	IL6	CC	Efficacy	increased	Efficacy_Response	Other:patients_with_a_high_risk_of_cardiovascular_disease		C10AB05	rs1800795:CC
fenofibrate	rs1800795	IL6	CG	Efficacy	increased	Efficacy_Response	Other:patients_with_a_high_risk_of_cardiovascular_disease		C10AB05	rs1800795:CG
ranibizumab	rs2070296	NRP1	T	Efficacy	decreased	Efficacy_Response	Disease:C0024437		S01LA04	rs2070296:T
atorvastatin	rs708272	CETP	GG	Efficacy	increased	Efficacy_Response	Disease:C0011849		C10AA05	rs708272:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs3828913	MICB	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs3828913:CC
methotrexate	rs13120400	ABCG2	CC	Efficacy	increased	Efficacy_Response	Side_Effect:C0235763		L04AX03	rs13120400:CC
nicotine	rs77905	DBH	GG	Dosage	decreased	Dosage	Disease:C0039338		N07BA01	rs77905:GG
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs9923231:CC
warfarin	rs9923231	VKORC1	CT	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs9923231:CT
nicotine	rs1137070	MAOA	TT	Dosage	increased	Dosage	Disease:C0039338		N07BA01	rs1137070:TT
omeprazole, pantoprazole	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02	rs1045642:AA
deferasirox	rs7975232	VDR	AA	Metabolism/PK	Indeterminado	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs7975232:AA
fluvoxamine, milnacipran, paroxetine	rs1364043	HTR1A	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08|N06AX17	rs1364043:TT
deferasirox	rs2228570	VDR	G	Metabolism/PK	Indeterminado	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2228570:G
antipsychotics	rs6465084	GRM3	AA	Toxicity	increased	Efficacy_Response	Disease:C0036341		N05A	rs6465084:AA
metformin	rs2289669	SLC47A1	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs2289669:AA
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CC
warfarin	rs2108622	CYP4F2	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
metformin	rs2289669	SLC47A1	AA	Metabolism/PK	decreased	LADME	Disease:C0011849		A10BA02	rs2289669:AA
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
efavirenz	rs2307424	NR1I3	G	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2307424:G
efavirenz	rs2307424	NR1I3	AG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2307424:AG
antihypertensives	rs12817819	ATP2B1	CT	Efficacy	increased	Efficacy_Response	Disease:C1956346|Disease:C0020538		C02	rs12817819:CT
antihypertensives	rs12817819	ATP2B1	TT	Efficacy	increased	Efficacy_Response	Disease:C1956346|Disease:C0020538		C02	rs12817819:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
warfarin	rs1051741	EPHX1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs1051741:CT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8103142	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8103142:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12980275:AA
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11881222	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11881222:AA
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC
isoniazid	rs1799930	NAT2	AA	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J04AC01	rs1799930:AA
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
mercaptopurine	rs73189762	NUDT15	T	Dosage	decreased	Dosage	Other:C0023449		L01BB02	rs73189762:T
warfarin	rs7294	PRSS53, VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:CT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
isoniazid	rs2472677	NR1I2	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J04AC01	rs2472677:TT
amlodipine, felodipine	rs2238032	CACNA1C	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01|C08CA02	rs2238032:TT
isoniazid	rs4149032	SLCO1B1	CC	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J04AC01	rs4149032:CC
calcium channel blockers	rs2239128	CACNA1C	C	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs2239128:C
morphine	rs1799971	OPRM1	AG	Efficacy	increased	Dosage	Healthy		N02AA01	rs1799971:AG
morphine	rs1799971	OPRM1	GG	Efficacy	increased	Dosage	Healthy		N02AA01	rs1799971:GG
gefitinib	rs121434568	EGFR	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007131		L01EB01	rs121434568:G
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
erlotinib	rs121434568	EGFR	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007131		L01EB02	rs121434568:G
hmg coa reductase inhibitors	rs2900478	SLCO1B1	A	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs2900478:A
calcium channel blockers	rs2239050	CACNA1C	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs2239050:GG
hmg coa reductase inhibitors	rs646776	CELSR2	C	Efficacy	increased	Efficacy_Response	Healthy		C10AA	rs646776:C
valproic acid	rs12233719	UGT2B7	GG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs12233719:GG
efavirenz	rs28399454	CYP2A6	T	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399454:T
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
calcium channel blockers	rs2238032	CACNA1C	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs2238032:TT
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	rs9923231:TT
phenprocoumon, warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03|B01AA04	rs9923231:TT
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG
atazanavir	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE08	rs1045642:GG
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T
warfarin	rs7900194	CYP2C9	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs7900194:A
efavirenz	rs2279343	CYP2B6	AG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:AG
valproic acid	rs7668258	UGT2B7	CT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs7668258:CT
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
warfarin	rs28371686	CYP2C9	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs28371686:G
warfarin	rs429358	APOC1, APOE	T	Dosage	decreased	Dosage	Other:haplotype_epsilon2		B01AA03	rs429358:T
valproic acid	rs7668258	UGT2B7	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs7668258:TT
warfarin	rs7412	APOC1, APOE	T	Dosage	decreased	Dosage	Other:haplotype_epsilon2		B01AA03	rs7412:T
infliximab	rs2097432	__INTRONIC__	CC	Efficacy	increased	Adverse_Event	Efficacy:C0010346		L04AB02	rs2097432:CC
infliximab	rs2097432	__INTRONIC__	CT	Efficacy	increased	Adverse_Event	Efficacy:C0010346		L04AB02	rs2097432:CT
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
photodynamic therapy	rs1061170	CFH	TT	Efficacy	decreased	Efficacy_Response	Disease:C0024437		No_ATC	rs1061170:TT
valproic acid	rs7439366	UGT2B7	TT	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N03AG01	rs7439366:TT
risperidone	rs2231142	ABCG2	GT	Metabolism/PK	decreased	LADME	Healthy		N05AX08	rs2231142:GT
risperidone	rs2231142	ABCG2	TT	Metabolism/PK	decreased	LADME	Healthy		N05AX08	rs2231142:TT
fluoxetine	rs9361233	HTR1B	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs9361233:CC
fluoxetine	rs9361233	HTR1B	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs9361233:TT
efavirenz	rs8192709	CYP2B6	CC	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs8192709:CC
infliximab	rs73277969	__INTRONIC__	T	Efficacy	increased	Adverse_Event	Efficacy:C0010346		L04AB02	rs73277969:T
ivacaftor	rs121908757	CFTR	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121908757:C
ivacaftor	rs121909005	CFTR	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121909005:G
aspirin, clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A
ivacaftor	rs121908755	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121908755:A
aspirin, prasugrel	rs2768759	PEAR1	AC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs2768759:AC
aspirin, prasugrel	rs2768759	PEAR1	CC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs2768759:CC
cyclosporine	rs2032582	ABCB1	AC	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD01	rs2032582:AC
cyclosporine	rs2032582	ABCB1	CC	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD01	rs2032582:CC
aspirin, clopidogrel, prasugrel	rs12041331	PEAR1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC04|B01AC22	rs12041331:AA
aspirin, clopidogrel, prasugrel	rs12041331	PEAR1	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04|B01AC22	rs12041331:AG
cyclosporine	rs4646437	CYP3A4	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs4646437:AG
cyclosporine	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs4646437:GG
hydralazine / isosorbide dinitrate	rs5443	GNB3	TT	Efficacy	increased	Efficacy_Response	Disease:C0085605		C05AE02	rs5443:TT
ivacaftor	rs397508453	CFTR	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs397508453:C
tacrolimus	rs776746	CYP3A5	CC	Dosage	increased	LADME	Other:Liver_transplantation		L04AD02	rs776746:CC
ivacaftor	rs121909013	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121909013:A
lovastatin acid	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA02	rs4149056:CC
lovastatin acid	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA02	rs4149056:CT
simvastatin	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		C10AA01	rs776746:CC
ivacaftor	rs121909041	CFTR	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121909041:C
tacrolimus	rs2242480	CYP3A4	T	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:T
simvastatin	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		C10AA01	rs776746:CC
aspirin, clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A
ivacaftor	rs74503330	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs74503330:A
lovastatin	rs4823613	PPARA	AG	Metabolism/PK	increased	LADME	Healthy		C10AA02	rs4823613:AG
lovastatin	rs4823613	PPARA	GG	Metabolism/PK	increased	LADME	Healthy		C10AA02	rs4823613:GG
nevirapine	rs762551	CYP1A2	CC	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AG01	rs762551:CC
fentanyl	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Disease:C0030193		N02AB03	rs1799971:AG
fentanyl	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Disease:C0030193		N02AB03	rs1799971:GG
anastrozole, letrozole, tamoxifen	rs4646	CYP19A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1458155|Disease:C0025320		L02BA01|L02BG03|L02BG04	rs4646:AA
ivacaftor	rs267606723	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs267606723:A
serotonin	rs696692	ERICH3	T	Other	decreased	LADME	Disease:C0011581		A03AE	rs696692:T
ivacaftor	rs80282562	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs80282562:A
tacrolimus	rs1045642	ABCB1	AG	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:AG
tacrolimus	rs1045642	ABCB1	GG	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:GG
cyclosporine	rs4646437	CYP3A4	AG	Efficacy	increased	Efficacy_Response	Disease:Kidney_Transplantation		L04AD01	rs4646437:AG
cyclosporine	rs4646437	CYP3A4	GG	Efficacy	increased	Efficacy_Response	Disease:Kidney_Transplantation		L04AD01	rs4646437:GG
anastrozole, letrozole, tamoxifen	rs4646	CYP19A1	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01|L02BG03|L02BG04	rs4646:AA
platinum compounds	rs1799793	ERCC2	CT	Efficacy	increased	Efficacy_Response	Other:C0007131		L01XA	rs1799793:CT
platinum compounds	rs1799793	ERCC2	TT	Efficacy	increased	Efficacy_Response	Other:C0007131		L01XA	rs1799793:TT
serotonin	rs11947402	TSPAN5	G	Other	decreased	LADME	Disease:C0011581		A03AE	rs11947402:G
nevirapine	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3761847	TRAF1	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs3761847:G
thalidomide	rs4533622	CTNNB1	AA	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02	rs4533622:AA
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Dosage	Disease:C0004238|Disease:C0878544|Disease:Heart_valve_replacement|Disease:C0085096|Disease:C0034065|Disease:C0042487		B01AA03	rs9934438:AG
fentanyl	rs1799971	OPRM1	AG	Dosage	decreased	Dosage	Disease:C0030193		N02AB03	rs1799971:AG
fentanyl	rs1799971	OPRM1	GG	Dosage	decreased	Dosage	Disease:C0030193		N02AB03	rs1799971:GG
ivacaftor	rs193922525	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs193922525:A
cyclophosphamide, dexamethasone, thalidomide	rs4135385	CTNNB1	AA	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01AA01|L04AX02|S02BA06	rs4135385:AA
opioids	rs2275913	IL17A	A	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02A	rs2275913:A
platinum compounds	rs1048943	CYP1A1	CC	Efficacy	increased	Efficacy_Response	Other:C0007131		L01XA	rs1048943:CC
platinum compounds	rs1048943	CYP1A1	CT	Efficacy	increased	Efficacy_Response	Other:C0007131		L01XA	rs1048943:CT
warfarin	rs2108622	CYP4F2	C	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	rs2108622:C
tacrolimus	rs2032582	ABCB1	AC	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:AC
tacrolimus	rs2032582	ABCB1	CC	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:CC
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	rs9923231:T
antidepressants, citalopram, escitalopram	rs11580409	ERICH3	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A|N06AB04|N06AB10	rs11580409:C
ethanol	rs1799971	OPRM1	AG	Other	decreased	Dosage	Healthy		V03AB16	rs1799971:AG
ethanol	rs1799971	OPRM1	GG	Other	decreased	Dosage	Healthy		V03AB16	rs1799971:GG
cyclosporine	rs2032582	ABCB1	AC	Dosage	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs2032582:AC
cyclosporine	rs2032582	ABCB1	CC	Dosage	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs2032582:CC
tacrolimus	rs10211	CYP3A7	TT	Metabolism/PK	increased	LADME	Other:null		L04AD02	rs10211:TT
warfarin	rs9923231	VKORC1	C	Dosage, Efficacy	increased	Dosage	Healthy		B01AA03	rs9923231:C
warfarin	rs9923231	VKORC1	T	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:T
acetaminophen, tramadol	rs1799971	OPRM1	AA	Efficacy	increased	Efficacy_Response	Disease:C0522067		N02AX02|N02BE01	rs1799971:AA
rituximab	rs1801274	FCGR2A	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs1801274:AA
methadone	rs3745274	CYP2B6	T	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs3745274:T
cotinine	rs2942857	UGT2B10	CC	Metabolism/PK	decreased	LADME	Disease:C0039338		No_ATC	rs2942857:CC
fentanyl	rs6961071	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0030193|Postoperative		N02AB03	rs6961071:GG
rituximab	rs396991	FCGR3A	AC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs396991:AC
rituximab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs396991:CC
warfarin	rs2359612	VKORC1	G	Dosage	increased	Dosage	Healthy		B01AA03	rs2359612:G
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs13959	ALDH1A1	AG	Efficacy	increased	Efficacy_Response	Other:C1458155		L01AA01|L01BC02|L01DB01	rs13959:AG
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs13959	ALDH1A1	GG	Efficacy	increased	Efficacy_Response	Other:C1458155		L01AA01|L01BC02|L01DB01	rs13959:GG
tacrolimus	rs1057868	POR	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:CC
methadone	rs2032582	ABCB1	CC	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs2032582:CC
tocilizumab	rs396991	FCGR3A	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs396991:AA
carvedilol	rs1042714	ADRB2	GG	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AG02	rs1042714:GG
fentanyl	rs13093031	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0030193|Postoperative		N02AB03	rs13093031:GG
atorvastatin, lovastatin, simvastatin	rs776746	CYP3A5	CC	Efficacy	increased	Efficacy_Response	Disease:C0003850		C10AA01|C10AA02|C10AA05	rs776746:CC
cotinine	rs2942857	UGT2B10	CC	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs2942857:CC
clopidogrel	rs1045642	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0027051		B01AC04	rs1045642:A
cisplatin	rs11615	ERCC1	A	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01XA01	rs11615:A
warfarin	rs2884737	VKORC1	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs2884737:C
warfarin	rs7294	PRSS53, VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:G
phenobarbital	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA02	rs1045642:GG
tacrolimus	rs1800822	FMO3	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs1800822:CC
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A
fenofibrate	rs1417938	CRP	TT	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AB05	rs1417938:TT
pravastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0242339		C10AA03	rs4149056:CC
pravastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0242339		C10AA03	rs4149056:CT
metformin	rs2076828	SLC22A3	G	Efficacy	decreased	Efficacy_Response	Healthy		A10BA02	rs2076828:G
fluoxetine	rs9361235	HTR1B	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs9361235:CC
fluoxetine	rs9361235	HTR1B	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs9361235:TT
n-desmethylclozapine(clozapine)	rs61750900	UGT2B10	T	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs61750900:T
warfarin	rs10517	NQO1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs10517:GG
fenofibrate	rs3091244	CRP	AG	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AB05	rs3091244:AG
fenofibrate	rs3091244	CRP	GG	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AB05	rs3091244:GG
pravastatin	rs35068180	MMP3	A/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C10AA03	rs35068180:A/del
pravastatin	rs35068180	MMP3	AA	Efficacy	increased	Efficacy_Response	Disease:C1956346		C10AA03	rs35068180:AA
n-desmethylclozapine(clozapine)	rs2011425	UGT1A4	G	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs2011425:G
fenofibrate	rs3091244	CRP	GG	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AB05	rs3091244:GG
fenofibrate	rs3091244	CRP	GT	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AB05	rs3091244:GT
fentanyl	rs1128503	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027651|Disease:C0030193		N02AB03	rs1128503:AA
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Disease:C0007222		B01AA03	rs2108622:T
clozapine	rs1126545	CYP2C18	T	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs1126545:T
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A
simvastatin	rs4149056	SLCO1B1	C	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01	rs4149056:C
desloratadine, mizolastine	rs2298805	FCER1A	AA	Efficacy	increased	Efficacy_Response	Disease:C0042109		R06AX25|R06AX27	rs2298805:AA
atorvastatin	rs17161788	CYP3A5	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs17161788:TT
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:G
capecitabine, fluorouracil, leucovorin, oxaliplatin	rs3917412	SELE	CC	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01BC02|L01BC06|L01XA03	rs3917412:CC
atorvastatin	rs776746	CYP3A5	CC	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs776746:CC
opioids	rs2952768	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N02A	rs2952768:CC
hmg coa reductase inhibitors	rs11591147	PCSK9	T	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA	rs11591147:T
imatinib	rs28371759	CYP3A4	AG	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs28371759:AG
digoxin	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Disease:C0085605		C01AA05	rs2032582:CC
capecitabine, fluorouracil, leucovorin, oxaliplatin	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01BC02|L01BC06|L01XA03	rs1801133:AA
platinum	rs17655	ERCC5	GG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs17655:GG
elexacaftor / tezacaftor / ivacaftor, ivacaftor / tezacaftor	rs75389940	CFTR	AG	Efficacy	increased	Efficacy_Response	Other:C0156318		R07AX02|R07AX31	rs75389940:AG
elexacaftor / tezacaftor / ivacaftor, ivacaftor / tezacaftor	rs75389940	CFTR	GG	Efficacy	increased	Efficacy_Response	Other:C0156318		R07AX02|R07AX31	rs75389940:GG
carvedilol	rs12233719	UGT2B7	T	Metabolism/PK	decreased	LADME	Disease:C0271093		C07AG02	rs12233719:T
bupropion, nicotine, varenicline	rs2036527	CHRNA5	AA	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12|N07BA01|N07BA03	rs2036527:AA
bupropion, nicotine, varenicline	rs2036527	CHRNA5	AG	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12|N07BA01|N07BA03	rs2036527:AG
bupropion, nicotine, varenicline	rs16969968	CHRNA5	AA	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12|N07BA01|N07BA03	rs16969968:AA
bupropion, nicotine, varenicline	rs16969968	CHRNA5	AG	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12|N07BA01|N07BA03	rs16969968:AG
carvedilol	rs28365063	UGT2B7	G	Metabolism/PK	decreased	LADME	Disease:C0271093		C07AG02	rs28365063:G
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC
tacrolimus	rs909530	FMO3	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs909530:CC
digoxin	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:C0085605		C01AA05	rs2032582:AA
digoxin	rs2032582	ABCB1	AT	Metabolism/PK	decreased	LADME	Disease:C0085605		C01AA05	rs2032582:AT
tacrolimus	rs3814055	NR1I2	CT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs3814055:CT
tacrolimus	rs3814055	NR1I2	TT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs3814055:TT
lumacaftor	rs121909047	CFTR	AA	Efficacy	Indeterminado	Efficacy_Response	Healthy		R07AX30	rs121909047:AA
methadone	rs8094439	CDH2	AA	Efficacy	increased	Efficacy_Response	Healthy		N07BC02	rs8094439:AA
pertussis vaccines	rs4986790	TLR4	AA	Efficacy	increased	Efficacy_Response	Healthy		J07AJ	rs4986790:AA
tacrolimus	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT
tacrolimus	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT
methadone	rs17446819	CDH2	CC	Efficacy	increased	Efficacy_Response	Healthy		N07BC02	rs17446819:CC
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
sorafenib	rs2231137	ABCG2	CT	Metabolism/PK	Indeterminado	LADME	Disease:C2239176		L01EX02	rs2231137:CT
nicotine	rs376817657	CYP2A6	CT	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs376817657:CT
nicotine	rs376817657	CYP2A6	TT	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs376817657:TT
sorafenib	rs2231142	ABCG2	GT	Metabolism/PK	Indeterminado	LADME	Disease:C2239176		L01EX02	rs2231142:GT
imatinib	rs683369	SLC22A1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CC
imatinib	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:GG
simvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01	rs4149056:CC
simvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01	rs4149056:CT
fentanyl	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs1799971:GG
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC
bilirubin	rs887829	UGT1A1	TT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs887829:TT
warfarin	rs1799853	CYP2C9	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:CT
methotrexate	rs3758149	GGH	AA	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs3758149:AA
methotrexate	rs3758149	GGH	AG	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs3758149:AG
mercaptopurine	rs186364861	NUDT15	A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs186364861:A
imiquimod	rs179008	TLR7	A	Efficacy	increased	Efficacy_Response	Disease:C0007117		D06BB10	rs179008:A
mercaptopurine	rs116855232	NUDT15	T	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:T
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A
methotrexate	rs11545077	GGH	CC	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs11545077:CC
methotrexate	rs11545077	GGH	CT	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs11545077:CT
warfarin	rs9923231	VKORC1	T	Dosage, Other	decreased	Dosage	Healthy		B01AA03	rs9923231:T
clonidine	rs5443	GNB3	CT	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		S01EA04	rs5443:CT
clonidine	rs5443	GNB3	TT	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		S01EA04	rs5443:TT
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A
clozapine	rs61750900	UGT2B10	T	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs61750900:T
opioids	rs1277441	TAOK3	AG	Dosage	increased	Dosage	Other:C0027651|Other:C0030193		N02A	rs1277441:AG
opioids	rs1277441	TAOK3	GG	Dosage	increased	Dosage	Other:C0027651|Other:C0030193		N02A	rs1277441:GG
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A
opioids	rs795484	TAOK3	TT	Dosage	decreased	Efficacy_Response	Other:C0027651|Other:C0030193		N02A	rs795484:TT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
fentanyl	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs1799971:GG
opioids	rs795484	TAOK3	CT	Dosage	increased	Dosage	Other:C0027651|Other:C0030193		N02A	rs795484:CT
opioids	rs795484	TAOK3	TT	Dosage	increased	Dosage	Other:C0027651|Other:C0030193		N02A	rs795484:TT
fentanyl	rs1128503	ABCB1	AA	Dosage	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs1128503:AA
tenofovir	rs3742106	ABCC4	AC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs3742106:AC
tenofovir	rs3742106	ABCC4	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs3742106:CC
vitamin b12 and folic acid	rs1801133	MTHFR	A	Efficacy	decreased	Efficacy_Response	Other:C0267988|Other:C0018839		B03B	rs1801133:A
methotrexate	rs1801133	MTHFR	AA	Toxicity, Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Toxicity, Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs1801133:AG
captopril	rs5186	AGTR1	AC	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA01	rs5186:AC
captopril	rs5186	AGTR1	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA01	rs5186:CC
anthracyclines and related substances	rs1695	GSTP1	A	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01DB	rs1695:A
simvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01	rs4149056:CC
simvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01	rs4149056:CT
daunorubicin	rs25678	CBR1	CC	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		L01DB02	rs25678:CC
silibinin	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:GG
ivacaftor	rs78655421	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs78655421:A
mercaptopurine	rs1142345	TPMT	CC	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs1142345:CC
citalopram	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Other:C0085762|Other:C0011581		N06AB04	rs4244285:AG
bilirubin	rs1910167	SLCO1B1, SLCO1B3, SLCO1B7	C	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1910167:C
citalopram	rs4244285	CYP2C19	AG	Metabolism/PK	increased	LADME	Other:C0085762|Other:C0011581		N06AB04	rs4244285:AG
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A
atenolol	rs5443	GNB3	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs5443:CC
etanercept	rs2233945	PSORS1C1	C	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01	rs2233945:C
tacrolimus	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT
tacrolimus	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT
mercaptopurine	rs2274407	ABCC4	AA	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs2274407:AA
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J05AG03	rs3745274:TT
disulfiram	rs4290270	TPH2	AA	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs4290270:AA
disulfiram	rs4290270	TPH2	AT	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs4290270:AT
atenolol	rs11064426	GNB3	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs11064426:AA
enalapril	rs5522	NR3C2	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs5522:TT
atenolol	rs2301339	GNB3	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs2301339:GG
atenolol	rs5443	GNB3	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs5443:CC
mercaptopurine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:TT
atenolol	rs11064426	GNB3	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs11064426:AA
acenocoumarol	rs4086116	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA07	rs4086116:T
atenolol	rs11064426	GNB3	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs11064426:AA
etanercept	rs7574865	STAT4	T	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01	rs7574865:T
atenolol	rs2301339	GNB3	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs2301339:GG
methotrexate	rs11545076	GGH	AC	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs11545076:AC
methotrexate	rs11545076	GGH	CC	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs11545076:CC
digoxin	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		C01AA05	rs1128503:AG
allopurinol	rs2231142	ABCG2	T	Efficacy	decreased	Efficacy_Response	Disease:C0018099		M04AA01	rs2231142:T
pravastatin	rs4149015	SLCO1B1	AG	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Healthy		C10AA03	rs4149015:AG
digoxin	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs1045642:GG
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A
digoxin	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs2032582:CC
ivacaftor, tezacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX31	rs75527207:A
atorvastatin, hmg coa reductase inhibitors, pravastatin, simvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Other:C0020473		C10AA|C10AA01|C10AA03|C10AA05	rs4149056:CC
atorvastatin, hmg coa reductase inhibitors, pravastatin, simvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Other:C0020473		C10AA|C10AA01|C10AA03|C10AA05	rs4149056:CT
fenofibrate	rs2230806	ABCA1	CT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs2230806:CT
sertraline	rs6313	HTR2A	AA	Dosage	increased	Dosage	Other:C0235876|Other:C0003469		N06AB06	rs6313:AA
sertraline	rs6313	HTR2A	AG	Dosage	increased	Dosage	Other:C0235876|Other:C0003469		N06AB06	rs6313:AG
fenofibrate	rs2230808	ABCA1	CC	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs2230808:CC
platinum compounds	rs79419059	NUP107	C	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01XA	rs79419059:C
fenofibrate	rs2230806	ABCA1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs2230806:TT
venlafaxine	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Disease:C0003469		N06AX16	rs4680:AA
venlafaxine	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Disease:C0003469		N06AX16	rs4680:AG
warfarin	rs1800566	NQO1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs1800566:AA
ketoprofen	rs1799853	CYP2C9	CC	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		M02AA10	rs1799853:CC
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
etanercept	rs1800629	TNF	AG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800629:AG
etanercept	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800629:GG
antidepressants	rs1516338	CHL1	TT	Efficacy	increased	Efficacy_Response	Disease:C0005586|Disease:C0011581|Disease:C0011581		N06A	rs1516338:TT
adalimumab	rs1267067	TANK	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs1267067:CC
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG
tacrolimus	rs15524	CYP3A5	AA	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs15524:AA
adalimumab	rs25648	VEGFA	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs25648:T
carvedilol	rs1801253	ADRB1	GG	Dosage	increased	Dosage	Disease:C0085605		C07AG02	rs1801253:GG
tacrolimus	rs4646450	CYP3A5	GG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs4646450:GG
infliximab	rs361525	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB02	rs361525:GG
methotrexate	rs11045879	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs11045879:CC
methotrexate	rs11045879	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs11045879:CT
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
tacrolimus	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs4646437:GG
hydrochlorothiazide	rs10995	VASP	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs10995:AG
hydrochlorothiazide	rs10995	VASP	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs10995:GG
adalimumab	rs2230926	TNFAIP3	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs2230926:T
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC
methotrexate	rs2838958	SLC19A1	AA	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs2838958:AA
methotrexate	rs2838958	SLC19A1	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs2838958:AG
simvastatin, simvastatin acid	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Disease:C0020443		C10AA01	rs4149056:C
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
ivacaftor	rs121908757	CFTR	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121908757:C
methotrexate	rs3788200	SLC19A1	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3788200:AG
methotrexate	rs3788200	SLC19A1	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3788200:GG
lithium	rs2314339	NR1D1, THRA	T	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs2314339:T
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CT
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	rs1057910:C
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
atenolol	rs2301339	GNB3	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs2301339:GG
bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin, trastuzumab	rs13181	ERCC2	GG	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD02|L01DB03|L01FG01|L01XA01|L01XA03	rs13181:GG
acenocoumarol	rs429358	APOE	C	Dosage	decreased	Dosage	Disease:C1861172		B01AA07	rs429358:C
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T
warfarin	rs8050894	VKORC1	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:CG
warfarin	rs8050894	VKORC1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:GG
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CC
warfarin	rs2359612	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:AA
warfarin	rs2359612	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:AG
atazanavir	rs73208473	SORCS2	A	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AE08	rs73208473:A
rosuvastatin	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:GT
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:TT
bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin, trastuzumab	rs11615	ERCC1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD02|L01DB03|L01FG01|L01XA01|L01XA03	rs11615:GG
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin, trastuzumab	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD02|L01DB03|L01FG01|L01XA01|L01XA03	rs1801133:AA
methadone	rs806368	CNR1	CT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs806368:CT
methadone	rs806368	CNR1	TT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs806368:TT
methadone	rs1386493	TPH2	GG	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs1386493:GG
bumetanide, furosemide, torasemide	rs5065	NPPA-AS1	GG	Efficacy	decreased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5065:GG
morphine	rs7439366	UGT2B7	CT	Metabolism/PK	decreased	LADME	Other:C0027651|Other:C0030193		N02AA01	rs7439366:CT
morphine	rs7439366	UGT2B7	TT	Metabolism/PK	decreased	LADME	Other:C0027651|Other:C0030193		N02AA01	rs7439366:TT
atorvastatin, simvastatin	rs20455	KIF6	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01|C10AA05	rs20455:GG
efavirenz	rs35303484	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs35303484:GG
methadone	rs16974799	CYP2B6	CT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs16974799:CT
methadone	rs2229205	OPRL1	CT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs2229205:CT
rosuvastatin	rs20455	KIF6	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA07	rs20455:GG
adrenergics, inhalants	rs34548976	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03A	rs34548976:T
topiramate	rs2832407	GRIK1	AA	Metabolism/PK	increased	LADME	Disease:C0221016		N03AX11	rs2832407:AA
topiramate	rs2832407	GRIK1	AC	Metabolism/PK	increased	LADME	Disease:C0221016		N03AX11	rs2832407:AC
bumetanide, furosemide, torasemide	rs4961	ADD1	TT	Efficacy	increased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs4961:TT
cisplatin, gemcitabine	rs2072671	CDA	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs2072671:AA
topiramate	rs2832407	GRIK1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0221016		N03AX11	rs2832407:AA
topiramate	rs2832407	GRIK1	AC	Efficacy	decreased	Efficacy_Response	Disease:C0221016		N03AX11	rs2832407:AC
atorvastatin	rs20455	KIF6	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs20455:GG
cisplatin, gemcitabine	rs11615	ERCC1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs11615:AA
bumetanide, furosemide, torasemide	rs1529927	SLC12A3	CC	Efficacy	increased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs1529927:CC
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
fluvastatin	rs1922242	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA04	rs1922242:AA
gliclazide	rs2237897	KCNQ1	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BB09	rs2237897:CT
gliclazide	rs2237897	KCNQ1	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BB09	rs2237897:TT
warfarin	rs1060467	CYP4F11	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs1060467:G
carboplatin, taxanes	rs9369421	VEGFA	CC	Efficacy	increased	Efficacy_Response	Healthy		L01CD|L01XA02	rs9369421:CC
carboplatin, taxanes	rs9369421	VEGFA	CT	Efficacy	increased	Efficacy_Response	Healthy		L01CD|L01XA02	rs9369421:CT
debrisoquine	rs1080985	CYP2D6	C	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1080985:C
tacrolimus	rs35599367	CYP3A4	AA	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs35599367:AA
tacrolimus	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs35599367:AG
efavirenz	rs28399433	CYP2A6	AC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399433:AC
fluvastatin	rs4783961	CETP	GG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA04	rs4783961:GG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs9282564	ABCB1	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs9282564:CC
tacrolimus	rs9282564	ABCB1	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs9282564:CT
methotrexate	rs1801394	MTRR	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1801394:AG
methotrexate	rs1801394	MTRR	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1801394:GG
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
tenofovir	rs12979860	IFNL3, IFNL4	C	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AF07	rs12979860:C
glucocorticoids	rs1128503	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		R03BA	rs1128503:GG
metformin	rs622342	SLC22A1	A	Efficacy	increased	Efficacy_Response	Efficacy:C0011849		A10BA02	rs622342:A
glucocorticoids	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		R03BA	rs1045642:GG
hydroxyurea	rs1427407	BCL11A	T	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		No_ATC	rs1427407:T
hydroxyurea	rs766432	BCL11A	C	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		No_ATC	rs766432:C
warfarin	rs2860905	CYP2C9	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2860905:A
fentanyl	rs7439366	UGT2B7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0030193|Postoperative		N02AB03	rs7439366:TT
warfarin	rs1057910	CYP2C9	AC	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA03	rs1057910:AC
warfarin	rs1057910	CYP2C9	CC	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA03	rs1057910:CC
tiotropium	rs1042713	ADRB2	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		A07DA02	rs1042713:AA
lumefantrine	rs8187710	ABCC2	AA	Metabolism/PK	increased	LADME	Other:C0024530		P01BF01	rs8187710:AA
elexacaftor / tezacaftor / ivacaftor	rs80034486	CFTR	G	Efficacy	increased	Efficacy_Response	Other:C0156318		R07AX02	rs80034486:G
atorvastatin	rs7412	APOE	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs7412:CT
methadone	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1045642:AG
bumetanide, furosemide, torasemide	rs5065	NPPA-AS1	GG	Efficacy	increased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5065:GG
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A
clopidogrel	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		B01AC04	rs1045642:GG
bumetanide, furosemide, torasemide	rs5443	GNB3	TT	Efficacy	decreased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5443:TT
morphine	rs7439366	UGT2B7	CT	Efficacy	decreased	Efficacy_Response	Other:C0027651|Other:C0030193		N02AA01	rs7439366:CT
morphine	rs7439366	UGT2B7	TT	Efficacy	decreased	Efficacy_Response	Other:C0027651|Other:C0030193		N02AA01	rs7439366:TT
bumetanide, furosemide, torasemide	rs5063	NPPA-AS1	TT	Efficacy	decreased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5063:TT
valproic acid	rs2070959	UGT1A6	AG	Metabolism/PK	decreased	LADME	Other:C0014544		N03AG01	rs2070959:AG
valproic acid	rs2070959	UGT1A6	GG	Metabolism/PK	decreased	LADME	Other:C0014544		N03AG01	rs2070959:GG
valproic acid	rs1105879	UGT1A6	AC	Metabolism/PK	decreased	LADME	Other:C0014544		N03AG01	rs1105879:AC
valproic acid	rs1105879	UGT1A6	CC	Metabolism/PK	decreased	LADME	Other:C0014544		N03AG01	rs1105879:CC
clozapine	rs6314	HTR2A	AA	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH02	rs6314:AA
clozapine	rs6314	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH02	rs6314:AG
fluvastatin	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs4149056:TT
pravastatin	rs4341	ACE	CG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03	rs4341:CG
pravastatin	rs4341	ACE	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03	rs4341:GG
pravastatin	rs328	LPL	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03	rs328:GG
lovastatin	rs708272	CETP	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA02	rs708272:AG
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
fentanyl	rs10028494	UGT2B7	CC	Efficacy	decreased	Efficacy_Response	Disease:C0030193|Postoperative		N02AB03	rs10028494:CC
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs1801133:AA
nicotine	rs1051730	CHRNA3	A	Metabolism/PK	increased	Dosage	Healthy		N07BA01	rs1051730:A
fluvastatin	rs1800588	LIPC	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs1800588:CC
fluvastatin	rs1800588	LIPC	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs1800588:CT
clozapine	rs2472297	CYP1A1	T	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs2472297:T
methylphenidate	rs114119971	CES1	CG	Dosage	decreased	Dosage	Other:C1263846		N06BA04	rs114119971:CG
simvastatin	rs1800588	LIPC	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs1800588:CT
cisplatin, fluorouracil, oxaliplatin	rs25648	VEGFA	CT	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01XA01|L01XA03	rs25648:CT
cisplatin, fluorouracil, oxaliplatin	rs25648	VEGFA	TT	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01XA01|L01XA03	rs25648:TT
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Disease:C0007222		B01AA03	rs2108622:T
atorvastatin	rs2032582	ABCB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs2032582:CC
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A
atorvastatin	rs4149036	SLCO1B1	AC	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs4149036:AC
atorvastatin	rs4149036	SLCO1B1	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs4149036:CC
atorvastatin	rs776746	CYP3A5	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs776746:CC
atorvastatin	rs776746	CYP3A5	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs776746:CT
pertussis vaccines	rs2770150	TLR4	GG	Efficacy	decreased	Efficacy_Response	Healthy		J07AJ	rs2770150:GG
cisplatin, fluorouracil, mitoxantrone	rs6025211	__INTRONIC__	CC	Efficacy	increased	Efficacy_Response	Other:C0023885		L01BC02|L01DB07|L01XA01	rs6025211:CC
cisplatin, fluorouracil, mitoxantrone	rs6025211	__INTRONIC__	TT	Efficacy	increased	Efficacy_Response	Other:C0023885		L01BC02|L01DB07|L01XA01	rs6025211:TT
tacrolimus	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0027726		L04AD02	rs2032582:AA
tacrolimus	rs2032582	ABCB1	TT	Efficacy	increased	Efficacy_Response	Disease:C0027726		L04AD02	rs2032582:TT
lovastatin	rs2291073	SLCO1B1	GT	Efficacy	increased	Efficacy_Response	Healthy		C10AA02	rs2291073:GT
lovastatin	rs2291073	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA02	rs2291073:TT
tacrolimus	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0027726		L04AD02	rs1128503:AA
catecholamines, metformin	rs8187725	SLC22A3	T	Other, Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs8187725:T
lovastatin	rs688	LDLR	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA02	rs688:TT
amlodipine	rs2239050	CACNA1C	GG	Efficacy	increased	Efficacy_Response	Other:C0020538		C08CA01	rs2239050:GG
fluvastatin	rs4986910	CYP3A4	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs4986910:AG
naltrexone	rs698	ADH1C	C	Efficacy	increased	Efficacy_Response	Other:C0085762		N07BB04	rs698:C
naltrexone	rs2066702	ADH1B	A	Efficacy	decreased	Efficacy_Response	Other:C0085762		N07BB04	rs2066702:A
lovastatin	rs5925	LDLR	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA02	rs5925:CC
cisplatin, fluorouracil, mitoxantrone	rs9679162	GALNT14	TT	Efficacy	increased	Efficacy_Response	Other:C0023885		L01BC02|L01DB07|L01XA01	rs9679162:TT
naltrexone	rs671	ALDH2	G	Efficacy	increased	Efficacy_Response	Other:C0085762		N07BB04	rs671:G
varenicline	rs8109525	CYP2B6	AG	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs8109525:AG
varenicline	rs8109525	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs8109525:GG
tacrolimus	rs1128503	ABCB1	AG	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs1128503:AG
warfarin	rs7089580	CYP2C9	T	Dosage	increased	Dosage	Healthy		B01AA03	rs7089580:T
clopidogrel	rs2046934	P2RY12	AA	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs2046934:AA
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:null		L04AD02	rs776746:CC
tacrolimus	rs1045642	ABCB1	AA	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs1045642:AA
warfarin	rs3814637	CYP2C19	C	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs3814637:C
tacrolimus	rs2032582	ABCB1	AA	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2032582:AA
warfarin	rs4917639	CYP2C9	A	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs4917639:A
warfarin	rs2359612	VKORC1	A	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs2359612:A
tacrolimus	rs2257401	CYP3A7	CG	Metabolism/PK	decreased	LADME	Other:null		L04AD02	rs2257401:CG
tacrolimus	rs2257401	CYP3A7	GG	Metabolism/PK	decreased	LADME	Other:null		L04AD02	rs2257401:GG
clopidogrel	rs3732759	P2RY12	GG	Efficacy	decreased	Efficacy_Response	Disease:C0010068		B01AC04	rs3732759:GG
antibiotics, esomeprazole	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0079487		A02BC05|S01AA	rs1045642:AA
carfilzomib, dexamethasone, lenalidomide	rs833061	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs833061:CT
carfilzomib, dexamethasone, lenalidomide	rs833061	VEGFA	TT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs833061:TT
dolutegravir	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AJ03	rs2231142:TT
quetiapine	rs6280	DRD3	TT	Metabolism/PK	increased	LADME	Healthy		N05AH04	rs6280:TT
clopidogrel	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs1128503:AA
clopidogrel	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs1128503:AG
cisplatin, fluorouracil	rs9679162	GALNT14	GG	Efficacy	increased	Efficacy_Response	Other:C0023885		L01BC02|L01XA01	rs9679162:GG
carfilzomib, dexamethasone, lenalidomide	rs2305948	KDR	CT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs2305948:CT
carfilzomib, dexamethasone, lenalidomide	rs2305948	KDR	TT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs2305948:TT
carfilzomib, dexamethasone, lenalidomide	rs1870377	KDR	AT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs1870377:AT
carfilzomib, dexamethasone, lenalidomide	rs1870377	KDR	TT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs1870377:TT
morphine	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0023885|Other:C0030193		N02AA01	rs1799971:AG
morphine	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0023885|Other:C0030193		N02AA01	rs1799971:GG
sorafenib	rs9679162	GALNT14	GG	Efficacy	increased	Efficacy_Response	Other:C0019372|Other:C0023885		L01EX02	rs9679162:GG
mycophenolic acid	rs2273697	ABCC2	A	Metabolism/PK	decreased	LADME	Healthy		L04AA06	rs2273697:A
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Other:Liver_transplantation		L04AD02	rs776746:CC
mycophenolic acid	rs717620	ABCC2	T	Metabolism/PK	Indeterminado	LADME	Other:Kidney_Transplantation		L04AA06	rs717620:T
fentanyl	rs7583431	ATF2	A	Efficacy	increased	Efficacy_Response	Disease:C0030193|Postoperative		N02AB03	rs7583431:A
mycophenolic acid	rs717620	ABCC2	T	Metabolism/PK	Indeterminado	LADME	Other:Kidney_Transplantation		L04AA06	rs717620:T
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
tacrolimus	rs3814055	NR1I2	CT	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs3814055:CT
tacrolimus	rs3814055	NR1I2	TT	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs3814055:TT
aflibercept, ranibizumab	rs2110166	ANO2	TT	Efficacy	increased	Efficacy_Response	Other:C0024437		S01LA04|S01LA05	rs2110166:TT
tacrolimus	rs3814055	NR1I2	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs3814055:CT
tacrolimus	rs3814055	NR1I2	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs3814055:TT
venlafaxine	rs2242446	SLC6A2	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX16	rs2242446:CC
mycophenolic acid	rs2273697	ABCC2	A	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AA06	rs2273697:A
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	C	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|J05AP03|L03AB10|L03AB11	rs12979860:C
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799724	TNF	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs1799724:TT
donepezil, galantamine, rivastigmine	rs6494223	CHRNA7	T	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs6494223:T
adalimumab	rs1801274	FCGR2A	A	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs1801274:A
fluorouracil	rs2612091	ENOSF1	CC	Efficacy	increased	Efficacy_Response	Other:C0026640		L01BC02	rs2612091:CC
simvastatin acid	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CT
dobutamine	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C01CA07	rs1801253:CC
daclatasvir, sofosbuvir	rs7728773	HINT1	CT	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP07|J05AP08	rs7728773:CT
daclatasvir, sofosbuvir	rs7728773	HINT1	TT	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP07|J05AP08	rs7728773:TT
mercaptopurine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:CT
mercaptopurine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:TT
adalimumab, etanercept, infliximab	rs1800795	IL6	G	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs1800795:G
lithium	rs78015114	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs78015114:T
buprenorphine	rs678849	OPRD1	CC	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01	rs678849:CC
carbamazepine, phenobarbital, phenytoin, valproic acid	rs17183814	SCN2A	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		N03AA02|N03AB02|N03AF01|N03AG01	rs17183814:A
quetiapine	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		N05AH04	rs776746:CC
lithium	rs79663003	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs79663003:T
apremilast	rs1203844	CYP3A4, TMEM130	C	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs1203844:C
apremilast	rs35599367	CYP3A4	A	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs35599367:A
atorvastatin	rs9370867	MYLIP	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs9370867:AA
lithium	rs75222709	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs75222709:T
lithium	rs74795342	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs74795342:G
apremilast	rs295943	PDE4D	T	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AA32	rs295943:T
methylphenidate	rs1800544	ADRA2A	CG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:CG
methylphenidate	rs1800544	ADRA2A	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:GG
simvastatin	rs12487736	SCAP	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01	rs12487736:TT
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Other:total_knee_or_hip_arthroplasty		B01AA03	rs1057910:C
caffeine	rs2069514	CYP1A2	AA	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	rs2069514:AA
caffeine	rs2069514	CYP1A2	AG	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	rs2069514:AG
apremilast	rs1063192	CDKN2B, CDKN2B-AS1	G	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs1063192:G
pravastatin	rs1800588	LIPC	CT	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA03	rs1800588:CT
pravastatin	rs1800588	LIPC	TT	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA03	rs1800588:TT
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Other:total_knee_or_hip_arthroplasty		B01AA03	rs1799853:T
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT
losartan	rs5186	AGTR1	AC	Efficacy	increased	Efficacy_Response	Healthy		C09CA01	rs5186:AC
losartan	rs5186	AGTR1	CC	Efficacy	increased	Efficacy_Response	Healthy		C09CA01	rs5186:CC
dextromethadone	rs2307424	NR1I3	GG	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		N07BC02	rs2307424:GG
olanzapine	rs6314	HTR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs6314:GG
simvastatin	rs1128503	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01	rs1128503:GG
azathioprine, mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:CT
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
dextromethadone	rs3003596	NR1I3	GG	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		N07BC02	rs3003596:GG
bevacizumab	rs1061170	CFH	CT	Dosage	increased	Dosage	Disease:C0024437		L01FG01	rs1061170:CT
methadone	rs678849	OPRD1	CC	Efficacy	increased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs678849:CC
azathioprine, mercaptopurine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0021390		L01BB02|L04AX01	rs116855232:CT
bevacizumab	rs10490924	ARMS2	GT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01	rs10490924:GT
bevacizumab	rs10490924	ARMS2	TT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01	rs10490924:TT
pravastatin	rs4149056	SLCO1B1	C	Metabolism/PK	decreased	LADME	Healthy		C10AA03	rs4149056:C
simvastatin	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01	rs2032582:CC
warfarin	rs1800566	NQO1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs1800566:AA
warfarin	rs1800566	NQO1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs1800566:AG
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CT
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CT
deferasirox	rs2273697	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2273697:AG
budesonide	rs2392165	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Other:C0004096		R03BA02	rs2392165:AG
budesonide	rs2392165	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Other:C0004096		R03BA02	rs2392165:GG
thioridazine	rs1080985	CYP2D6	CC	Metabolism/PK	decreased	LADME	Healthy		N05AC02	rs1080985:CC
thioridazine	rs1080985	CYP2D6	CG	Metabolism/PK	decreased	LADME	Healthy		N05AC02	rs1080985:CG
pravastatin	rs2306283	SLCO1B1	G	Metabolism/PK	decreased	LADME	Healthy		C10AA03	rs2306283:G
deferasirox	rs2470890	CYP1A2	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2470890:CC
deferasirox	rs2470890	CYP1A2	CT	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2470890:CT
mercaptopurine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:CT
mercaptopurine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:TT
deferasirox	rs762551	CYP1A2	AC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs762551:AC
deferasirox	rs762551	CYP1A2	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs762551:CC
atorvastatin	rs2273697	ABCC2	AG	Efficacy	decreased	Efficacy_Response	Healthy		C10AA05	rs2273697:AG
olanzapine	rs1076560	DRD2	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs1076560:AA
olanzapine	rs1076560	DRD2	AC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs1076560:AC
deferasirox	rs2606345	CYP1A1	AC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2606345:AC
deferasirox	rs2606345	CYP1A1	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2606345:CC
deferasirox	rs887829	UGT1A1	TT	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs887829:TT
pravastatin	rs2296651	SLC10A1	A	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs2296651:A
adalimumab, etanercept, infliximab	rs1801274	FCGR2A	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01|L04AB02|L04AB04	rs1801274:GG
capecitabine	rs1801133	MTHFR	GG	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC06	rs1801133:GG
daclatasvir, sofosbuvir	rs12979860	IFNL3	CC	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP07|J05AP08	rs12979860:CC
buprenorphine	rs6973474	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs6973474:T
buprenorphine	rs13169373	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs13169373:T
haloperidol	rs3892097	CYP2D6	CC	Efficacy	decreased	Efficacy_Response	Disease:C0033936|Disease:C0085762|Disease:C0221016		N05AD01	rs3892097:CC
nevirapine	rs28399499	CYP2B6	C	Metabolism/PK	increased	LADME	Healthy		J05AG01	rs28399499:C
imatinib	rs628031	SLC22A1	GG	Metabolism/PK	decreased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs628031:GG
nicotine	rs16969968	CHRNA5	A	Dosage	increased	Dosage	Disease:C0039338		N07BA01	rs16969968:A
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT
buprenorphine	rs62368105	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs62368105:G
buprenorphine	rs11782370	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs11782370:T
adalimumab, etanercept, infliximab	rs396991	FCGR3A	AA	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01|L04AB02|L04AB04	rs396991:AA
buprenorphine	rs7205113	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs7205113:T
etanercept	rs1800896	IL10	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800896:CC
buprenorphine	rs756770	ADAMTSL2	A	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs756770:A
dextromethadone	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		N07BC02	rs2032582:AA
etanercept	rs1800471	TGFB1	CG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800471:CG
atorvastatin	rs2306283	SLCO1B1	AG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2306283:AG
atorvastatin	rs2306283	SLCO1B1	GG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2306283:GG
efavirenz, non-nucleoside reverse transcriptase inhibitors	rs3745274	CYP2B6	T	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AG|J05AG03	rs3745274:T
efavirenz	rs2279345	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CC
efavirenz	rs2279345	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CT
efavirenz	rs3745274	CYP2B6	TT	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease|Disease:C0041296		J05AG03	rs3745274:TT
methotrexate	rs4149056	SLCO1B1	TT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs4149056:TT
xk469	rs10931910	AOX1	G	Metabolism/PK	decreased	LADME	Disease:C0027651		No_ATC	rs10931910:G
simvastatin	rs662	PON1	CC	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA01	rs662:CC
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J05AG03	rs3745274:TT
mercaptopurine	rs116855232	NUDT15	T	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:T
etanercept	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800629:GG
mercaptopurine	rs1142345	TPMT	CT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs1142345:CT
nevirapine	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Healthy		J05AG01	rs3745274:T
bucindolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085605		No_ATC	rs1801253:CC
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
tacrolimus	rs4986907	CYP3A4	CT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs4986907:CT
nevirapine	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
phenprocoumon	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA04	rs9923231:CC
warfarin	rs2189784	CYP4F2	AG	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2189784:AG
warfarin	rs2189784	CYP4F2	GG	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2189784:GG
phenprocoumon	rs1051740	EPHX1	CC	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA04	rs1051740:CC
aspirin, diclofenac, ibuprofen, indomethacin, ketorolac, naproxen	rs1800629	TNF	A	Efficacy	decreased	Efficacy_Response	Other:C0338480		M02AA12|M02AA13|S01BC01|S01BC03|S01BC05	rs1800629:A
phenprocoumon	rs1799808	PROC	CC	Dosage, Metabolism/PK	increased	Dosage	Healthy		B01AA04	rs1799808:CC
infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB02	rs1800629:GG
imatinib	rs1050152	SLC22A4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EA01	rs1050152:TT
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs9923231:TT
atorvastatin	rs1800629	TNF	AA	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs1800629:AA
atorvastatin	rs1800629	TNF	AG	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs1800629:AG
imatinib	rs2631367	SLC22A5	CG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs2631367:CG
imatinib	rs2631367	SLC22A5	GG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs2631367:GG
imatinib	rs2631372	SLC22A5	CG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs2631372:CG
imatinib	rs2631372	SLC22A5	GG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs2631372:GG
metformin	rs784888	SP1	G	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs784888:G
etanercept	rs1799724	TNF	CT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1799724:CT
etanercept	rs1799724	TNF	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1799724:TT
warfarin	rs2260863	EPHX1	CG	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2260863:CG
warfarin	rs7412	APOE	CC	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs7412:CC
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
cyclophosphamide	rs2279343	CYP2B6	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L01AA01	rs2279343:AG
cyclophosphamide	rs2279343	CYP2B6	GG	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L01AA01	rs2279343:GG
warfarin	rs28371759	CYP3A4	AA	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs28371759:AA
clopidogrel	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1045642:AA
warfarin	rs2069514	CYP1A2	GG	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2069514:GG
imatinib	rs9561765	ABCC4	AG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs9561765:AG
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC
atorvastatin	rs6280	DRD3	TT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs6280:TT
warfarin	rs1143671	SLC15A2	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs1143671:TT
atorvastatin	rs1801133	MTHFR	AA	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs1801133:AA
atorvastatin	rs1801133	MTHFR	AG	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs1801133:AG
warfarin	rs2260863	EPHX1	CC	Dosage	decreased	Dosage	Other:C0004238		B01AA03	rs2260863:CC
ritonavir	rs1523130	NR1I2	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs1523130:CC
ritonavir	rs1523130	NR1I2	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs1523130:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
l-tryptophan	rs316019	SLC22A2	CC	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs316019:CC
warfarin	rs9923231	VKORC1	AA	Dosage	increased	Dosage	Other:C0004238		B01AA03	rs9923231:AA
phenprocoumon	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA04	rs9934438:A
ritonavir	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs4149056:CC
ritonavir	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs4149056:CT
ritonavir	rs2032582	ABCB1	AC	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AE03	rs2032582:AC
ritonavir	rs2032582	ABCB1	CC	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AE03	rs2032582:CC
erenumab	rs13386048	RAMP1	A	Efficacy	decreased	Efficacy_Response	Other:C0338480|Other:C0338480		N02CD01	rs13386048:A
adalimumab, infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Other:C0038012|Ankylosing		L04AB02|L04AB04	rs1800629:GG
erlotinib	rs2472304	CYP1A2	AA	Metabolism/PK	increased	LADME	Healthy		L01EB02	rs2472304:AA
erlotinib	rs2472304	CYP1A2	AG	Metabolism/PK	increased	LADME	Healthy		L01EB02	rs2472304:AG
sirolimus	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		No_ATC	rs1057868:CT
sirolimus	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		No_ATC	rs1057868:TT
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Other:C0004238		B01AA03	rs1057910:AC
olanzapine	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs6265:CC
ritonavir	rs6785049	NR1I2	AA	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AE03	rs6785049:AA
ritonavir	rs6785049	NR1I2	AG	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AE03	rs6785049:AG
erenumab	rs6431564	RAMP1	G	Efficacy	increased	Efficacy_Response	Other:C0338480|Other:C0338480		N02CD01	rs6431564:G
infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB02	rs1800629:GG
losartan	rs1529909	SLC22A12	CC	Efficacy	decreased	Efficacy_Response	Disease:C0020538|Disease:C0740394		C09CA01	rs1529909:CC
losartan	rs1529909	SLC22A12	CT	Efficacy	decreased	Efficacy_Response	Disease:C0020538|Disease:C0740394		C09CA01	rs1529909:CT
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T
erenumab	rs12465864	RAMP1	G	Efficacy	decreased	Efficacy_Response	Other:C0338480|Other:C0338480		N02CD01	rs12465864:G
adalimumab, etanercept, infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs1800629:GG
losartan	rs3825016	SLC22A12	CT	Efficacy	decreased	Efficacy_Response	Disease:C0020538|Disease:C0740394		C09CA01	rs3825016:CT
losartan	rs3825016	SLC22A12	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020538|Disease:C0740394		C09CA01	rs3825016:TT
ethanol	rs1799971	OPRM1	AG	Metabolism/PK	increased	LADME	Healthy		V03AB16	rs1799971:AG
ethanol	rs1799971	OPRM1	GG	Metabolism/PK	increased	LADME	Healthy		V03AB16	rs1799971:GG
adalimumab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs1800629:GG
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
sirolimus	rs1800896	IL10	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		No_ATC	rs1800896:CC
cyclosporine	rs9282564	ABCB1	CT	Toxicity, Metabolism/PK	increased	LADME	Other:Heart_transplantation		L04AD01	rs9282564:CT
cladribine, cytarabine	rs1042919	RRM1	AT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs1042919:AT
cladribine, cytarabine	rs1265138	RRM2B	AA	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs1265138:AA
fluorouracil	rs1801265	DPYD	AA	Efficacy	increased	Efficacy_Response	Disease:C0023449		L01BC02	rs1801265:AA
cladribine, cytarabine	rs2898950	RRM1	AC	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs2898950:AC
cladribine, cytarabine	rs2898950	RRM1	CC	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs2898950:CC
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB04|L03AB05	rs12979860:CC
bupropion	rs2279343	CYP2B6	AA	Efficacy	increased	Efficacy_Response	Disease:C0039338		N06AX12	rs2279343:AA
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB04|L03AB05	rs8099917:TT
cladribine, cytarabine	rs1561876	RRM1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs1561876:GG
cotinine	rs57064725	PSMA4	A	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs57064725:A
methotrexate	rs16853826	ATIC	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs16853826:GG
methotrexate	rs35592	ABCC1	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AX03	rs35592:TT
cotinine	rs16969968	CHRNA5	A	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs16969968:A
infliximab	rs20575	TNFRSF10A	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB02	rs20575:CC
cladribine, cytarabine	rs1130609	RRM2	GT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs1130609:GT
cladribine, cytarabine	rs1130609	RRM2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs1130609:TT
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs9939609	FTO	AA	Efficacy	decreased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB04|L03AB05	rs9939609:AA
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs9939609	FTO	AT	Efficacy	decreased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB04|L03AB05	rs9939609:AT
cotinine	rs77107237	__INTRONIC__	G	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs77107237:G
clozapine	rs742105	DTNBP1	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs742105:CT
clozapine	rs742105	DTNBP1	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs742105:TT
cladribine, cytarabine	rs5030743	RRM2	CG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs5030743:CG
cladribine, cytarabine	rs5030743	RRM2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs5030743:GG
cotinine	rs10851907	CHRNB4	A	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs10851907:A
sirolimus	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		No_ATC	rs1045642:AA
sirolimus	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		No_ATC	rs1045642:AG
warfarin	rs7311358	SLCO1B3	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs7311358:AA
warfarin	rs1143672	SLC15A2	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs1143672:AA
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB04|L03AB05	rs12979860:CC
warfarin	rs4149117	SLCO1B3	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs4149117:GG
etanercept	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800629:GG
cotinine	rs7170068	CHRNA3	A	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs7170068:A
sunitinib	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs1045642:AA
warfarin	rs2108622	CYP4F2	CC	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA03	rs2108622:CC
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB04|L03AB05	rs8099917:TT
flupenthixol	rs230504	NFKB1	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs230504:CT
flupenthixol	rs230504	NFKB1	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs230504:TT
montelukast	rs12422149	SLCO2B1	AG	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C0004096		R03DC03	rs12422149:AG
deferasirox	rs927650	CYP24A1	CT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs927650:CT
deferasirox	rs927650	CYP24A1	TT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs927650:TT
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T
deferasirox	rs2585428	CYP24A1	CT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2585428:CT
deferasirox	rs2585428	CYP24A1	TT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2585428:TT
flupenthixol	rs3774959	NFKB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs3774959:AG
antidepressants	rs10879346	TPH2	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs10879346:C
methotrexate polyglutamate	rs4731448	IMPDH1	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs4731448:GG
carboplatin, cisplatin	rs3740556	EIF3A	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA01|L01XA02	rs3740556:AA
carboplatin, cisplatin	rs3740556	EIF3A	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA01|L01XA02	rs3740556:AG
methotrexate polyglutamate	rs924607	CEP72	TT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs924607:TT
tacrolimus	rs1800896	IL10	TT	Dosage	decreased	Dosage	Disease:Liver_transplantation		L04AD02	rs1800896:TT
mirtazapine, venlafaxine	rs1487278	TPH2	C	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AX11|N06AX16	rs1487278:C
tacrolimus	rs1045642	ABCB1	GG	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs1045642:GG
bilirubin	rs4124874	UGT1A1	GG	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	rs4124874:GG
bilirubin	rs4124874	UGT1A1	GT	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	rs4124874:GT
carboplatin, cisplatin	rs3740556	EIF3A	AA	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA01|L01XA02	rs3740556:AA
carboplatin, cisplatin	rs3740556	EIF3A	AG	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA01|L01XA02	rs3740556:AG
deferasirox	rs2248359	CYP24A1	CT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2248359:CT
deferasirox	rs2248359	CYP24A1	TT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2248359:TT
flupenthixol	rs230493	NFKB1	AT	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs230493:AT
methotrexate polyglutamate	rs7311358	SLCO1B3	AA	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs7311358:AA
methotrexate polyglutamate	rs7311358	SLCO1B3	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs7311358:AG
nicotine	rs2266780	FMO3	AA	Metabolism/PK	increased	LADME	Healthy		N07BA01	rs2266780:AA
pazopanib	rs699947	VEGFA	A	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs699947:A
methotrexate polyglutamate	rs3749598	FSTL5	AA	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3749598:AA
methotrexate polyglutamate	rs3749598	FSTL5	AC	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3749598:AC
methotrexate polyglutamate	rs2241880	ATG16L1	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs2241880:AG
methotrexate polyglutamate	rs2241880	ATG16L1	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs2241880:GG
fluorouracil	rs3918290	DPYD	CC	Efficacy	increased	Efficacy_Response	Disease:C0023449		L01BC02	rs3918290:CC
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
theophylline	rs2069514	CYP1A2	AA	Other, Metabolism/PK	decreased	LADME	Disease:C0004096		R03DA04	rs2069514:AA
theophylline	rs2069514	CYP1A2	AG	Other, Metabolism/PK	decreased	LADME	Disease:C0004096		R03DA04	rs2069514:AG
infliximab	rs20575	TNFRSF10A	CC	Efficacy	increased	Efficacy_Response	Disease:C0235889|Psoriatic		L04AB02	rs20575:CC
adalimumab, etanercept, infliximab	rs767455	TNFRSF1A	TT	Efficacy	increased	Efficacy_Response	Disease:C0235889|Psoriatic		L04AB01|L04AB02|L04AB04	rs767455:TT
pazopanib	rs2010963	VEGFA	G	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs2010963:G
adalimumab, etanercept, infliximab	rs20575	TNFRSF10A	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs20575:CC
adalimumab, etanercept, infliximab	rs767455	TNFRSF1A	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs767455:TT
pazopanib	rs833061	VEGFA	T	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs833061:T
etanercept	rs2431697	PTTG1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs2431697:CC
etanercept	rs2431697	PTTG1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs2431697:CT
cisplatin, gemcitabine	rs4492666	CMPK1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs4492666:CC
bupropion, nicotine, varenicline	rs503464	CHRNA5	A	Efficacy	increased	Efficacy_Response	Disease:C0039338		N06AX12|N07BA01|N07BA03	rs503464:A
voriconazole	rs6785049	NR1I2	GG	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs6785049:GG
etanercept	rs13437088	HLA-B	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs13437088:TT
etanercept	rs96844	MAP3K1	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB01	rs96844:AG
etanercept	rs96844	MAP3K1	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB01	rs96844:GG
clozapine	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs4680:GG
clozapine	rs6295	HTR1A	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs6295:GG
etanercept	rs928655	GBP6	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB01	rs928655:AG
etanercept	rs928655	GBP6	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB01	rs928655:GG
celiprolol	rs1045642	ABCB1	G	Metabolism/PK	decreased	LADME	Healthy		C07AB08	rs1045642:G
atorvastatin	rs4149056	SLCO1B1	TT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA05	rs4149056:TT
celiprolol	rs11568563	SLCO1A2	G	Metabolism/PK	decreased	LADME	Healthy		C07AB08	rs11568563:G
etanercept	rs2546890	IL12B	AG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs2546890:AG
etanercept	rs2546890	IL12B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs2546890:GG
temozolomide	rs1128503	ABCB1	AA	Metabolism/PK	decreased	LADME	Other:C0017638		L01AX03	rs1128503:AA
temozolomide	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Other:C0017638		L01AX03	rs1128503:AG
ivacaftor	rs7512462	SLC26A9	CC	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs7512462:CC
ivacaftor	rs7512462	SLC26A9	CT	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs7512462:CT
gemcitabine	rs66878317	DCK	AG	Metabolism/PK	increased	LADME	Healthy		L01BC05	rs66878317:AG
gemcitabine	rs66878317	DCK	GG	Metabolism/PK	increased	LADME	Healthy		L01BC05	rs66878317:GG
voriconazole	rs3814057	NR1I2	CC	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs3814057:CC
nicotine	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C0039338		N07BA01	rs4680:GG
milnacipran	rs1800544	ADRA2A	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX17	rs1800544:CC
milnacipran	rs1800544	ADRA2A	CG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX17	rs1800544:CG
platinum compounds	rs4244809	IGF2, IGF2-AS, INS-IGF2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01XA	rs4244809:GG
voriconazole	rs2266780	FMO3	AA	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs2266780:AA
hmg coa reductase inhibitors	rs2306283	SLCO1B1	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA	rs2306283:GG
fluvoxamine	rs1449683	FGF2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB08	rs1449683:CC
fluvoxamine	rs1449683	FGF2	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB08	rs1449683:CT
voriconazole	rs10954732	POR	GG	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs10954732:GG
platinum compounds	rs3842761	INS-IGF2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01XA	rs3842761:GG
milnacipran	rs6295	HTR1A	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX17	rs6295:CC
milnacipran	rs6295	HTR1A	CG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX17	rs6295:CG
valproic acid	rs17183814	SCN2A	AA	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs17183814:AA
valproic acid	rs17183814	SCN2A	AG	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs17183814:AG
valproic acid	rs2298771	SCN1A	TT	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs2298771:TT
voriconazole	rs2461817	NR1I2	AA	Metabolism/PK	decreased	LADME	Healthy		J02AC03	rs2461817:AA
voriconazole	rs3732359	NR1I2	GG	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs3732359:GG
methotrexate	rs3740066	ABCC2	TT	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs3740066:TT
cisplatin, gemcitabine	rs720106	RRM1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs720106:TT
voriconazole	rs7643645	NR1I2	AA	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs7643645:AA
simvastatin	rs2306283	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs2306283:AA
cisplatin, gemcitabine	rs232043	RRM1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs232043:AA
cisplatin, gemcitabine	rs11211524	CMPK1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs11211524:CC
simvastatin	rs2306283	SLCO1B1	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs2306283:GG
cisplatin, gemcitabine	rs2284449	RRM1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs2284449:TT
acenocoumarol	rs11676382	GGCX	G	Dosage	decreased	Dosage	Healthy		B01AA07	rs11676382:G
acenocoumarol	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:T
acenocoumarol	rs7294	VKORC1	T	Dosage	increased	Dosage	Healthy		B01AA07	rs7294:T
methotrexate	rs6785049	NR1I2	G	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs6785049:G
rituximab	rs1800470	TGFB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs1800470:AG
rituximab	rs1800471	TGFB1	CG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs1800471:CG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	A	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12980275:A
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:T
simvastatin	rs35599367	CYP3A4	A	Efficacy	increased	Efficacy_Response	Other:C0020443		C10AA01	rs35599367:A
pioglitazone	rs2241766	ADIPOQ	GT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG03	rs2241766:GT
morphine	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1799971:GG
morphine	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1799971:GG
acenocoumarol	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:T
rosuvastatin	rs776746	CYP3A5	C	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA07	rs776746:C
methotrexate	rs3732361	GSK3B	A	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs3732361:A
naloxone	rs1799971	OPRM1	AG	Other	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:AG
naloxone	rs1799971	OPRM1	GG	Other	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:GG
tipifarnib	rs1128503	ABCB1	AA	Other, Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs1128503:AA
etanercept	rs9304742	ZNF816	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs9304742:CC
rosuvastatin	rs2231142	ABCG2	T	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA07	rs2231142:T
naltrexone	rs1799971	OPRM1	G	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1799971:G
antipsychotics	rs13250975	NRG1	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs13250975:G
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Disease:C0271093		B01AA03	rs9934438:AA
methotrexate	rs4149009	SLCO1A2	CC	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs4149009:CC
methotrexate	rs4149009	SLCO1A2	CT	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs4149009:CT
antipsychotics	rs2513265	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs2513265:A
antipsychotics	rs1544938	ADCY2	C	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs1544938:C
antipsychotics	rs17716295	NRG1	A	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs17716295:A
nicotine	rs16969968	CHRNA5	GG	Other	decreased	Dosage	Disease:C0039338		N07BA01	rs16969968:GG
methadone	rs55944529	DAO	TT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs55944529:TT
antipsychotics	rs4795893	CCL2	G	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs4795893:G
antipsychotics	rs4586	CCL2	T	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs4586:T
methadone	rs55944529	DAO	TT	Metabolism/PK	increased	LADME	Other:C0028043		N07BC02	rs55944529:TT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
escitalopram, fluoxetine, fluvoxamine, sertraline	rs3803189	HTR2A	GG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03|N06AB06|N06AB08|N06AB10	rs3803189:GG
escitalopram, fluoxetine, fluvoxamine, sertraline	rs3803189	HTR2A	GT	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03|N06AB06|N06AB08|N06AB10	rs3803189:GT
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease|Other:C0024530		J05AG03	rs3745274:T
ivacaftor	rs121908755	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs121908755:A
methadone	rs5326	DRD1	TT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs5326:TT
ivacaftor	rs121908757	CFTR	C	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs121908757:C
ivacaftor	rs80282562	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs80282562:A
rifampicin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:C0041296		J04AB02	rs4149056:CT
methylphenidate	rs1065852	CYP2D6	GG	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA04	rs1065852:GG
hmg coa reductase inhibitors	rs11045819	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs11045819:CC
methylphenidate	rs1135840	CYP2D6	CG	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA04	rs1135840:CG
ivacaftor	rs121909041	CFTR	C	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs121909041:C
pravastatin	rs2306283	SLCO1B1	GG	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs2306283:GG
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs1057910:AA
ivacaftor	rs193922525	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs193922525:A
warfarin	rs7196161	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs7196161:AA
warfarin	rs7196161	VKORC1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs7196161:AG
ivacaftor	rs267606723	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs267606723:A
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
ivacaftor	rs74503330	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs74503330:A
ivacaftor	rs121909005	CFTR	G	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs121909005:G
ivacaftor	rs121909013	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs121909013:A
sunitinib	rs6923761	GLP1R	A	Metabolism/PK	decreased	LADME	Other:C0007134|Other:C0238198		L01EX01	rs6923761:A
doxorubicin	rs1128503	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs1128503:AA
atomoxetine	rs1135840	CYP2D6	CC	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA09	rs1135840:CC
beta blocking agents	rs3740563	GRK5	A	Efficacy	decreased	Efficacy_Response	Other:C1956346		S01ED	rs3740563:A
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2069705	IFNG	G	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2069705:G
montelukast	rs6475448	MLLT3	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03DC03	rs6475448:AA
beta blocking agents	rs10787959	GRK5	A	Efficacy	decreased	Efficacy_Response	Other:C1956346		S01ED	rs10787959:A
bupropion	rs1908557	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AX12	rs1908557:C
beta blocking agents	rs11198893	GRK5	A	Efficacy	decreased	Efficacy_Response	Other:C1956346		S01ED	rs11198893:A
rifampicin	rs4646536	CYP27B1	AG	Metabolism/PK	increased	LADME	Disease:C0041296		J04AB02	rs4646536:AG
rifampicin	rs4646536	CYP27B1	GG	Metabolism/PK	increased	LADME	Disease:C0041296		J04AB02	rs4646536:GG
corticosteroids	rs138335	ST13	G	Efficacy	decreased	Efficacy_Response	Disease:C0004096		S02BA	rs138335:G
rifampicin	rs1544410	VDR	TT	Metabolism/PK	increased	LADME	Disease:C0041296		J04AB02	rs1544410:TT
docetaxel	rs2740574	CYP3A4	C	Metabolism/PK	increased	LADME	Disease:C0027651		L01CD02	rs2740574:C
methadone	rs3745274	CYP2B6	GG	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs3745274:GG
methadone	rs3745274	CYP2B6	GT	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs3745274:GT
docetaxel	rs776746	CYP3A5	T	Metabolism/PK	increased	LADME	Disease:C0027651		L01CD02	rs776746:T
hmg coa reductase inhibitors	rs4149056	SLCO1B1	C	Efficacy	decreased	Efficacy_Response	Disease:C0007222		C10AA	rs4149056:C
ramipril	rs2053044	ADRB2	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs2053044:AA
ramipril	rs2053044	ADRB2	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs2053044:AG
opioids	rs4680	COMT	GG	Dosage	increased	Dosage	"""Other:C1458155|""Other:C0030193|Postoperative"""		N02A	rs4680:GG
methadone	rs2239622	NGF	AA	Dosage	decreased	Dosage	Disease:Opioid-Related_Disorders		N07BC02	rs2239622:AA
nicotine	rs35694136	CYP1A2	T/del	Efficacy	increased	LADME	Other:C0877645		N07BA01	rs35694136:T/del
nicotine	rs35694136	CYP1A2	del/del	Efficacy	increased	LADME	Other:C0877645		N07BA01	rs35694136:del/del
methadone	rs2279343	CYP2B6	AA	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs2279343:AA
methadone	rs2279343	CYP2B6	AG	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs2279343:AG
gemcitabine	rs3750117	NT5C3A	AA	Other, Metabolism/PK	increased	LADME	Disease:C0027651		L01BC05	rs3750117:AA
gemcitabine	rs11598702	NT5C2	TT	Other, Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC05	rs11598702:TT
fentanyl, remifentanil	rs199670311	PGAP6	T	Efficacy	increased	Dosage	Disease:C0030193		N01AH06|N02AB03	rs199670311:T
olanzapine	rs2011425	UGT1A4	GT	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AH03	rs2011425:GT
antidepressants	rs2230739	ADCY9	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06A	rs2230739:CC
dabigatran	rs2244613	CES1	GG	Metabolism/PK	decreased	LADME	Other:C0018839		B01AE07	rs2244613:GG
dabigatran	rs2244613	CES1	GT	Metabolism/PK	decreased	LADME	Other:C0018839		B01AE07	rs2244613:GT
antipsychotics	rs165854	PI4KA	AG	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs165854:AG
antipsychotics	rs165854	PI4KA	GG	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs165854:GG
antipsychotics	rs1468412	GRM3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1468412:AA
antipsychotics	rs1468412	GRM3	AT	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1468412:AT
budesonide, corticosteroids, fluticasone / salmeterol, fluticasone propionate	rs3752120	ZNF432	TT	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03AC12|R03BA02|R03BA05|S02BA	rs3752120:TT
azathioprine	rs1127354	ITPA	AA	Efficacy	increased	Efficacy_Response	Disease:C0024141		L04AX01	rs1127354:AA
azathioprine	rs1127354	ITPA	AC	Efficacy	increased	Efficacy_Response	Disease:C0024141		L04AX01	rs1127354:AC
carboplatin, docetaxel, trastuzumab	rs1136201	ERBB2	G	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02|L01XA02	rs1136201:G
antipsychotics	rs1529461	SLC1A3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1529461:AA
antipsychotics	rs1529461	SLC1A3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1529461:AG
antipsychotics	rs2299214	GRM3	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs2299214:CC
carboplatin, docetaxel, trastuzumab	rs2284922	RNF8	A	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02|L01XA02	rs2284922:A
antipsychotics	rs6465084	GRM3	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs6465084:AG
antipsychotics	rs6465084	GRM3	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs6465084:GG
carboplatin, docetaxel, trastuzumab	rs2070096	BARD1	A	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02|L01XA02	rs2070096:A
gemcitabine	rs1048977	CDA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs1048977:CC
carboplatin, docetaxel, trastuzumab	rs2229046	ERBB3	C	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02|L01XA02	rs2229046:C
corticosteroids	rs138337	ST13	G	Efficacy	decreased	Efficacy_Response	Disease:C0004096		S02BA	rs138337:G
carboplatin, docetaxel, trastuzumab	rs773123	ERBB3	A	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02|L01XA02	rs773123:A
antipsychotics	rs10211524	SLC1A4	AA	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs10211524:AA
risperidone	rs2299214	GRM3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs2299214:CC
risperidone	rs2299214	GRM3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs2299214:CT
pravastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs4149056:CC
pravastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs4149056:CT
sufentanil	rs4680	COMT	AA	Dosage, Efficacy	decreased	Dosage	Healthy		N01AH03	rs4680:AA
fluindione	rs9923231	VKORC1	TT	Metabolism/PK	Indeterminado	Dosage	Healthy		No_ATC	rs9923231:TT
apremilast	rs1045895	LEPR, LEPROT	AA	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AA32	rs1045895:AA
apremilast	rs1045895	LEPR, LEPROT	AG	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AA32	rs1045895:AG
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC
opioids	rs1045642	ABCB1	AA	Dosage, Efficacy	decreased	Dosage	Disease:C0027651|Disease:C0030193		N02A	rs1045642:AA
carboplatin, cisplatin	rs2494752	AKT1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA01|L01XA02	rs2494752:AG
quinapril	rs699	AGT	GG	Efficacy	increased	Efficacy_Response	Disease:C1956346		C09AA06	rs699:GG
opioids	rs6517442	KCNJ6	CC	Dosage	increased	Dosage	Other:C0024031		N02A	rs6517442:CC
olanzapine	rs35694136	CYP1A2	T/del	Metabolism/PK	increased	LADME	Disease:C0036341		N05AH03	rs35694136:T/del
opioids	rs1799971	OPRM1	AG	Dosage, Efficacy	increased	Dosage	Disease:C0027651|Disease:C0030193		N02A	rs1799971:AG
opioids	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0027651|Disease:C0030193		N02A	rs1799971:GG
olanzapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AH03	rs762551:AA
fentanyl	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs1799971:GG
rosuvastatin	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:GT
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:TT
phenprocoumon	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA04	rs2108622:TT
capecitabine, fluorouracil, tegafur	rs183205964	TYMS	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs183205964:C
ketoprofen	rs1057910	CYP2C9	AC	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		M02AA10	rs1057910:AC
atorvastatin	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C10AA05	rs1045642:GG
imatinib	rs683369	SLC22A1	CC	Metabolism/PK	increased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CC
caffeine	rs762551	CYP1A2	AA	Other, Metabolism/PK	increased	LADME	Healthy		N06BC01	rs762551:AA
imatinib	rs683369	SLC22A1	CC	Metabolism/PK	decreased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CC
etanercept	rs1061622	TNFRSF1B	GT	Efficacy	decreased	Efficacy_Response	Disease:C0038012|Ankylosing		L04AB01	rs1061622:GT
fentanyl, remifentanil	rs4839603	SLC9A9	GG	Efficacy	decreased	Dosage	Disease:C0030193		N01AH06|N02AB03	rs4839603:GG
efavirenz	rs3745274	CYP2B6	T	Efficacy	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
apremilast	rs12745871	PDE4B	T	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs12745871:T
atorvastatin	rs5888	SCARB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs5888:AA
apremilast	rs322144	TSPAN16	C	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AA32	rs322144:C
pravastatin	rs11666735	FCAR	AA	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03	rs11666735:AA
pravastatin	rs11666735	FCAR	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03	rs11666735:AG
cyclophosphamide, epirubicin	rs1695	GSTP1	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB03	rs1695:AA
cyclophosphamide, epirubicin	rs1695	GSTP1	AG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB03	rs1695:AG
fenofibrate	rs964184	APOA1	G	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs964184:G
antiepileptics	rs10188577	SCN1A	CT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs10188577:CT
apremilast	rs12979813	DOCK6	G	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs12979813:G
daptomycin	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J01XX09	rs1045642:AA
naltrexone	rs1611115	DBH	CT	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1611115:CT
naltrexone	rs1611115	DBH	TT	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1611115:TT
gemcitabine	rs11854484	SLC28A2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05	rs11854484:CC
antineoplastic agents	rs2231142	ABCG2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01	rs2231142:GG
gemcitabine	rs1060896	SLC28A2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05	rs1060896:CC
apremilast	rs2305795	EIF3G, P2RY11, PPAN-P2RY11	G	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs2305795:G
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs767455	TNFRSF1A	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs767455:TT
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT
methotrexate	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs4149056:CC
methotrexate	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs4149056:CT
drugs for treatment of tuberculosis	rs1139130	METTL3	GG	Efficacy	increased	Efficacy_Response	Other:C0041296		J04A	rs1139130:GG
methotrexate	rs11045879	SLCO1B1	CC	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs11045879:CC
methotrexate	rs11045879	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs11045879:CT
sufentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	rs1799971:AG
apremilast	rs76966440	ILF3	T	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs76966440:T
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
cyclophosphamide, epirubicin, fluorouracil	rs1695	GSTP1	A	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs1695:A
sulfasalazine	rs2231142	ABCG2	GT	Efficacy	increased	Efficacy_Response	Disease:C0003873		A07EC01	rs2231142:GT
sulfasalazine	rs2231142	ABCG2	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		A07EC01	rs2231142:TT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:T
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC
warfarin	rs9923231	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CT
tacrolimus	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0009324		L04AD02	rs1128503:AG
tacrolimus	rs1128503	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0009324		L04AD02	rs1128503:GG
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
rosuvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs4149056:CC
rosuvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs4149056:CT
peginterferon alfa-2b	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB10	rs8099917:TT
warfarin	rs9934438	PRSS53, VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	PRSS53, VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	T	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:T
peginterferon alfa-2b, ribavirin	rs2228570	VDR	A	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs2228570:A
nortriptyline	rs1799983	NOS3	TT	Efficacy	increased	Efficacy_Response	Other:C0338480|Other:C0338480		N06AA10	rs1799983:TT
allopurinol	rs1934341	GREM2	T	Efficacy	increased	Efficacy_Response	Healthy		M04AA01	rs1934341:T
cotinine	rs13253389	NAT1	AG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs13253389:AG
cotinine	rs13253389	NAT1	GG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs13253389:GG
allopurinol	rs77567654	GREM2	G	Efficacy	increased	Efficacy_Response	Healthy		M04AA01	rs77567654:G
tacrolimus	rs2032582	ABCB1	CC	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2032582:CC
allopurinol	rs45499402	ABCG2	C	Efficacy	decreased	Efficacy_Response	Healthy		M04AA01	rs45499402:C
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
allopurinol	rs2231142	ABCG2	T	Efficacy	decreased	Efficacy_Response	Healthy		M04AA01	rs2231142:T
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
exenatide	rs10305420	GLP1R	T	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BJ01	rs10305420:T
topiramate	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Other:C0338480|Other:C0338480		N03AX11	rs1045642:AA
lamotrigine	rs7668258	UGT2B7	TT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AX09	rs7668258:TT
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT
benazepril	rs4762	AGT	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C09AA07	rs4762:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10|L03AB11	rs12979860:CC
imatinib	rs1128503	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1128503:GG
lamotrigine	rs28365063	UGT2B7	GG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs28365063:GG
3,4-methylenedioxymethamphetamine	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		V04CX05	rs3745274:TT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
methotrexate	rs7317112	ABCC4	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs7317112:GG
benazepril	rs2640543	AGTR1	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C09AA07	rs2640543:GG
alendronate	rs10161126	MVK	GG	Efficacy	increased	Efficacy_Response	Disease:C0006079		No_ATC	rs10161126:GG
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	A	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs1127354:A
sarilumab	rs11265618	IL6R	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC14	rs11265618:CC
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs14158	LDLR	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10|L03AB11	rs14158:GG
benazepril	rs2106089	SPTA1	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C09AA07	rs2106089:G
imatinib	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:GG
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
sarilumab	rs4329505	IL6R	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC14	rs4329505:TT
losartan	rs1934969	CYP2C9	AT	Metabolism/PK	decreased	LADME	Healthy		C09CA01	rs1934969:AT
losartan	rs1934969	CYP2C9	TT	Metabolism/PK	decreased	LADME	Healthy		C09CA01	rs1934969:TT
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
imatinib	rs2032582	ABCB1	C	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2032582:C
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
buprenorphine	rs678849	OPRD1	CC	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01	rs678849:CC
phenprocoumon	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:CT
phenprocoumon	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:TT
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1052248	NCR3	AT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs1052248:AT
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1052248	NCR3	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs1052248:TT
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
salbutamol	rs3809324	COL2A1	GT	PD	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs3809324:GT
salbutamol	rs3809324	COL2A1	TT	PD	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs3809324:TT
antipsychotics	rs2238087	CACNA1C	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs2238087:CC
"""diuretics"", ""hydrochlorothiazide"", ""thiazides, plain"""	rs4791040	PRKCA	T	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03|C03AA03	rs4791040:T
antipsychotics	rs2229949	CACNA1B	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs2229949:CC
acenocoumarol	rs10871454	STX4	T	Dosage	decreased	Dosage	Healthy		B01AA07	rs10871454:T
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
warfarin	rs12777823	__INTRONIC__	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AA
warfarin	rs12777823	__INTRONIC__	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AG
corticosteroids	rs37973	GLCCI1	GG	Efficacy	decreased	Efficacy_Response	Other:C0035455		S02BA	rs37973:GG
deferasirox	rs7041	GC	AA	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs7041:AA
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT
acenocoumarol	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA07	rs9934438:AA
acenocoumarol	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA07	rs9934438:AG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:GT
aspirin, clopidogrel	rs2108622	CYP4F2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs2108622:CC
aspirin, clopidogrel	rs2108622	CYP4F2	CT	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs2108622:CT
acenocoumarol	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:T
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs9934438:AG
methylphenidate	rs71647871	CES1	T	Metabolism/PK	decreased	LADME	Healthy		N06BA04	rs71647871:T
warfarin	rs7294	VKORC1	CT	Dosage	increased	Dosage	Disease:C0007222		B01AA03	rs7294:CT
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Disease:C0007222		B01AA03	rs7294:TT
interferon beta-1a, interferon beta-1b	rs12044852	CD58	CC	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs12044852:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs610604	TNFAIP3	GG	Efficacy	increased	Efficacy_Response	"""Other:C0235889|Psoriatic""|""Other:C0235763"		No_ATC	rs610604:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs610604	TNFAIP3	GT	Efficacy	increased	Efficacy_Response	"""Other:C0235889|Psoriatic""|""Other:C0235763"		No_ATC	rs610604:GT
morphine	rs1799971	OPRM1	AG	Efficacy	decreased	Efficacy_Response	Healthy		N02AA01	rs1799971:AG
morphine	rs1799971	OPRM1	GG	Efficacy	decreased	Efficacy_Response	Healthy		N02AA01	rs1799971:GG
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs9923231:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6920220	TNFAIP3	AA	Efficacy	decreased	Efficacy_Response	"""Other:C0235889|Psoriatic""|""Other:C0235763"		No_ATC	rs6920220:AA
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs2108622:CC
warfarin	rs2108622	CYP4F2	CT	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs2108622:CT
antipsychotics	rs12245847	CACNB2	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs12245847:TT
tacrolimus	rs2257401	CYP3A7	C	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs2257401:C
deferasirox	rs887829	UGT1A1	CC	Efficacy	decreased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs887829:CC
antipsychotics	rs1859204	CACNG3	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs1859204:TT
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs776746:C
deferasirox	rs1983023	UGT1A3	TT	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs1983023:TT
deferasirox	rs10877012	CYP27B1	GG	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs10877012:GG
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
tacrolimus	rs4646437	CYP3A4	A	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs4646437:A
adalimumab	rs10210302	ATG16L1	CT	Efficacy	increased	Efficacy_Response	Disease:C0010346		L04AB04	rs10210302:CT
adalimumab	rs10210302	ATG16L1	TT	Efficacy	increased	Efficacy_Response	Disease:C0010346		L04AB04	rs10210302:TT
antipsychotics	rs982003	CACNB2	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs982003:CC
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
tacrolimus	rs2242480	CYP3A4	T	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs2242480:T
deferasirox	rs731236	VDR	GG	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs731236:GG
deferasirox	rs1544410	VDR	TT	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs1544410:TT
tacrolimus	rs41303343	CYP3A5	A	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs41303343:A
capecitabine, fluorouracil, irinotecan, leucovorin	rs1051266	SLC19A1	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01CE02	rs1051266:CC
capecitabine, fluorouracil, irinotecan, leucovorin	rs2306283	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01CE02	rs2306283:AA
capecitabine, fluorouracil, irinotecan, leucovorin	rs2306283	SLCO1B1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01CE02	rs2306283:AG
tacrolimus	rs4646450	CYP3A5	A	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs4646450:A
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
simvastatin acid	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CC
simvastatin acid	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CT
"""diuretics"", ""hydrochlorothiazide"", ""thiazides, plain"""	rs2776546	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03|C03AA03	rs2776546:A
warfarin	rs28371686	CYP2C9	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs28371686:CG
antipsychotics	rs10741058	CACNB2	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs10741058:TT
atazanavir	rs887829	UGT1A1	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	rs887829:TT
"""diuretics"", ""hydrochlorothiazide"", ""thiazides, plain"""	rs238	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03|C03AA03	rs238:A
antipsychotics	rs4505744	CACNA2D3	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs4505744:AA
"""diuretics"", ""hydrochlorothiazide"", ""thiazides, plain"""	rs4815273	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03|C03AA03	rs4815273:T
antipsychotics	rs12060765	CACNA1E	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs12060765:TT
corticosteroids	rs7772821	TAAR6	GG	Efficacy	increased	Efficacy_Response	Disease:C0004096		S02BA	rs7772821:GG
salbutamol	rs3025039	VEGFA	CT	PD	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs3025039:CT
salbutamol	rs3025039	VEGFA	TT	PD	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs3025039:TT
bevacizumab, ranibizumab	rs1061170	CFH	CC	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01|S01LA04	rs1061170:CC
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T
morphine	rs795484	TAOK3	TT	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs795484:TT
prednisone	rs6196	NR3C1	G	Efficacy	decreased	Efficacy_Response	Disease:C0027726		H02AB07	rs6196:G
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT
sn-38(irinotecan)	rs4148323	UGT1A1	AA	Metabolism/PK	decreased	LADME	Disease:C0007131		L01CE02	rs4148323:AA
docetaxel	rs4842198	__INTRONIC__	G	Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs4842198:G
fluvoxamine	rs6311	HTR2A	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB08	rs6311:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3794271	SLCO1C1	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs3794271:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3794271	SLCO1C1	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs3794271:GG
acenocoumarol	rs9934438	VKORC1	AA	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA07	rs9934438:AA
acenocoumarol	rs9934438	VKORC1	AG	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA07	rs9934438:AG
prednisone	rs258751	NR3C1	A	Efficacy	decreased	Efficacy_Response	Disease:C0027726		H02AB07	rs258751:A
ledipasvir, sofosbuvir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP08|J05AP51	rs12979860:CC
sn-38(irinotecan)	rs3832043	UGT1A9	del/del	Metabolism/PK	decreased	LADME	Disease:C0007131		L01CE02	rs3832043:del/del
phenytoin	rs28371686	CYP2C9	G	Other, Metabolism/PK	decreased	LADME	Other:C0024198		N03AB02	rs28371686:G
imatinib	rs2231137	ABCG2	CT	Dosage	decreased	Dosage	Other:C0238198		L01EA01	rs2231137:CT
imatinib	rs2231137	ABCG2	TT	Dosage	decreased	Dosage	Other:C0238198		L01EA01	rs2231137:TT
prednisone	rs10052957	NR3C1	A	Efficacy	decreased	Efficacy_Response	Disease:C0027726		H02AB07	rs10052957:A
imatinib	rs762551	CYP1A2	CC	Dosage	decreased	Dosage	Other:C0238198		L01EA01	rs762551:CC
phenytoin	rs7900194	CYP2C9	A	Other, Metabolism/PK	decreased	LADME	Other:C0024198		N03AB02	rs7900194:A
lurasidone	rs6295	HTR1A	CG	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AE05	rs6295:CG
lurasidone	rs6295	HTR1A	GG	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AE05	rs6295:GG
phenytoin	rs28371685	CYP2C9	T	Other, Metabolism/PK	increased	LADME	PK:C0024198		N03AB02	rs28371685:T
phenytoin	rs9332131	CYP2C9	del	Other, Metabolism/PK	decreased	LADME	PK:C0024198		N03AB02	rs9332131:del
docetaxel	rs3132291	RXRA	A	Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs3132291:A
infliximab	rs1061622	TNFRSF1B	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB02	rs1061622:G
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
metformin	rs12208357	SLC22A1	TT	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs12208357:TT
codeine	rs1799971	OPRM1	AA	Dosage	decreased	Dosage	Healthy		R05DA04	rs1799971:AA
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
codeine	rs7439366	UGT2B7	TT	Dosage	decreased	Dosage	Healthy		R05DA04	rs7439366:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
peginterferon alfa-2b	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB10	rs8099917:TT
antipsychotics	rs4237348	CACNB2	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs4237348:CC
tacrolimus	rs2740574	CYP3A4	T	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs2740574:T
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
antipsychotics	rs3768652	CACNB4	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs3768652:AA
antipsychotics	rs3768652	CACNB4	AC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs3768652:AC
tacrolimus	rs35599367	CYP3A4	A	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs35599367:A
antipsychotics	rs7427395	CACNA2D3	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs7427395:CC
antipsychotics	rs1277733	CACNB2	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs1277733:TT
sofosbuvir	rs4513095	CES1	A	Efficacy	decreased	Efficacy_Response	Other:C0019372		J05AP08	rs4513095:A
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
propofol	rs6746030	SCN9A	AA	Other	increased	Efficacy_Response	Healthy		N01AX10	rs6746030:AA
propofol	rs6746030	SCN9A	AG	Other	increased	Efficacy_Response	Healthy		N01AX10	rs6746030:AG
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:C0277631		L04AD02	rs776746:CC
salbutamol	rs7081864	PRKG1	A	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs7081864:A
tacrolimus	rs776746	CYP3A5	C	Dosage	decreased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:C
tocilizumab	rs12083537	IL6R	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs12083537:AA
antipsychotics	rs11030104	BDNF	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs11030104:AG
antipsychotics	rs11030104	BDNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs11030104:GG
sunitinib	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:C0007134		L01EX01	rs1045642:GG
propofol	rs6313	HTR2A	AA	Dosage	decreased	Dosage	Healthy		N01AX10	rs6313:AA
antipsychotics	rs10501087	BDNF-AS	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs10501087:CC
antipsychotics	rs10501087	BDNF-AS	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs10501087:CT
propofol	rs2279020	GABRA1	GG	Other	increased	Efficacy_Response	Healthy		N01AX10	rs2279020:GG
sunitinib	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs1045642:GG
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
opioids	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Healthy		N02A	rs4680:AA
opioids	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Healthy		N02A	rs4680:AG
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
doxorubicin, methotrexate, prednisolone, vincristine	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L01CA02|L01DB01|L04AX03|S02BA03	rs1045642:AA
antipsychotics	rs6265	BDNF	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs6265:CT
antipsychotics	rs6265	BDNF	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs6265:TT
opioids	rs4680	COMT	AG	Dosage	decreased	Dosage	Healthy		N02A	rs4680:AG
"""metformin"", ""sulfonamides, urea derivatives"""	rs5219	ABCC8, KCNJ11	CT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02|S01AB	rs5219:CT
"""metformin"", ""sulfonamides, urea derivatives"""	rs5219	ABCC8, KCNJ11	TT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02|S01AB	rs5219:TT
paliperidone, risperidone	rs28379954	NFIB	CT	Metabolism/PK	increased	LADME	Healthy		N05AX08|N05AX13	rs28379954:CT
remifentanil, sevoflurane	rs1128503	ABCB1	GG	Efficacy	increased	Efficacy_Response	Other:tonsillectomy		N01AB08|N01AH06	rs1128503:GG
morphine	rs1277441	TAOK3	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1277441:GG
doxorubicin, methotrexate, prednisolone, vincristine	rs2229109	ABCB1	CT	Efficacy	increased	Efficacy_Response	Disease:C0023449		L01CA02|L01DB01|L04AX03|S02BA03	rs2229109:CT
hydroxyurea	rs2236599	KLF4	C	Efficacy	increased	Efficacy_Response	Other:C0002895|Other:Beta-thalassemia_and_related_diseases		No_ATC	rs2236599:C
oxycodone	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AA05	rs1799971:GG
tacrolimus	rs2242480	CYP3A4	CT	Metabolism/PK	increased	LADME	Other:Heart_transplantation		L04AD02	rs2242480:CT
tacrolimus	rs2242480	CYP3A4	TT	Metabolism/PK	increased	LADME	Other:Heart_transplantation		L04AD02	rs2242480:TT
methotrexate	rs11045821	SLCO1B1	A	Efficacy, Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs11045821:A
methylphenidate	rs28386840	SLC6A2	AT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs28386840:AT
methylphenidate	rs28386840	SLC6A2	TT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs28386840:TT
bilirubin	rs11563250	UGT1A	AG	Metabolism/PK	decreased	LADME	Disease:C0023055		No_ATC	rs11563250:AG
bilirubin	rs11563250	UGT1A	GG	Metabolism/PK	decreased	LADME	Disease:C0023055		No_ATC	rs11563250:GG
deferasirox	rs1983023	UGT1A3	CT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs1983023:CT
deferasirox	rs1983023	UGT1A3	TT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs1983023:TT
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs13393173	CERS6	A	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs13393173:A
morphine	rs12208357	SLC22A1	CT	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs12208357:CT
morphine	rs12208357	SLC22A1	TT	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs12208357:TT
midazolam	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Disease:C0027651		N05CD08	rs35599367:AG
morphine	rs55918055	SLC22A1	CC	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs55918055:CC
morphine	rs55918055	SLC22A1	CT	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs55918055:CT
bupropion, drugs used in nicotine dependence	rs4803381	CYP2A6	T	Efficacy	increased	Efficacy_Response	Disease:C0039338		N06AX12|N07BA	rs4803381:T
metformin	rs391300	SRR	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs391300:CC
metformin	rs391300	SRR	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs391300:CT
methylphenidate	rs5569	SLC6A2	AG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs5569:AG
methylphenidate	rs5569	SLC6A2	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs5569:GG
erythromycin	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Disease:C0027651		S01AA17	rs35599367:AG
nicotine	rs4803381	CYP2A6	T	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs4803381:T
clozapine	rs7787082	ABCB1	G	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH02	rs7787082:G
caffeine	rs762551	CYP1A2	AA	Metabolism/PK	increased	LADME	Healthy		N06BC01	rs762551:AA
caffeine	rs762551	CYP1A2	AC	Metabolism/PK	increased	LADME	Healthy		N06BC01	rs762551:AC
atenolol	rs12346562	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs12346562:AA
atenolol	rs12346562	__INTRONIC__	AC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs12346562:AC
hydrochlorothiazide	rs12346562	__INTRONIC__	AA	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03	rs12346562:AA
hydrochlorothiazide	rs12346562	__INTRONIC__	AC	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03	rs12346562:AC
atenolol	rs1104514	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs1104514:AA
atenolol	rs1104514	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs1104514:AG
morphine	rs34130495	SLC22A1	AA	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs34130495:AA
morphine	rs34130495	SLC22A1	AG	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs34130495:AG
atenolol	rs10739150	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs10739150:GG
atenolol	rs10739150	__INTRONIC__	GT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs10739150:GT
clozapine	rs10248420	ABCB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH02	rs10248420:A
deferasirox	rs3806596	UGT1A3	CC	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs3806596:CC
trandolapril, verapamil	rs4742610	PTPRD	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C08DA01|C09AA10	rs4742610:T
deferasirox	rs13120400	ABCG2	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs13120400:CC
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
"""metformin"", ""sulfonamides, urea derivatives"""	rs2289669	SLC47A1	A	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02|S01AB	rs2289669:A
sunitinib	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Disease:C0027651		L01EX01	rs2231142:GT
sunitinib	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0027651		L01EX01	rs2231142:TT
warfarin	rs11168292	VDR	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs11168292:GG
tamoxifen, endoxifen	rs1136703	SULT1A2	AA	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	rs1136703:AA
ara-ctp	rs17343066	SLC28A3	AA	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs17343066:AA
warfarin	rs4760658	VDR	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs4760658:GG
warfarin	rs11168293	VDR	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs11168293:TT
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs885814	ALPL	T	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs885814:T
methotrexate	rs4149056	SLCO1B1	C	Efficacy, Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149056:C
methotrexate	rs2306283	SLCO1B1	A	Efficacy, Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs2306283:A
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1350948	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs1350948:A
tamoxifen, endoxifen	rs1059491	SULT1A2	TT	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	rs1059491:TT
methotrexate	rs4149081	SLCO1B1	A	Efficacy, Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149081:A
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs17301249	EYA4	C	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs17301249:C
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs12081765	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs12081765:G
methotrexate	rs11045879	SLCO1B1	C	Efficacy, Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs11045879:C
phenylephrine	rs1042713	ADRB2	AA	Dosage	increased	Dosage	Healthy		S01GA05	rs1042713:AA
warfarin	rs2108622	CYP4F2	CT	Dosage, Efficacy	increased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage, Efficacy	increased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	rs2108622:TT
anastrozole	rs6990851	CSMD1	G	Efficacy	increased	Efficacy_Response	Other:C1458155		L02BG03	rs6990851:G
n-desmethyltramadol, o-desmethyltramadol	rs2273697	ABCC2	AA	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs2273697:AA
peginterferon alfa-2b, ribavirin	rs6806020	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs6806020:C
nicotine	rs28399433	CYP2A6	C	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs28399433:C
atorvastatin	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2032582:AA
atorvastatin	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2032582:AC
warfarin	rs7294	VKORC1	CT	Dosage, Efficacy	increased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	rs7294:CT
warfarin	rs7294	VKORC1	TT	Dosage, Efficacy	increased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	rs7294:TT
peginterferon alfa-2b, ribavirin	rs1931704	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs1931704:A
acamprosate	rs6801605	CHDH, IL17RB	A	Efficacy	increased	Efficacy_Response	Other:C0085762		N07BB03	rs6801605:A
warfarin	rs9923231	VKORC1	TT	Dosage, Efficacy	decreased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	rs9923231:TT
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GG
cyclophosphamide	rs3745274	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Other:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01	rs3745274:GG
fentanyl	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		N02AB03	rs1128503:AG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG
coumarin	rs28399433	CYP2A6	C	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs28399433:C
peginterferon alfa-2b, ribavirin	rs3093390	IL21R	C	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs3093390:C
bevacizumab, irinotecan	rs1570360	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01CE02|L01FG01	rs1570360:GG
peginterferon alfa-2b, ribavirin	rs7512595	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs7512595:A
peginterferon alfa-2b, ribavirin	rs1792774	CARD16	C	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs1792774:C
warfarin	rs3814637	CYP2C19	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs3814637:CC
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs1057910:AA
warfarin	rs1057910	CYP2C9	AC	Dosage	increased	Dosage	Healthy		B01AA03	rs1057910:AC
n-desmethyltramadol(tramadol)	rs3740066	ABCC2	TT	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs3740066:TT
peginterferon alfa-2b, ribavirin	rs7750468	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs7750468:G
warfarin	rs699664	GGCX	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs699664:CT
warfarin	rs699664	GGCX	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs699664:TT
atorvastatin	rs2306283	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2306283:AA
fentanyl	rs11079921	ABCC3	C	Metabolism/PK	increased	LADME	Other:C0030193|Other:C0022876		N02AB03	rs11079921:C
peginterferon alfa-2b, ribavirin	rs1503391	CARD16	A	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs1503391:A
peginterferon alfa-2b, ribavirin	rs557905	CASP1	T	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs557905:T
peginterferon alfa-2b, ribavirin	rs2066911	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs2066911:A
hmg coa reductase inhibitors	rs13064411	CFAP44	G	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs13064411:G
atorvastatin	rs3808607	CYP7A1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs3808607:TT
peginterferon alfa-2b, ribavirin	rs568910	CASP1	A	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs568910:A
nicotine	rs2072658	CHRNB2	AG	Other	increased	Efficacy_Response	Other:C0234925		N07BA01	rs2072658:AG
metformin	rs622342	SLC22A1	AC	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs622342:AC
metformin	rs622342	SLC22A1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs622342:CC
n-desmethyltramadol(tramadol)	rs8330	UGT1A8	CC	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs8330:CC
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CT
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CT
nicotine	rs2229959	CHRNA4	C	Other	increased	Efficacy_Response	Other:C0234925		N07BA01	rs2229959:C
peginterferon alfa-2b, ribavirin	rs17461620	TUT7	C	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs17461620:C
acetylcysteine	rs3750920	TOLLIP	TT	Efficacy	increased	Efficacy_Response	Disease:C0034069		V03AB23	rs3750920:TT
oxcarbazepine	rs1045642	ABCB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N03AF02	rs1045642:A
peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs12979860:CC
oxcarbazepine	rs7439366	UGT2B7	C	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N03AF02	rs7439366:C
ara-ctp	rs12404655	CDA	AG	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs12404655:AG
ara-ctp	rs12404655	CDA	GG	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs12404655:GG
peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs8099917:TT
ara-ctp	rs11030918	RRM1	CT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs11030918:CT
ara-ctp	rs11030918	RRM1	TT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs11030918:TT
clozapine	rs762551	CYP1A2	AA	Metabolism/PK	increased	LADME	Other:C0036341		N05AH02	rs762551:AA
clopidogrel	rs776746	CYP3A5	CC	Efficacy	increased	Efficacy_Response	Disease:C0018839		B01AC04	rs776746:CC
clopidogrel	rs776746	CYP3A5	CT	Efficacy	increased	Efficacy_Response	Disease:C0018839		B01AC04	rs776746:CT
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:TT
ara-ctp	rs11577910	CTPS1	AG	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs11577910:AG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
ara-ctp	rs12067645	CTPS1	AA	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs12067645:AA
ara-ctp	rs12067645	CTPS1	AG	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs12067645:AG
ara-ctp	rs4364871	CTPS1	CT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs4364871:CT
ara-ctp	rs4364871	CTPS1	TT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs4364871:TT
n-desmethyltramadol(tramadol)	rs10929303	UGT1A8	CC	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs10929303:CC
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT
n-desmethyltramadol, o-desmethyltramadol	rs34650714	UGT1A8	CC	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs34650714:CC
ara-ctp	rs11853372	SLC28A1	TT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs11853372:TT
ara-ctp	rs4742	DCTD	GG	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs4742:GG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
allopurinol	rs2231142	ABCG2	GT	Efficacy	decreased	Efficacy_Response	Disease:C0018099		M04AA01	rs2231142:GT
allopurinol	rs2231142	ABCG2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0018099		M04AA01	rs2231142:TT
oxcarbazepine	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF02	rs1045642:GG
amantadine, anticholinergics, levodopa, selegiline	rs622342	SLC22A1	C	Dosage, Efficacy	increased	Dosage	Disease:C0030567		N04BA02|N04BD01|S01FA	rs622342:C
ara-ctp	rs4643786	DCK	CC	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs4643786:CC
ara-ctp	rs4643786	DCK	CT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs4643786:CT
peginterferon alfa-2a, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12980275:AA
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
morphine-3-glucuronide, morphine-6-glucuronide	rs4793665	ABCC3	CC	Metabolism/PK	increased	LADME	Disease:C0036439|Disease:tonsillectomy		N02AA01	rs4793665:CC
tacrolimus	rs1128503	ABCB1	GG	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs1128503:GG
morphine-3-glucuronide	rs4148412	ABCC3	TT	Metabolism/PK	increased	LADME	Disease:tonsillectomy		N02AA01	rs4148412:TT
glucose	rs8450	CRTC2	AA	Toxicity	increased	LADME	Disease:C0277631		V06DC01	rs8450:AA
glucose	rs8450	CRTC2	AG	Toxicity	increased	LADME	Disease:C0277631		V06DC01	rs8450:AG
acenocoumarol	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:CT
acenocoumarol	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3794271	SLCO1C1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0235889|Psoriatic		No_ATC	rs3794271:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3794271	SLCO1C1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235889|Psoriatic		No_ATC	rs3794271:GG
tacrolimus	rs1128503	ABCB1	GG	Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs1128503:GG
sertraline	rs5441	GNB3	GG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB06	rs5441:GG
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
fentanyl	rs2242480	CYP3A4	TT	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		N02AB03	rs2242480:TT
sufentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1799971:AG
sufentanil	rs1799971	OPRM1	GG	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1799971:GG
sufentanil	rs1323040	OPRM1	AG	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1323040:AG
sufentanil	rs1323040	OPRM1	GG	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1323040:GG
sufentanil	rs1128503	ABCB1	AA	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1128503:AA
sufentanil	rs1128503	ABCB1	AG	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1128503:AG
cyclosporine	rs1045642	ABCB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AD01	rs1045642:A
sufentanil	rs2032582	ABCB1	AA	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs2032582:AA
sufentanil	rs2032582	ABCB1	AC	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs2032582:AC
morphine	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AA01	rs1799971:GG
hdl cholesterol	rs8450	CRTC2	AA	Toxicity	decreased	LADME	Disease:C0277631		No_ATC	rs8450:AA
o-desmethyltramadol	rs34130495	SLC22A1	GG	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs34130495:GG
mycophenolic acid	rs717620	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs717620:TT
methylphenidate	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs4680:GG
n-desmethyltramadol, o-desmethyltramadol	rs1867351	SLC22A1	TT	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs1867351:TT
phenytoin	rs12782374	CYP2C9	AA	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AB02	rs12782374:AA
phenytoin	rs12782374	CYP2C9	AG	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AB02	rs12782374:AG
warfarin	rs1057910	CYP2C9	C	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs1057910:C
fentanyl	rs8077268	ABCC3	T	Metabolism/PK	increased	LADME	Other:C0030193|Other:C0022876		N02AB03	rs8077268:T
methylphenidate	rs4680	COMT	G	Efficacy	increased	LADME	Disease:C1263846		N06BA04	rs4680:G
warfarin	rs1799853	CYP2C9	T	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs1799853:T
platinum compounds	rs25487	XRCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:CC
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T
cyclosporine	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs1045642:GG
nicotine	rs35694136	CYP1A2	T/del	Efficacy	decreased	LADME	Healthy		N07BA01	rs35694136:T/del
nicotine	rs35694136	CYP1A2	del/del	Efficacy	decreased	LADME	Healthy		N07BA01	rs35694136:del/del
sirolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	LADME	Disease:C0277631		No_ATC	rs776746:CC
platinum compounds	rs3212986	ERCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs3212986:CC
mycophenolic acid	rs7662029	UGT2B7	G	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs7662029:G
methylphenidate	rs2070762	TH	GG	Efficacy	decreased	Efficacy_Response	Disease:C1263846		N06BA04	rs2070762:GG
atorvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA05	rs4149056:CC
atorvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA05	rs4149056:CT
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
tacrolimus	rs5744247	IL18	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs5744247:CC
tacrolimus	rs5744247	IL18	CG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs5744247:CG
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC
sirolimus	rs2740574	CYP3A4	CC	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		No_ATC	rs2740574:CC
sirolimus	rs2740574	CYP3A4	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		No_ATC	rs2740574:CT
sirolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		No_ATC	rs776746:CT
sirolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		No_ATC	rs776746:TT
cetuximab	rs1801274	FCGR2A	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs1801274:AA
carbamazepine	rs2242480	CYP3A4	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2242480:CC
risperidone	rs518147	HTR2C	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs518147:CC
carbamazepine	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs776746:CC
sitagliptin, vildagliptin	rs6923761	GLP1R	AA	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02	rs6923761:AA
desethylchloroquine, hydroxychloroquine	rs7910936	CYP2C8	C	Metabolism/PK	increased	LADME	Other:C0024141		P01BA01|P01BA02	rs7910936:C
carbamazepine	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs1045642:GG
carbamazepine	rs3738046	EPHX1	CG	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N03AF01	rs3738046:CG
rosuvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0020443		C10AA07	rs4149056:CC
rosuvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0020443		C10AA07	rs4149056:CT
phenytoin	rs1799853	CYP2C9	CT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AB02	rs1799853:CT
simvastatin acid	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CC
phenytoin	rs4244285	CYP2C19	AG	Other, Metabolism/PK	decreased	LADME	Disease:C0014544		N03AB02	rs4244285:AG
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB11	rs12979860:CC
clozapine	rs6318	HTR2C	C	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs6318:C
carbamazepine	rs2234922	EPHX1	AG	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N03AF01	rs2234922:AG
carbamazepine	rs2234922	EPHX1	GG	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N03AF01	rs2234922:GG
carbamazepine	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:C0014544		N03AF01	rs776746:CT
carbamazepine	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:C0014544		N03AF01	rs776746:TT
sulfonamides, urea derivatives	rs12255372	TCF7L2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		S01AB	rs12255372:TT
simvastatin	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Other:C0020443		C10AA01	rs4149056:TT
carboplatin, cisplatin, fluorouracil	rs25487	XRCC1	T	Efficacy	decreased	Efficacy_Response	Disease:C0007869		L01BC02|L01XA01|L01XA02	rs25487:T
tramadol	rs2032582	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs2032582:AA
tramadol	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs1045642:AA
carboplatin, cisplatin, fluorouracil	rs12659	SLC19A1	A	Efficacy	decreased	Efficacy_Response	Disease:C0007869		L01BC02|L01XA01|L01XA02	rs12659:A
tramadol	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs1128503:AA
tocilizumab	rs12083537	IL6R	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AC07	rs12083537:AA
caffeine	rs16851030	ADORA1	CC	Efficacy	increased	Efficacy_Response	Other:Apnea_of_prematurity		N06BC01	rs16851030:CC
tocilizumab	rs4329505	IL6R	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AC07	rs4329505:CC
tocilizumab	rs4329505	IL6R	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AC07	rs4329505:CT
risperidone	rs1023574	HTR2C	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs1023574:CC
risperidone	rs9698290	HTR2C	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs9698290:TT
"""diuretics"", ""hydrochlorothiazide"", ""thiazides, plain"""	rs16960228	PRKCA	A	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03|C03AA03	rs16960228:A
antidepressants	rs672170	RGS17	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs672170:A
warfarin	rs7089580	CYP2C9	AT	Dosage	increased	Dosage	Healthy		B01AA03	rs7089580:AT
warfarin	rs7089580	CYP2C9	AT	Dosage	increased	LADME	Healthy		B01AA03	rs7089580:AT
voriconazole	rs4149117	SLCO1B3	GT	Metabolism/PK	decreased	LADME	Healthy		J02AC03	rs4149117:GT
voriconazole	rs4149117	SLCO1B3	TT	Metabolism/PK	decreased	LADME	Healthy		J02AC03	rs4149117:TT
oxaliplatin	rs1042522	TP53	CG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs1042522:CG
oxaliplatin	rs1042522	TP53	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs1042522:GG
antidepressants	rs9315310	NBEA	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs9315310:T
antidepressants	rs4737771	CRH	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs4737771:C
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
antidepressants	rs49411	FHIT	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs49411:C
antidepressants	rs2532560	PARP11	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs2532560:G
antidepressants	rs2831440	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs2831440:T
sildenafil	rs5443	GNB3	TT	Efficacy	increased	Efficacy_Response	Disease:C0242350		G04BE03	rs5443:TT
antidepressants	rs766127	MTRF1L	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs766127:G
atorvastatin	rs1057868	POR	CT	Efficacy	decreased	Efficacy_Response	Disease:C0342881		C10AA05	rs1057868:CT
atorvastatin	rs1057868	POR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0342881		C10AA05	rs1057868:TT
tacrolimus	rs846908	HSD11B1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs846908:AA
sarilumab	rs4845625	IL6R	CC	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC14	rs4845625:CC
salvianolic acid b	rs1799983	NOS3	GG	Efficacy	increased	Efficacy_Response	Disease:C0010068		No_ATC	rs1799983:GG
bupropion	rs165599	COMT	AA	Efficacy	increased	Efficacy_Response	Other:smokers		N06AX12	rs165599:AA
bupropion	rs165599	COMT	AG	Efficacy	increased	Efficacy_Response	Other:smokers		N06AX12	rs165599:AG
bupropion	rs737865	COMT	AA	Efficacy	decreased	Efficacy_Response	Other:smokers		N06AX12	rs737865:AA
salbutamol	rs2267715	CRHR2	G	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs2267715:G
desethylchloroquine, hydroxychloroquine	rs10882521	CYP2C8	T	Metabolism/PK	decreased	LADME	Other:C0024141		P01BA01|P01BA02	rs10882521:T
salmeterol	rs1042713	ADRB2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03AC12	rs1042713:AA
warfarin	rs4889606	STX1B	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs4889606:AG
warfarin	rs4889606	STX1B	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs4889606:GG
adalimumab	rs2071303	HFE	CC	Efficacy	increased	Efficacy_Response	Disease:C0010346		L04AB04	rs2071303:CC
adalimumab	rs2071303	HFE	CT	Efficacy	increased	Efficacy_Response	Disease:C0010346		L04AB04	rs2071303:CT
rosiglitazone	rs10192566	LPIN1	G	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs10192566:G
tacrolimus	rs4844880	HSD11B1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4844880:AA
desethylchloroquine, hydroxychloroquine	rs1065852	CYP2D6	AA	Metabolism/PK	decreased	LADME	Other:C0024141		P01BA01|P01BA02	rs1065852:AA
tacrolimus	rs846910	HSD11B1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs846910:AA
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
acenocoumarol	rs3735814	GATA4	AG	Dosage	decreased	Dosage	Healthy		B01AA07	rs3735814:AG
acenocoumarol	rs3735814	GATA4	GG	Dosage	decreased	Dosage	Healthy		B01AA07	rs3735814:GG
"""beta blocking agents, selective"", ""diuretics"""	rs4149601	NEDD4L	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03|S01ED	rs4149601:AG
"""beta blocking agents, selective"", ""diuretics"""	rs4149601	NEDD4L	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03|S01ED	rs4149601:GG
antidepressants	rs10997242	CTNNA3	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs10997242:C
aldosterone antagonists, amiloride	rs4149601	NEDD4L	G	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03DA|C03DB01	rs4149601:G
antidepressants	rs7997012	HTR2A	AG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs7997012:AG
antidepressants	rs7997012	HTR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs7997012:GG
salbutamol	rs255100	CRHR2	A	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs255100:A
antidepressants	rs6313	HTR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs6313:GG
antidepressants	rs2112460	CACNA1A	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs2112460:A
salbutamol	rs2284220	CRHR2	G	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs2284220:G
warfarin	rs17650	ORM1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs17650:AG
warfarin	rs17650	ORM1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs17650:GG
antidepressants	rs521093	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs521093:T
morphine	rs7439366	UGT2B7	CC	Dosage	decreased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs7439366:CC
warfarin	rs7294	VKORC1	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs7294:C
antidepressants	rs16873129	RAPGEF5	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs16873129:C
valproic acid	rs1128503	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AG01	rs1128503:AA
antidepressants	rs2299267	PON2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs2299267:G
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:C
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:C
cisplatin	rs7937567	GALNT18	GG	Efficacy	increased	Efficacy_Response	Disease:C0877645		L01XA01	rs7937567:GG
efavirenz	rs2279343	CYP2B6	AG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:AG
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG
rituximab	rs3759467	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Disease:C0042384		L01FA01	rs3759467:CC
antipsychotics, aripiprazole, clozapine, haloperidol, olanzapine, quetiapine, risperidone	rs680055	CYP3A43	CG	Efficacy	increased	Efficacy_Response	Disease:C0036337|Disease:C0036341		N05A|N05AD01|N05AH02|N05AH03|N05AH04|N05AX08|N05AX12	rs680055:CG
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
corticosteroids	rs1741981	HDAC1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0004096		S02BA	rs1741981:CC
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
vincristine	rs8192552	MTNR1B	AG	Metabolism/PK	increased	LADME	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs8192552:AG
morphine	rs3804100	TLR2	CC	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs3804100:CC
morphine	rs3804100	TLR2	CT	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs3804100:CT
tacrolimus	rs776746	CYP3A5	CT	Other, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
docetaxel, thalidomide	rs4148947	CHST3	T	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs4148947:T
morphine	rs1143634	IL1B	A	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1143634:A
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
cisplatin	rs10964552	MLLT3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0877645		L01XA01	rs10964552:AA
cisplatin	rs10964552	MLLT3	AC	Efficacy	decreased	Efficacy_Response	Disease:C0877645		L01XA01	rs10964552:AC
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	T	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:T
morphine	rs1143634	IL1B	A	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1143634:A
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT
docetaxel, thalidomide	rs4148950	CHST3	A	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs4148950:A
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
atorvastatin	rs1800591	MTTP	TT	Efficacy	increased	Efficacy_Response	Disease:C0342882		C10AA05	rs1800591:TT
nitroglycerin	rs671	ALDH2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0018798		No_ATC	rs671:AA
nitroglycerin	rs671	ALDH2	AG	Efficacy	decreased	Efficacy_Response	Disease:C0018798		No_ATC	rs671:AG
tocilizumab	rs4910008	GALNT18	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs4910008:CC
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
cisplatin	rs244898	RARS1	TT	Efficacy	increased	Efficacy_Response	Disease:C0877645		L01XA01	rs244898:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
risperidone	rs2235048	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs2235048:AG
risperidone	rs2235048	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs2235048:GG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Other:heart_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
nitroglycerin	rs671	ALDH2	AA	Metabolism/PK	increased	LADME	Disease:C0018798|Disease:C0020542		No_ATC	rs671:AA
nitroglycerin	rs671	ALDH2	AG	Metabolism/PK	increased	LADME	Disease:C0018798|Disease:C0020542		No_ATC	rs671:AG
digoxin	rs2032582	ABCB1	AT	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs2032582:AT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
tocilizumab	rs11052877	CD69	A	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs11052877:A
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
phenazepam	rs12248560	CYP2C19	CC	Efficacy	increased	Efficacy_Response	Disease:C0221016		No_ATC	rs12248560:CC
phenazepam	rs12248560	CYP2C19	CT	Efficacy	increased	Efficacy_Response	Disease:C0221016		No_ATC	rs12248560:CT
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
vincristine	rs6519270	SNU13	G	Metabolism/PK	increased	LADME	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs6519270:G
atenolol	rs7184292	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Other:C0020538		C07AB03	rs7184292:A
atenolol	rs7606603	XIRP2	C	Efficacy	decreased	Efficacy_Response	Other:C0020538		C07AB03	rs7606603:C
cyclosporine	rs10211	CYP3A7	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs10211:TT
cyclosporine	rs2257401	CYP3A7	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs2257401:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs12343867	JAK2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs12343867:CC
nilotinib	rs1695	GSTP1	A	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA03	rs1695:A
hydrochlorothiazide	rs16872401	__INTRONIC__	C	Efficacy	increased	Efficacy_Response	Other:C0020538		C03AA03	rs16872401:C
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3212217	IL12B	GG	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs3212217:GG
cyclosporine	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs4646437:GG
carvedilol	rs1801252	ADRB1	G	Efficacy	increased	Efficacy_Response	Healthy		C07AG02	rs1801252:G
paroxetine	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AB05	rs2032582:CC
paroxetine	rs2032582	ABCB1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AB05	rs2032582:CT
nilotinib	rs1048943	CYP1A1	CT	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA03	rs1048943:CT
nilotinib	rs1048943	CYP1A1	TT	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA03	rs1048943:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10754558	NLRP3	CG	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs10754558:CG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10754558	NLRP3	GG	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs10754558:GG
atenolol	rs7184292	__INTRONIC__	GG	Dosage	decreased	Dosage	Other:C0020538		C07AB03	rs7184292:GG
atorvastatin	rs2306283	SLCO1B1	GG	Efficacy	decreased	Efficacy_Response	Other:C0020473		C10AA05	rs2306283:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1946518	IL18	GT	Efficacy	increased	Efficacy_Response	Disease:C0009324		No_ATC	rs1946518:GT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1946518	IL18	TT	Efficacy	increased	Efficacy_Response	Disease:C0009324		No_ATC	rs1946518:TT
carvedilol	rs1801253	ADRB1	C	Efficacy	increased	Efficacy_Response	Healthy		C07AG02	rs1801253:C
risperidone	rs3803300	AKT1	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs3803300:CT
risperidone	rs2494732	AKT1	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs2494732:TT
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3745274:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2234711	IFNGR1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs2234711:AG
imatinib	rs3745274	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs3745274:GG
imatinib	rs3745274	CYP2B6	TT	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs3745274:TT
warfarin	rs4986893	CYP2C19	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs4986893:AA
warfarin	rs4986893	CYP2C19	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs4986893:AG
cyclosporine	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs776746:CC
warfarin	rs3814637	CYP2C19	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs3814637:CT
warfarin	rs3814637	CYP2C19	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs3814637:TT
cannabidiol	rs12539	AOC1	CT	Efficacy	increased	Efficacy_Response	Other:C0014544		No_ATC	rs12539:CT
cannabidiol	rs12539	AOC1	TT	Efficacy	increased	Efficacy_Response	Other:C0014544		No_ATC	rs12539:TT
efavirenz	rs3211371	CYP2B6	CT	Metabolism/PK	decreased	LADME	Healthy		J05AG03	rs3211371:CT
efavirenz	rs3211371	CYP2B6	TT	Metabolism/PK	decreased	LADME	Healthy		J05AG03	rs3211371:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs17250932	TBX21	CC	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs17250932:CC
vincristine	rs4548	RAB7A	CT	Metabolism/PK	increased	LADME	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs4548:CT
docetaxel, thalidomide	rs730720	CHST3	C	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs730720:C
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs8126756	IFNGR2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0010346		No_ATC	rs8126756:CC
cannabidiol	rs1339067	SLC15A1	TT	Efficacy	decreased	Efficacy_Response	Other:C0014544		No_ATC	rs1339067:TT
warfarin	rs12772169	__INTRONIC__	T	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs12772169:T
rosiglitazone	rs4149056	SLCO1B1	C	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs4149056:C
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3212217	IL12B	CG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		No_ATC	rs3212217:CG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3212217	IL12B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		No_ATC	rs3212217:GG
corticosteroids for systemic use	rs1741981	HDAC1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0004096		H02	rs1741981:CC
risperidone	rs165599	COMT	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs165599:G
risperidone	rs724226	GRM3	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs724226:G
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs5744174	TLR5	AG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		No_ATC	rs5744174:AG
morphine	rs6517442	KCNJ6	CC	Efficacy	increased	Efficacy_Response	Disease:C0030193		N02AA01	rs6517442:CC
methotrexate	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs2231142:GT
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT
tacrolimus	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT
morphine, remifentanil	rs6517442	KCNJ6	TT	Efficacy	decreased	Efficacy_Response	Disease:C0030193		N01AH06|N02AA01	rs6517442:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
low density lipoprotein	rs3888190	SH2B1	CC	Other	increased	LADME	Disease:C0005586|Disease:C0011581|Disease:C0033975|Disease:C0036337		No_ATC	rs3888190:CC
tacrolimus	rs776746	CYP3A5	T	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:T
enalapril	rs699947	VEGFA	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs699947:AA
enalapril	rs699947	VEGFA	AC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs699947:AC
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs8099917:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
lithium	rs2284018	CACNG2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs2284018:TT
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
efavirenz	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs1045642:GG
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3745274:TT
anastrozole	rs1437153	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Other:C1458155		L02BG03	rs1437153:T
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
docetaxel	rs2250242	ORM2	AA	Metabolism/PK	increased	LADME	Disease:C0033578		L01CD02	rs2250242:AA
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
etanercept, infliximab	rs2043211	CARD8	TT	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02	rs2043211:TT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
methotrexate	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0023449		L04AX03	rs1045642:AA
methotrexate	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Other:C0023449		L04AX03	rs1045642:AG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs12979860:CC
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2234711	IFNGR1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0021390		No_ATC	rs2234711:AG
etanercept, infliximab	rs4612666	NLRP3	TT	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02	rs4612666:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
anastrozole	rs2449598	DLG2	T	Efficacy	decreased	Efficacy_Response	Other:C1458155		L02BG03	rs2449598:T
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:C0027726		L04AD02	rs776746:CC
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs2242480	CYP3A4	CC	Metabolism/PK	increased	LADME	Other:C0027726		L04AD02	rs2242480:CC
digoxin	rs2032582	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs2032582:AA
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1801133:AA
peginterferon alfa-2b	rs3077	HLA-DPA1	GG	Efficacy	increased	Efficacy_Response	Disease:C0019163|Chronic		L03AB10	rs3077:GG
rivastigmine	rs1803274	BCHE	CC	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA03	rs1803274:CC
digoxin	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs1045642:AG
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CC
methotrexate	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1045642:AG
adalimumab, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800629	TNF	A	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs1800629:A
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
cannabidiol	rs3749442	ABCC5	AA	Efficacy	decreased	Efficacy_Response	Other:C0014544		No_ATC	rs3749442:AA
cannabidiol	rs3749442	ABCC5	AG	Efficacy	decreased	Efficacy_Response	Other:C0014544		No_ATC	rs3749442:AG
peginterferon alfa-2b, ribavirin	rs4803217	IFNL3	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs4803217:CC
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
efavirenz	rs3181842	CYP2B6	CC	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3181842:CC
efavirenz	rs3181842	CYP2B6	CT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3181842:CT
efavirenz	rs707265	CYP2B6	AA	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs707265:AA
efavirenz	rs707265	CYP2B6	AG	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs707265:AG
efavirenz	rs7246465	CYP2B6	CT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs7246465:CT
efavirenz	rs7246465	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs7246465:TT
sufentanil	rs696	NFKBIA	TT	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	rs696:TT
efavirenz	rs1042389	CYP2B6	TT	Metabolism/PK	decreased	LADME	Healthy		J05AG03	rs1042389:TT
peginterferon alfa-2b, ribavirin	rs11881222	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs11881222:AA
glucose	rs1000940	RABEP1	AG	Other	decreased	LADME	Disease:C0005586|Disease:C0011581|Disease:C0033975|Disease:C0036337		V06DC01	rs1000940:AG
glucose	rs1000940	RABEP1	GG	Other	decreased	LADME	Disease:C0005586|Disease:C0011581|Disease:C0033975|Disease:C0036337		V06DC01	rs1000940:GG
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT
paroxetine	rs6265	BDNF	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs6265:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT
remifentanil	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Disease:C0030193		N01AH06	rs4680:AA
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
morphine	rs4680	COMT	GG	Efficacy	decreased	Efficacy_Response	Disease:C0030193		N02AA01	rs4680:GG
morphine, remifentanil	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Disease:C0030193		N01AH06|N02AA01	rs4680:AA
morphine, remifentanil	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Disease:C0030193		N01AH06|N02AA01	rs4680:AG
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
antipsychotics	rs2032582	ABCB1	CC	Dosage, Metabolism/PK	increased	Dosage	Disease:C0036341		N05A	rs2032582:CC
adalimumab, infliximab	rs3804099	TLR2	T	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AB02|L04AB04	rs3804099:T
interferon alfa-n1, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB06|L03AB10	rs12979860:CC
morphine	rs4680	COMT	G	Dosage, Efficacy	increased	Dosage	"""Other:C1956346|""Efficacy:C0030193|Postoperative"""		N02AA01	rs4680:G
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
interferon alfa-n1, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB06|L03AB10	rs8099917:TT
peginterferon alfa-2b, ribavirin	rs8103142	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs8103142:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Other:HSCT		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Other:HSCT		L04AD02	rs776746:TT
peginterferon alfa-2b, ribavirin	rs28416813	IFNL3	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs28416813:CC
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Other:C1561643		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Other:C1561643		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
imatinib	rs2231142	ABCG2	GT	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs2231142:GT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
peginterferon alfa-2b, ribavirin	rs8113007	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs8113007:AA
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs12979860:CC
clozapine	rs2075748	CHRM1	CC	Dosage	decreased	Dosage	Other:C0036341		N05AH02	rs2075748:CC
cyclophosphamide, epirubicin, fluorouracil	rs1056836	CYP1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs1056836:CC
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs28416813	IFNL3	G	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs28416813:G
interferon alfa-n1, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB06|L03AB10	rs8099917:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
interferon alfa-n1, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB06|L03AB10	rs12979860:CC
erenumab, fremanezumab, galcanezumab	rs12615320	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Other:C0338480|Other:C0338480		N02CD01|N02CD02|N02CD03	rs12615320:G
rosuvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs4149056:CC
rosuvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs4149056:CT
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A
hydroxyurea	rs10901080	ASS1	T	Efficacy	increased	Efficacy_Response	Disease:C0002895|Disease:Beta-thalassemia_and_related_diseases		No_ATC	rs10901080:T
anastrozole	rs6981827	CSMD1	T	Efficacy	decreased	Efficacy_Response	Other:C1458155		L02BG03	rs6981827:T
hydroxyurea	rs10793902	ASS1	T	Efficacy	increased	Efficacy_Response	Disease:C0002895|Disease:Beta-thalassemia_and_related_diseases		No_ATC	rs10793902:T
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GG
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GT
doxorubicin	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs2032582:AA
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GG
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8103142	IFNL3	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8103142:T
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
epirubicin	rs1800566	NQO1	AA	Efficacy, Toxicity	decreased	Efficacy_Response	Other:C0235653		L01DB03	rs1800566:AA
docetaxel, epirubicin	rs1563828	MDM4	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02|L01DB03	rs1563828:AA
gemcitabine	rs2072671	CDA	C	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC05	rs2072671:C
hydrochlorothiazide	rs75982813	NEDD4L	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs75982813:AG
hydrochlorothiazide	rs75982813	NEDD4L	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs75982813:GG
gliclazide	rs5219	KCNJ11	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BB09	rs5219:TT
warfarin	rs12777823	__INTRONIC__	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AA
warfarin	rs12777823	__INTRONIC__	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AG
doxorubicin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs1045642:AA
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
aripiprazole	rs6277	DRD2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX12	rs6277:GG
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CC
digoxin	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs1045642:AA
capecitabine, radiotherapy	rs11942466	AREG	AA	Efficacy	decreased	Efficacy_Response	Disease:C0022665		L01BC06	rs11942466:AA
capecitabine, radiotherapy	rs11942466	AREG	AC	Efficacy	decreased	Efficacy_Response	Disease:C0022665		L01BC06	rs11942466:AC
levomethadone	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC05	rs3745274:GT
levomethadone	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC05	rs3745274:TT
dextromethadone	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs3745274:GT
dextromethadone	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs3745274:TT
capecitabine, radiotherapy	rs11615	ERCC1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0022665		L01BC06	rs11615:AG
capecitabine, radiotherapy	rs11615	ERCC1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0022665		L01BC06	rs11615:GG
capecitabine, oxaliplatin	rs2010963	VEGFA	CG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC06|L01XA03	rs2010963:CG
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
acetaminophen	rs1902023	UGT2B15	AA	Efficacy	increased	Efficacy_Response	Healthy		N02BE01	rs1902023:AA
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
aripiprazole	rs1800497	ANKK1	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX12	rs1800497:AA
aripiprazole	rs1800497	ANKK1	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX12	rs1800497:AG
morphine	rs4633	COMT	C	Dosage, Efficacy	increased	Dosage	"""Other:C1956346|""Efficacy:C0030193|Postoperative"""		N02AA01	rs4633:C
acetaminophen	rs224534	TRPV1	AA	Efficacy	increased	Efficacy_Response	Healthy		N02BE01	rs224534:AA
acetaminophen	rs224534	TRPV1	AG	Efficacy	increased	Efficacy_Response	Healthy		N02BE01	rs224534:AG
clozapine	rs1150226	HTR3A	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs1150226:G
risperidone	rs2069062	GRM7	CC	Efficacy	increased	Efficacy_Response	Healthy		N05AX08	rs2069062:CC
clopidogrel	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs1045642:AA
clopidogrel	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs1045642:AG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
clozapine	rs2276302	HTR3A	A	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2276302:A
glucose	rs4680	COMT	AA	Toxicity	increased	LADME	Healthy		V06DC01	rs4680:AA
glucose	rs4680	COMT	AG	Toxicity	increased	LADME	Healthy		V06DC01	rs4680:AG
clozapine	rs1062613	HTR3A	C	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs1062613:C
clopidogrel	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC04	rs1045642:AA
clopidogrel	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC04	rs1045642:AG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
adalimumab, etanercept, infliximab	rs10919563	PTPRC	G	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs10919563:G
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Adverse_Event	Disease:C0178298		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Adverse_Event	Disease:C0178298		L04AD02	rs776746:TT
risperidone	rs1875705	GRID2	GG	Efficacy	increased	Efficacy_Response	Healthy		N05AX08	rs1875705:GG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:TT
clopidogrel	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs1045642:AA
clopidogrel	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs1045642:AG
paclitaxel	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD01	rs2032582:CC
tacrolimus	rs2276707	NR1I2	CC	Metabolism/PK	increased	LADME	Other:Hematopoietic_stem_cell_transplantation		L04AD02	rs2276707:CC
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
capecitabine, oxaliplatin	rs699947	VEGFA	AC	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC06|L01XA03	rs699947:AC
warfarin	rs17886199	PRSS53, VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs17886199:A
4-hydroxyatorvastatin, 4-hydroxyatorvastatin lactone	rs12422149	SLCO2B1	AG	Metabolism/PK	increased	LADME	Other:C0010068		C10AA05	rs12422149:AG
paclitaxel	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01CD01	rs2032582:AA
paclitaxel	rs2032582	ABCB1	AT	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01CD01	rs2032582:AT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
peginterferon alfa-2b, ribavirin	rs11881222	IFNL3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11881222:AG
peginterferon alfa-2b, ribavirin	rs11881222	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11881222:GG
tacrolimus	rs776746	CYP3A5	CT	Other, Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Other, Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:TT
2-hydroxyatorvastatin lactone, 4-hydroxyatorvastatin lactone, atorvastatin lactone	rs887829	UGT1A1	CC	Metabolism/PK	decreased	LADME	Other:C0010068		C10AA05	rs887829:CC
bevacizumab, fluorouracil, irinotecan, leucovorin	rs1056515	RGS5	TT	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs1056515:TT
sn-38(irinotecan)	rs4148323	UGT1A1	AA	Dosage	decreased	LADME	Disease:C0027651		L01CE02	rs4148323:AA
peginterferon alfa-2b, ribavirin	rs8105790	IFNL3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8105790:CC
peginterferon alfa-2b, ribavirin	rs8105790	IFNL3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8105790:CT
peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12980275:AG
peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12980275:GG
valproic acid	rs10068980	GABRA1	AA	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs10068980:AA
valproic acid	rs10068980	GABRA1	AG	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs10068980:AG
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CT
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:TT
clozapine	rs1942499	CHRM1	GG	Dosage	decreased	Dosage	Other:C0036341		N05AH02	rs1942499:GG
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GG
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
rosuvastatin	rs12487736	SCAP	C	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AA07	rs12487736:C
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		L04AD02	rs776746:CC
peginterferon alfa-2b, ribavirin	rs4803219	IFNL3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs4803219:CT
bevacizumab, fluorouracil, irinotecan, leucovorin	rs329007	RALBP1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs329007:GG
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A
rocuronium	rs1128503	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Healthy		M03AC09	rs1128503:AA
mycophenolic acid	rs6714486	UGT1A9	AA	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AA06	rs6714486:AA
mycophenolic acid	rs6714486	UGT1A9	AT	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AA06	rs6714486:AT
acenocoumarol	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:T
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC
rocuronium	rs2306283	SLCO1B1	AA	Efficacy	decreased	Efficacy_Response	Healthy		M03AC09	rs2306283:AA
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:G
perampanel	rs776746	CYP3A5, ZSCAN25	C	Metabolism/PK	increased	LADME	Other:C0014544		N03AX22	rs776746:C
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
morphine	rs7438135	UGT2B7	AA	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs7438135:AA
morphine	rs7438135	UGT2B7	AG	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs7438135:AG
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GT
peginterferon alfa-2b, ribavirin	rs7248668	IFNL3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs7248668:AA
peginterferon alfa-2b, ribavirin	rs7248668	IFNL3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs7248668:AG
peginterferon alfa-2b, ribavirin	rs10853728	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10853728:GG
pravastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0020443		C10AA03	rs4149056:CC
pravastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0020443		C10AA03	rs4149056:CT
peginterferon alfa-2b, ribavirin	rs10853728	__INTRONIC__	CG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10853728:CG
peginterferon alfa-2b, ribavirin	rs10853728	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10853728:GG
acenocoumarol	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:TT
imatinib	rs2725252	ABCG2	C	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2725252:C
phenprocoumon	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Other:maintenance_dosage_by_1.5_mg/week		B01AA04	rs2108622:T
atenolol, irbesartan	rs5370	EDN1	GT	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03|C09CA04	rs5370:GT
paroxetine	rs6311	HTR2A	CC	Efficacy	increased	Efficacy_Response	Other:C0028768		N06AB05	rs6311:CC
phenprocoumon	rs4086116	CYP2C9	T	Dosage	decreased	Dosage	Other:maintenance_dosage_by_2.2_mg/week		B01AA04	rs4086116:T
atorvastatin, pravastatin, simvastatin	rs7412	APOE	C	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA01|C10AA03|C10AA05	rs7412:C
imatinib	rs2725252	ABCG2	C	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2725252:C
atazanavir	rs2472677	NR1I2	CT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease	deficiency	J05AE08	rs2472677:CT
pravastatin	rs4149015	SLCO1B1	AG	Metabolism/PK	increased	LADME	Disease:C0342882		C10AA03	rs4149015:AG
apixaban	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:C0004238		B01AF02	rs776746:CC
apixaban	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:C0004238		B01AF02	rs776746:CT
imatinib	rs12505410	ABCG2	G	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs12505410:G
niacin	rs2454727	HCAR2	CT	Efficacy	decreased	Efficacy_Response	Healthy		No_ATC	rs2454727:CT
niacin	rs2454727	HCAR2	TT	Efficacy	decreased	Efficacy_Response	Healthy		No_ATC	rs2454727:TT
atorvastatin, pravastatin, simvastatin	rs12003906	ABCA1	C	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA01|C10AA03|C10AA05	rs12003906:C
ceftriaxone	rs13120400	ABCG2	TT	Metabolism/PK	Indeterminado	LADME	Disease:C0007682		J01DD04	rs13120400:TT
ribavirin	rs1127354	ITPA	CC	Dosage	decreased	Dosage	Healthy		J05AP01	rs1127354:CC
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
pravastatin	rs4149015	SLCO1B1	AG	Metabolism/PK	increased	Efficacy_Response	Disease:C0342882		C10AA03	rs4149015:AG
creatine	rs616147	MOBP	AA	Efficacy	increased	Efficacy_Response	Other:C1388177		No_ATC	rs616147:AA
creatine	rs616147	MOBP	AG	Efficacy	increased	Efficacy_Response	Other:C1388177		No_ATC	rs616147:AG
pemetrexed	rs1047840	EXO1	AA	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01BA04	rs1047840:AA
pemetrexed	rs1047840	EXO1	AG	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01BA04	rs1047840:AG
pravastatin	rs4149056	SLCO1B1	CT	Efficacy	increased	Efficacy_Response	Disease:C0277631		C10AA03	rs4149056:CT
phenprocoumon	rs10871454	STX4	T	Dosage	decreased	Dosage	Other:maintenance_dosage_by_4.8_mg/week		B01AA04	rs10871454:T
pravastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:C0277631		C10AA03	rs4149056:CT
propofol	rs3745274	CYP2B6	GT	Dosage	decreased	Dosage	Healthy		N01AX10	rs3745274:GT
propofol	rs3745274	CYP2B6	TT	Dosage	decreased	Dosage	Healthy		N01AX10	rs3745274:TT
adalimumab, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs352139	TLR9	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04	rs352139:CT
adalimumab, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs352139	TLR9	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04	rs352139:TT
valproic acid	rs4244285	CYP2C19	AA	Dosage, Metabolism/PK	increased	Dosage	Disease:C0026986		N03AG01	rs4244285:AA
valproic acid	rs4244285	CYP2C19	AG	Dosage, Metabolism/PK	increased	Dosage	Disease:C0026986		N03AG01	rs4244285:AG
apixaban	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0004238		B01AF02	rs2231142:TT
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC
3,4-methylenedioxymethamphetamine	rs2242446	SLC6A2	TT	Other	decreased	Efficacy_Response	Healthy		V04CX05	rs2242446:TT
atenolol	rs699	AGT	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs699:AG
atenolol	rs699	AGT	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs699:GG
irbesartan	rs1057910	CYP2C9	AC	Metabolism/PK	decreased	LADME	Healthy		C09CA04	rs1057910:AC
3,4-methylenedioxymethamphetamine	rs1861647	SLC6A2	GG	Other	increased	Efficacy_Response	Healthy		V04CX05	rs1861647:GG
3,4-methylenedioxymethamphetamine	rs36029	SLC6A2	AA	Other	increased	Efficacy_Response	Healthy		V04CX05	rs36029:AA
atenolol	rs5051	AGT	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs5051:CT
atenolol	rs5051	AGT	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs5051:TT
irbesartan	rs1057910	CYP2C9	AC	Metabolism/PK	decreased	LADME	Healthy		C09CA04	rs1057910:AC
irbesartan	rs72558187	CYP2C9	CT	Metabolism/PK	decreased	LADME	Healthy		C09CA04	rs72558187:CT
irbesartan	rs1057910	CYP2C9	AC	Metabolism/PK	increased	LADME	Healthy		C09CA04	rs1057910:AC
adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab, methotrexate	rs1264457	HLA-E	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AX03|R03BA	rs1264457:AA
repaglinide	rs13266634	SLC30A8	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs13266634:CT
repaglinide	rs13266634	SLC30A8	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs13266634:TT
disulfiram	rs1048101	ADRA1A	AA	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs1048101:AA
disulfiram	rs1048101	ADRA1A	AG	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs1048101:AG
adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab, methotrexate	rs1059150	ATP5F1E	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AX03|R03BA	rs1059150:GG
sirolimus	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:AG
mercaptopurine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Other:C0023449		L01BB02	rs116855232:TT
felodipine	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C08CA02	rs2231142:TT
dexmedetomidine	rs28399433	CYP2A6	C	Metabolism/PK	decreased	LADME	Healthy		N05CM18	rs28399433:C
irbesartan	rs1799853	CYP2C9	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA04	rs1799853:CT
fentanyl	rs145837941	CALCA	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AB03	rs145837941:GG
nitric oxide	rs1319501	NAMPT	TT	Efficacy	increased	LADME	Other:C0032914		R07AX01	rs1319501:TT
tocilizumab	rs4910008	GALNT18	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC07	rs4910008:CC
tocilizumab	rs4910008	GALNT18	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC07	rs4910008:CT
buprenorphine	rs529520	OPRD1	AA	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01	rs529520:AA
nicotine	rs12459249	__INTRONIC__	C	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs12459249:C
warfarin	rs2592551	GGCX	AA	Dosage	increased	Dosage	Disease:C0004238		B01AA03	rs2592551:AA
warfarin	rs2592551	GGCX	AG	Dosage	increased	Dosage	Disease:C0004238		B01AA03	rs2592551:AG
arsenic compounds	rs11191439	AS3MT	C	Toxicity, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs11191439:C
selective serotonin reuptake inhibitors	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AB	rs7905446:TT
escitalopram	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AB10	rs7905446:TT
atomoxetine, desvenlafaxine, duloxetine, selective serotonin reuptake inhibitors, venlafaxine	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AB|N06AX16|N06AX21|N06AX23|N06BA09	rs7905446:TT
irbesartan	rs72558187	CYP2C9	CT	Metabolism/PK	decreased	LADME	Healthy		C09CA04	rs72558187:CT
tocilizumab	rs2069840	IL6	CC	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs2069840:CC
antidepressants	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06A	rs7905446:TT
irbesartan	rs72558187	CYP2C9	CT	Metabolism/PK	increased	LADME	Healthy		C09CA04	rs72558187:CT
benazepril	rs1801131	MTHFR	G	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA07	rs1801131:G
fluoxetine, paroxetine	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N06AB03|N06AB05	rs7905446:TT
benazepril	rs1801133	MTHFR	G	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA07	rs1801133:G
tramadol	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs3745274:TT
irbesartan	rs1057910	CYP2C9	AC	Metabolism/PK	increased	LADME	Disease:C0085580		C09CA04	rs1057910:AC
paroxetine	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N06AB05	rs7905446:TT
fentanyl	rs145837941	CALCA	AG	Dosage	increased	Dosage	"""Other:C0030193|Postoperative""|""Other:C0699744"		N02AB03	rs145837941:AG
fentanyl	rs145837941	CALCA	GG	Dosage	increased	Dosage	"""Other:C0030193|Postoperative""|""Other:C0699744"		N02AB03	rs145837941:GG
pemetrexed	rs1653586	CAMKK2	GT	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01BA04	rs1653586:GT
abiraterone	rs523349	SRD5A2	CC	Efficacy	increased	Efficacy_Response	Other:C0033578		L02BX03	rs523349:CC
buprenorphine	rs581111	OPRD1	AA	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01	rs581111:AA
buprenorphine	rs581111	OPRD1	AG	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01	rs581111:AG
carboplatin, lonafarnib, paclitaxel	rs11623866	FNTB	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0919267		L01CD01|L01XA02	rs11623866:GG
methotrexate	rs12505410	ABCG2	GG	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs12505410:GG
escitalopram	rs41271330	BMP5	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB10	rs41271330:A
enalapril	rs71647871	CES1	CT	Metabolism/PK	decreased	LADME	Healthy		C09AA02	rs71647871:CT
methotrexate	rs13137622	ABCG2	GT	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs13137622:GT
methotrexate	rs13137622	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs13137622:TT
methotrexate	rs13120400	ABCG2	CC	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs13120400:CC
amlodipine	rs2740574	CYP3A4	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01	rs2740574:CT
amlodipine	rs2740574	CYP3A4	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01	rs2740574:TT
tacrolimus	rs1946518	IL18	GG	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs1946518:GG
tacrolimus	rs1946518	IL18	GT	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs1946518:GT
tacrolimus	rs1800896	IL10	TT	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs1800896:TT
rivastigmine	rs1803274	BCHE	CT	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA03	rs1803274:CT
rivastigmine	rs1803274	BCHE	TT	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA03	rs1803274:TT
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
efavirenz	rs35303484	CYP2B6	G	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs35303484:G
valproic acid	rs1057910	CYP2C9	C	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs1057910:C
azathioprine	rs116855232	NUDT15	TT	Toxicity	decreased	Dosage	Disease:C0023530		L04AX01	rs116855232:TT
celecoxib	rs689466	PTGS2	CC	Efficacy	increased	Efficacy_Response	Healthy		M01AH01	rs689466:CC
clozapine	rs28379954	NFIB	CT	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs28379954:CT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs776746:CC
metformin	rs594709	SLC22A1	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs594709:AA
metformin	rs594709	SLC22A1	AG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs594709:AG
irinotecan	rs2401863	TDP1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01CE02	rs2401863:GG
losartan	rs1934969	CYP2C9	AA	Metabolism/PK	decreased	LADME	Healthy		C09CA01	rs1934969:AA
metformin	rs2289669	SLC47A1	GG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs2289669:GG
tacrolimus	rs5744247	IL18	CC	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs5744247:CC
tacrolimus	rs5744247	IL18	CG	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs5744247:CG
dexmedetomidine	rs16947	CYP2D6	GG	Dosage	increased	Dosage	Other:C0549433		N05CM18	rs16947:GG
carbamazepine	rs762551	CYP1A2	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs762551:AA
rivaroxaban	rs2242480	CYP3A4	T	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs2242480:T
cyclosporine, tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD01|L04AD02	rs776746:CC
methotrexate	rs4148324	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GG	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs4148324:GG
methotrexate	rs4148324	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GT	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs4148324:GT
efavirenz	rs3842	ABCB1	C	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs3842:C
cyclosporine, tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	Dosage	Other:Liver_transplantation		L04AD01|L04AD02	rs776746:CC
dexmedetomidine	rs5758550	WBP2NL	AG	Toxicity	increased	Efficacy_Response	Other:C0549433		N05CM18	rs5758550:AG
dexmedetomidine	rs5758550	WBP2NL	GG	Toxicity	increased	Efficacy_Response	Other:C0549433		N05CM18	rs5758550:GG
memantine, rivastigmine	rs1803274	BCHE	CT	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA03|N06DX01	rs1803274:CT
memantine, rivastigmine	rs1803274	BCHE	TT	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA03|N06DX01	rs1803274:TT
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CC
warfarin	rs699664	GGCX	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs699664:CC
methotrexate	rs1801131	MTHFR	GT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:GT
clopidogrel	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs1045642:AA
tacrolimus	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT
tacrolimus	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:GG
rivastigmine	rs1803274	BCHE	CT	Efficacy	increased	Efficacy_Response	Disease:Lewy_Body_Disease		N06DA03	rs1803274:CT
fentanyl	rs145837941	CALCA	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AB03	rs145837941:GG
apixaban	rs2231142	ABCG2	G	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF02	rs2231142:G
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1061622	TNFRSF1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs1061622:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3397	TNFRSF1B	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs3397:CC
amlodipine	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Healthy		C08CA01	rs1045642:GG
latanoprost	rs3766355	PTGFR	CC	Efficacy	increased	Efficacy_Response	Disease:C0020302|Disease:C0028840		S01EE01	rs3766355:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1061631	TNFRSF1B	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs1061631:AA
methotrexate	rs1801133	MTHFR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801133:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3397	TNFRSF1B	C	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs3397:C
amlodipine	rs2032582	ABCB1	CC	Metabolism/PK	decreased	LADME	Healthy		C08CA01	rs2032582:CC
methadone	rs11265549	NECTIN4	AA	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC02	rs11265549:AA
opioid anesthetics, other general anesthetics, volatile anesthetics	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Healthy		N01|N01AH|N01AX	rs1799971:GG
opioid anesthetics, other general anesthetics, volatile anesthetics	rs2231142	ABCG2	TT	Efficacy	increased	Efficacy_Response	Healthy		N01|N01AH|N01AX	rs2231142:TT
methadone	rs11265549	NECTIN4	AA	Dosage	decreased	Dosage	Other:Opioid-Related_Disorders		N07BC02	rs11265549:AA
dexmedetomidine	rs16934182	KCNMA1	AA	Dosage	decreased	Dosage	Other:C0549433		N05CM18	rs16934182:AA
dexmedetomidine	rs16934182	KCNMA1	AG	Dosage	decreased	Dosage	Other:C0549433		N05CM18	rs16934182:AG
dabigatran	rs2244613	CES1	GG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AE07	rs2244613:GG
dabigatran	rs2244613	CES1	GT	Metabolism/PK	decreased	LADME	Other:C0004238		B01AE07	rs2244613:GT
atorvastatin	rs11887534	ABCG8	CC	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs11887534:CC
atorvastatin	rs11887534	ABCG8	CG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs11887534:CG
dexmedetomidine	rs1800544	ADRA2A	GG	Dosage	decreased	Dosage	Other:C0549433		N05CM18	rs1800544:GG
tamoxifen-n-glucuronide	rs2011425	UGT1A4	GG	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	rs2011425:GG
tamoxifen-n-glucuronide	rs2011425	UGT1A4	GT	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	rs2011425:GT
imatinib	rs3745274	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs3745274:GG
imatinib	rs3745274	CYP2B6	GT	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs3745274:GT
methotrexate	rs4673993	ATIC	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs4673993:CC
benazepril	rs7079	AGT	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C09AA07	rs7079:GG
warfarin	rs9332098	CYP2C9	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9332098:GG
cannabidiol	rs6729738	__INTRONIC__	CC	Efficacy	increased	Efficacy_Response	Other:C0014544		No_ATC	rs6729738:CC
methotrexate	rs1801133	MTHFR	AG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs1801133:AG
methotrexate	rs1801133	MTHFR	GG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs1801133:GG
dexmedetomidine	rs1042713	ADRB2	AA	Efficacy	increased	Efficacy_Response	Other:C0549433		N05CM18	rs1042713:AA
warfarin	rs9332092	CYP2C9	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs9332092:TT
hydrochlorothiazide	rs3784921	TXNDC11	G	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs3784921:G
warfarin	rs1057910	CYP2C9	CC	Metabolism/PK	decreased	LADME	Healthy		B01AA03	rs1057910:CC
paroxetine	rs762551	CYP1A2	A	Metabolism/PK	increased	Dosage	Disease:C0011581		N06AB05	rs762551:A
warfarin	rs1799853	CYP2C9	TT	Metabolism/PK	decreased	LADME	Healthy		B01AA03	rs1799853:TT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
dexmedetomidine	rs16934182	KCNMA1	AA	Toxicity	increased	Efficacy_Response	Other:C0549433		N05CM18	rs16934182:AA
dexmedetomidine	rs16934182	KCNMA1	AG	Toxicity	increased	Efficacy_Response	Other:C0549433		N05CM18	rs16934182:AG
topotecan	rs4148157	ABCG2	AA	Metabolism/PK	increased	LADME	Disease:C0006118		L01CE01	rs4148157:AA
topotecan	rs4148157	ABCG2	AG	Metabolism/PK	increased	LADME	Disease:C0006118		L01CE01	rs4148157:AG
efavirenz	rs28399499	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT
rivaroxaban	rs2246709	CYP3A4	G	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs2246709:G
duloxetine	rs117986340	KMT2E	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs117986340:GG
rivastigmine	rs2571598	ACHE	TT	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA03	rs2571598:TT
morphine	rs1799971	OPRM1	AG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1799971:AG
morphine	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1799971:GG
duloxetine	rs2303377	NCAM1	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs2303377:TT
rivaroxaban	rs776746	CYP3A5	T	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs776746:T
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	rs776746:TT
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
duloxetine	rs4261893	ZNF385D	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs4261893:TT
efavirenz	rs2279343	CYP2B6	AG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:AG
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG
rivaroxaban	rs3735451	CYP3A4	C	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs3735451:C
warfarin	rs2359612	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs2359612:GG
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT
dexmedetomidine	rs141294036	__INTRONIC__	CC	Toxicity	increased	Efficacy_Response	Other:C0549433		N05CM18	rs141294036:CC
amphetamine	rs3784943	CDH13	AG	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs3784943:AG
amphetamine	rs3784943	CDH13	GG	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs3784943:GG
everolimus	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Disease:C1458155		L01EG02	rs35599367:AG
pravastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0242231		C10AA03	rs4149056:CT
dexmedetomidine	rs11739136	KCNMB1	CC	Efficacy	increased	Efficacy_Response	Other:C0549433		N05CM18	rs11739136:CC
dexmedetomidine	rs11739136	KCNMB1	CT	Efficacy	increased	Efficacy_Response	Other:C0549433		N05CM18	rs11739136:CT
morphine	rs7668282	UGT2B7	CC	Metabolism/PK	decreased	LADME	Disease:C0002895		N02AA01	rs7668282:CC
morphine	rs7668282	UGT2B7	CT	Metabolism/PK	decreased	LADME	Disease:C0002895		N02AA01	rs7668282:CT
efavirenz	rs3745274	CYP2A7P1, CYP2B6	T	Metabolism/PK	increased	LADME	Other:C0032961		J05AG03	rs3745274:T
dabigatran	rs8192935	CES1	GG	Metabolism/PK	increased	LADME	Other:C0004238		B01AE07	rs8192935:GG
ethanol	rs1799971	OPRM1	AG	Dosage	decreased	Dosage	Healthy		V03AB16	rs1799971:AG
ethanol	rs1799971	OPRM1	GG	Dosage	decreased	Dosage	Healthy		V03AB16	rs1799971:GG
methotrexate	rs1801133	CLCN6, MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801133:AA
methotrexate	rs1801131	C1orf167, CLCN6, MTHFR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:TT
methotrexate	rs1805087	MTR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1805087:AA
ranibizumab	rs4073	CXCL8	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024437		S01LA04	rs4073:AA
ethanol	rs10485057	OPRM1	AA	Dosage	increased	Dosage	Healthy		V03AB16	rs10485057:AA
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A
opioids	rs4680	COMT	AA	Dosage	decreased	Dosage	Other:C0030193|Other:C0027651		N02A	rs4680:AA
opioids	rs4680	COMT	AG	Dosage	decreased	Dosage	Other:C0030193|Other:C0027651		N02A	rs4680:AG
methotrexate	rs9904341	BIRC5	CG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs9904341:CG
acenocoumarol	rs9934438	VKORC1	GG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA07	rs9934438:GG
salbutamol	rs17834628	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Healthy		R03CC02	rs17834628:A
nicotine	rs1051730	CHRNA3	A	Dosage	decreased	Dosage	Other:C0039338		N07BA01	rs1051730:A
abiraterone, prednisolone	rs3828743	TSPYL1	A	Efficacy	decreased	Efficacy_Response	Disease:C0033578		L02BX03|S02BA03	rs3828743:A
platinum	rs6878291	RICTOR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs6878291:GG
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
clozapine	rs2514218	DRD2	T	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2514218:T
methotrexate	rs1801394	FASTKD3, MTRR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801394:AA
methotrexate	rs1801394	FASTKD3, MTRR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801394:AG
ranibizumab	rs2071559	KDR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024437		S01LA04	rs2071559:AA
ranibizumab	rs2071559	KDR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024437		S01LA04	rs2071559:AG
ethanol	rs1799971	OPRM1	AG	Other	increased	Efficacy_Response	Other:C0085762		V03AB16	rs1799971:AG
busulfan	rs3957356	GSTA1	CT	Metabolism/PK	decreased	LADME	Other:Hematopoietic_stem_cell_transplantation		L01AB01	rs3957356:CT
methotrexate	rs12995526	ATIC	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs12995526:CT
methotrexate	rs12995526	ATIC	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs12995526:TT
clozapine	rs1062613	HTR3A	T	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs1062613:T
methotrexate	rs7563206	ATIC	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs7563206:CT
methotrexate	rs7563206	ATIC	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs7563206:TT
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CC
methotrexate	rs2372536	ATIC	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs2372536:CC
methotrexate	rs2372536	ATIC	CG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs2372536:CG
methotrexate	rs4673993	ATIC	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs4673993:CT
methotrexate	rs4673993	ATIC	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs4673993:TT
candesartan	rs1275988	KCNK3	C	Efficacy	increased	Efficacy_Response	Other:C0020538		C09CA06	rs1275988:C
risperidone	rs1523130	NR1I2	CC	Metabolism/PK	decreased	LADME	Disease:C0005586|Disease:C0235876|Disease:C0036502		N05AX08	rs1523130:CC
sufentanil	rs1045642	ABCB1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	rs1045642:GG
adalimumab	rs763780	IL17F	TT	Efficacy	increased	Efficacy_Response	Healthy		L04AB04	rs763780:TT
immunoglobulins	rs113420705	CASP3, PRIMPOL	CT	Efficacy	decreased	Efficacy_Response	Disease:C0236036		J06B	rs113420705:CT
immunoglobulins	rs113420705	CASP3, PRIMPOL	TT	Efficacy	decreased	Efficacy_Response	Disease:C0236036		J06B	rs113420705:TT
sufentanil	rs4680	COMT	AA	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	rs4680:AA
warfarin	rs7294	VKORC1	CC	Dosage	decreased	LADME	Other:Heart_valve_replacement		B01AA03	rs7294:CC
immunoglobulins	rs28493229	COQ8B, ITPKC	CC	Efficacy	decreased	Efficacy_Response	Disease:C0236036		J06B	rs28493229:CC
immunoglobulins	rs28493229	COQ8B, ITPKC	CG	Efficacy	decreased	Efficacy_Response	Disease:C0236036		J06B	rs28493229:CG
ustekinumab	rs763780	IL17F	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs763780:TT
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1057910:AA
infliximab	rs763780	IL17F	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB02	rs763780:CT
hydrochlorothiazide	rs1378942	CSK	C	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs1378942:C
salbutamol	rs35661809	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Healthy		R03CC02	rs35661809:G
antipsychotics	rs6280	DRD3	CT	Efficacy	increased	Efficacy_Response	Other:C0040435|Other:C0036341		N05A	rs6280:CT
antipsychotics	rs6280	DRD3	TT	Efficacy	increased	Efficacy_Response	Other:C0040435|Other:C0036341		N05A	rs6280:TT
hydrochlorothiazide	rs12579720	PDE3A	C	Efficacy	increased	Efficacy_Response	Other:C0020538		C03AA03	rs12579720:C
candesartan	rs6722745	SULT1C3	T	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA06	rs6722745:T
atenolol	rs4387287	STN1	A	Efficacy	decreased	Efficacy_Response	Other:C0020538		C07AB03	rs4387287:A
metformin	rs10783050	__INTRONIC__	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs10783050:TT
metformin	rs1143623	IL1B	GG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs1143623:GG
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
warfarin	rs9923231	VKORC1	TT	Metabolism/PK	decreased	LADME	Healthy		B01AA03	rs9923231:TT
cisplatin, paclitaxel	rs1042522	TP53	CG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01CD01|L01XA01	rs1042522:CG
cisplatin, paclitaxel	rs1042522	TP53	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01CD01|L01XA01	rs1042522:GG
rifapentine	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:AA
rifapentine	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:AG
bevacizumab, pegaptanib, ranibizumab	rs2010963	VEGFA	CC	Efficacy	decreased	Efficacy_Response	Disease:Choroidal_Neovascularization		L01FG01|S01LA03|S01LA04	rs2010963:CC
epirubicin, fluorouracil, oxaliplatin	rs1800566	NQO1	AA	Efficacy	decreased	Efficacy_Response	Disease:C2939419|Disease:C0026640		L01BC02|L01DB03|L01XA03	rs1800566:AA
epirubicin, fluorouracil, oxaliplatin	rs1800566	NQO1	AG	Efficacy	decreased	Efficacy_Response	Disease:C2939419|Disease:C0026640		L01BC02|L01DB03|L01XA03	rs1800566:AG
warfarin	rs9923231	VKORC1	CT	Efficacy	increased	Dosage	Other:C0242698		B01AA03	rs9923231:CT
epirubicin, fluorouracil, oxaliplatin	rs662	PON1	CC	Efficacy	increased	Efficacy_Response	Disease:C2939419|Disease:C0026640		L01BC02|L01DB03|L01XA03	rs662:CC
risperidone	rs2276707	NR1I2	CC	Metabolism/PK	decreased	LADME	Disease:C0005586|Disease:C0235876|Disease:C0036502		N05AX08	rs2276707:CC
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs28399499:C
warfarin	rs9923231	VKORC1	CT	Efficacy	decreased	Efficacy_Response	Other:C0242698		B01AA03	rs9923231:CT
rituximab	rs396991	FCGR3A	C	Efficacy	increased	Efficacy_Response	Other:C0004364		L01FA01	rs396991:C
nicotine	rs16969968	CHRNA3, CHRNA5	AA	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA01	rs16969968:AA
nicotine	rs16969968	CHRNA3, CHRNA5	AG	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA01	rs16969968:AG
clozapine	rs2276302	HTR3A	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2276302:G
imatinib	rs2032582	ABCB1	AT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2032582:AT
imatinib	rs2032582	ABCB1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2032582:TT
imatinib	rs2231142	ABCG2	T	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2231142:T
telmisartan	rs5443	GNB3	TT	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C09CA07	rs5443:TT
efavirenz	rs8192719	CYP2B6	T	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs8192719:T
lithium, valproic acid	rs2769605	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N03AG01|N05AN01	rs2769605:CC
cisplatin, fluorouracil	rs7121	GNAS	CC	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs7121:CC
atenolol, metoprolol	rs1367094	ZMAT4	T	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB02|C07AB03	rs1367094:T
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs3745274:T
atenolol, hydrochlorothiazide, metoprolol	rs11313667	LRRC15	del	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03|C07AB02|C07AB03	rs11313667:del
ondansetron	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		A04AA01	rs776746:CC
lithium, olanzapine	rs1800497	DRD2	GG	Efficacy	increased	Efficacy_Response	Other:C0005586		N05AH03|N05AN01	rs1800497:GG
hmg coa reductase inhibitors	rs247616	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Healthy		C10AA	rs247616:T
boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|J05AP03|L03AB10|L03AB11	rs12979860:CC
adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab, methotrexate	rs7301582	KLRC1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AX03|R03BA	rs7301582:CC
hydrochlorothiazide	rs10224002	PRKAG2	A	Efficacy	increased	Efficacy_Response	Other:C0020538		C03AA03	rs10224002:A
agomelatine, melatonin receptor agonists, selective serotonin reuptake inhibitors, venlafaxine	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N05CH|N06AB|N06AX16|N06AX22	rs1045642:GG
adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab, methotrexate	rs2302489	KLRD1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AX03|R03BA	rs2302489:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
hydrochlorothiazide	rs932764	PLCE1	A	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs932764:A
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, simeprevir	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10|L03AB11	rs8099917:TT
metoprolol	rs1446468	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:C0020538		C07AB02	rs1446468:T
atenolol	rs9306160	RRP1B	T	Efficacy	increased	Efficacy_Response	Other:C0020538		C07AB03	rs9306160:T
atenolol	rs8068318	TBX2	C	Efficacy	decreased	Efficacy_Response	Other:C0020538		C07AB03	rs8068318:C
amisulpride	rs1079597	DRD2	C	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AL05	rs1079597:C
ustekinumab	rs2145623	NFKBIA	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs2145623:CC
hydrochlorothiazide	rs10995311	ADO	C	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs10995311:C
platinum compounds	rs2269577	XBP1	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs2269577:CC
candesartan	rs740406	DOT1L, PLEKHJ1	A	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA06	rs740406:A
ustekinumab	rs2787094	ADAM33	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs2787094:CC
hydrochlorothiazide	rs757081	NUCB2	C	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs757081:C
ustekinumab	rs1975974	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs1975974:AG
ustekinumab	rs1975974	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs1975974:GG
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT
exenatide	rs163184	KCNQ1	G	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BJ01	rs163184:G
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J05AG03	rs3745274:TT
ustekinumab	rs191190	AGBL4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs191190:CC
ustekinumab	rs191190	AGBL4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs191190:CT
nortriptyline	rs17060812	SLC39A14	C	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AA10	rs17060812:C
acenocoumarol	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA07	rs9923231:CC
ustekinumab	rs11591741	CHUK	CC	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs11591741:CC
ustekinumab	rs11591741	CHUK	CG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs11591741:CG
ustekinumab	rs6311	HTR2A	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs6311:CT
ustekinumab	rs6311	HTR2A	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs6311:TT
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC
warfarin	rs9923231	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CT
hydrochlorothiazide	rs12521868	C5orf56	G	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs12521868:G
pitavastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs4149056:CC
pitavastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs4149056:CT
candesartan	rs3184504	SH2B3	T	Efficacy	increased	Efficacy_Response	Other:C0020538		C09CA06	rs3184504:T
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
carbamazepine	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs776746:CC
2-hydroxyatorvastatin, 2-hydroxyatorvastatin lactone, 4-hydroxyatorvastatin, 4-hydroxyatorvastatin lactone, atorvastatin, atorvastatin lactone	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:C
carbamazepine	rs15524	CYP3A5	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs15524:AA
paroxetine	rs4680	COMT	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	rs4680:A
capecitabine, paclitaxel	rs1042522	TP53	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD01	rs1042522:GG
sufentanil	rs2242480	CYP3A4	CC	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	rs2242480:CC
triglycerides	rs749292	CYP19A1	A	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs749292:A
hdl cholesterol	rs1062033	CYP19A1	G	Other	increased	LADME	Disease:C1458155|Disease:C0025320		No_ATC	rs1062033:G
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Disease:C0026265		B01AA03	rs1057910:AA
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Other:heart_valve_replacement		B01AA03	rs9934438:AA
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
nortriptyline	rs2273623	PPM1A	AA	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AA10	rs2273623:AA
amiloride, spironolactone	rs1126742	CYP4A11	GG	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03DA01|C03DB01	rs1126742:GG
azathioprine, mercaptopurine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0021390		L01BB02|L04AX01	rs116855232:TT
deferasirox	rs3806596	UGT1A3	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs3806596:CC
lopinavir	rs776746	CYP3A5	C	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs776746:C
propofol	rs2279343	CYP2B6	AA	Metabolism/PK	decreased	LADME	Healthy		N01AX10	rs2279343:AA
propofol	rs2279343	CYP2B6	AG	Metabolism/PK	decreased	LADME	Healthy		N01AX10	rs2279343:AG
spironolactone	rs3890011	CYP4A11	CC	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03DA01	rs3890011:CC
opioids	rs1799971	OPRM1	AG	Dosage, Efficacy	increased	Dosage	Other:C0030193|Postoperative		N02A	rs1799971:AG
opioids	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Other:C0030193|Postoperative		N02A	rs1799971:GG
atazanavir	rs2472677	NR1I2	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE08	rs2472677:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs776746:TT
rifampicin	rs1803155	AADAC	AA	Metabolism/PK	decreased	LADME	Other:C0041296		J04AB02	rs1803155:AA
apatinib, apatinib metabolite m1-1	rs1934968	CYP2C9	GG	Metabolism/PK	increased	LADME	Other:C0027651		L01EH01	rs1934968:GG
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs11075995	FTO	AT	Efficacy	increased	Efficacy_Response	Other:C0027651		No_ATC	rs11075995:AT
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs11075995	FTO	TT	Efficacy	increased	Efficacy_Response	Other:C0027651		No_ATC	rs11075995:TT
amprenavir	rs4149056	SLCO1B1	C	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AE05	rs4149056:C
acamprosate	rs77583603	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Other:C0085762		N07BB03	rs77583603:G
everolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L01EG02	rs776746:CC
everolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L01EG02	rs776746:CT
naltrexone	rs12749274	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Other:C0085762		N07BB04	rs12749274:A
deferasirox	rs13120400	ABCG2	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs13120400:CC
fluvastatin	rs4149056	SLCO1B1	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs4149056:CC
fluvastatin	rs4149056	SLCO1B1	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs4149056:CT
ritonavir	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE03	rs1128503:AA
ritonavir	rs2032582	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE03	rs2032582:AA
fluvastatin	rs429358	APOE	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs429358:CC
ritonavir	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE03	rs1045642:AA
doxorubicin	rs20572	CBR1	CC	Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs20572:CC
dehydroaripiprazole	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Other:C0036341		N05AX12	rs762551:AA
clozapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0039338		N05AH02	rs762551:AA
ethanol	rs1799971	OPRM1	AA	Dosage	increased	Dosage	Healthy		V03AB16	rs1799971:AA
prednisolone	rs3824662	GATA3	AA	Efficacy	decreased	Efficacy_Response	Other:C0023449		S02BA03	rs3824662:AA
tacrolimus	rs7483	GSTM3	TT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs7483:TT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1051792	MICA	AG	Efficacy	increased	Efficacy_Response	Other:C0003873		No_ATC	rs1051792:AG
adalimumab	rs1799724	TNF	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB04	rs1799724:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1051792	MICA	GG	Efficacy	decreased	Efficacy_Response	Other:C0003873		No_ATC	rs1051792:GG
fluoxetine	rs130058	HTR1B	AA	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06AB03	rs130058:AA
fluoxetine	rs130058	HTR1B	TT	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06AB03	rs130058:TT
adalimumab	rs1800629	TNF	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB04	rs1800629:GG
clozapine	rs762551	CYP1A2	AA	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AH02	rs762551:AA
fluvastatin	rs7412	APOE	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs7412:TT
adalimumab	rs361525	TNF	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB04	rs361525:GG
morphine	rs1042173	SLC6A4	CC	Dosage	decreased	Dosage	Other:C0024121|Other:C0030193		N02AA01	rs1042173:CC
fluoxetine	rs4570625	TPH2	TT	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06AB03	rs4570625:TT
methotrexate	rs17004921	ADORA2A-AS1	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs17004921:CT
methotrexate	rs17004921	ADORA2A-AS1	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs17004921:TT
antiepileptics	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs2032582:AA
antiepileptics	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs1045642:AA
atenolol, hydrochlorothiazide	rs261316	ALDH1A2	T	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03|C07AB03	rs261316:T
cisplatin	rs462779	REV3L	AG	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01XA01	rs462779:AG
cisplatin	rs462779	REV3L	GG	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01XA01	rs462779:GG
cisplatin	rs3087403	REV1	CT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01XA01	rs3087403:CT
cisplatin	rs3087403	REV1	TT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01XA01	rs3087403:TT
antiepileptics	rs2298771	SCN1A	CC	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs2298771:CC
antiepileptics	rs2298771	SCN1A	CT	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs2298771:CT
azithromycin	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		S01AA26	rs2032582:AA
azithromycin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		S01AA26	rs1045642:AA
lopinavir	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs4149056:C
fentanyl	rs9384179	OPRM1	AA	Dosage, Efficacy	increased	Dosage	Side_Effect:C0030193|Postoperative		N02AB03	rs9384179:AA
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
fluvastatin	rs1057910	CYP2C9	AC	Metabolism/PK	increased	LADME	Healthy		C10AA04	rs1057910:AC
fentanyl	rs2835859	KCNJ6	TT	Dosage, Efficacy	increased	Dosage	Side_Effect:C0030193|Postoperative		N02AB03	rs2835859:TT
abiraterone	rs1047303	HSD3B1	AC	Metabolism/PK	increased	LADME	Other:C0033578		L02BX03	rs1047303:AC
fentanyl	rs2952768	__INTRONIC__	CC	Dosage, Efficacy	increased	Dosage	Side_Effect:C0030193|Postoperative		N02AB03	rs2952768:CC
fentanyl	rs11959113	__INTRONIC__	AA	Dosage, Efficacy	increased	Dosage	Side_Effect:C0030193|Postoperative		N02AB03	rs11959113:AA
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Heart_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Heart_transplantation		L04AD02	rs776746:TT
cyclophosphamide	rs3957356	GSTA1	CT	Efficacy, Toxicity, Metabolism/PK	decreased	Efficacy_Response	Disease:C0027697		L01AA01	rs3957356:CT
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
bilirubin	rs4880	SOD2	GG	Toxicity	increased	LADME	Other:C0023449		No_ATC	rs4880:GG
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
ethanol	rs1799971	OPRM1	AG	Other	increased	LADME	Healthy		V03AB16	rs1799971:AG
ethanol	rs1799971	OPRM1	GG	Other	increased	LADME	Healthy		V03AB16	rs1799971:GG
methylphenidate	rs5569	SLC6A2	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs5569:GG
tacrolimus	rs1057868	POR	CT	Metabolism/PK	increased	LADME	Disease:Heart_transplantation		L04AD02	rs1057868:CT
tacrolimus	rs1057868	POR	TT	Metabolism/PK	increased	LADME	Disease:Heart_transplantation		L04AD02	rs1057868:TT
montelukast	rs7604115	UGT1A3	T	Metabolism/PK	decreased	LADME	Healthy		R03DC03	rs7604115:T
montelukast	rs704212	ABCC9	T	Metabolism/PK	decreased	LADME	Healthy		R03DC03	rs704212:T
ivacaftor	rs77010898	CFTR	AA	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs77010898:AA
docetaxel, doxorubicin	rs1937840	AKR1C3	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02|L01DB01	rs1937840:GG
cyclophosphamide, doxorubicin	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs4244285:AA
cyclophosphamide, doxorubicin	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs4244285:AG
antidepressants	rs1954787	GRIK4	TT	Efficacy	decreased	Efficacy_Response	Other:C0011581		N06A	rs1954787:TT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Hematopoietic_stem_cell_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Other:Hematopoietic_stem_cell_transplantation		L04AD02	rs776746:TT
antidepressants	rs1954787	GRIK4	C	Efficacy	increased	Efficacy_Response	Other:C0011581		N06A	rs1954787:C
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Other:C0580417		B01AA03	rs1057910:AC
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
warfarin	rs7294	VKORC1	T	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs7294:T
warfarin	rs1057910	CYP2C9	A	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs1057910:A
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:AG
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:GG
buprenorphine	rs2075572	OPRM1	CC	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders		N07BC01	rs2075572:CC
buprenorphine	rs2075572	OPRM1	CG	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders		N07BC01	rs2075572:CG
selective serotonin (5ht1) agonists	rs2651899	PRDM16	C	Efficacy	increased	Efficacy_Response	Other:C0338480|Other:C0338480		No_ATC	rs2651899:C
afatinib	rs6785049	NR1I2	AA	Metabolism/PK	decreased	LADME	Other:C0007131		L01EB03	rs6785049:AA
afatinib	rs6785049	NR1I2	AG	Metabolism/PK	decreased	LADME	Other:C0007131		L01EB03	rs6785049:AG
warfarin	rs4917639	CYP2C9	C	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs4917639:C
lopinavir	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs4149056:CT
naltrexone	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1799971:AG
naltrexone	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1799971:GG
atazanavir	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs1128503:AG
atazanavir	rs1128503	ABCB1	GG	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs1128503:GG
antidepressants	rs1128503	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0011581		N06A	rs1128503:A
methadone	rs933271	COMT	CC	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	rs933271:CC
methadone	rs933271	COMT	CT	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	rs933271:CT
valproic acid	rs2070959	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	AG	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs2070959:AG
atazanavir	rs2032582	ABCB1	AC	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs2032582:AC
atazanavir	rs2032582	ABCB1	CC	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs2032582:CC
atazanavir	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs1045642:AG
atazanavir	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs1045642:GG
methotrexate	rs1801131	MTHFR	GT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:GT
methotrexate	rs1801131	MTHFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:TT
valproic acid	rs1019385	GRIN2B	AC	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AG01	rs1019385:AC
valproic acid	rs1019385	GRIN2B	CC	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AG01	rs1019385:CC
methotrexate	rs1051266	SLC19A1	CT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:CT
methotrexate	rs1051266	SLC19A1	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:TT
carbamazepine, clobazam, ethosuximide, lamotrigine, levetiracetam, oxcarbazepine, valproic acid	rs2298771	SCN1A	C	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AD01|N03AF01|N03AF02|N03AG01|N03AX09|N03AX14|N05BA09	rs2298771:C
lopinavir	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs4149056:C
valproic acid	rs1105879	UGT1A6	AC	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs1105879:AC
fluvastatin	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs4149056:TT
everolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:C1458155|Other:C0005967|Other:Neuroendocrine_Tumors		L01EG02	rs776746:CT
warfarin	rs2108622	CYP4F2	C	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2108622:C
amisulpride	rs8636	SNAP25	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AL05	rs8636:CT
clopidogrel	rs2487032	ABCA1	A	Metabolism/PK	increased	LADME	Healthy		B01AC04	rs2487032:A
clopidogrel	rs2254638	N6AMT1	G	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs2254638:G
tenofovir	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs2231142:GT
tenofovir	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs2231142:TT
sirolimus	rs2032582	ABCB1	A	Metabolism/PK	increased	LADME	Disease:Hematopoietic_stem_cell_transplantation		No_ATC	rs2032582:A
antipsychotics	rs12467557	NRXN1	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs12467557:AA
antipsychotics	rs10490162	NRXN1	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs10490162:TT
clopidogrel	rs4986893	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4986893:AA
dabigatran	rs8192935	CES1	GG	Metabolism/PK	increased	LADME	Disease:C0004238		B01AE07	rs8192935:GG
atazanavir	rs2032582	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE08	rs2032582:AA
adalimumab, certolizumab pegol, golimumab, infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Other:C0023370		L04AB02|L04AB04|L04AB05|L04AB06	rs1800629:GG
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:AA
tacrolimus	rs776746	CYP3A5	CC	Other, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
atazanavir	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE08	rs1045642:AA
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
bevacizumab	rs1061170	CFH	CC	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01	rs1061170:CC
valproic acid	rs2070959	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GG	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs2070959:GG
cisplatin, fluorouracil	rs3918290	DPYD	CT	Efficacy	decreased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		L01BC02|L01XA01	rs3918290:CT
cisplatin, docetaxel, irinotecan	rs861539	XRCC3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01CD02|L01CE02|L01XA01	rs861539:AA
valproic acid	rs6759892	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GG	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs6759892:GG
valproic acid	rs6759892	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GT	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs6759892:GT
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC
valproic acid	rs1105879	UGT1A6	CC	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs1105879:CC
10-monohydroxy oxcarbazepine	rs2396185	INSR	C	Metabolism/PK	decreased	LADME	Other:C0014544		N03AF02	rs2396185:C
atazanavir	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE08	rs1128503:AA
risperidone	rs6295	HTR1A	GG	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs6295:GG
fentanyl	rs3845446	CACNA1E	CC	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs3845446:CC
fentanyl	rs3845446	CACNA1E	CT	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs3845446:CT
fentanyl	rs2076222	LAMB3	G	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs2076222:G
cetuximab	rs833061	VEGFA	TT	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs833061:TT
cetuximab	rs1570360	VEGFA	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs1570360:GG
cisplatin, fluorouracil, mitoxantrone	rs1734791	MECP2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs1734791:A
cisplatin, fluorouracil, mitoxantrone	rs1734787	MECP2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs1734787:A
cisplatin, fluorouracil, mitoxantrone	rs17435	MECP2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs17435:A
voriconazole	rs2242480	CYP3A4	CT	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	J02AC03	rs2242480:CT
cisplatin, fluorouracil, mitoxantrone	rs5906072	__INTRONIC__	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs5906072:T
prochlorperazine	rs1800497	ANKK1, DRD2	AA	Efficacy	decreased	Efficacy_Response	Other:C0027497		No_ATC	rs1800497:AA
prochlorperazine	rs1800497	ANKK1, DRD2	AG	Efficacy	decreased	Efficacy_Response	Other:C0027497		No_ATC	rs1800497:AG
prochlorperazine	rs1079597	DRD2	CT	Efficacy	decreased	Efficacy_Response	Other:C0027497		No_ATC	rs1079597:CT
prochlorperazine	rs1079597	DRD2	TT	Efficacy	decreased	Efficacy_Response	Other:C0027497		No_ATC	rs1079597:TT
metformin	rs11212617	ATM	AC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs11212617:AC
morphine	rs1051660	OPRK1	A	Dosage, Efficacy	decreased	Dosage	Disease:C0030193		N02AA01	rs1051660:A
cisplatin, fluorouracil, mitoxantrone	rs12613732	GALNT14	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs12613732:G
cisplatin, fluorouracil, mitoxantrone	rs5009910	GALNT14	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs5009910:C
atorvastatin	rs17671591	HMGCR	CT	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs17671591:CT
atorvastatin	rs17671591	HMGCR	TT	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs17671591:TT
escitalopram	rs1800532	TPH1	GT	Efficacy	decreased	Efficacy_Response	Other:C0235876		N06AB10	rs1800532:GT
escitalopram	rs1800532	TPH1	TT	Efficacy	decreased	Efficacy_Response	Other:C0235876		N06AB10	rs1800532:TT
cisplatin, fluorouracil, mitoxantrone	rs6752303	GALNT14	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs6752303:C
tenofovir alafenamide	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Healthy		J05AF13	rs35599367:AG
cisplatin, fluorouracil, mitoxantrone	rs10209881	GALNT14	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs10209881:C
dabigatran	rs2244613	CES1	GG	Metabolism/PK	decreased	LADME	Disease:C0004238		B01AE07	rs2244613:GG
clopidogrel	rs4244285	CYP2C19	A	Metabolism/PK	increased	Dosage	Healthy	poor metabolizer	B01AC04	rs4244285:A
cisplatin, fluorouracil, mitoxantrone	rs12999804	GALNT14	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs12999804:A
tacrolimus	rs2740574	CYP3A4	TT	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2740574:TT
apatinib, apatinib metabolite m1-1	rs34532201	CYP2C9	TT	Metabolism/PK	increased	LADME	Other:C0027651		L01EH01	rs34532201:TT
cisplatin, fluorouracil, mitoxantrone	rs5934731	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs5934731:C
cisplatin, fluorouracil, mitoxantrone	rs715171	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs715171:C
cisplatin, fluorouracil, mitoxantrone	rs4932551	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs4932551:C
cisplatin, fluorouracil, mitoxantrone	rs7170769	__INTRONIC__	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs7170769:T
cisplatin, fluorouracil, mitoxantrone	rs6458232	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs6458232:C
cisplatin, fluorouracil, mitoxantrone	rs7608731	GALNT14	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs7608731:C
allopurinol, febuxostat	rs3731722	AOX1	G	Dosage	Indeterminado	Dosage	Disease:C0018099		M04AA01|M04AA03	rs3731722:G
pazopanib	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Other:C0027651		L01EX03	rs35599367:AG
rituximab	rs6822844	IL2	GG	Efficacy	increased	Efficacy_Response	Disease:C0004364		L01FA01	rs6822844:GG
rituximab	rs6822844	IL2	GG	Efficacy	increased	Efficacy_Response	Disease:C0024141		L01FA01	rs6822844:GG
allopurinol, febuxostat	rs11678615	AOX1	T	Dosage	Indeterminado	Dosage	Disease:C0018099		M04AA01|M04AA03	rs11678615:T
methotrexate	rs1801131	MTHFR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:GG
diazepam	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N05BA01	rs1128503:AA
allopurinol, febuxostat	rs34650714	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	T	Dosage	decreased	Dosage	Disease:C0018099		M04AA01|M04AA03	rs34650714:T
allopurinol, febuxostat	rs1884725	XDH	G	Dosage	decreased	Dosage	Disease:C0018099		M04AA01|M04AA03	rs1884725:G
allopurinol, febuxostat	rs75995567	AOX1	T	Dosage	increased	Dosage	Disease:C0018099		M04AA01|M04AA03	rs75995567:T
metformin	rs622342	SLC22A1	AC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs622342:AC
propofol, remifentanil	rs1128503	ABCB1	GG	Efficacy	increased	Efficacy_Response	Healthy		N01AH06|N01AX10	rs1128503:GG
methotrexate	rs4148416	ABCC3	TT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs4148416:TT
tacrolimus	rs2740574	CYP3A4	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2740574:TT
methotrexate	rs17004785	SLC19A1	CG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs17004785:CG
donepezil	rs1803274	BCHE	T	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA02	rs1803274:T
cisplatin, doxorubicin, methotrexate	rs2236225	MTHFD1	AA	Efficacy	increased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs2236225:AA
cisplatin, doxorubicin, methotrexate	rs2236225	MTHFD1	AG	Efficacy	increased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs2236225:AG
cisplatin, fluorouracil, mitoxantrone	rs9679162	GALNT14	TT	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs9679162:TT
paroxetine	rs2973049	GDNF	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs2973049:CT
paroxetine	rs2973049	GDNF	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs2973049:TT
paroxetine	rs2216711	GDNF	AA	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs2216711:AA
paroxetine	rs2216711	GDNF	AG	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs2216711:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4819554	IL17RA	AA	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs4819554:AA
atomoxetine	rs3785143	SLC6A2	T	Efficacy	decreased	Efficacy_Response	Disease:C1263846		N06BA09	rs3785143:T
paroxetine	rs6265	BDNF	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs6265:CC
paroxetine	rs6265	BDNF	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs6265:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs396991	FCGR3A	AC	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs396991:AC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs396991:CC
rosuvastatin	rs5882	CETP	G	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs5882:G
fluoxetine	rs1135840	CYP2D6	C	Metabolism/PK	increased	LADME	Healthy		N06AB03	rs1135840:C
disulfiram	rs1611115	DBH	CC	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB01	rs1611115:CC
risperidone	rs9606186	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs9606186:GG
rivaroxaban	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs1045642:AA
rivaroxaban	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs1045642:AG
tacrolimus	rs10052999	C6	CC	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs10052999:CC
tacrolimus	rs10052999	C6	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs10052999:TT
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:GG
tacrolimus	rs9200	C6	CC	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs9200:CC
tacrolimus	rs9200	C6	CT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs9200:CT
cisplatin, doxorubicin, methotrexate	rs717620	ABCC2	CT	Efficacy	decreased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs717620:CT
cisplatin, doxorubicin, methotrexate	rs717620	ABCC2	TT	Efficacy	decreased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs717620:TT
risperidone	rs2661319	RGS4	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs2661319:C
lamotrigine	rs628031	SLC22A1	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs628031:AA
lamotrigine	rs628031	SLC22A1	AG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs628031:AG
risperidone	rs1800497	ANKK1	A	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs1800497:A
tacrolimus	rs2740574	CYP3A4	CT	Metabolism/PK	increased	Dosage	Other:C0277631		L04AD02	rs2740574:CT
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
cisplatin, doxorubicin, methotrexate	rs1695	GSTP1	AG	Efficacy	decreased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1695:AG
cisplatin, doxorubicin, methotrexate	rs1695	GSTP1	GG	Efficacy	decreased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1695:GG
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT
phenytoin	rs1057910	CYP2C9	C	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AB02	rs1057910:C
carbamazepine	rs3812718	SCN1A	TT	Dosage	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:TT
phenytoin	rs3812718	SCN1A	T	Dosage	increased	Dosage	Disease:C0014544		N03AB02	rs3812718:T
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT
tacrolimus	rs2032582	ABCB1	T	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:T
alpha-hydroxymetoprolol	rs28371738	CYP2D6	A	Metabolism/PK	increased	LADME	Healthy		C07AB02	rs28371738:A
rivaroxaban	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs1128503:AG
rivaroxaban	rs1128503	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs1128503:GG
fluvoxamine, milnacipran, paroxetine	rs6295	HTR1A	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08|N06AX17	rs6295:GG
lansoprazole	rs1045642	ABCB1	G	Other, Metabolism/PK	increased	LADME	Healthy		A02BC03	rs1045642:G
fluvoxamine, milnacipran, paroxetine	rs10042486	HTR1A	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08|N06AX17	rs10042486:CC
lamotrigine	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs2231142:TT
rivaroxaban	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs1045642:AG
rivaroxaban	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs1045642:GG
rivaroxaban	rs4148738	ABCB1	T	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs4148738:T
phenytoin	rs1934969	CYP2C9	AT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	rs1934969:AT
phenytoin	rs1934969	CYP2C9	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	rs1934969:TT
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Disease:C0004238|Disease:Heart_valve_replacement|Disease:C0020542|Disease:C0034065|Disease:C0042487		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Disease:C0004238|Disease:Heart_valve_replacement|Disease:C0020542|Disease:C0034065|Disease:C0042487		B01AA03	rs9923231:TT
hmg coa reductase inhibitors	rs4420638	APOC1	G	Efficacy	decreased	Efficacy_Response	Disease:C0007222|Disease:C0020443		C10AA	rs4420638:G
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Disease:C0004238|Disease:Heart_valve_replacement|Disease:C0020542|Disease:C0034065|Disease:C0042487		B01AA03	rs1057910:AC
warfarin	rs1057910	CYP2C9	CC	Dosage	decreased	Dosage	Disease:C0004238|Disease:Heart_valve_replacement|Disease:C0020542|Disease:C0034065|Disease:C0042487		B01AA03	rs1057910:CC
photodynamic therapy	rs5985	F13A1	AA	Efficacy	decreased	Efficacy_Response	Disease:Choroidal_Neovascularization		No_ATC	rs5985:AA
photodynamic therapy	rs5985	F13A1	AC	Efficacy	decreased	Efficacy_Response	Disease:Choroidal_Neovascularization		No_ATC	rs5985:AC
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Disease:C0004238|Disease:Heart_valve_replacement|Disease:C0020542|Disease:C0034065|Disease:C0042487		B01AA03	rs2108622:TT
citalopram	rs1800532	TPH1	GT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs1800532:GT
citalopram	rs1800532	TPH1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs1800532:TT
hmg coa reductase inhibitors	rs2072183	NPC1L1	G	Efficacy	decreased	Efficacy_Response	Disease:C0007222|Disease:C0020443		C10AA	rs2072183:G
hmg coa reductase inhibitors	rs629301	SORT1	T	Efficacy	decreased	Efficacy_Response	Disease:C0007222|Disease:C0020443		C10AA	rs629301:T
mycophenolic acid	rs3832043	UGT1A9	del	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AA06	rs3832043:del
bisoprolol	rs2514036	ACY3	T	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB07	rs2514036:T
mycophenolic acid	rs2306283	SLCO1B1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AA06	rs2306283:AA
mycophenolic acid	rs2306283	SLCO1B1	AG	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AA06	rs2306283:AG
imatinib	rs724710	BCL2L11	T	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs724710:T
fluorouracil	rs3918290	DPYD	CT	Metabolism/PK	decreased	LADME	Disease:C0023055		L01BC02	rs3918290:CT
itopride	rs2266782	FMO3	AA	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266782:AA
metoprolol	rs56234624	SEPTIN3	G	Metabolism/PK	increased	LADME	Healthy		C07AB02	rs56234624:G
itopride	rs2266780	FMO3	GG	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266780:GG
alemtuzumab, chlorambucil, cyclophosphamide, fludarabine, prednisone, rituximab, vincristine	rs1801157	CXCL12	CT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		H02AB07|L01AA01|L01AA02|L01BB05|L01CA02|L01FA01	rs1801157:CT
alemtuzumab, chlorambucil, cyclophosphamide, fludarabine, prednisone, rituximab, vincristine	rs1801157	CXCL12	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		H02AB07|L01AA01|L01AA02|L01BB05|L01CA02|L01FA01	rs1801157:TT
mycophenolic acid	rs3740066	ABCC2	CT	Metabolism/PK	decreased	LADME	Disease:Lung_transplantation		L04AA06	rs3740066:CT
gemcitabine	rs9937	RRM1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05	rs9937:AA
tacrolimus	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs1045642:AA
tacrolimus	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs1045642:AG
bevacizumab	rs4073	CXCL8	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01	rs4073:AA
gemcitabine	rs183484	RRM1	AC	Efficacy, Toxicity	decreased	Efficacy_Response	Disease:C0030297		L01BC05	rs183484:AC
hydrochlorothiazide	rs4149601	NEDD4L	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4149601:AG
hydrochlorothiazide	rs4149601	NEDD4L	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4149601:GG
sn-38(irinotecan)	rs4148323	UGT1A1	AA	Dosage	increased	LADME	Other:C0007131		L01CE02	rs4148323:AA
cotinine	rs12471326	UGT1A9	CT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs12471326:CT
nicotine	rs145014075	CYP2A6	GT	Metabolism/PK	increased	LADME	Healthy		N07BA01	rs145014075:GT
bevacizumab, ranibizumab	rs3025000	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01|S01LA04	rs3025000:CT
bevacizumab, ranibizumab	rs3025000	VEGFA	TT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01|S01LA04	rs3025000:TT
cyclosporine	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Healthy		L04AD01	rs776746:CC
cyclosporine	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Healthy		L04AD01	rs776746:CT
granisetron	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Side_Effect:C0027497|Side_Effect:C0042963		A04AA02	rs1045642:AA
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Other:C0085605		B01AA03	rs9923231:CC
warfarin	rs9923231	VKORC1	CT	Dosage	increased	Dosage	Other:C0085605		B01AA03	rs9923231:CT
carbamazepine	rs3812718	SCN1A	CC	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AF01	rs3812718:CC
carbamazepine	rs3812718	SCN1A	CT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AF01	rs3812718:CT
bevacizumab, ranibizumab	rs3025000	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01|S01LA04	rs3025000:CT
bevacizumab, ranibizumab	rs3025000	VEGFA	TT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01|S01LA04	rs3025000:TT
carbamazepine	rs3812718	SCN1A	TT	Dosage	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:TT
etanercept	rs6427528	CD84	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB01	rs6427528:AG
lopinavir	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs4149056:CC
lopinavir	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs4149056:CT
carbamazepine	rs2298771	SCN1A	TT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AF01	rs2298771:TT
methadone	rs10485058	OPRM1	AA	Efficacy	increased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs10485058:AA
carbamazepine	rs2290732	GABRA1	AA	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AF01	rs2290732:AA
carbamazepine	rs2290732	GABRA1	AG	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AF01	rs2290732:AG
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
ustekinumab	rs3213094	IL12B	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs3213094:CT
gemcitabine	rs2072671	CDA	AA	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs2072671:AA
tocilizumab	rs11265618	IL6R	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs11265618:CC
tocilizumab	rs12083537	IL6R	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs12083537:AA
efavirenz	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2032582:AA
alfentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Disease:C0030193		N01AH02	rs1799971:AG
alfentanil	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Disease:C0030193		N01AH02	rs1799971:GG
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
efavirenz	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs1045642:AA
cetuximab	rs396991	FCGR3A	AA	Efficacy	increased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		No_ATC	rs396991:AA
cetuximab	rs1801274	FCGR2A	GG	Efficacy	increased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		No_ATC	rs1801274:GG
efavirenz	rs1884613	HNF4A	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs1884613:CC
methadone	rs2760118	ALDH5A1	CT	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs2760118:CT
methadone	rs2760118	ALDH5A1	TT	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs2760118:TT
atazanavir	rs887829	UGT1A1	TT	Toxicity	increased	Adverse_Event	Healthy		J05AE08	rs887829:TT
platinum compounds	rs25487	XRCC1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C0026640		L01XA	rs25487:CT
platinum compounds	rs25487	XRCC1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C0026640		L01XA	rs25487:TT
olanzapine	rs1880676	CHAT	A	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs1880676:A
pravastatin	rs113646094	ABCC2	CG	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs113646094:CG
ramipril	rs4359	ACE	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs4359:CC
ramipril	rs4359	ACE	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs4359:TT
ramipril	rs4344	ACE	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs4344:AA
ramipril	rs4344	ACE	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs4344:GG
warfarin	rs2108622	CYP4F2	T	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs2108622:T
tacrolimus	rs776746	CYP3A5	CT	Efficacy	decreased	LADME	Other:C0017658|Membranous		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Efficacy	decreased	LADME	Other:C0017658|Membranous		L04AD02	rs776746:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs8099917:TT
oxycodone	rs581111	OPRD1	AA	Efficacy	decreased	Efficacy_Response	Healthy		N02AA05	rs581111:AA
oxycodone	rs581111	OPRD1	AG	Efficacy	decreased	Efficacy_Response	Healthy		N02AA05	rs581111:AG
peginterferon alfa-2b, ribavirin	rs1049174	KLRK1	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs1049174:GG
citalopram	rs2270007	CRHR2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs2270007:CC
citalopram	rs2270007	CRHR2	CG	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs2270007:CG
rifampicin	rs3732357	NR1I2	AA	Metabolism/PK	decreased	LADME	Other:C0041296		J04AB02	rs3732357:AA
rifampicin	rs3732357	NR1I2	AG	Metabolism/PK	decreased	LADME	Other:C0041296		J04AB02	rs3732357:AG
methotrexate	rs1051266	SLC19A1	CT	Metabolism/PK	decreased	LADME	Other:C0029463		L04AX03	rs1051266:CT
methotrexate	rs1051266	SLC19A1	TT	Metabolism/PK	decreased	LADME	Other:C0029463		L04AX03	rs1051266:TT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs12979860:CC
oxycodone	rs6848893	__INTRONIC__	CT	Efficacy	decreased	Efficacy_Response	Healthy		N02AA05	rs6848893:CT
platinum compounds	rs9535826	ATP7B	G	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs9535826:G
antidepressants	rs6313	HTR2A	AA	Efficacy	increased	Efficacy_Response	Other:C0005586|Other:C0235876|Other:C0011581		N06A	rs6313:AA
antidepressants	rs6313	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0005586|Other:C0235876|Other:C0011581		N06A	rs6313:AG
platinum compounds	rs9535828	ATP7B	A	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs9535828:A
risperidone	rs4795893	CCL2	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs4795893:AA
risperidone	rs4795893	CCL2	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs4795893:AG
risperidone	rs4586	CCL2	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs4586:CC
risperidone	rs4586	CCL2	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs4586:CT
ethanol	rs1799971	OPRM1	AG	Toxicity	decreased	LADME	Healthy		V03AB16	rs1799971:AG
ethanol	rs1799971	OPRM1	GG	Toxicity	decreased	LADME	Healthy		V03AB16	rs1799971:GG
methotrexate	rs1544105	FPGS	TT	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs1544105:TT
acenocoumarol	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:T
methotrexate	rs1544105	FPGS	TT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1544105:TT
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
atorvastatin, rosuvastatin, simvastatin	rs769705621	ABCA1	AAAA	Efficacy	decreased	Efficacy_Response	Other:C0342881		C10AA01|C10AA05|C10AA07	rs769705621:AAAA
corticosteroids, selective beta-2-adrenoreceptor agonists	rs1042713	ADRB2	A	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC|S02BA	rs1042713:A
risperidone	rs2857657	CCL2	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs2857657:GG
lamotrigine	rs2011425	UGT1A4	TT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AX09	rs2011425:TT
mercaptopurine	rs1127354	ITPA	A	Metabolism/PK	Indeterminado	LADME	Disease:C0023449		L01BB02	rs1127354:A
lamotrigine	rs2011425	UGT1A4	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs2011425:TT
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C
olanzapine	rs34059508	SLC22A1	AG	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs34059508:AG
efavirenz	rs28399499	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC
nicotine	rs4950	CHRNB3	G	Efficacy, Other	increased	Efficacy_Response	Other:smokers		N07BA01	rs4950:G
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
platinum compounds	rs1412125	HMGB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs1412125:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs352139	TLR9	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs352139:CT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs352139	TLR9	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs352139:TT
nicotine	rs13280604	CHRNB3	G	Efficacy, Other	increased	Efficacy_Response	Other:smokers		N07BA01	rs13280604:G
warfarin	rs749671	VKORC1	G	Dosage	increased	Dosage	Healthy		B01AA03	rs749671:G
olanzapine	rs3842	ABCB1	T	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs3842:T
platinum compounds	rs2249825	HMGB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs2249825:GG
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T
efavirenz	rs2279343	CYP2B6	G	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:G
cisplatin, radiotherapy	rs25487	XRCC1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C0039338		L01XA01	rs25487:TT
losartan	rs4291	ACE	AT	Efficacy	increased	Efficacy_Response	Other:C0020538		C09CA01	rs4291:AT
losartan	rs4291	ACE	TT	Efficacy	increased	Efficacy_Response	Other:C0020538		C09CA01	rs4291:TT
vegf/vegfr (vascular endothelial growth factor) inhibitors	rs699947	VEGFA	AC	Efficacy	increased	Efficacy_Response	Other:C0024437		L01EK	rs699947:AC
vegf/vegfr (vascular endothelial growth factor) inhibitors	rs699947	VEGFA	CC	Efficacy	increased	Efficacy_Response	Other:C0024437		L01EK	rs699947:CC
oxycodone	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Healthy		N02AA05	rs4680:AA
oxycodone	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Healthy		N02AA05	rs4680:AG
adalimumab, infliximab	rs2546890	IL12B	AA	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs2546890:AA
adalimumab, infliximab	rs2546890	IL12B	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs2546890:AG
tacrolimus	rs2740574	CYP3A4	T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2740574:T
adalimumab, infliximab	rs6661932	IVL	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs6661932:CT
adalimumab, infliximab	rs6661932	IVL	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs6661932:TT
opioids	rs4680	COMT	AA	Dosage	increased	Dosage	Other:C0030193		N02A	rs4680:AA
opioids	rs4680	COMT	AG	Dosage	increased	Dosage	Other:C0030193		N02A	rs4680:AG
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
ustekinumab	rs8177374	TIRAP	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs8177374:CT
ustekinumab	rs8177374	TIRAP	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs8177374:TT
nicotine	rs1799971	OPRM1	AG	Other	increased	LADME	Other:C0036341		N07BA01	rs1799971:AG
nicotine	rs1799971	OPRM1	GG	Other	increased	LADME	Other:C0036341		N07BA01	rs1799971:GG
ustekinumab	rs5744174	TLR5	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs5744174:AG
ustekinumab	rs5744174	TLR5	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs5744174:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11938228	TLR2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs11938228:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11938228	TLR2	AC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs11938228:AC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11465996	LY96	CG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs11465996:CG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11465996	LY96	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs11465996:GG
rivaroxaban	rs467387	BRD3	AA	PD	increased	Efficacy_Response	Healthy		B01AF01	rs467387:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4696480	TLR2	AT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs4696480:AT
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4696480	TLR2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs4696480:TT
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:C
tumor necrosis factor alpha (tnf-alpha) inhibitors, ustekinumab	rs1143623	IL1B	CG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs1143623:CG
tumor necrosis factor alpha (tnf-alpha) inhibitors, ustekinumab	rs1143623	IL1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs1143623:GG
warfarin	rs1045642	ABCB1	A	Dosage	increased	Dosage	Healthy		B01AA03	rs1045642:A
warfarin	rs429358	APOE	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs429358:CC
warfarin	rs429358	APOE	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs429358:CT
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors, ustekinumab	rs1143627	IL1B	AG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs1143627:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors, ustekinumab	rs1143627	IL1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs1143627:GG
repaglinide	rs2276706	NR1I2	GG	Metabolism/PK	decreased	LADME	Healthy		A10BX02	rs2276706:GG
cotinine	rs510769	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs510769:T
risperidone	rs9606186	COMT	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs9606186:C
repaglinide	rs3814058	NR1I2	CC	Metabolism/PK	decreased	LADME	Healthy		A10BX02	rs3814058:CC
atezolizumab, bevacizumab	rs16906115	IL7	AA	Efficacy	decreased	Efficacy_Response	Other:C2239176		L01FG01	rs16906115:AA
cotinine	rs12209447	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs12209447:T
risperidone	rs2020917	COMT	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs2020917:C
cotinine	rs3798676	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs3798676:T
warfarin	rs2359612	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:A
fentanyl	rs1045642	ABCB1	AA	Dosage	decreased	Dosage	Healthy		N02AB03	rs1045642:AA
risperidone	rs933271	COMT	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs933271:C
cotinine	rs553202	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs553202:T
cotinine	rs1074287	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs1074287:G
methadone	rs529520	OPRD1	AA	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs529520:AA
methadone	rs529520	OPRD1	AC	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs529520:AC
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC
cotinine	rs1799971	OPRM1	A	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs1799971:A
cotinine	rs6912029	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs6912029:T
prednisone	rs5333	EDNRA	CC	Efficacy	increased	Efficacy_Response	Disease:C0027726		H02AB07	rs5333:CC
prednisone	rs5333	EDNRA	CT	Efficacy	increased	Efficacy_Response	Disease:C0027726		H02AB07	rs5333:CT
repaglinide	rs3814058	NR1I2	CC	Metabolism/PK	increased	LADME	Healthy		A10BX02	rs3814058:CC
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs1927907	TLR4	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs1927907:CC
pazopanib	rs3814055	NR1I2	T	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs3814055:T
acenocoumarol	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Disease:C0004238		B01AA07	rs2108622:T
adalimumab, infliximab	rs9304742	ZNF816	CC	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs9304742:CC
adalimumab, infliximab	rs9304742	ZNF816	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs9304742:CT
acenocoumarol	rs1043550	CALU	G	Dosage	increased	Dosage	Disease:C0004238		B01AA07	rs1043550:G
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT
tacrolimus	rs1946518	IL18	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1946518:GG
tacrolimus	rs1946518	IL18	GT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1946518:GT
adalimumab, infliximab	rs2145623	NFKBIA	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs2145623:CC
adalimumab, infliximab	rs2145623	NFKBIA	CG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs2145623:CG
adalimumab, infliximab	rs1061624	TNFRSF1B	AG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs1061624:AG
adalimumab, infliximab	rs1061624	TNFRSF1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs1061624:GG
repaglinide	rs2276706	NR1I2	GG	Metabolism/PK	increased	LADME	Healthy		A10BX02	rs2276706:GG
adalimumab, infliximab	rs645544	SLC9A8	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs645544:GG
fluorouracil, platinum compounds, radiotherapy	rs10040363	XRCC4	G	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01XA	rs10040363:G
fluorouracil, platinum compounds, radiotherapy	rs2075685	XRCC4	T	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01XA	rs2075685:T
mycophenolic acid	rs4149056	SLCO1B1	TT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AA06	rs4149056:TT
hmg coa reductase inhibitors	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA	rs4149056:TT
fluorouracil, platinum compounds, radiotherapy	rs2298881	ERCC1	A	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC02|L01XA	rs2298881:A
cotinine	rs563649	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs563649:T
cotinine	rs2075572	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs2075572:G
simvastatin	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs4149056:TT
cotinine	rs7748401	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs7748401:G
cotinine	rs495491	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs495491:G
cotinine	rs10457090	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs10457090:G
cotinine	rs3778152	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs3778152:G
pravastatin	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA03	rs4149056:TT
cotinine	rs589046	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs589046:T
methotrexate	rs3814055	NR1I2	T	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs3814055:T
methotrexate	rs2306283	SLCO1B1	AA	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs2306283:AA
methotrexate	rs2306283	SLCO1B1	AG	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs2306283:AG
methotrexate	rs4793665	ABCC3	C	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs4793665:C
methotrexate	rs7643038	NR1I2	G	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs7643038:G
methotrexate	rs9282564	ABCB1	C	Metabolism/PK	increased	LADME	Healthy		L04AX03	rs9282564:C
methotrexate	rs2231142	ABCG2	T	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs2231142:T
glucocorticoids	rs17446593	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Other:C0040034		R03BA	rs17446593:AA
dabigatran glucuronide	rs1902023	UGT2B15	AA	Metabolism/PK	decreased	LADME	Healthy		B01AE07	rs1902023:AA
sunitinib	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		L01EX01	rs776746:CC
clozapine	rs10465180	NTRK2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH02	rs10465180:CC
warfarin	rs9332238	CYP2C9	G	Dosage	increased	Dosage	Healthy		B01AA03	rs9332238:G
clopidogrel	rs6809699	P2RY12	AA	Efficacy	increased	Efficacy_Response	Other:C0010068		B01AC04	rs6809699:AA
clopidogrel	rs6809699	P2RY12	AC	Efficacy	increased	Efficacy_Response	Other:C0010068		B01AC04	rs6809699:AC
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs3745274:T
doxorubicin	rs20572	CBR1	CC	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs20572:CC
selective serotonin reuptake inhibitors	rs1800544	ADRA2A	CG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB	rs1800544:CG
erlotinib	rs1045642	ABCB1	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0007131		L01EB02	rs1045642:AA
erlotinib	rs1128503	ABCB1	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0007131		L01EB02	rs1128503:AA
methotrexate	rs28364006	ABCC1	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AX03	rs28364006:GG
dolutegravir	rs2472677	NR1I2	TT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AJ03	rs2472677:TT
erlotinib	rs2032582	ABCB1	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0007131		L01EB02	rs2032582:AA
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
losartan	rs5186	AGTR1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C09CA01	rs5186:CC
clopidogrel	rs2305948	KDR	T	Efficacy	decreased	Efficacy_Response	Disease:C0010068		B01AC04	rs2305948:T
lamotrigine	rs7668258	UGT2B7	CT	Dosage	increased	Dosage	Other:C0014544		N03AX09	rs7668258:CT
lamotrigine	rs7668258	UGT2B7	TT	Dosage	increased	Dosage	Other:C0014544		N03AX09	rs7668258:TT
mercaptopurine	rs73189762	NUDT15	T	Dosage	decreased	Dosage	Other:C0023449		L01BB02	rs73189762:T
metformin	rs143276236	ARFGEF3	AC	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs143276236:AC
trastuzumab	rs1136201	ERBB2	G	Toxicity	Indeterminado	Efficacy_Response	Healthy		No_ATC	rs1136201:G
doxorubicin	rs9024	CBR1	GG	Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs9024:GG
metformin	rs7541245	PRKAB2	A	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs7541245:A
azathioprine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0021390|Disease:C0023449		L04AX01	rs116855232:CT
azathioprine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0021390|Disease:C0023449		L04AX01	rs116855232:TT
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
tacrolimus	rs1057868	POR	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT
tacrolimus	rs1057868	POR	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT
doxorubicin	rs9024	CBR1	GG	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs9024:GG
doxorubicin	rs9024	CBR1	GG	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs9024:GG
pramipexole	rs6280	DRD3	T	Efficacy	increased	Efficacy_Response	Healthy		N04BC05	rs6280:T
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT
warfarin	rs7196161	VKORC1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs7196161:GG
antidepressants, benzodiazepine derivatives, mirtazapine, selective serotonin reuptake inhibitors	rs948854	GAL	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N05CD|N06A|N06AB|N06AX11	rs948854:C
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:GG
sufentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0032961		N01AH03	rs1799971:AG
sufentanil	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0032961		N01AH03	rs1799971:GG
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC
tacrolimus	rs41303343	CYP3A5	A	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs41303343:A
metformin	rs628031	SLC22A1	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs628031:GG
tacrolimus	rs10264272	CYP3A5	T	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs10264272:T
warfarin	rs2884737	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs2884737:AA
warfarin	rs61742245	VKORC1	A	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:A
tacrolimus	rs776746	CYP3A5	C	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:C
mycophenolic acid	rs717620	ABCC2	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AA06	rs717620:CC
warfarin	rs2359612	PRSS53, VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:A
caffeine	rs762551	CYP1A2	AA	Other, Metabolism/PK	increased	LADME	Disease:C0039338		N06BC01	rs762551:AA
doxorubicin	rs20572	CBR1	CC	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs20572:CC
warfarin	rs11676382	GGCX	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:CG
caffeine	rs762551	CYP1A2	AA	Other, Metabolism/PK	increased	LADME	Other:heavy_coffee_consumption		N06BC01	rs762551:AA
ticagrelor	rs4661012	PEAR1	GT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC24	rs4661012:GT
ticagrelor	rs4661012	PEAR1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC24	rs4661012:TT
methotrexate	rs2372536	ATIC	GG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AX03	rs2372536:GG
tacrolimus	rs35599367	CYP3A4	AA	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs35599367:AA
tacrolimus	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs35599367:AG
ticagrelor	rs12566888	PEAR1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AC24	rs12566888:TT
tacrolimus	rs2740574	CYP3A4	C	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs2740574:C
tacrolimus	rs35599367	CYP3A4	A	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs35599367:A
ticagrelor	rs12041331	PEAR1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC24	rs12041331:AA
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs776746:TT
ticagrelor	rs12041331	PEAR1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC24	rs12041331:AA
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:TT
warfarin	rs7294	PRSS53, VKORC1	T	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:T
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2069885	IL9	AA	Efficacy	increased	Efficacy_Response	Other:C0038012|Ankylosing		No_ATC	rs2069885:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2069885	IL9	AG	Efficacy	increased	Efficacy_Response	Other:C0038012|Ankylosing		No_ATC	rs2069885:AG
rituximab	rs396991	FCGR3A	AA	Efficacy	decreased	Efficacy_Response	Disease:C0030353		L01FA01	rs396991:AA
prednisolone	rs1883832	CD40	CC	Efficacy	decreased	Efficacy_Response	Other:C0040034		S02BA03	rs1883832:CC
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs776746:TT
metformin	rs2289669	SLC47A1	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs2289669:AA
erenumab	rs6710852	CALCRL	G	Efficacy	increased	Efficacy_Response	Other:C0338480|Other:C0338480		N02CD01	rs6710852:G
tacrolimus	rs2032582	ABCB1	AA	Dosage, Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs2032582:AA
tacrolimus	rs2032582	ABCB1	TT	Dosage, Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs2032582:TT
warfarin	rs7294	VKORC1	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs7294:CC
halothane	rs118192161	RYR1	T	Other	increased	Efficacy_Response	Healthy		N01AB01	rs118192161:T
warfarin	rs8050894	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs8050894:CC
warfarin	rs2359612	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs2359612:GG
2-hydroxyatorvastatin	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs35599367:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2069812	IL5	AA	Efficacy	increased	Efficacy_Response	Other:C0038012|Ankylosing		No_ATC	rs2069812:AA
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2069812	IL5	AG	Efficacy	increased	Efficacy_Response	Other:C0038012|Ankylosing		No_ATC	rs2069812:AG
beta blocking agents, selective	rs28404156	BST1	A	Efficacy	increased	Efficacy_Response	Other:C0020538		C07AA|S01ED	rs28404156:A
tamoxifen	rs4646	CYP19A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1458155|Disease:C0025320		L02BA01	rs4646:AA
bisphosphonates	rs2297480	FDPS	T	Efficacy	increased	Efficacy_Response	Disease:C0029456		M05BA	rs2297480:T
simvastatin	rs5882	CETP	A	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA01	rs5882:A
selective serotonin reuptake inhibitors	rs405509	APOE	TT	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB	rs405509:TT
methotrexate	rs17731538	ABCG2	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AX03	rs17731538:GG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799724	TNF	C	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390|Disease:C0235763|Disease:C0038012		No_ATC	rs1799724:C
cyclosporine	rs12917707	UMOD	GT	Efficacy	increased	Efficacy_Response	Disease:Kidney_Transplantation		L04AD01	rs12917707:GT
cyclosporine	rs12917707	UMOD	TT	Efficacy	increased	Efficacy_Response	Disease:Kidney_Transplantation		L04AD01	rs12917707:TT
modafinil	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Disease:C0027404		N06BA07	rs2032582:AC
modafinil	rs2032582	ABCB1	CT	Efficacy	increased	Efficacy_Response	Disease:C0027404		N06BA07	rs2032582:CT
modafinil	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0027404		N06BA07	rs1045642:AG
warfarin	rs4645962	MYC	CT	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs4645962:CT
warfarin	rs4645943	MYC	CT	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs4645943:CT
warfarin	rs4645943	MYC	TT	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs4645943:TT
carbamazepine	rs2234922	EPHX1	G	Dosage, Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs2234922:G
modafinil	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0027404		N06BA07	rs1128503:AG
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs361525	TNF	G	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390|Disease:C0235763|Disease:C0038012		No_ATC	rs361525:G
bisphosphonates	rs11264359	FDPS	A	Efficacy	increased	Efficacy_Response	Disease:C0029456		M05BA	rs11264359:A
warfarin	rs4645974	MYC	CC	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs4645974:CC
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800629	TNF	G	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390|Disease:C0235763|Disease:C0038012		No_ATC	rs1800629:G
atorvastatin, simvastatin	rs717620	ABCC2	T	Efficacy	decreased	Dosage	Healthy		C10AA01|C10AA05	rs717620:T
leflunomide	rs3213422	DHODH	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		No_ATC	rs3213422:CC
antipsychotics	rs1799732	DRD2	G	Efficacy	increased	Efficacy_Response	Other:C0040435|Other:C0036341		N05A	rs1799732:G
imatinib	rs1050152	SLC22A4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1050152:TT
risperidone	rs6313	HTR2A	AA	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs6313:AA
risperidone	rs6313	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs6313:AG
antipsychotics	rs7997012	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0040435|Other:C0036341		N05A	rs7997012:AG
methadone	rs3745274	CYP2B6	TT	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0028043		N07BC02	rs3745274:TT
methadone	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders		N07BC02	rs1045642:AA
methadone	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders		N07BC02	rs1045642:AG
olanzapine	rs6313	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs6313:AG
olanzapine	rs6313	HTR2A	GG	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs6313:GG
olanzapine	rs6313	HTR2A	AA	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs6313:AA
olanzapine	rs6313	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs6313:AG
carbamazepine	rs1051740	EPHX1	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs1051740:CC
efavirenz	rs3745274	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GG
carbamazepine	rs2234922	EPHX1	GG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2234922:GG
azathioprine, mercaptopurine	rs7270101	ITPA	AC	Toxicity, Metabolism/PK	increased	LADME	Disease:C0021390|Disease:C0023449		L01BB02|L04AX01	rs7270101:AC
azathioprine, mercaptopurine	rs7270101	ITPA	CC	Toxicity, Metabolism/PK	increased	LADME	Disease:C0021390|Disease:C0023449		L01BB02|L04AX01	rs7270101:CC
imatinib	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AA
imatinib	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AG
imatinib	rs1050152	SLC22A4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1050152:TT
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT
carbamazepine	rs1045642	ABCB1	AG	Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs1045642:AG
antiepileptics	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs1045642:AG
raloxifene	rs737865	COMT	AG	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0036337		G03XC01	rs737865:AG
paclitaxel	rs717620	ABCC2	CT	Toxicity	decreased	Dosage	Side_Effect:Peripheral_Nervous_System_Diseases		L01CD01	rs717620:CT
raloxifene	rs737865	COMT	AA	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0036337		G03XC01	rs737865:AA
buprenorphine	rs678849	OPRD1	CT	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs678849:CT
buprenorphine	rs678849	OPRD1	TT	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs678849:TT
methadone	rs2032582	ABCB1	AC	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs2032582:AC
ethanol	rs1799971	OPRM1	AG	Other	increased	LADME	Healthy		V03AB16	rs1799971:AG
ethanol	rs1799971	OPRM1	GG	Other	increased	LADME	Healthy		V03AB16	rs1799971:GG
antiepileptics	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs1045642:AA
risperidone	rs7627954	TNIK	CC	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs7627954:CC
raloxifene	rs4818	COMT	CG	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0036337		G03XC01	rs4818:CG
methadone	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs35599367:AG
sunitinib	rs2032582	ABCB1	AA	Dosage, Toxicity	increased	Dosage	Disease:C0007134		L01EX01	rs2032582:AA
sunitinib	rs2032582	ABCB1	AT	Dosage, Toxicity	increased	Dosage	Disease:C0007134		L01EX01	rs2032582:AT
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Other:C0024141		L04AD02	rs776746:CT
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Other:C0024141		L04AD02	rs776746:TT
adalimumab, etanercept, infliximab	rs1800629	TNF	AG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs1800629:AG
adalimumab, etanercept, infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs1800629:GG
sunitinib	rs1128503	ABCB1	AA	Dosage, Toxicity	increased	Dosage	Disease:C0007134		L01EX01	rs1128503:AA
methadone	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1045642:AA
methadone	rs1128503	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1128503:AG
methadone	rs1057868	POR	CT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1057868:CT
methadone	rs1057868	POR	TT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1057868:TT
methadone	rs2279343	CYP2B6	AA	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs2279343:AA
dolutegravir	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AJ03	rs2231142:TT
methadone	rs3745274	CYP2B6	GG	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs3745274:GG
prednisolone	rs4986791	TLR4	T	Efficacy	decreased	Efficacy_Response	Other:C0040034		S02BA03	rs4986791:T
perampanel	rs4986908	CYP3A4	CG	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AX22	rs4986908:CG
telbivudine	rs3826160	TK2	CC	Metabolism/PK	increased	LADME	Other:C0019163|Chronic		J05AF11	rs3826160:CC
telbivudine	rs3826160	TK2	CT	Metabolism/PK	increased	LADME	Other:C0019163|Chronic		J05AF11	rs3826160:CT
warfarin	rs1877724	EPHX1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs1877724:TT
nevirapine	rs3745274	CYP2B6	TT	Toxicity, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT
ethanol	rs3778150	OPRM1	CC	Dosage	increased	Dosage	Healthy		V03AB16	rs3778150:CC
ethanol	rs3778150	OPRM1	CT	Dosage	increased	Dosage	Healthy		V03AB16	rs3778150:CT
olanzapine	rs1695	GSTP1	AA	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs1695:AA
cefotaxime	rs11568482	SLC22A8	AT	Metabolism/PK	decreased	LADME	Healthy		J01DD01	rs11568482:AT
ivacaftor	rs75527207	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs75527207:A
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT
escitalopram	rs11188059	CYP2C18	G	Metabolism/PK	decreased	LADME	Healthy		N06AB10	rs11188059:G
donepezil, galantamine, rivastigmine	rs6720975	PRKCE	T	Efficacy	increased	Efficacy_Response	Other:C0002395		N06DA02|N06DA03|N06DA04	rs6720975:T
escitalopram	rs2860840	CYP2C18	T	Metabolism/PK	decreased	LADME	Healthy		N06AB10	rs2860840:T
efavirenz	rs2279345	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:TT
perampanel	rs2242480	CYP3A4	CT	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AX22	rs2242480:CT
perampanel	rs2242480	CYP3A4	TT	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AX22	rs2242480:TT
donepezil, galantamine, rivastigmine	rs17798800	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs17798800:T
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T
prednisolone	rs4986790	TLR4	G	Efficacy	decreased	Efficacy_Response	Other:C0040034		S02BA03	rs4986790:G
methadone	rs2032582	ABCB1	CC	Dosage	decreased	Dosage	Other:C0028043		N07BC02	rs2032582:CC
methadone	rs1045642	ABCB1	AA	Dosage, Metabolism/PK	increased	Dosage	Disease:C0028043		N07BC02	rs1045642:AA
sn-38(irinotecan)	rs12720066	ABCB1	AC	Metabolism/PK	decreased	LADME	Disease:C0023055		L01CE02	rs12720066:AC
sn-38(irinotecan)	rs12720066	ABCB1	CC	Metabolism/PK	decreased	LADME	Disease:C0023055		L01CE02	rs12720066:CC
antipsychotics	rs4627835	GABRB1	T	Dosage	increased	Dosage	Disease:C0036337|Disease:C0036341		N05A	rs4627835:T
antipsychotics	rs16860087	GABRB1	A	Dosage	increased	Dosage	Disease:C0036337|Disease:C0036341		N05A	rs16860087:A
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Other:a_stable_international_normalized_ratio_of_between_two_and_three		B01AA03	rs9923231:CC
sn-38(irinotecan)	rs35621	ABCC1	CT	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs35621:CT
sn-38(irinotecan)	rs35621	ABCC1	TT	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs35621:TT
carbamazepine	rs1045642	ABCB1	AA	Dosage	increased	Dosage	Other:C0014544		N03AF01	rs1045642:AA
lithium	rs11869731	ASIC2	CC	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs11869731:CC
sn-38(irinotecan)	rs6498588	ABCC1	AT	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs6498588:AT
sn-38(irinotecan)	rs6498588	ABCC1	TT	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs6498588:TT
capecitabine, fluorouracil	rs9380142	HLA-G	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06	rs9380142:GG
antidepressants	rs8136867	MAPK1	AG	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06A	rs8136867:AG
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:G
capecitabine, fluorouracil	rs17179108	HLA-G	CT	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06	rs17179108:CT
warfarin	rs9923231	VKORC1	CC	Dosage, Efficacy	increased	Dosage	Disease:C0271093		B01AA03	rs9923231:CC
donepezil, galantamine, rivastigmine	rs3793790	CHAT	G	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs3793790:G
fluvoxamine	rs4680	COMT	GG	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB08	rs4680:GG
2-hydroxyatorvastatin	rs4253728	PPARA	AA	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs4253728:AA
2-hydroxyatorvastatin	rs4253728	PPARA	AG	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs4253728:AG
lithium	rs16909440	OR52E2	TT	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs16909440:TT
lithium	rs2499984	OR52J3	GG	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs2499984:GG
antidepressants	rs889895	CREB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs889895:GG
lithium	rs16973410	__INTRONIC__	CC	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs16973410:CC
mercaptopurine	rs1142345	TPMT	C	Efficacy	Indeterminado	LADME	Disease:C0023418		L01BB02	rs1142345:C
ivacaftor	rs75527207	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs75527207:A
donepezil, galantamine, rivastigmine	rs2177370	CHAT	A	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs2177370:A
methotrexate	rs2372536	ATIC	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs2372536:GG
zidovudine	rs28365062	UGT2B7	G	Metabolism/PK	increased	LADME	Healthy		J05AF01	rs28365062:G
rosuvastatin	rs2231142	ABCG2	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs2231142:CT
cholesterol	rs429358	APOE	TT	Toxicity	increased	LADME	Other:C0023449		V09XA01	rs429358:TT
methadone	rs6275	DRD2	AA	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0028043		N07BC02	rs6275:AA
metformin	rs12943590	SLC47A2	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs12943590:AA
metformin	rs12943590	SLC47A2	AG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs12943590:AG
atenolol, carvedilol, diltiazem, metoprolol, verapamil	rs1801253	ADRB1	CG	Efficacy	increased	Efficacy_Response	Disease:C0004238		C07AB02|C07AB03|C07AG02|C08DA01|C08DB01	rs1801253:CG
atenolol, carvedilol, diltiazem, metoprolol, verapamil	rs1801253	ADRB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0004238		C07AB02|C07AB03|C07AG02|C08DA01|C08DB01	rs1801253:GG
methadone	rs1799978	DRD2	CC	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0028043		N07BC02	rs1799978:CC
metformin	rs316019	SLC22A2	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs316019:AA
metformin	rs316019	SLC22A2	AC	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs316019:AC
carbamazepine	rs1128503	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs1128503:AA
carbamazepine	rs1128503	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs1128503:AG
carbamazepine	rs2032582	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs2032582:AA
carbamazepine	rs2032582	ABCB1	AC	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs2032582:AC
erythromycin	rs717620	ABCC2	TT	Other, Metabolism/PK	increased	LADME	Healthy		S01AA17	rs717620:TT
warfarin	rs11676382	GGCX	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:CG
warfarin	rs11676382	GGCX	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:GG
carbamazepine	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs1045642:AA
carbamazepine	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs1045642:AG
abiraterone, dutasteride	rs1047303	HSD3B1	AC	Efficacy	decreased	Efficacy_Response	Other:C0033578		G04CB02|L02BX03	rs1047303:AC
azathioprine	rs2413739	PACSIN2	CT	Efficacy	decreased	Efficacy_Response	Other:C0022104		L04AX01	rs2413739:CT
azathioprine	rs2413739	PACSIN2	TT	Efficacy	decreased	Efficacy_Response	Other:C0022104		L04AX01	rs2413739:TT
rosuvastatin	rs12422149	SLCO2B1	AA	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs12422149:AA
rosuvastatin	rs12422149	SLCO2B1	AG	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs12422149:AG
gefitinib	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Healthy		L01EB01	rs776746:CC
sildenafil	rs2070744	NOS3	CC	Efficacy	increased	Efficacy_Response	Disease:C0242350		G04BE03	rs2070744:CC
sildenafil	rs2070744	NOS3	CT	Efficacy	increased	Efficacy_Response	Disease:C0242350		G04BE03	rs2070744:CT
nevirapine	rs3745274	CYP2B6	TT	Toxicity, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT
abiraterone	rs523349	SRD5A2	CC	Metabolism/PK	increased	LADME	Other:C0033578		L02BX03	rs523349:CC
gefitinib	rs1057910	CYP2C9	AC	Metabolism/PK	increased	LADME	Healthy		L01EB01	rs1057910:AC
triglycerides	rs10046	CYP19A1	A	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs10046:A
triglycerides	rs3759811	CYP19A1	C	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs3759811:C
hdl cholesterol	rs1008805	CYP19A1	G	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		No_ATC	rs1008805:G
opioids	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02A	rs1799971:AG
opioids	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02A	rs1799971:GG
triglycerides	rs2289105	CYP19A1	C	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs2289105:C
methotrexate	rs1051296	SLC19A1	AC	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs1051296:AC
methotrexate	rs1051296	SLC19A1	CC	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs1051296:CC
hdl cholesterol	rs10046	CYP19A1	G	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		No_ATC	rs10046:G
fentanyl	rs2242480	CYP3A4	T	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs2242480:T
hdl cholesterol	rs2289105	CYP19A1	T	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		No_ATC	rs2289105:T
leflunomide	rs2234693	ESR1	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2234693:TT
nevirapine	rs3745274	CYP2B6	GT	Toxicity, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:GT
leflunomide	rs9340799	ESR1	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs9340799:AA
2-hydroxyatorvastatin, 4-hydroxyatorvastatin, atorvastatin, atorvastatin lactone	rs1975991	LPP	A	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs1975991:A
ustekinumab	rs774359	C9orf72	CC	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs774359:CC
ustekinumab	rs774359	C9orf72	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs774359:CT
methotrexate	rs3758149	GGH	GG	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs3758149:GG
hdl cholesterol	rs4646	CYP19A1	A	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		No_ATC	rs4646:A
ustekinumab	rs848	IL13	AA	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs848:AA
ustekinumab	rs848	IL13	AC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs848:AC
triglycerides	rs700518	CYP19A1	C	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs700518:C
ustekinumab	rs9304742	ZNF816	CC	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs9304742:CC
ustekinumab	rs9304742	ZNF816	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs9304742:CT
triglycerides	rs4775936	CYP19A1	C	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs4775936:C
warfarin	rs11676382	GGCX	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:CG
warfarin	rs11676382	GGCX	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:GG
ustekinumab	rs7574865	STAT4	GT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs7574865:GT
ustekinumab	rs7574865	STAT4	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs7574865:TT
ustekinumab	rs1050152	SLC22A4	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs1050152:CT
nicotine	rs16969968	CHRNA5	GG	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA01	rs16969968:GG
warfarin	rs72800847	STX1B	AA	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs72800847:AA
warfarin	rs72800847	STX1B	AG	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs72800847:AG
warfarin	rs3826041	CYP1A1	CC	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs3826041:CC
varenicline	rs16969968	CHRNA5	AA	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs16969968:AA
varenicline	rs16969968	CHRNA5	AG	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs16969968:AG
warfarin	rs2304429	DNMT3A	TT	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2304429:TT
warfarin	rs10517	NQO1	AA	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs10517:AA
raloxifene	rs2234693	ESR1	TT	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0036337		G03XC01	rs2234693:TT
acenocoumarol, phenprocoumon	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA04|B01AA07	rs9934438:AA
acenocoumarol, phenprocoumon	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA04|B01AA07	rs9934438:AG
fentanyl	rs966775	DRD1	AG	Efficacy	increased	LADME	Other:C0030193|Postoperative		N02AB03	rs966775:AG
fentanyl	rs966775	DRD1	GG	Efficacy	increased	LADME	Other:C0030193|Postoperative		N02AB03	rs966775:GG
fluticasone / salmeterol	rs8191992	CHRM2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004096		R03AK06	rs8191992:A
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	increased	LADME	Other:C0024299		L04AX03	rs1801133:AA
methotrexate	rs1801133	MTHFR	AG	Metabolism/PK	increased	LADME	Other:C0024299		L04AX03	rs1801133:AG
phenprocoumon	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:TT
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs1057910:AA
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs9934438:AG
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs9934438:GG
aripiprazole, risperidone	rs2514218	DRD2	CC	Efficacy	increased	Efficacy_Response	Other:C0033975|Other:C0036337|Other:C0036341		N05AX08|N05AX12	rs2514218:CC
voriconazole	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Other:C0023418|Other:C0024299|Other:C0026986		J02AC03	rs2231142:GT
voriconazole	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Other:C0023418|Other:C0024299|Other:C0026986		J02AC03	rs2231142:TT
warfarin	rs4889606	STX1B	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs4889606:AG
warfarin	rs4889606	STX1B	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs4889606:GG
warfarin	rs887829	UGT1A1	CC	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs887829:CC
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2108622:CC
warfarin	rs2108622	CYP4F2	CT	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2108622:CT
azathioprine, mercaptopurine	rs1127354	ITPA	AA	Metabolism/PK	decreased	LADME	Disease:C0021390		L01BB02|L04AX01	rs1127354:AA
azathioprine, mercaptopurine	rs1127354	ITPA	AC	Metabolism/PK	decreased	LADME	Disease:C0021390		L01BB02|L04AX01	rs1127354:AC
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs9923231:TT
bevacizumab, fluorouracil, irinotecan, leucovorin	rs1979277	SHMT1	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs1979277:A
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800795	IL6	G	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs1800795:G
warfarin	rs1057910	CYP2C9	AC	Dosage	increased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs1057910:AC
warfarin	rs1057910	CYP2C9	CC	Dosage	increased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs1057910:CC
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs2108622:CT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs2108622:TT
platinum compounds	rs6983267	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs6983267:GG
platinum compounds	rs6983267	__INTRONIC__	GT	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs6983267:GT
fluvastatin	rs77760615	CYP2C9	G	Metabolism/PK	increased	LADME	Healthy		C10AA04	rs77760615:G
metformin	rs316009	SLC22A2	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs316009:TT
opioids	rs1799971	OPRM1	AG	Dosage, Efficacy	increased	Dosage	"""Other:C0030193|""Other:C0030193|Postoperative"""		N02A	rs1799971:AG
opioids	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	"""Other:C0030193|""Other:C0030193|Postoperative"""		N02A	rs1799971:GG
fluvastatin	rs58310495	SLCO1B1	T	Metabolism/PK	increased	LADME	Healthy		C10AA04	rs58310495:T
atorvastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Other:C0020443		C10AA05	rs4149056:C
cyclosporine	rs35599367	CYP3A4	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs35599367:AA
cyclosporine	rs35599367	CYP3A4	AG	Toxicity, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs35599367:AG
fluvastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA04	rs4149056:C
platinum compounds	rs619586	MALAT1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs619586:AG
platinum compounds	rs619586	MALAT1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs619586:GG
platinum compounds	rs7958904	HOTAIR	CC	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs7958904:CC
platinum compounds	rs7958904	HOTAIR	CG	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs7958904:CG
platinum compounds	rs2839698	H19	AA	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs2839698:AA
platinum compounds	rs2839698	H19	AG	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs2839698:AG
tacrolimus	rs35599367	CYP3A4	AG	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs35599367:AG
carbamazepine	rs1051740	EPHX1	C	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs1051740:C
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:AG
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:GG
fluticasone / salmeterol	rs6962027	CHRM2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004096		R03AK06	rs6962027:A
nicotine	rs1799971	OPRM1	AG	Other	increased	LADME	Healthy		N07BA01	rs1799971:AG
nicotine	rs1799971	OPRM1	GG	Other	increased	LADME	Healthy		N07BA01	rs1799971:GG
beta blocking agents	rs1801253	ADRB1	C	Efficacy	increased	Efficacy_Response	Other:C0878544|Dilated		S01ED	rs1801253:C
simvastatin acid	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CC
beta blocking agents	rs1042713	ADRB2	A	Efficacy	increased	Efficacy_Response	Other:C0878544|Dilated		S01ED	rs1042713:A
fluticasone / salmeterol	rs6962027	CHRM2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004096		R03AK06	rs6962027:A
carbamazepine	rs2234922	EPHX1	G	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs2234922:G
fluticasone propionate	rs1876831	CRHR1	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs1876831:T
risperidone	rs2088885	TNIK	AA	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs2088885:AA
fluticasone propionate	rs1876828	CRHR1	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs1876828:T
metformin	rs2617102	CSMD1	AC	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2617102:AC
metformin	rs2617102	CSMD1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2617102:CC
fluticasone propionate	rs1876829	CRHR1	C	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs1876829:C
fluticasone propionate	rs739645	CRHR1	G	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs739645:G
warfarin	rs9923231	VKORC1	CT	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs9923231:CT
warfarin	rs9923231	VKORC1	TT	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs9923231:TT
nevirapine	rs3745274	CYP2B6	T	Toxicity, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:T
nicotine	rs1057868	POR	CT	Metabolism/PK	increased	LADME	PK:CYP2A6_normal|but_not_reduced|metabolizers		N07BA01	rs1057868:CT
nicotine	rs1057868	POR	TT	Metabolism/PK	increased	LADME	PK:CYP2A6_normal|but_not_reduced|metabolizers		N07BA01	rs1057868:TT
carbamazepine	rs3812718	SCN1A	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs3812718:TT
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Disease:C0004238		B01AA03	rs2108622:TT
voriconazole	rs2860840	CYP2C18	T	Metabolism/PK	decreased	LADME	Other:C0023418|Other:C0024299|Other:C0026986		J02AC03	rs2860840:T
voriconazole	rs11188059	CYP2C18	G	Metabolism/PK	decreased	LADME	Other:C0023418|Other:C0024299|Other:C0026986		J02AC03	rs11188059:G
remifentanil	rs1045642	ABCB1	GG	Dosage	increased	Dosage	Healthy		N01AH06	rs1045642:GG
warfarin	rs12714145	GGCX	CT	Dosage	decreased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs12714145:CT
warfarin	rs12714145	GGCX	TT	Dosage	decreased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs12714145:TT
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Dosage	Disease:C0004238		B01AA03	rs9934438:AG
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Disease:C0004238		B01AA03	rs9934438:GG
remifentanil	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Healthy		N01AH06	rs1045642:GG
fluorouracil	rs1801159	DPYD	CC	Metabolism/PK	increased	LADME	Disease:C0023055		L01BC02	rs1801159:CC
fluorouracil	rs1801159	DPYD	CT	Metabolism/PK	increased	LADME	Disease:C0023055		L01BC02	rs1801159:CT
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Disease:C0004238		B01AA03	rs9934438:AA
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT
clopidogrel	rs71647871	CES1	CT	Metabolism/PK	increased	LADME	Healthy		B01AC04	rs71647871:CT
clopidogrel	rs71647871	CES1	TT	Metabolism/PK	increased	LADME	Healthy		B01AC04	rs71647871:TT
clopidogrel	rs71647871	CES1	CT	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs71647871:CT
clopidogrel	rs71647871	CES1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs71647871:TT
carbamazepine	rs3812718	SCN1A	TT	Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:TT
naltrexone	rs1799971	OPRM1	AA	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BB04	rs1799971:AA
aspirin	rs1371097	P2RY1	T	Efficacy	decreased	Efficacy_Response	Other:C0018839		No_ATC	rs1371097:T
gemcitabine	rs1044457	CMPK1	TT	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01BC05	rs1044457:TT
mercaptopurine	rs55713253	NUDT15	CC	Dosage	increased	Dosage	Other:C0023449		L01BB02	rs55713253:CC
cyclophosphamide, doxorubicin, paclitaxel	rs145008610	ABCC2	AA	Efficacy	decreased	Efficacy_Response	Other:C1458155		L01AA01|L01CD01|L01DB01	rs145008610:AA
deoxy-thioguanosine triphosphate, thioguanosine triphosphate	rs1142345	TPMT	CT	Metabolism/PK	increased	LADME	Other:C0021390		No_ATC	rs1142345:CT
azathioprine	rs2413739	PACSIN2	CC	Efficacy	increased	Efficacy_Response	Other:C0021390		L04AX01	rs2413739:CC
azathioprine	rs2413739	PACSIN2	CT	Efficacy	increased	Efficacy_Response	Other:C0021390		L04AX01	rs2413739:CT
clopidogrel	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Other:C0007222		B01AC04	rs1045642:AA
clopidogrel	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Other:C0007222		B01AC04	rs1045642:AG
thioridazine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Other:C0004936		N05AC02	*3/*4
thioridazine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Other:C0004936		N05AC02	*4/*4
thioridazine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Other:C0004936		N05AC02	*4/*5
thioridazine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Other:C0004936		N05AC02	*4/*6
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*4/*4
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*4/*5	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*4/*5
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*4/*9	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*4/*9
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*2/*4	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*2/*4
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*1/*4	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*1/*4
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*1/*5	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*1/*5
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*9/*9	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*9/*9
cyclosporine	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD01	rs776746:CT
clozapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Healthy		N05AH02	rs762551:AA
n-desmethylclozapine(clozapine)	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Healthy		N05AH02	rs2032582:CC
dulaglutide, liraglutide, semaglutide	rs6923761	GLP1R	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ02|A10BJ05|A10BJ06	rs6923761:GG
n-desmethylclozapine(clozapine)	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0036341		N05AH02	rs4149056:CC
n-desmethylclozapine(clozapine)	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0036341		N05AH02	rs4149056:CT
norclobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Other:C0014544	poor metabolizer	No_ATC	*2/*2
norclobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Other:C0014544	poor metabolizer	No_ATC	*2/*3
norclobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Other:C0014544	poor metabolizer	No_ATC	*3/*3
artemether, lumefantrine	rs3745274	CYP2B6	GT	Efficacy	decreased	Efficacy_Response	Other:C0024530		P01BE02|P01BF01	rs3745274:GT
4-ene valproic acid	rs2228502	CPT1A	GG	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs2228502:GG
methotrexate	rs4673991	ATIC	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs4673991:CC
methotrexate	rs4673991	ATIC	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs4673991:CT
methotrexate	rs4673993	ATIC	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs4673993:CT
methotrexate	rs4673993	ATIC	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs4673993:TT
methotrexate	rs2057638	ADA	GT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs2057638:GT
methotrexate	rs2057638	ADA	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs2057638:TT
methotrexate	rs2372536	ATIC	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs2372536:CC
methotrexate	rs2372536	ATIC	CG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs2372536:CG
methotrexate	rs6017375	ADA	CG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs6017375:CG
methotrexate	rs6017375	ADA	GG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs6017375:GG
methotrexate	rs371927	ADA	AA	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs371927:AA
codeine, hydrocodone, oxycodone, tramadol	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0030193	poor metabolizer	N02AA05|N02AX02|R05DA03|R05DA04	__UNKNOWN__
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Other:C0027051	poor metabolizer	B01AC04	*2/*2
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Other:C0027051	poor metabolizer	B01AC04	*2/*3
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Other:C0027051	poor metabolizer	B01AC04	*3/*3
zuclopenthixol	normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	normal metabolizer and ultrarapid metabolizer	N05AF05	__UNKNOWN__
sitagliptin	rs6923761	GLP1R	GG	Efficacy	increased	Efficacy_Response	Other:C0020538|Other:C0011849		A10BH01	rs6923761:GG
salbutamol	rs1042717	ADRB2	AA	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs1042717:AA
salbutamol	rs1042714	ADRB2	GG	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs1042714:GG
zuclopenthixol	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0004936	intermediate metabolizer and poor metabolizer	N05AF05	__UNKNOWN__
perphenazine	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0004936	intermediate metabolizer and poor metabolizer	N05AB03	__UNKNOWN__
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs7754840	CDKAL1	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		No_ATC	rs7754840:CC
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs7756992	CDKAL1	GG	Efficacy	increased	Efficacy_Response	Disease:C0011849		No_ATC	rs7756992:GG
sitagliptin, vildagliptin	rs6923761	GLP1R	AA	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BH01|A10BH02	rs6923761:AA
hydroxyurea	rs7943316	CAT	AT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs7943316:AT
hydroxyurea	rs7943316	CAT	TT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs7943316:TT
nortriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*1/*4
nortriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*2/*4
nortriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*5	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*2/*5
nortriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*4/*41
nortriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*4/*10
antidepressants, antipsychotics	CYP2C19*17	CYP2C19	*17	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0004936|Other:C0029132|Other:C0031212		N05A|N06A	*17
antidepressants, antipsychotics	CYP2D6*3	CYP2D6	*3	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0004936|Other:C0029132|Other:C0031212		N05A|N06A	*3
antidepressants, antipsychotics	CYP1A2*30	CYP1A2	*30	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0004936|Other:C0029132|Other:C0031212		N05A|N06A	*30
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Dosage	increased	Dosage	Other:Liver_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:Liver_transplantation		L04AD02	*1/*3
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Dosage	increased	Dosage	Other:Liver_transplantation		L04AD02	*1/*6
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Dosage	increased	Dosage	Other:Liver_transplantation		L04AD02	*1/*7
tacrolimus	rs35599367	CYP3A4	AG	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	rs35599367:AG
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*3
tacrolimus	rs2740574	CYP3A4	CC	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	rs2740574:CC
tacrolimus	rs2740574	CYP3A4	CT	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	rs2740574:CT
antidepressants	rs2292334	SLC22A3	AG	Dosage	increased	Dosage	Other:C0235876		N06A	rs2292334:AG
antidepressants	rs2292334	SLC22A3	GG	Dosage	increased	Dosage	Other:C0235876		N06A	rs2292334:GG
hydroxyurea	rs2298720	SLC14A1	AA	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs2298720:AA
hydroxyurea	rs2298720	SLC14A1	AG	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs2298720:AG
cisplatin, gemcitabine, pemetrexed	rs11549465	HIF1A	CT	Efficacy	decreased	Efficacy_Response	Other:C0025500		L01BA04|L01BC05|L01XA01	rs11549465:CT
"""1,7-dimethylxanthine"", ""caffeine"""	rs4410790	AHR	C	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs4410790:C
silodosin	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Other:C1704272		G04CA04	rs35599367:AG
silodosin	rs7439366	UGT2B7	CT	Metabolism/PK	increased	LADME	Healthy		G04CA04	rs7439366:CT
silodosin	rs7439366	UGT2B7	TT	Metabolism/PK	increased	LADME	Healthy		G04CA04	rs7439366:TT
endoxifen	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C1458155	intermediate metabolizer	No_ATC	__UNKNOWN__
mercaptopurine	rs60561071	GNAQ	T	Dosage	decreased	Dosage	Other:C0023449		L01BB02	rs60561071:T
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	*3/*3
hydroxyurea	rs3892097	CYP2D6	CT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs3892097:CT
hydroxyurea	rs3892097	CYP2D6	TT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs3892097:TT
hydroxyurea	rs1001179	CAT	CT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs1001179:CT
hydroxyurea	rs1001179	CAT	TT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs1001179:TT
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	increased	Efficacy_Response	Other:C0027697		L04AD02	*3/*3
"""1,7-dimethylxanthine"", ""caffeine"""	rs2472297	CYP1A1	T	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs2472297:T
"""1,7-dimethylxanthine"", ""caffeine"""	rs56113850	CYP2A6	C	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs56113850:C
empagliflozin	rs1860561	ATP2A2	GG	Efficacy	increased	Efficacy_Response	Other:C0085605		A10BK03	rs1860561:GG
hydroxychloroquine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Other:C0024138		P01BA02	*1/*10
hydroxychloroquine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Other:C0024138		P01BA02	*10/*10
letrozole	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*1/*9	Efficacy	increased	Efficacy_Response	Other:C1458155	intermediate metabolizer and poor metabolizer	L02BG04	*1/*9
letrozole	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*1/*4	Efficacy	increased	Efficacy_Response	Other:C1458155	intermediate metabolizer and poor metabolizer	L02BG04	*1/*4
letrozole	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*4/*4	Efficacy	increased	Efficacy_Response	Other:C1458155	intermediate metabolizer and poor metabolizer	L02BG04	*4/*4
letrozole	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*4/*9	Efficacy	increased	Efficacy_Response	Other:C1458155	intermediate metabolizer and poor metabolizer	L02BG04	*4/*9
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	*1/*1
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	*1/*3
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*1	Efficacy	increased	Efficacy_Response	Other:C0018839|Other:C0007787		B01AC04	*1/*1
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Efficacy_Response	Other:C0018839|Other:C0007787		B01AC04	*1/*17
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	increased	Efficacy_Response	Other:C0018839|Other:C0007787		B01AC04	*17/*17
clozapine, n-desmethylclozapine	rs2472297	CYP1A1	CT	Metabolism/PK	decreased	LADME	Healthy		N05AH02	rs2472297:CT
clozapine, n-desmethylclozapine	rs2472297	CYP1A1	TT	Metabolism/PK	decreased	LADME	Healthy		N05AH02	rs2472297:TT
mepolizumab	rs1042713	ADRB2	G	Efficacy	increased	Efficacy_Response	Other:C0004096		R03DX09	rs1042713:G
immunosuppressants	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0002874		L04A	
corticosteroids, montelukast	rs11572080	CYP2C8	CC	Efficacy	increased	Efficacy_Response	Other:C0004096		R03DC03|S02BA	rs11572080:CC
loratadine	CYP2D6*1, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Other:C0004096|Other:C0035455	intermediate metabolizer	R06AX13	*10/*41
loratadine	CYP2D6*1, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Other:C0004096|Other:C0035455	intermediate metabolizer	R06AX13	*10/*10
empagliflozin	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Other:C0085605		A10BK03	rs6265:CC
